Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,response to copper ion (GO:0046688),0.9126307401900672,2.4027567016262794,0.0,0.0,0.0,8/20,0.12%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,zinc ion homeostasis (GO:0055069),0.8248641214333137,2.355145013209707,0.0,0.0,0.0,8/28,0.12%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,cellular response to copper ion (GO:0071280),0.9307809268178889,2.3330207861670895,0.0,0.0,0.0,8/16,0.12%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,response to cadmium ion (GO:0046686),0.8329212518435398,2.320065498792216,0.0,0.0,0.0,9/26,0.82%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;MAPK3
prerank,cellular zinc ion homeostasis (GO:0006882),0.8283589719583867,2.316359459374666,0.0,0.0,0.0,8/26,0.12%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,response to zinc ion (GO:0010043),0.8396666777392251,2.3056897315376013,0.0,0.0,0.0,8/25,0.12%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,cellular response to cadmium ion (GO:0071276),0.8355053954292562,2.2681920331132615,0.0,0.00012974989920467998,0.001,9/24,0.82%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;MAPK3
prerank,cellular response to zinc ion (GO:0071294),0.9135961224846202,2.2500450938259227,0.0,0.00011353116180409496,0.001,8/15,0.12%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E
prerank,cellular potassium ion homeostasis (GO:0030007),-0.8347945827994389,-2.133117408607696,0.0,0.010196374622356496,0.009,8/13,9.45%,ATP1A2;KCNMA1;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.7524938142652184,-2.071138569013897,0.0,0.02209214501510574,0.036,9/17,10.49%,ATP1A2;CACNA1C;ATP1B1;ATP1A1;GJC1;GJD3;ATP1B2;PRKACA;GJA1
prerank,regulation of NMDA receptor activity (GO:2000310),-0.6252431043181231,-2.0322016143017745,0.0,0.032854984894259816,0.077,19/32,22.14%,DLG2;LRRC7;GRIA4;GRIA2;GRIN2B;DLG4;RELN;SLC6A9;NLGN1;DLG3;ACTN2;EPHB2;DLG1;NEFL;OPRM1;DAPK1;CAPN1;CAMK2B;GRIN1
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7829641777796507,-2.026657286662568,0.0,0.026340634441087613,0.082,6/14,9.72%,ANK2;ATP1B1;ATP1B3;AKAP9;ATP1B2;ACTN2
prerank,digestive tract development (GO:0048565),-0.6028748189865024,-1.969225899404746,0.0,0.05845921450151058,0.198,12/32,10.03%,FGFR2;CLMP;PKD1;GLI2;GLI3;RARB;PCSK5;KIT;SMO;COBL;NIPBL;SALL1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.5375387616194381,-1.9615092550434894,0.0,0.05324773413897281,0.216,32/57,24.92%,DLG2;DLGAP1;LRRC7;GRIA4;GRIA2;GRIN2B;DLGAP2;SHISA9;DLG4;DLGAP4;NLGN2;RELN;SHISA6;AKAP9;NLGN1;DLG3;ACTN2;CACNG7;DLG1;NEFL;CACNG4;OPRM1;CACNG2;DAPK1;SHANK1;PRRT1;CAPN1;CAMK2B;GRIN1;CACNG3;CACNG8;CAMK2A
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6600780028439223,-1.9482736515792278,0.0,0.05810315062580924,0.272,15/20,28.21%,IGF1;LRP1;PDGFRB;IGFBP5;NRP1;SORL1;VTN;S100A11;ACE;BMPR1A;PDGFA;NDRG4;SERPINE1;CCN4;TRIB1
prerank,mesonephric tubule development (GO:0072164),-0.7304918058618238,-1.947704013800107,0.0023148148148148147,0.05126510574018127,0.274,8/15,10.03%,ROBO2;FGFR2;PKD1;BMP7;BMP4;OSR1;FOXC1;SALL1
prerank,chondrocyte differentiation (GO:0002062),-0.6155440588628778,-1.9325786228313322,0.0,0.05891238670694865,0.335,20/32,29.06%,SULF1;NFIB;WNT5B;SOX5;SULF2;BMP4;OSR1;SLC39A14;CREB3L2;GPLD1;CCN3;TGFB1;BMPR1B;SOX6;BMPR2;EIF2AK3;SNX19;RUNX2;BMP2;HMGA2
prerank,regulation of cytoplasmic translation (GO:2000765),-0.7345676867246334,-1.928595465197397,0.0,0.05800604229607251,0.359,6/14,13.82%,CPEB4;CPEB1;CPEB2;YBX3;PKM;UNK
prerank,extracellular structure organization (GO:0043062),-0.4187492773094234,-1.9103944873270717,0.0,0.06952073606152157,0.441,60/204,11.44%,LAMA2;COL1A2;FBN1;COL4A5;ADAMTS12;ADAMTSL3;ITGA9;ADAMTS2;THSD4;SMOC1;ADAM12;COL1A1;TNR;COL4A6;COL8A1;ITGB8;COL11A1;COL3A1;COL22A1;MMP16;TGFBR1;COL5A1;COL4A3;ADAMTS6;ADAMTSL5;COL5A2;COL4A4;LAMC3;LOXL1;NID2;ADAMTS17;JAM3;FBN2;VCAN;MMP14;ADAMTS9;ATP7A;ITGB5;ADAMTS5;COL6A1;DDR1;ADAM19;ITGA5;COL8A2;HSPG2;MFAP5;SH3PXD2A;ADAMTSL4;COL6A2;ADAMTS1;COL13A1;COL15A1;SPARC;SMOC2;THBS1;CDH1;VTN;FN1;ITGA11;ADAMTS3
prerank,cellular transition metal ion homeostasis (GO:0046916),0.5484272290106964,1.9079041657933047,0.0,0.09718267450430532,0.556,22/91,12.00%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;CAND1;HMOX2;SOD1;ABCG2;FBXL5;ATP6V0D1;ISCU;ARF1;GLRX3;ATP6AP1;APP;SLC39A10;ACO1;PRNP
prerank,ureteric bud development (GO:0001657),-0.6872277252676012,-1.8926566024779603,0.004739336492890996,0.08251510574018127,0.517,8/17,10.03%,ROBO2;FGFR2;BMP7;BMP4;OSR1;GPC3;FOXC1;SALL1
prerank,synaptic membrane adhesion (GO:0099560),-0.7272291042503496,-1.8911510506649425,0.0,0.0779979084359749,0.525,7/14,11.29%,LRRC4C;LRFN5;GPC6;NTNG1;PTPRS;PTPRF;LRRC4
prerank,membrane repolarization (GO:0086009),-0.7141583100699859,-1.8886683942753326,0.0,0.07493526111350884,0.532,6/15,9.45%,ATP1A2;ATP1B1;ATP1B3;ATP1A1;KCNJ2;ATP1B2
prerank,regulation of cellular localization (GO:0060341),-0.5457370489188442,-1.880285811446921,0.0,0.07870090634441088,0.571,20/46,21.02%,MAP2;ADCY5;GSN;EFNA5;DYNC1H1;PARD6G;FER;LRP5;CSNK1E;CDK16;DVL3;BRSK1;CAMK2D;STXBP4;KDM1A;TTL;DVL1;PARP1;PINK1;PPM1F
prerank,external encapsulating structure organization (GO:0045229),-0.4117910433220406,-1.8775744101932972,0.0,0.07618957703927492,0.581,59/205,11.44%,LAMA2;COL1A2;FBN1;COL4A5;ADAMTS12;ADAMTSL3;ITGA9;ADAMTS2;THSD4;SMOC1;ADAM12;COL1A1;TNR;COL4A6;COL8A1;ITGB8;COL11A1;COL3A1;COL22A1;MMP16;COL5A1;COL4A3;ADAMTS6;ADAMTSL5;COL5A2;COL4A4;LAMC3;LOXL1;NID2;ADAMTS17;JAM3;FBN2;VCAN;MMP14;ADAMTS9;ATP7A;ITGB5;ADAMTS5;COL6A1;DDR1;ADAM19;ITGA5;COL8A2;HSPG2;MFAP5;SH3PXD2A;ADAMTSL4;COL6A2;ADAMTS1;COL13A1;COL15A1;SPARC;SMOC2;THBS1;CDH1;VTN;FN1;ITGA11;ADAMTS3
prerank,cardiac muscle cell action potential (GO:0086001),-0.5953185700193174,-1.874317332264964,0.005291005291005291,0.07417362715478941,0.593,9/30,8.74%,ANK2;ATP1A2;FGF12;CACNA1C;CACNA1D;ATP1B1;ATP1A1;KCNJ2;SCN1A
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6534118721153043,-1.8634598455869336,0.0,0.08194864048338368,0.653,13/21,26.80%,BMP6;DAB2;TGFBR1;SMAD4;BMP4;NUP93;CCN3;WWTR1;TGFB1;BMPR1A;TGFB3;SLC2A10;SH2B1
prerank,positive regulation of chemotaxis (GO:0050921),-0.5403207372452242,-1.8602720707531777,0.0024875621890547263,0.08121322944824297,0.667,19/43,22.43%,NTRK3;PDGFRB;NRP1;DSCAM;IL6R;P2RX4;F3;STX3;SMOC2;THBS1;LGMN;TGFB1;SEMA5A;MET;HSPB1;PPM1F;PRKD1;P2RY12;VEGFA
prerank,eye morphogenesis (GO:0048592),-0.6727805206116497,-1.8572925162461804,0.002304147465437788,0.08049471299093655,0.682,10/19,8.00%,TENM3;FBN1;COL5A1;COL5A2;EFEMP1;FBN2;NKD1;SKI;MFAP5;NIPBL
prerank,cardiac muscle cell contraction (GO:0086003),-0.6772817266473261,-1.8474317868185495,0.0,0.08901596892533448,0.719,9/19,12.92%,FGF12;CACNA1C;CACNA1D;GSN;ATP1A1;KCNJ2;SCN1A;CAMK2D;CACNA1G
prerank,regulation of potassium ion transport (GO:0043266),-0.5881098912151339,-1.8400299636538282,0.0,0.09429071683603406,0.751,11/31,12.89%,ANK2;DPP6;ANK3;KCNIP4;CACNA1D;FHL1;KCNIP1;KCNIP3;ACTN2;DPP10;DLG1
prerank,outflow tract septum morphogenesis (GO:0003148),-0.62169561130318,-1.8381457373137566,0.0,0.09309733350847235,0.766,11/24,9.55%,ROBO2;FGFR2;ROBO1;PARVA;NRP1;TGFBR2;SMAD4;BMP4;SMAD6;ACVR1;NRP2
prerank,receptor clustering (GO:0043113),-0.5927104510203177,-1.8344158094811898,0.0,0.09393882175226587,0.784,10/27,12.89%,MAGI2;DLG2;LRRC7;NRXN1;DLG4;FLNA;NLGN1;DLG3;NRXN2;DLG1
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7716274238879628,-1.8321383302400258,0.002136752136752137,0.09290030211480363,0.793,6/11,16.33%,DDX5;EGFR;BMP4;MAP2K2;TP53;TGFB1
prerank,embryonic digestive tract development (GO:0048566),-0.6600104205126486,-1.8255394445993607,0.002325581395348837,0.09725772716709273,0.824,8/18,10.03%,FGFR2;GLI2;GLI3;RARB;PCSK5;PDGFRA;NIPBL;SALL1
prerank,negative regulation of growth (GO:0045926),0.5028844075863419,1.8245383607378565,0.0,0.3195221017814449,0.931,18/121,5.58%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;CCDC85B;PTPRJ;FRZB;ST7L;RERG;PPT1;ING4;PPP2CA;SMARCA2;CDKN1A
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5065359997993601,1.8146177768861906,0.0,0.33415317223357993,0.957,54/110,19.89%,NCBP1;RPL30;RPL17;RPL23;SMG8;RPL31;RPL3;RPS21;PPP2CA;SMG1;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;RPL4;PYM1;RPLP0;UPF2;RPS28;RPS24;RPS9;RPL24;RPS23;RPL34;RPS3;RPS11;RPL23A;RPS15A;RPL21;RPL35;DCP1A;UPF3B;RPL19;SMG6;RPL38;RPSA;RPL36;RPL26;RPS8;SMG5;RPL15;RPL10;RPS2;RPL32;EIF4G1;RPL27A;EIF3E;SMG7;RPL14;RPL39;RPL7
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7824396760252946,1.8086042834492342,0.0035971223021582736,0.3317380547915656,0.963,6/11,14.60%,TNFAIP3;TIRAP;PJA2;LYN;MFHAS1;CYBA
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.6311171516927438,-1.8075807203871104,0.002398081534772182,0.11795065458207452,0.896,5/21,8.15%,ANK2;CACNA1D;SNTA1;FLNA;AKAP9
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7671673616728479,-1.8068505934065298,0.0,0.11446644367716875,0.896,5/11,9.01%,DAB2;WNT5B;NKD1;CSNK1E;RSPO3
prerank,collagen fibril organization (GO:0030199),-0.4582210068364429,-1.8062189532109638,0.0,0.11165225544327534,0.898,43/88,23.42%,COL1A2;COL4A5;ADAMTS2;COL1A1;COL4A6;COL8A1;COL11A1;COL3A1;PLOD2;COL25A1;COL22A1;TGFBR1;COL5A1;COL4A3;PLEC;COL5A2;COL4A4;LOXL1;COL12A1;ATP7A;COL6A1;COL8A2;P4HB;COL6A2;COL13A1;PLOD1;COL15A1;ADAMTS3;LOXL3;COL23A1;ITGB4;COL6A3;COL5A3;P4HA2;COL20A1;COL14A1;COL16A1;P3H1;LUM;LOX;CRTAP;COL26A1;COL18A1
prerank,regulation of cation transmembrane transport (GO:1904062),-0.5772892156214344,-1.8052658684982068,0.002421307506053269,0.10940332326283989,0.9,11/29,13.02%,DPP6;FGF12;KCNIP4;CACNA1D;SNTA1;KCNIP1;WNK1;KCNIP3;DPP10;DLG1;WNK3
prerank,cytoplasmic translation (GO:0002181),0.5097512012953858,1.7963414652706897,0.0014619883040935672,0.3603653738987827,0.979,45/91,19.89%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;RPL4;EIF2B3;RPLP0;RPS28;RPS24;RPS9;RPL24;RPS23;RPL34;DRG2;RPS3;RPS11;RPL23A;RPS15A;RPL21;RPL35;EIF3M;RPL19;RPL38;RPSA;RPL36;RPL26;RPS8;RPL15;RPL10;RPS2;RPL32;RPL27A;FTSJ1;RPL14;RPL39;RPL7
prerank,respiratory tube development (GO:0030323),-0.562440108063143,-1.7864376224992655,0.007772020725388601,0.132187408634636,0.945,12/28,23.57%,FGFR2;GLI2;PCSK5;FGF1;PDPN;BMP4;RBP4;LOXL3;CCDC39;BAG6;VEGFA;STRA6
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5235751015612429,-1.7846065478027557,0.0028089887640449437,0.13007458459214502,0.95,19/43,24.73%,FOXP1;IGF1;PDGFRB;IGFBP5;IL6R;BMP4;ADAMTS1;THBS1;GJA1;IL18;JUN;RBPMS2;DNMT1;BMPR1A;STAT1;CX3CL1;MMP2;MEF2D;AKT1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.5731573574399734,-1.7819107124611493,0.002544529262086514,0.13066465256797585,0.953,11/30,12.92%,ANK2;FGF12;CACNA1C;CACNA1D;SNTA1;ATP1A1;KCNJ2;GJC1;SCN1A;GJA1;CACNA1G
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5090281875895247,1.7640789586959615,0.0,0.4914277432377255,0.995,43/87,19.89%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;RPL4;RPLP0;RPS28;RPS24;RPS9;RPL24;RPS23;RPL34;RPS3;RPS11;SEC61A2;RPL23A;RPS15A;SRP9;RPL21;RPL35;RPL19;RPL38;RPSA;RPL36;RPL26;RPS8;RPL15;RPL10;RPS2;RPL32;RPL27A;RPL14;RPL39;RPL7
prerank,aorta development (GO:0035904),-0.6949082010401674,-1.757608928336239,0.002207505518763797,0.16897325395414964,0.974,6/14,5.60%,ROBO2;LRP1;ROBO1;PDGFRB;HECTD1;ADAMTS9
prerank,cartilage development (GO:0051216),-0.5026409554144278,-1.7565500105586453,0.0,0.16667026327147172,0.977,17/49,17.52%,SULF1;NFIB;PKD1;ITGB8;WNT5B;SOX5;SULF2;BMP4;OSR1;ATP7A;SLC39A14;CREB3L2;DDRGK1;GPLD1;CCN3;TGFB1;SOX6
prerank,response to cholesterol (GO:0070723),-0.632807695835501,-1.7536028551292888,0.0,0.16814577039274925,0.979,10/17,19.37%,GRAMD1B;TGFBR1;TGFBR2;SMO;GRAMD1C;GRAMD1A;LRP6;GPLD1;TGFB1;OSBPL7
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.7357490101666864,1.751500503164565,0.003937007874015748,0.5322946364905594,0.998,8/13,14.57%,SAE1;UBA1;UBA2;DESI2;DESI1;NAE1;ATG7;UBA6
prerank,lung development (GO:0030324),-0.534243635832327,-1.7503919432658597,0.008130081300813009,0.17015391524454967,0.983,14/33,23.57%,FGFR2;PKD1;GLI2;ERRFI1;FGF1;PDPN;BMP4;RBP4;LOXL3;RCN3;CCDC39;BAG6;VEGFA;STRA6
prerank,peptide biosynthetic process (GO:0043043),0.4675951165821827,1.7468839876272975,0.0,0.5254789824102536,0.998,62/153,19.89%,PCSK1;RPL30;MRPS33;RSL24D1;EEF1A1;MRPL24;MRPL23;RPL17;RPL23;RPL31;RPL3;RPS21;MRPL18;RPL35A;RPS14;YARS2;RPL8;RPL5;ABCF1;MRPS12;RPS12;HBS1L;RPS26;HARS1;RPL37A;RPL4;RPLP0;RPS28;RPS24;RPS9;RPL24;RPS23;RPL34;DMD;MRPL52;RPS3;RPS11;MRPS15;DHPS;RPL23A;RPS15A;RPL21;RPL35;HARS2;WARS1;RPL19;RPL38;RPSA;RPL36;RPL26;RPS8;RPL15;RPL10;RPS2;RPL32;EIF4G1;MRPL13;RPL27A;FURIN;RPL14;RPL39;RPL7
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.4888925241773192,-1.7417203220558606,0.0,0.1836241850850692,0.987,29/50,30.71%,FGFR2;ZIC1;GLI3;TULP3;GLIS2;IFT81;MGRN1;SMO;DCDC2;GPC3;VCP;BTRC;GAS1;WDR11;RACK1;INTU;RORA;EVC;HERC4;KCTD6;GLI1;PTCH1;SFRP1;SUFU;DLG5;TTC23;PDCL;FUZ;FBXL17
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.7469606673558322,-1.7400750797073985,0.008602150537634409,0.18240181268882177,0.988,4/10,8.15%,DLGAP1;DLGAP2;DLGAP4;AKAP9
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6636468328633693,-1.7397136397379482,0.0022172949002217295,0.17832326283987918,0.988,6/16,14.09%,IGF1;IGFBP2;IGFBP5;BMP5;IGFBP6;IGFBP4
prerank,bone morphogenesis (GO:0060349),-0.6954312019895842,-1.7387372418856595,0.006507592190889371,0.17588055412276177,0.988,8/14,20.00%,FGFR2;SKI;LRP5;CYP26B1;LRP6;BMPR1B;SFRP4;BMPR2
prerank,positive regulation of bone mineralization (GO:0030501),-0.5273844339868877,-1.7377867027458433,0.002380952380952381,0.1734192921881744,0.99,18/35,21.80%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;OSR1;WNT4;ACVR1;KL;ANO6;TGFB1;BMPR1B;BMPR1A;BMPR2;CCN1;PKDCC
prerank,melanocyte differentiation (GO:0030318),-0.7343432790560898,-1.7366484471691495,0.0021598272138228943,0.17141502142907328,0.991,4/11,5.81%,LRMDA;KIT;USP13;ENPP1
prerank,actin filament polymerization (GO:0030041),-0.5459965869454063,-1.7352833568454469,0.004761904761904762,0.1704030486130184,0.994,10/29,7.21%,GSN;GAS7;SPIRE1;WASL;PSTPIP2;ARHGAP6;WASHC5;WASHC3;COBL;WASF1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.7043500405841157,-1.7334575985479652,0.004357298474945534,0.16961228600201408,0.994,10/13,26.80%,BMP6;DAB2;TGFBR1;SMAD4;BMP4;NUP93;TGFB1;BMPR1A;TGFB3;SH2B1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.4545124220990084,1.726803371999958,0.0,0.6201739888103222,1.0,79/168,20.04%,NCBP1;RPL30;PATL2;RPL17;RPL23;SMG8;RPL31;RPL3;RPS21;ZFP36L1;PPP2CA;CNOT11;SMG1;RPL35A;RPS14;RPL8;RPL5;CNOT2;RPS12;RPS26;RPL37A;RPL4;PYM1;CNOT7;EXOSC9;RPLP0;UPF2;XRN2;DXO;PATL1;RPS28;RPS24;RPS9;RPL24;RPS23;PAN3;RPL34;RPS3;RPS11;TUT7;CNOT6;PAN2;RPL23A;RPS15A;RPL21;RPL35;CNOT1;DCP1A;CNOT6L;TUT4;NBDY;UPF3B;PARN;CNOT10;LSM1;RPL19;SMG6;RPL38;RPSA;RPL36;RPL26;RPS8;SMG5;RPL15;RPL10;RPS2;RPL32;RC3H1;EIF4G1;DIS3L2;RPL27A;EIF3E;DCP1B;SMG7;EXOSC7;RPL14;RPL39;RPL7;AGO1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.49782118914766765,-1.726420315511617,0.0,0.17981577564691975,0.996,16/44,14.26%,ANK2;KCNMA1;AKAP6;ATP1B1;WNK1;FLNA;ATP1B3;GABBR2;AKAP9;KCNJ2;ATP1B2;ACTN2;WNK4;KCNJ6;WNK3;ANO6
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.48788643750330457,1.7261644940540468,0.0,0.5584777108872597,1.0,31/104,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TAB2;SRC;NRAS;RPS6KA5;PSMD11;PSMB4;FYN;PSMC1;EP300;PAK3;SYK;TAB3;RELA;LYN;PSMC2;PAK1;PSMD2;CREBBP;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,cellular response to lectin (GO:1990858),0.48788643750330457,1.7261644940540468,0.0,0.5584777108872597,1.0,31/104,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TAB2;SRC;NRAS;RPS6KA5;PSMD11;PSMB4;FYN;PSMC1;EP300;PAK3;SYK;TAB3;RELA;LYN;PSMC2;PAK1;PSMD2;CREBBP;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,protein targeting to ER (GO:0045047),0.48894373119098605,1.7245779063759825,0.001440922190201729,0.5398179681461109,1.0,46/99,19.89%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;SGTB;RPL8;RPL5;SPCS3;RPS12;RPS26;RPL37A;RPL4;RPLP0;RPS28;RPS24;RPS9;RPL24;RPS23;RPL34;RPS3;SEC62;RPS11;RPL23A;RPS15A;SPCS2;SRP9;RPL21;RPL35;RPL19;RPL38;RPSA;RPL36;RPL26;RPS8;RPL15;RPL10;RPS2;RPL32;RPL27A;RPL14;RPL39;RPL7
prerank,translation (GO:0006412),0.4431872982817963,1.7245539683995506,0.0,0.5142421005145483,1.0,80/208,19.89%,RPL30;MRPS2;MRPS33;RSL24D1;EEF1A1;MRPL24;MRPL23;RPL17;RPL23;FASTKD2;RPL31;RPL3;EEF1D;RPS21;MRPL18;FARS2;GARS1;RPL35A;RPS14;YARS2;RPL8;IARS1;RPL5;LARS2;ABCF1;MRPS12;RPS12;HBS1L;RPS26;HARS1;RPL37A;RARS2;RPL4;RPLP0;RPS28;TSFM;RPS24;RPS9;RPL24;RPS23;GTPBP2;WARS2;RPL34;DRG2;MRPL52;RPS3;RPS11;MRPS15;MRPS24;LARS1;DHPS;EEF1B2;RPL23A;RPS15A;RPL21;RPL35;GATB;MRPS28;HARS2;WARS1;MRPS34;RPL19;IARS2;RPL38;RPSA;RPL36;RPL26;GFM2;RPS8;RPL15;RPL10;RPS2;RPL32;EIF4G1;MRPL13;RPL27A;FTSJ1;RPL14;RPL39;RPL7
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.48731286435912674,1.7220782494166773,0.0,0.5033765294099383,1.0,31/105,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TAB2;SRC;NRAS;RPS6KA5;PSMD11;PSMB4;FYN;PSMC1;EP300;PAK3;SYK;TAB3;RELA;LYN;PSMC2;PAK1;PSMD2;CREBBP;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,positive regulation of telomerase activity (GO:0051973),0.5824000995751941,1.7201386173228281,0.0016722408026755853,0.492152650283282,1.0,13/33,17.61%,MAP2K7;MAPK3;PNKP;GREM1;CCT2;MAP3K4;ACD;NEK7;TNKS;TCP1;DKC1;PARN;PARM1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.6015956690500461,-1.7200432247141884,0.004672897196261682,0.1890547663431253,0.997,8/20,9.45%,ATP1A2;KCNMA1;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2
prerank,odontogenesis (GO:0042476),-0.5233098347498604,-1.7179358717199547,0.005063291139240506,0.18967145015105738,0.997,8/35,8.19%,FGFR2;COL1A2;EDA;GLI2;HDAC1;BMP4;OSR1;FOXC1
prerank,regulation of muscle contraction (GO:0006937),-0.5577149017578907,-1.7177154325247048,0.0069124423963133645,0.18607805660028362,0.997,7/26,12.06%,ATP1A2;KCNB2;CHRM2;PLCE1;TPM1;KCNA1;SRI
prerank,establishment of endothelial barrier (GO:0061028),0.6007218054736778,1.7165703921714885,0.006688963210702341,0.4907573687585013,1.0,12/29,12.39%,PDE4D;MARVELD2;PECAM1;PPP1R16B;ICAM1;RAPGEF3;F11R;RAPGEF6;TJP1;RAB1A;ROBO4;RAP2C
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.511407527305042,-1.7148238325034608,0.0026041666666666665,0.18817975830815709,0.998,9/38,12.92%,ANK2;CTNNA3;CACNA1C;CACNA1D;AKAP9;KCNJ2;BIN1;CAMK2D;CACNA1G
prerank,positive regulation of kinase activity (GO:0033674),-0.4224892506995688,-1.712839853722976,0.0,0.18775546472365381,0.998,28/107,10.73%,ERBB4;NTRK3;FGFR2;PRKAG2;EGFR;LMO4;EPHA6;IQGAP1;PDGFRB;EPHB1;NTRK2;RASSF2;AXL;RYK;MAPT;PRKAG1;EPHA7;KIT;ROR1;RELN;DDR1;PDGFRA;EPHB4;RAD50;VAC14;MRE11;EPHA3;EPHB2
prerank,neurotransmitter uptake (GO:0001504),-0.6987283413918278,-1.71254666470729,0.008298755186721992,0.18464588659075065,0.998,4/12,5.87%,ATP1A2;SNAP25;SLC1A3;GLUL
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.6487932914796732,1.7123667860157998,0.006944444444444444,0.49347000665120705,1.0,3/19,6.46%,SLC5A7;APOE;RIC3
prerank,positive regulation of telomere capping (GO:1904355),0.6667768936227704,1.711565376545463,0.009487666034155597,0.478682310831235,1.0,6/17,11.75%,MAP2K7;MAPK3;PNKP;MAP3K4;NEK7;TNKS
prerank,endodermal cell differentiation (GO:0035987),-0.5355216523366952,-1.7105240315498331,0.0,0.18545858747078608,0.999,18/31,31.06%,COL8A1;COL11A1;COL12A1;MMP14;ITGB5;COL6A1;ITGA5;CDC73;VTN;FN1;PAF1;ITGA4;LAMB1;MMP2;RTF1;INHBA;HMGA2;MMP15
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.7638234067042489,1.7099336811341306,0.005639097744360902,0.4688248302410879,1.0,1/11,0.20%,RTP3
prerank,respiratory system development (GO:0060541),-0.5246220273147826,-1.7033628294438998,0.013020833333333334,0.1957871769050017,1.0,13/32,24.71%,FGFR2;GLI2;FGF1;PDPN;BMP4;RBP4;LOXL3;SMCHD1;CCDC39;BAG6;VEGFA;STRA6;BASP1
prerank,regulation of hippo signaling (GO:0035330),-0.6229416248670361,-1.7006252489096116,0.0041841004184100415,0.19797445756660256,1.0,9/17,16.62%,WWC2;MAPK14;MOB3B;SCHIP1;CIT;VGLL4;LIMD1;NF2;SHANK2
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.6558806474010841,1.6996033245127316,0.012152777777777778,0.5048244203306086,1.0,6/18,6.74%,LRP8;RPS6KA4;CAMK1D;PRKD2;RPS6KA5;EPHA5
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.5007049609511165,1.6992092204337408,0.0,0.48920186134619686,1.0,27/74,14.25%,PSMB10;PSMC4;PSMB6;ELOC;PSMD8;PSMD5;PSMD12;STOX1;PSMD11;PSMB4;PSMC1;EP300;NOTCH1;PSMC2;PSMD2;CITED2;RBPJ;CREBBP;HIGD1A;ELOB;EGLN2;PSMD14;PSMC6;EPAS1;PSMD1;PSMB1;BACH1
prerank,regulation of cation channel activity (GO:2001257),-0.42984659418195054,-1.698253907267864,0.003257328990228013,0.19957784851100563,1.0,35/89,22.14%,DLG2;ANK2;ANK3;LRRC7;FGF12;GRIA4;GRIA2;AHNAK;CACNB4;GRIN2B;FGF14;SHISA9;DLG4;NLGN2;RELN;SHISA6;NLGN1;DLG3;PRKACA;ACTN2;CAMK2D;CACNG7;DLG1;VAMP2;NEFL;CACNG4;OPRM1;CACNG2;SELENON;DAPK1;SHANK1;PRRT1;CAPN1;CAMK2B;GRIN1
prerank,positive regulation of immune effector process (GO:0002699),0.602352689134442,1.6949138195430964,0.00847457627118644,0.49481421560696764,1.0,3/27,2.02%,PCK1;PTPRJ;PTPRC
prerank,regulation of B cell activation (GO:0050864),0.6153172012166253,1.6928600237113733,0.008710801393728223,0.4886674187691613,1.0,4/25,5.41%,TNFAIP3;FCGR2B;ZFP36L1;SAMSN1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.475125426374728,1.6906534494410494,0.0,0.48335892138093434,1.0,16/107,8.40%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;CXCL12;ATP2A2;SLC10A7;NPTN;HTR2A;ATP13A4;TRPV4;TMEM165
prerank,extracellular matrix organization (GO:0030198),-0.3630509908730177,-1.689264968742068,0.0,0.21569406900938143,1.0,104/276,22.11%,LAMA2;COL1A2;FBN1;COL4A5;ADAMTS12;ADAMTSL3;ITGA9;ADAMTS2;THSD4;GSN;SMOC1;ADAM12;COL1A1;TNR;GPM6B;COL4A6;TIMP2;COL8A1;ITGB8;COL11A1;CAPN2;COL3A1;PLOD2;COL25A1;COL22A1;MMP16;FLRT2;TGFBR1;COL5A1;COL4A3;PLEC;ADAMTS6;ADAMTSL5;COL5A2;COL4A4;LAMC3;LOXL1;NID2;ADAMTS17;JAM3;FBN2;VCAN;COL12A1;MMP14;ADAMTS9;ATP7A;ITGB5;ADAMTS5;COL6A1;DDR1;ADAM19;ITGA5;COL8A2;HSPG2;MFAP5;SH3PXD2A;P4HB;ADAMTSL4;COL6A2;ADAMTS1;COL13A1;PLOD1;COL15A1;SPARC;SMOC2;THBS1;CDH1;VTN;FN1;ITGA11;ADAMTS3;LOXL3;SCUBE1;SLC39A8;ITGA8;SPP1;COL23A1;ITGB4;ADAMTS10;QSOX1;TGFB1;VIT;COL6A3;COL5A3;ITGA4;P4HA2;LAMB1;LAMA1;COL20A1;ADAMTS16;TGFBI;ADAMTS15;COL14A1;PDGFA;FLOT1;ADAMTS20;ITGA1;COL16A1;MMP2;P3H1;LUM;LOX;CAPN1;CRTAP
prerank,negative regulation of protein catabolic process (GO:0042177),-0.48614155228078904,-1.6885214290054602,0.0053475935828877,0.21373320137514323,1.0,13/40,9.21%,SNRNP70;EGFR;TIMP3;TIMP2;NELL1;FLNA;SIRT2;FMN2;ROCK1;PTPN3;IRAK3;BANP;AZIN1
prerank,cotranslational protein targeting to membrane (GO:0006613),0.48278455698529527,1.6856428333261355,0.0,0.49326193499466425,1.0,43/91,19.89%,RPL30;RPL17;RPL23;RPL31;RPL3;RPS21;RPL35A;RPS14;RPL8;RPL5;RPS12;RPS26;RPL37A;RPL4;RPLP0;RPS28;RPS24;RPS9;RPL24;RPS23;RPL34;RPS3;SEC62;RPS11;RPL23A;RPS15A;SRP9;RPL21;RPL35;RPL19;RPL38;RPSA;RPL36;RPL26;RPS8;RPL15;RPL10;RPS2;RPL32;RPL27A;RPL14;RPL39;RPL7
prerank,regulation of kinase activity (GO:0043549),-0.429963645904476,-1.6853243107571148,0.0,0.2172346254288494,1.0,27/89,10.73%,ERBB4;NTRK3;FGFR2;EGFR;LMO4;EPHA6;PDGFRB;EPHB1;NTRK2;AXL;RYK;MAPT;RBL2;PLCE1;EPHA7;KIT;ROR1;DDR1;LDB1;PDGFRA;EPHB4;RAD50;VAC14;CDKN1B;MRE11;EPHA3;EPHB2
prerank,neuron projection morphogenesis (GO:0048812),-0.3951298851215952,-1.6821787620658288,0.0036363636363636364,0.21995845921450152,1.0,38/137,10.96%,MAP2;FGFR2;CNTN4;ALCAM;DCLK1;ANK3;DCC;MAP1B;CTNNA2;EPB41L3;IQGAP1;NRCAM;GAS7;EPHB1;NBL1;NTNG1;SDC2;WASL;DLG4;RYK;CTNNB1;BMP7;GPM6A;ATP7A;DCDC2;MYO16;SHTN1;CTNND2;TAOK3;ROCK1;CTTN;DOCK10;NLGN1;SGK1;BRSK1;BTBD3;EPHB2;PLPPR4
prerank,positive regulation of cell projection organization (GO:0031346),-0.40748157307109806,-1.6799779688742782,0.0,0.22097716804516862,1.0,44/115,18.67%,MAGI2;NTRK3;ROBO2;TENM3;LRRC7;PLXNA2;ROBO1;CUX1;DPYSL3;NTRK2;TIAM2;DLG4;TOX;PTK7;RHOA;ROR1;RELN;CBFA2T2;PLPPR5;STMN2;ARSB;ATP1B2;DVL3;EPHA3;CUX2;RIT2;GRIP1;IL1RAPL1;OBSL1;PLXND1;CAMK1;ARHGDIA;SETX;PLXNB2;NGF;RAPGEF2;PLXNC1;ABL2;FZD4;ROR2;TWF2;DVL1;SCARF1;SNX3
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.48601822620341995,-1.679693041586072,0.00477326968973747,0.21807085079426958,1.0,19/40,21.80%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;OSR1;WNT4;ACVR1;KL;ANO6;TGFB1;BMPR1B;BMPR1A;BMPR2;CCN1;CEBPB;PKDCC
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.6463028790348901,-1.6782236106046555,0.01327433628318584,0.21784635304272762,1.0,6/14,8.56%,KMT2A;AUTS2;CTNNB1;SMAD4;PAXIP1;SNW1
prerank,modified amino acid transport (GO:0072337),-0.6414523471424836,-1.6748079882935056,0.0020964360587002098,0.22145251132930516,1.0,7/15,17.24%,SLC16A12;SLC6A13;PDPN;SLC25A32;CTNS;SLC19A1;SLC5A6
prerank,regulation of synapse assembly (GO:0051963),-0.4844046824551832,-1.673350319424063,0.007772020725388601,0.22127004415524051,1.0,15/46,11.94%,ROBO2;LRFN5;GPC6;PDLIM5;NRXN1;GRID2;EPHB1;NLGN2;IL1RAPL2;SYNDIG1;CLSTN2;NLGN1;EPHB2;CUX2;IL1RAPL1
prerank,heart development (GO:0007507),-0.3889947513229171,-1.6693631196312633,0.0,0.22653460587750618,1.0,41/150,14.67%,ERBB4;NTRK3;TGFBR3;FGF12;CACNA1C;FBN1;AKAP13;PDLIM5;PKD1;MICAL2;GLI2;ADAP2;COL3A1;PCSK5;CXADR;FLRT2;NCOA6;TGFBR1;TGFBR2;BMP5;BMP7;PLCE1;BMP4;PDLIM7;OSR1;GPC3;EPHB4;RBP4;CDKN1B;NIPBL;FOXC1;ACVR1;SALL1;FN1;FOXC2;MTHFD1;SCUBE1;WDR11;PDLIM1;TCF25;PTK2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.64073021266627,-1.6663228137763615,0.006369426751592357,0.22998489425981872,1.0,5/16,1.32%,ERBB4;FGFR2;TGFBR3;IGF1;AKAP6
prerank,potassium ion transport (GO:0006813),-0.39881640675709595,-1.6648972014761572,0.0,0.22971832237426693,1.0,23/120,12.51%,ATP1A2;KCNK2;SLC24A3;KCNQ3;KCNB2;HCN1;NALCN;KCNH7;KCNQ5;KCNMA1;SLC1A3;KCNC2;KCND2;ATP1B3;KCNH5;KCNK5;KCNJ2;KCNA1;SLC24A2;KCNK10;KCNJ6;SLC9A2;ABCC9
prerank,mesenchyme development (GO:0060485),-0.621557817591093,-1.6648308288500844,0.011013215859030838,0.2265696834362275,1.0,4/15,4.63%,FGFR2;TGFBR1;BMP7;BMP4
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.55612914382136,-1.6644367641112285,0.009950248756218905,0.22398036253776435,1.0,12/26,13.97%,ANK2;CACNA1D;ATP1B1;FHL1;ATP1B3;WWP2;CAB39;AKAP9;ATP1B2;ACTN2;DLG1;VAMP2
prerank,cellular sodium ion homeostasis (GO:0006883),-0.6261384962354535,-1.663629430753656,0.015184381778741865,0.2225490404663631,1.0,6/15,9.45%,ATP1A2;ATP1B1;ATP1B3;SLC12A2;ATP1A1;ATP1B2
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.75058799523138,1.663093811255056,0.009671179883945842,0.5998452325437537,1.0,2/10,6.25%,SAG;GNB1
prerank,glutamate metabolic process (GO:0006536),0.634227030334272,1.6615148410257146,0.009057971014492754,0.5919968901112729,1.0,7/19,6.26%,GCLC;ALDH5A1;GLS2;GLS;GOT2;GCLM;MTHFS
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.6182916421613337,-1.6614345031456033,0.004750593824228029,0.22441465256797583,1.0,4/17,1.32%,ANK2;ATP1A2;CACNA1C;CACNA1D
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5408402446313119,-1.6585173259489,0.007177033492822967,0.22813806232669784,1.0,9/27,11.90%,DDX5;EGFR;PUM1;BMP4;PUM2;EIF4E2;MAP2K2;TP53;LIMD1
prerank,regulation of telomerase activity (GO:0051972),0.5302614053385613,1.6573278683167738,0.007911392405063292,0.5994697634726891,1.0,17/45,17.61%,MAP2K7;CERS1;MAPK3;PNKP;GREM1;SRC;CCT2;ERCC4;MAP3K4;ACD;NEK7;TNKS;TCP1;DKC1;PARN;SMG6;PARM1
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6481579972079433,1.6551953728380269,0.014598540145985401,0.5951487606357369,1.0,8/18,12.23%,HRH4;GNAQ;RGS8;GNB1;RGS10;GNA11;PLCB1;AGRN
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4757845393754373,1.6507681945675021,0.001430615164520744,0.6026473081533581,1.0,28/86,14.62%,ATF3;PSMB10;PSMC4;PSMB6;ELOC;PSMD8;PSMD5;PSMD12;KLF2;STOX1;PSMD11;PSMB4;PSMC1;EP300;PSMC2;PSMD2;CREBBP;HIGD1A;ELOB;EGLN2;PSMD14;DDIT3;PSMC6;EPAS1;PSMD1;PSMB1;BACH1;INO80
prerank,negative regulation of transferase activity (GO:0051348),0.5845464267226707,1.6485362176612448,0.015202702702702704,0.6003527836200543,1.0,9/28,9.70%,PHPT1;CERS1;GSK3A;SRC;ERCC4;FBXO5;SMAD7;IRS2;PARK7
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6284181464731473,-1.6463231453446971,0.013245033112582781,0.2535314770964318,1.0,7/15,15.29%,COL11A1;ADGRV1;KIT;PIEZO2;SCN1A;KCNA1;WHRN
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.6231920104753726,1.6438291037983626,0.012589928057553957,0.6136359295511334,1.0,4/22,2.28%,PHPT1;PTPRJ;SH2D1A;FCGR2B
prerank,positive regulation of histone methylation (GO:0031062),-0.5500490782628111,-1.6405218704738198,0.016706443914081145,0.26444108761329305,1.0,14/24,22.10%,OGT;KMT2A;AUTS2;CTNNB1;SMAD4;JARID2;TET1;PAXIP1;SNW1;MTF2;PAF1;DNMT1;RIF1;PHF1
prerank,cAMP biosynthetic process (GO:0006171),-0.7056951315142548,-1.6396131008868515,0.01171875,0.26336162346955,1.0,8/10,22.36%,ADCY5;ADCY2;ADCY1;ADCY9;ADCY7;ADCY3;ADCY8;ADCY4
prerank,peptidyl-methionine modification (GO:0018206),0.6978005695717794,1.6395856729071157,0.020618556701030927,0.6225273578573028,1.0,4/12,16.22%,NAA25;METAP2;METAP1;NAA15
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.5104669623775763,-1.638738176742878,0.014251781472684086,0.2620159296896457,1.0,6/30,12.41%,LPAR1;ROBO1;AKAP13;COL3A1;PRAG1;GPR4
prerank,regulation of intracellular pH (GO:0051453),0.5505576923043053,1.6356405449420843,0.011456628477905073,0.63045476023554,1.0,9/34,8.40%,SLC4A4;SLC4A5;SLC9A7;CA2;GPR89A;GPR89B;SLC9A6;SLC9A8;TMEM165
prerank,regulation of cell communication (GO:0010646),-0.4976600083959441,-1.6345906376677144,0.013227513227513227,0.2689693237276319,1.0,16/35,25.34%,ANK2;CXADR;IGFBP7;SCG5;GRK5;GRK3;SOCS2;CAMK2D;SRI;ANXA1;MTCH1;GRK4;TBX18;GRK2;TSPYL2;GLRX2
prerank,regulation of protein metabolic process (GO:0051246),0.52282150991716,1.6322068877732325,0.0076103500761035,0.6355632853367847,1.0,18/44,16.55%,KLF2;SPOP;MAP2K5;LTBP4;NEDD4L;APOE;WFS1;TMEM9;MAPK8;TRAF3;MDM2;SPOPL;APP;CHEK2;FAF1;VPS35;ODC1;FKBP1A
prerank,myotube cell development (GO:0014904),-0.7043153897472394,-1.6304467207742956,0.018518518518518517,0.27518738766300815,1.0,5/10,18.70%,IGF1;SKI;CAV2;SIX1;SELENON
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.4516675642476193,1.6257122565938578,0.0,0.6580678978753725,1.0,33/109,13.85%,PSMB10;PSMC4;MAP2K7;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;MAP3K7;VAV3;TAB2;PPP3CB;PSMD11;PSMB4;PSMC1;MAPK8;SYK;LCP2;TAB3;PLCG1;RELA;LYN;PSMC2;PAK1;PSMD2;PPP3CA;PPP3R1;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,retina homeostasis (GO:0001895),0.584783450391384,1.6256467023590735,0.028070175438596492,0.6438478331645564,1.0,5/23,5.39%,SOD1;POC1B;POTEF;ACTB;B2M
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.5537545172492245,-1.6255345404499353,0.008791208791208791,0.2842522658610272,1.0,7/22,7.50%,MAGI2;NTRK3;NTRK2;SH3GL2;MAPT;WASF1;STMN2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.3705411428942591,-1.6251021357340876,0.0,0.28191786953116255,1.0,36/159,12.50%,LRRC4C;TENM2;ROBO2;LRFN5;CNTN4;ALCAM;TENM3;SDK1;GPC6;ROBO1;CDH10;UNC5D;CNTN6;GRID2;KIRREL3;PKD1;NTNG1;CXADR;PTPRS;TGFBR2;DSCAM;CLDN11;IGSF11;PALLD;SDK2;CDH11;NLGN1;CDH7;MPZL2;ACVR1;CDH1;PTPRF;LRRC4;IL1RAPL1;CDH4;OBSL1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.5124616322025778,-1.6246051712039007,0.010443864229765013,0.27958514479404617,1.0,8/29,10.49%,PKD1;IFNAR2;FER;STAT2;GHR;IL31RA;STAT6;SOCS2
prerank,ribosome assembly (GO:0042255),0.522061067791079,1.6227281410758005,0.009630818619582664,0.6461009056896349,1.0,15/47,13.61%,MRPS2;MTERF3;RSL24D1;EIF2A;RPL3;RPS14;RPL5;MRPL20;RPLP0;RPS28;RRP7A;DDX3X;RPL24;EFL1;RPL23A
prerank,nuclear migration (GO:0007097),-0.6398775713414829,-1.620671358313872,0.014830508474576272,0.2863038255742001,1.0,6/13,5.86%,SYNE2;CLMN;DYNC1H1;SYNE3;FBXW11;CEP120
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.5985395110930911,-1.6205533888243842,0.03111111111111111,0.28319216659473456,1.0,7/17,10.21%,IGF1;DOCK5;PDGFRB;IGFBP5;NRP1;ADAMTS1;VTN
prerank,connective tissue development (GO:0061448),-0.49588890473518804,-1.6187294033272497,0.00980392156862745,0.28480540252354714,1.0,11/35,13.83%,SULF1;PKD1;ITGB8;SOX5;SULF2;ATP7A;CREB3L2;SLC39A13;LRP5;DDRGK1;PGRMC2
prerank,chordate embryonic development (GO:0043009),-0.4458898757141516,-1.611443278444907,0.009202453987730062,0.3009906555188646,1.0,12/55,4.65%,FGFR2;SULF1;ARNT2;ALDH1A2;COL1A1;PKD1;PCSK5;TGFBR1;BMP5;BMP7;SULF2;FUT8
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6642009274227283,1.608669927794453,0.02862595419847328,0.7152173326861888,1.0,6/13,16.31%,PTPRC;PTPRT;MGAT5;DOT1L;HES1;PIGU
prerank,Fc receptor signaling pathway (GO:0038093),0.44581083345947603,1.6059489357740706,0.0,0.7171006616752653,1.0,33/110,13.85%,PSMB10;PSMC4;MAP2K7;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;MAP3K7;VAV3;TAB2;PPP3CB;PSMD11;PSMB4;PSMC1;MAPK8;SYK;LCP2;TAB3;PLCG1;RELA;LYN;PSMC2;PAK1;PSMD2;PPP3CA;PPP3R1;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,central nervous system neuron differentiation (GO:0021953),-0.5058397685873934,-1.6053123234168514,0.010230179028132993,0.31419939577039274,1.0,9/33,5.68%,MAP2;GRID2;SPOCK1;NTRK2;TOX;RYK;MAPT;CTNNB1;ATP7A
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.7111400339999929,1.6024528070878792,0.03206412825651302,0.7241712588610918,1.0,2/10,2.28%,PTPRC;FCGR2B
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.5472497350380894,-1.600223048303976,0.02040816326530612,0.32475195687997804,1.0,12/22,26.21%,KAT7;ERCC6;ELL;DDX39B;CDC73;BRD4;CCNT1;THOC5;CCNK;CDK12;THOC1;SUPT4H1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),-0.45287752723387115,-1.5996450028857914,0.012084592145015106,0.3227833599239621,1.0,17/54,12.89%,DPP6;KCNIP4;KCNMA1;AKAP6;CACNA1D;FHL1;KCNIP1;FLNA;KCNIP3;WWP2;CAB39;GABBR2;KCNJ2;BIN1;DPP10;KCNJ6;DLG1
prerank,renal system development (GO:0072001),-0.44672055076680733,-1.5990351866800345,0.013513513513513514,0.3210347432024169,1.0,25/52,24.74%,SULF1;GREB1L;PKD1;GLI2;PCSK5;TGFBR1;SULF2;BMP4;WNT4;RBP4;FOXC1;PYGO1;SALL1;ITGA8;ACE;SIX1;PYGO2;AGTR1;TBX18;STAT1;BAG6;VEGFA;STRA6;PAX2;IFT88
prerank,regulation of biosynthetic process (GO:0009889),0.7004902093500959,1.5966019087864474,0.02895752895752896,0.7456000107857412,1.0,2/11,7.39%,PCK1;PIKFYVE
prerank,"phototransduction, visible light (GO:0007603)",0.6618359050890278,1.5956333422956108,0.026871401151631478,0.7366614130237473,1.0,4/14,8.98%,SAG;GNAQ;GNB1;GNA11
prerank,membrane assembly (GO:0071709),-0.49275678742096907,-1.5942796226246845,0.007518796992481203,0.32986952624414856,1.0,12/34,11.94%,ANK3;NRXN1;ANXA2;NLGN2;UBXN2A;FLOT2;NLGN1;UBXN2B;TLCD2;NSFL1C;NRXN2;IL1RAPL1
prerank,muscle contraction (GO:0006936),-0.37860605927685564,-1.5933994772200273,0.0,0.3290547418888743,1.0,20/126,9.72%,SORBS1;CALD1;GNAO1;PABPN1;SNTA1;TMOD2;VIM;TPM1;TLN1;PXN;ROCK2;VCL;ITGB5;EDNRA;ROCK1;GLRA1;GJC1;SMTN;MYOF;ACTN2
prerank,T cell proliferation (GO:0042098),0.6594072735641703,1.592989856941576,0.03571428571428571,0.7378128210659355,1.0,3/13,2.57%,CADM1;PIK3CG;PPP3CB
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.7229671655486399,1.5905585027702507,0.0419047619047619,0.7388008222940592,1.0,4/10,4.55%,INSIG1;DERL2;SVIP;YOD1
prerank,actin polymerization or depolymerization (GO:0008154),-0.4381263714261289,-1.5889900102233676,0.002544529262086514,0.3384904005457558,1.0,14/50,7.21%,SVIL;GSN;MICAL2;GAS7;SPIRE1;WASL;ABI1;MICAL3;PSTPIP2;ARHGAP6;WASHC5;WASHC3;COBL;WASF1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.4528092251205301,1.5885269332324288,0.004392386530014641,0.7382048431972932,1.0,31/94,14.19%,PSMB10;PSMC4;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;IL1R1;MAP3K7;TAB2;RPS6KA4;RPS6KA5;PSMD11;PSMB4;PSMC1;TAB3;RELA;PSMC2;PLCB1;PSMD2;UBE2V1;NOD1;TNIP2;IKBKB;CHUK;PSMD14;PSMC6;NFKBIA;PSMD1;PSMB1;MAP3K3
prerank,metanephros development (GO:0001656),-0.5135856615542373,-1.5885182907381745,0.037914691943127965,0.33643215272867516,1.0,7/26,8.00%,ROBO2;PKD1;FOXD1;BMP7;BMP4;OSR1;NIPBL
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.5595035359622047,-1.5877260957120771,0.029545454545454545,0.3350969947527429,1.0,6/19,12.89%,DLG2;LRRC7;PARD3B;CLIC4;DLG3;DLG1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.5693849967802681,-1.5871750269493956,0.027659574468085105,0.3329635574018127,1.0,6/19,7.69%,ERBB4;FGFR2;TGFBR3;TGFBR1;VGLL4;RBP4
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.6403503450174606,-1.5868802049653679,0.02268041237113402,0.33036020182514714,1.0,9/12,28.41%,UST;DSE;VCAN;CSPG4;DSEL;BGN;CSPG5;CHST12;DCN
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6438231981489024,-1.583742129111447,0.01680672268907563,0.3360988655280844,1.0,9/12,22.80%,KHDRBS1;PTPN14;BMP4;RBM4;SIRT7;TGFB1;AAAS;NEDD4;NUP214
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.7059133475585204,1.5826927783396176,0.02626641651031895,0.7606505272756687,1.0,6/10,10.58%,DIP2A;DIP2B;SIRT1;SETD5;PARK7;PRKAA2
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6412476153351473,-1.581545180296126,0.025477707006369428,0.33904376087155547,1.0,7/12,13.02%,ANK3;ATP1B1;WNK1;ATP1B3;ATP1B2;WNK4;WNK3
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.5246545690766187,-1.581464066277986,0.023148148148148147,0.33594788519637464,1.0,13/25,26.21%,LDB1;ELL;CDC73;RNF168;RNF8;NELFB;BRD4;WDR43;EAF1;NELFA;CDK12;LARP7;SUPT4H1
prerank,camera-type eye development (GO:0043010),-0.5269295709458902,-1.5797313148048895,0.0196078431372549,0.3370636534952589,1.0,6/25,6.79%,TENM3;CACNA1C;FBN1;EFEMP1;FBN2;SKI
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.5263042218467573,-1.578340430522343,0.012376237623762377,0.33764661453705347,1.0,5/25,6.57%,CTNNA3;PARVA;CXADR;JAM3;ITGA5
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5204757900772299,-1.5775408688131942,0.01366742596810934,0.33634837063326783,1.0,12/25,14.13%,ANK2;ANK3;ATP1B1;WNK1;ATP1B3;SLC6A9;AKAP9;ATP1B2;ACTN2;WNK4;WNK3;NDUFA4
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.44814007075941004,-1.5751228186645627,0.016216216216216217,0.3398573669532884,1.0,19/46,28.21%,FOXP1;IGF1;PDGFRB;IGFBP5;CTNNB1;IL6R;BMP4;OGN;THBS1;IL18;RBPMS2;TCF7L2;STAT1;APOD;CX3CL1;AKT1;NDRG4;CCN4;TRIB1
prerank,acyl-CoA biosynthetic process (GO:0071616),0.6326332136951454,1.574451509240397,0.02181818181818182,0.7995513163740392,1.0,5/16,5.45%,SLC25A1;DIP2A;MLYCD;PPT1;ACAT1
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.5520365393488589,-1.5724835529017414,0.029339853300733496,0.34421665947345703,1.0,8/20,17.79%,B4GALT1;FUT8;ST6GALNAC5;B3GALT5;ST3GAL4;B3GALT1;ST6GALNAC6;MPDU1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.5395117023390221,-1.5704587253282003,0.01904761904761905,0.3465484808755629,1.0,4/23,5.60%,FGFR2;TGFBR3;TPM1;ADAMTS9
prerank,protein import into mitochondrial matrix (GO:0030150),0.6067864040990065,1.5701372958049662,0.024179620034542316,0.8129787237062078,1.0,6/18,9.85%,TOMM20;ROMO1;TIMM17B;GRPEL2;TOMM40L;TIMM21
prerank,regulation of phospholipase C activity (GO:1900274),-0.5940839306667911,-1.5666015875311445,0.01927710843373494,0.354744896518621,1.0,5/15,6.59%,NTRK3;BICD1;PDGFRB;KIT;PDGFRA
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.6247111226831216,1.5663826912200505,0.026881720430107527,0.8236098558739828,1.0,3/17,2.19%,PHPT1;PTPRJ;SH2D1A
prerank,cellular response to metal ion (GO:0071248),0.42462874697170583,1.5660108014196246,0.005509641873278237,0.8121903860046171,1.0,11/123,1.84%,MT1B;MT1X;MT1A;MT1H;MT1G;MT1M;MT1F;MT1E;CPNE5;MAPK3;SLC25A24
prerank,regulation of bone mineralization (GO:0030500),-0.43080162117643056,-1.5645947719727593,0.008595988538681949,0.35688360187982543,1.0,24/55,22.17%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;OSR1;ENPP1;WNT4;ANKH;ACVR1;KL;ECM1;ANO6;TGFB1;BMPR1B;BCOR;BMPR1A;BMPR2;TXLNG;CCN1;PKDCC;NOTUM
prerank,potassium ion transmembrane transport (GO:0071805),-0.37172296510062947,-1.5645909801265356,0.0037313432835820895,0.35360944039468944,1.0,36/135,19.92%,ATP1A2;KCNK2;SLC24A3;KCNQ3;KCNB2;HCN1;NALCN;KCNH7;KCNQ5;SLC1A3;KCNC2;KCND2;ATP1B1;ATP1B3;SLC12A2;KCNH5;ATP1A1;KCNK5;KCNJ2;KCNA1;SLC24A2;ATP1B2;KCNK10;KCNJ6;SLC9A2;ABCC9;SLC12A6;KCNJ13;KCNS3;KCNQ4;SLC12A4;ATP1A3;KCNJ10;SLC12A9;KCNA2;KCNA6
prerank,positive regulation of tissue remodeling (GO:0034105),-0.6709300160317517,-1.5643562455793,0.022448979591836733,0.3511260642680582,1.0,4/10,17.91%,ROCK2;ROCK1;IL18;TMBIM1
prerank,sulfation (GO:0051923),-0.6652187099322895,-1.564315973650867,0.03368421052631579,0.34809545194741565,1.0,2/11,1.14%,UST;HS3ST5
prerank,glutathione biosynthetic process (GO:0006750),0.6845311844834168,1.5619013149834506,0.04127579737335835,0.8254018212922517,1.0,5/11,13.08%,GCLC;GCLM;CNDP2;HAGH;GSS
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.5766339815921646,-1.5618194990410752,0.03090507726269316,0.35218965796288304,1.0,5/16,11.26%,ANK2;ATP1A2;CACNA1C;PRKACA;CAMK2D
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.5799216563114932,-1.5604380021067037,0.023758099352051837,0.35279255674678506,1.0,6/17,7.54%,ATP1A2;TFPI;BMP7;BMP4;MED1;ATP1A1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6707674674472726,1.5594299737968602,0.05223880597014925,0.8283382458553727,1.0,6/12,15.48%,GCLC;GCLM;CNDP2;HAGH;GSS;BDH2
prerank,T cell activation involved in immune response (GO:0002286),0.6662201719008627,1.558082716157521,0.046464646464646465,0.8235184247714843,1.0,2/12,6.45%,LCP1;ICAM1
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.5380140803111864,-1.5547823470573088,0.03110047846889952,0.36577754809985685,1.0,6/22,5.90%,FGFR2;NOTCH2;MED1;KLF9;SRSF6;EPB41L4B
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.5869103305191996,1.5533971375406816,0.0338409475465313,0.8412839297876779,1.0,7/20,8.25%,BBS12;CCT2;NDUFAF1;PFDN6;LONP1;PSMG1;TMEM35A
prerank,positive regulation of ossification (GO:0045778),-0.4617481771300236,-1.552855055085565,0.015189873417721518,0.3683206357546302,1.0,18/39,21.80%,BMP6;GPM6B;NELL1;BMP7;ADGRV1;BMP4;FBN2;OSR1;WNT4;ACVR1;KL;ANO6;TGFB1;BMPR1B;BMPR1A;BMPR2;CCN1;PKDCC
prerank,neural tube development (GO:0021915),-0.5919013569647315,-1.5503917050339926,0.03177966101694915,0.37219697364308785,1.0,6/15,17.40%,ALDH1A2;PKD1;ARL13B;DACT1;TGFB1;DVL1
prerank,histone H2B ubiquitination (GO:0033523),-0.6556202820516298,-1.5503331221556862,0.029411764705882353,0.36917073359671554,1.0,7/10,21.21%,WAC;UBE2E1;CDC73;RNF8;PAF1;RNF40;DTX3L
prerank,ganglion development (GO:0061548),-0.6447143358616968,-1.5503324483425767,0.03909465020576132,0.36604216805776024,1.0,5/11,9.55%,NRP1;CTNNB1;UNC5C;SEMA3A;NRP2
prerank,heme catabolic process (GO:0042167),0.6378462747051985,1.550164732214799,0.03825136612021858,0.8348487783765247,1.0,2/14,2.52%,HMOX2;ABCG2
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.6378462747051985,1.550164732214799,0.03825136612021858,0.8348487783765247,1.0,2/14,2.52%,HMOX2;ABCG2
prerank,regulation of smooth muscle contraction (GO:0006940),-0.5441967271762633,-1.5488449936169852,0.024498886414253896,0.3672884561679657,1.0,6/20,9.82%,KCNB2;CHRM2;PLCE1;CTTN;CHRM3;ZDHHC21
prerank,axonal fasciculation (GO:0007413),-0.6371049000388164,-1.5453134669859334,0.022271714922048998,0.37509441087613293,1.0,5/12,18.57%,CNTN4;NRCAM;EPHA3;EPHB2;SEMA5A
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.52330045039316,-1.545195762019742,0.03184713375796178,0.37226598586801835,1.0,14/23,27.31%,GLI3;TULP3;GLIS2;MGRN1;ENPP1;GPC3;VCP;BTRC;RACK1;HERC4;KCTD6;PTCH1;GPR161;SUFU
prerank,regulation of lipid catabolic process (GO:0050994),0.6017568974614674,1.5441373070044722,0.035653650254668934,0.8619285804166891,1.0,1/19,0.14%,CIDEA
prerank,endoderm formation (GO:0001706),-0.4669946341659541,-1.5426313493575263,0.007075471698113208,0.37701513050368973,1.0,13/35,22.38%,COL8A1;COL11A1;COL12A1;MMP14;ITGB5;COL6A1;ITGA5;VTN;FN1;ITGA4;LAMB1;MMP2;DUSP1
prerank,T cell receptor signaling pathway (GO:0050852),0.4188194606132775,1.5412549068485202,0.004043126684636119,0.8684896648719945,1.0,35/138,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PTPRJ;PDE4D;PTPRC;MAP3K7;TAB2;PRKD2;PSMD11;PSMB4;FYN;PSMC1;PAK3;LCP2;SPPL3;PRAM1;PLCG1;EIF2B3;RELA;RBCK1;INPP5D;PSMC2;PAK1;PSMD2;PIK3CD;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5870619945182804,1.5406100822653037,0.04655172413793104,0.8602189346859922,1.0,7/20,10.58%,MAPK3;DIP2A;RUVBL2;RPS6KA4;RPS6KA5;DIP2B;PRKAA2
prerank,regulation of cell cycle phase transition (GO:1901987),0.4363172474740805,1.5400670012095314,0.010279001468428781,0.8510822410165065,1.0,25/91,13.85%,PSMB10;ERCC3;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ANAPC2;NEK11;PSMD11;PSMB4;PSMC1;CDKN1A;FBXO5;ANAPC7;PSMC2;PSMD2;TFAP4;ANAPC11;ANAPC10;ANAPC4;PSMD14;PSMC6;PSMD1;PSMB1
prerank,pre-replicative complex assembly (GO:0036388),0.46264049705969984,1.5394064866162587,0.007751937984496124,0.8432964948908972,1.0,18/64,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ORC3;PSMD11;PSMB4;PSMC1;ORC4;PSMC2;PSMD2;ORC2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.5010583934626354,-1.5380619977983978,0.03132530120481928,0.3873609166605261,1.0,4/25,8.47%,ANK2;AKAP6;CEMIP;TRPC1
prerank,cellular response to drug (GO:0035690),0.5553409309435664,1.5359864686698852,0.03130434782608696,0.8532042702927012,1.0,4/25,2.14%,CERS1;RBM22;RAP2A;ACER2
prerank,central nervous system neuron development (GO:0021954),-0.5945097087086654,-1.5358826187364547,0.03296703296703297,0.3907331156807329,1.0,6/15,15.76%,MAP2;NTRK2;MAPT;ATP7A;B4GALT6;RAPGEF2
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.38130933901542147,1.5354554798921194,0.002336448598130841,0.8448610624254737,1.0,74/306,14.44%,POLR2J;RPL30;MRPS33;NR4A2;RSL24D1;EEF1A1;POLR2B;MRPL24;MRPL23;RPL17;RPL23;RPL31;RPL3;EEF1D;RPS21;ING4;PAX8;MRPL18;ORC3;EXT2;APOE;RAD1;RPL35A;RPS14;YARS2;RPL8;RPL5;ABCF1;PWP1;MRPS12;RPS12;POLE;CDC45;HBS1L;RPS26;HARS1;RPL37A;ORC4;RPL4;POLD3;RPLP0;POLA1;RPS28;TSFM;RPS24;TERT;EIF4G2;RPS9;THRB;RPL24;RPS23;GTPBP2;RPL34;HUS1;MRPL52;RPS3;RPS11;ORC2;TOP3A;MRPS15;NBN;HELB;RRAGC;DHPS;ING5;PPP5C;EEF1B2;RPL23A;RPS15A;RPL21;RPL35;RMI1;BRIP1;BAZ2A
prerank,regulation of nervous system process (GO:0031644),-0.5550832627433947,-1.5349463696053567,0.0437636761487965,0.39041691842900306,1.0,6/18,8.15%,DLGAP1;HTR2C;DLGAP2;DLGAP4;ROCK2;AKAP9
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.6384758737893756,-1.5340956609454033,0.026804123711340205,0.3898539778449144,1.0,7/11,30.62%,CAT;PRDX2;PRDX1;PRDX3;GPX1;PRDX4;PRDX5
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.40315487032651737,-1.5339286113532884,0.01466275659824047,0.3873195042462592,1.0,23/66,17.51%,FGFR2;TGFBR3;SULF1;ROBO1;NR2F2;NFIB;MCC;MTSS1;MED1;KLF9;NUPR1;XDH;CDC73;SPARC;THBS1;CDK6;AIMP1;CAV2;MAGED1;PEX2;TGFB1;SCG2;ATP5IF1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6869747965297319,1.5338013252290685,0.043478260869565216,0.8434774337914318,1.0,5/10,11.59%,MAPK3;GREM1;LYN;RNF13;NBR1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.537821640941751,1.5323725446393264,0.02280130293159609,0.8407565529451146,1.0,9/30,8.79%,CERS1;DACH1;CTC1;SRC;ERCC4;CDKN1A;HNRNPC;ACD;ACVRL1
prerank,positive regulation of protein binding (GO:0032092),0.46746677271031045,1.5319931047251183,0.015060240963855422,0.8321501135498871,1.0,16/56,11.24%,TRIB3;RALB;PIN1;TIAM1;HIPK2;PPP2CA;APOE;B2M;PPP2CB;BDNF;SPPL3;EPB41;AKTIP;CLDN5;TERT;APP
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.5188516692117733,-1.5315471007014412,0.013071895424836602,0.3912681740936556,1.0,10/24,18.05%,CTNNA2;BOC;CDON;CTNNA1;MAPK14;CTNNB1;RBM4;CAMK1;OLFM2;CDC42
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.6026627958233566,1.530313883257172,0.03759398496240601,0.8318487978629093,1.0,2/16,5.41%,PTPRC;CYRIB
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.6305672097000762,-1.5294522541984088,0.037037037037037035,0.39420712428862503,1.0,4/12,10.04%,DPYD;DPYSL3;CTPS1;ALDH6A1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3877174937555923,-1.5289984700394519,0.005698005698005698,0.3925604229607251,1.0,26/82,16.37%,DDX5;BMP6;FGFR2;RANBP3L;IGF1;SMOC1;NELL1;BMP7;IL6R;BMP4;CRIM1;FBN2;SKI;WNT4;TMEM64;LRP5;SMAD6;ACVR1;PRKACA;CDK6;SEMA4D;LIMD1;IL6ST;PTK2;WWTR1;BMPR1B
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5703846291090291,1.5288815213033549,0.041379310344827586,0.8300454915484846,1.0,7/22,10.60%,TNFAIP3;TIRAP;IFI35;RAB7B;WDFY1;LYN;MFHAS1
prerank,membrane depolarization during action potential (GO:0086010),-0.4959563992721814,-1.5281194790469876,0.021897810218978103,0.39211503424736516,1.0,7/26,8.74%,ATP1A2;CACNA1C;CACNA1D;SCN8A;SCN3A;KCNJ2;SCN1A
prerank,negative regulation of catalytic activity (GO:0043086),0.5522467971758164,1.5274405713411507,0.03626943005181347,0.8283117123009535,1.0,7/24,10.24%,PHPT1;CAND1;IFIT1;SIRT1;NOTCH1;PPP1R12A;CCAR2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.599994999444447,1.5254703874004734,0.045454545454545456,0.8302088360706135,1.0,7/19,15.39%,KLF2;PAX8;MAP2K5;WFS1;MAPK8;APP;SLCO1C1
prerank,amide biosynthetic process (GO:0043604),0.4842756003617689,1.5248250588637364,0.034482758620689655,0.8234528696812815,1.0,8/47,11.52%,PCSK1;CERS1;SMPD4;CERS4;SGMS1;DMD;PAM;SLC25A2
prerank,circulatory system development (GO:0072359),-0.36832508956960797,-1.522246210416473,0.006756756756756757,0.40675638560834937,1.0,34/118,14.06%,ERBB4;NTRK3;FGF12;CACNA1C;FBN1;AKAP13;PDLIM5;PKD1;MICAL2;GLI2;ADAP2;COL3A1;NXN;PCSK5;CXADR;NCOA6;TGFBR1;TGFBR2;PLCE1;PDLIM7;OSR1;HSPG2;RBP4;CDKN1B;FOXC1;ACVR1;SALL1;FN1;FOXC2;STK11;MTHFD1;WDR11;PDLIM1;TCF25
prerank,ceramide metabolic process (GO:0006672),0.4841903000652848,1.5221266035199434,0.027552674230145867,0.8297025498957046,1.0,8/49,6.76%,CERS1;SMPD4;ACER2;ST6GALNAC3;CERS4;PPP2CA;SGMS1;PLPP1
prerank,dermatan sulfate metabolic process (GO:0030205),-0.6057318169218516,-1.5220276994456439,0.05183585313174946,0.4043795288826295,1.0,9/13,28.41%,UST;DSE;VCAN;CSPG4;DSEL;BGN;CSPG5;CHST12;DCN
prerank,neuromuscular synaptic transmission (GO:0007274),0.5876624018066172,1.520206765895167,0.053763440860215055,0.8312807048350374,1.0,5/18,12.88%,SLC5A7;KIF1B;DTNA;TBC1D24;ERC1
prerank,embryonic organ morphogenesis (GO:0048562),-0.4461953356998178,-1.5195869127126698,0.017902813299232736,0.4087089101321188,1.0,11/42,9.38%,FGFR2;FBN1;EFEMP1;FBN2;HOXA3;DYNC2I1;PDGFRA;MFAP5;RBP4;NIPBL;ACVR1
prerank,dicarboxylic acid metabolic process (GO:0043648),0.47099451668594267,1.5190761003596847,0.028346456692913385,0.827721504580583,1.0,9/52,6.26%,PCK1;ALDH1L1;GCLC;ALDH5A1;SDHAF3;ME3;GOT2;GCLM;MTHFS
prerank,regulation of chemotaxis (GO:0050920),-0.4811283788024899,-1.5165073698898308,0.038860103626943004,0.4151980530379322,1.0,14/30,21.40%,PDGFRB;ADGRA2;EFNB2;P2RX4;PDGFRA;ZSWIM8;YTHDF1;STX3;THBS1;TGFB1;PTPN2;ZSWIM4;PPM1F;P2RY12
prerank,Rap protein signal transduction (GO:0032486),0.6828033550588462,1.5100055604300366,0.047244094488188976,0.8745575706059446,1.0,4/10,12.39%,RAP2A;PLK2;RAPGEF3;RAP2C
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.5091360103813963,-1.5092657727158318,0.046052631578947366,0.43503698684912034,1.0,7/23,8.96%,IGF1;AKAP6;MAPK14;EFNB2;MAML1;MMP14;NIBAN2
prerank,hexose metabolic process (GO:0019318),0.4904724726302593,1.5075794224168015,0.03453947368421053,0.8790677788669262,1.0,7/39,8.59%,PCK1;HECTD4;FUCA1;PPARD;OMA1;IRS2;GALM
prerank,inorganic anion transport (GO:0015698),-0.4169376386112518,-1.5073221439186548,0.0182370820668693,0.438253908748098,1.0,20/53,26.86%,SLC4A10;CLIC4;SLC26A7;ENPP1;SLC13A4;GLRA1;CLCN6;ANO1;CLCN2;ANO6;SLC26A11;ENPP3;CLIC5;SLC5A5;ANO10;TTYH3;SLC25A30;SLC25A11;TTYH1;FXYD1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5524464845242577,-1.507261318849808,0.05215419501133787,0.4352916064626297,1.0,3/17,8.15%,ANK2;SNTA1;AKAP9
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.5197145058229902,1.506201856045468,0.023178807947019868,0.8770203041579033,1.0,8/33,12.00%,PHPT1;PTPRJ;SH2D1A;PRKD2;RELA;CD81;RPS3;PRNP
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.5647543432716781,-1.5056754672161572,0.031180400890868598,0.4371481666630442,1.0,8/16,22.17%,PID1;PPARGC1A;VCP;PPARA;ATPSCKMT;PARP1;PINK1;FLCN
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5257829456459534,1.5054983109609803,0.030560271646859084,0.8713764610082023,1.0,3/29,6.89%,CADM1;CYRIB;AP1G1
prerank,regulation of mRNA processing (GO:0050684),0.5079998966209508,1.5054297940179988,0.03035413153456998,0.8618872963578513,1.0,13/32,10.63%,NCBP1;KHDRBS3;AHCYL1;ZFP36L1;SF1;QKI;HNRNPK;CPSF4;SRSF10;CDK11B;YTHDC1;SRPK2;PAPOLA
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.507458602901945,-1.5051235952185151,0.045454545454545456,0.43581409149762623,1.0,4/22,7.87%,ZBTB20;SORBS1;PPARA;CREBL2
prerank,positive regulation of receptor internalization (GO:0002092),-0.521585972684188,-1.5049630636892737,0.03278688524590164,0.43328565918878964,1.0,2/22,1.72%,MAGI2;AHI1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6685367877925642,1.5049046022154402,0.06554307116104868,0.855417759631879,1.0,3/10,13.15%,PRKAR1A;PRNP;CD274
prerank,receptor signaling pathway via STAT (GO:0097696),-0.49466037989224143,-1.5044810109642948,0.029925187032418952,0.4320215097229905,1.0,7/25,10.49%,PKD1;IFNAR2;STAT2;GHR;IL31RA;STAT6;SOCS2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.46504317298093456,1.502416949650375,0.01904761904761905,0.8615249140636078,1.0,5/53,6.76%,HRH4;MTNR1A;HTR1F;TSHR;HTR2A
prerank,metanephric mesenchyme development (GO:0072075),-0.6283719095219432,-1.5018051683022826,0.05708245243128964,0.4377310755709547,1.0,6/10,24.71%,OSR1;WNT4;SIX1;STAT1;PAX2;BASP1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.5924589287938428,1.5016264248738633,0.051233396584440226,0.8565888730263428,1.0,7/16,18.45%,NAA25;EP300;NAA35;CREBBP;NAA80;NAA15;NAA50
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.5150953791904269,1.500378007409707,0.03758169934640523,0.8549390097595326,1.0,4/32,6.00%,ROMO1;RPL30;RNASE6;FAM3A
prerank,skin development (GO:0043588),-0.40319389863743416,-1.50010491028297,0.021341463414634148,0.43980519889224573,1.0,12/65,6.12%,COL1A2;COL1A1;PKD1;COL3A1;ERRFI1;COL5A1;CLIC4;COL5A2;MED1;ATP7A;BCR;PIP5K1A
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5144380220068402,-1.4997262500501238,0.04328018223234624,0.4378190436503802,1.0,7/21,12.06%,ANK2;ATP1A2;CACNA1C;AKAP6;PRKACA;CAMK2D;SRI
prerank,regulation of cardiac conduction (GO:1903779),-0.4217013937641024,-1.4995564709182458,0.023391812865497075,0.4352936307577701,1.0,13/54,10.35%,ANK2;ATP1A2;ITPR1;RYR3;ATP1B1;STIM1;TMEM65;ATP1B3;ATP1A1;TRPC1;ATP1B2;PRKACA;DMPK
prerank,regulation of ERAD pathway (GO:1904292),-0.6298325970812719,-1.496153006068957,0.04771371769383698,0.4427985695788889,1.0,9/11,25.65%,USP13;HERPUD1;TMEM259;USP19;RNFT1;BAG6;UBXN1;AQP11;RNF185
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.5800912611249834,-1.4959130580697184,0.052980132450331126,0.4403884624806075,1.0,6/14,17.71%,MALT1;PRKCZ;RARA;ANXA1;IL18;SOCS5
prerank,negative regulation of hippo signaling (GO:0035331),-0.6108914945498348,-1.4957579906528702,0.060041407867494824,0.4379118595267544,1.0,6/12,16.62%,WWC2;MAPK14;CIT;VGLL4;LIMD1;SHANK2
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.5255104820007889,-1.4957565351999553,0.04925053533190578,0.43499999999999994,1.0,11/21,22.36%,ADCY5;ADCY2;ADCY1;ADCY9;ADCY7;GUCY1A1;NPR1;ADCY3;ADCY8;GUCY1B1;ADCY4
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.39911171947909424,1.4956775192256428,0.010540184453227932,0.8746440705387478,1.0,37/163,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PTPRJ;PDE4D;PTPRC;MAP3K7;VAV3;TAB2;PRKD2;PSMD11;PSMB4;FYN;PSMC1;PAK3;SYK;LCP2;SPPL3;PRAM1;PLCG1;EIF2B3;RELA;RBCK1;INPP5D;PSMC2;PAK1;PSMD2;PIK3CD;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.6395180637720641,1.495501193854838,0.05952380952380952,0.8663538801704147,1.0,4/12,10.59%,BOD1;CHAMP1;CENPC;MIS12
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5819583387915838,1.493386135527149,0.04195804195804196,0.86997853732103,1.0,2/17,6.89%,CADM1;AP1G1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.6031149625993883,1.4932371604758363,0.07282415630550622,0.8619001976262382,1.0,5/15,9.70%,RPL23;RPL5;FBXO5;SMAD7;PARK7
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.4306197922764781,1.4924483399903203,0.017804154302670624,0.8575652384454967,1.0,22/84,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ANAPC2;PSMD11;PSMB4;PSMC1;FBXO5;ANAPC7;PSMC2;PSMD2;ANAPC11;ANAPC10;ANAPC4;CUL3;PSMD14;PSMC6;PSMD1;PSMB1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5889367051152905,1.4923485318875243,0.0421792618629174,0.849481857942983,1.0,2/16,6.89%,CADM1;AP1G1
prerank,neuron cell-cell adhesion (GO:0007158),-0.5773248635006127,-1.4918905941258191,0.05870020964360587,0.4444538924791421,1.0,7/14,11.81%,NRXN3;CNTN4;NRXN1;NCAM2;NLGN2;NLGN1;NRXN2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.5064676831609021,1.4908803688004955,0.04152249134948097,0.8497268474712794,1.0,12/32,16.45%,MAP2K7;MAPK3;PNKP;CCT2;CCT5;MAP3K4;ACD;NEK7;TNKS;ATR;TCP1;PARN
prerank,regulation of blood circulation (GO:1903522),-0.4585034043412559,-1.490454570684644,0.035,0.4461212036889808,1.0,18/34,36.18%,CELF2;TPM1;PER2;DMPK;CAMK2D;SRI;ACE;BDKRB2;AGTR1;TBX2;FXYD1;KCNQ1;KCNJ12;S100A1;DES;KCNMB4;CACNA1H;ACE2
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.41144445800785173,1.4901773319435039,0.012747875354107648,0.8455255981592334,1.0,27/114,13.85%,PSMB10;PSMC4;PSMB6;EIF5A;PSMD8;PSMD5;PSMD12;BIRC2;PSMD11;PSMB4;TNFRSF1B;EDAR;PSMC1;TRAF5;ACTN4;TRAF3;RELA;PSMC2;PSMD2;CDIP1;IKBKB;CHUK;PSMD14;PSMC6;NFKBIA;PSMD1;PSMB1
prerank,embryonic digit morphogenesis (GO:0042733),-0.5440402853536603,-1.4895528301185739,0.05021834061135371,0.44594514542977315,1.0,7/18,14.43%,GLI3;HDAC1;OSR1;MAP3K20;SALL1;TBX3;INTU
prerank,neuron development (GO:0048666),-0.345875179502857,-1.4894364891411058,0.010752688172043012,0.44335102208969274,1.0,41/141,16.65%,TENM2;MAP2;CNTN4;TENM3;PLP1;PBX1;PPP1R9A;GPM6B;MYT1L;GLI2;NTRK2;HDGFL3;SH3GL2;RASGRF1;RYK;MAPT;WNK1;ATP8A2;GPM6A;ATP7A;ERCC6;ROCK1;STMN2;ETV1;TDP2;NLGN1;CDK16;STX3;B4GALT6;GSK3B;DCX;UGDH;RAB11A;UNK;BICDL1;STMN1;SRRM4;RAPGEF2;GPRIN3;PBX4;EHD1
prerank,kidney development (GO:0001822),-0.40009532194102404,-1.4890192418345016,0.015015015015015015,0.44162362342851574,1.0,17/65,10.03%,ROBO2;SULF1;GREB1L;KANK2;PKD1;GLI2;PCSK5;TGFBR1;BMP7;SULF2;BMP4;OSR1;WNT4;NIPBL;FOXC1;PYGO1;SALL1
prerank,nerve growth factor signaling pathway (GO:0038180),-0.642744571671036,-1.4867785143052916,0.0486815415821501,0.44566290959795496,1.0,1/10,0.01%,MAGI2
prerank,heterocycle biosynthetic process (GO:0018130),0.6084267304449875,1.4862336971902714,0.06883365200764818,0.8604537993841449,1.0,2/14,0.85%,GPHN;MOCS3
prerank,regulation of cytokine production (GO:0001817),0.40443357781333983,1.4843512055282226,0.013869625520110958,0.863237527929254,1.0,21/126,11.68%,CIDEA;CADM1;PIK3CG;PTPRC;SOD1;FCGR2B;RPS6KA4;HDAC9;BCL6B;RPS6KA5;TNFRSF1B;NPTN;RGCC;PPP1R11;TRAF3;CD47;POLA1;LYN;LURAP1;PIK3CD;DTX4
prerank,import into cell (GO:0098657),-0.4350216795687303,-1.48376950342786,0.03209876543209877,0.4519887620990244,1.0,16/41,17.36%,ATP1A2;SNAP25;SLC1A3;SLC6A13;SLC47A1;LRRC8D;GLUL;SLC39A14;SLC22A4;SLC27A1;SLC12A6;SLC19A1;SLC16A2;LRSAM1;SLC5A6;SLC12A4
prerank,cell morphogenesis involved in differentiation (GO:0000904),-0.39449183603394394,-1.481848505078347,0.019662921348314606,0.4551942712914452,1.0,24/70,21.87%,TMEFF2;PARVA;NTNG1;NRP1;FER;RHOA;LAMC3;RILPL1;PXN;RELN;SRCIN1;RADIL;FN1;ILK;ARL13B;NTN4;UNK;ITGA8;ITGA4;LAMB1;PIK3R1;SIPA1L3;ATF4;RILPL2
prerank,cellular response to alcohol (GO:0097306),-0.4338982773735648,-1.4816393030432182,0.03865979381443299,0.45290144217066636,1.0,20/42,21.53%,ADCY5;GRAMD1B;ADCY2;CTNNA1;SPIDR;ADCY1;CTNNB1;KLF9;SMO;GLRA1;GRAMD1C;CDH1;ADCY7;GRAMD1A;LRP6;GPLD1;OSBPL7;BLM;ADCY3;ADCY8
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.5358910918768097,-1.4814660873834269,0.047619047619047616,0.4506726774924471,1.0,13/18,26.82%,RIMS1;NRXN1;DLG4;NLGN2;PRKCZ;RELN;NLGN1;CUX2;SHANK1;GRIN1;NLGN3;CHRNA7;STX1B
prerank,DNA replication-independent nucleosome assembly (GO:0006336),0.4941515791798905,1.481418759093262,0.04508856682769726,0.8725894871833804,1.0,13/38,18.94%,MIS18A;ASF1B;HJURP;RUVBL1;RSF1;CENPC;CABIN1;CENPP;RBBP4;CENPO;NPM1;ATRX;HAT1
prerank,neuron projection fasciculation (GO:0106030),-0.6353744588156838,-1.4812402113278154,0.03854389721627409,0.448563078193316,1.0,4/10,18.57%,CNTN4;NRCAM;EPHB2;SEMA5A
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.48620690376047004,1.48108381965666,0.034482758620689655,0.8659371037450029,1.0,11/39,12.87%,TNFAIP3;RAMP2;TEK;KRIT1;ICAM1;RGCC;PLCG1;TNIP2;PRKCI;CDH5;ECSCR
prerank,regulation of immune effector process (GO:0002697),0.4831472442390888,1.4804300653691822,0.04304635761589404,0.8613836308400294,1.0,6/41,12.87%,C1QB;C1QC;FCGR2B;PHB2;CD81;CD55
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.45754744159882543,-1.4798214848882256,0.05357142857142857,0.45039582633993513,1.0,5/31,4.20%,FGFR2;TGFBR3;TGFBR1;SMAD4;TPM1
prerank,dopamine metabolic process (GO:0042417),-0.5501161546730032,-1.4795157001426422,0.0585480093676815,0.44868218634737644,1.0,5/18,13.20%,MOXD1;SNCAIP;ATP7A;COMT;MAOB
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.5631684976520426,1.4787251682857627,0.06390977443609022,0.8634537537601705,1.0,4/19,5.70%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,plasma membrane organization (GO:0007009),-0.39462024272044294,-1.478180114095591,0.023809523809523808,0.45027770613808854,1.0,28/61,32.07%,ANK2;ANK3;EPB41L3;A4GALT;COL5A1;BIN1;MYOF;BIN3;PLSCR1;AHNAK2;TLCD2;SYT11;ABCD2;ANO6;SYT7;PACSIN1;ARV1;DEGS1;ANXA6;CLN3;SERP1;SPTBN1;SYTL4;ABCA7;PACSIN3;CAVIN2;PLSCR4;MICALL1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),-0.42903635959877723,-1.4768619559755902,0.02518891687657431,0.4516547651744026,1.0,16/46,18.17%,TMEFF2;PARVA;NTNG1;NRP1;FER;RHOA;LAMC3;PXN;SRCIN1;RADIL;FN1;ILK;NTN4;ITGA8;ITGA4;LAMB1
prerank,regulation of muscle cell differentiation (GO:0051147),-0.4704935263569169,-1.4764855594723219,0.034722222222222224,0.45023068103228625,1.0,13/31,18.05%,FGFR2;CTNNA2;BOC;CDON;CTNNA1;MAPK14;CTNNB1;RBM4;CAMK1;IGF2;MEGF10;CDK9;CDC42
prerank,mitochondrial fusion (GO:0008053),0.5703863441015931,1.4746608866593174,0.05938697318007663,0.8797540338588274,1.0,2/18,0.19%,THG1L;MIGA1
prerank,estrogen metabolic process (GO:0008210),0.5927267868251588,1.473690431935035,0.0616822429906542,0.8776883876182353,1.0,4/15,11.92%,SULT1A1;HSD17B11;CYP1B1;HSD17B4
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.44290250822631894,1.4735863931870183,0.021739130434782608,0.8702028148145949,1.0,20/70,14.60%,PSMB10;PSMC4;PSMB6;MFSD6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;B2M;PSMC1;PSMC2;PSMD2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;CYBA
prerank,regulation of protein localization to centrosome (GO:1904779),-0.6375872712269093,-1.4730773329983424,0.052854122621564484,0.45881650596088785,1.0,5/10,16.48%,BICD1;UBXN2B;GSK3B;NSFL1C;CEP250
prerank,carbohydrate biosynthetic process (GO:0016051),-0.5059511192604549,-1.471714173308909,0.04926108374384237,0.4602125593439793,1.0,8/21,17.79%,B4GALT1;FUT8;ST6GALNAC5;B3GALT5;ST3GAL4;B3GALT1;ST6GALNAC6;MPDU1
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.5529494671969652,-1.4714977296926959,0.05895196506550218,0.4582134110370225,1.0,6/15,12.56%,FGFR2;TGFBR1;TGFBR2;PDGFRA;NIPBL;MTHFD1
prerank,protein localization to cell surface (GO:0034394),-0.4816700641857985,-1.4694642095195507,0.043478260869565216,0.46235560689532607,1.0,13/26,24.14%,ANK2;CTNNB1;FLNA;JAM3;VCL;USP4;GGA2;MESD;PTPRU;GGA3;PRRT1;UNC50;EMP2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.5352314764017261,-1.4690491218491855,0.05077262693156733,0.46099008851433715,1.0,6/18,16.33%,DDX5;EGFR;BMP4;MAP2K2;TP53;TGFB1
prerank,cellular response to hypoxia (GO:0071456),0.3991749130181877,1.4687939775214935,0.00398406374501992,0.8911329236385861,1.0,37/126,14.25%,PSMB10;PSMC4;PSMB6;ELOC;PSMD8;PSMD5;PSMD12;HIPK2;STOX1;ZFP36L1;PSMD11;SCN2A;PSMB4;PSMC1;EP300;CARD16;RGCC;SIRT1;MDM2;PSMC2;PSMD2;TERT;BAD;CREBBP;UBQLN1;HP1BP3;HYOU1;HIGD1A;ELOB;EGLN2;BNIP3L;PSMD14;PSMC6;EPAS1;PSMD1;PSMB1;BACH1
prerank,negative regulation of glycolytic process (GO:0045820),-0.6387858507644714,-1.4686208141614063,0.0550098231827112,0.4569966645128617,1.0,3/10,6.61%,HDAC4;NUPR1;PPARA
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6387858507644714,-1.4686208141614063,0.0550098231827112,0.4569966645128617,1.0,3/10,6.61%,HDAC4;NUPR1;PPARA
prerank,regulation of humoral immune response (GO:0002920),0.46967038045080384,1.468178652566271,0.05591054313099041,0.8868440678180203,1.0,6/44,12.87%,C1QB;C1QC;FCGR2B;PHB2;CD81;CD55
prerank,positive regulation of biosynthetic process (GO:0009891),-0.43600453548244694,-1.467693602123943,0.046632124352331605,0.45711792895093234,1.0,7/40,7.87%,ZBTB20;SORBS1;VIM;BMP4;PPARA;WNT4;CREBL2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.43221897641032636,1.4646282801145767,0.02064896755162242,0.9004237536369776,1.0,21/72,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;MAP3K7;TIRAP;BIRC2;PSMD11;TNFRSF10B;PSMB4;PSMC1;RELA;PSMC2;PSMD2;CHUK;PSMD14;PSMC6;PSMD1;PSMB1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.510230654832043,-1.4638842483906636,0.052752293577981654,0.46654078549848943,1.0,6/20,11.26%,ANK2;ATP1A2;CACNA1C;ATP1B1;PRKACA;CAMK2D
prerank,regulation of telomere capping (GO:1904353),0.534108580178425,1.4631382998316327,0.05925925925925926,0.9013530298785712,1.0,7/23,12.66%,MAP2K7;MAPK3;PNKP;MAP3K4;NEK7;TNKS;NBN
prerank,sphingolipid catabolic process (GO:0030149),0.5849035523325814,1.4624083191649264,0.07547169811320754,0.8977566249523393,1.0,3/15,3.18%,SMPD4;ACER2;PPT1
prerank,cardiac muscle tissue development (GO:0048738),-0.4094892244792134,-1.4620193649264983,0.045454545454545456,0.469619009200769,1.0,17/50,20.00%,NOTCH2;AKAP13;GJB6;BMP5;BMP7;SMAD4;MAML1;BMP4;ADAMTS9;RBP4;SIK1;GJA1;CACNA1G;SMAD5;BMPR1A;TBX18;BMPR2
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5953879785174306,-1.4619890513899747,0.05496828752642706,0.46705540478263097,1.0,5/12,18.54%,RIMS1;UNC13C;UNC13B;SYT7;SYT2
prerank,protein localization to membrane (GO:0072657),-0.3304008768243849,-1.460784647044961,0.004347826086956522,0.46835856614277466,1.0,56/187,18.01%,MAGI2;DLG2;ANK2;DPP6;ANK3;KCNB2;LRRC7;KCNIP4;EPB41L3;NRXN1;MAP7;RAB3C;ATP1B1;PACS2;DLG4;NLGN2;FLNA;KCNIP3;SYNE3;ATP1B3;ROCK2;FLOT2;RAB8B;PIP5K1A;ROCK1;TTC7B;NUP155;NLGN1;EZR;DLG3;TM9SF4;ACTN2;CDH1;TTC7A;DPP10;LRRC4;NRXN2;RAMP1;ARL5A;DLG1;MYADM;RAB11A;WNK3;WDR19;STXBP1;AP4M1;FYB1;LRP6;RAPGEF2;EHD3;EHD1;RAB8A;DVL1;ITGA4;ZFYVE27;FRMPD1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.3991103440949561,1.4604360705608903,0.013831258644536652,0.9018362646320695,1.0,34/124,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;FRZB;LEF1;TIAM1;MAP3K7;PPP3CB;AP2S1;PSMD11;PFN1;PSMB4;PSMC1;GNB1;DAAM1;CCDC88C;WNT5A;FZD3;FZD9;PSMC2;PLCB1;PSMD2;CELSR1;NLK;AGO4;PPP3CA;PPP3R1;PSMD14;PSMC6;PSMD1;PSMB1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.6102657682737174,-1.4594724370844456,0.057203389830508475,0.46996362807811104,1.0,5/11,30.03%,BIN1;CAMK2D;CACNA2D1;CACNB1;NOS1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.553580205673195,-1.4581512169859605,0.05307855626326964,0.47156344410876133,1.0,7/16,18.69%,IGF1;AKAP6;ROCK2;ROCK1;CAMK2D;IL6ST;PARP1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5870278278372292,-1.4576033682674172,0.08879492600422834,0.4706043130643789,1.0,4/13,10.49%,ANK2;CACNA1C;GJC1;GJA1
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3990331711410385,1.4573067862499862,0.01680672268907563,0.9126104569930964,1.0,18/116,10.62%,GPR176;PRKAR1A;PTGER2;FCGR2B;PLK2;SRC;TSHR;INSL3;RAMP2;FYN;GNB1;RXFP1;SYK;PLCG1;LYN;RHBDF2;YES1;CD163
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.619833683405471,-1.4568974153234444,0.05964214711729622,0.47048985757444967,1.0,3/10,13.16%,PRKCZ;RARA;IL18
prerank,plasma membrane invagination (GO:0099024),-0.45700893624364214,-1.4564128039098312,0.05045871559633028,0.46955326630677036,1.0,6/29,5.59%,GULP1;GSN;DOCK1;SPIRE1;RHOA;ARHGAP12
prerank,regulation of T cell cytokine production (GO:0002724),0.600565805814761,1.4555065048299267,0.07303370786516854,0.9156705450778687,1.0,6/15,12.87%,MAP3K7;TNFRSF1B;B2M;SMAD7;TRPM4;CD55
prerank,7-methylguanosine mRNA capping (GO:0006370),0.5046413057334892,1.4549346695605732,0.055846422338568937,0.9035019745912709,1.0,6/31,8.70%,POLR2J;ERCC3;NCBP1;POLR2B;CCNH;GTF2H1
prerank,7-methylguanosine RNA capping (GO:0009452),0.5046413057334892,1.4549346695605732,0.055846422338568937,0.9035019745912709,1.0,6/31,8.70%,POLR2J;ERCC3;NCBP1;POLR2B;CCNH;GTF2H1
prerank,cellular response to light stimulus (GO:0071482),0.43888222798889226,1.454800275263002,0.0258751902587519,0.8967523721140652,1.0,20/66,18.03%,GPR52;SAG;EIF2S1;RUVBL2;ERCC4;YY1;POLK;EP300;GNB1;USP47;CREBBP;BMF;INO80;ATR;TAF1;TMEM161A;N4BP1;USP28;NPM1;RPL26
prerank,eye development (GO:0001654),-0.4003640425854723,-1.454574559211985,0.01912568306010929,0.472918445422304,1.0,23/54,24.70%,CACNA1C;FBN1;PBX1;SMOC1;COL5A1;COL5A2;EFEMP1;MEIS2;FBN2;SKI;RBP4;NIPBL;FOXC1;HIPK1;BMPR1B;PBX4;LAMA1;PBX2;SMG9;SIPA1L3;SH3PXD2B;STRA6;PAX2
prerank,iron ion transmembrane transport (GO:0034755),-0.627301176668423,-1.4542639488388718,0.05543710021321962,0.47147056421980893,1.0,5/10,22.64%,SLC39A14;SCARA5;SLC39A8;SLC11A2;SLC25A28
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.5385679037349764,1.4541320894185688,0.056672760511883,0.8931243165130738,1.0,8/24,15.42%,TNFAIP3;RAMP2;TEK;KRIT1;ICAM1;TNIP2;CDH5;GAS6
prerank,mesenchymal cell differentiation (GO:0048762),-0.3968250757681834,-1.4530807862326374,0.023622047244094488,0.47270002923691645,1.0,14/51,11.79%,DDX5;FGFR2;TGFBR3;RANBP3L;DDX17;TGFBR1;CTNNB1;BMP7;ROCK2;ROCK1;WNT4;FOXC1;GSK3B;LOXL3
prerank,striated muscle tissue development (GO:0014706),-0.4690344254587942,-1.4525519977396602,0.02962962962962963,0.47180194516697094,1.0,6/29,7.69%,SVIL;CFLAR;BMP5;BMP7;IGSF8;RBP4
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.5682445736593006,1.4522784639726778,0.06862745098039216,0.896911067585046,1.0,4/17,5.70%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,embryonic limb morphogenesis (GO:0030326),-0.4419169472502191,-1.4521909339652277,0.050359712230215826,0.4705337629362988,1.0,14/34,15.70%,AFF3;CACNA1C;GLI3;CTNNB1;HDAC1;OSR1;SKI;MAP3K20;NIPBL;SALL1;TBX3;CYP26B1;INTU;LRP6
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.4560376522292504,-1.4521200695358072,0.04308390022675737,0.46830192298470247,1.0,7/31,6.59%,FGFR2;TGFBR1;TGFBR2;HOXA3;OSR1;DYNC2I1;PDGFRA
prerank,positive regulation of cellular senescence (GO:2000774),0.63589716534034,1.45171427627587,0.08695652173913043,0.8931413427546344,1.0,3/10,7.59%,B2M;SIRT1;YPEL3
prerank,neurogenesis (GO:0022008),-0.4264434780581491,-1.4516534145520512,0.0427807486631016,0.4675484973763714,1.0,11/43,12.16%,LPAR1;SPOCK1;EPHB1;RYK;MAPT;CIT;ERCC6;TRAK1;CDK6;BTBD3;ANXA1
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.44773970044394285,1.4511774707104426,0.0350076103500761,0.8890075936547368,1.0,17/55,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;USP47;PSMC2;PSMD2;PSMD14;PSMC6;AVEN;PSMD1;PSMB1
prerank,bone development (GO:0060348),-0.4355760599416169,-1.4497777728407004,0.04176904176904177,0.47115080432134887,1.0,18/39,24.40%,FGFR2;RANBP3L;SULF1;AKAP13;SULF2;SKI;LRP5;GJA1;TP53;DYM;CYP26B1;LRP6;MBTPS2;SFRP4;P3H1;NOTUM;SH3PXD2B;RPL13
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.48851206507884326,1.4496977459509048,0.05454545454545454,0.890106106527171,1.0,9/33,9.39%,PIK3CG;ACER2;CIB1;NEXMIF;RET;SYK;EFNA1;LYN;CYP1B1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.5820861845208134,-1.4480914692368836,0.0658682634730539,0.4738599886706949,1.0,4/12,5.85%,SORBS1;GKAP1;PRKCZ;SORL1
prerank,positive regulation of lipid localization (GO:1905954),-0.6089113313931446,-1.447909056433991,0.05,0.471997636303868,1.0,4/11,14.43%,LRP1;NFKB1;IKBKE;VSTM2A
prerank,inositol lipid-mediated signaling (GO:0048017),-0.40157535248349707,-1.4474036197926055,0.029333333333333333,0.47125821471953155,1.0,19/50,16.54%,IGF1;OGT;PDGFRB;ADAP2;PLCL2;PLCE1;RHOA;PIK3C2B;PIK3C3;PDGFRA;PLCD3;EZR;PLCB3;GAB2;PLCH1;NGF;EXOC1;PLCL1;PLCD1
prerank,protein polymerization (GO:0051258),-0.3944534887834885,-1.4468149966493844,0.044444444444444446,0.4707878224494539,1.0,14/55,9.14%,GSN;GAS7;HDGFL3;SPIRE1;WASL;MAPT;PSTPIP2;ARHGAP6;WASHC5;WASHC3;COBL;WASF1;RNF135;CKAP5
prerank,cell-matrix adhesion (GO:0007160),-0.3610135672899474,-1.4468015430020589,0.017793594306049824,0.4684147450520994,1.0,23/95,11.40%,SORBS1;ADAMTS12;ITGBL1;PKD1;ITGB8;COL3A1;SGCE;NID2;PPFIA1;ADAMTS9;VCL;BCR;ITGB5;PIP5K1A;DDR1;CTTN;COL13A1;ACTN2;VTN;FN1;ITGA11;ILK;CD34
prerank,lung epithelium development (GO:0060428),-0.6167930614163666,-1.4465685797349,0.09259259259259259,0.4667903752664591,1.0,4/10,14.58%,PKD1;ERRFI1;BMP4;RCN3
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.42088656890872395,-1.4457458112686532,0.034666666666666665,0.46691041838322805,1.0,9/40,6.59%,NTRK3;LPAR1;EGFR;PDGFRB;NTRK2;KIT;ARHGAP6;EDNRA;PDGFRA
prerank,acute inflammatory response (GO:0002526),-0.4849424566334981,-1.4455318855660735,0.0659090909090909,0.46517329851675293,1.0,6/23,21.20%,IL6R;F3;LBP;PLSCR1;ANO6;CEBPB
prerank,synaptic vesicle cycle (GO:0099504),-0.4618486210590692,-1.4441743303029688,0.05250596658711217,0.4670392749244713,1.0,9/30,16.55%,RIMS1;SNAP25;PCLO;SYNDIG1;NLGN1;BRSK1;VAMP2;SYT7;STX1A
prerank,negative regulation of developmental growth (GO:0048640),-0.45316395971252926,-1.4427929971975064,0.06133333333333333,0.4686555891238671,1.0,7/30,7.78%,MAP2;DCC;ULK2;WWC2;PTPRS;NKD1;CDKN1B
prerank,positive regulation of neutrophil migration (GO:1902624),0.5578752248355014,1.44222010894356,0.06679764243614932,0.927300904632647,1.0,4/18,5.70%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.4894160387939002,-1.4422092381905858,0.059496567505720827,0.4681863390266519,1.0,8/23,19.98%,FBXW11;HTT;UBXN2B;GJA1;NSFL1C;DCTN1;NDE1;ZW10
prerank,regulation of glucose import (GO:0046324),-0.462057789678289,-1.4413037661467136,0.05025125628140704,0.46865372881103684,1.0,10/30,9.78%,SORBS1;PRKAG2;IGF1;PID1;OCLN;APPL2;ENPP1;AKT2;CREBL2;ARPP19
prerank,response to X-ray (GO:0010165),-0.5594955665913843,-1.4411931189393825,0.09403669724770643,0.4666729607250755,1.0,7/14,19.95%,NIPBL;IKBIP;ANXA1;NUCKS1;MSH2;ATM;BLM
prerank,regulation of cellular amine metabolic process (GO:0033238),0.4592428146509592,1.4398515760600272,0.04231974921630094,0.9340235500007572,1.0,15/50,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,tRNA modification (GO:0006400),0.42691888050423216,1.4393612709232744,0.031914893617021274,0.9297350668041848,1.0,15/62,16.94%,THG1L;MOCS3;THUMPD1;TRMO;BCDIN3D;THUMPD2;PUS10;TRMT61B;ANKRD16;METTL2B;METTL2A;WDR4;SSB;NSUN6;CDKAL1
prerank,positive regulation of synapse assembly (GO:0051965),-0.46921468302636354,-1.4391695065219028,0.07263922518159806,0.4708127625082898,1.0,11/27,11.94%,NRXN1;GRID2;EPHB1;NLGN2;SYNDIG1;CLSTN2;NLGN1;EPHB2;CUX2;SEMA4D;IL1RAPL1
prerank,embryonic eye morphogenesis (GO:0048048),-0.5982242253661945,-1.4374284289328685,0.08884297520661157,0.47372994456340006,1.0,5/11,15.70%,FBN1;EFEMP1;FBN2;MFAP5;LRP6
prerank,regulation of cellular component movement (GO:0051270),-0.40931969249193073,-1.4370594907854113,0.05084745762711865,0.4725633784316301,1.0,27/49,30.30%,ERBB4;TGFBR3;EGFR;TGFBR1;PDPN;RHOA;ROCK2;ROCK1;ZSWIM8;YTHDF1;CDK6;PRAG1;RAF1;ABL2;DIAPH1;CADM4;ZSWIM4;VEGFA;ZSWIM5;ERBB2;INPP5F;DAPK3;HDAC6;HBEGF;NRG4;ARAP1;ARHGAP18
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.5043653019034917,1.4368557545677594,0.05582922824302135,0.9371513359338954,1.0,9/31,10.09%,TOMM20;ROMO1;TIMM17B;PEX1;PEX7;GRPEL2;TOMM40L;TIMM21;AIFM1
prerank,positive regulation of catalytic activity (GO:0043085),0.48378015174057465,1.4366812911521174,0.054276315789473686,0.9310393651899881,1.0,9/37,9.74%,MAPK3;SOD1;PSEN2;CIB1;MAPK8;CHTOP;YWHAB;SSBP1;MSH3
prerank,regulation of heart contraction (GO:0008016),-0.36788150039924367,-1.436494615985898,0.019169329073482427,0.4721596851034162,1.0,20/90,12.51%,CELF2;ANK2;ATP1A2;ITPR1;RYR3;ATP1B1;STIM1;ASB3;TMEM65;TPM1;P2RX4;ATP1B3;ATP1A1;TRPC1;ATP1B2;PRKACA;DMPK;CAMK2D;SRI;ABCC9
prerank,organelle fusion (GO:0048284),0.5258707635661843,1.4355892692379648,0.06902654867256637,0.930255273520772,1.0,3/22,4.50%,THG1L;MIGA1;VPS11
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.5411047623162829,-1.4349761392833145,0.05664488017429194,0.47471414735685685,1.0,5/15,12.87%,DAB2;SNAP91;WASL;HIP1R;SCYL2
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5183610531444983,1.4341809780742496,0.05536332179930796,0.9315197422643628,1.0,9/25,15.76%,RPL23;PDCL3;PSME3IP1;HIPK2;RPL5;EFNA1;OPHN1;CSNK2A2;TAF1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.41729536905324394,-1.434129616942058,0.040214477211796246,0.4750863185153215,1.0,16/43,19.24%,SORBS1;OGT;TNS2;PID1;GKAP1;PRKCZ;ENPP1;SORL1;PRKCD;PIP4K2B;NUCKS1;GRB10;IGF2;PTPN2;TSC2;RPS6KB1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.4870865692043297,1.4334391319970492,0.05405405405405406,0.9292073176253474,1.0,7/30,11.96%,NUDT14;ASGR1;ALG8;OST4;STT3B;MGAT5;MCFD2
prerank,organophosphate biosynthetic process (GO:0090407),0.47391396295334753,1.4333272102874408,0.05362776025236593,0.9230456243562429,1.0,9/37,11.91%,GPHN;MOCS3;PPIP5K2;GPAM;FITM2;TPI1;MBOAT1;AGPAT3;IP6K2
prerank,nervous system development (GO:0007399),-0.2962952746178318,-1.4329413207303667,0.0,0.47658789249867556,1.0,106/429,16.62%,NAV3;ERBB4;ROBO2;NOTCH2;CNTN4;DCLK1;SDK1;LPAR1;FGF12;TEAD1;ROBO1;ZIC1;ADAM22;ARNT2;ALDH1A2;ZIC4;NRXN1;CNTN6;SPOCK1;GSN;GPM6B;MYT1L;KIRREL3;NRCAM;AHI1;EFNA5;ADAM23;PKD1;GLRB;ADGRA2;CHRM2;EPHB1;NBL1;HDAC4;TMOD2;SH3GL2;MBP;NELL1;TGFBR1;MOBP;DLG4;AXL;RYK;TRPC5;DNER;ZEB2;DSCAM;JARID2;ADGRV1;NLGN2;GLIS2;CRIM1;IL1RAPL2;GPM6A;SCN8A;GMFB;RELN;VCAN;SMO;ZIC5;ERCC6;IGSF8;LDB1;FEZ1;MOG;TRAK1;CHRM3;SDK2;NLGN1;FUT10;RBFOX3;CDH1;BTBD3;EPHB2;FN1;ZIC2;DCX;NR2C2;NUMBL;NRXN2;TBX3;ALDH3A2;APBA1;ACVR1B;OBSL1;DPF2;FKTN;COX7B;ATXN1;PLXND1;VLDLR;INTU;ATN1;DACT1;ARHGAP26;SRRM4;DCTN1;NINJ2;NGF;WWTR1;NHEJ1;NES;TGFB1;NPAS2;SZT2;SHANK2
prerank,metal ion export (GO:0070839),-0.4516143540493023,-1.4325311684497486,0.0639386189258312,0.4755796471527105,1.0,7/31,9.45%,ATP1A2;ATP1B1;ATP1B3;ATP7A;ATP1A1;KCNK5;ATP1B2
prerank,negative regulation of lipid metabolic process (GO:0045833),0.534335011627711,1.4324435210490951,0.07321428571428572,0.9209042346018563,1.0,2/22,6.15%,CIDEA;ASXL3
prerank,stem cell differentiation (GO:0048863),-0.4321281429178092,-1.4324417023652556,0.04774535809018567,0.4736234628313689,1.0,14/39,17.54%,FGFR2;UFL1;PUM1;JARID2;KIT;GPM6A;OSR1;TP53;NELFB;LMBR1L;MTF2;LRP6;ACE;METTL5
prerank,cellular response to tumor necrosis factor (GO:0071356),0.37542659514169574,1.4323816762399002,0.010243277848911651,0.914466795117443,1.0,36/175,13.85%,PSMB10;PSMC4;PSMB6;EIF5A;PSMD8;PSMD5;PSMD12;SMPD4;ZFP36L1;BIRC2;PSMD11;GBP3;PSMB4;TNFRSF1B;EDAR;PSMC1;CIB1;TRAF5;ACTN4;SIRT1;CCL25;ERBIN;TRAF3;RELA;PSMC2;PSMD2;CDIP1;NPNT;RPS3;IKBKB;CHUK;PSMD14;PSMC6;NFKBIA;PSMD1;PSMB1
prerank,positive regulation of immune response (GO:0050778),0.4334545344397112,1.4321556756232487,0.03469079939668175,0.9090713594875749,1.0,9/64,14.60%,PCK1;PTPRC;FCGR2B;IFI35;SIRT1;CD81;POLR3F;POLR3B;CYBA
prerank,positive regulation of cilium assembly (GO:0045724),-0.5234483259819618,-1.431625260188375,0.07610993657505286,0.4739408334980377,1.0,9/18,32.87%,TAPT1;CEP120;HTT;ENTR1;CCP110;FUZ;KCTD17;WRAP73;CROCC
prerank,SNARE complex assembly (GO:0035493),-0.6140645025029475,-1.4314677331534833,0.06471816283924843,0.4722212463992131,1.0,6/10,28.99%,UVRAG;VAMP2;STXBP1;VAMP1;VAMP8;SNCA
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.5501707655078507,1.4310524362770407,0.06825938566552901,0.908841630929129,1.0,8/20,12.24%,GNAQ;RGS8;GNB1;RGS10;GNA11;PLCB1;AGRN;LYPD1
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.49363001195067635,-1.4288213240905503,0.08545034642032333,0.47835368412218865,1.0,6/21,6.44%,ERRFI1;MAFG;BMP4;CBFB;ROCK2;ROCK1
prerank,histone H2A acetylation (GO:0043968),0.5740812358666223,1.4284310939892357,0.07567567567567568,0.9177369057674102,1.0,7/16,13.17%,ACTL6A;RUVBL2;DMAP1;RUVBL1;ING3;YEATS4;TRRAP
prerank,regulation of metal ion transport (GO:0010959),-0.5286031964995161,-1.427452203309385,0.08520179372197309,0.4806549069291492,1.0,9/16,22.75%,ANK2;STIM1;SLC30A10;IL16;SRI;DLG1;BCL2;CAMK2B;CACNA2D1
prerank,immunoglobulin mediated immune response (GO:0016064),0.6381120472724371,1.4271387826387312,0.08547008547008547,0.9185125114598502,1.0,2/10,10.85%,FCGR2B;CD81
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.500148512668963,-1.426760853432244,0.07444168734491315,0.48067435350203724,1.0,9/21,24.18%,IGF1;IGFBP5;ADAMTS1;GJA1;JUN;DNMT1;BMPR1A;MMP2;MEF2D
prerank,base conversion or substitution editing (GO:0016553),0.6073793692107501,1.4267536419679188,0.09695817490494296,0.9142849652759053,1.0,3/11,15.70%,ADAR;ADARB2;ADARB1
prerank,myoblast differentiation (GO:0045445),-0.5515719075835267,-1.4266365489659565,0.10085836909871244,0.47880023175930136,1.0,3/14,2.12%,DDX5;IGF1;DDX17
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.4502368891836146,1.4265880494998333,0.0421216848673947,0.9089208872208967,1.0,15/53,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.5100769666809483,-1.4260928736249123,0.07439824945295405,0.4782511672617412,1.0,11/18,24.55%,NRXN1;TSHZ3;NLGN2;RELN;NLGN1;CACNG7;CACNG4;CACNG2;NLGN3;CACNG3;CACNG8
prerank,activation of adenylate cyclase activity (GO:0007190),-0.4383424470944294,-1.425774857171229,0.03818615751789976,0.4770355155773674,1.0,13/35,22.46%,ADCY5;LGR4;ADCY2;ADCY1;ADCY9;EDNRA;ADCY7;RAF1;LGR5;ADCY3;ADCY8;ADCY4;CAP1
prerank,inorganic cation transmembrane transport (GO:0098662),-0.30930260521285596,-1.425403972030437,0.0,0.4759532946844125,1.0,51/268,13.25%,TRPM3;ATP1A2;KCNK2;SLC24A3;KCNQ3;KCNB2;CACNA1C;HCN1;NALCN;KCNH7;KCNQ5;CACNA1D;SLC1A3;RYR3;SLC6A13;KCNC2;PKD1;KCND2;ATP1B1;TRPM6;SLC41A1;TRPC5;SLC6A1;P2RX4;SCN8A;ATP1B3;SCN3A;SLC12A2;SLC39A14;SLC30A10;KCNH5;SLC6A9;SLC6A12;ATP1A1;SLC39A13;KCNK5;KCNJ2;TRPC1;SCN1A;KCNA1;SCARA5;SLC24A2;KCNK10;SLC30A4;ATP6V0A4;SLC9A2;ABCC9;ATP6V0C;TMCO1;CACNA1G;SLC39A8
prerank,cardiac myofibril assembly (GO:0055003),-0.5377286934191094,-1.4246591143515237,0.07221006564551423,0.4761508812810752,1.0,3/15,12.50%,PDGFRB;PDGFRA;OBSL1
prerank,regulation of immunoglobulin production (GO:0002637),0.5174603862087349,1.4245400422405479,0.0705244122965642,0.9139591973397182,1.0,4/23,10.79%,PTPRC;FCGR2B;PHB2;GPI
prerank,regulation of cell killing (GO:0031341),0.5805474205252874,1.4242777270538742,0.0975609756097561,0.9091827728742602,1.0,5/16,14.60%,MAPK8;ICAM1;WNT5A;CD55;CYBA
prerank,presynapse assembly (GO:0099054),-0.5293798919393844,-1.4230751454997943,0.08008658008658008,0.4791082218385844,1.0,7/16,17.40%,LRRTM3;PCLO;NLGN2;NLGN1;IL1RAPL1;BSN;DVL1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.5404304792208479,-1.4225778910892966,0.06153846153846154,0.47834843907351454,1.0,5/17,7.76%,HDAC4;PID1;NUPR1;PPARA;FIS1
prerank,cGMP-mediated signaling (GO:0019934),-0.5670875499258116,-1.4223755530026403,0.0881057268722467,0.4768334090848328,1.0,3/13,1.79%,HTR2C;IRAG1;KCNC2
prerank,actin cytoskeleton reorganization (GO:0031532),-0.38900950763615233,-1.4221968124692221,0.04,0.4752718367781519,1.0,16/63,8.47%,MCU;GSN;PARVA;AUTS2;NRP1;CXADR;CDC42BPB;FER;PTK7;RHOA;FLNA;NEDD9;KIT;PIP5K1A;CTTN;EZR
prerank,ventricular septum morphogenesis (GO:0060412),-0.45197480602556,-1.4211528392964035,0.05378973105134474,0.47623827317538553,1.0,7/27,4.63%,ROBO2;TGFBR3;ROBO1;TGFBR1;TGFBR2;SMAD4;BMP4
prerank,skeletal muscle tissue development (GO:0007519),-0.4514578432443696,-1.4207225510082808,0.058823529411764705,0.4756081874431061,1.0,7/32,18.70%,SVIL;CFLAR;IGSF8;SKI;CAV2;SIX1;SELENON
prerank,neuron fate commitment (GO:0048663),-0.5526496866556134,-1.4206690998717404,0.07692307692307693,0.47373243136739784,1.0,2/14,3.39%,MYT1L;TGFBR1
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4277332854027089,1.4206481876275827,0.04503105590062112,0.9237834892616787,1.0,24/60,21.02%,MAP2K7;MAPK3;PNKP;GREM1;CCT2;PRKD2;CCT5;MAP3K4;RGCC;ACD;NEK7;TNKS;ATR;TCP1;DKC1;PARN;PARM1;TNKS2;NVL;CCT8;RFC5;PTGES3;HSP90AB1;PDGFB
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.3878713706823817,1.4204122844266698,0.022222222222222223,0.9187750328312547,1.0,18/117,10.85%,GPR176;PRKAR1A;PTGER2;PLK2;SRC;TSHR;INSL3;RAMP2;FYN;GNB1;RXFP1;SYK;PLCG1;LYN;RHBDF2;YES1;CD163;CD81
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.48319227959743005,1.420217565225448,0.06386554621848739,0.913587576000038,1.0,6/32,8.70%,ERCC3;MAPK3;POLR1C;CCNH;POLR1G;GTF2H1
prerank,axonal transport of mitochondrion (GO:0019896),-0.6049861662070861,-1.4190229975744524,0.08125,0.4767234276297721,1.0,4/11,16.03%,MAPT;TRAK1;NEFL;ACTR10
prerank,peptidyl-asparagine modification (GO:0018196),0.47748693181140467,1.4182432300664223,0.057755775577557754,0.9182707207693052,1.0,7/31,11.96%,NUDT14;ASGR1;ALG8;OST4;STT3B;MGAT5;MCFD2
prerank,relaxation of muscle (GO:0090075),-0.5603972875120076,-1.4179943482933328,0.08096280087527352,0.477622994582769,1.0,7/13,11.26%,ATP1A2;GSN;ATP1B1;P2RX4;ATP1A1;KCNJ2;CAMK2D
prerank,acetyl-CoA metabolic process (GO:0006084),0.560066716409275,1.4179372553902978,0.10124333925399645,0.9138572766534184,1.0,5/15,10.12%,DIP2A;MLYCD;ACAT1;ACACB;HMGCS2
prerank,positive regulation of phosphatase activity (GO:0010922),-0.4924594410811173,-1.417333200221645,0.05466970387243736,0.47750346848540637,1.0,2/21,1.90%,MAGI2;PDGFRB
prerank,amino sugar metabolic process (GO:0006040),0.6062709510198769,1.41688727809823,0.09647495361781076,0.9135292503310624,1.0,4/10,13.27%,CSGALNACT1;EXTL2;SLC35A3;ST3GAL1
prerank,relaxation of cardiac muscle (GO:0055119),-0.5521761672924592,-1.416814738020688,0.10084033613445378,0.4768378650553878,1.0,7/13,11.26%,ATP1A2;GSN;ATP1B1;P2RX4;ATP1A1;KCNJ2;CAMK2D
prerank,myeloid dendritic cell activation (GO:0001773),-0.580025042732079,-1.4162265880042837,0.07692307692307693,0.47640451243813076,1.0,3/12,9.80%,TGFBR2;CAMK4;DOCK2
prerank,embryonic skeletal system development (GO:0048706),-0.43301101629113287,-1.4153307093608196,0.04964539007092199,0.4771413666854421,1.0,9/35,7.69%,SULF1;COL1A1;PCSK5;SULF2;HOXA3;OSR1;DYNC2I1;PDGFRA;RBP4
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4800024799221384,-1.4153067894361429,0.049217002237136466,0.47520459673410076,1.0,8/24,8.37%,TENM2;DPYSL3;NRP1;WASL;GPM6A;PLPPR5;NLGN1;DOCK11
prerank,regulation of histone methylation (GO:0031060),0.5968834515183474,1.4151995729494098,0.11090573012939002,0.9168265361139594,1.0,4/13,6.19%,CTCFL;AASS;TTLL12;CHTOP
prerank,snRNA metabolic process (GO:0016073),-0.5306518718220365,-1.415043292073332,0.08370044052863436,0.47385532762954125,1.0,13/17,33.55%,INTS10;INTS8;MTREX;INTS11;RBM7;ZCCHC8;INTS7;TUT1;INTS12;INTS9;INTS3;MEPCE;INTS1
prerank,tRNA metabolic process (GO:0006399),0.5559343420726621,1.4141225556688375,0.08228980322003578,0.9169971692159806,1.0,4/17,8.74%,THG1L;FARS2;YARS2;POP5
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5685987065333149,-1.414115100495572,0.08588957055214724,0.4746078195906914,1.0,3/13,0.38%,ERBB4;FGFR2;TGFBR3
prerank,positive regulation of phospholipase activity (GO:0010518),-0.48053986271434196,-1.4140245583752296,0.06088992974238876,0.47284271148036255,1.0,9/22,19.53%,NTRK3;FGFR2;PDGFRB;KIT;PDGFRA;ARL1;ARF4;ABL2;AGTR1
prerank,positive regulation of cell killing (GO:0031343),0.5842869082824154,1.4135710160718344,0.1033210332103321,0.9140787114728447,1.0,4/13,14.60%,MAPK8;SYK;WNT5A;CYBA
prerank,regulation of programmed cell death (GO:0043067),0.3702608828537242,1.413038186929803,0.018641810918774968,0.9112217466690853,1.0,28/161,12.14%,LRP8;CIDEA;MECOM;ACER2;GLS2;CHM;DNAJA3;PAX8;BIRC2;NME1;TNFRSF10B;SLK;TOX3;CASP6;WFS1;AKT1S1;CRADD;ACTN4;OMA1;SIRT1;PHLPP1;FBXO11;TARDBP;NAE1;CREBBP;RPS3;ACER3;BNIP3L
prerank,regulation of striated muscle contraction (GO:0006942),-0.4654526096075203,-1.4124809943409322,0.057736720554272515,0.4756427774504519,1.0,6/27,12.06%,ANK2;ATP1A2;ASB3;P2RX4;PRKACA;SRI
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.5393820945580127,-1.4122543304650366,0.07974137931034483,0.47437017802302067,1.0,12/15,43.81%,ENTPD5;ENTPD7;ENTPD6;AK5;ENTPD1;ENTPD2;AK4;CMPK2;AK1;NME2;ENTPD3;AK7
prerank,skeletal system development (GO:0001501),-0.3289333025866465,-1.4119145989543633,0.008064516129032258,0.47348103390399465,1.0,27/148,8.30%,BMP6;FGFR2;IGF1;COL1A2;SULF1;FBN1;AKAP13;COL1A1;PKD1;ITGB8;GLI2;PCSK5;MMP16;TGFBR1;BMP5;SOX5;BMP7;SULF2;VCAN;NPR3;MMP14;ATP7A;CREB3L2;ANKH;RBP4;CDH11;COL13A1
prerank,ribosomal large subunit assembly (GO:0000027),0.5165588670801613,1.4116472595023815,0.07570422535211267,0.91351714034047,1.0,8/24,13.61%,RSL24D1;FASTKD2;RPL3;RPL5;MRPL20;RPLP0;RPL24;RPL23A
prerank,neuron projection extension (GO:1990138),-0.44557110926789845,-1.4110083045555726,0.05088495575221239,0.4745075157248278,1.0,10/32,9.55%,ALCAM;MAP1B;ULK2;IQGAP1;SH3GL2;AUTS2;NRP1;CTNNB1;SEMA3A;NRP2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.5616915535709158,-1.4109849775303094,0.08333333333333333,0.4726123682101239,1.0,7/13,16.44%,PLXNA2;NRP1;SEMA3A;NRP2;PLXND1;PLXNB2;PLXNC1
prerank,protein localization to plasma membrane (GO:0072659),-0.3384906948600051,-1.4105391900020354,0.007380073800738007,0.47187937513816225,1.0,39/129,16.85%,ANK2;DPP6;ANK3;KCNB2;KCNIP4;EPB41L3;MAP7;RAB3C;ATP1B1;PACS2;ASB3;FLNA;KCNIP3;ATP1B3;ROCK2;FLOT2;RAB8B;PIP5K1A;ROCK1;TTC7B;EZR;AFDN;ACTN2;CDH1;TTC7A;DPP10;RAMP1;DLG1;MYADM;RAB11A;WNK3;STXBP1;NECTIN3;FYB1;LRP6;RAPGEF2;EHD3;EHD1;RAB8A
prerank,cellular response to interleukin-1 (GO:0071347),0.38197772948844555,1.4096282735495227,0.018995929443690638,0.9187640266490776,1.0,34/143,14.19%,PSMB10;PSMC4;PSMB6;MAPK3;PSMD8;PSMD5;PSMD12;IL1R1;MAP3K7;TAB2;RPS6KA4;RPS6KA5;PSMD11;GBP3;PSMB4;PSMC1;TAB3;CCL25;RELA;CD47;PSMC2;PLCB1;PSMD2;UBE2V1;NOD1;TNIP2;IKBKB;CHUK;PSMD14;PSMC6;NFKBIA;PSMD1;PSMB1;MAP3K3
prerank,positive regulation of potassium ion transport (GO:0043268),-0.4274008392234645,-1.4092975114137476,0.05945945945945946,0.47354660762992773,1.0,10/38,12.89%,ANK2;KCNMA1;AKAP6;FHL1;FLNA;GABBR2;KCNJ2;ACTN2;KCNJ6;DLG1
prerank,embryonic appendage morphogenesis (GO:0035113),0.5901239369472403,1.4085625395357269,0.08614232209737828,0.9191193608291877,1.0,1/12,0.04%,TBX4
prerank,cellular response to BMP stimulus (GO:0071773),-0.375031410247957,-1.4082156632608336,0.025787965616045846,0.47480752363317413,1.0,15/66,10.30%,DDX5;BMP6;TGFBR3;ADAMTS12;SMAD3;RGMA;BMP5;BMP7;SMAD4;BMP4;SMAD6;ZFYVE16;ACVR1;HIVEP1;RGMB
prerank,calcium ion transport (GO:0006816),-0.3410756911606678,-1.4079945662114686,0.007220216606498195,0.4735831543697448,1.0,16/113,6.00%,TRPM3;ANK2;SLC24A3;CACNA1C;NALCN;ITPR1;CALCRL;STIM2;CACNA1D;RYR3;PKD1;STIM1;TRPM6;TRPC5;P2RX4;CACNA1B
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.507424168633858,1.4078825609489996,0.08250825082508251,0.9173317873770874,1.0,2/23,6.89%,CADM1;AP1G1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5005119697820927,1.4068986846439322,0.08089500860585198,0.9171489950662581,1.0,6/25,11.45%,PDE4D;PTPRC;MAP3K7;PRKD2;PNP;RPS3
prerank,regulation of leukocyte migration (GO:0002685),0.5494362302447021,1.4067492983393188,0.1062618595825427,0.9122626210025346,1.0,4/16,11.14%,RAC2;HOXA7;CD81;RHOG
prerank,regulation of microtubule polymerization (GO:0031113),-0.41696700275279225,-1.4064780324692552,0.04738154613466334,0.47617069486404834,1.0,12/40,15.65%,NAV3;MAP2;EML2;MAPT;OCLN;STMN2;AKAP9;SLAIN2;CLIP3;STMN1;TUBB4A;DCTN1
prerank,phagolysosome assembly (GO:0001845),0.5922744576932415,1.4064553268823374,0.07766990291262135,0.9082380118328292,1.0,4/12,8.27%,RAB7A;RAB7B;PIKFYVE;RAB14
prerank,regulation of microtubule-based process (GO:0032886),-0.4207432245499143,-1.4058002747295264,0.054404145077720206,0.47631377812014775,1.0,12/36,14.27%,BICD1;PHLDB2;EFNA5;PHLDB1;CYLD;MAPT;MACF1;ROCK1;EPHA3;GSK3B;TAOK1;TRIM36
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.4583605786331474,-1.4053435727930481,0.06466512702078522,0.4757858581499064,1.0,10/26,25.27%,SULF1;SULF2;CCBE1;IL6ST;TGFB1;RORA;SARS1;PTGS2;ATF4;EIF2AK3
prerank,transcription by RNA polymerase I (GO:0006360),0.46888102593503656,1.4046732193187688,0.0625,0.9126784113624011,1.0,6/34,8.70%,ERCC3;MAPK3;POLR1C;CCNH;POLR1G;GTF2H1
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.42458234070893663,1.404506314508706,0.0352760736196319,0.9080264111703223,1.0,19/67,14.60%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;B2M;PSMC1;PSMC2;PSMD2;IKBKB;CHUK;PSMD14;PSMC6;PSMD1;PSMB1;CYBA
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5434383007742586,-1.4034174014729517,0.08669354838709678,0.4794669405204018,1.0,3/14,9.17%,PIBF1;IRAK3;THBS1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5517938434922117,-1.4028430590184313,0.0872210953346856,0.4792028451126389,1.0,4/13,5.85%,SORBS1;GKAP1;PRKCZ;SORL1
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.3703866341407851,-1.4024375165721146,0.03857566765578635,0.4785498489425982,1.0,14/67,6.59%,ERBB4;FGFR2;EGFR;PDGFRB;ABI1;FER;PIBF1;KIT;EFEMP1;TEC;RELN;GHR;DDR1;PDGFRA
prerank,histone exchange (GO:0043486),0.46808086113791725,1.40209624793234,0.071875,0.9157312749009224,1.0,13/37,18.59%,MIS18A;DMAP1;VPS72;HJURP;RUVBL1;RSF1;CENPC;ZNHIT1;CENPP;RBBP4;CENPO;NPM1;ACTR6
prerank,regulation of cellular pH (GO:0030641),0.4900340463524822,1.401378847308677,0.06937394247038917,0.9143097942701568,1.0,6/29,6.87%,SLC4A4;SLC4A5;SLC9A7;CA2;SLC9A6;SLC9A8
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5558149436008772,-1.4011823380382722,0.08977035490605428,0.4806811744712991,1.0,10/13,39.64%,ENPP1;ENTPD5;ENPP3;ENTPD7;ENTPD6;ITPA;ENTPD1;ENTPD2;SMPDL3A;ENTPD3
prerank,histone ubiquitination (GO:0016574),-0.4925239230971641,-1.401061740781477,0.07205240174672489,0.4791634829017128,1.0,12/21,25.36%,UBE2N;WAC;UBE2E1;CDC73;HUWE1;RNF8;PHC1;PAF1;RNF40;DTX3L;UBR2;UBE2B
prerank,cardiac muscle cell differentiation (GO:0055007),-0.48006505103431724,-1.4010290897344984,0.07268722466960352,0.477429213798918,1.0,10/21,34.10%,AKAP13;CXADR;SIK1;ACVR1;KDM6B;VEGFA;MYH11;BMP2;CBY1;MYOCD
prerank,regulation of defense response (GO:0031347),0.41413648640762174,1.4007177788413843,0.04437869822485207,0.9124950863151685,1.0,17/76,12.02%,LRP8;PIK3AP1;IL1R1;SEMA7A;FCGR2B;TIRAP;SBNO2;BCL6B;BIRC2;APOE;SPATA2;WNT5A;TRAF3;RELA;PARK7;NLRP6;USP18
prerank,atrial septum development (GO:0003283),-0.5575935946317248,-1.4006233533507633,0.08713692946058091,0.47663567754202196,1.0,2/13,0.29%,ANK2;NOTCH2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.49273254663469707,1.3999674228505623,0.07,0.9109740423160582,1.0,9/29,9.70%,TRIB3;PIN1;DCUN1D4;FBXO5;SMAD7;BMI1;AXIN1;MAGEC2;PARK7
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.42287387171919544,-1.3998919173419047,0.06878306878306878,0.4771380432256565,1.0,14/37,15.10%,BICD1;PHLDB2;EFNA5;PHLDB1;CYLD;MAPT;ROCK1;STMN2;SKA2;EPHA3;GSK3B;TAOK1;TRIM36;STMN1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.46735997488439424,1.3993100309031783,0.07357859531772576,0.9091359187439918,1.0,15/35,19.71%,MAP2K7;MAPK3;PNKP;CCT2;CCT5;MAP3K4;ACD;NEK7;TNKS;ATR;TCP1;PARN;TNKS2;DHX36;CCT8
prerank,protein import into peroxisome membrane (GO:0045046),-0.4782527255144093,-1.3977623913264832,0.08196721311475409,0.4814433795186999,1.0,13/22,30.88%,ACBD5;RAB8B;PEX14;FIS1;ALDH3A2;PXMP4;ABCD2;PEX2;PEX5;GDAP1;ABCD3;PEX26;PEX19
prerank,histone H4 acetylation (GO:0043967),0.44206412198267164,1.3959437128862688,0.044585987261146494,0.922211611988596,1.0,16/47,14.02%,JADE3;ACTL6A;LEF1;RUVBL2;DMAP1;ING4;KANSL2;BEND3;EP300;RUVBL1;KANSL3;ING3;YEATS4;TRRAP;ING5;HCFC1
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.539569400117544,-1.3957546214122571,0.09853249475890985,0.4854564009132631,1.0,6/15,18.69%,IGF1;ROCK2;ROCK1;CAMK2D;IL6ST;PARP1
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.40054002263586974,-1.3945775510135685,0.0449438202247191,0.48721181349292964,1.0,19/45,20.68%,DDX5;EGFR;BMP4;RIOK1;LIN28B;RIOK2;MAP2K2;NFKB1;TP53;POLR2A;ZC3H18;WDR43;SETX;SIRT7;TGFB1;HABP4;GRSF1;SUPV3L1;PIK3R1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.40609331840465884,-1.3942597161167345,0.051630434782608696,0.48627609173304037,1.0,17/43,28.67%,DDX5;TEAD1;SMAD3;NFIB;BMP4;PPARA;TP53;JUN;TGFB1;NR3C1;NFATC4;GNL3;KLF5;ATOH8;GATA2;EGR1;FOXO3
prerank,glutamine family amino acid metabolic process (GO:0009064),0.4771075050609643,1.3941807816543725,0.07731958762886598,0.9266920977526533,1.0,7/33,6.26%,GCLC;ALDH5A1;GLS2;GLS;GOT2;GCLM;MTHFS
prerank,cellular response to fluid shear stress (GO:0071498),0.5995807505891778,1.3937825615099952,0.09233791748526522,0.9234983220603415,1.0,3/12,3.74%,KLF2;MAP2K5;HDAC3
prerank,retinoic acid metabolic process (GO:0042573),-0.5488059323237533,-1.393657555789745,0.09876543209876543,0.4860186399133557,1.0,3/14,13.37%,ALDH1A2;SCPEP1;CYP26B1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.4367070725303582,1.3934231768039393,0.05451713395638629,0.9202307923924572,1.0,18/51,18.24%,MAP2K7;MAPK3;CTC1;PNKP;SRC;CCT2;CCT5;MAP3K4;HNRNPC;ACD;NEK7;TNKS;ATR;TCP1;PARN;SMG6;TNKS2;SMG5
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5768446328047383,1.3925634156114048,0.11720226843100189,0.919757285492856,1.0,5/13,16.65%,KPNA3;NUP54;KPNA1;NUP35;KPNB1
prerank,mitochondrial gene expression (GO:0140053),0.4548290036004611,1.3922489942117897,0.04975922953451043,0.9162982623179053,1.0,15/42,18.13%,MRPS2;MRPL23;FASTKD2;LARS2;MRPS12;HARS1;RARS2;MRPS15;MRPS24;TFAM;GATB;MRPS28;MRPS34;IARS2;GFM2
prerank,defense response to Gram-positive bacterium (GO:0050830),0.45194145412111775,1.3916477892897126,0.061191626409017714,0.9142022198082704,1.0,6/40,7.63%,ROMO1;DMBT1;TIRAP;RNASE6;GBP4;PPP1R11
prerank,cell-cell junction assembly (GO:0007043),-0.36942560538329555,-1.3910818820024353,0.03943661971830986,0.4918110987438385,1.0,19/63,11.14%,EPB41L3;CDH10;GJB6;CTNNA1;CTNNB1;TLN1;RHOA;CLDN11;JAM3;VCL;CTNND2;TLN2;CDH11;CDH7;GJC1;GJD3;ARVCF;GJA1;GJB2
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.612615070715761,-1.3909697665792145,0.07610993657505286,0.4902576462201704,1.0,3/10,9.26%,ATP1A2;VDAC1;BIN1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.6013936541573697,1.3909441456523557,0.10701754385964912,0.9127802198902143,1.0,2/11,0.85%,TIMM29;ROMO1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.4406489189931542,-1.3906214142811046,0.07035175879396985,0.48937102628849705,1.0,13/31,26.50%,SYT9;SYT12;SYT11;CACNA1G;SYT4;STXBP1;SYT7;SCAMP5;STX1A;SYT2;ADRA2A;SYT10;SYT6
prerank,response to organonitrogen compound (GO:0010243),-0.4114918710948029,-1.3905628891077766,0.05555555555555555,0.48772448028392057,1.0,17/38,32.78%,GLRB;KAT7;VCP;RHBDD1;GLRA3;HLCS;GLRA1;IRAK3;RCN3;RNF139;ERLEC1;UBXN6;RNF185;SYVN1;DRD2;DHFR;MTOR
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.4007788768637603,1.3901997616340354,0.04011461318051576,0.911594935901518,1.0,24/87,13.97%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ZFP36L1;PSMD11;PSMB4;PSMC1;CDKN1A;RGCC;FBXO5;USP47;CDK4;WEE1;PSMC2;PSMD2;PSMD14;PSMC6;AVEN;PSMD1;PSMB1;APC
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.5769494591340156,-1.3901708320031347,0.08350730688935282,0.48711396441758975,1.0,2/12,1.69%,MAGI2;IQGAP1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.553762028402354,-1.3894454866616617,0.07755102040816327,0.4874067736145639,1.0,4/13,9.82%,NFAT5;RHOA;IRAK1;ZDHHC21
prerank,positive regulation of wound healing (GO:0090303),-0.42096157405053647,-1.3893713403176866,0.056338028169014086,0.48584392216100947,1.0,18/36,32.78%,OCLN;PLPP3;RREB1;SMOC2;THBS1;VTN;FOXC2;ANXA1;ST3GAL4;PTK2;ENPP4;ADRA2A;DMTN;SERPINE1;HBEGF;MYLK;CLDN1;MTOR
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.49989844776851144,-1.389199904654554,0.09339407744874716,0.4845996148866239,1.0,6/18,11.40%,SMAD3;ITGB8;SMAD4;LTBP1;FN1;CD34
prerank,stress-activated MAPK cascade (GO:0051403),0.4128926543652488,1.3889510775562868,0.057902973395931145,0.9134742791378113,1.0,16/61,12.92%,MAP2K7;MAP3K11;MAPK3;MAP3K7;TAB2;ZFP36L1;MAPK8;ARHGEF6;TAB3;MINK1;UBE2V1;NOD1;TNIP2;CRKL;IKBKB;CHUK
prerank,microtubule-based transport (GO:0099111),0.6143393546973659,1.388331997089778,0.098,0.9116742568559002,1.0,2/12,2.16%,DYNC1I1;CABYR
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.35011620613908745,-1.3879143023850147,0.022508038585209004,0.48654817297726427,1.0,14/85,5.90%,BMP6;FGFR2;TGFBR3;IGF1;EGFR;MCC;FGF1;BMP5;MTSS1;BMP4;NUPR1;OSR1;SRSF6;EPB41L4B
prerank,neutral amino acid transport (GO:0015804),0.494874920837631,1.3871632373631786,0.07167832167832168,0.9131487947932833,1.0,5/28,5.75%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC6A6
prerank,regulation of mitotic cell cycle (GO:0007346),0.3637417425246276,1.3868673572712087,0.02064516129032258,0.9096894466289047,1.0,39/171,14.43%,DYNLT3;PSMB10;ERCC3;PSMC4;PSMB6;CKS2;PSMD8;PSMD5;PSMD12;TAL1;BRINP3;ANAPC2;PIN1;NEK11;TTLL12;PSMD11;PSMB4;PSMC1;CDK11B;FBXO5;SIRT1;ANAPC7;MDM2;PSMC2;PSMD2;TFAP4;USP22;ANAPC11;NEK7;APP;ANAPC10;ANAPC4;NEK6;PSMD14;PSMC6;PSMD1;PSMB1;RNF20;RCC1
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.5428173630762512,-1.386705323726137,0.09719222462203024,0.48838368580060426,1.0,7/13,17.05%,RNF152;DEPDC5;CASTOR2;STK11;ATM;SZT2;ITFG2
prerank,regulation of lysosomal lumen pH (GO:0035751),0.5991156475797197,1.3867004537107896,0.10133843212237094,0.9056143734027572,1.0,4/12,8.40%,PPT1;TMEM9;ATP6AP2;TMEM165
prerank,regulation of mRNA metabolic process (GO:1903311),0.6044100909440793,1.3863423149377936,0.12280701754385964,0.9027303151135838,1.0,7/11,21.59%,NCBP1;CDK11B;SRPK2;PTCD2;SAFB;DHX9;SLTM
prerank,sphingolipid metabolic process (GO:0006665),0.38544648787617847,1.3860746265193902,0.043909348441926344,0.8992161628631298,1.0,19/108,8.28%,SERINC1;CERS1;GLB1;SMPD4;ACER2;ST6GALNAC3;CERS4;PPT1;PRKD2;PPP2CA;ESYT2;KDSR;ELOVL6;SGMS1;CERKL;UGCG;PLPP1;TEX2;SGPP2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.41896324987648664,1.3840808064826196,0.04675716440422323,0.9050777860857134,1.0,18/65,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;PSMC1;USP47;PSMC2;PSMD2;CHFR;PSMD14;PSMC6;AVEN;PSMD1;PSMB1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.556709543482181,-1.3838221655649185,0.09978308026030369,0.49489360304741886,1.0,4/13,6.61%,PID1;PPARGC1A;VCP;PPARA
prerank,positive regulation of neuron projection development (GO:0010976),-0.35469201887744295,-1.3835521467390957,0.022435897435897436,0.493912713907097,1.0,37/85,22.12%,MAGI2;NTRK3;TENM3;LRRC7;DPYSL3;NTRK2;TOX;BMP5;BMP7;PTK7;ROR1;RELN;CBFA2T2;COBL;PLPPR5;STMN2;ARSB;ATP1B2;EPHA3;CUX2;RIT2;CAMK1;VLDLR;SETX;PLXNB2;RAPGEF2;ABL2;ROR2;TWF2;SCARF1;SNX3;PACSIN1;CX3CL1;PRKD1;P3H1;DBNL;CAMK2B
prerank,regulation of stem cell differentiation (GO:2000736),0.3970559821752748,1.3823340587774895,0.04518950437317784,0.909733744892478,1.0,20/89,13.89%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TAL1;OCIAD1;PSMD11;PSMB4;PSMC1;NOTCH1;PSMC2;PSMD2;LMO2;PSMD14;PSMC6;PSMD1;PSMB1;HES1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),-0.5174865513881307,-1.382130343830391,0.10151187904967603,0.4963539742224347,1.0,2/17,1.32%,ANK3;AKAP6
prerank,Rho protein signal transduction (GO:0007266),-0.38885095573443457,-1.381236185259783,0.06944444444444445,0.49706818698632366,1.0,25/53,26.89%,COL1A2;ARHGAP29;PDPN;RHOA;ROCK2;CTNNAL1;ARHGAP6;SHTN1;ROCK1;PLEKHG5;RHOJ;RHOB;ARHGDIA;CDC42EP5;CDC42EP1;CDC42;AGTR1;ARHGEF1;ARHGDIB;EPS8L2;RHOU;ADRA2A;RIPOR1;ADGRG1;CDC42EP2
prerank,positive regulation of axonogenesis (GO:0050772),-0.40116728377876487,-1.3804723016736595,0.0456989247311828,0.49747788088044886,1.0,17/43,18.00%,ROBO2;PLXNA2;ROBO1;NTRK2;TIAM2;MAPT;MACF1;RHOA;SHTN1;SEMA4D;PLXND1;ARHGDIA;PLXNB2;NGF;PLXNC1;TWF2;ZFYVE27
prerank,JNK cascade (GO:0007254),0.44519933717966714,1.3802279816929235,0.08702791461412152,0.9163361130168806,1.0,11/40,12.34%,MAP2K7;MAP3K11;MAP3K7;TAB2;MAPK8;ARHGEF6;TAB3;MINK1;UBE2V1;NOD1;CRKL
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5633110070619605,-1.37997692108525,0.11909650924024641,0.49722344668910123,1.0,4/12,16.33%,TMEFF2;AP2A1;SELENOS;TGFB1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.4554606768967286,1.379412682464821,0.08169934640522876,0.9158776222833415,1.0,15/40,16.32%,RPL23;PDCL3;HIPK2;UBE3A;RPL5;FOXF2;AXIN1;DESI1;GNA12;RAD23A;XPO1;CSNK2A2;UBQLN4;TAF1;PTK2B
prerank,negative regulation of DNA metabolic process (GO:0051053),0.4973652905094244,1.3787704566968264,0.0782608695652174,0.9145589839755652,1.0,7/24,11.45%,ZRANB3;DACH1;ERCC4;CDKN1A;ACVRL1;MSH3;RPS3
prerank,histone deacetylation (GO:0016575),-0.3994548787442346,-1.3784054441041673,0.06476683937823834,0.5002691714340811,1.0,15/43,12.52%,PRDM5;MIER1;HDAC4;TBL1XR1;HDAC1;SIRT2;MORF4L2;PER2;MTA3;MIDEAS;MORF4L1;MTA1;TBL1X;PER1;RCOR3
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.5237033020645978,1.377901442073759,0.10288808664259928,0.9142246187382386,1.0,3/23,4.08%,SLC12A1;SLC9A7;CLCN3
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.5230637947288791,1.3772831876717178,0.08957952468007313,0.9127715199772916,1.0,6/20,11.92%,SLC25A1;PPT1;FITM2;FAR2;ACSL4;HSD17B4
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.44614000487428024,1.3763833537551242,0.08077544426494346,0.912800001835074,1.0,20/42,19.00%,ACTL6A;DMAP1;ACTB;SMARCA2;VPS72;ACTR8;HNRNPC;ACTR5;CHD3;CECR2;ZNHIT1;INO80;PBRM1;SMARCA4;RBBP4;SMARCAD1;CHD8;HDAC2;ACTR6;SMARCB1
prerank,AMP metabolic process (GO:0046033),-0.5331177254004434,-1.3762793305757792,0.10329670329670329,0.504786598059206,1.0,11/13,41.57%,AMPD3;XDH;AK3;AMPD2;ADSS2;ADSL;NUDT2;AK4;NT5C1A;ADSS1;NT5E
prerank,type I interferon signaling pathway (GO:0060337),0.45560928013705193,1.3759150507216407,0.08823529411764706,0.9057305412347968,1.0,13/41,12.78%,IFITM2;IFIT1;IFI35;XAF1;IRF9;IFITM3;ADAR;IFITM1;IFNAR1;IFI27;IP6K2;TYK2;IRF2
prerank,cellular response to type I interferon (GO:0071357),0.45560928013705193,1.3759150507216407,0.08823529411764706,0.9057305412347968,1.0,13/41,12.78%,IFITM2;IFIT1;IFI35;XAF1;IRF9;IFITM3;ADAR;IFITM1;IFNAR1;IFI27;IP6K2;TYK2;IRF2
prerank,negative regulation of ion transport (GO:0043271),-0.4500370012921493,-1.3756771980570397,0.08633093525179857,0.5047045870388495,1.0,12/24,30.03%,GPM6B;WNK1;ACTN2;WNK4;SYT11;WNK3;NEDD4;ADRA2A;INPP5K;SNCA;PACSIN3;NOS1
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.38090404231994807,-1.3754627636371668,0.05722070844686648,0.50357767530609,1.0,17/52,17.43%,CELF2;DDX5;DDX17;KHDRBS1;CELF4;KHDRBS2;RBMX;SRSF6;RBM15;RBFOX3;HNRNPA1;SMU1;RBM4;SRRM4;NOVA1;RBM7;RNPS1
prerank,regulation of acute inflammatory response (GO:0002673),-0.4927992081666744,-1.3750009194519612,0.09417040358744394,0.5032588257663787,1.0,3/18,17.39%,OSMR;IL6ST;PTGES
prerank,negative regulation of epithelial cell migration (GO:0010633),0.46131393141118776,1.3746447141934097,0.09657320872274143,0.9072525490532286,1.0,8/33,11.20%,PTPRR;PTPRG;PTPRM;EVL;APOE;KRIT1;ACVRL1;ADIPOR1
prerank,inner mitochondrial membrane organization (GO:0007007),0.43527522079961867,1.3743053354925692,0.07368421052631578,0.9045050830557104,1.0,16/47,14.82%,TIMM29;ROMO1;ATP5F1E;UQCC3;ATP5MG;ATP5PF;ATP5MC2;IMMT;MAIP1;CHCHD6;CHCHD3;LETM1;DNAJC11;NDUFA13;MICOS10;ATP5F1C
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),-0.3559366269091299,-1.3737207822064303,0.03550295857988166,0.5053304314873102,1.0,19/75,13.82%,MAP2;FGFR2;CNTN4;ANK3;DCC;MAP1B;CTNNA2;NRCAM;NTNG1;SDC2;RYK;DCDC2;SHTN1;BRSK1;BTBD3;PLPPR4;AFG3L2;MAP1A;UNK
prerank,positive regulation of cartilage development (GO:0061036),-0.5023172647126507,-1.373684970319357,0.08817204301075268,0.5036780903826787,1.0,9/17,29.17%,SOX5;TAPT1;BMP4;BMPR1B;SOX6;BMPR2;PKDCC;BMP2;MDK
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.5284043549391548,-1.373641469825759,0.08951965065502183,0.5020567850385222,1.0,10/14,37.75%,ENPP1;ENPP3;AK5;AK3;ITPA;AK4;SMPDL3A;CMPK2;AK1;NME2
prerank,regulation of stress fiber assembly (GO:0051492),-0.36085730826623097,-1.3736169177460467,0.03353658536585366,0.5004075945410981,1.0,18/74,6.44%,TMEFF2;PHLDB2;LPAR1;CGNL1;WASF2;ARHGEF10L;CCN2;NRP1;TGFBR1;ARHGAP28;TPM1;RHOA;PXN;PPFIA1;ROCK2;ARHGAP6;PPM1E;ROCK1
prerank,regulation of Ras protein signal transduction (GO:0046578),-0.3451922466635124,-1.373608003631778,0.02120141342756184,0.498715233438191,1.0,21/85,16.75%,NOTCH2;IGF1;AKAP13;DENND4A;OGT;KANK2;RALGPS1;RASGRF1;PLCE1;ARFGAP1;BCR;STARD13;LZTR1;EPHB2;GRB2;ARHGDIA;MADD;RAF1;NGF;RASGEF1A;RABL3
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5477658238526787,1.3733007893844293,0.10707456978967496,0.9053585720591084,1.0,3/15,8.71%,REEP1;ATL1;REEP3
prerank,potassium ion import across plasma membrane (GO:1990573),-0.40460567530987984,-1.3730292159421122,0.060526315789473685,0.498656261639697,1.0,20/41,27.27%,ATP1A2;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2;KCNJ6;ABCC9;SLC12A6;KCNJ13;SLC12A4;ATP1A3;KCNJ10;SLC12A9;SLC12A7;KCNK9;HCN2;SLC12A8;SLC12A5
prerank,protein neddylation (GO:0045116),0.5712165939509449,1.3727884553940264,0.11293260473588343,0.9033686012545961,1.0,7/13,16.84%,RNF7;DCUN1D4;UBE2M;NAE1;UBE2F;DCUN1D1;DCUN1D2
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.5310938351598633,1.3725274635617886,0.10583941605839416,0.9002439212546942,1.0,2/18,3.77%,PCK1;ZFP36L1
prerank,protein acylation (GO:0043543),0.45308880305574645,1.3725032590212343,0.09666666666666666,0.8958743977961136,1.0,13/38,14.14%,ZDHHC17;ING4;ZDHHC13;EP300;ZDHHC14;CLOCK;SELENOK;ZDHHC15;CREBBP;ZDHHC9;NAA80;ING5;ZDHHC7
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.4557739023537558,-1.3718431228646895,0.07432432432432433,0.5005735541280432,1.0,9/24,25.27%,SULF1;SULF2;CCBE1;IL6ST;TGFB1;RORA;PTGS2;ATF4;EIF2AK3
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4130958902024166,1.3715600280356268,0.06491499227202473,0.8964239789923095,1.0,18/70,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TAL1;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;LMO2;N4BP2L2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,neutrophil migration (GO:1990266),0.4236743368055016,1.3711490590020876,0.08450704225352113,0.8940949935472435,1.0,8/58,11.64%,PIK3CG;BSG;PECAM1;PPIB;SYK;PIKFYVE;CCL25;PIK3CD
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6262258207462598,1.3687344818026204,0.122568093385214,0.9020391958087566,1.0,2/10,3.46%,PTPRC;MAP2K5
prerank,regulation of aerobic respiration (GO:1903715),-0.5297909338566449,-1.3686018761917564,0.10989010989010989,0.5084584438004809,1.0,7/15,24.82%,ATP7A;VCP;COX7A2L;PINK1;SLC25A33;NOP53;UQCC2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.4408215266973358,-1.3685753905549054,0.06772009029345373,0.506807824261355,1.0,12/27,14.60%,PER2;PER3;CRY2;PML;BHLHE40;SIK1;MTA1;TP53;CRY1;PER1;RBM4;FBXL12
prerank,positive regulation of viral life cycle (GO:1903902),-0.4714266950164945,-1.3681211525149923,0.09090909090909091,0.5064888340001633,1.0,8/22,21.15%,AXL;DDB1;P4HB;TSG101;CHMP2B;LGALS1;TRIM11;VPS4A
prerank,vacuolar acidification (GO:0007035),0.5081530903329972,1.367956578816059,0.10135135135135136,0.9015709907972249,1.0,7/21,13.75%,PPT1;ATP6V0D1;TMEM9;ATP6AP2;ATP6V0E1;DMXL2;DMXL1
prerank,organic anion transport (GO:0015711),0.4023364284775822,1.3672269161563235,0.06041335453100159,0.9008548160307682,1.0,13/76,10.17%,SLC4A4;SLC4A5;ABCC4;SLC25A24;ABCG2;CA2;SLC52A2;CA4;SLC52A3;LRRC8C;SLC35A1;CYB5R4;SLC35B1
prerank,intracellular pH reduction (GO:0051452),0.46941399498753433,1.3667333153970094,0.08780487804878048,0.8989022628589858,1.0,11/33,14.87%,ATP6V1D;CLCN3;RAB7A;ATP6V0D1;TMEM9;GPR89A;GPR89B;ATP6V0E1;DMXL2;DMXL1;ATP6V1B2
prerank,cardiocyte differentiation (GO:0035051),-0.5766749541040622,-1.3666288056081475,0.10805500982318271,0.5090901461747384,1.0,8/10,34.10%,AKAP13;SIK1;KDM6B;EEF1AKMT4-ECE2;BMP2;CBY1;GATA6;MYOCD
prerank,smooth muscle cell differentiation (GO:0051145),0.594519782206119,1.3653543670922068,0.13001912045889102,0.9013957417858808,1.0,5/12,8.29%,MRTFA;MRTFB;HEY1;HEY2;EDNRB
prerank,CENP-A containing nucleosome assembly (GO:0034080),0.4843302771091258,1.3652587723617444,0.10474631751227496,0.8932827366814373,1.0,9/29,17.30%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;CENPP;RBBP4;CENPO;NPM1
prerank,CENP-A containing chromatin organization (GO:0061641),0.4843302771091258,1.3652587723617444,0.10474631751227496,0.8932827366814373,1.0,9/29,17.30%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;CENPP;RBBP4;CENPO;NPM1
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",0.3982009400972091,1.364210574774822,0.06259097525473072,0.8943487552312985,1.0,24/80,15.49%,SURF4;VPS50;HEATR5B;PREPL;SNX8;RAB7A;RAB7B;VPS29;VPS26A;TBC1D10B;GOSR2;RAB6B;PIKFYVE;RAB6A;SNX1;VPS53;GCC2;RBSN;TBC1D14;ERC1;TRIM27;TBC1D23;VPS35;TRAPPC10
prerank,regulation of gene expression by genetic imprinting (GO:0006349),0.5979937602676604,1.3633817498199312,0.10077519379844961,0.8945050290435475,1.0,2/10,6.17%,CTCFL;PCGF3
prerank,'de novo' posttranslational protein folding (GO:0051084),0.4679662277177988,1.3631649298353068,0.09185441941074524,0.8913524302004824,1.0,12/30,17.94%,HSPA8;CCT2;DNAJB5;BAG1;HSPE1;SDF2;HSPA13;DNAJB14;HSPA14;GAK;ST13;UGGT1
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5185756537499455,-1.3623172612445484,0.14634146341463414,0.5205891745574728,1.0,5/13,9.45%,ATP1A2;ATP1B1;ATP1B3;ATP1A1;ATP1B2
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3752708555068268,-1.3621464015699745,0.06077348066298342,0.5193330739928664,1.0,13/56,10.73%,ERBB4;FGFR2;EGFR;PDGFRB;ABI1;FER;KIT;EFEMP1;TEC;RELN;PDGFRA;EPHA3;EPHB2
prerank,endocytic recycling (GO:0032456),0.42972364417927267,1.362111517714035,0.07496251874062969,0.8926726058291784,1.0,20/50,18.36%,VPS50;EHD4;RAB7A;VPS29;VPS26A;RAB11B;DENND1A;SNX17;RAB14;VPS53;EIPR1;ACAP2;CCDC93;ANKRD27;VPS35;DENND1B;ARF6;ANKRD50;SNX27;VPS26C
prerank,cellular response to UV-A (GO:0071492),0.5939217482964846,1.3619504849056283,0.13523809523809524,0.8894052436510709,1.0,2/11,4.46%,CERS1;MME
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.5963093180232226,1.3614098903921075,0.1556420233463035,0.8880903845116755,1.0,2/11,7.27%,PTPRC;SMAD7
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.39266139504306313,1.3612916422025045,0.05627705627705628,0.8846179933461298,1.0,19/79,10.64%,DYNC1I1;MFSD6;KIF18A;CAPZA2;FCGR2B;AP2S1;KIFAP3;RAB7A;DCTN2;CLTA;AP1G1;AP1S2;PIKFYVE;DCTN3;KIF15;ARF1;OSBPL1A;KIF2A;DYNLL1
prerank,response to metal ion (GO:0010038),0.4032647567317703,1.3609705787027464,0.04675716440422323,0.8821528227701411,1.0,14/67,14.86%,MT1X;MT1A;GPHN;AHCYL1;PPP2CA;NEDD4L;CALM3;PPP2CB;PAM;PPP3CA;SLC25A12;PPP5C;MT2A;HOMER1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.3695273897697491,-1.3607045055708473,0.05847953216374269,0.5218240181268882,1.0,8/61,3.21%,NOTCH2;LPAR1;IGF1;ROBO1;AKAP13;COL3A1;AUTS2;RASGRF1
prerank,positive regulation of ion transport (GO:0043270),-0.3851984311764696,-1.3599330313833944,0.06982543640897755,0.5225482028685852,1.0,18/48,24.92%,ANK2;ANK3;STIM2;CACNA1D;FHL1;SNX4;P2RX4;ACTN2;DLG1;WNK3;ANO6;GPD1L;TRPC6;SCN1B;VAMP8;CRACR2A;ADRA2A;CAMK2A
prerank,signal release from synapse (GO:0099643),-0.4013720765160771,-1.359292516205175,0.08616187989556136,0.5228286748964606,1.0,14/43,17.40%,RIMS1;SNAP25;NRXN1;SYN2;PCLO;PTPRN2;SYN1;BRSK1;NRXN2;SNPH;VAMP2;STXBP1;STX1A;DVL1
prerank,protein-DNA complex assembly (GO:0065004),0.37425154553333645,1.3587324117346031,0.046742209631728045,0.8890594033769925,1.0,24/116,13.85%,PSMB10;ERCC3;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;NAP1L4;ORC3;PSMD11;CCNH;PSMB4;PSMC1;ORC4;GTF2H1;RSF1;PSMC2;PSMD2;ORC2;PSMD14;PSMC6;BRD2;PSMD1;PSMB1
prerank,macrophage activation involved in immune response (GO:0002281),0.5688072215416491,1.3582086553656254,0.13701067615658363,0.887492272886477,1.0,3/13,6.82%,SBNO2;IFI35;SYK
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.41719948989839567,1.358195003954351,0.06880733944954129,0.88352427159477,1.0,17/61,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PANK2;PSMB4;PSMC1;SIRT1;PSMC2;PSMD2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,neuromuscular process controlling balance (GO:0050885),-0.5543290001303302,-1.355186890420508,0.12574850299401197,0.5333560168705692,1.0,2/12,1.33%,PCDH15;NRXN1
prerank,epithelial cell-cell adhesion (GO:0090136),-0.5673945883992432,-1.3549933300131969,0.11764705882352941,0.5322015622515504,1.0,5/11,21.90%,KIT;VCL;ITGB5;CCN3;PLEKHA7
prerank,positive regulation of nervous system development (GO:0051962),-0.39216237762641015,-1.3549290286801008,0.08152173913043478,0.5306052201475905,1.0,13/42,11.94%,NRXN1;GRID2;EPHB1;NLGN2;SYNDIG1;CLSTN2;NLGN1;SPEN;SNW1;EPHB2;CUX2;NUMBL;IL1RAPL1
prerank,chloride transport (GO:0006821),-0.3599592651222494,-1.3548871103948308,0.03164556962025317,0.5289896925537587,1.0,35/74,27.69%,GABRB1;SLC4A10;SLC1A3;GLRB;GABRA2;ANO3;CLIC4;SLC6A1;SLC26A7;SLC12A2;GLRA3;GABRG2;GLRA1;CLCN6;ANO1;CLCN2;ANO6;SLC12A6;GABRA5;GABRG3;CLIC5;SLC12A4;ANO10;GABRA4;SLC12A9;GABRG1;SLC4A8;TTYH3;SLC12A7;GABRA1;TTYH1;FXYD1;SLC12A8;SLC12A5;LRRC8A
prerank,neurotransmitter secretion (GO:0007269),-0.3954124835976054,-1.354543503039314,0.07989690721649484,0.5282962004389029,1.0,14/44,17.40%,RIMS1;SNAP25;NRXN1;SYN2;PCLO;PTPRN2;SYN1;BRSK1;NRXN2;SNPH;VAMP2;STXBP1;STX1A;DVL1
prerank,dendrite morphogenesis (GO:0048813),-0.41199021341115893,-1.3540085481090334,0.0759493670886076,0.5281994251971593,1.0,11/35,10.73%,MAP2;CTNNA2;EPHB1;SDC2;WASL;DLG4;DCDC2;CTNND2;DOCK10;BTBD3;EPHB2
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.3938213642879092,-1.3534236275842675,0.07493540051679587,0.5282975977473382,1.0,22/43,28.03%,BMP6;IGF1;NELL1;BMP7;IL6R;BMP4;FBN2;WNT4;LRP5;ACVR1;IL6ST;WWTR1;BMPR1B;BMPR1A;BMPR2;PRKD1;CCN1;YAP1;CCN4;LRP3;RUNX2;BMP2
prerank,potassium ion homeostasis (GO:0055075),-0.4597189657499325,-1.3533361684567176,0.09534883720930233,0.5268382711236721,1.0,12/23,19.53%,ATP1A2;KCNMA1;ATP1B1;ATP1B3;SLC12A2;ATP1A1;KCNJ2;ATP1B2;SLC12A6;SLC12A4;ATP1A3;SLC12A9
prerank,regulation of axonogenesis (GO:0050770),-0.37946196573406177,-1.353254170842397,0.057441253263707574,0.5253300434229317,1.0,15/51,16.44%,LRRC4C;ROBO2;PLXNA2;ROBO1;NTRK2;TIAM2;RHOA;BRSK1;GSK3B;GDI1;PLXND1;ARHGDIA;PLXNB2;NGF;PLXNC1
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.43782139803502773,-1.352684157154013,0.10123456790123457,0.5253711073669532,1.0,3/29,4.20%,FGFR2;TGFBR3;TPM1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),-0.48544018648072307,-1.3519377930352772,0.1186046511627907,0.5259077922453983,1.0,7/20,14.53%,ZC3H7A;PUM1;ZC3H7B;PUM2;TSN;AGO3;DICER1
prerank,regulation of catabolic process (GO:0009894),0.5339085245044912,1.3514307494052538,0.1125,0.9139371542675786,1.0,10/18,19.46%,NEDD4L;TMEM9;MDM2;CHEK2;FAF1;ZDHHC7;ODC1;HPGD;CENATAC;FURIN
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.39063547626218476,-1.351188482110173,0.05027932960893855,0.5264302345719399,1.0,6/40,3.34%,MAGI2;BICD1;DAB2;AHI1;ANXA2;WASL
prerank,catecholamine metabolic process (GO:0006584),-0.535150585389088,-1.3511310139542176,0.11187214611872145,0.5249136814846784,1.0,3/14,6.45%,SNCAIP;ATP7A;COMT
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.42291263996896467,-1.3509994938241323,0.09595959595959595,0.5235859879918926,1.0,18/29,33.53%,ZBTB20;SORBS1;LPGAT1;PPARA;CREBL2;LDLR;SLC27A1;GPLD1;SREBF1;CTDNEP1;NR1H2;AKT1;SLC45A3;MFSD2A;SIRT4;MTOR;CHP1;MID1IP1
prerank,phosphatidylinositol dephosphorylation (GO:0046856),-0.4648505616183539,-1.3503650200004103,0.09004739336492891,0.5237712886101766,1.0,11/23,27.08%,MTMR7;PIP4P2;SACM1L;MTMR12;MTMR9;MTMR4;MTMR11;INPP5F;OCRL;PIP4P1;INPP5K
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.5122174043315931,1.3499887319860677,0.11307420494699646,0.9172786016075937,1.0,6/20,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,protein localization to cell periphery (GO:1990778),-0.3228709294293578,-1.349540263674785,0.025547445255474453,0.5245112010488514,1.0,38/133,16.85%,ANK2;DPP6;ANK3;KCNB2;KCNIP4;EPB41L3;MAP7;RAB3C;ATP1B1;PACS2;FLNA;KCNIP3;ATP1B3;ROCK2;FLOT2;RAB8B;PIP5K1A;ROCK1;TTC7B;EZR;ACTN2;CDH1;TTC7A;DPP10;RAMP1;DLG1;MYADM;RAB11A;WNK3;WDR19;STXBP1;AP4M1;FYB1;LRP6;RAPGEF2;EHD3;EHD1;RAB8A
prerank,regulation of establishment of planar polarity (GO:0090175),0.3894131457856212,1.3490719301644463,0.056296296296296296,0.917800167058073,1.0,24/88,14.61%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TIAM1;AP2S1;PSMD11;PFN1;PSMB4;PSMC1;DAAM1;WNT5A;FZD3;PSMC2;PSMD2;CELSR1;PSMD14;PSMC6;PSMD1;PSMB1;SPEF1;AP2M1
prerank,activin receptor signaling pathway (GO:0032924),-0.5130667080330665,-1.3488379465409535,0.12258064516129032,0.5249197359573441,1.0,4/15,12.45%,SMAD3;TGFBR1;ACVR1;ACVR1B
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.5480741434107547,-1.3486543770539843,0.11572052401746726,0.5238989331570997,1.0,3/12,13.49%,NUPR1;IL18;IL33
prerank,microvillus organization (GO:0032528),0.5602222563524571,1.3483461591126455,0.1147227533460803,0.9174331544858412,1.0,6/13,15.69%,RAP2A;MINK1;RAPGEF6;MAP4K4;RAP2C;FXYD5
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.4178354364447303,-1.348319316621864,0.07435897435897436,0.5233362509529321,1.0,7/35,3.73%,HTR2C;KSR1;AKAP6;IRAG1;ADCY2;ADCY1;NUDT4
prerank,insulin secretion (GO:0030073),0.5129372829400329,1.3471433742267702,0.0919931856899489,0.9196972722061435,1.0,6/19,9.72%,SELENOT;RAB11B;RAB11FIP5;RAB11FIP2;PARK7;CYB5R4
prerank,retrograde axonal transport (GO:0008090),-0.5065599885914842,-1.3468764009436318,0.1079913606911447,0.5260456737535419,1.0,9/16,16.03%,DLG2;DYNC1H1;KIF1C;FBXW11;KIF1A;MAP1A;NEFL;KIF5A;ACTR10
prerank,positive regulation of glucose import (GO:0046326),-0.46646042735076454,-1.3463276947078642,0.10585585585585586,0.5259743903921881,1.0,11/21,25.50%,SORBS1;IGF1;OCLN;AKT2;CREBL2;ARPP19;PIK3R1;OSBPL8;APPL1;AKT1;CAPN10
prerank,stabilization of membrane potential (GO:0030322),-0.5068626115240167,-1.345585182873445,0.11713665943600868,0.5264420387154526,1.0,3/16,10.23%,KCNK2;KCNK5;KCNK10
prerank,BMP signaling pathway (GO:0030509),-0.36332594206227486,-1.3452892054819001,0.05813953488372093,0.5256867301882409,1.0,14/62,10.30%,DDX5;BMP6;TGFBR3;SMAD3;RGMA;BMP5;BMP7;SMAD4;BMP4;SMAD6;ZFYVE16;ACVR1;HIVEP1;RGMB
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.4699718327892213,1.345216896629959,0.13066202090592335,0.9255381814444844,1.0,6/26,14.38%,SPR;ACER2;CYP1B1;NOS3;ACER3;GCH1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.33064093617038126,1.3450657604475866,0.005720823798627002,0.9221531107241864,1.0,102/341,18.08%,PSMB10;PSMC4;PSMB6;ELOC;GSK3A;RNF7;CBL;PSMD8;PSMD5;PSMD12;ARIH1;RNF149;TNFAIP3;ANAPC2;KLHL3;FEM1C;SPOP;UBA1;UBXN11;RFFL;BIRC2;PSMD11;NEDD4L;UBAP1;NHLRC1;RBBP6;PSMB4;PSMC1;UBE2I;RNF130;COP1;SIRT1;CLOCK;UBL7;RNF187;PPP1R11;TTC3;TRIM25;FBXO11;RBCK1;CRBN;ANAPC7;RAD23A;MDM2;PSMC2;UBE3D;FBXO7;PSMD2;RNF6;ZNRF1;RNF13;VPS37B;CHFR;UBQLN1;ANAPC11;SPOPL;IFI27;ANAPC10;PLAA;ANAPC4;RNF11;FBXO8;CUL3;PSMD14;UBE2R2;USP33;DDIT3;PSMC6;RNF146;RNF216;APPBP2;FAF1;PSMD1;PSMB1;USP9X;RNF20;TRIM3;UBA6;NHLRC3;FBXO22;UBE2G1;RMND5A;UBQLN4;RNF114;TAF1;PELI1;KLHL42;RNF128;RNF125;UBE2H;PSMA4;UFD1;UBQLN2;VPS37C;UBR3;ATXN3;CDC26;RNF215;RAD23B;KCTD10;VPS4B;AGAP3
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.5322288542697515,-1.3449851099876657,0.125,0.5250298871239782,1.0,3/13,3.91%,NRP1;TGFBR2;CTNNB1
prerank,positive regulation of actin nucleation (GO:0051127),-0.5585259042613814,-1.344551151449622,0.12770137524557956,0.5246680894703291,1.0,4/11,13.21%,GSN;WASF2;WASF1;FCHSD2
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.4913687437218614,-1.3443186767647812,0.1193058568329718,0.523776573207575,1.0,4/17,19.38%,PLA2G4A;LPGAT1;CRLS1;LPCAT1
prerank,transition metal ion transport (GO:0000041),-0.409043169002925,-1.3440985900511113,0.0741687979539642,0.5227906133205997,1.0,15/35,30.10%,CP;TRPC5;ATP7A;SLC30A10;TRPC1;SLC31A1;SLC39A8;SLC31A2;COX17;SLC11A2;TRPC6;SLC30A5;TTYH1;TRPC3;ATOX1
prerank,diterpenoid metabolic process (GO:0016101),-0.362524090002393,-1.343761736595289,0.05830903790087463,0.5221917055753914,1.0,13/55,12.08%,GPC6;LRP1;ALDH1A1;SDC2;DHRS3;GPC3;HSPG2;ABCA4;RBP4;NAPEPLD;GPC5;RBP1;ALDH3A2
prerank,myofibril assembly (GO:0030239),-0.38779290279179635,-1.3432945959844376,0.0703883495145631,0.5219797646972919,1.0,9/42,14.28%,CFLAR;PDGFRB;TMOD2;TPM1;PDGFRA;ACTN2;CSRP2;OBSL1;WDR1
prerank,mitotic metaphase plate congression (GO:0007080),0.41555574684011004,1.343057617561186,0.07716535433070866,0.9286410845125903,1.0,11/51,12.85%,KIF18A;NUDC;BOD1;CHAMP1;DCTN2;CHMP1A;CDCA8;CENPC;CHMP2A;MIS12;CUL3
prerank,T cell activation (GO:0042110),0.3935094804397496,1.3429614813314712,0.06417910447761194,0.925125280231063,1.0,11/69,11.80%,LCP1;JAG2;PIK3CG;PTPRC;PPP3CB;GPR89A;GPR89B;NLRC3;LFNG;PIK3CD;PPP3CA
prerank,muscle organ development (GO:0007517),-0.36836297639382864,-1.3421402833967144,0.03939393939393939,0.5236049939941033,1.0,16/54,17.52%,LAMA2;IGF1;VAMP5;SGCE;FHL1;CHD2;MKX;SMTN;SPEG;ITGA11;LARGE1;SRI;FKTN;COL6A3;EVC;SOX6
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),-0.5044013507846433,-1.3417634371595588,0.11286681715575621,0.5232233744318336,1.0,7/17,30.26%,AKAP13;ADCY9;ADRA1B;RAPGEF2;ADRA1A;ADRA2A;DRD2
prerank,synaptic vesicle exocytosis (GO:0016079),-0.39720178354615254,-1.3416069019484576,0.07012987012987013,0.5222097346093312,1.0,12/40,18.87%,RIMS1;SNAP25;PCLO;STX3;UNC13C;UNC13B;SNPH;VAMP2;SYT7;STX1A;SYT2;SNAP29
prerank,protein targeting to mitochondrion (GO:0006626),0.4259593032208501,1.3412888106682241,0.07975460122699386,0.9295378681122687,1.0,11/52,10.09%,TOMM20;TIMM29;ROMO1;IMMP2L;TIMM17B;TSPO;GRPEL2;TOMM40L;FBXO7;TIMM21;AIFM1
prerank,T cell mediated immunity (GO:0002456),0.5670820380839595,1.3409744942622752,0.12103174603174603,0.9270944843384578,1.0,4/13,20.24%,CADM1;CD55;CD46;BTN3A3
prerank,cardiac muscle contraction (GO:0060048),-0.41413926302217413,-1.3409467074610915,0.09644670050761421,0.5226732650944672,1.0,4/34,4.20%,ATP1A2;GSN;ATP1B1;TPM1
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3817011501187968,-1.3409027504595477,0.06593406593406594,0.5212087289598619,1.0,7/45,4.63%,BMP6;DAB2;TGFBR1;BMP5;BMP7;SMAD4;BMP4
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.5167904815932006,1.3405972540338957,0.14471243042671614,0.9251106293944922,1.0,5/19,4.60%,NDST3;CSGALNACT1;XYLT1;EXT2;HS6ST1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.37180217403718047,1.340418001744115,0.06241331484049931,0.9220328545405464,1.0,19/104,10.75%,TRIB3;RALB;EZH2;MTCP1;RPTOR;ACTB;SRC;CDC37;PPP2CA;CCNH;CDKN1A;CIB1;CALM3;SIRT1;GTF2H1;CCNG2;CSF1R;BCCIP;DDX3X
prerank,sodium ion transport (GO:0006814),-0.3406605759520843,-1.3392928072292536,0.037037037037037035,0.524230817502936,1.0,23/85,17.88%,ATP1A2;SLC24A3;HCN1;NALCN;SLC6A13;ATP1B1;SLC6A1;SCN8A;ATP1B3;SCN3A;SLC12A2;SLC6A9;SLC6A12;SCN1A;SLC24A2;SGK1;SLC9B2;SLC6A15;ANO6;NDUFA9;SLC5A6;SLC38A7;SLC5A5
prerank,membrane lipid biosynthetic process (GO:0046467),0.4061503542162225,1.3391205629754022,0.08255451713395638,0.9247646822439198,1.0,17/58,16.39%,CERS1;ACER2;CERS4;PRKD2;KDSR;ELOVL6;SGMS1;PLPP1;SGPP2;HACD2;ACER3;SGPP1;SPNS2;ST8SIA6;CERT1;GBGT1;PPM1L
prerank,regulation of complement activation (GO:0030449),0.4362402239764158,1.3389891118668353,0.10210696920583469,0.9214363012098007,1.0,5/40,12.87%,C1QB;C1QC;PHB2;CD81;CD55
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.39294299802234933,-1.3385717332596572,0.07567567567567568,0.5247010136041045,1.0,9/41,11.76%,ANK2;ANK3;KCNMA1;AKAP6;FLNA;GABBR2;KCNJ2;ACTN2;KCNJ6
prerank,alanine transport (GO:0032328),0.5962297264564502,1.3383226741145968,0.12209302325581395,0.9209224509012645,1.0,2/10,5.75%,SLC36A4;SLC6A6
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.532614636754293,1.3380505269985847,0.12361623616236163,0.9183856631406697,1.0,6/16,19.11%,ZC3H12D;ZFP36L1;TARDBP;MOV10;RC3H1;DHX36
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.570028614097576,-1.3377520346222564,0.11181434599156118,0.5255527631473411,1.0,2/11,1.44%,ST18;GSN
prerank,defense response to Gram-negative bacterium (GO:0050829),0.43214661118785924,1.3377396856948585,0.09457364341085271,0.9160495530790647,1.0,5/42,6.72%,ROMO1;RPL30;DMBT1;RNASE6;SELP
prerank,positive regulation of blood coagulation (GO:0030194),-0.49469015972784736,-1.3376337998324586,0.12389380530973451,0.5243868846632308,1.0,7/17,25.88%,F3;THBS1;ANO6;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.3875626340070417,-1.336773000875694,0.07537688442211055,0.5254471919270672,1.0,14/47,14.67%,DOCK5;EFNA5;DOCK1;FBLN1;NRP1;PDPN;FLNA;NEDD9;RREB1;P4HB;ILK;MYADM;TRIOBP;PTK2
prerank,positive regulation of coagulation (GO:0050820),-0.5722059774237114,-1.336736837166943,0.13390928725701945,0.5225154800806814,1.0,5/10,25.88%,THBS1;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,positive regulation of hemostasis (GO:1900048),-0.5722059774237114,-1.336736837166943,0.13390928725701945,0.5225154800806814,1.0,5/10,25.88%,THBS1;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,regulation of calcium ion transport (GO:0051924),-0.3690580336621709,-1.334558261720543,0.06722689075630252,0.527425261715731,1.0,21/54,30.41%,ANK2;STIM2;CACNA1D;STIM1;CTNNB1;P2RX4;IL16;SRI;WNK3;EFHB;BCL2;CAMK2B;TRPC6;CACNA2D1;CRACR2A;ADRA2A;CAMK2A;INPP5K;PACSIN3;NOS1;MYLK
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.5299229176645786,-1.3339231322507579,0.11546840958605664,0.527889793773808,1.0,5/12,16.62%,NFIB;GLI2;EPHB1;EPHB2;SZT2
prerank,mammary gland development (GO:0030879),-0.46732475658115996,-1.3337587861705067,0.10961968680089486,0.5268847248659693,1.0,8/21,25.82%,ERBB4;GLI2;WNT4;TBX3;PRLR;VEGFA;TGFB3;NOTCH4
prerank,response to light stimulus (GO:0009416),0.41206026028217435,1.333721570812107,0.08695652173913043,0.9327340233199158,1.0,9/55,10.24%,ERCC3;ZRANB3;MAP2K7;GPR52;ERCC4;MAPK8;CLOCK;SPRTN;CCAR2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),-0.5019322810859135,-1.332423490512648,0.14072494669509594,0.5291993522380003,1.0,8/15,22.43%,P2RX4;SMOC2;LGMN;SEMA5A;MET;HSPB1;PRKD1;VEGFA
prerank,proteolysis (GO:0006508),0.3349630949196299,1.332398467505745,0.026474127557160047,0.935508126381923,1.0,31/252,9.25%,LRP8;CAPN8;PCSK1;LVRN;FBXL6;CELA1;PSMC4;PRCP;PSEN2;RSPRY1;DPP8;MMP12;MME;ATG4C;UBE3A;METAP2;CASP6;FBXW2;CNDP2;RET;SPCS3;PGPEP1;LONP1;NAPSA;SPPL3;ATG4B;DESI2;DESI1;TPP1;SPRTN;MDM2
prerank,regulation of protein dephosphorylation (GO:0035304),0.447414561051904,1.3322167074723246,0.11295681063122924,0.9324856065178101,1.0,16/37,16.87%,PIN1;TIPRL;PPP1R16B;CNEP1R1;YWHAB;CALM3;SPPL3;TSC1;MFHAS1;ANKLE2;PTBP1;CDH5;PTPA;PPP6R1;PPP1R8;PPP2R5A
prerank,microvillus assembly (GO:0030033),0.5444240787614868,1.332071820035393,0.14022140221402213,0.9293416954026447,1.0,6/14,15.69%,RAP2A;MINK1;RAPGEF6;MAP4K4;RAP2C;FXYD5
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.4730234341760572,1.331840235515777,0.12972972972972974,0.9266871288748866,1.0,3/25,4.33%,NDST3;CSGALNACT1;EXT2
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.5495262009233597,-1.331233518581665,0.13692946058091288,0.5312825554745285,1.0,4/12,12.89%,CTNNA3;CACNA1C;BIN1;DLG1
prerank,regulation of cellular senescence (GO:2000772),0.46996359725466824,1.3311331791658143,0.11775043936731107,0.9264998939844149,1.0,11/28,16.05%,B2M;FBXO5;SIRT1;YPEL3;ZKSCAN3;TERT;ING2;NEK6;YBX1;MAP3K3;RSL1D1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.42865061262718446,-1.3305424193937634,0.09951456310679611,0.5316203395112492,1.0,2/27,0.63%,LPAR1;HTR2C
prerank,positive regulation of calcium ion transport (GO:0051928),-0.40067532280577545,-1.3296826055457356,0.06067961165048544,0.5326197669400086,1.0,5/36,4.77%,ANK2;STIM2;CACNA1D;PDGFRB;P2RX4
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.5704502859395267,1.3292512753192836,0.16173570019723865,0.9321937115459893,1.0,5/11,18.94%,ASF1B;CABIN1;RBBP4;ATRX;HAT1
prerank,spindle assembly (GO:0051225),0.39254418627436255,1.3291974556626507,0.09200603318250378,0.9286516749247739,1.0,23/67,17.26%,ABRAXAS1;HAUS5;HAUS4;CLASP2;HDAC3;TUBGCP5;MZT1;STARD9;KIF2A;BCCIP;NEK7;RPS3;TNKS;NEK6;KIF3B;CHEK2;RCC1;INO80;ARHGEF10;STAG2;TUBGCP2;KPNB1;CLASP1
prerank,actomyosin structure organization (GO:0031032),-0.3450077484031674,-1.328513761430766,0.05740181268882175,0.534494667802825,1.0,19/75,14.28%,SORBS1;EPB41L3;TMOD2;EPB41L1;CDC42BPB;TPM1;RHOA;ROCK2;EPB41L4B;ITGB5;CIT;FRMD3;ROCK1;TNFAIP1;EPB41L2;ACTN2;CSRP2;PDLIM1;WDR1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.34602226464410246,1.3276768444603588,0.045576407506702415,0.9324521157119356,1.0,38/184,13.85%,PSMB10;ERCC3;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ANAPC2;ALMS1;NEK11;HAUS5;CEP41;HAUS4;ZFP36L1;TUBB;PSMD11;PSMB4;DCTN2;PSMC1;RGCC;FBXO5;ODF2;DCTN3;CEP164;ANAPC7;PSMC2;PSMD2;TFAP4;DYNLL1;ANAPC11;ANAPC10;ANAPC4;NEK6;CUL3;PSMD14;PSMC6;PSMD1;PSMB1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.5442822644182589,1.32728602979061,0.16489361702127658,0.9307650874253914,1.0,8/14,18.64%,ACD;TPP1;TERT;TNKS;TERF2IP;ATR;TNKS2;ATRX
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.5692201843750507,1.326806892893708,0.14836223506743737,0.9296715759837784,1.0,1/12,1.45%,IL1R1
prerank,positive regulation of dendritic spine development (GO:0060999),0.507871657874949,1.3267598434789345,0.16055846422338568,0.9261745025076848,1.0,3/20,4.37%,LRP8;SHANK3;APOE
prerank,organelle organization (GO:0006996),0.3241705106708866,1.326257176611203,0.015873015873015872,0.9249813451796008,1.0,64/388,10.31%,CIDEA;ROPN1;SURF4;FAM161B;CHCHD2;SEMA6A;SYNE1;SH3D19;TNFAIP3;SMPD4;LYSMD3;CYCS;GORASP2;KIFAP3;DNAJA3;SORT1;CLASP2;GABPA;FITM2;ZMYM4;MTFR1;ATL1;SIRT3;LMAN2;APOE;CFAP126;VPS11;RAB7A;PRPF40A;PLAAT3;TMED4;PHB2;SEC23IP;RAB43;CFL1;DST;PEX1;TRAPPC8;SSBP1;USP6NL;ARHGEF7;PEX7;TRIP11;VMP1;TTC17;CHMP1A;LONP1;TMED5;AGTPBP1;PIKFYVE;TMED10;ODF2;RAB14;FGD5;CDCA8;AUP1;RAB1A;TMEM135;GOLPH3L;PARK7;TRAPPC11;DOP1B;CHMP2A;TERT
prerank,sodium ion transmembrane transport (GO:0035725),-0.34140324284474055,-1.3257039366743806,0.05263157894736842,0.5415182556303214,1.0,17/84,9.45%,ATP1A2;SLC24A3;HCN1;NALCN;SLC6A13;ATP1B1;SLC6A1;SCN8A;ATP1B3;SCN3A;SLC12A2;SLC6A9;SLC6A12;ATP1A1;SCN1A;SLC24A2;ATP1B2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5049320829513275,-1.3256811805604967,0.1319910514541387,0.5400483982780312,1.0,12/15,44.29%,IGF1;GHITM;AKT1;BCL2L1;GPX1;FXN;PRELID1;CLU;HGF;OPA1;PPIF;PSMD10
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.3536206667877424,1.3248341609239407,0.0520694259012016,0.9282487997296146,1.0,31/145,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ALMS1;HAUS5;CEP41;HAUS4;STOX1;TUBB;PSMD11;PSMB4;DCTN2;PSMC1;FBXO5;ODF2;USP47;CDK4;DCTN3;CEP164;RAD51B;PSMC2;PSMD2;DYNLL1;PSMD14;PSMC6;AVEN;PSMD1;PSMB1
prerank,regulation of neuron projection development (GO:0010975),-0.3095566540836843,-1.3246440000944715,0.008264462809917356,0.5417040043012955,1.0,55/163,22.12%,MAGI2;LRRC4C;NTRK3;TENM3;DCC;LPAR1;LRRC7;CTNNA2;PDLIM5;SPOCK1;DPYSL3;NTRK2;NTNG1;PTPRS;TOX;EFNB2;PTK7;ROR1;RELN;CBFA2T2;SEMA3A;SRCIN1;PLPPR5;STMN2;ARSB;ULK4;ATP1B2;BRSK1;EPHA3;GSK3B;PRAG1;RIT2;DISC1;IL1RAPL1;KIF1A;CAMK1;SETX;PTPRO;PLXNB2;RAPGEF2;ABL2;ROR2;TWF2;SCARF1;SNX3;MYLIP;NCS1;KNDC1;MAG;PAQR3;CX3CL1;PRKD1;P3H1;RTN4IP1;CAMK2B
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4795072765065842,1.3231262970668696,0.1280148423005566,0.9331669163800238,1.0,12/21,16.93%,CNOT11;CNOT2;CNOT7;PAN3;TUT7;CNOT6;PAN2;CNOT1;CNOT6L;TUT4;PARN;CNOT10
prerank,regulation of cytoskeleton organization (GO:0051493),-0.32122997049038565,-1.3231180372241522,0.03322259136212625,0.5447959661291009,1.0,33/108,17.47%,BICD1;PHLDB2;LRP1;GPM6B;IQGAP1;EFNA5;PDGFRB;CAPN2;PHLDB1;CYLD;MAPT;CLIC4;RHOA;ROCK2;PRKCD;ROCK1;EZR;RND3;RHOBTB2;EPHA3;GSK3B;RHOB;RHOBTB1;HIP1R;PFDN2;TAOK1;TRIM36;PTK2;ARHGEF5;IQGAP2;NEXN;TWF2;DIAPH1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.40005271471350384,-1.3228498778983278,0.10714285714285714,0.5440135018160833,1.0,14/37,23.08%,MAPK14;APPL2;PPARA;IL17RA;PER1;ADCY7;SIRPA;ABCD2;PLD3;GBP5;CHID1;APOD;APPL1;IL17D
prerank,peripheral nervous system development (GO:0007422),0.5014600720027415,1.322838196442349,0.13286713286713286,0.9310699519015389,1.0,7/23,14.33%,GFRA3;BDNF;NFASC;PMP22;NF1;ARTN;ADGRG6
prerank,regulation of B cell proliferation (GO:0030888),0.4263715076963416,1.3224448026251985,0.1073170731707317,0.929377666254623,1.0,7/44,10.85%,PTPRC;VAV3;FCGR2B;TIRAP;IRS2;LYN;CD81
prerank,regulation of T cell migration (GO:2000404),0.5127381915381327,1.3223766796203464,0.13272727272727272,0.9260240169527134,1.0,5/18,15.09%,CXCL12;LRCH1;RIPOR2;APP;DOCK8
prerank,sensory perception of mechanical stimulus (GO:0050954),-0.34059889897462436,-1.322210890158318,0.038461538461538464,0.5443556576709234,1.0,18/85,11.48%,PCDH15;EYA1;CACNA1D;COL1A1;EML2;COL11A1;COL4A3;ADGRV1;P2RX4;CEMIP;ROR1;PIEZO2;DCDC2;GSDME;NIPBL;TIMM9;ATP6V0A4;TBL1X
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.4296633308113303,-1.3222000319070835,0.12614678899082568,0.5428762510759675,1.0,12/28,27.97%,NAV3;MAPT;OCLN;AKAP9;SLAIN2;CKAP5;DCTN1;MET;GIT1;ARL2;TOGARAM1;MAPRE1
prerank,sprouting angiogenesis (GO:0002040),-0.37113208581900364,-1.321947641419667,0.08469945355191257,0.5421561655824757,1.0,14/51,11.01%,ROBO1;PARVA;ADGRA2;BMPER;NRP1;EFNB2;BMP4;PIK3R3;EPHB4;RSPO3;THBS1;CCBE1;OTULIN;RNF213
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.39676501443943857,1.3213576446742048,0.09662576687116564,0.9274038126266337,1.0,17/73,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TAL1;PSMD11;PSMB4;PSMC1;PSMC2;PSMD2;LMO2;PSMD14;PSMC6;PSMD1;PSMB1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.5389442679913068,1.3209686771500508,0.16791044776119404,0.9257806180229737,1.0,5/13,14.71%,PTTG1IP;SIRT1;YJU2;MDM2;CD44
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5662335772426433,-1.3208005269347247,0.15531914893617021,0.5441905840886203,1.0,5/10,26.38%,UFL1;TP53;LMBR1L;ACE;SFRP1
prerank,granulocyte differentiation (GO:0030851),0.5062931548675161,1.3207090526484533,0.15129151291512916,0.9234580866719679,1.0,5/18,8.63%,TAL1;LEF1;CDKN1A;EP300;CDK4
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.2977223631961961,-1.3203810363909176,0.024875621890547265,0.5440545731477684,1.0,41/182,15.36%,FOXP1;NOTCH2;SLC24A3;IGF1;ROBO1;ITGB8;SH3GL2;DLG4;MAPT;OCLN;PARP14;RBL2;HDAC1;TET1;BMP4;KDM4A;ROCK2;FLOT2;SMO;WWP2;WNT4;XDH;LDLR;MAP2K2;OPTN;SFMBT2;AGO3;LGMN;NDFIP1;NFKB1;REL;CD34;DDRGK1;MYADM;SETDB2;HINFP;RACK1;DICER1;PTPN22;ANXA7;RIN3
prerank,myeloid cell differentiation (GO:0030099),0.42182478948003516,1.3197495461284772,0.08823529411764706,0.9245523692678279,1.0,8/47,10.60%,PRKX;SNRK;TAL1;TIRAP;HIPK2;RPS14;LYN;MFHAS1
prerank,centromere complex assembly (GO:0034508),0.4481615646499672,1.319406867203546,0.11396468699839486,0.922544651143602,1.0,11/36,17.30%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;MIS12;POGZ;CENPP;RBBP4;CENPO;NPM1
prerank,mesonephros development (GO:0001823),-0.5382091747994772,-1.3192235478345211,0.14767932489451477,0.5460318222029343,1.0,4/11,5.43%,FGF1;BMP7;BMP4;OSR1
prerank,positive regulation of signal transduction (GO:0009967),-0.29169537379201094,-1.3191678249055816,0.015706806282722512,0.5446805323212903,1.0,54/238,14.25%,SORBS1;BMP6;NTRK3;FGFR2;RIMS1;IGF1;SULF1;ROBO1;SASH1;WLS;NRXN1;FGF1;NRP1;TGFBR1;DLG4;AXL;MACF1;SULF2;NLGN2;MAML1;FLNA;GKAP1;PRKCZ;RELN;SMO;DCDC2;F3;SORL1;SLC39A14;ITGA5;SKI;HTT;PTGIS;ZDHHC5;CDC73;NLGN1;SNW1;RSPO3;SMOC2;CCBE1;SALL1;VTN;CUX2;ILK;ADAMTS3;DISC1;LOXL3;ATP6V0C;LY86;TRIM39;GRB10;IGF2;IL6ST;CAV2
prerank,negative regulation of peptidase activity (GO:0010466),-0.37265627242126936,-1.3190397668021034,0.09016393442622951,0.5435794379336675,1.0,5/47,1.98%,SPOCK3;LRP1;TIMP3;SPOCK1;TIMP2
prerank,acute-phase response (GO:0006953),-0.5402210076428324,-1.3189093924988262,0.12989690721649486,0.5425061043744568,1.0,5/12,29.54%,IL6R;LBP;PLSCR1;CEBPB;IL22
prerank,mitochondrial translation (GO:0032543),0.3679714766267477,1.3184324079211462,0.054945054945054944,0.9236756660366751,1.0,19/104,12.31%,MRPS22;MRPS2;MRPS33;MRPL24;MRPL23;FASTKD2;MRPL18;MRPL38;LARS2;MRPS12;HARS1;RARS2;MRPL20;EARS2;TSFM;MRPL52;MRPL48;MRPS15;MRPS24
prerank,Rac protein signal transduction (GO:0016601),0.500601096919782,1.3179896087509253,0.14097744360902256,0.9222321894637798,1.0,10/18,20.64%,RAC2;TIAM1;RHOG;ELMO1;ABI2;CDH13;CYFIP1;HACE1;EPS8;RAC1
prerank,anterograde trans-synaptic signaling (GO:0098916),-0.29236060739781294,-1.3178239841420103,0.014354066985645933,0.5442214352929523,1.0,49/224,14.35%,DLG2;DLGAP1;KCNQ3;PLP1;HTR2C;GABRB1;GRIA4;SNAP25;GRIA2;NRXN1;SLC1A3;CACNB4;AMPH;GRM5;GRIN2B;GLRB;KCND2;CHRM2;SYN2;GABRA2;MBP;DLG4;SLC6A1;NLGN2;CACNA1B;GLRA3;CAMK4;CHRM3;GABRG2;GLRA1;GABBR2;AKAP9;NLGN1;SYN1;KCNA1;PRKACA;HTR4;RIT2;NRXN2;UNC13C;PRKAR1B;APBA1;DLG1;UNC13B;BSN;CAMK1;HTR7;GRIK4;SLC12A6
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.37525226959652297,-1.3167756759492875,0.07123287671232877,0.5456742840208435,1.0,8/49,6.98%,ERBB4;IGF1;PARP14;IL6R;PIBF1;KIT;GHR;IL31RA
prerank,purine ribonucleotide catabolic process (GO:0009154),0.4928597843603281,1.3161837541096972,0.13917525773195877,0.9278454610277939,1.0,7/21,12.10%,NUDT11;PDE4D;MLYCD;FITM2;ACAT1;PNP;NT5C2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.4328543500121421,-1.3156512000870797,0.11832946635730858,0.5475902650072245,1.0,7/25,12.89%,ANK2;CTNNA3;CACNA1C;CXADR;AKAP9;CAMK2D;DLG1
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.4921930565931479,1.3154065008201805,0.1306715063520871,0.9281519497262355,1.0,7/21,11.45%,PTPRC;PRKCH;PRKD2;RELA;CD81;SLC39A10;RPS3
prerank,calcium ion transmembrane transport (GO:0070588),-0.33492925657813255,-1.3153610681805668,0.05177993527508091,0.5469690270920836,1.0,13/86,4.77%,TRPM3;SLC24A3;CACNA1C;NALCN;MCU;CACNA1D;GRIN2B;RYR3;PKD1;TRPM6;TRPC5;MICU2;P2RX4
prerank,regulation of TORC1 signaling (GO:1903432),-0.3954869143775465,-1.3153001474516515,0.10789473684210527,0.5456377071935984,1.0,23/33,36.65%,RNF152;GPR137C;DEPDC5;KLHL22;CASTOR2;STK11;SEH1L;ATM;SZT2;ITFG2;DGKQ;FLCN;TELO2;LAMTOR5;SESN2;PIP4P1;GPR137B;SPAAR;PIH1D1;SMCR8;RRAGD;GPR137;RRAGA
prerank,extracellular matrix assembly (GO:0085029),-0.43653968568736723,-1.315256549081978,0.10835214446952596,0.5443135642217897,1.0,11/23,24.61%,GPM6B;TNXB;NTNG1;ATP7A;NTN4;QSOX1;TGFB1;LAMB1;EFEMP2;EMILIN1;MYH11
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.37308190958644544,1.3151992627285336,0.07670454545454546,0.9256494388103137,1.0,11/88,5.43%,FBXL6;PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PSMD11;PSMB4;FBXL5;PSMC1
prerank,response to cAMP (GO:0051591),-0.39410746090884824,-1.31512612020892,0.09358288770053476,0.5432614998538153,1.0,14/37,27.20%,HCN1;AKAP6;IGFBP5;AKAP9;EZR;RAPGEF2;SLC5A5;STAT1;DGKQ;DMTN;PDE2A;HCN2;INPP5K;KCNQ1
prerank,vascular transport (GO:0010232),-0.3379307507255137,-1.314928427237651,0.06070287539936102,0.5424368029288127,1.0,17/81,6.78%,ATP1A2;SLC24A3;LRP1;SLCO3A1;SLC2A13;SLC1A3;LEPR;SLC16A12;SLC6A13;SLC13A3;SLC7A2;SLC22A8;SLC6A1;SLC16A7;SLC1A5;SLC12A2;SLC6A9
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.47203413588855214,1.3147150433553882,0.12792792792792793,0.9245807733187961,1.0,10/25,17.73%,HSPA8;DNAJB5;BAG1;HSPE1;SDF2;HSPA13;DNAJB14;HSPA14;GAK;ST13
prerank,glutamate receptor signaling pathway (GO:0007215),-0.39040509300785703,-1.3145741433392484,0.1053921568627451,0.5420830169475096,1.0,6/37,1.54%,GRIA4;GRIA2;CPEB4;GRID2;GRM5;GRIN2B
prerank,establishment of protein localization to membrane (GO:0090150),0.3968346470281343,1.3141027736357065,0.08536585365853659,0.9241504350651425,1.0,19/66,17.12%,RTP3;REEP1;GORASP2;CHM;RAB11B;ZDHHC14;PIKFYVE;ZDHHC15;ICMT;VPS37B;PRKCI;ZDHHC9;NPC1;ZDHHC7;PARD3;RAB3GAP1;BRAF;VPS37C;RTP4
prerank,transport across blood-brain barrier (GO:0150104),-0.3349905716113488,-1.3136508185172784,0.06070287539936102,0.5433776435045318,1.0,17/83,6.78%,ATP1A2;SLC24A3;LRP1;SLCO3A1;SLC2A13;SLC1A3;LEPR;SLC16A12;SLC6A13;SLC13A3;SLC7A2;SLC22A8;SLC6A1;SLC16A7;SLC1A5;SLC12A2;SLC6A9
prerank,positive regulation of transporter activity (GO:0032411),-0.5179841256500026,-1.3136125459010763,0.15466101694915255,0.5420409622677894,1.0,4/13,13.02%,KMT2A;SGK1;RXRA;WNK3
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.5840739666094258,1.3136030240066021,0.1401151631477927,0.9230581472408718,1.0,4/11,10.63%,NCBP1;AHCYL1;ZFP36L1;PAPOLA
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.4442555490786624,-1.313598857632736,0.11058823529411765,0.5406332390393229,1.0,5/25,11.40%,ITPR1;MAPT;P2RX4;HTT;RIT2
prerank,endothelial cell development (GO:0001885),0.47562784372797806,1.3132741164472643,0.11518324607329843,0.9212540787745268,1.0,7/25,10.92%,PDE4D;MARVELD2;PECAM1;PPP1R16B;ICAM1;RAPGEF3;ROBO4
prerank,positive regulation of dephosphorylation (GO:0035306),0.4714998856299621,1.313065998436906,0.15070921985815602,0.9188600592525906,1.0,10/27,14.01%,PIN1;SRC;PPP1R16B;CNEP1R1;CALM3;SPPL3;ANKLE2;PTBP1;CDH5;PTPA
prerank,regulation of tissue remodeling (GO:0034103),-0.48497279587570996,-1.3127220392237524,0.14444444444444443,0.5417565817867933,1.0,7/18,30.61%,LEPR;IL18;SYT7;TGFB1;MDK;CEACAM1;FLT4
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5137317959374552,-1.3127195494559292,0.13024282560706402,0.540330134158104,1.0,3/14,9.17%,SULF1;SULF2;THBS1
prerank,non-motile cilium assembly (GO:1905515),-0.4238961650342421,-1.3120706901920487,0.12895377128953772,0.5407030131976467,1.0,17/30,31.66%,PIBF1;TTC8;IFT57;CEP89;ARL13B;DISC1;DCTN1;CEP250;GORAB;TMEM80;IFT88;TOGARAM1;C2CD3;FUZ;TMEM216;BBS1;VANGL2
prerank,epithelium development (GO:0060429),-0.3264406660157606,-1.311975152708487,0.04868913857677903,0.539581202274187,1.0,43/107,32.03%,FGFR2;ALDH1A2;AHI1;KANK2;PKD1;ERRFI1;ANXA4;OSR1;VDAC1;SMO;VCL;MEOX2;CPT1A;WNT4;SALL1;PTER;CD34;LOXL3;MTHFD1;TOLLIP;RCN3;DACT1;ANXA7;TGFB1;DVL1;SIX1;TAGLN2;STAT1;PGK1;VEGFA;PAX2;NDRG4;PTCH1;TBX2;TAGLN;BMP2;CTSB;PCNA;ALDOC;PIH1D1;MFSD2A;FGF10;GATA6
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.49407454323405625,-1.3116078020194757,0.15367965367965367,0.539171121937331,1.0,5/16,7.38%,DDX5;DDX17;CELF4;SRSF6;SRSF1
prerank,regulation of osteoblast proliferation (GO:0033688),-0.4778556874531753,-1.311136017386073,0.12527964205816555,0.5391832251346895,1.0,11/17,31.04%,FGFR2;NELL1;RHOA;NPR3;EIF2AK2;MN1;CCN1;PLXNB1;SFRP1;BMP2;TMEM119
prerank,regulation of innate immune response (GO:0045088),0.4035820107805823,1.3108277190380626,0.10747663551401869,0.9262773750968866,1.0,7/57,3.90%,LRP8;TNFAIP3;FCGR2B;TIRAP;CDC37;IFI35;BIRC2
prerank,negative regulation of lipid catabolic process (GO:0050995),0.5275506267076583,1.310743663026763,0.16453382084095064,0.9233302250249346,1.0,1/17,0.14%,CIDEA
prerank,regulation of receptor internalization (GO:0002090),-0.39999913820641636,-1.3106305390803026,0.0925,0.5391392088368581,1.0,3/35,3.58%,MAGI2;AHI1;DLG4
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.49520190990646795,-1.3103644703985513,0.14432989690721648,0.5384774590967945,1.0,9/15,18.74%,WNT5B;GPC3;CSNK1E;RSPO3;ZNRF3;RNF213;DAAM2;DACT1;SFRP4
prerank,activation of protein kinase A activity (GO:0034199),-0.4886241729448705,-1.3102763757498919,0.16768916155419222,0.5372702831739273,1.0,11/16,22.36%,ADCY5;ADCY2;ADCY1;PRRC1;ADCY9;PRKACA;PRKAR1B;ADCY7;ADCY3;ADCY8;ADCY4
prerank,dephosphorylation (GO:0016311),0.3495757732958336,1.3102012379939276,0.06166219839142091,0.9223901392869576,1.0,22/147,6.87%,PHPT1;PTPRR;PTPN18;PTPRG;DUSP7;PTPRJ;PTPRC;CTDSP1;PPP3CB;PNKP;PTPRM;PTPRB;DUSP12;PTPRE;PPP2CA;PLPP6;PTPN12;PXYLP1;SSH2;PTPRT;PLPP1;PPP2CB
prerank,cell chemotaxis (GO:0060326),-0.35621902073537337,-1.310163564876193,0.07297297297297298,0.536212791868662,1.0,12/60,10.65%,LPAR1;PARVA;PDGFRB;EPHB1;NRP1;KIT;PIP5K1A;PRKCD;PDGFRA;CCR9;PLEKHG5;ACKR3
prerank,negative regulation of immune response (GO:0050777),0.3465293057859531,1.3100762274472972,0.050666666666666665,0.9196370892225932,1.0,22/154,10.76%,GPR176;PRKAR1A;PTGER2;TNFAIP3;FCGR2B;PLK2;SRC;TSHR;INSL3;RAMP2;FYN;SAMSN1;GNB1;RXFP1;SYK;NLRC3;PLCG1;LYN;RHBDF2;YES1;CD163;TRAF3IP1
prerank,regulation of osteoclast differentiation (GO:0045670),-0.40379797031672265,-1.3096989130508034,0.09782608695652174,0.5361535257109041,1.0,12/33,35.42%,FBN1;CAMK4;UBASH3B;TCTA;CEBPB;PRXL2A;TLR3;GPR137B;TMEM178A;MTOR;MAFB;GPR137
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.49601809790757784,-1.3093141101537131,0.14847161572052403,0.5359169067793319,1.0,11/16,41.25%,NUPR1;ATP7A;VCP;COX7A2L;PINK1;SLC25A33;UQCC2;AK4;PDE12;MLXIPL;PPIF
prerank,innate immune response (GO:0045087),0.33853198951110164,1.309176301723294,0.044270833333333336,0.920652162515068,1.0,40/217,14.60%,DMBT1;PIK3CG;CAPZA2;TRIM28;IFNLR1;IFITM2;SRC;TRIM8;IFIT1;RNASE6;FYN;PHB2;TRIM14;B2M;SYK;IFITM3;RNF187;ADAR;TRIM25;IFITM1;RELA;PJA2;LYN;YES1;MFHAS1;SRPK2;SERINC5;DDX3X;APP;SERINC3;ANKHD1;PIK3CD;IFI27;IKBKB;CHUK;NLRC5;ANKRD17;TRIM27;GCH1;CYBA
prerank,cell-cell junction organization (GO:0045216),-0.3331863523671242,-1.3084234792226357,0.07419354838709677,0.5371107366953288,1.0,33/79,24.63%,SDK1;CDH10;SMAD3;CTNNA1;CXADR;OCLN;TLN1;NLGN2;CTNND2;TLN2;SDK2;CDH11;CDH7;GJC1;ARVCF;AFDN;CDH1;CSK;CDH4;MYADM;CTNND1;CADM2;NECTIN3;TGFB1;CDH9;CADM3;CDH8;CDH19;NECTIN2;FLCN;DCHS1;PVR;TGFB3
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.5668622904283888,1.3083009625067825,0.1765834932821497,0.9216566278801805,1.0,2/11,1.52%,ATF3;ATF6
prerank,spinal cord development (GO:0021510),-0.5297916420523381,-1.3081442751437988,0.1574074074074074,0.5365106899189467,1.0,5/12,16.58%,PKD1;GLI2;RELN;LOXL3;VIT
prerank,positive regulation of integrin activation (GO:0033625),0.5819236761729192,1.3078705438343767,0.15427509293680297,0.9205629332482891,1.0,3/11,13.32%,SRC;RASIP1;PLEK
prerank,positive regulation of neurogenesis (GO:0050769),-0.34378104406351634,-1.307853563553459,0.06646525679758308,0.5359570565386276,1.0,23/68,16.66%,ROBO2;PLXNA2;ROBO1;CUX1;NTRK2;TIAM2;CTNNB1;RHOA;SPEN;SNW1;SMARCD3;CUX2;NUMBL;DISC1;IL1RAPL1;OBSL1;PLXND1;ARHGDIA;KDM1A;PLXNB2;NGF;PLXNC1;OPRM1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.4313572126514097,-1.3075586847795426,0.1377672209026128,0.5354581305781693,1.0,7/24,5.92%,TMEFF2;PHLDB2;CGNL1;WASF2;ARHGAP28;PPFIA1;ARHGAP6
prerank,negative regulation of response to wounding (GO:1903035),-0.4635158228219984,-1.3075574057230588,0.15198237885462554,0.5341048507062125,1.0,8/19,29.17%,PTPRS;AJAP1;CERS2;CD109;GIT1;SERPINE1;INPP5F;MDK
prerank,spliceosomal snRNP assembly (GO:0000387),0.42738845804600456,1.307404965501476,0.13029315960912052,0.9195031217118067,1.0,7/38,8.52%,SNRPD2;PRPF31;PRPF3;SNRPD1;SRSF10;GEMIN5;COIL
prerank,cellular metal ion homeostasis (GO:0006875),-0.32751940108711913,-1.3073426060223177,0.05693950177935943,0.5333377949443574,1.0,17/102,10.35%,ANK2;ATP1A2;SLC24A3;HTR2C;KCNMA1;STIM2;ATP1B1;STIM1;SLC41A1;ATP13A5;ATP1B3;SLC12A2;ATP1A1;KCNJ2;SLC24A2;ATP1B2;DMPK
prerank,ceramide biosynthetic process (GO:0046513),0.43257880926069614,1.3072373156460468,0.14052287581699346,0.9170074126290758,1.0,5/40,5.32%,CERS1;SMPD4;ST6GALNAC3;CERS4;SGMS1
prerank,chromatin remodeling (GO:0006338),0.37090618278931453,1.3066833831776556,0.06582633053221289,0.9162877855190741,1.0,38/100,19.00%,ACTL6A;RUVBL2;ACTB;NUDT5;SMARCA2;ACTR8;HNRNPC;SIRT1;ACTR5;KDM6A;RUVBL1;KDM4D;RSF1;PAK1;ESR1;SMARCD1;CHD3;HDAC5;CECR2;KDM5C;HCFC1;DR1;BAZ2A;INO80;EZH1;PBRM1;TAF6L;TOP1;SMARCA4;RBBP4;SMARCAD1;NPM1;TADA2A;CHD8;KDM4C;HDAC2;ATRX;SMARCB1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.37370019093427487,1.3063499539445769,0.06268221574344024,0.914610260235968,1.0,20/87,13.25%,TTC19;SDHAF3;IMMP2L;NDUFAF1;NDUFAF5;UQCC3;NDUFB6;NDUFB4;OMA1;NDUFA10;NDUFA1;NDUFS2;TIMM21;AIFM1;NDUFB7;TIMMDC1;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,somite development (GO:0061053),-0.5379517802169608,-1.3061425964622573,0.15418502202643172,0.5354069394854893,1.0,4/11,12.56%,SMO;MEOX2;LOXL3;MTHFD1
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.4583122016251214,-1.3057635504198923,0.11547344110854503,0.5351056260320988,1.0,5/22,7.81%,CACNA1C;CACNA1D;STIM1;ADGRV1;GABBR2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.47933008845135305,-1.3054695412859694,0.15869565217391304,0.534615107258346,1.0,2/17,1.90%,MAGI2;PDGFRB
prerank,neurotrophin signaling pathway (GO:0038179),-0.45886553113960704,-1.305454094260348,0.12072892938496584,0.5333206505690208,1.0,9/21,25.97%,MAGI2;NTRK2;GRB2;NGF;RAPGEF2;ZFYVE27;CASP3;KIDINS220;DDIT4
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.4727071036899393,-1.3049743580137798,0.14012738853503184,0.5332420694864048,1.0,7/18,15.28%,PABPN1;ENY2;POLDIP3;NXF1;NUP93;DDX19B;DDX19A
prerank,membrane lipid catabolic process (GO:0046466),0.589215417704867,1.3044880855603551,0.1718146718146718,0.9206213828781249,1.0,3/10,9.39%,PPT1;FUCA1;CYP1B1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.42409665786327555,-1.3041707046695248,0.12325581395348838,0.5341555476866745,1.0,14/25,26.37%,KAT7;ERCC6;LDB1;ELL;DDX39B;HTATSF1;CCNT1;WDR43;THOC5;CCNK;EAF1;THOC1;SUPT4H1;ZNF326
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.3536135917441141,-1.3041467034295253,0.07309941520467836,0.532900076655995,1.0,12/56,11.06%,BMP6;LDLRAD4;DAB2;BMPER;TGFBR1;BMP5;BMP7;SMAD4;BMP4;SMAD6;ACVR1;SNX25
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5659117472762127,-1.3036477075456605,0.1601642710472279,0.5330114773638797,1.0,2/10,4.63%,GLI3;BMP4
prerank,in utero embryonic development (GO:0001701),-0.4270105071707836,-1.3032995189583134,0.13513513513513514,0.5326736412311927,1.0,5/25,4.65%,FGFR2;ARNT2;PKD1;TGFBR1;FUT8
prerank,RNA splicing (GO:0008380),0.36912420642121285,1.3032004736301255,0.09915014164305949,0.9237215130470756,1.0,33/95,18.00%,SNRPD2;NCBP1;PRPF3;SNRPD1;PPP2CA;PPIG;SRSF10;USB1;SFPQ;HNRNPC;IVNS1ABP;SMNDC1;SF3B3;SRSF4;YJU2;RSRC1;TARDBP;U2AF1;CCAR2;SRPK2;PTBP1;RRAGC;SRSF7;FUS;USP39;TCERG1;TRA2B;NONO;LSM1;SNRPA1;DHX8;PRPF18;DDX23
prerank,diol metabolic process (GO:0034311),0.5002431966885004,1.302539128315172,0.16934046345811052,0.9237150271551534,1.0,7/19,14.38%,SPR;PTS;PLPP1;SGPP2;NOS3;SGPP1;GCH1
prerank,negative regulation of dephosphorylation (GO:0035305),0.503373748387024,1.3020406867673218,0.15636363636363637,0.9229559464695364,1.0,6/18,15.59%,PPP1R36;PPP1R16B;YWHAB;MFHAS1;PTPA;PPP1R8
prerank,chromatin organization (GO:0006325),0.3554272473563946,1.301928075421321,0.04660452729693742,0.9201736266328386,1.0,43/132,19.00%,MECOM;EZH2;ACTL6A;RUVBL2;HDAC3;NUDT5;SOX2;SMARCA2;FAM50A;SIRT1;KDM6A;SETD5;RUVBL1;KDM4D;RSF1;PAK1;CHD1;ESR1;HP1BP3;PWWP3A;SMARCD1;HDAC5;KDM5C;HCFC1;DR1;BAZ2A;INO80;EZH1;PBRM1;TAF6L;TOP1;SMARCA4;TCF7L1;RBBP4;SETD2;SMARCAD1;NPM1;TADA2A;KDM4C;SAFB;HDAC2;ATRX;SMARCB1
prerank,cardiac conduction system development (GO:0003161),-0.4380350598198043,-1.301613465487635,0.13411764705882354,0.5361838424527247,1.0,10/24,19.67%,NOTCH2;GJB6;SMAD4;MAML1;BMP4;GJA1;CACNA1G;SMAD5;BMPR1A;TBX18
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.5293485270993066,-1.3013762571353327,0.16563146997929606,0.5355161623978688,1.0,5/11,16.33%,TGFBR3;TGFBR1;TGFBR2;ACVR1;TGFB1
prerank,lymphocyte proliferation (GO:0046651),0.4799344752234529,1.301084368380024,0.14028776978417265,0.9209143262606835,1.0,3/22,2.57%,PIK3CG;PTPRC;PPP3CB
prerank,response to hydroxyurea (GO:0072710),-0.538331592177166,-1.3010638029102368,0.1574468085106383,0.535096721274969,1.0,5/11,19.95%,SPIDR;KAT7;DDI2;RTF2;BLM
prerank,cristae formation (GO:0042407),0.4665379251647748,1.3007226535505862,0.12307692307692308,0.9192739952108573,1.0,11/27,14.82%,ATP5F1E;UQCC3;ATP5MG;ATP5PF;ATP5MC2;IMMT;CHCHD6;CHCHD3;LETM1;DNAJC11;ATP5F1C
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4431857426445608,1.3006979889341546,0.13095238095238096,0.9162230968590558,1.0,7/34,6.58%,PTPRQ;PTPN18;DUSP7;PTPRJ;PTPRB;PTPN12;PTPRT
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.5698521289533645,1.300517669094995,0.1793372319688109,0.9139921765693795,1.0,4/11,10.50%,RGS2;GSK3A;NOTCH1;GLRX3
prerank,protein localization to cell junction (GO:1902414),-0.45237146651318827,-1.3002970936429388,0.16937354988399073,0.5359261151590545,1.0,9/22,13.52%,CGNL1;PCLO;JAK1;DLG4;NLGN2;JAM3;NLGN1;KIF3A;BSN
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),-0.3152844173041682,-1.2995233303467073,0.045307443365695796,0.5368234733599746,1.0,29/108,16.56%,ST18;UACA;ROBO1;GSN;SMAD3;CFLAR;COL4A3;MAPT;MALT1;CASP8AP2;F3;VCP;XDH;FAM162A;FIS1;IFT57;ANP32B;MAP3K5;GRAMD4;CASP12;CTSD;HIP1R;PDCD5;RACK1;HSPD1;NGF;EGLN3;TRAF2;MTCH1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.525074457915821,-1.2990014467801023,0.1346153846153846,0.5370449856311252,1.0,3/13,5.12%,GLI3;TGFBR2;CBFB
prerank,negative regulation of cell projection organization (GO:0031345),-0.3625318205339802,-1.297166644272649,0.0748663101604278,0.5407717158797716,1.0,10/48,7.50%,DCC;LPAR1;SPOCK1;GRIN2B;DPYSL3;PTPRS;EFNB2;CBFA2T2;SEMA3A;STMN2
prerank,epithelial cell migration (GO:0010631),-0.3890792372274845,-1.2967037789992901,0.10123456790123457,0.5407460842401666,1.0,13/37,10.47%,FSTL1;KANK2;ADGRA2;NRP1;ZEB2;RHOA;KIT;PXN;ROCK1;DPP4;STARD13;PLEKHG5;FAP
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.4027035664141332,1.2965070924875564,0.10570469798657718,0.9299384120015257,1.0,26/52,20.96%,PATL2;CNOT11;CNOT2;HBS1L;CNOT7;EXOSC9;PATL1;PAN3;NT5C3B;TUT7;EXOSC1;CNOT6;PAN2;CNOT1;DCP1A;CNOT6L;TUT4;PARN;CNOT10;LSM1;RC3H1;DCP1B;EXOSC7;CNOT4;DDX6;CNOT8
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5388437032818858,-1.2962894297439502,0.15690376569037656,0.5406602269152835,1.0,7/11,25.27%,IGF1;GHR;TSC2;PIK3R1;GIGYF1;AKT1;EIF2AK3
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.45030715023047896,1.2954976298246552,0.13924050632911392,0.9317924800683122,1.0,8/27,12.92%,MAP2K7;MAPK3;MAP3K7;MAPK8;CCDC88C;TNIP2;IKBKB;CHUK
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3100609236790213,1.295025400634573,0.00974025974025974,0.930909187543863,1.0,86/532,13.01%,LRP8;CISH;LCP1;PSMB10;PSMC4;PSMB6;MAPK3;EIF5A;CBL;PSMD8;PSMD5;PSMD12;PTPRJ;IL1R1;HSPA8;MAP3K7;SOD1;CXCL12;TAB2;RPS6KA4;IFNLR1;IFITM2;SRC;CRLF1;TRIM8;IFIT1;IFI35;BIRC2;RPS6KA5;XAF1;PSMD11;IRF9;SOX2;PSMB4;FYN;TNFRSF1B;EDAR;RALA;B2M;PSMC1;CFL1;CDKN1A;UGCG;TRAF5;ICAM1;TALDO1;SYK;PIM1;ACTN4;SIRT1;ADIPOR2;IFITM3;IRS2;TAB3;ADAR;TRIM25;CCL25;RPLP0;IFITM1;TRAF3;RELA;SOD2;ARF1;CSF1R;IL10RB;INPP5D;PSMC2;PLCB1;PSMD2;IFNAR1;PITPNA;UBE2V1;CDIP1;NOD1;ADIPOR1;PIK3CD;IFI27;IP6K2;TNIP2;TYK2;CRKL;MID1;IKBKB;IRF2;CHUK;PSMD14
prerank,protein localization to organelle (GO:0033365),-0.3021043387818805,-1.2946529378226468,0.0379746835443038,0.5439161084110513,1.0,54/133,25.37%,ANK2;BICD1;TIA1;COL1A1;TULP3;BMP7;BMP4;LMNA;WDR35;TTC21B;SORL1;UBE2J2;CYB5A;DDX1;BANP;TOR1AIP1;OPTN;RPA1;TRAM1;DDRGK1;ALDH3A2;BBS9;OBSL1;TOLLIP;RAB11A;ARL1;VAMP2;TOPORS;TOR1B;BBS2;PAF1;CEP250;TRAM2;STX1A;EHD1;ZNF423;SCG3;DVL1;IFT20;SGTA;GBP5;SIX1;PAQR3;CNTLN;MTCH2;GBP2;CTDNEP1;EMD;RAB33B;SERP1;ARFRP1;DNAJA1;RIPOR1;SEC61B
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5033962752647155,1.2938193982761053,0.14684014869888476,0.9336771958657096,1.0,6/17,14.71%,RFFL;PTTG1IP;SIRT1;YJU2;MDM2;CD44
prerank,positive regulation of nuclear division (GO:0051785),-0.4304449709257765,-1.2930056987247172,0.12280701754385964,0.5472218177847342,1.0,5/25,13.94%,IGF1;PDGFRB;SIRT2;LRP5;IGF2
prerank,synapse organization (GO:0050808),-0.31237501797460066,-1.2930037615307617,0.0421455938697318,0.5459145508947246,1.0,33/125,13.50%,LRRC4C;LRFN5;ANK3;PDZRN3;SDK1;GPC6;NRXN1;CACNB4;GRM5;KIRREL3;NRCAM;NTNG1;PPFIBP1;PTPRS;RYK;MAPT;DNER;DSCAM;SLC6A1;NLGN2;GPM6A;PPFIA1;CTNND2;SDK2;NLGN1;CDH1;PTPRF;LRRC4;NRXN2;UNC13C;OBSL1;UNC13B;PLXND1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.49037169019614374,-1.2929392708174328,0.15483870967741936,0.5447847160338194,1.0,5/15,14.73%,MAGI2;SKI;ACVR1;ACVR1B;DACT1
prerank,ventricular septum development (GO:0003281),-0.38034411180064664,-1.2927821785364295,0.11197916666666667,0.5439096402087339,1.0,7/37,4.05%,ROBO2;TGFBR3;ROBO1;TGFBR1;TGFBR2;SMAD4;HECTD1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.3196718828756465,-1.2917325695239152,0.035830618892508145,0.5455668798534852,1.0,28/95,16.61%,UST;GPC6;HS3ST5;HS6ST2;DSE;SDC2;GLCE;B4GALT1;CHSY1;CEMIP;OGN;VCAN;HS3ST3A1;GPC3;HEXA;HSPG2;CSGALNACT2;CHST15;GPC5;B4GALT6;CHST11;SLC35D2;UGDH;CSPG4;ST3GAL4;PRELP;HS3ST3B1;DSEL
prerank,regulation of postsynapse organization (GO:0099175),0.4604323133332767,1.2916086916122604,0.14067796610169492,0.9409339953932252,1.0,12/28,16.11%,FCGR2B;SHANK3;CFL1;TANC2;WNT5A;ZDHHC15;PPFIA2;ABHD17B;HOMER1;VPS35;CDKL5;ABI2
prerank,axon extension (GO:0048675),-0.44238480585320017,-1.2915020017277954,0.15299334811529933,0.5449584592145015,1.0,7/23,9.55%,ALCAM;MAP1B;ULK2;AUTS2;NRP1;SEMA3A;NRP2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5013002793997084,-1.2914574331039743,0.16458333333333333,0.5437905002475764,1.0,5/14,19.90%,UFL1;BCL2L11;TMEM33;DDRGK1;COPS5
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.4183130869292644,1.2911035781116904,0.1362940275650842,0.940261259463474,1.0,10/46,10.09%,TOMM20;ROMO1;RALA;TIMM17B;TSPO;GRPEL2;TOMM40L;FBXO7;TIMM21;AIFM1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3611835202743762,-1.291046329126873,0.10263929618768329,0.5436616743746511,1.0,13/51,7.21%,DCLK1;EPB41L3;GAS7;NBL1;SNX2;BMP7;GPM6A;ATP7A;MYO16;SHTN1;TAOK3;CTTN;WASF1
prerank,bicarbonate transport (GO:0015701),0.46682477514702164,1.2905734497381907,0.17086330935251798,0.9395320822114774,1.0,5/25,9.72%,SLC4A4;SLC4A5;CA2;CA4;CYB5R4
prerank,cellular response to osmotic stress (GO:0071470),0.4860019786158017,1.290529723449446,0.1582608695652174,0.9366085433050819,1.0,6/21,10.75%,OXSR1;ZFP36L1;SCN2A;ZFAND1;TRPV4;DDX3X
prerank,regulation of Golgi organization (GO:1903358),0.5039345119678023,1.2903096525915982,0.16815742397137745,0.9344704515630337,1.0,6/17,10.96%,MAPK3;MYO5A;USP6NL;CAMSAP2;PDE4DIP;RBSN
prerank,purine ribonucleotide transport (GO:0015868),0.5120021909359616,1.2896209232687823,0.1791907514450867,0.9345462798180805,1.0,3/16,6.49%,ABCC4;SLC25A24;LRRC8C
prerank,regulation of intracellular protein transport (GO:0033157),0.4448626494540289,1.2895242165914989,0.12078152753108348,0.9318577611920221,1.0,7/32,11.81%,LCP1;PRR5L;ZFAND1;ICE1;RUFY3;GCC2;IFI27
prerank,regulation of filopodium assembly (GO:0051489),-0.3891437082391569,-1.2894333760964747,0.10539845758354756,0.5470849135437423,1.0,10/38,8.37%,TENM2;DPYSL3;NRP1;WASL;GPM6A;PRKCD;GAP43;PLPPR5;NLGN1;DOCK11
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.5761868780395688,1.2893984689816835,0.17357001972386588,0.9293158820277218,1.0,3/10,7.77%,TIRAP;IFI35;WDFY1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.49489397240846733,-1.2893847299161374,0.17584745762711865,0.5458908111497464,1.0,8/14,26.35%,PXN;GHR;STAT6;SOCS2;PTK2;PIK3R1;PRLR;STAT5A
prerank,Golgi organization (GO:0007030),0.36040021701408625,1.2889194956488874,0.08507670850767085,0.9285952736929147,1.0,22/112,10.83%,SURF4;SYNE1;LYSMD3;GORASP2;CLASP2;LMAN2;TMED4;SEC23IP;RAB43;TRAPPC8;USP6NL;ARHGEF7;GOSR2;TRIP11;VMP1;TMED5;TMED10;RAB1A;GOLPH3L;TRAPPC11;GCC2;TMED7
prerank,isotype switching (GO:0045190),-0.5445888889921254,-1.288292117744566,0.16883116883116883,0.5477119246490136,1.0,8/10,43.55%,RNF168;RNF8;MSH2;HSPD1;MSH6;EXOSC3;BATF;LIG4
prerank,positive regulation of phagocytosis (GO:0050766),0.4114302042146629,1.2877216345081257,0.10845295055821372,0.93105379638937,1.0,12/47,18.44%,PTPRJ;PTPRC;FCGR2B;CAMK1D;LMAN2;MERTK;CD47;CYBA;GAS6;CALR;RAB27A;MYO18A
prerank,triglyceride metabolic process (GO:0006641),0.41207338479098493,1.2876678376611417,0.1254071661237785,0.9282574921248227,1.0,7/48,7.36%,GPAM;FABP7;APOE;PLAAT3;LMF1;GPAT4;SIRT1
prerank,regulation of receptor binding (GO:1900120),0.5676873241172682,1.2871204178076927,0.18216318785578747,0.9277988427637426,1.0,3/10,7.15%,ATP2A2;B2M;BDNF
prerank,water transport (GO:0006833),-0.527404207471414,-1.2869787549446856,0.18067226890756302,0.5502345644866176,1.0,3/12,24.54%,PDPN;AQP4;AQP11
prerank,receptor catabolic process (GO:0032801),-0.4307740625791119,-1.2868135149128046,0.16063348416289594,0.5493731294706977,1.0,13/24,20.43%,AP2B1;RNF43;AP2A2;AP2A1;ZNRF3;LGMN;GPRASP1;UVRAG;SNX25;VLDLR;TGFB1;MYLIP;NEDD4
prerank,N-terminal protein amino acid modification (GO:0031365),0.5164645321610929,1.2867278937324447,0.17025440313111545,0.9267121153173167,1.0,6/14,18.45%,METAP2;NAA35;METAP1;NTMT1;NAA15;NAA50
prerank,protein heterotetramerization (GO:0051290),-0.5018444735560184,-1.2863610677652988,0.17894736842105263,0.5494527698562837,1.0,2/13,1.93%,GRIN2B;PKD1
prerank,synapse assembly (GO:0007416),-0.344419238483951,-1.2856523484255349,0.10119047619047619,0.5501394376016733,1.0,24/67,17.40%,SDK1;NRXN1;GRID2;KIRREL3;LRRTM3;NRCAM;GABRA2;RYK;DNER;DSCAM;NLGN2;GPM6A;GABRG2;SDK2;NLGN1;CDH1;LRRC4;NRXN2;OBSL1;PLXND1;PLXNB2;LGI2;SHANK2;DVL1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4216406689604712,-1.2855700187801495,0.1320754716981132,0.5491261504953278,1.0,12/26,25.50%,SORBS1;IGF1;OCLN;AKT2;CREBL2;ARPP19;CLIP3;PIK3R1;OSBPL8;APPL1;AKT1;CAPN10
prerank,negative regulation of neuron projection development (GO:0010977),-0.3531213958912131,-1.2855611196445866,0.08022922636103152,0.5478731047728531,1.0,16/56,15.04%,DCC;LPAR1;SPOCK1;DPYSL3;PTPRS;EFNB2;RHOA;CBFA2T2;SEMA3A;STMN2;NLGN1;BCL11A;PRAG1;GDI1;ARHGDIA;PTPRO
prerank,ATP transport (GO:0015867),0.5698726595821113,1.2854743195654856,0.1956521739130435,0.9297445277343352,1.0,3/10,15.49%,SLC25A24;CD47;SLC25A42
prerank,regulation of cell-substrate junction assembly (GO:0090109),-0.44218894246416496,-1.2852345853693767,0.1515837104072398,0.5475122734138972,1.0,9/21,10.68%,GPM6B;EFNA5;MACF1;RHOA;ROCK2;VCL;ROCK1;LDB1;EPHA3
prerank,regulation of fat cell differentiation (GO:0045598),0.37969728707537476,1.2849548082157514,0.10454545454545454,0.9292122741155547,1.0,15/74,12.28%,CCDC85B;PTPRQ;TRIB3;FRZB;CCDC71L;BBS12;ZFP36L1;PPARD;TRIO;SIRT1;WNT5A;AAMDC;TRPM4;CARM1;WDFY2
prerank,cellular response to organic cyclic compound (GO:0071407),-0.29988336932206683,-1.2847343786802634,0.03319502074688797,0.5476502375752671,1.0,42/141,22.55%,ATP1A2;GABRB1;HCN1;ADCY5;EGFR;AKAP6;RYR3;TFPI;ADCY2;IGFBP5;CTNNA1;SPIDR;ADCY1;CTNNB1;MED1;P2RX4;ROCK2;ATP1A1;GABRG2;AKAP9;EZR;CDH1;NCOA4;IL18;SPP1;RAPGEF2;TGFB1;CASP7;NR3C1;RORA;DIAPH1;ATP1A3;SLC5A5;RIOK3;MSN;SSH1;BLM;P2RY12;ADCY3;ADCY8;IMPACT;CASP3
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5433424981202759,1.284644160493479,0.19342359767891681,0.9276525365942109,1.0,2/12,1.39%,CBL;PTPRJ
prerank,anterior/posterior axis specification (GO:0009948),-0.4842518095300592,-1.2846046785595102,0.15932914046121593,0.5467355590516102,1.0,3/15,11.84%,WLS;SKI;TBX3
prerank,magnesium ion transport (GO:0015693),-0.5188341485718418,-1.284555702959163,0.16766467065868262,0.5456271486613189,1.0,6/12,22.59%,SLC41A1;NIPA2;MRS2;NIPAL2;MAGT1;NIPAL3
prerank,L-amino acid transport (GO:0015807),0.45298236437309003,1.2843099861536384,0.16013628620102216,0.9262658164944405,1.0,8/28,13.84%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC1A2;SFXN1;SLC25A12;SLC38A5
prerank,positive regulation of B cell proliferation (GO:0030890),0.4470188465866713,1.2839166971278844,0.16415410385259632,0.9251636239447361,1.0,5/29,10.85%,PTPRC;VAV3;TIRAP;IRS2;CD81
prerank,DNA biosynthetic process (GO:0071897),0.5152869761826804,1.283658498099524,0.1760299625468165,0.9233887110157569,1.0,5/16,10.31%,POLE;SIRT1;POLD3;POLA1;TERT
prerank,positive regulation of cellular component movement (GO:0051272),0.4555620673549069,1.28358596177364,0.1582608695652174,0.9207975513513992,1.0,5/24,9.34%,PHPT1;SPOCK2;ACTN4;CSF1R;LYN
prerank,muscle cell migration (GO:0014812),-0.5518880774814483,-1.2831000616090595,0.16521739130434782,0.5485540411319605,1.0,8/10,28.92%,DDR1;ROCK1;CCN3;MEGF10;SIX1;AAMP;ITGB1BP1;ITGB3
prerank,photoreceptor cell development (GO:0042461),-0.5069651459618735,-1.2828954220798672,0.1744421906693712,0.5478639377242528,1.0,6/14,31.23%,AHI1;DCX;TOPORS;VEGFA;RP1;MFSD2A
prerank,phagosome-lysosome fusion (GO:0090385),0.5651854256218422,1.2828445452558428,0.18181818181818182,0.9213671734827317,1.0,3/10,7.39%,RAB7A;RAB7B;PIKFYVE
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.41945723122476625,-1.2826072959174324,0.12878787878787878,0.5473787402226545,1.0,9/29,9.71%,SMAD3;ZC3H7A;PUM1;ZC3H7B;PUM2;LIN28B;SRRT;HNRNPA2B1;AGO3
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.4767137018531672,-1.2824750710935497,0.16774193548387098,0.5465060663826742,1.0,9/17,25.54%,ROBO1;NRP1;EFNB2;PIK3R3;EPHB4;GPLD1;VEGFA;AKT1;NR4A1
prerank,pulmonary valve morphogenesis (GO:0003184),-0.47180194533760833,-1.281913058801567,0.16880341880341881,0.5467934633342487,1.0,5/17,8.64%,ROBO2;NOTCH2;ROBO1;BMP4;SMAD6
prerank,protein heterooligomerization (GO:0051291),-0.47061286677413455,-1.2818333640410922,0.155902004454343,0.5457667961444396,1.0,3/17,1.93%,GRIN2B;KCNC2;PKD1
prerank,neuron projection development (GO:0031175),-0.2943765405840958,-1.2815347093838843,0.05128205128205128,0.5453086765731159,1.0,33/168,8.59%,MAP2;CNTN4;DCLK1;PLP1;EPB41L3;PPP1R9A;GPM6B;GAS7;EPHB1;NBL1;HDGFL3;SH3GL2;RASGRF1;WASL;DLG4;RYK;MAPT;BMP7;ADGRV1;GPM6A;ATP7A;MYO16;SHTN1;CTNND2;ERCC6;TAOK3;ROCK1;CTTN;STMN2;DOCK10;NLGN1;CDK16;STX3
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.517753497095311,-1.2814554005820558,0.16846652267818574,0.5443206849754147,1.0,6/13,11.27%,FBN1;FSTL1;NBL1;FBN2;LTBP1;GREM2
prerank,regulation of presynapse assembly (GO:1905606),-0.46891311917746764,-1.2812195058298004,0.16233766233766234,0.5425285990698937,1.0,9/18,29.70%,LRFN5;GPC6;IL1RAPL2;IL1RAPL1;SLITRK1;GPC4;LRRC4B;SNCA;MDGA1
prerank,regulation of presynapse organization (GO:0099174),-0.46891311917746764,-1.2812195058298004,0.16233766233766234,0.5425285990698937,1.0,9/18,29.70%,LRFN5;GPC6;IL1RAPL2;IL1RAPL1;SLITRK1;GPC4;LRRC4B;SNCA;MDGA1
prerank,regulation of primary metabolic process (GO:0080090),0.34952148915821357,1.280767294769174,0.08771929824561403,0.9283024074035323,1.0,31/126,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;GPAM;HMGCR;HDAC3;PSMD11;APOE;PSMB4;ELOVL6;PSMC1;PLPP1;PPARD;SC5D;IRS2;ACACB;PSMC2;PSMD2;IDI1;CREBBP;CARM1;ADIPOR1;LSS;SP1;PSMD14;PSMC6;PSMD1;PSMB1
prerank,DNA-dependent DNA replication (GO:0006261),0.3516318683969936,1.2803311270668567,0.06267409470752089,0.9273910767324087,1.0,27/128,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PNKP;ORC3;PSMD11;PSMB4;PSMC1;SSBP1;POLE;CDC45;ORC4;POLD3;CDK2AP1;POLA1;PSMC2;PSMD2;SRPK2;ORC2;HELB;PSMD14;PSMC6;PSMD1;PSMB1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.32773215942824657,-1.2802995185365684,0.07250755287009064,0.5438879330199289,1.0,25/80,18.05%,TENM2;DPYSL3;WASF2;AUTS2;NRP1;WASL;OCLN;PLCE1;TAPT1;GPM6A;CEP120;HTT;PLPPR5;ACTR3;NLGN1;DOCK11;FAM98A;ENTR1;CCP110;CDC42EP5;PLEKHM1;CDC42EP1;TWF2;ACTR2;CDC42
prerank,renal filtration (GO:0097205),-0.5455104292928283,-1.280162978856434,0.19254658385093168,0.5430969808795798,1.0,4/10,11.40%,SULF1;SULF2;TBC1D8B;CD34
prerank,protein insertion into ER membrane (GO:0045048),-0.38010194366227734,-1.2794506164004185,0.11311053984575835,0.5437990599374192,1.0,18/37,27.42%,UBE2J2;EMC7;CYB5A;CAMLG;TRAM1;ALDH3A2;VAMP2;TRAM2;STX1A;SGTA;BAG6;EMC1;EMC8;EMD;EMC9;SERP1;SEC61B;GET4
prerank,neutrophil chemotaxis (GO:0030593),0.4016510677475419,1.2794141137721209,0.14488188976377953,0.9287233404398633,1.0,7/53,11.64%,PIK3CG;BSG;PPIB;SYK;PIKFYVE;CCL25;PIK3CD
prerank,regulation of mRNA catabolic process (GO:0061013),0.3525105392300014,1.2790984306089372,0.08309859154929577,0.9272175132911791,1.0,29/121,15.24%,PSMB10;PSMC4;PSMB6;PRR5L;PSMD8;PSMD5;PSMD12;HSPA8;ZFP36L1;PSMD11;PSMB4;PSMC1;FXR1;YWHAB;CNOT7;EXOSC9;PCID2;PSMC2;PSMD2;ZC3H14;EXOSC1;XPO1;PSMD14;PSMC6;PSMD1;PSMB1;CNOT1;DCP1A;MOV10
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.49350370850836106,1.2789653817220603,0.1797153024911032,0.9250363444759674,1.0,7/20,13.08%,GCLC;GCLM;CNDP2;GATM;MTHFS;HAGH;GSS
prerank,lipid droplet organization (GO:0034389),0.4693097090455845,1.2788039022511684,0.18563922942206654,0.9228884678430271,1.0,3/22,9.33%,CIDEA;FITM2;AUP1
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5154307590553011,-1.2785863534146176,0.16,0.545126296099422,1.0,9/13,28.41%,VCAN;HEXA;HEXB;ARSB;CSPG4;HYAL1;BGN;CSPG5;DCN
prerank,positive regulation of cell-substrate adhesion (GO:0010811),-0.34338413429246406,-1.2783856814026522,0.08179419525065963,0.5445317220543806,1.0,27/67,29.17%,DOCK5;RSU1;PLEKHA2;DOCK1;NRP1;FLNA;NEDD9;RREB1;P4HB;CDK6;GSK3B;FN1;ILK;MYADM;TRIOBP;VIT;CDC42;CX3CL1;PPM1F;EMP2;DMTN;SFRP1;ARL2;CSPG5;MYOC;NDNF;MDK
prerank,protein acetylation (GO:0006473),0.4433519808451428,1.2770355521852543,0.13728813559322034,0.9284444846266178,1.0,12/30,18.94%,ING4;EP300;SIRT1;CLOCK;NAA35;ESCO1;CREBBP;NAA80;ING5;NAA15;NAA50;HAT1
prerank,rRNA processing (GO:0006364),0.3331337424954077,1.2769112229718882,0.06388526727509779,0.9262096439063113,1.0,61/172,20.09%,RPL30;UTP20;THUMPD1;UTP18;RPL17;RPL23;RPL31;RPL3;DDX54;DDX10;RRP15;RPL35A;RPS14;RPL8;RPL5;RPL37A;RPL4;EMG1;SNU13;POP5;EXOSC9;RPLP0;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;DDX27;WDR12;SRFBP1;EXOSC1;UTP11;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;RSL1D1;DKC1;PRKDC;RPL19;RPL38;EIF6;DCAF13;RPL36;RPL26;RPL15;RPL10;RPS2;RPL32;RPL27A;TFB1M;NOP58;NVL;EXOSC7;RPL14;RPL39;RPL7;MDN1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.5726949446783378,1.276225582398931,0.19805825242718447,0.9265651894349517,1.0,3/10,13.25%,VSIR;PRNP;DDIT3
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.46567307136698366,1.2751128991465024,0.17267552182163187,0.9286737593943751,1.0,4/23,5.70%,RAC2;CAMK1D;TIRAP;RIPOR2
prerank,modification-dependent protein catabolic process (GO:0019941),0.3296171247928731,1.275110172157226,0.06426735218508997,0.9258421110411302,1.0,60/193,18.86%,ELOC;RNF7;CBL;ARIH1;RNF149;ANAPC2;KLHL3;FEM1C;UBA1;RFFL;PSMD11;NEDD4L;RBBP6;UBE2I;RNF130;LONP1;UBL7;PPP1R11;TTC3;TRIM25;FBXO11;ANAPC7;MDM2;PSMC2;FBXO7;RNF6;RNF13;CHFR;UBQLN1;ANAPC11;ANAPC10;ANAPC4;RNF11;FBXO8;CUL3;PSMD14;UBE2R2;USP33;RNF146;RNF20;UBA6;FBXO22;UBE2G1;UBQLN4;RNF114;TAF1;RNF128;RNF125;UBE2H;UFD1;UBQLN2;UBR3;ATXN3;CDC26;RNF215;KCTD10;NDFIP2;TRPC4AP;FBXW4;RC3H1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.4167382812427742,-1.2748392585397919,0.1400437636761488,0.5528625545112908,1.0,6/26,8.39%,NAV3;MAPT;OCLN;STMN2;AKAP9;SLAIN2
prerank,positive regulation of regulated secretory pathway (GO:1903307),-0.46226634084475743,-1.2747251535070279,0.1590909090909091,0.5519853019811245,1.0,10/17,35.30%,NLGN1;CACNA1G;SYT4;SCAMP5;STX1A;SLC4A8;SYT10;RAB3D;CACNA1H;RAB3A
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.30349686209176757,-1.2743097573789026,0.05905511811023622,0.5518722114403473,1.0,23/138,7.56%,ERBB4;NTRK3;FGFR2;EGFR;EPHA6;AHI1;PDGFRB;EPHB1;NTRK2;AXL;RYK;ABI1;FER;MTSS1;NEDD9;EPHA7;KIT;ROR1;DDR1;PDGFRA;FRK;IL31RA;EPHB4
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.4764599015113851,-1.2740766281362224,0.16591928251121077,0.5513154304803226,1.0,4/15,8.19%,EDA;GLI2;HDAC1;FOXC1
prerank,membrane repolarization during action potential (GO:0086011),-0.5083537130278024,-1.273477616529648,0.19298245614035087,0.551774509478437,1.0,3/13,8.27%,ATP1B1;ATP1A1;KCNJ2
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.5225579869666427,-1.2728129585407029,0.16869918699186992,0.5524328192081412,1.0,6/12,15.56%,MAP2;EML2;STMN2;CLIP3;STMN1;TUBB4A
prerank,regulation of endothelial cell chemotaxis (GO:2001026),-0.48156724691445096,-1.2726574000073336,0.18162393162393162,0.5516156861708106,1.0,9/15,21.09%,FGF1;P2RX4;SMOC2;THBS1;LGMN;SEMA5A;MET;HSPB1;PRKD1
prerank,negative regulation of receptor binding (GO:1900121),0.569314024664835,1.2722800624662787,0.20616570327552985,0.936025662336586,1.0,2/10,5.39%,ATP2A2;B2M
prerank,positive regulation of cellular respiration (GO:1901857),0.555762870222234,1.2720073663905895,0.20226843100189035,0.9344532527997986,1.0,5/11,9.90%,IFNLR1;ISCU;IL10RB;PARK7;IFNAR1
prerank,TOR signaling (GO:0031929),0.4508474055062549,1.27134657739314,0.14385964912280702,0.934558248994829,1.0,4/26,4.87%,PRR5L;TIPRL;RPTOR;SMG1
prerank,histone H2A ubiquitination (GO:0033522),-0.46440423825352856,-1.2707213239907125,0.1530398322851153,0.555868151294872,1.0,11/17,31.76%,DDB1;DDB2;RNF168;RNF8;BCOR;DTX3L;UBR2;UBE2B;KDM2B;RING1;TRIM37
prerank,secretion (GO:0046903),-0.5018079885485209,-1.270686494075397,0.18876404494382024,0.554778054222696,1.0,4/14,16.34%,RIMS1;SLC22A4;SLC22A6;NPR1
prerank,translational elongation (GO:0006414),0.35579170846203473,1.2704871884926163,0.08916323731138547,0.9357656809118287,1.0,17/101,12.31%,MRPS22;MRPS2;MRPS33;EEF1A1;MRPL24;MRPL23;EEF1D;MRPL18;MRPL38;MRPS12;MRPL20;TSFM;GTPBP2;MRPL52;MRPL48;MRPS15;MRPS24
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3669447135957456,1.2702179001987297,0.1111111111111111,0.9314028327523985,1.0,18/78,10.64%,DYNC1I1;KIF18A;CAPZA2;FCGR2B;AP2S1;KIFAP3;RAB7A;DCTN2;CLTA;AP1G1;AP1S2;PIKFYVE;DCTN3;KIF15;ARF1;OSBPL1A;KIF2A;DYNLL1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3669447135957456,1.2702179001987297,0.1111111111111111,0.9314028327523985,1.0,18/78,10.64%,DYNC1I1;KIF18A;CAPZA2;FCGR2B;AP2S1;KIFAP3;RAB7A;DCTN2;CLTA;AP1G1;AP1S2;PIKFYVE;DCTN3;KIF15;ARF1;OSBPL1A;KIF2A;DYNLL1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.49345928378609727,-1.2700122815518002,0.188911704312115,0.5554167213976093,1.0,5/14,13.02%,ANK3;ATP1B1;WNK1;WNK4;WNK3
prerank,ear morphogenesis (GO:0042471),-0.44382336529250954,-1.2699881896846716,0.15172413793103448,0.55429792713856,1.0,5/20,10.73%,FGFR2;ZIC1;OSR1;NIPBL;EPHB2
prerank,positive regulation of protein acetylation (GO:1901985),0.5532444940962248,1.2696630504113053,0.1988527724665392,0.9311214046587298,1.0,6/12,15.09%,DIP2A;DIP2B;RAPGEF3;PRKAA2;DDX3X;TERF2IP
prerank,cellular response to sterol (GO:0036315),-0.5052421113347229,-1.2689584113613828,0.1830065359477124,0.5560359202730805,1.0,9/13,19.37%,GRAMD1B;SMO;GRAMD1C;INSIG2;GRAMD1A;LRP6;GPLD1;RORA;OSBPL7
prerank,ncRNA processing (GO:0034470),0.32710135345797475,1.26857011401956,0.05739795918367347,0.9334471121714407,1.0,66/200,20.09%,THG1L;RPL30;UTP20;UTP18;RPL17;RPL23;RPL31;RPL3;DDX54;DDX10;FARS2;SMAD1;RPL35A;RPS14;RPL8;RPL5;RPL37A;PUS10;ADAR;RPL4;EMG1;SNU13;POP5;EXOSC9;RPLP0;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;AGO4;DDX27;WDR12;TUT7;EXOSC1;UTP11;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;SSB;TUT4;DKC1;INTS6;RPL19;RPL38;DCAF13;RPL36;RPL26;RPL15;RPL10;RPS2;RPL32;RPL27A;NOP58;NVL;POP1;EXOSC7;RPL14;RPL39;RPL7;AGO1;MDN1
prerank,positive regulation of JNK cascade (GO:0046330),0.37417783387554543,1.268568588840159,0.10735294117647058,0.930679808257769,1.0,14/70,11.24%,MAP3K11;FCGR2B;TIRAP;HIPK2;EDAR;TRAF5;AXIN1;MTURN;MINK1;TRAF3;PJA2;PLCB1;MFHAS1;APP
prerank,acylglycerol biosynthetic process (GO:0046463),-0.4336506025616236,-1.2685519092738495,0.13657407407407407,0.5560755743770105,1.0,6/23,7.94%,AGMO;PLA2G4A;LPGAT1;PLCE1;GK;LPIN1
prerank,axon development (GO:0061564),-0.3253228250511745,-1.2684960497970028,0.06,0.5550236352745077,1.0,16/78,10.96%,FGFR2;CNTN4;ANK3;DCC;PLP1;MAP1B;CTNNA2;NRCAM;NTNG1;RYK;MAPT;SHTN1;GAP43;BRSK1;EPHB2;PLPPR4
prerank,ribosomal large subunit biogenesis (GO:0042273),0.39320813366048,1.2678481082791195,0.13258785942492013,0.9310902818817737,1.0,24/54,21.19%,RSL24D1;RPL3;RRP15;RPL35A;RPL5;MRPL20;SNU13;RPLP0;RPL24;WDR12;PAK1IP1;LTO1;RPL23A;RSL1D1;NPM1;EIF6;RPL26;RPL10;NVL;RPL14;RPL7;MDN1;GTF3A;SDAD1
prerank,positive regulation of cation channel activity (GO:2001259),-0.3699993307644339,-1.2676524451858333,0.1320754716981132,0.5562396452587467,1.0,7/40,10.73%,ANK2;ANK3;AKAP6;RELN;HTT;ACTN2;EPHB2
prerank,ERBB signaling pathway (GO:0038127),0.3779745599835281,1.2675770942448554,0.10814814814814815,0.9295770300833895,1.0,10/64,8.66%,FAM83B;PTPRR;PTPN18;CBL;SRC;CDC37;RPS6KA5;PTPN12;PLCG1;ERBIN
prerank,regulation of actin filament depolymerization (GO:0030834),-0.5149077825588719,-1.2675414658278428,0.1831578947368421,0.5553401708958418,1.0,4/12,18.57%,PLEKHH2;LIMA1;WDR1;SEMA5A
prerank,leukotriene biosynthetic process (GO:0019370),-0.5001989956152348,-1.2675198949957733,0.19616204690831557,0.5542116550327668,1.0,3/14,13.74%,PLA2G4A;GGTA1;GGT5
prerank,protein prenylation (GO:0018342),0.568775930726053,1.2673482082471816,0.2127659574468085,0.927807465079837,1.0,2/10,3.00%,CHML;CHM
prerank,photoperiodism (GO:0009648),-0.4031419985220466,-1.2669426559802694,0.14446952595936793,0.5545985359051824,1.0,12/28,14.60%,PER2;PER3;CRY2;PML;BHLHE40;SIK1;MTA1;TP53;CRY1;PER1;RBM4;FBXL12
prerank,axonogenesis (GO:0007409),-0.2787579899998503,-1.2667045792049196,0.024242424242424242,0.5540658275304531,1.0,60/237,13.69%,NRXN3;NCAM1;ROBO2;FGFR2;NOTCH2;CNTN4;ANK3;LAMA2;DCC;MAP1B;ROBO1;CTNNA2;UNC5D;NRXN1;CNTN6;EPHA6;ULK2;TNR;NRCAM;EFNA5;SEMA3D;GLI2;EPHB1;NTNG1;AUTS2;NRP1;RYK;EFNB2;DSCAM;EPHA7;PDLIM7;KIF5C;UNC5C;RELN;DAB1;SHTN1;FEZ1;SEMA3A;PALLD;NOTCH3;EPHB4;EZR;NIBAN2;NRP2;B4GALT6;SPTAN1;BRSK1;EPHA3;EPHB2;PLPPR4;SEMA4D;NTN4;GAB2;GRB2;SHC3;AFG3L2;RANBP9;VLDLR;GRB10;MAP1A
prerank,regulation of protein modification process (GO:0031399),0.3956441675253752,1.2666817702195141,0.15132605304212168,0.9281693385168337,1.0,13/50,12.86%,ROPN1;PIN1;PPIB;PPP2CA;PPP1R16B;SPRED1;HPF1;CCDC88C;KDM4D;LYN;CCAR2;ATG7;CDH5
prerank,regulation of lipid kinase activity (GO:0043550),-0.5241523366707322,-1.266448701167056,0.16774193548387098,0.5536848364080479,1.0,6/11,30.79%,RBL2;PIK3R3;PIK3R1;RBL1;PIK3R2;WDR81
prerank,myotube differentiation (GO:0014902),-0.4674132473964103,-1.2652252617064697,0.16105769230769232,0.5558671849442915,1.0,5/17,6.79%,IGF1;ADGRB3;ADAM12;ADAMTS5;SKI
prerank,negative regulation of lymphocyte activation (GO:0051250),0.4832081067914427,1.265072888495932,0.1911504424778761,0.9328252951357837,1.0,3/21,5.41%,TNFAIP3;FCGR2B;SAMSN1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.2973157344966802,-1.264900320270879,0.0423728813559322,0.5556400097291208,1.0,66/151,28.03%,MAGI2;BMP6;NTRK3;ADAMTS12;EGFR;SMAD3;IQGAP1;NTRK2;NRP1;TGFBR1;MAPK14;TGFBR2;MAPT;SOX5;CTNNB1;BMP7;SMAD4;SIRT2;BMP4;MED1;APPL2;WNT4;STMN2;FOXC1;CLEC3B;GAS1;ACVR1;LGMN;ANXA1;ACVR1B;MTSS2;PDCD5;DUSP22;RACK1;VSTM2A;SETX;RAPGEF2;TGFB1;BMPR1B;EHD1;NR3C1;TWF2;SOX6;BMPR1A;RPS6KB1;CPNE3;BMPR2;HSPB1;PRKD1;APPL1;VEGFA;ITGB1BP1;EMD;KIDINS220;AKT1;HYAL1;ERBB2;NR4A1;DSTYK;PDE2A;SFRP1;INPP5K;RAB35;RUNX2;MAPKAPK2;BMP2
prerank,cellular response to nutrient levels (GO:0031669),0.3766474130443909,1.264322057443499,0.14242424242424243,0.9337546342682342,1.0,21/62,21.12%,RALB;GAS2L1;MAP1LC3B;HSPA8;RPTOR;SIRT1;TSC1;PRKAA2;ATG7;RRAGC;USP33;ATG14;TFEB;ZFYVE1;LAMP2;ULK1;EIF4G1;XBP1;WDR45B;LRRK2;STK24
prerank,digestive tract morphogenesis (GO:0048546),-0.4860426974884553,-1.2642429481379205,0.15198237885462554,0.556280858184884,1.0,6/14,23.57%,FGFR2;PDGFRA;NIPBL;RBPMS2;GLI1;STRA6
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.36991625541971523,1.2641948851434552,0.12804878048780488,0.9315725008040828,1.0,19/72,15.07%,ACER2;PLK2;HIPK2;ING4;CNOT11;CDKN1A;EP300;CRADD;CNOT2;RGCC;CNOT7;MDM2;TFAP4;CARM1;NBN;CNOT6;CHEK2;CNOT1;CNOT6L
prerank,wound healing (GO:0042060),-0.33861793101886456,-1.2634970783064197,0.10443037974683544,0.5572321121266588,1.0,17/62,15.31%,IGF1;SMAD3;CFLAR;COL3A1;FGF1;TGFBR1;PLEC;MACF1;TPM1;EPB41L4B;PDGFRA;MYOF;FUT10;AHNAK2;SYT11;SYT7;RAF1
prerank,regulation of signal transduction (GO:0009966),-0.27955828405555017,-1.2631589344889669,0.03524229074889868,0.556953410717125,1.0,74/190,25.91%,NCAM1;FGFR2;SULF1;ZIC1;KCTD8;OGT;TULP3;IGFBP2;IGFBP5;PLCE1;IFT81;IGFBP7;PXN;CBFB;DHRS3;POFUT1;DCDC2;IRAK1;IGFBP6;UBASH3B;CASTOR2;GAS1;SNW1;RGS12;RSPO3;GRK5;ELF1;ACVR1;GRK3;PLSCR1;SOCS2;CSK;PRAG1;ILK;NUCKS1;WDR11;USP20;FRRS1L;IGFBP4;INTU;TMEM204;WWTR1;RGS20;TGFB1;MTCH1;GRK4;PTPN2;RORA;SOCS5;TSC2;FRMPD1;SEMA5A;SNX3;TRIM5;TMEM237;DTX1;CX3CL1;PRKD1;GLI1;GRK2;DOK5;DGKQ;ITGB1BP1;TSPYL2;IRAK2;RIC8B;LLGL1;FOXL1;TSPAN15;RGS4;GLRX2;GIT1;PTCH1;PPIA
prerank,positive regulation of cell division (GO:0051781),-0.3842533300579538,-1.2627794344640355,0.15025906735751296,0.5567092018076112,1.0,6/38,5.99%,FGFR2;SVIL;FGF1;RHOA;SIRT2;CIT
prerank,motor neuron axon guidance (GO:0008045),0.509581501082275,1.2627124718148603,0.192090395480226,0.9353357174315555,1.0,3/15,11.14%,RAC2;TMEFF1;RHOG
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.4095098224674787,-1.2624609768601744,0.1610738255033557,0.5563947633434039,1.0,4/26,2.14%,IGF1;AKAP6;FHL2;CAMTA1
prerank,diol biosynthetic process (GO:0034312),0.505461713506974,1.2621380329273573,0.19245283018867926,0.9352308799940392,1.0,4/15,14.38%,SPR;ACER2;ACER3;GCH1
prerank,sensory perception of sound (GO:0007605),-0.3223210416366478,-1.2619759829771755,0.07368421052631578,0.5565295984022046,1.0,17/88,11.48%,PCDH15;EYA1;CACNA1D;COL1A1;EML2;COL11A1;COL4A3;ADGRV1;KIT;CEMIP;ROR1;DCDC2;GSDME;NIPBL;TIMM9;ATP6V0A4;TBL1X
prerank,regulation of insulin secretion (GO:0050796),-0.31013402908599685,-1.2619025310370733,0.052083333333333336,0.5555735135510158,1.0,24/101,16.67%,CACNA1C;ITPR1;SNAP25;ADCY5;MCU;CACNA1D;EFNA5;KCNC2;NLGN2;PER2;GLUD1;DPP4;ENSA;RBP4;LRP5;CDK16;STXBP4;TM7SF3;NNAT;PSMD9;SYT7;CCN3;STX1A;KCNS3
prerank,mammary gland epithelium development (GO:0061180),-0.4899754157585752,-1.2618395458614486,0.17391304347826086,0.5545671261329306,1.0,3/14,7.01%,ERBB4;WNT4;AKT2
prerank,response to glucagon (GO:0033762),-0.4506775237884109,-1.261815950721698,0.15517241379310345,0.5534565764928303,1.0,11/19,22.36%,ADCY5;ADCY2;ADCY1;ADCY9;PRKACA;CRY1;PRKAR1B;ADCY7;ADCY3;ADCY8;ADCY4
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.4737965500162139,1.2611007933935718,0.1687170474516696,0.9371688969667649,1.0,9/21,16.55%,TIPRL;BOD1;PPP1R16B;YWHAB;PPP1R11;MFHAS1;PTPA;PPP1R8;FKBP1A
prerank,cellular response to UV (GO:0034644),0.3671244121320885,1.2610818478665076,0.11755952380952381,0.9345387927419317,1.0,23/76,18.03%,CERS1;EIF2S1;RUVBL2;MME;ERCC4;YY1;POLK;CDKN1A;EP300;CARD16;SIRT1;ACTR5;USP47;CREBBP;BMF;INO80;ATR;TAF1;TMEM161A;N4BP1;USP28;NPM1;RPL26
prerank,negative regulation of phosphatase activity (GO:0010923),0.4548134066001914,1.2610772703476425,0.17157712305025996,0.9318716058233085,1.0,4/25,7.63%,PPP1R36;TIPRL;BOD1;PPP1R11
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5135074108808735,-1.2609813037785518,0.18454935622317598,0.5546258978826892,1.0,3/12,4.44%,FOXP1;DAB2;HDAC1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.4102785228500653,-1.2607534524541293,0.13901345291479822,0.5540569702201122,1.0,8/26,10.98%,RIMS1;NRXN1;DLG4;NLGN2;PRKCZ;RELN;NLGN1;CUX2
prerank,nuclear export (GO:0051168),-0.32837515578944976,-1.2607262716488654,0.08955223880597014,0.552980106614067,1.0,27/80,17.43%,RANBP3L;SRSF5;PKD1;SRSF11;CASC3;SRSF2;MALT1;SRSF6;XPO6;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;PHAX;LSG1;STRADA;RANBP3;HNRNPA1;ATXN1;THOC5;SLU7;CDC40;NUTF2;TGFB1;RNPS1
prerank,regulation of microtubule-based movement (GO:0060632),-0.5193132992824638,-1.2606104513245742,0.17355371900826447,0.552183324508674,1.0,2/11,5.82%,MAP2;TTC21B
prerank,artery development (GO:0060840),-0.4222548708491888,-1.2602232148160188,0.16166281755196305,0.5521614262802581,1.0,5/23,4.05%,ROBO2;ROBO1;NRP1;TGFBR1;HECTD1
prerank,androgen receptor signaling pathway (GO:0030521),-0.5337831033423178,-1.2589559699223785,0.18008474576271186,0.55454273342556,1.0,3/11,4.49%,DDX5;DDX17;RNF14
prerank,negative regulation of innate immune response (GO:0045824),0.4292416768086548,1.2585641291679524,0.15692821368948248,0.9404700237003014,1.0,9/34,13.23%,TNFAIP3;TTLL12;FAM3A;NLRC3;CNOT7;USP15;A2M;USP18;NLRC5
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.39124313835569735,-1.2584266238813169,0.1588089330024814,0.55484807587539,1.0,7/32,6.61%,ZBTB20;IGF1;PID1;NUPR1;PPARGC1A;VCP;PPARA
prerank,muscle cell differentiation (GO:0042692),0.4274453875233842,1.2573197039903823,0.18013468013468015,0.9435775969882101,1.0,7/32,11.27%,SYNE1;MRTFA;MRTFB;TBX1;HEY2;SEMA4C;DMD
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.41334230272387645,1.257112332481861,0.15447154471544716,0.9418364050929801,1.0,14/42,17.49%,FARS2;GARS1;YARS2;IARS1;LARS2;HARS1;NARS2;RARS2;EARS2;WARS2;LARS1;HARS2;WARS1;IARS2
prerank,carbohydrate homeostasis (GO:0033500),0.37721512950364244,1.256830161453856,0.10903873744619799,0.9404250577895115,1.0,11/67,11.20%,PCK1;HECTD4;PYGL;SELENOT;WFS1;ADIPOR2;PARK7;CYB5R4;PRKAA2;BAD;ADIPOR1
prerank,modulation of chemical synaptic transmission (GO:0050804),-0.30496582133060623,-1.2566939668366222,0.056338028169014086,0.5584860897447779,1.0,21/107,8.57%,LRRC4C;ATP1A2;RIMS1;DLGAP1;DGKI;GRID2;GRM5;DLGAP2;DLG4;SNCAIP;DLGAP4;NLGN2;RELN;SLC12A2;BCR;CACNA1B;GRID1;CLSTN2;AKAP9;NLGN1;SYN1
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.48736767774211226,-1.2565731516876533,0.1696035242290749,0.557695449781121,1.0,4/13,6.96%,GLI2;TOX;BMP4;CAMK4
prerank,cellular protein-containing complex assembly (GO:0034622),0.33311008381476886,1.255984300919467,0.08792650918635171,0.9416255262950313,1.0,37/159,16.75%,HIGD2A;IMMP2L;TIAM1;AP2S1;SRC;BBS12;CCT2;NDUFAF1;SMAD1;PSMD11;SGIP1;CLTA;PFDN6;LONP1;OMA1;PDE4DIP;AXIN1;PSMG1;TMEM35A;TBCEL;EIF4H;CENPC;AIFM1;CHMP2A;MIS12;HIGD1A;DMD;EIF4B;PICALM;POGZ;CYBA;AP2M1;PIK3C2A;NDC1;TCP1;FKBP1A;DNAJB14
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.47197950139720646,-1.2555066562487458,0.1830065359477124,0.559353868115505,1.0,4/18,13.94%,IGF1;IGFBP2;IL18;IGF2
prerank,nucleoside salvage (GO:0043174),0.5675225361834011,1.2553319529084253,0.21485943775100402,0.9421187829519884,1.0,3/10,9.47%,UPP1;UCK2;UPP2
prerank,regulation of macrophage cytokine production (GO:0010935),0.534487569131434,1.254575053929662,0.19744058500914077,0.9430160540441593,1.0,4/13,8.24%,SEMA7A;SIRT1;CUEDC2;WNT5A
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.39825521763294136,-1.2545536446112941,0.15,0.5607430366222091,1.0,11/30,20.23%,TGFBR3;SMAD3;FSTL1;SMURF2;SMAD4;DKK3;XIAP;PCSK6;TGFB1;SFRP4;TWSG1
prerank,retinal metabolic process (GO:0042574),0.5275394338806376,1.253848173825069,0.20530973451327433,0.9438674640944896,1.0,4/12,13.54%,RDH13;CYP1B1;RDH11;RDH10
prerank,copper ion transport (GO:0006825),-0.5282871262334435,-1.2537353647734426,0.19,0.5619381308101947,1.0,8/11,30.10%,ATP7A;STEAP3;SLC31A1;SLC31A2;COX17;SLC11A2;STEAP2;ATOX1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),-0.49863131244800396,-1.2533082597727818,0.17073170731707318,0.5620436170603129,1.0,5/13,25.80%,CACNA1G;SYT4;SCAMP5;STX1A;SYT10
prerank,central nervous system development (GO:0007417),-0.27309650030272337,-1.2531658606697385,0.024390243902439025,0.5612675089261191,1.0,56/250,16.62%,ROBO2;CNTN4;DCLK1;ZIC1;ADAM22;ARNT2;PBX1;ZIC4;CNTN6;SPOCK1;GSN;GRIN2B;NRCAM;AHI1;NFIB;ADAM23;PKD1;ADGRA2;AFF2;SH3GL2;MBP;NCOA6;TGFBR2;DNER;JARID2;EPHA7;GLIS2;IL1RAPL2;MEIS2;RELN;VCAN;SMO;ZIC5;HSPG2;MOG;NIPBL;SMARCA1;ZIC2;DCX;LOXL3;TBX3;ALDH3A2;NNAT;SCYL2;COX7B;CTNS;ATXN1;CIC;ATN1;PLXNB2;NHEJ1;NES;NPAS2;PBX4;VIT;SZT2
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.3411701642190366,-1.252989772957306,0.12806539509536785,0.560631578306208,1.0,16/59,12.50%,ROBO2;CNTN4;TENM3;SDK1;ROBO1;CNTN6;KIRREL3;PKD1;DSCAM;IGSF11;PALLD;SDK2;MPZL2;CDH1;CDH4;OBSL1
prerank,establishment of spindle localization (GO:0051293),0.5083034661999103,1.252617583923469,0.20656370656370657,0.9469834555188629,1.0,6/14,17.26%,CLASP2;CFL1;MAP4;ZBED3;KPNB1;CLASP1
prerank,bicellular tight junction assembly (GO:0070830),0.4024490085717394,1.2525399192173832,0.15210355987055016,0.9446883576057703,1.0,11/46,14.68%,MARVELD2;PECAM1;RAMP2;F11R;ESAM;CLDN5;PRKCI;CDH5;APC;PATJ;PARD3
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.43047106142707764,-1.2524303236045238,0.16441441441441443,0.5610422352848207,1.0,9/21,28.23%,SIRT2;AATF;SLC30A10;PPARA;ABCD2;SIRT5;PINK1;PAX2;HDAC6
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),-0.3868823888532107,-1.2524152203986643,0.14479638009049775,0.5599656935900702,1.0,10/34,14.18%,DOCK5;DOCK1;NRP1;FLNA;NEDD9;RREB1;P4HB;ILK;MYADM;TRIOBP
prerank,positive regulation of binding (GO:0051099),0.36110028826839463,1.2521681346162068,0.1092814371257485,0.9437241457044483,1.0,18/84,11.24%,NCBP1;TRIB3;RALB;PIN1;TIAM1;HIPK2;NME1;APOE;B2M;CEBPG;SPPL3;TXN;EPB41;KDM4D;AKTIP;CLDN5;TERT;APP
prerank,negative regulation of inflammatory response (GO:0050728),0.3267458753968632,1.2518541746443053,0.08041504539559015,0.942510476150529,1.0,25/182,10.62%,GPR176;PRKAR1A;PTGER2;TNFAIP3;PLK2;SRC;TSHR;INSL3;APOE;RAMP2;TEK;FYN;TNFRSF1B;LPCAT3;GNB1;RXFP1;PPARD;SYK;NLRC3;PLCG1;LYN;RHBDF2;YES1;MFHAS1;CD163
prerank,chromatin remodeling at centromere (GO:0031055),0.43839626533979237,1.2515515487724809,0.19543973941368079,0.9412834031194693,1.0,9/31,17.30%,MIS18A;HJURP;RUVBL1;RSF1;CENPC;CENPP;RBBP4;CENPO;NPM1
prerank,axon guidance (GO:0007411),-0.2772407212930843,-1.2503823787610628,0.03414634146341464,0.5643742167113683,1.0,52/201,13.66%,NRXN3;NCAM1;ROBO2;NOTCH2;CNTN4;ALCAM;LAMA2;DCC;PLXNA2;ROBO1;UNC5D;NRXN1;CNTN6;EPHA6;TNR;NFIB;EFNA5;SEMA3D;GLI2;EPHB1;NRP1;RYK;EFNB2;DSCAM;EPHA7;PDLIM7;KIF5C;UNC5C;RELN;SMO;DAB1;FEZ1;SEMA3A;PALLD;GAP43;NOTCH3;EPHB4;EZR;NIBAN2;NRP2;SPTAN1;EPHA3;EPHB2;SEMA4D;NTN4;GAB2;GRB2;SHC3;PLXND1;RANBP9;VLDLR;GRB10
prerank,adenine nucleotide transport (GO:0051503),0.49043584525897604,1.2493026490785262,0.19120458891013384,0.9488470343035238,1.0,3/17,6.49%,ABCC4;SLC25A24;LRRC8C
prerank,protein deubiquitination (GO:0016579),0.31537944136865936,1.2490129457579273,0.06567534076827757,0.9475417101897077,1.0,58/242,14.62%,TOMM20;PSMB10;PSMC4;ABRAXAS1;PSMB6;PSMD8;PSMD5;PSMD12;ACTL6A;TNFAIP3;MAP3K7;ACTB;SMAD1;BIRC2;PSMD11;YOD1;OTUD1;YY1;PSMB4;SPATA2;PSMC1;EP300;ACTR8;SMAD7;ACTR5;DESI2;RUVBL1;USP47;ATXN7L3;TRAF3;RAD23A;MDM2;USP48;USP31;PSMC2;PSMD2;OTUD3;ESR1;USP22;USP15;USP37;NFRKB;USP18;TNIP2;OTUD5;PSMD14;TRRAP;USP33;PSMC6;BRCC3;NFKBIA;PSMD1;PSMB1;USP9X;APC;HCFC1;MINDY2;INO80
prerank,homeostasis of number of cells (GO:0048872),0.5307042935581754,1.2487579643027518,0.19814814814814816,0.9461212938583106,1.0,4/12,11.33%,OCIAD1;LPCAT3;NOTCH1;NOS3
prerank,termination of RNA polymerase I transcription (GO:0006363),0.42952484870857893,1.2484884357829018,0.16751269035532995,0.944753451006263,1.0,5/30,8.70%,ERCC3;POLR1C;CCNH;POLR1G;GTF2H1
prerank,regulation of interleukin-2 production (GO:0032663),0.4060804355657957,1.2483223497026428,0.1719242902208202,0.9429339949472044,1.0,10/43,13.91%,PDE4D;TNFAIP3;PTPRC;MAP3K7;HDAC7;PRKD2;PNP;RPS3;PRNP;TRIM27
prerank,contractile actin filament bundle assembly (GO:0030038),-0.4700366462641089,-1.2482786743665601,0.17787418655097614,0.5680346256128226,1.0,6/15,18.16%,SORBS1;RHOA;ITGB5;TNFAIP1;PDLIM1;KCTD13
prerank,stress fiber assembly (GO:0043149),-0.4700366462641089,-1.2482786743665601,0.17787418655097614,0.5680346256128226,1.0,6/15,18.16%,SORBS1;RHOA;ITGB5;TNFAIP1;PDLIM1;KCTD13
prerank,DNA conformation change (GO:0071103),0.48175835582288173,1.2481412302031387,0.19444444444444445,0.9412308703098863,1.0,5/17,19.04%,ERCC3;TOP3A;TOP1;HAT1;TOP3B
prerank,regulation of sodium ion transport (GO:0002028),-0.382808510603232,-1.2479421642492845,0.13842482100238662,0.5678283843478051,1.0,12/34,13.76%,ANK3;FGF12;SNTA1;WNK1;P2RX4;ATP1A1;SIK1;WNK4;PER1;DLG1;WNK3;NKAIN4
prerank,neuron maturation (GO:0042551),-0.44583362105010815,-1.2479219662278924,0.21478060046189376,0.5667422954718817,1.0,12/18,35.59%,ADGRB3;B4GALT6;SRRM4;MTCH1;SCARF1;CX3CL1;EPHA8;PICK1;LGI4;CLN5;C1QA;B4GALT5
prerank,early endosome to Golgi transport (GO:0034498),0.5481983856996249,1.2477980254616516,0.2309090909090909,0.9402107845493474,1.0,5/11,10.96%,SURF4;SNX8;RAB6A;SNX1;RBSN
prerank,mitochondrion organization (GO:0007005),0.3285242258127191,1.2472767959033924,0.10026385224274406,0.9399494100506447,1.0,26/165,11.33%,THG1L;MIGA1;TOMM20;HIGD2A;CHCHD2;DNM3;IMMP2L;CYCS;DNAJA3;GABPA;MTFR1;SIRT3;PHB2;TIMM17B;TSPO;SSBP1;LONP1;AGTPBP1;OMA1;PARK7;FBXO7;AIFM1;TERT;CHCHD3;HIGD1A;NOS3
prerank,phosphatidylserine metabolic process (GO:0006658),0.4256570447187038,1.2465914820938566,0.18803418803418803,0.9404062289113252,1.0,7/32,12.55%,SERINC1;OSBPL10;PLAAT3;LPCAT3;MBOAT1;SERINC5;ABHD12
prerank,regulation of Rho protein signal transduction (GO:0035023),-0.3214341695067553,-1.2461194506852764,0.09876543209876543,0.570565386275356,1.0,26/72,25.72%,LPAR1;ROBO1;AKAP13;KANK2;COL3A1;NRP1;BCR;TNFAIP1;STARD13;PRAG1;RIT2;GPR4;RALBP1;ABCA1;ARHGDIA;STMN1;RAF1;ABL2;KCTD13;MET;ARHGDIB;CCDC125;FLCN;EPS8L2;LPAR6;ADGRG1
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3325526709461723,1.2458365256313098,0.09587217043941411,0.9413697922882337,1.0,37/153,15.76%,PCK1;PRKX;STK32A;PLK2;RPS6KA1;RPS6KA4;CAMK1D;PRKCH;HIPK2;PRKD2;RPS6KA5;PKN3;SMG1;MAPK8;CSNK1G3;SBK1;PIKFYVE;DCLK3;LATS2;PKN1;SRPK2;NLK;TNKS;MAST4;PRKCI;IKBKB;NEK6;MAPK12;CHUK;TLK2;CSNK2A2;MAP3K10;GAS6;DYRK2;ATR;TOP1;TAF1
prerank,cellular response to interleukin-12 (GO:0071349),0.39138238023704036,1.2455299380347655,0.15981012658227847,0.9402186929846486,1.0,16/48,17.46%,LCP1;SOD1;RALA;CFL1;TALDO1;RPLP0;CD47;SOD2;ARF1;PLCB1;PITPNA;TYK2;TCP1;CAPZA1;HNRNPF;SNRPA1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3065936493644812,1.2449607933582827,0.06264501160092807,0.9402571683612281,1.0,103/366,18.90%,TBX4;ONECUT1;FOXN2;TRAPPC2;EZH2;ZFAT;HES6;EIF2A;GTF2IRD1;RPS6KA4;ATXN1L;SBNO2;RPS6KA5;PPP2CA;ORC3;SOX2;MYBL2;SMARCA2;RBBP6;SPIN1;EP300;RFX3;NFX1;MED23;TGFBRAP1;SRSF10;ACTR8;CDK11B;ZNF205;SFPQ;FBXO5;DRAP1;CLOCK;GEMIN5;ACTR5;PFDN5;NOTCH1;ACVRL1;TSC1;RELA;SOX13;NAB2;ESCO1;RNF6;UBE2V1;CCAR2;RYBP;ING2;METAP1;ESR1;NLK;CREBBP;CARM1;HP1BP3;APP;NANOS3;USP37;JMJD1C;MZF1;SP1;NUP35;IRF2;CHD3;ERC1;TRRAP;DDIT3;CHEK2;ANKRD17;ZKSCAN5;YBX1;HCFC1;RNF20;BACH1;BAZ2A;NSD2;FUS;RBM4B;TERF2IP;TFEB;TAF6L;TCF7L1;TCF3;APBB2;SOX17;WTIP;CYFIP1;CALR;NONO;MYT1;STAT3;FOXK2;ZNF219;INSR;PATZ1;ZSCAN21;YAF2;RPL10;HINT1;ATRX;MYBL1;NCOA2;MSL3;TCF7
prerank,positive regulation of heart contraction (GO:0045823),0.4796821092700678,1.2445590736994852,0.1875,0.9395863235647394,1.0,3/19,3.81%,RGS2;GSK3A;ATP2A2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5283675294040218,1.2440141356655288,0.1954459203036053,0.9394010342327443,1.0,4/13,6.20%,FCGR2B;MANF;WFS1;LPCAT3
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.45512954044615783,-1.2436061054915837,0.1724137931034483,0.5764238281834226,1.0,6/17,18.92%,CTNNA2;WASF2;GMFB;WASF1;FCHSD2;ARFIP2
prerank,clathrin coat assembly (GO:0048268),0.5001293342806582,1.242903599963072,0.18029739776951673,0.9419294005824301,1.0,5/15,14.65%,AP2S1;SGIP1;CLTA;PICALM;PIK3C2A
prerank,supramolecular fiber organization (GO:0097435),-0.2605339874858816,-1.2428565391310749,0.023809523809523808,0.5774004991461973,1.0,110/333,24.78%,COL1A2;COL4A5;PPP1R9A;ADAMTS2;GSN;COL1A1;TNXB;COL4A6;COL8A1;CGNL1;COL11A1;TMOD2;COL3A1;PLOD2;COL25A1;HDGFL3;COL22A1;TGFBR1;DYNC1H1;COL5A1;COL4A3;PLEC;CLIP4;SNCAIP;MAPT;SHROOM3;VIM;TPM1;COL5A2;COL4A4;RHOA;LOXL1;COL12A1;ARHGAP12;ATP7A;SORL1;COL6A1;TUBGCP4;COL8A2;HSPG2;STMN2;P4HB;COL6A2;COL13A1;PLOD1;SLAIN2;COL15A1;GGA2;CEP126;CKAP5;BACE1;RND3;RHOBTB2;BIN3;UBC;ADAMTS3;LOXL3;RHOB;RHOBTB1;CLIP3;TUBGCP6;INPPL1;HIP1R;DLG1;SIAH2;FIGNL2;TRIOBP;NEFL;STMN1;KATNAL1;COL23A1;ERMN;DCTN1;ITGB4;TPM4;COL6A3;GGA3;COL5A3;MYO1B;P4HA2;CDC42;COL20A1;TGFBI;COL14A1;MYO1F;ALDOA;COL16A1;TMOD1;WDR73;EFEMP2;P3H1;LUM;GFAP;LOX;MYO19;CRTAP;EMILIN1;HOOK2;RHOC;COL26A1;TPPP;COL18A1;STMN4;ARHGAP17;EMP2;KATNAL2;COL9A2;ELMO2;MYH11;TSPAN15
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5574843289894313,1.242420467183852,0.2262357414448669,0.941644922335749,1.0,2/10,1.03%,RSC1A1;GSK3A
prerank,inner dynein arm assembly (GO:0036159),0.5571479043199125,1.2421561166509474,0.2099009900990099,0.940311936191783,1.0,1/10,1.22%,CFAP73
prerank,ribosome biogenesis (GO:0042254),0.3216986989976698,1.24205584781626,0.0834403080872914,0.9383365500834282,1.0,63/187,20.09%,RPL30;UTP20;UTP18;RPL17;RPL23;EIF2A;RPL31;RPL3;DDX54;DDX10;RPL35A;RPS14;RPL8;RPL5;RPL37A;RPL4;EMG1;SNU13;POP5;EXOSC9;RPLP0;TSC1;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;LTV1;RBIS;DDX27;WDR12;PAK1IP1;EXOSC1;XPO1;UTP11;LTO1;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;DKC1;NPM1;RPL19;RPL38;EIF6;DCAF13;RPL36;RPL26;RPL15;RPL10;RPS2;RPL32;RPL27A;NOP58;NVL;EXOSC7;RPL14;RPL39;RPL7;MDN1
prerank,nucleic acid-templated transcription (GO:0097659),0.40751628892998426,1.241780498042998,0.16719745222929935,0.9371411825146103,1.0,10/42,14.44%,POLR2J;NR4A2;POLR2B;PAX8;PWP1;TERT;THRB;RRAGC;PPP5C;BAZ2A
prerank,positive regulation of dendrite morphogenesis (GO:0050775),0.4808626346793197,1.241669934179336,0.20898100172711573,0.9351916396445159,1.0,2/19,0.98%,LRP8;SS18L1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.39061527023444514,1.241272123437775,0.14838709677419354,0.9345671254277238,1.0,20/52,20.54%,RAC2;GSK3A;SAE1;VPS11;MAPK8;YWHAB;BAD;PPP3R1;YWHAH;CSNK2A2;ATG13;YWHAQ;LEPROT;USP36;UBE2D3;SH3GLB1;YWHAE;FBXW7;YWHAZ;UBE2L3
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.518761353305746,-1.2412083591138172,0.1895424836601307,0.5808201791236882,1.0,3/11,8.27%,ATP1B1;ATP1A1;KCNJ2
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.49748982591551916,-1.2409471777726555,0.22580645161290322,0.5803860289744749,1.0,2/12,7.29%,ANK2;UBASH3B
prerank,regulation of pH (GO:0006885),0.5533620930552733,1.2407893040309856,0.21346153846153845,0.9343490117552846,1.0,3/11,10.78%,SLC9A7;CLCN3;ATP6AP1
prerank,positive regulation of organelle organization (GO:0010638),-0.3840907980691467,-1.2407170390314377,0.1607565011820331,0.5799624879065046,1.0,11/32,13.38%,STX18;ANXA2;RAB3GAP2;PPARGC1A;AKT2;LMAN1;TMED9;GSK3B;UVRAG;ANXA1;PFDN2
prerank,spermatid development (GO:0007286),0.4259097001594741,1.2405996692343884,0.17504051863857376,0.9327649296848317,1.0,4/32,10.41%,SOX30;CIB1;CDYL;ING2
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.4243594659741549,1.2404501973222728,0.16666666666666666,0.9309673222389611,1.0,2/31,0.85%,GPHN;MOCS3
prerank,regulation of BMP signaling pathway (GO:0030510),-0.3254170910465624,-1.2404209446051877,0.10115606936416185,0.5797227652390262,1.0,26/73,21.10%,SULF1;FSTL1;FOXD1;NBL1;BMPER;SMURF2;SMAD4;VWC2L;BMP4;CRIM1;SORL1;SKI;HTRA3;SMAD6;SPART;XIAP;PCSK6;SMAD5;BMPR1B;RBPMS2;ZNF423;SFRP4;BMPR1A;BMPR2;TWSG1;CCN1
prerank,retinoid metabolic process (GO:0001523),-0.3223839564861048,-1.2400784618271445,0.09937888198757763,0.5795970521635795,1.0,14/71,10.87%,GPC6;LRP1;ALDH1A1;ALDH1A2;SDC2;DHRS3;GPC3;HSPG2;ABCA4;RBP4;NAPEPLD;SCPEP1;GPC5;RBP1
prerank,cellular response to cAMP (GO:0071320),-0.39279441058139375,-1.2397347217587373,0.15263157894736842,0.5793988092428248,1.0,12/30,27.20%,HCN1;AKAP6;IGFBP5;AKAP9;EZR;RAPGEF2;SLC5A5;DMTN;PDE2A;HCN2;INPP5K;KCNQ1
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.5327235191015932,-1.2394672222195455,0.20208333333333334,0.5789562021872405,1.0,8/10,30.26%,CTNNB1;SMARCD3;DISC1;KDM1A;CX3CL1;VEGFA;CX3CR1;DRD2
prerank,regulation of adaptive immune response (GO:0002819),0.4776309560086167,1.2393606361047407,0.20466786355475763,0.9335249781653938,1.0,4/18,13.91%,FCGR2B;SAMSN1;SIRT1;TRIM27
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.527663917440399,1.2390610296637088,0.21601489757914338,0.9324317252592073,1.0,3/13,4.55%,DERL2;SVIP;YOD1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.30255470038179877,-1.238544313397249,0.08626198083067092,0.58029626647231,1.0,33/104,20.00%,MAGI2;LDLRAD4;SMAD3;NBL1;BMPER;SMURF2;TGFBR1;TGFBR2;SMAD4;VWC2L;CRIM1;SORL1;PPARA;SKI;HTRA3;SMAD6;ACVR1;SPART;UBC;SNX25;PPM1A;SMAD5;MTMR4;CCN3;TGFB1;BMPR1B;RBPMS2;PRDM16;CD109;BMPR1A;STUB1;SPRED3;BMPR2
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.510465853790937,-1.2384427185095068,0.21616161616161617,0.579418062358842,1.0,6/11,20.54%,PARP4;PARP14;PARP6;PARP3;PARP12;PARP16
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.518337611766213,1.23758066770491,0.2292418772563177,0.9367491273186331,1.0,6/15,16.27%,RUVBL2;CCT2;CCT5;RUVBL1;TCP1;DKC1
prerank,negative regulation of MAPK cascade (GO:0043409),0.35539776674785833,1.2373740106092808,0.13229018492176386,0.9353006474540914,1.0,15/87,11.85%,RGS2;SEMA6A;PTPRR;DUSP7;PTPRJ;PTPRC;PIN1;PRDM15;APOE;SPRED1;CNKSR3;DAG1;LYN;P2RX7;NF1
prerank,calcium-mediated signaling (GO:0019722),-0.3084156886509628,-1.2366148108822708,0.09177215189873418,0.5833450432094429,1.0,17/93,10.65%,ANK2;CACNA1C;EGFR;MCU;PPP1R9A;GRM5;ATP1B1;NUDT4;PLCE1;P2RX4;CHRM3;FIS1;CCR9;KSR2;PRKACA;DMPK;ACKR3
prerank,cellular response to heat (GO:0034605),-0.3727371341635116,-1.2364652011623083,0.1417910447761194,0.5826286909722019,1.0,12/35,19.49%,FGF1;MAPT;RBBP7;BAG3;VCP;THBS1;PRKACA;ANO1;HSF1;SLU7;CLPB;STUB1
prerank,positive regulation of cell cycle process (GO:0090068),-0.31233276708078794,-1.236195234879438,0.09345794392523364,0.5822956642443047,1.0,17/91,15.18%,SVIL;IGF1;PDGFRB;DYNC1H1;RHOA;SIRT2;CEP120;CIT;MAP3K20;LRP5;UBXN2B;PLSCR1;NSFL1C;USP19;CENPV;IGF2;CEP295
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5315229745357646,1.2358883964998302,0.20776699029126214,0.9394325202082845,1.0,3/12,9.34%,MAPK3;CSF1R;LYN
prerank,regulation of oxidoreductase activity (GO:0051341),-0.4835829022571137,-1.2357443900154892,0.20087336244541484,0.5824179662260098,1.0,8/13,42.28%,ATP7A;ABL2;SZT2;ECSIT;HDAC6;SIRT4;MT3;NOD2
prerank,positive regulation of cell adhesion (GO:0045785),0.3611983608360421,1.2355083131376554,0.14444444444444443,0.93876972276921,1.0,13/74,11.80%,FRMD5;PTPRJ;CXCL12;PRKD2;CIB1;RET;SYK;MAGI1;SMAD7;CD47;CITED2;NPNT;PPP3CA
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.5336688514447121,1.235379738591597,0.2106299212598425,0.9369564596317953,1.0,3/12,9.47%,UPP1;UCK2;UPP2
prerank,tight junction assembly (GO:0120192),0.39679560849705914,1.2350123189387714,0.1598694942903752,0.9361392498658758,1.0,12/49,14.68%,MARVELD2;PECAM1;RAMP2;F11R;ESAM;CLDN5;PRKCI;CDH5;LSR;APC;PATJ;PARD3
prerank,pteridine-containing compound metabolic process (GO:0042558),0.5106273888469115,1.2349949348528764,0.22768670309653916,0.9338278075571912,1.0,4/13,14.38%,SPR;PTS;NOS3;GCH1
prerank,rRNA metabolic process (GO:0016072),0.3260690069849056,1.2345702005075072,0.10887096774193548,0.933328471785616,1.0,54/160,20.09%,RPL30;UTP20;UTP18;RPL17;RPL23;RPL31;RPL3;DDX54;DDX10;RPL35A;RPS14;RPL8;RPL5;RPL37A;RPL4;EMG1;SNU13;POP5;EXOSC9;RPLP0;XRN2;RPS28;RPS24;RRP7A;RPS9;RPL24;RPL34;DDX27;WDR12;EXOSC1;UTP11;RPL23A;RPL21;RPL35;MPHOSPH6;HEATR1;DKC1;RPL19;RPL38;DCAF13;RPL36;RPL26;RPL15;RPL10;RPS2;RPL32;RPL27A;NOP58;NVL;EXOSC7;RPL14;RPL39;RPL7;MDN1
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3255958615469264,1.2340727379734777,0.11772486772486772,0.9332055080002419,1.0,31/151,16.56%,PCSK1;GPHN;CERS1;MOCS3;ACER2;CERS4;PRKD2;APOE;LPCAT2;KDSR;ELOVL6;SGMS1;LPCAT3;GPAT4;PLPP1;SLC44A1;SGPP2;DMD;PAM;HACD2;SLC25A2;ACER3;CEPT1;CSNK2A2;SGPP1;GCH1;SPNS2;AKR1A1;CERT1;PPM1L;SLC44A2
prerank,response to UV (GO:0009411),0.3513800233717319,1.2338165244409833,0.14349112426035504,0.9319346973175517,1.0,28/95,18.03%,ERCC3;ZRANB3;MAP2K7;EIF2S1;RUVBL2;SDF4;ERCC4;YY1;MAP3K4;POLK;EP300;MAPK8;USP47;RELA;SPRTN;CCAR2;CREBBP;BMF;INO80;ATR;TAF1;TMEM161A;N4BP1;USP28;NPM1;UVSSA;POLH;RPL26
prerank,positive regulation of T cell cytokine production (GO:0002726),0.47227110565468666,1.2337667656330824,0.20411663807890223,0.9298145100920302,1.0,6/20,15.15%,IL1R1;MAP3K7;B2M;CD81;CD55;DENND1B
prerank,positive regulation of phosphorylation (GO:0042327),-0.27060362913458674,-1.2333364904351656,0.024691358024691357,0.588215343946084,1.0,50/240,14.16%,ZBTB20;ERBB4;NTRK3;FGFR2;IGF1;SLCO3A1;DAB2;EGFR;LMO4;EPHA6;LEPR;EFNA5;PDGFRB;EPHB1;NTRK2;FGF1;NRP1;AXL;RYK;DSCAM;EPHA7;KIT;BMP4;ROR1;ROCK2;IL34;DDR1;PDGFRA;PIK3R3;AKT2;EPHB4;RAD50;VAC14;NIBAN1;THBS1;PELI2;MRE11;DVL3;CCND3;EPHA3;EPHB2;SEMA4D;ILK;PFKFB4;CLIP3;FNIP1;FAM20A;RALBP1;IGF2;RACK1
prerank,regulation of neuron migration (GO:2001222),-0.4030717369177023,-1.2322987498395876,0.18518518518518517,0.5899371415648503,1.0,14/26,25.72%,CTNNA2;NTNG1;COL3A1;SHTN1;SEMA3A;NIPBL;ULK4;PLXNB2;RAPGEF2;NSMF;CX3CL1;CAMK2B;CAMK2A;ADGRG1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.5459779090845257,1.2322942867955957,0.25675675675675674,0.9340194454660262,1.0,3/10,9.80%,HIPK2;ING4;TFAP4
prerank,positive regulation of cellular protein localization (GO:1903829),-0.32499553737853115,-1.2321914954191586,0.09785932721712538,0.5891499114491093,1.0,31/69,31.52%,BICD1;MAPT;KAT7;GNL3L;STX3;TM9SF4;GSK3B;DDRGK1;SYT11;MAP1A;ENTR1;WWTR1;TGFB1;CEP250;LIMK2;CARD10;GPD1L;GNL3;DTX3L;LAMTOR5;SESN2;AKT1;YAP1;EIF2AK3;SLC5A3;ABCA7;GPR137B;ORMDL3;PARP9;CDK5RAP3;PRKAA1
prerank,tRNA aminoacylation (GO:0043039),0.41601622725032156,1.2320699462273503,0.19636963696369636,0.932624434872099,1.0,13/37,17.49%,FARS2;GARS1;YARS2;IARS1;LARS2;HARS1;RARS2;WARS2;LARS1;GATB;HARS2;WARS1;IARS2
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.4700983465396763,-1.2319706037333733,0.20935412026726058,0.5886516321708941,1.0,6/15,16.33%,LRP1;PDPN;DDR1;DPP4;FAP;TGFB1
prerank,protein K11-linked ubiquitination (GO:0070979),0.4353538417449494,1.2318458335157936,0.2039355992844365,0.9312567665845005,1.0,11/27,21.38%,ANAPC2;ANAPC13;ANAPC7;ANAPC11;ANAPC10;ANAPC4;UBE2H;CDC26;UBE2D3;UBE2L3;UBE2A
prerank,regulation of spindle organization (GO:0090224),-0.44435564114001447,-1.2318386324920214,0.20089285714285715,0.5878871566615161,1.0,6/18,20.52%,DYNC1H1;RNF4;PARP3;DCTN1;RAE1;MAP9
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.5348454052842727,-1.2318249780728507,0.19595959595959597,0.5868018990073371,1.0,6/10,37.59%,ERRFI1;ENPP1;IMPACT;CAV1;CHP1;TESK1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.2667009535083387,-1.231748432655786,0.041176470588235294,0.5859167690946895,1.0,77/248,17.40%,RNF220;BICC1;FGFR2;LRRK1;DAB2;WLS;EGFR;COL1A1;LGR4;ADGRA2;GLI3;IGFBP2;MCC;TBL1XR1;FZD6;SMURF2;CYLD;CTNNB1;WNK1;PTK7;ZEB2;HDAC1;PPM1B;NKD1;HECW1;GPC3;SHISA6;VCP;CTNND2;BTRC;CSNK1A1;IGFBP6;TMEM64;DKK3;PSMA2;PSMD4;CSNK1E;GPC5;UBR5;PSMA6;DVL3;ZNRF3;TLE1;INVS;CSNK1G2;OTULIN;XIAP;GSK3B;PSMD13;NFKB1;PSMA1;ILK;PSME4;DAAM2;PSMF1;TBL1X;STK11;LIMD1;PPM1A;SCYL2;USP34;SIAH2;PSMA5;IGFBP4;PSMD9;CTNND1;LMBR1L;DACT1;PTPRO;PTPRU;LRP6;WWTR1;TGFB1;FZD4;GPRC5B;PSMB3;DVL1
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.5086807470331834,-1.2315649499152594,0.2054794520547945,0.5853402661132672,1.0,5/11,15.57%,PDK1;PRKCD;MAP3K5;STK25;PRODH
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.32345771510271026,-1.2312574903581657,0.09815950920245399,0.5851242790442186,1.0,33/71,31.14%,OTUD7A;ADAMTS12;CAPN2;NGLY1;MALT1;DDB1;VCP;RHBDD1;PSMA6;LGMN;CLPP;FAP;UBC;NEDD8;CTSO;DDI2;RNF123;HM13;CTSZ;STUB1;VPS4A;BAG6;OTUD7B;CTSK;CTSF;CLPX;HDAC6;CTSC;CTSB;CTSS;ZRANB1;FBXL17;PRPF19
prerank,gene expression (GO:0010467),0.3047908482553442,1.2309198910244294,0.07345971563981042,0.932896288345613,1.0,112/348,20.00%,POLR2J;NCBP1;RPL30;MRPS33;NR4A2;RSL24D1;EEF1A1;POLR2B;MRPL24;MRPL23;RPL17;RPL23;FASTKD2;RPL31;RPL3;RPS21;DDX54;PAX8;MRPL18;HNRNPK;SMG1;RPL35A;LMF1;CPSF4;RPS14;YARS2;CHTOP;RPL8;RPL5;NUP54;ABCF1;PWP1;MRPS12;RPS12;HBS1L;NXT1;RPS26;HARS1;RPL37A;NUP50;ADAR;FYTTD1;YTHDC1;RPL4;SRSF4;SARNP;RPLP0;UPF2;XRN2;U2AF1;RPS28;RPS24;DUSP11;RPS9;THRB;RPL24;RPS23;ADARB2;RPL34;MRPL52;RPS3;RPS11;MRPS15;NUP35;RRAGC;DHPS;PPP5C;RPL23A;RPS15A;TSPAN17;RPL21;RPL35;SRSF7;BAZ2A;NDC1;HNRNPL;SLBP;ADARB1;UPF3B;U2AF2;DKC1;HARS2;WARS1;WDR33;NUP160;RPL19;SMG6;HNRNPF;RPL38;POM121;DHX8;RPSA;RPL36;RPL26;RPS8;SMG5;NUP42;CLP1;RPL15;RPL10;RPS2;RPL32;EIF4G1;MRPL13;RPL27A;AGFG1;NUP133;SMG7;RPL14;RPL39;RPL7;DNAJB11
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.29339800829549684,-1.2308999821194313,0.07196969696969698,0.5849947743847767,1.0,29/121,14.02%,ERBB4;BMP6;IGF1;GRM5;EFNA5;NRP1;DLG4;PARP14;IL6R;NEDD9;PIBF1;KIT;TEC;RELN;GHR;IL34;ITGA5;IL31RA;SRCIN1;DLG3;ACVR1;VTN;SEMA4D;TP53;NOX4;CSPG4;IL18;IGF2;IL6ST
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.3592564169624811,1.230683451168792,0.14285714285714285,0.9315550164023112,1.0,22/80,13.48%,SURF4;ARF5;KIF18A;KIFAP3;LMAN2;COPG2;TMEM115;RAB6B;NAPA;RAB6A;KDELR2;TMED10;KIF15;RAB1A;GOLPH3L;KIF2A;TMED7;SCFD1;ARCN1;COPG1;KIF3B;COG3
prerank,leukocyte cell-cell adhesion (GO:0007159),0.44839281478447807,1.2306066136441551,0.21160409556313994,0.9295616788664792,1.0,5/24,7.31%,PECAM1;ICAM1;SELP;SYK;F11R
prerank,RNA destabilization (GO:0050779),-0.4587871303554445,-1.2305871290592272,0.20704845814977973,0.5847930798609131,1.0,6/18,13.24%,PUM1;ROCK2;ROCK1;LIN28B;YTHDF1;ZC3H18
prerank,sympathetic nervous system development (GO:0048485),-0.4631435960696013,-1.2305597861798592,0.189010989010989,0.5837515148411764,1.0,4/15,9.55%,NRP1;CTNNB1;SEMA3A;NRP2
prerank,nitric oxide metabolic process (GO:0046209),0.5000127839994639,1.2304721673556334,0.22476190476190477,0.9278876625101616,1.0,4/14,14.38%,SPR;CYP1B1;NOS3;GCH1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.38626443161169705,-1.230376176363856,0.16968325791855204,0.5831589453240352,1.0,20/30,28.91%,DSE;CHSY1;VCAN;HEXA;CSGALNACT2;CHST15;HEXB;ARSB;CHST11;UGDH;CSPG4;DSEL;HYAL1;BGN;CHPF2;CHST3;CSPG5;CHST12;DCN;NDNF
prerank,peptide cross-linking (GO:0018149),-0.40866335897047146,-1.2302632422609316,0.16990291262135923,0.5823772977446251,1.0,4/25,12.16%,COL3A1;THBS1;FN1;ANXA1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5594893105894282,1.2297586647159449,0.2153846153846154,0.9286356880784883,1.0,5/10,13.56%,PSMC4;PSMC2;ESR1;PSMC6;THRA
prerank,positive regulation of autophagy (GO:0010508),0.35413419062035734,1.2283229528137054,0.1400304414003044,0.9325020053219374,1.0,28/81,19.41%,GSK3A;ATF6;MAP3K7;PLK2;SVIP;TRIM8;EPM2A;PHB2;TRIM14;SIRT1;PARK7;FBXO7;PRKAA2;BAD;TMEM59;BNIP3L;TRIM27;SCOC;PIK3C2A;CAMKK2;TFEB;SESN3;BNIP3;SH3GLB1;ULK1;MID2;SESN1;LARP1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.39045259933492804,1.2279026587495996,0.17363344051446947,0.9320262814764764,1.0,15/46,17.46%,LCP1;SOD1;RALA;CFL1;TALDO1;RPLP0;SOD2;ARF1;PLCB1;PITPNA;TYK2;TCP1;CAPZA1;HNRNPF;SNRPA1
prerank,positive regulation of T cell migration (GO:2000406),0.4587644085337733,1.2278437729115967,0.21913043478260869,0.930009526305979,1.0,5/20,15.09%,OXSR1;CXCL12;WNT5A;APP;DOCK8
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.5414681590418586,-1.2277032997403496,0.2145748987854251,0.5883303913914254,1.0,6/10,20.43%,ATP1A2;OSR1;HECW1;CAMK2D;HECW2;NEDD4
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.45769383541354314,-1.227598465143788,0.1889400921658986,0.5875144704520429,1.0,9/16,19.05%,KMT2A;AUTS2;CTNNB1;SMAD4;PAXIP1;SNW1;KDM1A;BCOR;DNMT1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.3788734894449053,-1.227073004299363,0.16279069767441862,0.5878366381837038,1.0,10/33,14.91%,KANK2;FHL1;RBL2;MYO16;CDC73;BRD7;CDK6;DLG1;DACT1;NACC2
prerank,negative regulation of viral entry into host cell (GO:0046597),0.5271560736250123,1.22639489303643,0.23473282442748092,0.9341166773866413,1.0,4/12,8.84%,LY6E;IFITM2;IFITM3;IFITM1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4213978740236954,1.2263703934079755,0.19968051118210864,0.9319411209184377,1.0,7/34,11.60%,MT1G;SEMA6A;PRKD2;RAMP2;NOTCH1;RELA;FLT1
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.3024460363382448,-1.226011593911592,0.09782608695652174,0.5898179716113352,1.0,30/108,14.73%,FGFR2;TRABD2B;SULF1;LRP1;WLS;NXN;CTNNB1;MACF1;PTK7;SULF2;RNF43;CBFB;NKD1;DCDC2;GPC3;CTNND2;VGLL4;BTRC;SKI;CDC73;RSPO3;SALL1;TLE1;OTULIN;DAAM2;DISC1;ATP6V0C;GRB10;RACK1;DACT1
prerank,negative regulation of nervous system development (GO:0051961),-0.44838026608271514,-1.225731371415763,0.1930232558139535,0.5896039937555454,1.0,3/17,5.85%,ROBO2;APPL2;SORL1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3936377566081811,-1.2243695536934431,0.171021377672209,0.5924217668391168,1.0,8/27,14.83%,ANK2;CTNNA3;CACNA1C;AKAP9;CAMK2D;SRI;DLG1;PDE4B
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.4074372785629682,-1.2243538260230291,0.1773049645390071,0.5913603558241021,1.0,5/23,7.25%,TGFBR3;SMAD3;SMURF2;SMAD4;DKK3
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.5094211638088134,1.2241715746156827,0.24125230202578268,0.9392245634523587,1.0,3/13,10.05%,NCBP1;CPSF4;CPSF6
prerank,positive regulation of response to external stimulus (GO:0032103),-0.2926083349948319,-1.2238037323549913,0.08130081300813008,0.5918148388069537,1.0,40/128,29.17%,BMP6;SASH1;PDGFRB;PUM1;PUM2;NAPEPLD;STX3;THBS1;OPTN;PLSCR1;POLR3C;IL17RA;IL16;GPR4;LY86;IL18;IL33;TNIP1;LRSAM1;TGFB1;GPRC5B;GBP5;SCARF1;RIOK3;AGTR1;SLC15A4;SETD4;CX3CL1;PPM1F;P2RY12;PLA2G7;FEM1A;TLR3;SERPINE1;PDE2A;CCN4;CD180;POLR3G;SNCA;MDK
prerank,epithelial structure maintenance (GO:0010669),-0.5163800004356078,-1.2234211468279197,0.23443983402489627,0.5918558600238571,1.0,2/11,7.69%,CXADR;RBP4
prerank,nitric oxide biosynthetic process (GO:0006809),0.5051193970632305,1.2229491763712415,0.23551401869158878,0.9421602002926949,1.0,4/13,14.38%,SPR;CYP1B1;NOS3;GCH1
prerank,protein K48-linked ubiquitination (GO:0070936),0.3805123437554054,1.2225321277993029,0.17700453857791226,0.9416592666668577,1.0,17/54,16.50%,TNFAIP3;KLHL3;RFFL;NEDD4L;UBE3A;RNF187;TTC3;RNF6;ZNRF1;IFI27;CUL3;UBE2R2;RNF146;RNF216;UBE2G1;PELI1;UBE2H
prerank,RNA transport (GO:0050658),-0.3264355857430895,-1.2221786854873165,0.12195121951219512,0.5940874797616464,1.0,30/71,24.32%,SRSF5;SRSF11;CASC3;TGFBR2;SIDT1;SRSF2;KIF5C;SRSF6;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;CKAP5;HNRNPA2B1;SIDT2;HNRNPA1;THOC5;SLU7;CDC40;RTRAF;RNPS1;RAE1;FLOT1;NUP214;EIF4A3;NCBP2;THOC1;RBM8A
prerank,histone monoubiquitination (GO:0010390),-0.4129602610811167,-1.221558298091355,0.1746031746031746,0.5947968500088857,1.0,10/24,21.21%,WAC;UBE2E1;DDB1;DDB2;CDC73;RNF168;PAF1;BCOR;RNF40;DTX3L
prerank,cellular protein localization (GO:0034613),0.3060149814790879,1.2214946189847682,0.06367924528301887,0.943824215591807,1.0,61/285,13.12%,RTP3;REEP1;ARF5;RAP2A;TM9SF2;ARL5C;ARL4D;TM9SF3;EVI5L;RAB5C;TBC1D30;TBC1D8;ITSN1;SNX8;VPS29;TBC1D9;TMED4;SEC23IP;VPS26A;RAB43;CNTNAP2;TBC1D10B;TRAPPC8;RIC3;USP6NL;LAMTOR1;TBC1D4;RAB6B;TMED5;NAPA;RABGAP1L;IFT22;RAB6A;SNX17;HEY2;TMED10;WNT5A;RAB14;ACD;DNAJC27;TBC1D12;SNX1;ARL5B;ESAM;ARF1;RAB1A;ZDHHC15;CELSR1;TBC1D25;KIF13A;TMED7;DMD;SCFD1;RAB5B;RAB22A;ARCN1;ADPRH;TBC1D14;RRAGC;YWHAH;RABGAP1
prerank,cholesterol biosynthetic process (GO:0006695),0.41772842776113916,1.2210665954133075,0.19370860927152317,0.9435422027128213,1.0,8/31,11.99%,EBP;INSIG1;HMGCR;PLPP6;SC5D;IDI1;NSDHL;LSS
prerank,regulation of cell adhesion (GO:0030155),0.3266627371681379,1.220662578931945,0.13220815752461323,0.9430176001570528,1.0,19/129,10.01%,PRKX;RAC2;FRMD5;PIK3CG;PTPRJ;CXCL12;SRC;PRKD2;CD164;PPP2CA;RIPOR2;RET;MINK1;EFNA1;ACVRL1;PLXNA4;LYN;PODXL;PPP1R12A
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.36562744404683506,-1.2206431009249537,0.18253968253968253,0.5961979267718064,1.0,5/37,3.13%,TENM2;ALCAM;TENM3;GRID2;CXADR
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.44191961980422245,-1.2196043476698515,0.20316027088036118,0.5980358387835729,1.0,7/19,9.26%,IGF1;NTRK2;RTN1;FLOT2;SORL1;ROCK1;BIN1
prerank,mitochondrial translational elongation (GO:0070125),0.34781627879620014,1.2194231308904895,0.1458625525946704,0.9461654432075247,1.0,14/88,12.31%,MRPS22;MRPS2;MRPS33;MRPL24;MRPL23;MRPL18;MRPL38;MRPS12;MRPL20;TSFM;MRPL52;MRPL48;MRPS15;MRPS24
prerank,protein deacetylation (GO:0006476),-0.35963955273377646,-1.2193722330779064,0.16321243523316062,0.5975307499848115,1.0,14/41,12.52%,PRDM5;MIER1;HDAC4;TBL1XR1;FLNA;HDAC1;SIRT2;MORF4L2;MTA3;MIDEAS;MORF4L1;MTA1;TBL1X;RCOR3
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.5421196347762772,1.2184374045671238,0.24857685009487665,0.9482317723225265,1.0,5/11,12.39%,F11R;RAPGEF6;TJP1;RAB1A;RAP2C
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.42031598835367,1.2183392233259158,0.1972318339100346,0.9464433397619775,1.0,7/29,11.40%,ACSL5;SLC25A1;PPT1;HSD17B12;ELOVL6;ACSL4;HACD2
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4234684546643023,1.2182687043193308,0.21453287197231835,0.944469240761101,1.0,4/30,4.50%,RAC2;GSK3A;SAE1;VPS11
prerank,cellular response to organonitrogen compound (GO:0071417),-0.2919336086684224,-1.2181216252350777,0.09507042253521127,0.6000769069618718,1.0,15/99,8.47%,GABRB1;HCN1;CPEB4;AKAP6;RYR3;CPEB1;CAPN2;IGFBP5;CTNNA1;CTNNB1;P2RX4;GABRG2;GLRA1;AKAP9;EZR
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.4497632687028047,-1.2176969741547745,0.22758620689655173,0.600102355835108,1.0,2/17,2.45%,ANK2;SNTA1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.44132220363818114,1.217608763816196,0.22164048865619546,0.9450011071145935,1.0,6/24,13.25%,ATF3;ATF6;KLF2;NOTCH1;RBPJ;DDIT3
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.41808012513436293,1.2173990807837776,0.18641114982578397,0.9436237793636812,1.0,10/30,16.66%,CXCL12;PTTG1IP;FBXO5;SIRT1;YJU2;MDM2;CCAR2;RPS3;CD44;TMEM161A
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.35527881510372067,-1.2173060582881454,0.16442048517520216,0.6000679758308157,1.0,20/44,24.63%,LPAR1;ARHGEF10L;CCN2;NRP1;TGFBR1;TPM1;RHOA;PXN;ROCK2;PPM1E;FHOD1;NF2;ARHGEF5;CDC42;PPM1F;ARHGEF15;PFN2;RHOC;ITGB1BP1;TGFB3
prerank,positive regulation of synaptic transmission (GO:0050806),-0.31848382457627145,-1.2170447143397067,0.12312312312312312,0.5997294126032865,1.0,30/72,24.55%,RIMS1;NRXN1;GRIN2B;TSHZ3;ADCY1;DLG4;NLGN2;PRKCZ;RELN;CLSTN2;NLGN1;SLC24A2;LGMN;EPHB2;CACNG7;VAMP2;CACNG4;SHANK2;CACNG2;KCTD13;NFATC4;CLSTN3;FLOT1;ADRA1A;GRIN2D;ADCY8;NLGN3;CACNG3;MPP2;CACNG8
prerank,epithelial cell morphogenesis (GO:0003382),-0.4489792353027087,-1.216913393049067,0.20319634703196346,0.5990164849599369,1.0,7/17,23.42%,COL22A1;RILPL1;COL15A1;MET;SIPA1L3;RILPL2;COL18A1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.4358960873965453,1.216855108777209,0.20707070707070707,0.9437331377400208,1.0,7/26,14.60%,TIRAP;IFI35;WDFY1;PJA2;MFHAS1;DDX3X;CYBA
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.29939906286950724,-1.216638164880979,0.11038961038961038,0.5986933398163273,1.0,32/101,19.53%,PLD1;SAMD4A;OGT;CYFIP2;VIM;FBXW11;VGLL4;BTRC;IST1;POLDIP3;EIF3C;YTHDF1;EZR;NIBAN1;THBS1;PRR16;EEF2;RBM3;ASPSCR1;TBC1D10A;DACT1;PLXNB2;TGFB1;METTL5;NAT10;PCIF1;UPF3A;CIRBP;MSN;RPS6KB1;STUB1;AGTR1
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.5119952083168544,-1.2163256871370156,0.2413793103448276,0.5984531612987665,1.0,7/10,39.37%,GALNT13;POGLUT3;POGLUT2;GALNT2;GALNT1;GALNT3;MGAT5B
prerank,regulation of integrin activation (GO:0033623),0.48850869473541725,1.2161946514726973,0.2469352014010508,0.9443035858359955,1.0,4/15,13.32%,SRC;SELP;RASIP1;PLEK
prerank,regulation of hormone secretion (GO:0046883),-0.47095600889930755,-1.215955173606812,0.21568627450980393,0.598426145178411,1.0,7/15,36.86%,SCG5;ANXA1;VAMP2;SNX6;EDN1;SOX11;EDN3
prerank,negative regulation of cation transmembrane transport (GO:1904063),-0.4400874072055957,-1.215828374228894,0.21184510250569477,0.5977757069269055,1.0,5/18,14.75%,ATP1A2;CAB39;BIN1;CAMK2D;COMMD1
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.4073119798894532,1.2157739749326497,0.18166666666666667,0.9439140695437253,1.0,11/36,12.03%,LEF1;MAP3K7;PPP3CB;GNB1;WNT5A;FZD3;PLCB1;NLK;AGO4;PPP3CA;PPP3R1
prerank,regulation of response to external stimulus (GO:0032101),0.33495097740976915,1.2155706042094272,0.1490857946554149,0.9426606693398635,1.0,19/121,10.80%,LRP8;SAG;PIK3AP1;IL1R1;SEMA7A;FCGR2B;TIRAP;SBNO2;BCL6B;BIRC2;METAP2;SPATA2;CYRIB;WNT5A;TRAF3;RELA;PARK7;METAP1;NLRP6
prerank,regulation of histone acetylation (GO:0035065),0.41480549400742744,1.21550347495345,0.20065789473684212,0.9407319391754755,1.0,9/33,13.02%,MAPK3;RUVBL2;RPS6KA4;RPS6KA5;RAPGEF3;SETD5;PARK7;CTBP1;HDAC5
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5065395647701242,1.2153016599711048,0.23827392120075047,0.9393817090589457,1.0,4/13,10.65%,GSK3A;HEY2;NOTCH1;RBPJ
prerank,regulation of cellular component size (GO:0032535),0.41465422696992227,1.2151957139385692,0.2037351443123939,0.9376132053425372,1.0,8/30,14.61%,PEX11G;VAV3;RPTOR;HP1BP3;RAB22A;PICALM;LARS1;AP2M1
prerank,regulation of neuron projection arborization (GO:0150011),-0.46238159555140035,-1.2151463856446363,0.22413793103448276,0.5985127490277544,1.0,7/15,17.40%,NTNG1;DLG4;MACF1;DVL3;GRIP1;FZD4;DVL1
prerank,negative regulation of viral process (GO:0048525),0.37451637683007916,1.2151123076772732,0.17182662538699692,0.9357728304758836,1.0,10/57,10.63%,ILF3;BANF1;TRIM28;IFITM2;TRIM8;IFIT1;TRIM14;IFITM3;IFITM1;SRPK2
prerank,hyaluronan catabolic process (GO:0030214),-0.44278230917530104,-1.2149419526813383,0.20175438596491227,0.5980005197674041,1.0,9/18,33.28%,CEMIP;HEXA;CEMIP2;HEXB;TGFB1;GUSB;HYAL1;SLC9A1;CHP1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.4630098693020805,-1.2149191674546127,0.2229038854805726,0.5969996595128331,1.0,4/15,10.47%,LRP1;AEBP1;DDR1;FAP
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.348221269525662,-1.214918865696727,0.14360313315926893,0.5959356117824773,1.0,14/48,14.18%,CUX1;DOCK5;DOCK1;NRP1;FLNA;NEDD9;RREB1;P4HB;CUX2;ILK;IL1RAPL1;OBSL1;MYADM;TRIOBP
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.553058419074629,1.214440109889587,0.2434077079107505,0.9365669095871925,1.0,4/10,9.31%,CSGALNACT1;XYLT1;PXYLP1;B3GAT2
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.3990880682117963,-1.2144107883189394,0.20861678004535147,0.5963455417871626,1.0,7/24,8.19%,ERRFI1;MED1;CBFB;ROCK2;SRSF6;ROCK1;FOXC1
prerank,positive regulation of rRNA processing (GO:2000234),-0.5254682941280838,-1.213454127262335,0.2388663967611336,0.5978264667619958,1.0,6/10,25.40%,RIOK1;RIOK2;WDR43;SIRT7;UTP15;BUD23
prerank,regulation of fatty acid oxidation (GO:0046320),-0.4495285995906373,-1.213163017482902,0.20408163265306123,0.5975695320171932,1.0,4/16,6.61%,PRKAG2;PPARGC1A;APPL2;PPARA
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.5204256918167268,1.2130654588585605,0.26053639846743293,0.9402037280387383,1.0,3/11,9.80%,HIPK2;ING4;TFAP4
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.5263034475537152,-1.2127915536985838,0.23809523809523808,0.5974521115896382,1.0,5/10,32.29%,APPL2;RAB31;ANO6;NCKAP1L;CD300A
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5177740262315582,1.2126566285364886,0.23302752293577983,0.9397471288348508,1.0,3/11,9.74%,ZRANB3;FBXO5;MSH3
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3259809917359611,-1.2125953853096683,0.13279132791327913,0.596948105766917,1.0,13/67,6.44%,SULF1;CYFIP2;DOCK1;WASF2;NRP1;MAPK14;AXL;ABI1;RHOA;VAV2;PXN;ROCK2;ROCK1
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.42200094374378183,-1.2119435500706999,0.2095435684647303,0.5977209281222977,1.0,11/21,31.29%,CTNNB1;CSNK1A1;DVL3;FZD2;GSK3B;LRP6;DVL1;AMER1;FZD1;CAV1;PPP1CA
prerank,positive regulation of T cell differentiation (GO:0045582),0.4006565058293475,1.2119042603147527,0.19031719532554256,0.9407854984675776,1.0,7/36,15.80%,PCK1;LEF1;VSIR;PNP;BCL6;NKAP;IL7
prerank,protein modification by small protein removal (GO:0070646),0.30325760270219587,1.2111915778868634,0.10132689987937274,0.9417503612975939,1.0,59/252,14.97%,TOMM20;PSMB10;PSMC4;ABRAXAS1;PSMB6;PSMD8;PSMD5;PSMD12;ACTL6A;TNFAIP3;MAP3K7;ACTB;SMAD1;BIRC2;PSMD11;YOD1;OTUD1;YY1;PSMB4;PSMC1;EP300;ACTR8;SMAD7;ACTR5;DESI2;DESI1;RUVBL1;USP47;TRAF3;RAD23A;MDM2;USP48;USP31;PSMC2;PSMD2;OTUD3;ESR1;USP22;USP15;COPS7B;USP37;NFRKB;USP18;TNIP2;OTUD5;PSMD14;TRRAP;USP33;PSMC6;BRCC3;NFKBIA;PSMD1;PSMB1;USP9X;APC;HCFC1;INO80;COPS8;UCHL5
prerank,nuclear envelope organization (GO:0006998),-0.42793152888829444,-1.2108434333595206,0.22093023255813954,0.5996918908550328,1.0,13/20,26.43%,NUP155;TOR1AIP1;DMPK;NUP93;TOR1B;NEMP1;SUN1;VPS4A;CTDNEP1;EMD;TMEM170A;LEMD2;TMEM43
prerank,negative regulation of lyase activity (GO:0051350),0.47178316992210917,1.210582740813191,0.2292418772563177,0.942141333893435,1.0,4/16,15.04%,PHPT1;EDNRB;PALM;GRM3
prerank,pharyngeal system development (GO:0060037),-0.45746992865151137,-1.2104575727171516,0.22048997772828507,0.5997171662907961,1.0,4/15,4.63%,TGFBR1;BMP5;BMP7;BMP4
prerank,positive regulation of phospholipid transport (GO:2001140),0.5431684094734225,1.2101920255968375,0.22350674373795762,0.9415953147610093,1.0,2/10,5.66%,APOE;DBI
prerank,body fluid secretion (GO:0007589),-0.45862984196382406,-1.2097976593165052,0.23640167364016737,0.6004213147569011,1.0,5/15,22.43%,ERBB4;SLC22A4;NPR1;PRLR;VEGFA
prerank,intracellular protein transmembrane transport (GO:0065002),0.39806101611923417,1.209759604654561,0.2088607594936709,0.9413331542670976,1.0,11/42,13.32%,TOMM20;ROMO1;TIMM17B;PEX1;PEX7;GRPEL2;TOMM40L;TIMM21;AIFM1;SEC62;SEC61A2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.4173192304745267,1.2097253755795758,0.2040133779264214,0.9393258697229535,1.0,9/29,10.86%,GPAM;SRARP;VPS11;CNOT2;AXIN1;PAK1;WBP2;ESR1;CARM1
prerank,response to interleukin-4 (GO:0070670),0.5404006296863848,1.209487567057591,0.23917525773195877,0.9382338782822985,1.0,1/10,2.08%,LEF1
prerank,positive regulation of protein secretion (GO:0050714),-0.3208288773421093,-1.2094854315997379,0.1337386018237082,0.600204722531404,1.0,27/69,27.77%,BMP6;IGF1;WLS;MCU;NLGN2;GLUD1;RBP4;EZR;PPID;TM7SF3;NNAT;UNC13B;PSMD9;EXOC1;TGFB1;PTPN23;TCF7L2;C1QTNF3;IER3IP1;TGFB3;CAPN10;APBB1;PPIA;SYTL4;AACS;LRRC8A;MYOM1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.37422579243677045,-1.2090519943629134,0.20812182741116753,0.6004293628076042,1.0,9/31,14.73%,KANK2;FHL1;RBL2;MYO16;CDC73;BRD7;CDK6;DLG1;DACT1
prerank,fluid transport (GO:0042044),-0.4961106069416182,-1.2090201901632198,0.2360248447204969,0.5994687902731709,1.0,3/12,24.54%,PDPN;AQP4;AQP11
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.47477644960063037,1.2088456168711417,0.23104693140794225,0.9388688028860236,1.0,3/17,5.12%,SORT1;HDAC9;LMF1
prerank,glucose metabolic process (GO:0006006),0.373073352838635,1.2088340245646685,0.1966205837173579,0.9367945651469525,1.0,9/58,8.59%,PCK1;HECTD4;SLC25A1;GOT2;TPI1;PPARD;OMA1;IRS2;GALM
prerank,cellular response to chemical stress (GO:0062197),0.33763993017019645,1.2087515882279667,0.16502115655853314,0.9350283293728934,1.0,17/96,11.69%,CHCHD2;PRR5L;TXNRD2;SLC25A24;SOD1;EIF2S1;CYCS;STOX1;ZFAND1;LONP1;GPX7;TRPV4;SOD2;PARK7;PRKAA2;DDX3X;ATG7
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3196518084464739,1.2086823348941318,0.11573472041612484,0.9332006374090306,1.0,41/173,15.42%,BCAP29;DYNC1I1;MIA2;TRAPPC2;SPTB;CAPZA2;CNIH1;LMAN2;TMED4;DCTN2;COG5;GOPC;COPG2;TRAPPC8;TMEM115;F8;GOSR2;TRIP11;TMED5;NAPA;KDELR2;TMED10;DCTN3;RAB1A;NRBP1;TRAPPC11;DYNLL1;TMED7;HYOU1;SCFD1;TRAPPC6B;MCFD2;ARCN1;COPG1;CUL3;CD55;COG3;PROC;DYNC1I2;WHAMM;GAS6
prerank,response to reactive oxygen species (GO:0000302),0.3728502276111632,1.2085753148189677,0.17956656346749225,0.931539983178113,1.0,12/54,12.92%,MAPK3;ROMO1;TXNRD2;SOD1;APOE;FYN;MAPK8;SIRT1;SOD2;APTX;RPS3;CHUK
prerank,tRNA processing (GO:0008033),0.3637645952550415,1.2079779971123976,0.1638846737481032,0.9319938162554473,1.0,20/61,19.78%,THG1L;THUMPD1;FARS2;CPSF4;TRMT10B;POP5;ANKRD16;PTCD1;WDR4;SSB;TSEN2;NSUN6;CDKAL1;TSEN15;CLP1;NSUN2;TRNT1;FTSJ1;POP1;URM1
prerank,stress granule assembly (GO:0034063),-0.4277642694648913,-1.2074347031212425,0.19910514541387025,0.6029740908875216,1.0,7/20,13.79%,BICD1;DYNC1H1;MAPT;OGFOD1;YTHDF1;G3BP1;ATXN2L
prerank,dendritic cell chemotaxis (GO:0002407),0.49254674811004684,1.2072661076294529,0.23177570093457944,0.9330011150482277,1.0,2/14,10.43%,PIK3CG;TRPM4
prerank,response to laminar fluid shear stress (GO:0034616),0.5452343510126116,1.207055159581576,0.26452905811623245,0.9318091597607295,1.0,3/10,7.27%,KLF2;MAP2K5;SMAD7
prerank,myoblast fusion (GO:0007520),-0.49193261201507177,-1.2063205132368064,0.2549889135254989,0.6048862069328506,1.0,3/12,6.09%,ADGRB3;ADAM12;ADAMTS5
prerank,negative regulation of axonogenesis (GO:0050771),-0.39316022676951207,-1.2055601306074106,0.18781725888324874,0.605914882437935,1.0,5/27,4.25%,MAP2;DCC;ULK2;PTPRS;RHOA
prerank,nucleosome assembly (GO:0006334),0.4126847351038034,1.2054401406179287,0.2136602451838879,0.9362919959813127,1.0,9/31,18.94%,ASF1B;NAP1L4;RSF1;CABIN1;BRD2;RBBP4;NPM1;ATRX;HAT1
prerank,negative regulation of signaling (GO:0023057),-0.39110139898747515,-1.205156263048645,0.20145631067961164,0.6059742415659617,1.0,6/25,17.71%,UBASH3B;GLRA1;OPTN;ACVR1;OPRM1;SOCS5
prerank,positive regulation of hormone secretion (GO:0046887),-0.4269380838311919,-1.2051286953054892,0.20444444444444446,0.6049848942598187,1.0,8/17,36.86%,SNX4;SPP1;C1QTNF3;VAMP8;EDN1;HFE;SOX11;EDN3
prerank,aminoglycan biosynthetic process (GO:0006023),-0.3322715994916584,-1.204639782138326,0.15447154471544716,0.6052691069319144,1.0,18/49,21.68%,GPC6;HS3ST5;HS6ST2;SDC2;HS3ST3A1;GPC3;HEXA;HSPG2;GPC5;SLC35D2;UGDH;B3GALT5;B3GALNT1;HS3ST3B1;B3GALT1;NDST2;SDC3;GPC4
prerank,negative regulation of transmembrane transport (GO:0034763),0.5396683115643295,1.2045888843686157,0.25190839694656486,0.9377885419953756,1.0,3/10,12.71%,RSC1A1;IRS2;CTTNBP2NL
prerank,negative regulation of cell motility (GO:2000146),-0.2966469396628458,-1.2041839372270444,0.08389261744966443,0.6054368924439992,1.0,12/108,4.20%,MAGI2;NAV3;SPOCK3;LDLRAD4;TMEFF2;SULF1;ROBO1;DPYSL3;IGFBP5;FBLN1;CLIC4;TPM1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),-0.26140185878501593,-1.204070403643004,0.04081632653061224,0.6046782216897594,1.0,79/259,19.66%,GSN;PARVA;AHI1;PKD1;CC2D2A;EXOC3;NRP1;MTSS1;RILPL1;FLNA;PIBF1;KIT;IFT81;DZIP1;TTC8;WDR35;DYNC2I1;VCL;DCDC2;RAB8B;SHTN1;PIP5K1A;CCDC66;NUDCD3;CCDC57;CFAP20;EXOC6;IFT46;TTC39C;IFT52;ACTR3;EZR;CEP89;SPATA13;CEP126;IFT172;CEP20;ABLIM2;FGD1;ACTN2;CFAP44;IFT74;RP2;ARL13B;ABLIM3;EMP1;TTBK2;DISC1;BBS9;KIF3A;DZIP1L;RAB11A;WDR19;WDR11;ANO6;INTU;RAB23;FGD4;BBS2;PTPRO;ARF4;CYS1;RAPGEF2;EXOC1;EXOC7;CEP250;PTPN23;EHD3;EHD1;DYNLL2;RAB8A;IFT20;ACTR2;BBS5;SNAP29;ARFIP2;TMEM237;CCDC28B;TTLL3
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.3671597775021672,-1.203770938852777,0.1811764705882353,0.6044311037850149,1.0,13/34,23.50%,AMBRA1;PDGFRB;KIT;PDGFRA;PIK3R3;PIK3IP1;PTK2;TGFB1;PIK3R1;PRKD1;P2RY12;EPHA8;TNFAIP8L3
prerank,chemical synaptic transmission (GO:0007268),-0.2606445726781562,-1.2034215763165994,0.036585365853658534,0.604291898962843,1.0,70/284,17.64%,DLG2;RIMS1;DLGAP1;KCNQ3;PLP1;HTR2C;GABRB1;GRIA4;SNAP25;GRIA2;NRXN1;SLC1A3;GRID2;CACNB4;AMPH;GRM5;GRIN2B;GLRB;KCND2;CHRM2;SYN2;DLGAP2;GABRA2;MBP;DLG4;PTPRN2;SLC6A1;NLGN2;SHISA6;CACNA1B;GLRA3;GRID1;CAMK4;CHRM3;GABRG2;GLRA1;GABBR2;AKAP9;NLGN1;SYN1;KCNA1;PRKACA;BRSK1;HTR4;RIT2;NRXN2;UNC13C;PRKAR1B;APBA1;DLG1;FCHSD2;UNC13B;BSN;CAMK1;HTR7;SNPH;GRIK4;VAMP2;STXBP1;SLC12A6;GABRA5;LRP6;ERC2;KIF5A;STX1A;GABRG3;NOVA1;SLC12A4;DVL1;HCRTR2
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.5173463665886417,-1.202835825602747,0.23711340206185566,0.6049052199012298,1.0,5/10,22.27%,ZEB2;ATP7A;CTNS;RAPGEF2;APPL1
prerank,pyruvate metabolic process (GO:0006090),0.3768492300554853,1.201900250000921,0.18364197530864199,0.9470950363796052,1.0,5/52,5.74%,PCK1;ENO4;BSG;ME3;TPI1
prerank,protein localization to synapse (GO:0035418),-0.4899034504450316,-1.2017252762769361,0.2435129740518962,0.6069267837189091,1.0,7/12,13.52%,NRXN1;PCLO;DLG4;NLGN2;NLGN1;NRXN2;BSN
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.31245674988821737,-1.2013851570708225,0.13353115727002968,0.6068285692152762,1.0,12/74,4.04%,LDLRAD4;PHLDB2;DAB2;COL1A1;SMAD3;PHLDB1;TGFBR1;TGFBR2;BMP5;CTNNB1;PDPN;SMAD4
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.3398598850912069,1.2012029763830687,0.1694915254237288,0.9481100101559777,1.0,19/93,12.40%,MAP3K11;FCGR2B;TIRAP;HIPK2;MAP3K4;EDAR;TRAF5;AXIN1;KLHDC10;MTURN;MINK1;TRAF3;SEMA4C;PJA2;PLCB1;MFHAS1;APP;RELL1;MID1
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.29832771292683585,1.2011056858633289,0.09568261376896149,0.9464217719373227,1.0,89/327,18.90%,TBX4;ONECUT1;FOXN2;TRAPPC2;EZH2;ZFAT;HES6;GTF2IRD1;RPS6KA4;ATXN1L;SBNO2;RPS6KA5;PPP2CA;SOX2;MYBL2;SMARCA2;SPIN1;EP300;RFX3;NFX1;MED23;TGFBRAP1;SRSF10;ACTR8;CDK11B;ZNF205;SFPQ;ACTN4;DRAP1;CLOCK;ACTR5;PFDN5;NOTCH1;ACVRL1;RELA;SOX13;NAB2;RNF6;UBE2V1;CCAR2;RYBP;ING2;ESR1;NLK;CREBBP;CARM1;HP1BP3;JMJD1C;MZF1;SP1;NUP35;IRF2;CHD3;ERC1;TRRAP;DDIT3;CHEK2;ZKSCAN5;YBX1;HCFC1;RNF20;BACH1;BAZ2A;NSD2;FUS;TERF2IP;TFEB;TAF6L;TCF7L1;TCF3;APBB2;SOX17;WTIP;CALR;NONO;MYT1;STAT3;FOXK2;ZNF219;INSR;PATZ1;ZSCAN21;YAF2;HINT1;ATRX;MYBL1;NCOA2;MSL3;TCF7
prerank,antibacterial humoral response (GO:0019731),0.4728551493254517,1.200951016519209,0.22873345935727787,0.9449784966691616,1.0,2/16,4.74%,DMBT1;RNASE6
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.273027420533591,-1.2006401161637732,0.06542056074766354,0.6078442871431076,1.0,46/166,19.24%,SORBS1;IGF1;PLD1;SAMD4A;EGFR;SMAD3;PDGFRB;GLI2;LPGAT1;KAT7;VIM;ZEB2;P2RX4;DDB1;PPARGC1A;ATP7A;LDB1;SLC6A9;AKT2;POLDIP3;LDLR;EIF3C;YTHDF1;NIBAN1;SMOC2;THBS1;PRR16;STN1;ARPP19;EEF2;DDAH1;RBM3;SLC27A1;BRPF3;IGF2;ATAD5;PLXNB2;GPLD1;PTPN2;METTL5;SREBF1;NAT10;PCIF1;UPF3A;CIRBP;RPS6KB1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.5006984149994999,1.2004917036026481,0.25047801147227533,0.9448979501730292,1.0,3/13,6.42%,PRPF31;PRPF3;SRSF10
prerank,regulation of actin filament-based process (GO:0032970),-0.31991340751051034,-1.2004785051570186,0.14779874213836477,0.6072218047628115,1.0,20/70,15.22%,LRP1;GPM6B;IQGAP1;EFNA5;PDGFRB;RHOA;ROCK2;PRKCD;ROCK1;EZR;RND3;RHOBTB2;CNN2;EPHA3;RHOB;RHOBTB1;HIP1R;TAOK1;ARHGEF5;IQGAP2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.4783336673963443,1.2003964950014356,0.23992673992673993,0.9432715462193991,1.0,4/17,9.69%,CIB1;RET;SYK;PODXL
prerank,camera-type eye morphogenesis (GO:0048593),-0.5320602402564357,-1.2003129223456137,0.2520491803278688,0.6066399747210063,1.0,6/10,30.17%,TENM3;SKI;LRP6;VEGFA;TBX2;KDM2B
prerank,dicarboxylic acid transport (GO:0006835),-0.3874861995870163,-1.2002816612097575,0.21577726218097448,0.6057023528023842,1.0,9/28,15.61%,SLC1A3;SLC13A3;PDPN;SLC26A7;SLC25A13;SLC25A32;GJA1;SLC22A6;SLC19A1
prerank,I-kappaB phosphorylation (GO:0007252),0.543811295009226,1.1999687825817544,0.2510204081632653,0.9429828891750957,1.0,3/10,12.92%,MAP3K7;ERC1;CHUK
prerank,cellular response to glucagon stimulus (GO:0071377),-0.4399488173117427,-1.1998057537519955,0.2069672131147541,0.6059738081827026,1.0,10/17,22.36%,ADCY5;ADCY2;ADCY1;ADCY9;PRKACA;PRKAR1B;ADCY7;ADCY3;ADCY8;ADCY4
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4046656117524272,1.1992304885256373,0.21553090332805072,0.9441558122906616,1.0,11/35,15.68%,CBL;PPT1;SGIP1;HNRNPK;B2M;ARF1;PICALM;SMAP1;LDLRAP1;BMP2K;ARF6
prerank,error-free translesion synthesis (GO:0070987),-0.4117111726462592,-1.1991692200374724,0.22850678733031674,0.6066737466836383,1.0,7/22,14.40%,RFC1;RCHY1;VCP;RPA1;UBC;NPLOC4;POLDIP2
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.37984834081309815,-1.1989992725307672,0.20388349514563106,0.6061675818567813,1.0,5/30,4.49%,DDX5;FOXP1;DAB2;HDAC1;RNF14
prerank,V(D)J recombination (GO:0033151),0.5347106144715777,1.1987007744420712,0.25343811394891946,0.9442929702368252,1.0,4/11,17.05%,DCAF1;TCF3;PRKDC;XRCC4
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.5195428239286828,-1.1983466976580472,0.2608695652173913,0.6070138524477413,1.0,5/10,20.49%,FGFR2;TGFBR2;LRP5;STAT1;PDGFA
prerank,cellular response to glucose starvation (GO:0042149),-0.35112007457825156,-1.1974063403327213,0.1956521739130435,0.6085953950379932,1.0,21/41,31.80%,PRKAG2;CPEB4;PRKAG1;PIK3C3;SIK1;BRSK1;HNRNPA1;TP53;SZT2;ITFG2;ATF4;IMPACT;SESN2;EIF2AK3;PICK1;ZC3H12A;FOXO3;MYBBP1A;PRKAG3;PRKAA1;TBL2
prerank,negative regulation of cell population proliferation (GO:0008285),-0.25272143844081496,-1.1972116453311814,0.0390625,0.6080733199624261,1.0,83/351,16.96%,MAGI2;ERBB4;ST18;TGFBR3;ALDH1A2;KANK2;CLMN;TNS2;IGFBP5;MCC;FBLN1;NELL1;PTPN14;COL4A3;BMP5;CTNNB1;ABI1;PDPN;MTSS1;ATP8A2;SIRT2;BMP4;NUPR1;IGFBP7;ZBTB7C;LMNA;OGN;PDS5B;APPL2;MYO16;PER2;VGLL4;PML;FRK;PODN;SKI;GSDME;IGFBP6;RBP4;CDKN1B;CDC73;ADAMTS1;SMAD6;NIBAN2;DLG3;CGRRF1;EIF2AK2;BRD7;CDK6;SPEG;FAP;CAMK2N1;DDAH1;TP53;NOX4;STK11;TBX3;FKTN;P3H3;PDCD5;WNT9A;NF2;MED25;TOB1;NACC2;MAGED1;PTPRU;PEX2;RAF1;MN1;NGF;RAPGEF2;GPLD1;CCN3;SLC16A2;RNF139;S100A11;TGFB1;BMPR1B;SMYD2;OPRM1;PTPN2;ROR2
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.4806898199017349,1.1965561984884059,0.24358974358974358,0.9511872231157698,1.0,3/15,4.99%,SH3D19;APOE;TNFRSF1B
prerank,T cell differentiation in thymus (GO:0033077),0.4833413401794513,1.196356594974673,0.26118067978533094,0.949954057489246,1.0,2/14,3.77%,PTPRC;ZFP36L1
prerank,motile cilium assembly (GO:0044458),-0.4908106483067973,-1.196168252706856,0.25149700598802394,0.6099728299438351,1.0,7/12,41.50%,SPATA6;BBOF1;BBS5;CCDC39;E2F4;RSPH9;DNAAF3
prerank,triglyceride biosynthetic process (GO:0019432),0.45764621969630304,1.1958884829905185,0.24601769911504426,0.949962065484203,1.0,3/18,6.67%,PCK1;GPAM;GPAT4
prerank,regulation of DNA repair (GO:0006282),-0.34990377987764165,-1.195490718193384,0.21079691516709512,0.6107520229546524,1.0,18/44,18.57%,EYA2;EYA1;EGFR;UBE2N;KAT7;DEK;ERCC6;PML;UBR5;RNF168;RNF8;WRNIP1;SIRT7;USP1;NPAS2;CDK9;BABAM1;SMCHD1
prerank,response to histamine (GO:0034776),-0.5125214482327652,-1.1952820450192203,0.2605932203389831,0.6103217926825572,1.0,3/10,17.47%,GABRB1;GABRG2;DIAPH1
prerank,regulation of cartilage development (GO:0061035),-0.42714395440046204,-1.1950314361555794,0.22894168466522677,0.6100405257503695,1.0,11/18,37.00%,SOX5;TAPT1;BMP4;BMPR1B;SOX6;BMPR2;BMP2;MDK;PTHLH;WNT11;KAT2A
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.2810868744480285,-1.194973290415708,0.11235955056179775,0.6092050604229606,1.0,47/152,14.73%,RNF220;FGFR2;LRRK1;SULF1;WLS;EGFR;COL1A1;LGR4;ADGRA2;WNT5B;TBL1XR1;SMURF2;WNK1;MACF1;PTK7;SULF2;ZEB2;PPM1B;GPC3;VCP;SKI;PSMA2;CDC73;PSMD4;CSNK1E;GPC5;RSPO3;UBR5;PSMA6;SALL1;CSNK1G2;XIAP;PSMD13;NFKB1;PSMA1;ILK;PSME4;DAAM2;PSMF1;TBL1X;DISC1;PPM1A;ATP6V0C;USP34;PSMA5;PSMD9;DACT1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.5258036416936658,1.194580242107961,0.2619047619047619,0.9533563994778214,1.0,4/11,14.38%,SPR;PTS;NOS3;GCH1
prerank,vasodilation (GO:0042311),0.5037863519982245,1.193715541751217,0.2608695652173913,0.9548786178865089,1.0,4/13,11.33%,SOD1;KLF2;SOD2;NOS3
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3096287086154359,1.193653145935293,0.14745972738537794,0.9530789983410173,1.0,30/198,12.33%,NUDT14;MAPK3;PIK3CG;PPIP5K2;NUDT11;PTPRC;PPP3CB;PNKP;PTPRB;DUSP12;NUDT5;PANK2;ACYP1;PLAAT3;PXYLP1;CERKL;PLPP1;PLCG1;INPP5D;PAK1;PLCB1;GPI;PFKFB3;PGP;PI4KA;PIK3CD;PPP3CA;IP6K2;INPP4B;PLAA
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.3406992074636723,-1.1934950763279564,0.17151162790697674,0.6123630806661606,1.0,13/45,8.32%,SMAD3;BRINP1;TOM1L2;CTNNB1;BMP7;ZWINT;BMP4;TRIM35;CDKN1B;PTPN3;FOXC1;BRINP2;GAS1
prerank,granulocyte chemotaxis (GO:0071621),0.3701447447108598,1.1933608854403646,0.22033898305084745,0.9523373099691544,1.0,7/55,11.64%,PIK3CG;BSG;PPIB;SYK;PIKFYVE;CCL25;PIK3CD
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.45293737081433305,1.1929928479668455,0.24156305506216696,0.9518025650858796,1.0,6/20,10.65%,SMAD1;EP300;CARF;NOTCH1;RELA;RBPJ
prerank,positive regulation of cell aging (GO:0090343),0.518915747262275,1.1922439889517937,0.2608695652173913,0.9528929425874686,1.0,3/11,7.59%,B2M;SIRT1;YPEL3
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.4090968416300656,1.1920074241448904,0.22279792746113988,0.9518587876826835,1.0,9/33,15.42%,TNFAIP3;RAMP2;TEK;WFS1;KRIT1;ICAM1;TNIP2;CDH5;GAS6
prerank,monocarboxylic acid transport (GO:0015718),-0.3286321706811197,-1.1908875561335852,0.15938303341902313,0.6184765534823499,1.0,14/51,18.79%,SLCO3A1;SLC16A12;SLC6A13;SLC16A7;SLC6A12;RXRA;SLC27A1;NCOA1;SLC16A11;STARD5;SLC16A2;ATP8B1;SLC5A6;SLC16A9
prerank,neurotransmitter biosynthetic process (GO:0042136),0.5074432719711308,1.190877302242267,0.24285714285714285,0.9544813046960835,1.0,1/14,0.33%,SLC5A7
prerank,bile acid biosynthetic process (GO:0006699),-0.3965120423099579,-1.19084759149692,0.2379862700228833,0.6175485863732695,1.0,5/24,9.99%,OSBPL9;OSBPL6;CYP27A1;CYP7B1;OSBP
prerank,mitochondrion morphogenesis (GO:0070584),-0.4929307138063742,-1.1902772561775024,0.24190064794816415,0.6180998779536224,1.0,3/11,7.76%,PID1;WASF1;FIS1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.4848616654743696,-1.1898047824180602,0.2565130260521042,0.6173050462145913,1.0,3/12,2.14%,IGF1;AKAP6;CAMTA1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.4848616654743696,-1.1898047824180602,0.2565130260521042,0.6173050462145913,1.0,3/12,2.14%,IGF1;AKAP6;CAMTA1
prerank,nucleic acid metabolic process (GO:0090304),0.35699373805323964,1.1896606158005836,0.1927710843373494,0.9574429241195682,1.0,13/69,11.70%,POLR2J;NCBP1;POLR2B;HNRNPH2;DDX54;PCBP1;HNRNPK;HNRNPC;XRN2;DXO;EXD2;DUSP11;PTBP1
prerank,transport along microtubule (GO:0010970),0.48708826426843393,1.1895410921185186,0.2536231884057971,0.9559141405970397,1.0,6/13,14.94%,DYNC1I1;COPG2;APP;COPG1;SPG11;DYNC1I2
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.37991783806774915,-1.1892430689588862,0.22439024390243903,0.6178092197275492,1.0,10/30,16.71%,ANK3;VAMP5;MACF1;RAB31;GGA2;OPTN;VAMP2;BBS2;GOLGA7;GGA3
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.42765170102860045,-1.1892063371111454,0.2471395881006865,0.6169067518683415,1.0,5/18,4.43%,ST18;JAK1;SMAD4;FER;IL6R
prerank,DNA recombination (GO:0006310),-0.3540220311771027,-1.1890952499283467,0.19543147208121828,0.6162156028157695,1.0,19/37,33.53%,TSN;RAD50;MRE11;RPA1;RAD51D;MSH2;BLM;SUPV3L1;RECQL;RTEL1;DMC1;RAD21;RPAIN;RHNO1;RAD54B;RAD51C;ERCC1;IGHMBP2;HMGB1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.5029357049958019,1.1889911635280523,0.2845849802371542,0.9561833964359875,1.0,5/13,18.23%,HEY1;HEY2;DDIT3;TAF1;SIN3A
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3152277735467557,1.1885993688796272,0.16822429906542055,0.9558319969421477,1.0,31/149,13.91%,MAP3K7;TAB2;RPS6KA4;PRKCH;TIRAP;TRIM8;PRKD2;RPS6KA5;RAB7B;TRIM14;CIB1;EP300;CARD16;TRAF5;CLOCK;TAB3;WNT5A;TRIM25;RELA;RBCK1;UBE2V1;RNF25;NOD1;APP;RPS3;PRKCI;IKBKB;ERC1;CHUK;NFKBIA;TRIM27
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.4919858666328353,1.1884054843313299,0.26217228464419473,0.9546825855672582,1.0,4/14,11.93%,CRAT;ACOX3;HSD17B4;ACOT8
prerank,regulation of cell migration (GO:0030334),-0.24763930537940998,-1.1884047334224495,0.023809523809523808,0.6171425387548908,1.0,69/382,12.16%,MAGI2;NAV3;ERBB4;NTRK3;LDLRAD4;TMEFF2;IGF1;SULF1;PLXNA2;ROBO1;CTNNA2;SASH1;DAB2;EGFR;LMO4;SYNE2;COL1A1;DPYSL3;PDGFRB;SEMA3D;NTNG1;IGFBP5;WNT5B;FGF1;TGFBR1;CLIC4;PDPN;MACF1;FER;TPM1;RHOA;FLNA;NEDD9;KIT;AMOTL2;CEMIP;LMNA;ROCK2;NKD1;MMP14;SMO;VCL;APPL2;F3;SORL1;ROCK1;LDB1;PDGFRA;PODN;SEMA3A;PIK3R3;AKT2;SRCIN1;DOCK10;ARSB;ULK4;SPATA13;THBS1;ACVR1;AFDN;CDH1;SGK1;EPHB2;SEMA4D;TTBK2;DDRGK1;RHOB;TBCCD1;ANXA1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.4797336321080501,1.1883290503772481,0.2805755395683453,0.9530200819799245,1.0,6/15,15.15%,ARPC3;ARPC5L;ARPC4;ARPC5;TRIM27;WHAMM
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.41180173727310015,1.1874284777699713,0.21666666666666667,0.9548892257740706,1.0,9/31,16.11%,LRP8;SHANK3;CFL1;TANC2;EFNA1;ZDHHC15;PPFIA2;CAPRIN1;ABI2
prerank,regulation of peptide hormone secretion (GO:0090276),-0.3132039177558438,-1.1872979784502302,0.1676470588235294,0.6192030794942668,1.0,9/67,7.25%,HTR2C;CACNA1C;ITPR1;SNAP25;CACNA1D;KCNC2;PER2;DPP4;ENSA
prerank,sulfate transport (GO:0008272),-0.46480801682005035,-1.1872076097530944,0.24838012958963282,0.6184837983531781,1.0,6/14,26.04%,SLC26A7;SLC13A4;SLC26A2;SLC26A11;SLC25A30;SLC25A11
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.4944675102455337,1.1867030248041481,0.27932960893854747,0.9559750454575461,1.0,3/14,10.05%,NCBP1;CPSF4;CPSF6
prerank,muscle cell development (GO:0055001),-0.37741825022460634,-1.186677709061103,0.1953727506426735,0.618901642656836,1.0,11/30,24.61%,ANK2;IGF1;CXADR;BIN1;MYOF;KDM1A;MEGF10;EFEMP2;VEGFA;SGCZ;MYH11
prerank,negative regulation of fat cell differentiation (GO:0045599),0.4028091710806261,1.1864586032127133,0.2341880341880342,0.9549919659335359,1.0,6/34,8.24%,CCDC85B;TRIB3;BBS12;TRIO;SIRT1;WNT5A
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.28388732095185465,-1.1863775497304545,0.12962962962962962,0.6187166025369771,1.0,33/128,16.37%,DDX5;BMP6;TGFBR3;COL1A2;SMAD3;COL3A1;SMURF2;RGMA;TGFBR1;TGFBR2;BMP5;BMP7;SMAD4;RHOA;BMP4;PRKCZ;PXN;APPL2;ITGB5;SKI;SMAD6;ZFYVE16;ACVR1;HIVEP1;RGMB;UBC;ACVR1B;DUSP22;SMAD5;PTK2;JUN;TGFB1;BMPR1B
prerank,cellular protein metabolic process (GO:0044267),0.2895700131254638,1.1859258754184219,0.09725400457665904,0.955306426795668,1.0,105/396,18.87%,RPL30;DMBT1;MRPS33;RSL24D1;EEF1A1;MRPL24;MRPL23;RPL17;RPL23;PSEN2;RPL31;RPL3;RPS21;MRPL18;DUSP12;CDH2;APOE;SEC11A;RPL35A;WFS1;PDIA6;VWA1;UBE2I;FBXW2;RPS14;YARS2;RPL8;RPL5;ABCF1;CSNK1G3;SPCS3;MRPS12;RPS12;HBS1L;NAPSA;RPS26;SPPL3;OMA1;HARS1;RPL37A;RPL4;MAGEC2;SLC35A1;PIGH;RPLP0;FBXO11;RPS28;UBE2M;MBTPS1;ICMT;RPS24;YES1;RPS9;RPL24;RPS23;RPL34;APP;MRPL52;RPS3;RPS11;PLAT;ADPRH;MRPS15;ST3GAL6;DHPS;ST3GAL1;CHEK2;RPL23A;RPS15A;SPCS2;RPL21;RPL35;PROC;MSRA;QPCT;FBXO22;UBE2G1;GAS6;APH1A;CALU;NTAQ1;HARS2;PRKDC;WARS1;LCMT1;YME1L1;MELTF;CKAP4;PRSS23;RPL19;RPL38;MGAT4A;RPSA;RPL36;SEPHS1;RPL26;RPS8;MIA3;RPL15;RPL10;MSRB3;UBE2D3;RPS2;RPL32;EIF4G1
prerank,endochondral bone morphogenesis (GO:0060350),-0.4953920774565507,-1.1845848813394373,0.24425887265135698,0.6225259745044581,1.0,6/11,20.00%,BMP4;FOXC1;COL13A1;INPPL1;BMPR1B;BMPR2
prerank,positive regulation of defense response to virus by host (GO:0002230),-0.39692276761932693,-1.1844734401574093,0.2169811320754717,0.6218004521913132,1.0,10/24,30.72%,AIM2;TRAF3IP2;PTPN22;MAVS;STAT1;DTX3L;HSP90AA1;ZC3H12A;TOMM70;PARP9
prerank,response to ATP (GO:0033198),-0.43016867720492546,-1.1838803558976358,0.24183006535947713,0.6224048485263947,1.0,8/18,29.68%,RYR3;P2RX4;ABCC9;SSH1;P2RY12;DGKQ;TRPC3;P2RY1
prerank,sphingolipid biosynthetic process (GO:0030148),0.3496567381493389,1.1835571878621025,0.18433179723502305,0.9631795333995843,1.0,17/71,16.39%,CERS1;SMPD4;ACER2;CERS4;PRKD2;KDSR;ELOVL6;SGMS1;ST8SIA1;PLPP1;SGPP2;HACD2;ACER3;SGPP1;SPNS2;CERT1;PPM1L
prerank,retinol metabolic process (GO:0042572),0.4788376887974869,1.183445042332497,0.2577696526508227,0.9616705246719737,1.0,4/14,13.54%,RETSAT;CYP1B1;RDH11;RDH10
prerank,postsynaptic membrane organization (GO:0001941),0.4585020230853549,1.1831628401627001,0.23925233644859814,0.9608489384884422,1.0,4/17,4.37%,GPHN;SHANK3;DNAJA3;APOE
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.501456991872912,-1.1826841388578855,0.2694736842105263,0.6245746927521779,1.0,6/10,25.12%,MAPT;WWP2;NDFIP1;SNX3;PPM1F;DNAJA1
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.30905205531812124,1.1824678934129706,0.13376623376623376,0.9617124059930915,1.0,32/166,13.56%,POLR2J;MAZ;ERCC3;MAPK3;NR4A2;POLR2B;POLR1C;GTF3C1;HDAC9;HDAC7;HDAC3;NR5A1;CCNH;MED23;PPARD;POLR1G;NOTCH1;NRBF2;GTF2H1;RSF1;NRBP1;TAF15;RBPJ;ESR1;THRB;CREBBP;GTF2A2;E2F3;TAF4B;TBP;HDAC5;THRA
prerank,natural killer cell mediated immunity (GO:0002228),0.47628435991839974,1.1822799819640442,0.26497277676951,0.9605016612482741,1.0,2/15,6.50%,TUBB;CEBPG
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4276800359370909,1.1820583906220108,0.25163398692810457,0.9594059230699069,1.0,6/23,13.25%,TIMM29;ROMO1;MAIP1;BAD;BMF;NDUFA13
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.3801619283566896,-1.182042877227183,0.22682926829268293,0.6253099239100195,1.0,3/27,1.38%,ANK2;AHNAK;CACNB4
prerank,negative regulation of cell communication (GO:0010648),-0.40651416884116154,-1.1820118556907764,0.20046082949308755,0.624374451807816,1.0,5/21,17.71%,UBASH3B;GLRA1;ACVR1;OPRM1;SOCS5
prerank,sphingosine metabolic process (GO:0006670),0.4604522357365509,1.181887971787004,0.2733812949640288,0.9580950579645184,1.0,5/17,13.99%,ACER2;PLPP1;SGPP2;ACER3;SGPP1
prerank,protein polyubiquitination (GO:0000209),0.29421296472990044,1.181836494049491,0.12941176470588237,0.9563456451062494,1.0,73/297,16.67%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;ARIH1;TNFAIP3;ANAPC2;KLHL3;SPOP;RFFL;BIRC2;PSMD11;NEDD4L;ANKRD39;NHLRC1;RBBP6;PSMB4;FBXL5;UBE3A;ANAPC13;TRIM14;PSMC1;FBXW2;TRAF5;RNF187;LMO7;UBE2V2;FBXO32;TTC3;AKTIP;TRAF3;FBXO11;RBCK1;ANAPC7;MDM2;PSMC2;UBE3D;FBXO7;PSMD2;RNF6;ZNRF1;UBE2V1;CHFR;ANAPC11;TNKS;IFI27;ANAPC10;ANAPC4;CUL3;PSMD14;UBE2R2;PSMC6;RNF146;RNF216;PSMD1;PSMB1;TRIM27;RNF20;TRIM3;NHLRC3;FBXO22;UBE2G1;RMND5A;RNF114;TAF1;PELI1;KLHL42;RNF125;UBE2H;PSMA4;FBXL20
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.45875448363365745,1.1816272040100992,0.2402135231316726,0.9552447079246951,1.0,3/19,9.25%,PIK3AP1;TIRAP;RAB11FIP2
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.32479070497129625,1.1815835595462008,0.1587516960651289,0.9534619813055206,1.0,32/125,17.75%,DYNC1I1;EML1;KIF18A;NUDC;PLK2;CLASP2;NEK9;DCTN2;MAP4;CDCA8;CENPC;KIF2A;BCCIP;MIS12;DYNLL1;TNKS;NEK6;XPO1;KIF3B;PTPA;EFHC2;RCC1;DYNC1I2;CENPP;CLIP1;CENPO;SETD2;KPNB1;NUP160;CLASP1;RANGAP1;PAFAH1B1
prerank,regulation of response to biotic stimulus (GO:0002831),0.41825723383819946,1.1815079674016715,0.2354948805460751,0.9518194160734144,1.0,4/28,3.90%,LRP8;FCGR2B;TIRAP;BIRC2
prerank,regulation of phosphatase activity (GO:0010921),0.43124702426432915,1.1812656221424003,0.23603603603603604,0.9509296421084673,1.0,5/24,15.13%,PPP1R36;TIPRL;TSC1;PTPA;PPP6R1
prerank,T cell differentiation (GO:0030217),0.3899542111212235,1.1811811959563734,0.20512820512820512,0.9493650413384276,1.0,8/40,11.64%,JAG2;PTPRC;ZFP36L1;GPR89A;GPR89B;SOX13;LFNG;PIK3CD
prerank,regulation of neutrophil migration (GO:1902622),0.511294014156123,1.181020866065876,0.2692307692307692,0.9481131816465905,1.0,2/10,11.14%,RAC2;RHOG
prerank,cAMP metabolic process (GO:0046058),-0.46383177335368164,-1.180898088126494,0.24444444444444444,0.6264813841820278,1.0,8/13,22.36%,ADCY5;ADCY2;ADCY1;ADCY9;ADCY7;ADCY3;ADCY8;ADCY4
prerank,negative regulation of secretion by cell (GO:1903531),0.39491902284072544,1.180895166898349,0.22666666666666666,0.9467400205798902,1.0,7/38,10.11%,PNKD;HMGCR;APOE;TNFRSF1B;GRM7;NOTCH1;RHBDF2
prerank,apical protein localization (GO:0045176),0.5252326073784761,1.1806122892928381,0.2922465208747515,0.9459717932973093,1.0,4/10,9.90%,ACTB;MAL;GOPC;CELSR1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.38028543288472333,-1.1803272139324446,0.2127659574468085,0.6270041820071692,1.0,10/31,18.94%,DLG2;LRRC7;PARD3B;RHOA;EZR;DLG3;DLG1;WDR1;CDC42;MSN
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.4278851383621211,1.1797619952499903,0.2417391304347826,0.9475119265824555,1.0,6/24,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.3778917271307095,-1.1795297332109367,0.22195704057279236,0.6282981674288236,1.0,7/27,5.92%,TMEFF2;PHLDB2;CGNL1;WASF2;ARHGAP28;PPFIA1;ARHGAP6
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4539587290853831,1.179122976494673,0.24714828897338403,0.9483160113031975,1.0,8/18,18.16%,TEK;CYRIB;RIPOR2;KRIT1;RUFY3;CDH5;PTK2B;ARFGEF1
prerank,regulation of cell differentiation (GO:0045595),0.31258925178583624,1.17838491175231,0.1593625498007968,0.9494311339409301,1.0,26/148,11.85%,SPOCK2;PTPRQ;TIAM1;OCIAD1;RPS6KA1;GREM1;CLASP2;LTBP4;BCL6B;ZFP36L1;BIRC2;PPP2CA;HEY1;CDK5RAP1;SINHCAF;SLC6A6;TBX1;BDNF;SMAD7;HEY2;DAG1;TRPS1;CREBBP;PA2G4;PTBP1;NF1
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.33407181152184556,-1.1780899645630911,0.19430051813471502,0.6312928480130141,1.0,17/51,16.40%,FBN1;FSTL1;NBL1;BMPER;SMURF2;SMAD4;VWC2L;CRIM1;SORL1;SKI;HTRA3;SMAD6;SPART;GREM2;SMAD5;BMPR1B;RBPMS2
prerank,inorganic anion transmembrane transport (GO:0098661),-0.3176623067003197,-1.177057700799237,0.18484848484848485,0.6330616314199397,1.0,32/63,27.69%,GABRB1;SLC1A3;GLRB;GABRA2;ANO3;SLC6A1;SLC12A2;SLC26A2;GLRA3;GABRG2;GLRA1;SLC25A3;ANO1;SLC20A1;ANO6;SLC12A6;GABRA5;GABRG3;SLC5A6;SLC12A4;SLC5A5;GABRA4;SLC12A9;GABRG1;SLC4A8;SLC12A7;GABRA1;SLC25A30;SLC25A11;SLC12A8;SLC12A5;LRRC8A
prerank,B cell mediated immunity (GO:0019724),0.5193175934780327,1.1769633571008211,0.2767676767676768,0.9535584254023367,1.0,1/10,2.28%,FCGR2B
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.2908702873553165,1.1762748521575794,0.1261682242990654,0.9545356324795194,1.0,80/314,18.08%,FBXL6;PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;ANAPC2;DERL2;FEM1C;SPOP;UBXN11;RFFL;BIRC2;PSMD11;NEDD4L;YOD1;NHLRC1;PSMB4;FBXL5;WFS1;PSMC1;FAM8A1;SGTB;COP1;FBXO5;SIRT1;CLOCK;RNF187;TRIM25;RBCK1;CRBN;ANAPC7;RAD23A;MDM2;AUP1;PSMC2;UBE3D;PSMD2;ZNRF1;RHBDD2;ERLIN2;UBQLN1;ANAPC11;STT3B;SPOPL;IFI27;ANAPC10;PLAA;ANAPC4;CUL3;PSMD14;DDIT3;PSMC6;RNF216;APPBP2;FAF1;PSMD1;PSMB1;TRIM3;NHLRC3;UBE2G1;RMND5A;DNAJC10;TAF1;PELI1;KLHL42;PSMA4;UFD1;FBXL20;UBQLN2;DNAJB14;UBR3;ATXN3;CDC26;RAD23B;KCTD10;UBXN4;AGAP3
prerank,negative regulation of reproductive process (GO:2000242),-0.4395327630056045,-1.176125634869332,0.23296703296703297,0.6346546432053125,1.0,2/17,0.64%,IGF1;SULF1
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.45286003045270645,1.1756109367483576,0.259581881533101,0.9533608114715204,1.0,3/19,8.61%,POLR2J;POLR2B;ACD
prerank,regulation of DNA recombination at telomere (GO:0072695),0.45286003045270645,1.1756109367483576,0.259581881533101,0.9533608114715204,1.0,3/19,8.61%,POLR2J;POLR2B;ACD
prerank,regulation of protein neddylation (GO:2000434),0.5234611557050304,1.175364376497558,0.2710951526032316,0.9524333744650957,1.0,5/10,16.84%,DCUN1D4;RPL5;EPAS1;DCUN1D1;DCUN1D2
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.41765633084715637,-1.174915955906129,0.25060827250608275,0.6369996675291635,1.0,5/19,13.98%,ABHD5;PRKCD;PPARA;AKT2;ABCD2
prerank,negative regulation of phosphorylation (GO:0042326),-0.2956817119396754,-1.1748322720796938,0.14497041420118342,0.6362451170935401,1.0,17/85,8.74%,NTRK3;PTPN13;HDAC4;SH3GL2;FBLN1;PID1;MAPT;OCLN;BMP7;PLPP3;BMP4;NUPR1;ROCK1;PPARA;XDH;CDKN1B;NIBAN1
prerank,presynapse organization (GO:0099172),-0.5033489285474524,-1.1742600478247458,0.2749003984063745,0.6367970067099266,1.0,6/10,28.27%,LRRTM3;NLGN2;NLGN1;DVL1;NLGN3;FZD1
prerank,regulation of JNK cascade (GO:0046328),0.32617107385261196,1.1742290641029618,0.1955617198335645,0.9551031112955629,1.0,19/101,11.87%,MAP3K11;MECOM;RAP2A;FCGR2B;TIRAP;HIPK2;HDAC3;EDAR;TRAF5;AXIN1;MTURN;MINK1;PHLPP1;TRAF3;PJA2;PLCB1;MFHAS1;APP;MAP4K4
prerank,regulation of sequestering of triglyceride (GO:0010889),0.4771668606426853,1.1735980383481817,0.2673992673992674,0.9558311672324218,1.0,2/15,3.53%,CIDEA;FITM2
prerank,positive regulation of cell communication (GO:0010647),-0.36934993430304874,-1.1735345144212148,0.20722891566265061,0.637830887642066,1.0,9/28,18.59%,ANK3;RIMS1;WLS;DLG4;CLSTN2;ILK;PTPN23;KCTD13;CLSTN3
prerank,cellular response to hydroxyurea (GO:0072711),-0.4978139708437449,-1.173440418317388,0.2776617954070981,0.6370804027558998,1.0,7/10,39.11%,SPIDR;DDI2;RTF2;BLM;DDX11;NSMCE3;TIMELESS
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.24567272158799525,-1.1734095208142161,0.03937007874015748,0.6361602021109793,1.0,62/348,13.52%,MAGI2;ANK2;BMP6;NTRK3;ANK3;RIMS1;SLC24A3;IGF1;ROBO1;GSN;SMAD3;AHI1;FOXD1;ITGB8;NTRK2;ANXA2;FGF1;TGFBR1;MAPK14;PID1;OCLN;MED26;BMP7;PRKAG1;BMP4;MED1;PPARGC1A;ROCK2;OSR1;SMO;F3;EPB41L4B;ADAM19;HOXA5;ROCK1;PIK3R3;MPHOSPH8;FUBP3;EZR;UBR5;AFDN;AGO3;PLSCR1;TLE1;GJA1;EPHB2;GSK3B;CAMK2N1;FN1;CUX2;TP53;CD34;FAM98A;DDRGK1;IFNGR1;RPS7;SNF8;SCYL2;PDCD5;SETDB2;IL33;HINFP
prerank,triglyceride homeostasis (GO:0070328),0.4277107613892597,1.1732465644597772,0.24381625441696114,0.9553870752353577,1.0,5/26,12.07%,FITM2;APOE;SIRT1;PNPLA8;SCARB1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.34245716199354365,1.1732193374533082,0.19849624060150375,0.9536296403188383,1.0,18/85,9.90%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;TIAM1;AP2S1;PSMD11;PFN1;PSMB4;PSMC1;DAAM1;WNT5A;FZD3;PSMC2;PSMD2;CELSR1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.45128720051207327,1.173021678393523,0.26444833625218916,0.9526413143588881,1.0,5/17,10.75%,SOD1;APOE;LPCAT3;MBTPS1;ERLIN2
prerank,positive regulation of GTPase activity (GO:0043547),0.3065136656122162,1.1728495202983278,0.14720812182741116,0.951468452639075,1.0,45/188,15.22%,EZH2;PIN1;TIAM1;ARHGEF26;EVI5L;TBC1D30;BCAR3;TBC1D8;RALGAPA2;RGS8;TBC1D9;TBC1D10B;ARHGAP25;USP6NL;ARHGEF7;TBC1D4;RALGAPB;RAPGEF3;F11R;RGS10;RABGAP1L;RAP1GDS1;CCL25;RAPGEF6;ITGA6;TBC1D12;DOCK9;TSC1;RAB11FIP2;TBC1D25;DOCK7;RHOG;NF1;MAP4K4;PICALM;ADPRH;AGRN;TBC1D14;LARS1;RABGAP1;SYDE1;ARHGEF10;RALGAPA1;DOCK8;RAB3GAP1
prerank,regulation of secretion (GO:0051046),-0.470225795540852,-1.1725159214729508,0.2627118644067797,0.6375946793430792,1.0,9/13,38.75%,SGK1;GPLD1;OAS2;KCNQ1;FGF10;POFUT2;EGF;ERBB3;OPRK1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3428906497715718,1.1721859268131058,0.1882183908045977,0.9523543768692475,1.0,16/80,10.91%,GSK3A;TRIB3;PIN1;HDAC3;DCUN1D4;BIRC2;UBE3A;WFS1;PTTG1IP;SMAD7;BMI1;AXIN1;MAGEC2;SPRTN;MYCBP2;UBQLN1
prerank,protein transport (GO:0015031),0.2906107831718308,1.1720529519723264,0.11813842482100238,0.9510432392587526,1.0,67/332,13.19%,ARF5;MIA2;ZDHHC17;ARL5C;ARL4D;EVI5L;PPT1;RAB5C;PREPL;TBC1D30;TBC1D8;ATP6V1D;SLC10A7;SNX8;APOE;RAB7A;VPS29;RAMP2;TBC1D9;TMED4;SEC23IP;VPS26A;RAB43;RAB11B;ATP6V0D1;COPG2;TBC1D10B;USP6NL;TBC1D4;VMP1;RAB6B;CHMP1A;TMED5;NAPA;RABGAP1L;IFT22;RAB6A;SNX17;TMED10;RAB14;ATP6V0E1;ACD;DNAJC27;TBC1D12;SNX1;ARL5B;ARF1;RAB1A;GOLPH3L;GCC2;CHMP2A;TBC1D25;PPY;ATP6AP1;KIF13A;TMED7;SCFD1;RAB5B;RAB22A;ARCN1;ADPRH;COPG1;TBC1D14;SCAMP1;YWHAH;RABGAP1;KIF3B
prerank,negative regulation of axon extension (GO:0030517),0.41220821712604727,1.1719086951073903,0.24958949096880131,0.9497831459223359,1.0,8/30,9.87%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;DIP2B;SEMA6B;SEMA4C;RNF6
prerank,cellular response to lipid (GO:0071396),-0.2652523004084654,-1.171536776871605,0.08796296296296297,0.6392855270807323,1.0,44/191,17.55%,ATP1A2;ADCY5;EGFR;TFPI;PABPN1;ADCY2;WNT5B;BRINP1;ADCY1;MAPK14;PID1;AXL;VIM;PTK7;RHOA;MED1;ROCK2;IRAK1;LBP;ATP1A1;CDC73;BRINP2;SNW1;TRIM41;EPHA3;NFKB1;NCOA4;SIRPA;WNT9A;ATM;SETX;SPP1;PDE4B;PAF1;UPF1;DEFA6;GPLD1;SELENOS;ABL2;FZD4;NR3C1;RORA;TWF2;ATP1A3
prerank,regulation of vacuole organization (GO:0044088),0.4394417160865738,1.171321970157024,0.259391771019678,0.9503656078314953,1.0,7/20,16.70%,ENO4;PIKFYVE;TBC1D12;ADPRH;TBC1D14;LAPTM4B;UBQLN2
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.3879110410719734,-1.171282613908169,0.2611764705882353,0.6389621048124271,1.0,5/24,5.64%,LEPR;PID1;COQ10B;PPARGC1A;SLC25A13
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.46117641148895916,1.1710719334858384,0.26714801444043323,0.9495693568102969,1.0,2/16,2.28%,GSK3A;PRCP
prerank,glucose transmembrane transport (GO:1904659),0.4521672930441044,1.170872164207406,0.2571428571428571,0.948503886952358,1.0,3/18,8.55%,SORT1;PPARD;SLC2A1
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.3308961942809616,-1.1708562830059843,0.1967654986522911,0.6392400102605027,1.0,7/47,10.21%,SPOCK3;TIMP3;SPOCK1;TIMP2;SORL1;BIN1;VTN
prerank,protein kinase B signaling (GO:0043491),-0.3942873804400754,-1.1707346436804156,0.24407582938388625,0.6385957590100879,1.0,9/23,24.73%,IGF1;SIRT2;PIK3R3;SETX;TGFB1;TSC2;THEM4;PAX2;AKT1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.3465219400465006,-1.170610230226073,0.19387755102040816,0.6378576366856397,1.0,8/40,4.04%,DAB2;COL1A1;SMAD3;TGFBR1;TGFBR2;CTNNB1;PDPN;SMAD4
prerank,plasma membrane repair (GO:0001778),-0.4727451047069825,-1.1702410400585619,0.25675675675675674,0.6378576088960753,1.0,9/13,37.76%,MYOF;AHNAK2;SYT11;SYT7;ANXA6;SYTL4;SMPD1;RAB3A;ARL8B
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.4743739891840818,-1.170212394573955,0.23061224489795917,0.6369441559667673,1.0,8/12,33.21%,GLUD1;ACLY;IDH2;IDH3B;IDH3A;ASS1;SIRT4;IDH3G
prerank,regulation of actin filament-based movement (GO:1903115),-0.49938144977417503,-1.170107898677251,0.2790224032586558,0.6362421113158726,1.0,4/10,14.83%,ANK2;PDPN;SRI;PDE4B
prerank,regulation of urine volume (GO:0035809),-0.5024513287273935,-1.1696724407791395,0.2892057026476578,0.6363981280176186,1.0,7/10,46.15%,NPR3;NPR1;INPP5K;ADCY6;ADM;HYAL2;HAS2
prerank,nuclear pore complex assembly (GO:0051292),-0.5017726850197448,-1.1694012336284754,0.27755905511811024,0.6360849821221334,1.0,5/10,28.12%,NUP205;AHCTF1;NUP93;TMEM170A;NUP153
prerank,rRNA transcription (GO:0009303),0.44985937518245983,1.1689644116466003,0.25996204933586337,0.9543859038621213,1.0,4/17,6.81%,GTF3C1;SPIN1;GTF3C5;POLR1G
prerank,ether lipid biosynthetic process (GO:0008611),0.524913905279973,1.1688422606892774,0.2781065088757396,0.9530072596628413,1.0,5/10,14.26%,LPCAT2;PEDS1;PEX7;AGPS;GNPAT
prerank,positive regulation of protein kinase activity (GO:0045860),0.3149433838295459,1.1685513462198278,0.18641810918774968,0.9523849702424164,1.0,26/148,12.04%,LRP8;RALB;EZH2;PTPRC;MTCP1;TAB2;RPTOR;SRC;STOX1;PPP2CA;CDKN1A;CIB1;PAK3;CALM3;LCP2;AXIN1;MINK1;EFNA1;NAB2;CSF1R;PAK1;DDX3X;MMD;MAP4K4;PRNP;STRADB
prerank,regulation of AMPA receptor activity (GO:2000311),-0.38466121140147885,-1.1684944515212972,0.24242424242424243,0.6376234964628175,1.0,13/25,24.55%,SHISA9;NLGN2;RELN;SHISA6;NLGN1;CACNG7;CACNG4;CACNG2;SHANK1;PRRT1;NLGN3;CACNG3;CACNG8
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.5330002879905971,1.166774138706555,0.28793774319066145,0.9578787553986068,1.0,4/10,11.24%,SHANK3;NETO1;NPTN;APP
prerank,cilium assembly (GO:0060271),-0.24489175852862424,-1.1666831501572403,0.06077348066298342,0.6414529614276681,1.0,83/296,19.77%,GSN;PARVA;AHI1;PKD1;CC2D2A;EXOC3;DYNC1H1;RILPL1;FLNA;PIBF1;IFT81;DZIP1;TTC8;WDR35;NINL;DYNC2I1;SPATA6;DCDC2;RAB8B;TTC21B;CCDC66;NUDCD3;CCDC57;CFAP20;EXOC6;IFT46;TTC39C;CEP57;IFT57;CEP70;AKAP9;IFT52;ACTR3;CSNK1E;CEP89;CEP152;CEP126;CKAP5;IFT172;CEP20;PRKACA;CFAP44;IFT74;RP2;DCX;ARL13B;ABLIM3;TTBK2;DISC1;BBS9;KIF3A;DZIP1L;RAB11A;WDR19;WDR11;INTU;RAB23;CCP110;BBS2;TUBB4A;ARF4;CYS1;DCTN1;EXOC1;EXOC7;CEP250;PTPN23;EHD3;EHD1;DYNLL2;RAB8A;GORAB;BBOF1;IFT20;NDE1;ACTR2;TUBA1A;BBS5;SNAP29;TMEM237;CCDC28B;TTLL3;TMEM80
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.4370345274841753,1.1665343543038869,0.2568306010928962,0.9569989663320263,1.0,4/20,6.22%,PIN1;PPIB;PPIG;PPIL3
prerank,nucleotide-excision repair (GO:0006289),0.3245706772694091,1.1656570195524942,0.20056497175141244,0.958720516696812,1.0,17/101,11.41%,POLR2J;ERCC3;POLR2B;PNKP;CCNH;ERCC4;XRCC1;POLK;EP300;POLE;SIRT1;POLD3;GTF2H1;RAD23A;POLA1;COPS7B;HUS1
prerank,peroxisome organization (GO:0007031),0.42393808967859337,1.1654154629365912,0.23367697594501718,0.9578719452921406,1.0,8/25,17.21%,PEX11G;PLAAT3;PEX1;PEX7;TMEM135;ACOT8;DNM1L;LONP2
prerank,cation transmembrane transport (GO:0098655),-0.3392075402489886,-1.165067205709011,0.1925133689839572,0.6450162749151178,1.0,7/44,7.65%,TRPM3;ATP1A2;SLC7A2;ATP1B1;TRPM6;SLC6A9;SFXN2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.39070170996897274,-1.1649892891220066,0.2528473804100228,0.644211956648627,1.0,4/24,6.96%,HTR2C;ITPR1;RYR3;ERO1A
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.46690994099246685,1.164718328246762,0.28804347826086957,0.9589780450244777,1.0,5/15,14.71%,PTTG1IP;SIRT1;MDM2;ING2;CD44
prerank,negative regulation of nuclear division (GO:0051784),-0.48587883360759293,-1.1645109787028132,0.2923387096774194,0.6445867600984669,1.0,3/11,4.63%,TOM1L2;BMP7;BMP4
prerank,response to chemokine (GO:1990868),0.4870549152478324,1.163859147606177,0.27808471454880296,0.9606842874442421,1.0,4/13,5.70%,OXSR1;CXCL12;LRCH1;RIPOR2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3437894944073222,1.163731933982669,0.20658682634730538,0.9594025151311636,1.0,10/72,8.70%,POLR2J;ERCC3;POLR2B;CCNH;ERCC4;XRCC1;POLK;EP300;POLD3;GTF2H1
prerank,response to insulin (GO:0032868),0.34032374454036735,1.1635965424664592,0.21216617210682492,0.9580963551412306,1.0,17/80,13.02%,PCK1;GSK3A;TRIB3;INSIG1;SORT1;HDAC9;ZFP36L1;MYO5A;TBC1D4;SIRT1;IRS2;EPM2AIP1;TSC1;RHOQ;ZBED3;PRKCI;HDAC5
prerank,natural killer cell activation (GO:0030101),-0.3855094336180882,-1.1635921993716967,0.2458233890214797,0.6461265065008216,1.0,8/23,22.00%,PBX1;TOX;AXL;KAT7;ELF4;RABL3;PRDX1;BAG6
prerank,positive regulation of histone modification (GO:0031058),0.40235823388400843,1.163580248657242,0.26163723916532905,0.9563384333510344,1.0,8/33,11.17%,MAPK3;RUVBL2;RPS6KA4;RPS6KA5;CHTOP;AKAP8L;ING2;CTBP1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.37860589362202623,-1.162664440398975,0.22325581395348837,0.6477957239135488,1.0,8/26,11.73%,FOXP1;DAB2;KANK2;HDAC1;CRY2;CNOT9;CRY1;PER1
prerank,positive regulation of response to stimulus (GO:0048584),0.38561815714136766,1.162617630453533,0.25241157556270094,0.9583675187063079,1.0,7/40,9.32%,FCGR2B;B2M;FXR1;SIRT1;YPEL3;WNT5A;BCLAF1
prerank,negative regulation of metabolic process (GO:0009892),-0.32104001363579926,-1.1626004107245416,0.2084507042253521,0.6469729349687443,1.0,21/54,24.31%,NRDC;ALDH1A1;LGR4;PLCL2;IP6K1;NPR3;ADAMTS5;ARRDC3;FIS1;ACOT11;FOXC2;STK11;RHEB;PLCL1;NOVA1;ZNF423;TFE3;ATF4;FLCN;CCDC3;NR1H2
prerank,response to interferon-alpha (GO:0035455),0.4654290305285199,1.1622154119932984,0.2557726465364121,0.9582577400473185,1.0,6/16,9.90%,IFITM2;RO60;IFITM3;ADAR;IFITM1;IFNAR1
prerank,positive regulation of histone acetylation (GO:0035066),0.4331803603189425,1.1620914651957257,0.26161790017211706,0.9569516019934426,1.0,4/23,3.90%,MAPK3;RUVBL2;RPS6KA4;RPS6KA5
prerank,positive regulation of dendrite development (GO:1900006),0.5096351193692836,1.1620895269505793,0.3013182674199623,0.9551681238378474,1.0,1/10,0.03%,LRP8
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4684338079915089,-1.1620520574800497,0.28227571115973743,0.6474854271310214,1.0,3/12,7.01%,SORBS1;IGF1;AKT2
prerank,exit from mitosis (GO:0010458),0.4930672935389253,1.1618566681476326,0.25769230769230766,0.9542587544771429,1.0,3/12,10.29%,PPP2R2D;CLASP2;CHMP2A
prerank,neurotransmitter transport (GO:0006836),-0.30341570019955366,-1.161772372777895,0.18429003021148035,0.6472537856881787,1.0,19/73,14.15%,ATP1A2;RIMS1;SNAP25;NRXN1;SLC1A3;SYN2;GABRA2;PTPRN2;PPFIA1;GLUL;SYN1;BRSK1;NRXN2;APBA1;UNC13B;SNPH;SLC6A15;VAMP2;STXBP1
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.40287763267503884,-1.1613409021671355,0.2716627634660422,0.6474541977327531,1.0,11/21,30.26%,TOX;CTNNB1;SMARCD3;DISC1;KDM1A;NES;CX3CL1;VEGFA;CX3CR1;MDK;DRD2
prerank,cellular response to nitrogen compound (GO:1901699),-0.40603578718506683,-1.1605911478336122,0.2620689655172414,0.648447914024123,1.0,7/20,19.95%,SPIDR;ROCK2;HSF1;DDI2;RTF2;RIOK3;BLM
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.24380020942456423,-1.160548908007741,0.05128205128205128,0.6475975886080613,1.0,74/390,11.37%,ERBB4;SORBS1;NTRK3;FGFR2;IGF1;SULF1;HNRNPH1;TIA1;EGFR;EPHA6;COL1A1;GRIN2B;AHI1;EFNA5;CYFIP2;PDGFRB;COL4A6;AP2B1;EPHB1;NTRK2;DOCK1;WASF2;SDC2;FGF1;NRP1;FLRT2;WASL;MAPK14;AXL;RYK;EFNB2;ABI1;FER;SULF2;RHOA;MTSS1;AP2A2;VAV2;NEDD9;EPHA7;SIRT2;KIT;ATP6V1E1;PXN;ROR1;GHR;ROCK2;ARPC1A;ATP6V0B;DDR1;SLC39A14;ROCK1;PDGFRA;FRK;PIK3R3;IL31RA;AKT2;UBASH3B;EPHB4;CEP57;AP2A1;FOXC1;ACTR3;NRP2;ARPC1B;SOCS2;EPHA3;KL;EPHB2;GSK3B;HNRNPA1;TCIRG1;ATP6V0A4;FOXC2
prerank,negative regulation of RNA splicing (GO:0033119),0.4391009905492944,1.1604369895148545,0.2733446519524618,0.9582064009510268,1.0,7/19,16.25%,SFSWAP;SRSF10;RPS26;SRSF4;PTBP1;SRSF7;U2AF2
prerank,regulation of neuroblast proliferation (GO:1902692),-0.4392139425802184,-1.1597346148415086,0.2753303964757709,0.6488932803597788,1.0,9/15,30.26%,TAFA1;CTNNB1;SMARCD3;DISC1;KDM1A;CX3CL1;VEGFA;CX3CR1;DRD2
prerank,actin filament bundle assembly (GO:0051017),-0.3605923383119657,-1.159549717998377,0.2607594936708861,0.6484701420582374,1.0,13/33,26.57%,CALD1;PAWR;DPYSL3;LIMA1;NEDD9;EZR;BAIAP2L1;MYO1B;ADD2;PLS1;DMTN;FAM107A;MICAL1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.484322734480583,1.1595486328599602,0.31001890359168244,0.9564624758448513,1.0,4/12,12.85%,ANAPC7;ANAPC11;ANAPC4;CUL3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.484322734480583,1.1595486328599602,0.31001890359168244,0.9564624758448513,1.0,4/12,12.85%,ANAPC7;ANAPC11;ANAPC4;CUL3
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.484322734480583,1.1595486328599602,0.31001890359168244,0.9564624758448513,1.0,4/12,12.85%,ANAPC7;ANAPC11;ANAPC4;CUL3
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.4932909907556626,1.1594959867623422,0.2922794117647059,0.9549188166194198,1.0,4/13,10.85%,INSIG1;TMEM30B;GCC2;CD81
prerank,regulation of cardiac muscle contraction (GO:0055117),0.39355474609204383,1.1594282484654632,0.24493243243243243,0.9534431065464789,1.0,6/34,7.27%,RGS2;PIK3CG;PDE4D;ATP2A2;CALM3;SMAD7
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.4468445877003805,-1.159401528782666,0.2885032537960954,0.6479245079746389,1.0,3/14,4.20%,LRP1;IGFBP5;TPM1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.3919445242938666,-1.1588885497069084,0.25790754257907544,0.6483967316671244,1.0,4/22,7.04%,ANK2;AKAP6;ATP1B1;HTT
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.3295195653250534,-1.1583193255369322,0.19633507853403143,0.6489755063051039,1.0,20/48,22.36%,ADCY5;AMPD3;ADCY2;ADCY1;ADCY9;DCAKD;SLC26A2;SLC35B3;PANK3;GMPS;ADCY7;GUCY1A1;PAPSS2;NPR1;ACOT7;AK5;ADCY3;ADCY8;GUCY1B1;ADCY4
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.3211287470081577,-1.157727652174129,0.20435967302452315,0.6496637717801043,1.0,13/52,13.02%,SORBS1;LRP1;EGFR;ZDHHC5;STX3;EPB41L2;EFCAB7;DPP10;EPHA3;EPHB2;CLIP3;DLG1;WNK3
prerank,protein localization to cell-cell junction (GO:0150105),0.4752662723693259,1.157686527168524,0.2867513611615245,0.9586848310378411,1.0,6/15,13.59%,ACTB;F11R;ARHGEF18;TJP1;CDH5;LSR
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4383880592021519,1.1576723281219805,0.26062846580406657,0.9569646362011266,1.0,5/19,11.11%,AEN;HIPK2;EP300;SIRT1;CDIP1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3267495779873546,-1.1572737244926623,0.2144702842377261,0.6499552295935804,1.0,15/46,16.95%,NRDC;ALDH1A1;LGR4;PLCL2;IP6K1;NPR3;ADAMTS5;ARRDC3;ACOT11;FOXC2;STK11;RHEB;PLCL1;NOVA1;ZNF423
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3813481729041952,-1.157168852597754,0.2517482517482518,0.6492937383976995,1.0,4/26,6.96%,HTR2C;ITPR1;RYR3;ERO1A
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),-0.2816197488375705,-1.1571210985093119,0.12863070539419086,0.6484297980601049,1.0,34/122,19.24%,SORBS1;IGF1;PLD1;SAMD4A;EGFR;PDGFRB;GLI2;KAT7;VIM;LDB1;SLC6A9;AKT2;POLDIP3;EIF3C;YTHDF1;NIBAN1;SMOC2;THBS1;PRR16;STN1;EEF2;NFKB1;RBM3;BRPF3;IL33;IGF2;ATAD5;PLXNB2;METTL5;NAT10;PCIF1;UPF3A;CIRBP;RPS6KB1
prerank,artery morphogenesis (GO:0048844),-0.36371059703801767,-1.1568196868283105,0.24154589371980675,0.6483084292751967,1.0,6/30,5.60%,LRP1;PDGFRB;NRP1;TGFBR1;BMP4;ADAMTS9
prerank,negative regulation of B cell activation (GO:0050869),0.4409599664537167,1.156114266813991,0.2743055555555556,0.9614446025558631,1.0,4/21,9.34%,TNFAIP3;FCGR2B;SAMSN1;LYN
prerank,intestinal absorption (GO:0050892),0.48491950533732375,1.1559867742234442,0.28256880733944956,0.9602215229004022,1.0,2/13,7.31%,UGCG;F11R
prerank,peptide metabolic process (GO:0006518),0.3368590528932018,1.1556110484962678,0.21973094170403587,0.9599728418663556,1.0,10/75,9.06%,PCSK1;LVRN;SOD1;PSEN2;MME;SEC11A;SPCS3;SPPL3;TPP1;CARNMT1
prerank,cellular response to radiation (GO:0071478),0.37718292579207335,1.155593879046436,0.25117004680187205,0.9582845151786261,1.0,8/40,11.41%,GPR52;EEF1D;RAD1;CDKN1A;SIRT1;CLOCK;KDM4D;HUS1
prerank,response to cytokine (GO:0034097),-0.26579719431735305,-1.1554492952687683,0.14566929133858267,0.6511921531681288,1.0,30/141,14.02%,AFF3;NFAT5;PTPN13;ALDH1A2;TIMP3;AKAP6;SMAD3;DPYSL3;TIMP2;HDAC4;COL3A1;PTPN14;OSMR;PID1;IFNAR2;RHOA;IL6R;PML;IRAK1;KLHL20;IRAK3;EIF2AK2;PLSCR1;REL;IKBKE;IL1RAPL1;ANXA1;RELB;GGT5;IL6ST
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.30230969109464256,-1.1550201105044124,0.19578313253012047,0.6513994292382004,1.0,19/76,16.94%,UACA;NFAT5;SASH1;EGFR;CYLD;RASSF2;BMP7;RHOA;PPM1B;IRAK1;EZR;EIF2AK2;ILK;NR3C2;PPM1A;DLG1;PTPN22;CCN3;RTKN2
prerank,positive regulation of hydrolase activity (GO:0051345),0.31206295277290097,1.154947455890278,0.20592193808882908,0.9590846882140275,1.0,27/137,13.25%,EZH2;PIN1;EVI5L;TBC1D30;BCAR3;RGS8;MAPK8;USP6NL;ARHGEF7;CALM3;RAPGEF3;F11R;RGS10;RAP1GDS1;CCL25;RAPGEF6;ITGA6;DOCK9;RAB11FIP2;RPS3;NF1;MAP4K4;PICALM;AGRN;LARS1;MAPK12;NDUFA13
prerank,phosphatidylinositol-mediated signaling (GO:0048015),-0.3012078278443388,-1.1548447696628508,0.19230769230769232,0.6508575725143267,1.0,20/69,16.54%,IGF1;OGT;PDGFRB;PLCL2;PLCE1;RHOA;PIK3C2B;SIRT2;PIK3C3;MYO16;PDGFRA;PLCD3;EZR;PLCB3;GAB2;PLCH1;NGF;EXOC1;PLCL1;PLCD1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.3239124774777144,-1.154787664948952,0.21529745042492918,0.6500298732921496,1.0,22/51,24.63%,LPAR1;ARHGEF10L;CCN2;NRP1;TGFBR1;TPM1;RHOA;PXN;ROCK2;PPM1E;SYNPO2;FHOD1;NF2;ARHGEF5;CDC42;CX3CL1;PPM1F;ARHGEF15;PFN2;RHOC;ITGB1BP1;TGFB3
prerank,histone acetylation (GO:0016573),0.352076811724996,1.1547722896897326,0.2220496894409938,0.9580936179378161,1.0,16/69,14.20%,JADE3;ACTL6A;LEF1;MAP3K7;RUVBL2;DMAP1;ING4;BEND3;EP300;RUVBL1;ING3;YEATS4;CREBBP;TRRAP;ING5;DR1
prerank,negative regulation of bone remodeling (GO:0046851),0.5048680895363831,1.1544523606042818,0.24767225325884543,0.9575908886157418,1.0,3/11,10.82%,TNFAIP3;GREM1;P2RX7
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.46178178296113725,1.1543799364835445,0.2695984703632887,0.9561173349740733,1.0,5/17,10.91%,SOD1;SFPQ;SIRT1;SOD2;UBQLN1
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3576997989580369,1.1539655314886925,0.22870662460567823,0.9560238666660534,1.0,14/56,13.44%,RPTOR;STOX1;PHB2;RGCC;FBXO5;CDK4;ANAPC7;RAD51B;PLCB1;DDX3X;ANAPC11;ANAPC4;CUL3;ANKRD17
prerank,negative regulation of viral life cycle (GO:1903901),0.47488077855071065,1.1538170977842999,0.29277566539923955,0.954890857384364,1.0,4/15,8.84%,LY6E;IFITM2;IFITM3;IFITM1
prerank,peptidyl-serine modification (GO:0018209),0.3052053788760651,1.1538146119694053,0.19261213720316622,0.9531756076333273,1.0,37/166,15.76%,PCK1;PRKX;STK32A;PLK2;RPS6KA1;RPS6KA4;CAMK1D;PRKCH;HIPK2;PRKD2;RPS6KA5;PKN3;SMG1;HPF1;MAPK8;CSNK1G3;SBK1;DCLK3;LATS2;PKN1;SRPK2;TNKS;MAST4;PRKCI;IKBKB;NEK6;MAPK12;CHUK;TLK2;CSNK2A2;NTMT1;MAP3K10;GAS6;DYRK2;ATR;TOP1;TAF1
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),-0.4906408461814039,-1.1537654827106398,0.2754237288135593,0.6518993611014808,1.0,1/11,4.82%,MALT1
prerank,response to peptide hormone (GO:0043434),0.3729500048672461,1.1533618635607323,0.22961730449251247,0.9531994373113833,1.0,10/43,11.37%,PCK1;SRC;SORT1;ZFP36L1;SIRT1;EPM2AIP1;EIF2B3;TSC1;ZBED3;GNAI1
prerank,protein oxidation (GO:0018158),-0.4935938941617669,-1.15310338864186,0.29713114754098363,0.6527163357790247,1.0,5/11,25.56%,LOXL1;SUMF1;LOXL3;LOX;PRDX3
prerank,glutathione derivative metabolic process (GO:1901685),-0.40051698278343295,-1.152962285959551,0.28,0.6511929948810815,1.0,12/20,40.20%,GSTT1;GSTZ1;ESD;GSTA4;GSTM1;HPGDS;MGST1;GSTA3;GSTM2;MGST3;GSTM5;GSTO1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.40051698278343295,-1.152962285959551,0.28,0.6511929948810815,1.0,12/20,40.20%,GSTT1;GSTZ1;ESD;GSTA4;GSTM1;HPGDS;MGST1;GSTA3;GSTM2;MGST3;GSTM5;GSTO1
prerank,sensory perception (GO:0007600),-0.3378850924114001,-1.152853434586694,0.225130890052356,0.6505572339711313,1.0,14/45,26.53%,PCDH15;ADGRV1;P2RX4;TTC8;GNAL;WHRN;OPRM1;PTGES;KCNA2;TMEM150C;ADORA2A;TRPV2;NIPSNAP1;CHRNA7
prerank,regulation of defense response to virus (GO:0050688),0.4657226316982618,1.1527742649102266,0.2841121495327103,0.9539137778775378,1.0,6/14,17.07%,TNFAIP3;IFNLR1;TRAF3;TRAF3IP1;RNF216;ZMPSTE24
prerank,monosaccharide transmembrane transport (GO:0015749),-0.42663615785187414,-1.1524260282207417,0.26548672566371684,0.6507780796939524,1.0,7/16,36.69%,SLC2A12;SLC2A10;SLC5A3;SLC50A1;SLC45A3;SLC2A8;SLC2A9
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.44410066128450265,-1.1520541772458408,0.2857142857142857,0.650794111215733,1.0,8/14,27.71%,LPIN1;CHKA;SLC27A1;ETNK2;PCYT2;LPIN2;CHKB;LPIN3
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3410408511826681,1.151801355788111,0.23684210526315788,0.9560875688706438,1.0,14/70,10.48%,MAPK3;ARPC3;VAV3;FCGR2B;ACTB;SRC;ARPC4;FYN;SYK;PLCG1;LYN;PAK1;WIPF3;YES1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.4368280688264504,-1.151551021703345,0.26636568848758463,0.6511442932385103,1.0,6/17,9.26%,IGF1;NTRK2;RTN1;SORL1;ROCK1;BIN1
prerank,regulation of interleukin-8 production (GO:0032677),0.3480517766528156,1.1506449232187053,0.25656877897990726,0.9590068959356378,1.0,11/69,13.25%,PTPRC;TIRAP;MAP2K5;PRKD2;SYK;RELA;RAB1A;PARK7;NOD1;MAPKBP1;DDIT3
prerank,blood vessel endothelial cell migration (GO:0043534),-0.39280280983162974,-1.1494339992641673,0.2526997840172786,0.6558983577235049,1.0,10/22,25.54%,ROBO1;NRP1;EFNB2;PIK3R3;EPHB4;GPLD1;VEGFA;EMP2;AKT1;NR4A1
prerank,positive regulation of telomere maintenance (GO:0032206),0.39653400673912764,1.149111661668404,0.27348993288590606,0.9634295082868192,1.0,7/31,12.66%,MAP2K7;MAPK3;PNKP;MAP3K4;NEK7;TNKS;NBN
prerank,mitochondrial translational termination (GO:0070126),0.32948929417371187,1.1488457199990985,0.22849083215796898,0.9628076183285696,1.0,13/88,12.31%,MRPS22;MRPS2;MRPS33;MRPL24;MRPL23;MRPL18;MRPL38;MRPS12;MRPL20;MRPL52;MRPL48;MRPS15;MRPS24
prerank,ERBB2 signaling pathway (GO:0038128),0.3919901812476189,1.148690133230495,0.2753623188405797,0.9617289591374489,1.0,6/31,8.66%,PTPRR;PTPN18;SRC;CDC37;PTPN12;ERBIN
prerank,regulation of double-strand break repair (GO:2000779),-0.3384977639224073,-1.148498219861454,0.24266666666666667,0.6575428736449261,1.0,11/39,17.98%,SPIRE1;SPIDR;FMN2;DEK;PML;UBR5;MGMT;RNF169;KDM1A;SIRT7;ACTR2
prerank,regulation of type I interferon production (GO:0032479),0.3307947188942542,1.1462082807761773,0.24599708879184862,0.9700863386410651,1.0,19/84,13.62%,LRRFIP1;TNFAIP3;PIN1;POLR1C;TIRAP;EP300;TRIM25;TRAF3;RELA;POLA1;TRAF3IP1;CREBBP;POLR3F;DTX4;OTUD5;NLRP4;NLRC5;RNF216;POLR3B
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.47128345829079243,1.1461401896053685,0.300556586270872,0.9686107021677484,1.0,4/14,11.45%,PRKD2;RELA;CD81;RPS3
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.33810925483395043,1.146073391431509,0.2515527950310559,0.967172572370871,1.0,14/71,10.48%,MAPK3;ARPC3;VAV3;FCGR2B;ACTB;SRC;ARPC4;FYN;SYK;PLCG1;LYN;PAK1;WIPF3;YES1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3448776476338838,1.1458517167921685,0.2583081570996979,0.9663160551750586,1.0,8/62,9.23%,POLR2J;ERCC3;NCBP1;ELOC;POLR2B;CCNH;GTF2H1;PCID2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.47215491621343564,-1.1456208848402794,0.2929936305732484,0.6645394412872486,1.0,6/12,35.24%,WNK1;PPARA;AKT1;MDK;ASS1;SKAP1
prerank,oligosaccharide metabolic process (GO:0009311),-0.32241304906205154,-1.1453730446936219,0.23480662983425415,0.6642527752921477,1.0,13/46,18.50%,AMY1B;AMY1C;AMY1A;B4GALT1;FUT8;ST6GALNAC5;B3GALT5;ST3GAL4;ST6GAL2;B3GALT1;ST6GALNAC6;MPDU1;ST8SIA2
prerank,integrin-mediated signaling pathway (GO:0007229),-0.29686684069963243,-1.145267087509535,0.20923076923076922,0.6635904110619136,1.0,16/73,11.33%,ITGBL1;DAB2;ITGB8;DOCK1;COL3A1;FBLN1;NRP1;NEDD9;PLPP3;TEC;ITGB5;ITGA5;ADAMTS1;FN1;ITGA11;ILK
prerank,neuron migration (GO:0001764),-0.3213822960449708,-1.1452174195084914,0.23076923076923078,0.6627908517517358,1.0,11/48,6.86%,MAP1B;SPOCK1;NRCAM;NTRK2;AUTS2;NRP1;DNER;GPM6A;RELN;DCDC2;SEMA3A
prerank,defense response to bacterium (GO:0042742),0.3218897277007906,1.1447972393592363,0.2288135593220339,0.9687547726507325,1.0,12/105,11.12%,ROMO1;RPL30;DMBT1;TIRAP;RNASE6;STAB1;GBP4;SELP;SYK;PPP1R11;RAB1A;NOD1
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4300662294372056,1.1438223146357287,0.2701688555347092,0.970743585548809,1.0,5/21,4.60%,NDST3;XYLT1;SGSH;EXT2;HS6ST1
prerank,negative regulation of cell migration (GO:0030336),-0.2671743705442146,-1.1436615882863386,0.13454545454545455,0.6660390985070678,1.0,14/137,4.20%,MAGI2;NAV3;LDLRAD4;TMEFF2;PHLDB2;SULF1;LRP1;ROBO1;DPYSL3;COL3A1;IGFBP5;MCC;CLIC4;TPM1
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.4006108188221938,-1.1435508635799738,0.2488479262672811,0.665332436384135,1.0,6/20,17.22%,IRAK1;LBP;IL18;PTPN22;TGFB1;MTDH
prerank,protein dephosphorylation (GO:0006470),0.3082012357010721,1.1435052089777966,0.22795115332428764,0.9703370239781105,1.0,19/135,6.87%,PHPT1;PTPRR;PTPN18;PTPRG;DUSP7;PTPRJ;PTPRC;CTDSP1;PPP3CB;PTPRM;PPP2R2D;PTPRB;DUSP12;PTPRE;PPP2CA;PTPN12;SSH2;PTPRT;PPP2CB
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.3731217353370515,-1.143353250718307,0.26976744186046514,0.6649428092718901,1.0,15/26,38.65%,B4GALT1;OGN;B4GALT6;SLC35D2;ST3GAL4;PRELP;B4GALT4;LUM;CHST2;OMD;B4GALT3;B4GALT2;B4GALT5;FMOD;CHST1
prerank,negative regulation of immune system process (GO:0002683),0.45595596398277294,1.1432781168153106,0.325,0.9695305373198041,1.0,3/16,9.47%,FCGR2B;LYN;HOXA7
prerank,"DNA-templated transcription, termination (GO:0006353)",0.3384772528903168,1.143261944840028,0.24592592592592594,0.9678920622473118,1.0,17/68,18.82%,MAZ;ERCC3;NCBP1;POLR1C;CCNH;CPSF4;POLR1G;GTF2H1;PAPOLA;TBP;SCAF8;SLBP;WDR33;TAF1D;POLR3K;CLP1;SNRPD3
prerank,response to exogenous dsRNA (GO:0043330),0.448434089605298,1.1432307585351478,0.2819047619047619,0.9663135124838647,1.0,3/18,4.13%,RALB;IFIT1;SLC3A2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.31824389496915234,1.1430447914897075,0.2100954979536153,0.9653656090816066,1.0,23/113,14.33%,LCP1;ERCC3;PSMC4;TAL1;SLF1;TIRAP;SRC;ERCC4;ICE1;SYK;GTF2H1;RASIP1;PSMC2;PARK7;ESR1;DDX3X;RPS3;BMF;CDH5;PLEK;PSMC6;FAF1;ASAP1
prerank,glycogen metabolic process (GO:0005977),-0.3695463944284052,-1.1424381733912674,0.2608695652173913,0.6665698772219489,1.0,12/27,19.45%,PRKAG2;PYGB;AGL;PER2;PGM1;PHKA2;GSK3B;GYS1;PYGM;PGM2;GAA;PHKG2
prerank,iron ion homeostasis (GO:0055072),0.35530570816242746,1.141979467221122,0.24423963133640553,0.9678571240009518,1.0,12/58,11.99%,CAND1;HMOX2;SOD1;ABCG2;FBXL5;ATP6V0D1;B2M;ISCU;GLRX3;ATP6AP1;PICALM;ACO1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.40003804728333126,-1.1410742532136084,0.2648401826484018,0.6694698520996759,1.0,4/22,5.49%,MBP;WNK1;BMP7;FLOT2
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.3460522309227868,1.1405943292839618,0.2652439024390244,0.9716333656121268,1.0,12/62,11.00%,TXNDC12;CXCL12;BCL2L2;SRC;PTTG1IP;SIRT1;SOD2;MDM2;PARK7;CCAR2;DDX3X;HYOU1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.34045051154222533,1.140566370739733,0.2548148148148148,0.9700687921404141,1.0,8/64,9.23%,POLR2J;ERCC3;NCBP1;ELOC;POLR2B;CCNH;GTF2H1;PCID2
prerank,response to estrogen (GO:0043627),0.3888905656073206,1.1405626690786754,0.2986798679867987,0.9683911933641117,1.0,6/31,10.70%,ARID5A;EP300;TRIM25;WBP2;CITED2;ESR1
prerank,regulation of gluconeogenesis (GO:0006111),-0.3695036059525221,-1.140546878778539,0.23349056603773585,0.6700068960987785,1.0,14/27,23.57%,OGT;DDB1;PPARGC1A;SIK1;ARPP19;CRY1;SIRT7;USP7;SELENOS;PTPN2;ZNF692;DGKQ;CLK2;C1QTNF3
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.3985203276197644,1.1403541005168703,0.28209459459459457,0.9676103238393844,1.0,9/27,17.43%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC1A2;SLC25A12;SLC38A5;SLC25A38;SLC7A5
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.34584279245676347,-1.1401965503173586,0.24742268041237114,0.6700128103672159,1.0,14/37,24.63%,IGF1;IGFBP5;TPM1;TAFA5;CDKN1B;ADAMTS1;GJA1;JUN;DNMT1;BMPR1A;MMP2;EFEMP2;MEF2D;TGFB3
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3391124695385148,1.1399195805429678,0.24663677130044842,0.9676223535951676,1.0,11/75,9.80%,PRKAR1A;RGS2;DUSP7;PTPRJ;APOE;CDK5RAP1;SIRT1;LATS2;RASIP1;LYN;TFAP4
prerank,regulation of protein localization to cell surface (GO:2000008),0.3841201312940103,1.1397399596617912,0.2676767676767677,0.9666616664430524,1.0,8/33,8.25%,NEDD4L;RAB11B;GOPC;LEPROTL1;RIC3;BDNF;RAB11FIP5;TMEM35A
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.44097593819609976,-1.1395341193099315,0.2777777777777778,0.6709355299233363,1.0,3/13,7.01%,SORBS1;IGF1;AKT2
prerank,anterograde axonal transport (GO:0008089),-0.33989260190555265,-1.1394177792895426,0.25440806045340053,0.6702976026994153,1.0,12/37,15.98%,DLG2;AP3B1;KIF5C;KIF1C;AP3S2;TRAK1;RAB27B;KIF3A;KIF1A;MAP1A;NEFL;KIF5A
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5118239615475951,1.1394034769696537,0.3182711198428291,0.9663254837726287,1.0,2/10,8.24%,OXSR1;WNT5A
prerank,negative regulation of cytokine production (GO:0001818),0.3015696187901518,1.1385963983714573,0.20314547837483618,0.9678304481475489,1.0,28/163,13.91%,CIDEA;TNFAIP3;PTPRC;PIN1;LEF1;FCGR2B;RPS6KA4;MAP2K5;HDAC9;HDAC7;RPS6KA5;NPTN;RGCC;PPP1R11;NLRC3;CUEDC2;TRIM25;CD84;VSIR;TRAF3IP1;PRNP;OTUD5;MAPKBP1;CD274;NLRC5;DDIT3;RNF216;TRIM27
prerank,cytoskeleton organization (GO:0007010),-0.26995685053202567,-1.1384705584202168,0.14388489208633093,0.672046544834011,1.0,56/114,29.43%,EPB41L3;MICAL2;PCLO;PDZD8;ARHGAP10;CDC42BPB;PLCE1;TPM1;RHOA;NEDD9;SYNE3;MICAL3;ZMYM6;PALLD;KLHL20;BIN1;RND3;FGD1;RHOBTB2;RANBP10;CNN2;SPRYD3;PAK5;LIMD1;RHOB;RHOBTB1;OBSL1;SIPA1;RANBP9;FGD4;PPP2R3C;STRIP2;BRWD1;DIAPH1;ARAP3;DIAPH3;CAPZB;FMNL2;PACSIN1;ZMYM3;SIPA1L3;CCL13;NECTIN2;RHOC;RHOU;MAST3;CNTNAP1;DMTN;FGD3;MICAL1;RHOH;CSPG5;BRWD3;AJUBA;MDK;PACSIN3
prerank,positive regulation of growth (GO:0045927),0.3489918103612075,1.138355177905766,0.2540861812778603,0.967016619261694,1.0,12/64,10.75%,NCBP1;DERL2;RPS6KA1;RPTOR;WFS1;CIB1;USP47;EXOSC9;LGI1;PLCB1;EIF4G2;DDX3X
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.32255038680776754,-1.138240305877305,0.23529411764705882,0.6717202069160382,1.0,7/46,5.19%,ATP1A2;DGKI;NRXN1;GRM5;TSHZ3;NLGN2;RELN
prerank,organic acid transport (GO:0015849),-0.28472224585960637,-1.1380666852853538,0.22259136212624583,0.6712662126263153,1.0,23/94,17.24%,SLC7A11;ACSL1;SLC6A13;SLC13A3;SLC7A2;LRRC8D;PDPN;SLC26A7;SLC7A14;SLC1A5;SLC6A12;SLC25A32;RXRA;SLC27A1;NCOA1;SLC6A15;SLC22A6;STARD5;SLC25A47;SLC19A1;ATP8B1;SLC16A10;SLC5A6
prerank,positive regulation of intracellular protein transport (GO:0090316),0.3074580542961341,1.1379497620230046,0.21296296296296297,0.9670420503064022,1.0,19/144,7.65%,RAC2;GSK3A;PRR5L;RBM22;TRIM28;SAE1;DMAP1;TCAF1;HDAC3;VPS11;FYN;ZFAND1;CIB1;MAPK8;ICE1;YWHAB;RAPGEF3;TMEM30B;RUFY3
prerank,nuclear membrane disassembly (GO:0051081),0.46720181356122376,1.1379036783080658,0.2949907235621521,0.9655951889920563,1.0,4/14,12.77%,NEK9;CNEP1R1;AKAP8L;NEK6
prerank,regulation of neuroinflammatory response (GO:0150077),-0.3978929797810419,-1.137028228406378,0.29698375870069604,0.6733394522056114,1.0,5/19,19.92%,IGF1;NUPR1;IL18;IL33;PTGS2
prerank,sodium ion homeostasis (GO:0055078),-0.3903418688967463,-1.1370229630904183,0.2757847533632287,0.6723861442706396,1.0,6/21,9.45%,ATP1A2;ATP1B1;ATP1B3;SLC12A2;ATP1A1;ATP1B2
prerank,regulation of cell-cell adhesion (GO:0022407),0.37242451713819474,1.1364441085499852,0.2947019867549669,0.9696323276553055,1.0,9/39,10.44%,PTPRR;PTPRG;SRC;MAGI1;SMAD7;MINK1;CD47;PODXL;CITED2
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.42344861079912827,1.1360200162273049,0.3018181818181818,0.969615895478485,1.0,4/21,7.89%,OSBPL10;PLAAT3;LPCAT3;MBOAT1
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.3350250230422311,1.1358259723769928,0.2625,0.9687362175804268,1.0,14/73,10.48%,MAPK3;ARPC3;VAV3;FCGR2B;ACTB;SRC;ARPC4;FYN;SYK;PLCG1;LYN;PAK1;WIPF3;YES1
prerank,regulation of T cell chemotaxis (GO:0010819),0.4915319130530576,1.1356260605040251,0.31992337164750956,0.9678177605083423,1.0,2/11,8.24%,OXSR1;WNT5A
prerank,positive regulation of locomotion (GO:0040017),0.3990590850418411,1.1354645768706966,0.2866666666666667,0.9668360078486445,1.0,2/27,0.43%,PHPT1;SPOCK2
prerank,negative regulation of ATPase activity (GO:0032780),0.44581222735938053,1.1353266195045038,0.3026315789473684,0.9657049289158919,1.0,3/16,8.90%,IFIT1;SIRT1;TSC1
prerank,aerobic electron transport chain (GO:0019646),0.3341858833625538,1.134941452467481,0.25914634146341464,0.9656952926028399,1.0,19/68,14.53%,CYCS;NDUFAF1;UQCC3;NDUFB6;NDUFB4;COX6B1;NDUFA10;NDUFA1;NDUFS2;SDHA;COX5A;NDUFB7;COX15;UQCRB;NDUFV3;NDUFA8;NDUFC2;NDUFA13;COX10
prerank,positive regulation of MAPK cascade (GO:0043410),-0.24491786732392754,-1.1345304780307095,0.11602209944751381,0.6786983130842938,1.0,30/245,7.03%,ERBB4;NTRK3;FGFR2;NOTCH2;LPAR1;IGF1;HTR2C;ROBO1;EGFR;KSR1;IQGAP1;PDGFRB;NTRK2;BMPER;CCN2;FGF1;NRP1;RYK;KIT;PRKCZ;ROR1;ROCK2;IL34;TAOK3;ROCK1;SLC30A10;PDGFRA;ADRA1B;IRAK1;GSDME
prerank,regulation of ion transmembrane transport (GO:0034765),-0.35428354885109814,-1.1343817063298594,0.26683291770573564,0.6781544022442814,1.0,12/33,20.43%,AKAP6;WNK1;WWP2;CHRM3;AKAP9;KCNJ2;KCNJ6;WNK3;ANO6;KCNJ13;KCNJ10;NEDD4
prerank,engulfment of apoptotic cell (GO:0043652),0.4577931080076726,1.1343737674249899,0.29080675422138835,0.9662727468195674,1.0,2/15,0.45%,RAC2;XKR8
prerank,positive regulation of interferon-gamma production (GO:0032729),0.36027988496740565,1.1342945134561855,0.25241157556270094,0.9649489045245697,1.0,4/48,6.50%,IL1R1;PDE4D;CYRIB;CEBPG
prerank,smooth muscle contraction (GO:0006939),-0.44873585653708375,-1.1342688034037656,0.30669546436285094,0.6774875986398369,1.0,7/14,24.61%,ROCK2;EDNRA;ROCK1;SMTN;BDKRB2;ADRA1A;MYH11
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.2962387030249305,-1.1336105229245652,0.21172638436482086,0.678376843029411,1.0,16/75,9.17%,SULF1;COL4A3;CTNNB1;GTF2I;ROCK2;HOXA5;ROCK1;PML;HSPG2;WNT4;FOXC1;ADAMTS1;SPARC;NIBAN2;THBS2;THBS1
prerank,detection of mechanical stimulus (GO:0050982),-0.4005143710620113,-1.133460606189504,0.2748917748917749,0.6778050908278289,1.0,3/19,5.74%,PKD1;CTNNB1;PIEZO2
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.39137855159685864,1.1332973691386394,0.29180887372013653,0.9672089176860299,1.0,7/31,9.42%,TRIB3;PIN1;DCUN1D4;BMI1;AXIN1;MAGEC2;RAB1A
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.33426064860971505,-1.1326933696679178,0.28065395095367845,0.6790808028357594,1.0,10/38,20.18%,BMP6;SASH1;PUM1;PUM2;PLSCR1;POLR3C;LY86;GBP5;RIOK3;SLC15A4
prerank,replicative senescence (GO:0090399),0.49196097360139035,1.1325263127464855,0.29818181818181816,0.9686341111595924,1.0,5/12,15.65%,ROMO1;MME;TERT;CHEK2;ATR
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4470097289786762,1.1321051413965493,0.3080895008605852,0.9686562680942518,1.0,3/18,6.82%,SBNO2;IFI35;SYK
prerank,small GTPase mediated signal transduction (GO:0007264),0.31624969731629904,1.1319717622788181,0.242467718794835,0.9675018935370125,1.0,24/103,12.90%,RALB;TRIM28;TIAM1;PLK2;NUCB2;RERG;NRAS;RRAD;RALA;CDKN1A;RASGRP3;KRIT1;GNB1;GRAP;CCDC88C;ARHGEF18;RAPGEF5;RAPGEF6;PARK7;NF1;G3BP2;CRKL;RIT1;RRAGC
prerank,histone modification (GO:0016570),-0.27660683352537513,-1.1317997457130178,0.19594594594594594,0.6805264511152536,1.0,31/109,16.33%,EYA2;EYA1;PRDM5;MIER1;HDAC4;NSD3;TBL1XR1;UBE2N;UFL1;HDAC1;SIRT2;KDM4A;PHF20;MORF4L2;PRKCD;ENY2;MTA3;HLCS;MIDEAS;MORF4L1;HUWE1;EHMT2;MTA1;TBL1X;RCOR3;PHC1;MAP3K12;SIRT7;SGF29;TAF6;USP16
prerank,dendritic cell migration (GO:0036336),0.45101424319003625,1.131783394099639,0.31390977443609025,0.9666069739723684,1.0,2/16,10.43%,PIK3CG;TRPM4
prerank,epithelial to mesenchymal transition (GO:0001837),-0.31490799192167807,-1.1315777671143967,0.21311475409836064,0.6801097412767559,1.0,12/47,11.84%,DDX5;TGFBR3;DDX17;TGFBR1;CTNNB1;BMP7;ROCK2;ROCK1;WNT4;GSK3B;LOXL3;TBX3
prerank,negative regulation of cell cycle (GO:0045786),-0.2888661738746131,-1.1315017374964942,0.21474358974358973,0.6793448766542601,1.0,16/73,12.58%,NR2F2;SMAD3;BRINP1;BMP7;BMP4;TRIM35;NUPR1;CDKN1B;PTPN3;FOXC1;BRINP2;GAS1;CDK6;CAMK2N1;RHOB;SIPA1
prerank,B cell differentiation (GO:0030183),0.36285442486041686,1.131354832451478,0.27724358974358976,0.96669316207452,1.0,6/46,9.99%,DCAF1;PTPRJ;PTPRC;HDAC9;CEBPG;KLF6
prerank,regulation of catecholamine secretion (GO:0050433),-0.3649042183080553,-1.1312319419666814,0.24936386768447838,0.6791534384761125,1.0,13/29,30.26%,SYT9;SYT12;SYT11;SYT4;SYT7;STX1A;SYT2;KCNA2;GRK2;SYT10;SYT6;SNCA;DRD2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.37415964472252683,1.1303774115729086,0.2965964343598055,0.968907913838073,1.0,11/39,16.86%,CISH;PIK3CG;PIK3C2G;EFR3B;SMG1;PI4KA;PIK3CD;IP6K2;PIK3C2A;ITPKB;PIP4K2A
prerank,regulation of steroid metabolic process (GO:0019218),0.41837761952452635,1.1302958451404574,0.300556586270872,0.9676230645586535,1.0,4/23,6.62%,PANK2;NR5A1;APOE;LAMTOR1
prerank,basement membrane organization (GO:0071711),-0.43676097069215736,-1.1301023910821046,0.3132780082987552,0.6813162873542157,1.0,5/14,18.17%,NTNG1;FLRT2;NID2;NTN4;LAMB1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.41550827917959343,1.1300376478476046,0.30303030303030304,0.9670376568333069,1.0,3/22,4.89%,PSMB10;PSMB6;PSMB4
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.29427992582960355,-1.1299060405087602,0.2314540059347181,0.6808832602867964,1.0,16/79,10.38%,SULF1;ADAMTS12;NBL1;BMPER;SMURF2;SMAD4;SULF2;VWC2L;CRIM1;SORL1;SKI;HTRA3;SMAD6;NIBAN2;THBS1;SPART
prerank,regulation of glycolytic process (GO:0006110),-0.29823783309248164,-1.129501232645868,0.22191011235955055,0.6810266804339237,1.0,14/68,11.67%,ZBTB20;PRKAG2;IGF1;OGT;HDAC4;PRKAG1;NUPR1;NUP205;PPARA;NUP155;NUP188;NUP93;NUP88;PFKFB4
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.48917191251240727,-1.1292518936540794,0.3111111111111111,0.6808069053599918,1.0,2/10,3.12%,ANXA2;NELL1
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.372811798312755,-1.1290471834363607,0.27078384798099764,0.6804050160379318,1.0,9/25,21.10%,SULF1;FOXD1;SMAD4;BMP4;BMPR1B;ZNF423;BMPR1A;BMPR2;CCN1
prerank,dopaminergic neuron differentiation (GO:0071542),0.430094532975129,1.1288358201371627,0.29245283018867924,0.9700404208493514,1.0,2/19,3.11%,NR4A2;MANF
prerank,intracellular protein transport (GO:0006886),0.281782916024623,1.1287853892837376,0.19148936170212766,0.9686350696617876,1.0,62/304,13.12%,SURF4;ARF5;ARL5C;ARL4D;EVI5L;RAB5C;CDC37;TBC1D30;TBC1D8;SNX8;MMP12;RAB7A;VPS29;TBC1D9;TMED4;PHB2;SEC23IP;VPS26A;RAB43;TBC1D10B;PTTG1IP;USP6NL;TBC1D4;RAB6B;SYK;TMED5;NXT1;NAPA;RABGAP1L;IFT22;RAB6A;SNX17;NUP50;TMED10;DESI1;RAB14;ACD;DNAJC27;RANBP17;XPO5;TBC1D12;SNX1;ARL5B;ARF1;AP4S1;RAB1A;CCHCR1;TBC1D25;MAIP1;KIF13A;TMED7;SCFD1;RAB5B;RAB22A;ARCN1;STRADB;ADPRH;E2F3;TBC1D14;XPO1;YWHAH;RABGAP1
prerank,skeletal muscle organ development (GO:0060538),-0.3681112369423314,-1.1287115082165196,0.29603729603729606,0.6803882429104573,1.0,7/26,24.71%,SVIL;CFLAR;IGSF8;LARGE1;SIX1;STRA6;BASP1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3894566564545001,1.1286316818797044,0.2823920265780731,0.9675576726144196,1.0,7/30,11.99%,EBP;INSIG1;HMGCR;PLPP6;IDI1;NSDHL;LSS
prerank,regulation of cell motility (GO:2000145),-0.27258999187839805,-1.1284393527490928,0.19014084507042253,0.6801892971077261,1.0,35/121,17.47%,ERBB4;SPOCK3;PLXNA2;EGFR;LMO4;FBLN1;FGF1;MACF1;RHOA;FLNA;AMOTL2;LMNA;ROCK2;ROCK1;LDB1;CFAP20;AKT2;SRCIN1;DOCK10;CAVIN1;SPATA13;CDK6;SGK1;PRAG1;TTBK2;RHOB;TBCCD1;PLXND1;PLXNB2;RAF1;TGFB1;PLXNC1;ABL2;NEXN;DIAPH1
prerank,actin nucleation (GO:0045010),0.42222100520217837,1.1283839845081358,0.30579964850615116,0.9668951765600586,1.0,7/21,15.15%,ARPC3;ARPC5L;ARPC4;ARPC5;TRIM27;LMOD1;WHAMM
prerank,protein localization to chromosome (GO:0034502),0.38587523033226684,1.1280005206592345,0.2891156462585034,0.966831373923673,1.0,12/34,18.64%,SLF1;BOD1;ACD;TPP1;ESR1;TNKS;TERF2IP;ATR;SLF2;XRCC4;TNKS2;ATRX
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3455242732422301,1.1278523851996325,0.2727272727272727,0.965844569294878,1.0,17/54,18.03%,PLK2;CNOT11;CDKN1A;EP300;CRADD;CNOT2;RGCC;CNOT7;MDM2;CARM1;CNOT6;CHEK2;CNOT1;CNOT6L;CNOT10;BAX;RPL26
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.38197578884631034,1.1278404878660995,0.2878535773710483,0.9642978364181499,1.0,10/36,15.82%,MAZ;NR4A2;SGMS1;CRADD;BDNF;RPS3;PTPMT1;ING5;CSNK2A2;TPD52L1
prerank,proteasomal protein catabolic process (GO:0010498),0.29124130945419446,1.1270674682119757,0.22139303482587064,0.9657106032426118,1.0,45/201,15.32%,PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;FEM1C;SPOP;UBXN11;RFFL;BIRC2;PSMD11;NEDD4L;NHLRC1;PSMB4;PSMC1;COP1;SIRT1;CLOCK;RNF187;RBCK1;CRBN;RAD23A;MDM2;PSMC2;UBE3D;PSMD2;ZNRF1;SPOPL;IFI27;PLAA;CUL3;PSMD14;DDIT3;PSMC6;RNF216;APPBP2;FAF1;PSMD1;PSMB1;TRIM3;NHLRC3;UBE2G1;RMND5A
prerank,negative regulation of cellular senescence (GO:2000773),0.466542985099288,1.127028972212388,0.32879377431906615,0.964271897633296,1.0,6/13,14.19%,FBXO5;SIRT1;ZKSCAN3;TERT;YBX1;MAP3K3
prerank,positive regulation of lipid storage (GO:0010884),0.42423303711821525,1.1267119452423169,0.3,0.9639066922758883,1.0,2/21,3.53%,CIDEA;FITM2
prerank,inner ear morphogenesis (GO:0042472),-0.3798603088529911,-1.1265648600614013,0.2988505747126437,0.6845400344309609,1.0,6/22,19.67%,FGFR2;ZIC1;TTC39C;EPHB2;SIX1;TBX18
prerank,icosanoid biosynthetic process (GO:0046456),-0.4910614652469575,-1.1263030501967226,0.32238193018480493,0.6843279525717681,1.0,1/10,1.27%,PLA2G4A
prerank,prostanoid biosynthetic process (GO:0046457),-0.4309122433477546,-1.126176829666366,0.2875,0.683756700805359,1.0,5/15,19.92%,PTGDS;PLA2G4A;PTGIS;PTGES;PTGS2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.29335846729246007,-1.1260302357686007,0.1977401129943503,0.6831507968855703,1.0,20/73,16.56%,ROBO1;SMAD3;CFLAR;COL4A3;MAPT;CASP8AP2;F3;VCP;XDH;FAM162A;IFT57;ANP32B;CASP12;HIP1R;RACK1;HSPD1;NGF;EGLN3;TRAF2;MTCH1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.43388732362048654,1.1257366305670544,0.30601092896174864,0.9660507544320526,1.0,2/18,1.20%,RSC1A1;TRIB3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.45932371231250735,-1.125615786070483,0.3036093418259023,0.6833427744209467,1.0,4/12,8.27%,DOCK5;IGFBP5;TPM1;ADAMTS1
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.28477029314403285,-1.1254455469593712,0.19407894736842105,0.6828726885703391,1.0,16/86,12.45%,BMP6;SULF1;DAB2;FOXD1;TGFBR1;BMP5;BMP7;SMAD4;ZEB2;BMP4;SNW1;THBS1;ACVR1;NUP93;STK11;ACVR1B
prerank,liver development (GO:0001889),0.3834019477309059,1.125380822502963,0.3016393442622951,0.9658749711185239,1.0,6/32,13.59%,PCK1;GFER;CEBPG;CITED2;NF1;LSR
prerank,cholesterol metabolic process (GO:0008203),0.3331613391138154,1.1253694244178567,0.2553846153846154,0.9643433033809434,1.0,13/68,12.81%,EBP;INSIG1;HMGCR;PLPP6;APOE;SOAT1;PPARD;SNX17;OSBPL1A;IDI1;NSDHL;LSS;LDLRAP1
prerank,defense response to tumor cell (GO:0002357),-0.48027804754244363,-1.1251814144049195,0.3399122807017544,0.6826596772978718,1.0,8/10,48.19%,DAPK1;RBMS3;PRDX2;ABI3;PLK5;LAPTM5;SPI1;DLEC1
prerank,positive regulation of histone deacetylation (GO:0031065),0.4898659006933473,1.1248792327550885,0.34709193245778613,0.9645843799375275,1.0,4/12,11.17%,PRKD2;AKAP8L;ING2;CTBP1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3309434311442433,1.124425919987542,0.26331360946745563,0.9647819152885079,1.0,13/72,11.67%,MAZ;CBL;PIK3CG;PIK3AP1;SRC;TEK;SELP;SIRT1;IRS2;LYN;FLT1;PIK3CD;PIK3R5
prerank,DNA repair (GO:0006281),0.28263974031354505,1.1243676004483876,0.20500595947556616,0.963416974833824,1.0,69/284,17.73%,ERCC3;ZRANB3;ABRAXAS1;RAD18;TRIM28;ALKBH2;PNKP;ERCC4;RAD1;HPF1;XRCC1;APLF;TENT4A;POLK;CIB1;MAPK8;TDG;ACTR8;PMS2;POLE;SIRT1;ACTR5;DCLRE1B;UBE2V2;EYA3;POLD3;USP47;MLH1;PMS1;GTF2H1;SPRTN;RAD23A;POLA1;RAD51B;EXD2;RFWD3;PARK7;MSH3;ASCC3;UBE2V1;SMUG1;APTX;HUS1;KMT5B;PWWP3A;MPG;NBN;DOT1L;TRRAP;CHEK2;BRCC3;PPP5C;BRIP1;BACH1;FANCL;INO80;NSD2;FTO;ATR;ENDOV;SETD2;PRKDC;WDR33;XRCC4;DCLRE1C;NPM1;ATXN3;POLH;RAD23B
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.3875496098306751,1.1243244315022214,0.29381443298969073,0.9620094225724855,1.0,8/30,13.67%,TNFAIP3;RFFL;TNFRSF10B;ICAM1;PARK7;DDX3X;NOS3;FAIM
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2988276121304352,1.1242376619672618,0.2255541069100391,0.9607824923141428,1.0,33/161,13.97%,PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;FRZB;RUVBL2;GREM1;TPBG;PSMD11;APOE;SOX2;PSMB4;PSMC1;CCDC88C;PFDN5;AXIN1;WNT5A;LATS2;SOX13;PSMC2;PSMD2;TMEM131L;TLE4;CUL3;PSMD14;DDIT3;PSMC6;PSMD1;PSMB1;APC
prerank,regulation of interleukin-1 production (GO:0032652),-0.42711505346803014,-1.1241568324345705,0.31808278867102396,0.6845564177457975,1.0,3/15,12.92%,FOXP1;ANXA1;SIRPA
prerank,actin filament bundle organization (GO:0061572),-0.3497717288017962,-1.1240291163031042,0.2794871794871795,0.6839629825908431,1.0,7/33,11.82%,CALD1;PAWR;DPYSL3;LIMA1;NEDD9;EZR;BAIAP2L1
prerank,negative regulation of cell differentiation (GO:0045596),-0.2547668731349015,-1.1237843006951476,0.14414414414414414,0.6836774664027502,1.0,37/181,13.94%,LDLRAD4;CNTN4;RANBP3L;ADAMTS12;EGFR;SMAD3;TGFBR1;COL5A1;BMP5;BMP7;COL5A2;ADGRV1;SIRT2;BMP4;EFEMP1;MED1;CRIM1;MEIS2;OSR1;ENPP1;PPARA;SKI;XDH;TMEM64;LRP5;ABCA5;CDC73;SMAD6;ANP32B;CDK6;SEMA4D;TBX3;LIMD1;NELFB;WNT9A;ABCA1;IGF2
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.3311223110788373,1.1233826461356502,0.27384615384615385,0.9625875058495251,1.0,19/69,14.53%,CYCS;NDUFAF1;UQCC3;NDUFB6;NDUFB4;COX6B1;NDUFA10;NDUFA1;NDUFS2;SDHA;COX5A;NDUFB7;COX15;UQCRB;NDUFV3;NDUFA8;NDUFC2;NDUFA13;COX10
prerank,organelle fission (GO:0048285),0.413089800018116,1.1233728486189096,0.31922398589065254,0.9610900975866425,1.0,7/24,17.17%,PEX11G;DNM3;MTFR1;ACOT8;MIEF1;DNM1L;CORO1C
prerank,cytosolic transport (GO:0016482),0.31410315485425766,1.1228054315035292,0.25245441795231416,0.9616111307924878,1.0,33/108,17.87%,VPS50;HEATR5B;SORT1;PREPL;RAB7A;VPS29;VPS26A;TBC1D10B;GOSR2;RAB6B;AP1G1;PIKFYVE;RAB6A;RAB14;AKTIP;SNX1;VPS53;GCC2;DOP1B;RBSN;MYO1D;ERC1;TRIM27;ANKRD27;TBC1D23;CORO7;VPS35;HOOK3;SNX16;BECN1;GAK;KIF16B;HEATR5A
prerank,regulation of protein binding (GO:0043393),0.3135308738849845,1.1227043009397117,0.25137362637362637,0.9604524898341215,1.0,24/114,13.20%,TRIB3;RALB;PIN1;TIAM1;BTBD1;ACTB;PSME3IP1;HIPK2;IFIT1;PPP2CA;B2M;CDKN1A;MAPK8;CARD16;SPPL3;EPB41;AKTIP;PARK7;CLDN5;TERT;APP;LDLRAP1;HDAC5;USP33
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.4441978896646689,-1.1226784184320433,0.31101511879049676,0.6860019100646675,1.0,10/13,51.86%,B3GALT5;B3GALNT1;B3GALT1;B3GALT2;B3GNT9;B3GNT3;B3GNT8;GAL3ST3;B3GNT6;B4GAT1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.3496445671220329,1.1225924929611242,0.28100470957613816,0.9593033845794322,1.0,10/54,12.56%,PRCP;PRKD2;APOE;RGCC;SIRT1;PLCG1;ACVRL1;NOS3;NF1;SP1
prerank,cellular response to ketone (GO:1901655),0.37813201264983975,1.1225545608848246,0.300509337860781,0.9579312574376674,1.0,4/35,6.25%,PCK1;PTGER2;SRC;GNB1
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3706537122570889,1.1222127795177086,0.2939244663382594,0.957695198513061,1.0,4/38,4.50%,RAC2;GSK3A;SAE1;VPS11
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3565878604689909,-1.12221268929438,0.2780487804878049,0.6863564206668136,1.0,11/28,19.24%,TNS2;PID1;PRKCZ;APPL2;ENPP1;PRKCD;PIP4K2B;GRB10;PTPN2;TSC2;RPS6KB1
prerank,embryonic organ development (GO:0048568),-0.30616270820894215,-1.1218517118935778,0.2195845697329377,0.686426724710335,1.0,24/61,21.85%,FGFR2;TEAD1;PBX1;GLI2;GLI3;KMT2A;RARB;PCSK5;TGFBR2;KIT;COBL;RBP4;COL13A1;SALL1;TEAD3;NES;TGFB1;PBX4;BMPR1A;TEAD2;PBX2;PDGFA;PKDCC;ATF4
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.3458207155926977,-1.121667746435163,0.27923627684964203,0.6859917571146171,1.0,10/32,15.56%,NAV3;MAP2;EML2;HDGFL3;STMN2;TTBK2;CLIP3;TAOK1;STMN1;TUBB4A
prerank,phospholipid homeostasis (GO:0055091),-0.46840478447677947,-1.1214797253956177,0.33191489361702126,0.6855735008070191,1.0,3/11,14.58%,TLCD2;ABCA1;RCN3
prerank,metal ion homeostasis (GO:0055065),0.3751864281645308,1.1212805963682124,0.2911392405063291,0.9596704004196404,1.0,4/40,5.25%,SLC12A1;SLC7A8;TMTC2;WFS1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.32954485086072144,-1.1211190481923132,0.2518518518518518,0.6856104909468882,1.0,16/38,32.82%,SMAD3;P2RX4;ROCK2;PTGIS;DDAH1;CD34;SIRPA;PTGS2;AKT1;HSP90AA1;CX3CR1;DDAH2;ZC3H12A;CAV1;ASS1;EDN1
prerank,blood vessel morphogenesis (GO:0048514),0.35244482884622885,1.1208092405433265,0.29505582137161085,0.9599023574115275,1.0,13/54,11.85%,SLC1A1;CDH2;EGFL7;RAMP2;TBX1;SYK;SMAD7;HEY2;RASIP1;CYP1B1;RBPJ;FLT1;NF1
prerank,hematopoietic stem cell proliferation (GO:0071425),0.49985526211920034,1.120459879673284,0.328740157480315,0.9597538160275487,1.0,2/11,8.24%,MECOM;WNT5A
prerank,pulmonary valve development (GO:0003177),-0.4097168630849334,-1.1201455871846084,0.30155210643015523,0.6874520207022932,1.0,5/18,8.64%,ROBO2;NOTCH2;ROBO1;BMP4;SMAD6
prerank,defense response to symbiont (GO:0140546),0.3184591969771924,1.1195009334408423,0.2764456981664316,0.9619513360480302,1.0,19/92,13.23%,PTPRC;IFNLR1;IFITM2;IFIT1;MLKL;RNASE6;IFITM3;CNOT7;IFITM1;RELA;SERINC5;NCBP3;SERINC3;ATG7;IFI27;BNIP3L;AGBL5;IRF2;NLRC5
prerank,positive regulation of lyase activity (GO:0051349),-0.433663670267451,-1.11939652474169,0.3053763440860215,0.6886718283097646,1.0,3/14,3.04%,CACNA1C;CACNA1D;STIM1
prerank,response to amino acid (GO:0043200),-0.3500400131771596,-1.1187239079068358,0.29133858267716534,0.6896104818196037,1.0,6/31,7.68%,CPEB4;CPEB1;GLRB;CAPN2;GLRA3;GLRA1
prerank,regulation of transport (GO:0051049),0.3667476248706085,1.118603555794042,0.31092436974789917,0.9638396208991428,1.0,6/36,11.48%,RSC1A1;ACTB;ICA1;EPB41;MBTPS1;SCFD1
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.3419703207241123,1.1182605782431305,0.29153605015673983,0.9620469232565544,1.0,14/56,13.25%,NDUFAF1;NDUFAF5;NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;TIMM21;NDUFB7;TIMMDC1;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.3419703207241123,1.1182605782431305,0.29153605015673983,0.9620469232565544,1.0,14/56,13.25%,NDUFAF1;NDUFAF5;NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;TIMM21;NDUFB7;TIMMDC1;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.40757522431320686,1.1180095575823263,0.3,0.9614262878228923,1.0,6/23,11.40%,ACSL5;HSD17B12;ELOVL6;FAR2;ACSL4;HACD2
prerank,endomembrane system organization (GO:0010256),0.29284062822167195,1.117844207357208,0.23205128205128206,0.9604915077857624,1.0,30/178,10.83%,SURF4;SYNE1;SMPD4;LYSMD3;GORASP2;EXOC8;CLASP2;LEMD3;ATL1;LMAN2;VPS11;TMED4;SEC23IP;RAB43;SYNGR2;TRAPPC8;USP6NL;ARHGEF7;LAMTOR1;TRIP11;VMP1;TMED5;TMED10;REEP3;AKTIP;RAB1A;GOLPH3L;TRAPPC11;DOP1B;TMED7
prerank,regulation of secretion by cell (GO:1903530),-0.3091739992435612,-1.1177823328266145,0.27170868347338933,0.6912895369628214,1.0,27/54,35.98%,RIMS1;RAB3C;SNCAIP;RAB8B;SCG5;SYN1;STXBP5;ANXA1;VAMP2;RAB8A;RHBDF1;P3H1;CPLX1;VAMP8;LLGL1;CAMK2A;RAB13;DNAJC1;RAB3D;LGI3;LLGL2;KCNMB4;CPLANE2;RAB3B;RAB21;RAB3A;CPLX2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.3745044938333919,-1.1177814218529116,0.2832512315270936,0.6903518241823197,1.0,2/23,0.15%,ANK2;ATP1A2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.4252571091194025,1.1177733728562025,0.31907308377896615,0.9592454930242597,1.0,5/18,11.40%,ACSL5;HSD17B12;ELOVL6;ACSL4;HACD2
prerank,hyaluronan metabolic process (GO:0030212),-0.38148931175074186,-1.1175974466091183,0.3062645011600928,0.6899101034241044,1.0,17/23,52.28%,CEMIP;HEXA;CEMIP2;HEXB;TGFB1;GUSB;HYAL1;SLC9A1;CHP1;HAS1;HYAL2;LYVE1;HAS2;HMMR;HAS3;HYAL3;STAB2
prerank,glucose homeostasis (GO:0042593),0.3249900989557446,1.1175573569965027,0.2714078374455733,0.9585124092323575,1.0,12/83,11.20%,PCK1;HECTD4;PYGL;SELENOT;WFS1;SIRT1;ADIPOR2;PARK7;CYB5R4;PRKAA2;BAD;ADIPOR1
prerank,ethanol metabolic process (GO:0006067),-0.4497845029985699,-1.1174497618130474,0.3197424892703863,0.6894004986122368,1.0,6/12,32.22%,ALDH1A1;ACSS2;ALDH2;ADH5;ACSS1;ADH1A
prerank,proteoglycan biosynthetic process (GO:0030166),0.38735592941402996,1.1173701923241208,0.27164685908319186,0.9577019025675642,1.0,6/31,9.31%,NDST3;CSGALNACT1;XYLT1;EXT2;PXYLP1;B3GAT2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),-0.47129171256060476,-1.11723956412908,0.32510288065843623,0.689022582979367,1.0,2/11,3.27%,ANK3;JAK1
prerank,fatty acid elongation (GO:0030497),-0.4457903505201664,-1.1172138073782536,0.32916666666666666,0.688164958765412,1.0,4/13,7.14%,HACD3;HACD1;HACD4;TECR
prerank,cellular component maintenance (GO:0043954),0.4883983517554564,1.1171949512799717,0.3471971066907776,0.9568271287611299,1.0,5/12,17.75%,FYN;PRNP;ITGA3;MTMR2;INSR
prerank,negative regulation of interleukin-10 production (GO:0032693),0.4521822852084786,1.1167418788265489,0.3333333333333333,0.9570251198228443,1.0,3/16,13.15%,FCGR2B;VSIR;CD274
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.2855271134822525,-1.116665786254263,0.24846625766871167,0.6887101410276796,1.0,26/80,19.24%,PLD1;SLC2A13;SAMD4A;LRRTM3;VIM;ROCK2;PRKCD;POLDIP3;EIF3C;YTHDF1;NIBAN1;THBS1;PRR16;SMPD3;EEF2;RBM3;IFNGR1;GSAP;RACK1;PLXNB2;METTL5;NAT10;PCIF1;UPF3A;CIRBP;RPS6KB1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.37476901440939253,1.116660276188825,0.3025210084033613,0.9558367399140769,1.0,8/32,16.30%,CDK17;NPAT;CDC45;FBXO5;POLA1;BACH1;ID2;CDK14
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.3054806519840182,-1.1165907219072404,0.24855491329479767,0.688014043045252,1.0,13/56,15.10%,ANK3;SON;SPIRE1;RHOA;ROCK2;CIT;ROCK1;IST1;BIN3;RHOB;MITD1;TRIM36;STMN1
prerank,regulation of axon guidance (GO:1902667),-0.4776086825591086,-1.116520998750319,0.35080645161290325,0.6872816986740291,1.0,6/10,25.24%,NRP1;ZSWIM8;YTHDF1;ZSWIM4;VEGFA;ZSWIM5
prerank,regulation of cell projection organization (GO:0031344),-0.43939583810367167,-1.116484647951448,0.3135593220338983,0.6864797534353376,1.0,4/13,15.44%,NTNG1;MACF1;SEMA4D;ERMN
prerank,regulation of phagocytosis (GO:0050764),0.3526310118161827,1.1164379367020842,0.29738058551617874,0.9551656049487625,1.0,12/53,17.83%,PTPRC;FCGR2B;CAMK1D;LMAN2;SYK;MERTK;CD47;SCARB1;CYBA;GAS6;CALR;RAB27A
prerank,cell junction assembly (GO:0034329),-0.2752178162459632,-1.1162778004321858,0.2089041095890411,0.6861681096534804,1.0,28/100,14.33%,SDK1;CDH10;NRXN1;KIRREL3;NRCAM;RYK;DNER;TLN1;RHOA;DSCAM;NLGN2;FLNA;GPM6A;CTNND2;TLN2;SDK2;CDH11;NLGN1;CDH7;GJC1;ARVCF;CDH1;FN1;ILK;NRXN2;OBSL1;PLXND1;CTNND1
prerank,"synaptic transmission, GABAergic (GO:0051932)",-0.47991331559022665,-1.1161176814553002,0.31856540084388185,0.6856826539125083,1.0,7/10,24.41%,GABRA2;GABRG2;GABRA5;GABRG3;GABRA4;GABRG1;GABRA1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.4309314300231924,-1.1160092637241494,0.33769063180827885,0.6850513837828655,1.0,10/15,28.41%,UST;DSE;VCAN;CSGALNACT2;CSPG4;DSEL;BGN;CSPG5;CHST12;DCN
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.34833716920384017,1.11587382313864,0.3082942097026604,0.9557861867419979,1.0,8/50,10.46%,ACTB;CDC37;STOX1;CCNH;CDKN1A;GTF2H1;CCNG2;BCCIP
prerank,oligodendrocyte development (GO:0014003),-0.4247669436572028,-1.115843057027791,0.32096069868995636,0.68458840896974,1.0,11/15,38.24%,PLP1;B4GALT6;TPPP;CNTNAP1;EIF2B5;EIF2B2;EIF2B4;MYRF;NSUN5;B4GALT5;SOX10
prerank,regulation of vasoconstriction (GO:0019229),-0.3701468881525216,-1.1156995838971133,0.2787286063569682,0.6840283520020651,1.0,15/27,38.77%,PER2;ADRA1B;CHRM3;ZDHHC21;ACE;BDKRB2;AGTR1;BMPR2;ADRA1A;CAV1;TBXA2R;KCNMB4;ADM;ACE2;AGT
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.4189589284894091,1.115343563743122,0.29818181818181816,0.9563413766379729,1.0,3/22,5.41%,MAP3K7;B2M;CYRIB
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.45880284496656165,1.115002332843987,0.33457943925233646,0.9561119200417049,1.0,3/14,4.57%,MAP3K7;TIRAP;TNFRSF10B
prerank,activation of protein kinase activity (GO:0032147),-0.2710303224599891,-1.114925593081046,0.23841059602649006,0.6852809667673717,1.0,41/106,25.91%,NTRK3;IGF1;ADCY5;ADCY2;FGF1;ADCY1;TGFBR2;PRRC1;PIBF1;ADCY9;MALT1;GHR;PRKCD;TAOK3;IRAK1;PRKACA;STRADA;PAK5;STK11;PRKAR1B;ADCY7;IL18;TAOK1;TOM1L1;TRAF2;CARD10;PINK1;CARD14;PRLR;OSBPL8;ADCY3;ADCY8;ADCY4;VEGFA;ITGB1BP1;EMP2;NRK;AKT1;ADRA2A;TLR3;PPIA
prerank,tRNA methylation (GO:0030488),0.3751946596164688,1.1146047686792449,0.31886477462437396,0.956171395362699,1.0,6/34,11.86%,TRMO;BCDIN3D;THUMPD2;TRMT61B;METTL2B;METTL2A
prerank,neural crest cell development (GO:0014032),0.35811373491822457,1.1134459709217928,0.29878048780487804,0.9591856555587146,1.0,8/44,9.12%,SEMA6A;SEMA6D;SEMA7A;CDH2;SEMA3C;TBX1;SEMA6B;SEMA4C
prerank,phagosome maturation (GO:0090382),0.3712957679244894,1.112811812136291,0.31788079470198677,0.9601330353772313,1.0,7/35,8.45%,ATP6V1D;RAB7A;RAB43;ATP6V0D1;PIKFYVE;RAB14;ATP6V0E1
prerank,protein kinase A signaling (GO:0010737),0.4720676010222016,1.1119635344205434,0.33527131782945735,0.9619297665989414,1.0,1/12,0.55%,LCP1
prerank,smooth muscle tissue development (GO:0048745),-0.47954335443981155,-1.111469655019421,0.3311965811965812,0.6941922351265785,1.0,6/10,30.41%,BMP4;SMO;EFEMP2;STRA6;PTCH1;MYLK
prerank,regulation of viral genome replication (GO:0045069),0.3409356162131117,1.111441859587835,0.2980030721966206,0.9624745719236093,1.0,12/56,12.24%,ILF3;BANF1;IFITM2;IFIT1;IFITM3;ADAR;CNOT7;IFITM1;RAD23A;SRPK2;DDX3X;TMEM39A
prerank,protein polyglutamylation (GO:0018095),0.47848695722447787,1.111356165161017,0.352165725047081,0.9613156080472676,1.0,2/11,2.98%,TTLL1;CEP41
prerank,chloride transmembrane transport (GO:1902476),-0.3210310786881938,-1.111283817674899,0.25872093023255816,0.6938235199588609,1.0,25/48,27.69%,GABRB1;SLC1A3;GLRB;GABRA2;ANO3;SLC6A1;SLC12A2;GLRA3;GABRG2;GLRA1;ANO1;ANO6;SLC12A6;GABRA5;GABRG3;SLC12A4;GABRA4;SLC12A9;GABRG1;SLC4A8;SLC12A7;GABRA1;SLC12A8;SLC12A5;LRRC8A
prerank,negative regulation of cellular process (GO:0048523),-0.22421944870970356,-1.11114787875334,0.10869565217391304,0.6932240825218763,1.0,180/521,28.25%,MAGI2;ERBB4;ST18;TGFBR3;PLXNA2;ADAM22;ALDH1A2;SMAD3;KANK2;CLMN;TNS2;VPS13C;FBLN1;FHL1;CCN2;PTPN14;BRINP1;PACRG;COL4A3;BMP5;CTNNB1;ABI1;BMP7;PDPN;SMAD4;DSCAM;RBBP7;ATP8A2;SIRT2;BMP4;NUPR1;IGFBP7;ZBTB7C;LMNA;PIP4P2;PDS5B;APPL2;SRSF6;ENPP1;MYO16;VGLL4;PML;FRK;PODN;SKI;GSDME;IGFBP6;CDKN1B;CDC73;ADAMTS1;NDUFS3;SMAD6;ANP32B;NIBAN2;DLG3;CGRRF1;SERTAD2;EIF2AK2;BRD7;PLSCR1;CDK6;SPEG;GJA1;EPHB2;CAMK2N1;DDAH1;SEMA4D;TP53;CD34;NOX4;STK11;RHOB;SYT11;ACVR1B;SIPA1;TNFRSF21;SIRPA;FKTN;P3H3;PDCD5;WNT9A;PLXND1;NF2;RACK1;ARHGDIA;DUS2;TOB1;NACC2;PTPRU;PLXNB2;RAF1;SIRT7;NGF;RAPGEF2;GPLD1;CCN3;CBLL1;TAF6;RNF139;S100A11;TGFB1;NPR1;NPAS2;PLXNC1;SMYD2;OPRM1;PTPN2;ROR2;TSC2;CRYAB;RNF167;SEMA5A;SNX3;SFRP4;ORC6;MDM4;SUZ12;ATF5;TGFBI;BLM;BMPR2;DNAJB2;PARP16;TMEM109;ITGA1;CCN5;ADRA1A;PRKD1;CCN1;ARHGDIB;P3H1;BCL2;IFIT3;MNT;FLCN;IMPACT;HGS;KLF10;DUSP1;OSGIN2;TBRG1;EMILIN1;UBR2;ITGB1BP1;ANXA6;COL18A1;TSPYL2;BST2;VAMP8;BTG2;PLXNB1;SESN2;NR1H2;AQP11;TGFB3;HYAL1;EIF2AK3;NR4A1;APBB1;ADGRG1;NOTCH4;SFRP1;RBM5;CCN4;ZBTB17;TEX15;DCBLD2;PLXNA1;SH3BP4;VHL;FGFBP1;CHERP;DLG5;KLF11;NME6;INHBA;DACT3;BMP2;NUDT6;LPXN
prerank,peptidyl-proline modification (GO:0018208),0.4014321085213521,1.1111448156317174,0.3272394881170018,0.9605669612287893,1.0,5/25,6.22%,PIN1;PPIB;PPIG;P3H2;PPIL3
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.40626982591067684,1.1106354125154914,0.33273056057866185,0.9609569621395432,1.0,5/23,13.93%,PLAAT3;LPCAT3;MBOAT1;PNPLA8;ABHD4
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3827284140972804,-1.1104700275054553,0.3119047619047619,0.6942505028568681,1.0,5/22,3.74%,MAP2;MAP1B;AEBP1;AKAP13;MAPT
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.31451190728250666,-1.1104124635698467,0.27348066298342544,0.6934855244993097,1.0,20/52,25.34%,SORBS1;LRP1;EGFR;ZDHHC5;STX3;DPP10;EPHA3;EPHB2;CLIP3;DLG1;WNK3;RACK1;CNST;ZDHHC8;PIK3R1;CLN3;PLS1;NKD2;AKT1;SPTBN1
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.425017498681296,1.1104109165510332,0.30715532286212915,0.9603264202614052,1.0,2/18,5.92%,CABYR;RFX3
prerank,ketone body metabolic process (GO:1902224),-0.47193242586912043,-1.110298689999737,0.3232931726907631,0.6929009015489378,1.0,4/10,10.88%,OXCT1;HMGCLL1;ACSS3;HMGCL
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.4389149185171647,-1.110151713578629,0.3497854077253219,0.6924106127303277,1.0,5/14,17.53%,SEC31A;SEC24D;SEC23A;SEC24C;SEC24A
prerank,regulation of phospholipase activity (GO:0010517),-0.47062579442902536,-1.110132396115029,0.3503184713375796,0.6915614114102145,1.0,2/10,0.72%,FGFR2;LRP1
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.286055090864492,-1.1098577719318934,0.22629969418960244,0.6914145062870928,1.0,31/84,26.35%,FOXP1;ANXA3;SASH1;FGF1;NRP1;MAPK14;PLPP3;BMP4;P2RX4;ROCK2;SPARC;SMOC2;THBS1;NRP2;LGMN;FOXC2;RHOB;GPLD1;TGFB1;SEMA5A;MET;BMPR2;AAMP;HSPB1;PRKD1;VEGFA;ITGB1BP1;ATOH8;AKT1;GATA2;STAT5A
prerank,regulation of dephosphorylation (GO:0035303),0.4463703969218735,1.1096205216545816,0.33584905660377357,0.9618041100809769,1.0,7/15,19.61%,SRC;PPP1R16B;MTMR2;SMG6;SMG5;IGBP1;SMG7
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.4015491442453973,-1.1091705822434907,0.3208791208791209,0.6924471299093655,1.0,6/17,25.84%,EGFR;PKD1;CCND3;CCNYL1;AKT1;SPDYA
prerank,gastrulation (GO:0007369),-0.42174807201686443,-1.1090664397131833,0.34328358208955223,0.6918081630546546,1.0,3/15,12.43%,GPC3;LRP5;UGDH
prerank,positive regulation of cell differentiation (GO:0045597),-0.24205932656639065,-1.108911351011546,0.17412935323383086,0.6913359064633537,1.0,36/237,8.28%,BMP6;RANBP3L;IGF1;CTNNA2;DAB2;COL1A1;SMAD3;NRCAM;BOC;NBL1;CDON;CTNNA1;CCN2;NELL1;BRINP1;TGFBR1;MEDAG;MAPK14;TGFBR2;SOX5;CTNNB1;BMP7;PDPN;SMAD4;RHOA;IL6R;BMP4;ZEB1;FBN2;HOXA5;WNT4;TMEM64;CREBL2;LRP5;FOXC1;BRINP2
prerank,defense response to virus (GO:0051607),0.3094554386552064,1.1087707397575743,0.28254847645429365,0.9634946653877232,1.0,20/100,13.23%,PTPRC;IFNLR1;IFITM2;IFIT1;MLKL;RNASE6;PHB2;IFITM3;CNOT7;IFITM1;RELA;SERINC5;NCBP3;SERINC3;ATG7;IFI27;BNIP3L;AGBL5;IRF2;NLRC5
prerank,lymphocyte differentiation (GO:0030098),0.3334749917799075,1.1085784421715053,0.3048780487804878,0.9627580762888995,1.0,12/68,13.02%,DCAF1;JAG2;PTPRJ;PTPRC;HDAC9;GPR89A;GPR89B;CEBPG;LFNG;KLF6;PIK3CD;HDAC5
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.39095288246892174,-1.108544656738504,0.3235955056179775,0.6914603073414293,1.0,13/21,39.49%,SMO;DCDC2;EVC;GLI1;SFRP1;DLG5;TTC23;PDCL;KIF7;GAS8;ULK3;RAB34;STK36
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.2932706447261863,-1.107977250731014,0.26331360946745563,0.6920900491925152,1.0,12/63,8.03%,TIMP3;LEPR;TIMP2;NELL1;SIRT2;NUPR1;KDM4A;KLHL22;SORL1;ROCK1;PTPN3;GOLGA2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3756399589237438,-1.107907760491954,0.2947845804988662,0.6913808423671584,1.0,4/23,5.25%,ERBB4;PIBF1;KIT;GHR
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.43844586242911027,1.1076866654723558,0.3333333333333333,0.9646214846829633,1.0,4/16,6.91%,ATP5F1E;ATP5MG;ATP5PF;ATP5MC2
prerank,thyroid hormone generation (GO:0006590),-0.46603184508486856,-1.1069848619304994,0.32558139534883723,0.6930680231595057,1.0,3/10,25.27%,CPQ;SLC5A5;CTSK
prerank,negative regulation of double-strand break repair (GO:2000780),-0.34856888128810853,-1.1069244839490358,0.308584686774942,0.6923328028927394,1.0,21/30,44.00%,ERCC6;SHLD1;UBR5;RNF169;HSF1;SMCHD1;RIF1;SHLD2;HMGA2;OTUB1;POLQ;TWIST1;OGG1;CYREN;FANCB;CGAS;MAD2L2;RMI2;TFIP11;NUDT16L1;PARPBP
prerank,cell cycle checkpoint signaling (GO:0000075),0.47519072515446625,1.106846625786663,0.3608058608058608,0.9663166074419269,1.0,4/12,10.86%,PLK2;PRCC;WEE1;CHFR
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.34065116932492095,-1.1064557614479509,0.29292929292929293,0.6927073498867069,1.0,12/33,28.67%,TEAD1;SMAD3;TP53;JUN;TGFB1;NR3C1;GNL3;KLF5;ATOH8;GATA2;EGR1;FOXO3
prerank,ameboidal-type cell migration (GO:0001667),0.3484571570325763,1.1063354722635217,0.2954898911353033,0.9667102740177486,1.0,10/51,9.67%,SEMA6A;SEMA6D;SEMA7A;PKN3;SEMA3C;AMOTL1;TBX1;SEMA6B;SEMA4C;PKN1
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.3360722701341127,-1.1062569847929782,0.3194805194805195,0.6923870212423244,1.0,13/36,16.71%,ANK3;VAMP5;MACF1;RILPL1;RAB31;GGA2;OPTN;AFDN;VAMP2;BBS2;NECTIN3;GOLGA7;GGA3
prerank,regulation of axon extension (GO:0030516),-0.33624317646893376,-1.1062304565775702,0.29155313351498635,0.6915407854984894,1.0,8/37,6.93%,MAP2;NRCAM;PTPRS;MAPT;MACF1;SHTN1;SEMA3A;CTTN
prerank,regulation of trophoblast cell migration (GO:1901163),-0.431072404554224,-1.106222262034192,0.35429769392033544,0.690676172899009,1.0,5/14,22.43%,SMURF2;GJA1;ACVR1B;ARHGDIB;VEGFA
prerank,nucleocytoplasmic transport (GO:0006913),0.3605637214848467,1.105808941073417,0.29329173166926675,0.9672635137165612,1.0,7/40,9.21%,SNRPD2;NCBP1;SNRPD1;BACH2;NXT1;GEMIN5;RSRC1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4051350328584353,-1.1056219847892461,0.3325942350332594,0.6914266119311868,1.0,2/17,2.78%,PLA2G4A;LPGAT1
prerank,organic cation transport (GO:0015695),0.4235212574462369,1.1055954926957325,0.33451957295373663,0.9666022536333856,1.0,3/20,8.07%,SLC5A7;SLC44A1;SLC25A26
prerank,regulation of mRNA stability (GO:0043488),0.2976984679574876,1.1055350406623392,0.2635135135135135,0.9653895452926163,1.0,32/145,16.53%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;HSPA8;ZFP36L1;PSMD11;PSMB4;PSMC1;FXR1;YWHAB;EXOSC9;PCID2;PSMC2;PSMD2;TAF15;ZC3H14;EXOSC1;XPO1;PSMD14;PSMC6;PSMD1;PSMB1;YBX1;DCP1A;FUS;FTO;NOCT;PARN;PSMA4
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.4395925385135539,1.1051790444899017,0.35071942446043164,0.965210477215988,1.0,7/18,16.45%,RUVBL2;CCT2;CCT5;RUVBL1;TCP1;DKC1;PARN
prerank,aggrephagy (GO:0035973),-0.3581039696804163,-1.1049161871001896,0.2833333333333333,0.692469700581952,1.0,6/27,4.07%,WDFY3;ACBD5;UBE2N;DYNC1H1;DYNC1LI2;VIM
prerank,phospholipid dephosphorylation (GO:0046839),-0.33476461263863394,-1.1047871546149268,0.30049261083743845,0.6919248694348814,1.0,17/37,27.08%,PLPPR1;PLPP3;MTMR7;PIP4P2;SACM1L;PLPPR5;MTMR12;PLPPR4;MTMR9;MTMR4;MTMR11;PLPP5;EPHX2;INPP5F;OCRL;PIP4P1;INPP5K
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.32794378937604546,1.104562943982921,0.2898134863701578,0.9661122863243964,1.0,16/73,14.59%,CTCFL;EZH2;EED;POLR1C;ACTB;EP300;TDG;POLR1G;BMI1;WBP2;TBP;HDAC5;PPHLN1;TRIM27;AEBP2;TASOR
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4809115033041861,1.1044600336904324,0.3352380952380952,0.9649848731058621,1.0,3/11,16.65%,PPIP5K2;IP6K2;ITPKB
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.379690676190683,1.1043152574273005,0.3277870216306156,0.9640582859354984,1.0,11/32,17.90%,ACER2;SRC;CLASP2;MMP12;NEXMIF;ACVRL1;HOXA7;MAP4K4;SEMA3E;CORO1C;CASK
prerank,autophagosome maturation (GO:0097352),0.37687307769368894,1.1040692385159105,0.31833910034602075,0.9635817993522742,1.0,12/32,19.01%,MAP1LC3B;ATP2A2;VMP1;EPG5;TECPR1;UBQLN1;ATG14;GABARAPL1;VPS33A;GABARAP;LAMP2;CALM1
prerank,aminoglycan metabolic process (GO:0006022),0.4978960229351377,1.1039756463143315,0.35660377358490564,0.9624863038686176,1.0,2/10,9.31%,XYLT1;B3GAT2
prerank,regulation of cytoplasmic transport (GO:1903649),0.4787460296272835,1.1036718936203633,0.3346303501945525,0.9621911689462948,1.0,2/11,3.17%,MAPK3;SRC
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.280272448350854,1.1035568426108169,0.2688039457459926,0.9612052365282784,1.0,43/234,13.91%,LRP8;MAP3K7;TAB2;RPS6KA4;CAMK1D;PRKCH;TIRAP;HIPK2;TRIM8;PRKD2;RPS6KA5;RAB7B;PHB2;TRIM14;CIB1;EP300;CARD16;TRAF5;CEBPG;EPHA5;RGCC;CLOCK;TAB3;WNT5A;TRIM25;RELA;RBCK1;PARK7;BUD31;UBE2V1;RNF25;ESR1;NOD1;APP;RPS3;PRKCI;IKBKB;ERC1;CHUK;HDAC5;DDIT3;NFKBIA;TRIM27
prerank,regulation of protein-containing complex assembly (GO:0043254),0.30478357980664555,1.1030998013474738,0.26620689655172414,0.9615291983551316,1.0,23/110,14.07%,RALB;TAL1;SLF1;HSPA8;TIRAP;SRC;SVIP;APOE;EP300;ICE1;SELP;SYK;NAPA;HJURP;PARK7;DDX3X;TRAF3IP1;RPS3;BMF;CDH5;FAF1;HCFC1;AIDA
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3342820879965419,1.1030352626433817,0.29892141756548535,0.960328551895108,1.0,13/60,11.57%,TRIM28;LEF1;CCNC;CDKN1A;MED23;MED12;HEY2;MED15;CDK4;RELA;CSF1R;AGO4;MED4
prerank,renal water homeostasis (GO:0003091),-0.3771503711581049,-1.102857656871971,0.3090507726269316,0.6964277360881006,1.0,9/23,13.00%,ADCY5;ADCY2;ADCY1;ADCY9;PRKACA;AQP4;PRKAR1B;ADCY7;RAB11A
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.30896131883748745,1.1027511871208657,0.28633093525179854,0.9599399987133923,1.0,15/102,9.93%,PCK1;PRKAR1A;GSK3A;TRIB3;NR4A2;INSIG1;SRC;HDAC9;ZFP36L1;TSHR;MYO5A;TBC1D4;IRS2;RELA;RHOQ
prerank,regulation of cholesterol esterification (GO:0010872),0.48469481050380003,1.1025379702890752,0.36213991769547327,0.959322506979107,1.0,2/10,6.62%,APOE;LAMTOR1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.35027150844787425,-1.102447259305441,0.2955665024630542,0.6966515284828854,1.0,19/29,44.52%,CYLD;PML;THBS1;TRAF2;PPP2R1B;LTBR;TNFSF12;BCL10;SFRP1;INHBA;BID;CAV1;DEDD2;GPER1;HTRA2;AGT;HYAL2;G0S2;PYCARD
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3773091375877907,1.1018865361428491,0.32078559738134205,0.9603056833570162,1.0,8/32,11.20%,PCK1;FITM2;NR5A1;APOE;ASXL3;ADIPOR2;PRKAA2;ADIPOR1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.3223182765128655,-1.1016705116786434,0.28061224489795916,0.6979406035297274,1.0,6/41,9.44%,HTR2C;ITPR1;GRIN2B;RYR3;ERO1A;SLC24A2
prerank,"wound healing, spreading of cells (GO:0044319)",-0.3662219379357622,-1.101423509909895,0.30985915492957744,0.6977148199349171,1.0,7/24,6.57%,TMEFF2;COL5A1;PDPN;RHOA;FLNA;DDR1;ITGA5
prerank,negative regulation of proteolysis (GO:0045861),-0.3370067384671576,-1.1013868241410596,0.29873417721518986,0.696932603965887,1.0,7/34,12.29%,TIMP3;TIMP2;ROCK1;PTPN3;GAS1;CAMK2N1;ECM1
prerank,actin filament depolymerization (GO:0030042),-0.45953027634946364,-1.1013724023128737,0.3553191489361702,0.696062340227748,1.0,5/11,17.28%,GSN;MICAL2;MICAL3;WDR1;TWF2
prerank,adrenergic receptor signaling pathway (GO:0071875),-0.38953221237893604,-1.1013102572126146,0.3325842696629214,0.6953451690643725,1.0,8/20,24.87%,AKAP13;ADCY9;ADRA1B;LMBRD2;ZDHHC21;RAPGEF2;ADRA1A;ADRA2A
prerank,cellular response to interleukin-7 (GO:0098761),0.43281129100159427,1.1011721931881093,0.344954128440367,0.9601105970650163,1.0,6/17,18.07%,CISH;IRS2;IL7;SMARCA4;STAT3;IRS1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.43281129100159427,1.1011721931881093,0.344954128440367,0.9601105970650163,1.0,6/17,18.07%,CISH;IRS2;IL7;SMARCA4;STAT3;IRS1
prerank,regulation of ATP metabolic process (GO:1903578),-0.31505734004780456,-1.1007407938616982,0.26944444444444443,0.6961061187906136,1.0,23/54,25.00%,PRKAG2;OGT;PRKAG1;ATP7A;NUP205;NUP155;FIS1;NUP188;NUP93;NUP88;SEH1L;COX7A2L;ATP5IF1;NUP85;AAAS;PINK1;SLC25A33;RAE1;NUP37;NUP214;PGAM1;UQCC2;SEC13
prerank,negative regulation of cell junction assembly (GO:1901889),-0.36506832724179056,-1.1007151037751117,0.3012345679012346,0.6952836522322927,1.0,12/25,26.19%,ROBO2;PHLDB2;ROCK2;ARHGAP6;ROCK1;THBS1;DUSP22;ACE;APOD;ITGB1BP1;DMTN;FAM107A
prerank,protein trimerization (GO:0070206),0.45589987227893713,1.100283970430761,0.36074766355140186,0.9605390762382717,1.0,3/14,8.27%,SIGMAR1;MLKL;SLC1A2
prerank,protein homotrimerization (GO:0070207),0.45589987227893713,1.100283970430761,0.36074766355140186,0.9605390762382717,1.0,3/14,8.27%,SIGMAR1;MLKL;SLC1A2
prerank,negative regulation of viral genome replication (GO:0045071),0.3612379317939286,1.1001512474476227,0.3338735818476499,0.9596434009833714,1.0,7/40,10.63%,ILF3;BANF1;IFITM2;IFIT1;IFITM3;IFITM1;SRPK2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.41289173781845595,1.1001484880686423,0.3286219081272085,0.9582456214292331,1.0,8/21,16.32%,GREM1;HEY1;HEY2;NOTCH1;TRPM4;NOS3;GAS6;PTK2B
prerank,response to ethanol (GO:0045471),0.4533725041119359,1.099774939911801,0.34057971014492755,0.958248218622185,1.0,3/14,4.51%,SOD1;GOT2;SDF4
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.488226756362049,1.0991915233702236,0.34766355140186916,0.9589054381949169,1.0,2/11,2.89%,SEMA6A;KLF2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.32150819337870207,1.0986023726826741,0.3233082706766917,0.9596097975993984,1.0,17/76,13.81%,TNFAIP3;NWD1;MAP2K5;SIRT1;NLRC3;MTURN;ERBIN;TRAF3;RBCK1;CYP1B1;NFKBIL1;G3BP2;CHUK;NLRC5;DDIT3;FAF1;NFKBIA
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.2892478039993248,1.098259393915013,0.27897574123989216,0.9594356296690062,1.0,35/158,15.09%,ZDHHC17;JMJD8;MAP3K7;TAB2;PLK2;EEF1D;TIRAP;TRIM8;BIRC2;ZDHHC13;TNFRSF10B;TMED4;EDAR;TRIM14;GPR89A;CARD16;TRAF5;TAB3;TRIM25;RELA;RBCK1;LURAP1;UBE2V1;NOD1;TNIP2;IKBKB;NEK6;CHUK;ANKRD17;PPP5C;ATP2C1;TRIM27;MAP3K3;S100A13;TERF2IP
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.431728857473718,-1.0982091472901159,0.3431151241534989,0.7013634664590912,1.0,7/13,21.58%,IDH2;PHYH;D2HGDH;ADHFE1;GPT2;L2HGDH;GOT1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.3235213859004068,1.097804026568518,0.3020030816640986,0.9597299749643635,1.0,7/72,4.86%,POLR2J;MAPK3;NCBP1;CBL;POLR2B;SHCBP1;SPRED1
prerank,heart trabecula morphogenesis (GO:0061384),-0.38843477938275733,-1.0977246181854123,0.34725274725274724,0.7018872553736025,1.0,5/18,7.69%,TGFBR3;TGFBR1;BMP5;BMP7;RBP4
prerank,post-translational protein modification (GO:0043687),0.2723608832682837,1.09771208393591,0.2273781902552204,0.9586822127397581,1.0,57/332,13.96%,CISH;PSMB10;PSMC4;PSMB6;CAND1;ELOC;RNF7;PSMD8;PSMD5;PSMD12;KLHL5;CHML;KLHL3;FEM1C;BTBD1;CHM;PSMD11;CDH2;NEURL2;APOE;PTP4A2;PSMB4;FBXL5;RAB11B;WFS1;PDIA6;PSMC1;VWA1;FBXW2;DCAF6;COP1;LMO7;KLHL2;FBXO32;FBXO11;RAB1A;ESCO1;PSMC2;FBXO7;PSMD2;UBE2M;MBTPS1;ICMT;NAE1;STT3B;COPS7B;APP;ELOB;DCAF10;CUL3;PSMD14;UBE2F;PSMC6;EPAS1;PSMD1;PSMB1;PROC
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.4216681355279223,1.0976693036709768,0.3315508021390374,0.957450305558171,1.0,7/19,17.92%,PTPRJ;PTPRC;SELP;PRNP;ADGRL1;BCAP31;RYR2
prerank,glutathione metabolic process (GO:0006749),0.3660538173407358,1.0972839536144199,0.3349282296650718,0.9574132236314027,1.0,7/38,13.08%,GCLC;SOD1;GCLM;CNDP2;PARK7;HAGH;GSS
prerank,pyroptosis (GO:0070269),-0.4192732210227428,-1.0972101291314145,0.3516483516483517,0.7023924148428311,1.0,9/15,51.20%,GSDME;AIM2;GSDMD;APIP;CASP8;CASP1;ZBP1;NLRC4;TREM2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.26789916110689416,-1.0968853243147867,0.23157894736842105,0.7023794899749325,1.0,14/113,5.79%,BMP6;FGFR2;NOTCH2;IGF1;EGFR;FGF1;NRP1;TGFBR1;BMP5;BMP4;RREB1;OSR1;SRSF6;F3
prerank,aortic valve morphogenesis (GO:0003180),-0.34587887656428823,-1.096776162252177,0.3370288248337029,0.7017857553636879,1.0,6/30,8.64%,ROBO2;ROBO1;BMP4;ROCK2;ROCK1;SMAD6
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.4896470584613645,1.0967199995624766,0.3424124513618677,0.9580387058265556,1.0,5/10,19.71%,CCT2;CCT5;TCP1;DKC1;CCT8
prerank,neuropeptide signaling pathway (GO:0007218),-0.29550545942981415,-1.0966997222759478,0.26256983240223464,0.7011332176949675,1.0,11/58,19.72%,SORCS1;GLRB;SORCS3;SORL1;GLRA3;GLRA1;GPR37;RAPGEF2;OPRM1;HCRTR2;SORCS2
prerank,glycogen catabolic process (GO:0005980),-0.4156915623376697,-1.096614752591793,0.31063829787234043,0.7004708593062832,1.0,7/15,19.45%,PYGB;AGL;PHKA2;PYGM;PGM2;GAA;PHKG2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.35479455065451265,1.0966057495273187,0.313953488372093,0.9570742565034226,1.0,11/38,13.25%,NDUFAF1;NDUFB6;NDUFB4;NDUFA10;NDUFA1;NDUFS2;NDUFB7;NDUFV3;NDUFA8;NDUFC2;NDUFA13
prerank,skeletal system morphogenesis (GO:0048705),-0.3186146701877658,-1.096143871966829,0.2860635696821516,0.7008328208967195,1.0,16/42,23.65%,FGFR2;TGFBR1;FBN2;HOXA3;DYNC2I1;PDGFRA;SKI;LRP5;CYP26B1;LRP6;HOXC4;SIX1;SFRP4;HOXB3;HOXC9;RAB33B
prerank,positive regulation of axon extension (GO:0045773),-0.3737664391087894,-1.095863892562374,0.32516703786191536,0.7006631648814429,1.0,10/22,22.43%,NRP1;MAPT;MACF1;DSCAM;SHTN1;TWF2;ZFYVE27;SEMA5A;DBNL;VEGFA
prerank,response to alcohol (GO:0097305),-0.3591595193275944,-1.095732477044882,0.3111111111111111,0.7001824880087473,1.0,5/27,7.68%,TGFBR3;GRIN2B;TGFBR1;TGFBR2;GLRA1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.39447207790330263,1.0956771363825,0.3229706390328152,0.9590326186184462,1.0,6/26,9.73%,FYN;SIRT1;TXN;SOD2;PARK7;FBXO7
prerank,peptidyl-lysine acetylation (GO:0018394),0.48985572696135066,1.0956204379107046,0.3629032258064516,0.9578666654699777,1.0,4/10,10.84%,EP300;SIRT1;ESCO1;CREBBP
prerank,transcription by RNA polymerase III (GO:0006383),0.38563606226417063,1.0954366920023537,0.3520140105078809,0.9571732208150322,1.0,9/27,18.57%,GTF3C1;ICE1;GTF3C5;RO60;IVNS1ABP;TBP;GTF3C2;POLR3K;POLR3GL
prerank,intraciliary retrograde transport (GO:0035721),-0.44469325007939875,-1.0952602764366328,0.36363636363636365,0.7005933854360878,1.0,6/12,27.33%,WDR35;DYNC2I1;TTC21B;WDR19;DYNLT2B;DYNC2I2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3954861385938224,-1.0946357188692328,0.33406593406593404,0.7014279199680784,1.0,7/19,25.10%,VIM;BMP4;WNT4;TGFB1;EMILIN1;TGFB3;CREB3L1
prerank,negative regulation of cell aging (GO:0090344),0.43484771757887114,1.0941222762458787,0.34572490706319703,0.9604122959361517,1.0,6/16,14.19%,FBXO5;SIRT1;ZKSCAN3;TERT;YBX1;MAP3K3
prerank,regulation of lipid metabolic process (GO:0019216),0.31575684156241407,1.0939430468252578,0.3098995695839311,0.9596885209718319,1.0,18/88,12.91%,PCK1;GPAM;HMGCR;HDAC3;PANK2;ELOVL6;PLPP1;PPARD;SC5D;IRS2;ACACB;IDI1;CREBBP;CARM1;ADIPOR1;LSS;SP1;NPC2
prerank,vesicle coating (GO:0006901),0.33388580988254757,1.093835443586678,0.3143712574850299,0.9559726048592332,1.0,15/61,15.49%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;F8;GOSR2;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3;PPP6R1;TRAPPC10
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.33388580988254757,1.093835443586678,0.3143712574850299,0.9559726048592332,1.0,15/61,15.49%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;F8;GOSR2;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3;PPP6R1;TRAPPC10
prerank,COPII vesicle coating (GO:0048208),0.33388580988254757,1.093835443586678,0.3143712574850299,0.9559726048592332,1.0,15/61,15.49%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;F8;GOSR2;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3;PPP6R1;TRAPPC10
prerank,heart process (GO:0003015),0.45160526791576877,1.0935709223402381,0.3525305410122164,0.9555806139404963,1.0,2/14,4.96%,SOD1;FYN
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.43199333669098605,1.0930153941071794,0.34210526315789475,0.9562144313166712,1.0,4/17,14.70%,BOD1;CHAMP1;MIS12;MTBP
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.465409306596435,-1.092922019348291,0.3443298969072165,0.7052919430991818,1.0,3/11,19.85%,JAK1;IL6ST;STAT1
prerank,RNA modification (GO:0009451),0.3384704065534443,1.0928669419572465,0.30647709320695105,0.9553115946437161,1.0,15/54,19.78%,THG1L;THUMPD1;BCDIN3D;ADAR;ANKRD16;WDR4;SSB;ADARB1;NSUN6;PARN;CDKAL1;NSUN2;TFB1M;FTSJ1;URM1
prerank,male meiosis I (GO:0007141),0.4270421997620446,1.0926883549965838,0.3498233215547703,0.9545712985756694,1.0,15/16,49.91%,ING2;FOXJ3;ZSCAN21;MYBL1;BRDT;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;FOXJ2;SLC25A31;DDX4;TDRD9;SYCP3
prerank,leukotriene metabolic process (GO:0006691),-0.39208401206817317,-1.0923801847198777,0.3378684807256236,0.7058626192633252,1.0,14/19,55.52%,PLA2G4A;GGT5;MAPKAPK2;ABCC10;MGST3;ALOX12;LTA4H;PTGR1;GGT1;MGST2;ALOX5;PLA2G5;ALOX5AP;DPEP1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.30192430111627755,-1.0923639671876824,0.3101449275362319,0.7050235104377258,1.0,8/57,6.98%,ERBB4;IGF1;PARP14;IL6R;PIBF1;KIT;GHR;IL31RA
prerank,positive regulation of protein metabolic process (GO:0051247),0.3038217737035204,1.092340494461487,0.28610354223433243,0.9544656564022362,1.0,20/110,13.97%,GSK3A;ABCB10;TNFAIP3;PLK2;KLF2;MAP2K5;NEDD4L;APOE;RAB7A;WFS1;MAPK8;AXIN1;WNT5A;RAB1A;APP;ATG7;EGLN2;NDUFA13;NFKBIA;APC
prerank,transcription preinitiation complex assembly (GO:0070897),0.4564752401121761,1.0923298484926205,0.35634328358208955,0.9531587485678211,1.0,5/12,15.76%,BDP1;GTF2A2;TBP;DR1;TAF1
prerank,smoothened signaling pathway (GO:0007224),-0.34382788798881,-1.0921744153052837,0.3038277511961722,0.7046841973917547,1.0,8/32,11.72%,GLI2;GLI3;CC2D2A;SMO;EVC2;HIPK1;ARL13B;TTBK2
prerank,cell junction organization (GO:0034330),-0.2865145828036809,-1.0920286259846224,0.27405247813411077,0.7041842900302114,1.0,15/71,7.62%,SDK1;GRM5;SMAD3;PPFIBP1;CXADR;MAPT;OCLN;RHOA;SLC6A1;NLGN2;FLNA;PPFIA1;RAB8B;CTNND2;SDK2
prerank,regulation of amyloid-beta formation (GO:1902003),-0.3373025231215155,-1.0920028806887974,0.2995049504950495,0.7033702207587947,1.0,11/34,12.84%,IGF1;SLC2A13;LRRTM3;NTRK2;RTN1;ROCK2;SORL1;ROCK1;BIN1;IFNGR1;GSAP
prerank,regulation of endopeptidase activity (GO:0052548),-0.28931406329991033,-1.091899466670625,0.28133704735376047,0.7027799647407161,1.0,6/59,4.44%,SPOCK3;NRDC;TIMP3;SPOCK1;TIMP2;HDAC1
prerank,heme biosynthetic process (GO:0006783),0.40798667859563553,1.0918231789266573,0.35934664246823955,0.9536784596364738,1.0,9/22,18.57%,ABCB10;ABCG2;TSPO;COX15;COX10;SLC25A38;ALAS1;FECH;NFE2L1
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.3417669422597538,-1.0915953579508444,0.2932692307692308,0.7027005037754944,1.0,9/31,11.90%,RANBP3L;CRIM1;SKI;TMEM64;LRP5;SMAD6;CDK6;SEMA4D;LIMD1
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.4256807278110587,-1.0912228241800186,0.33125,0.7028734725165713,1.0,7/14,26.70%,FLNA;LOXL3;PRKD1;ITGB1BP1;EMP2;DMTN;SLC2A10
prerank,homologous chromosome pairing at meiosis (GO:0007129),-0.3476317873644257,-1.0910449022601303,0.2992874109263658,0.7025027678219586,1.0,24/29,64.30%,SIRT7;BAG6;RAD21;PRDM9;P3H4;TERB1;MEI4;FANCD2;ZCWPW1;TEX11;REC8;TRIP13;SYCE2;MAJIN;MEIOB;TEX12;STAG3;IHO1;SYCP2;RAD21L1;RNF212B;ANKRD31;HORMAD1;TERB2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3979359024396477,1.0910006043339338,0.34501845018450183,0.9553602366485066,1.0,9/26,20.19%,RRM2B;ALG6;ALG8;TPI1;ST8SIA6;RRM1;GBGT1;ST3GAL2;ALG2
prerank,positive regulation of ERAD pathway (GO:1904294),-0.43139663156800634,-1.0907920198960506,0.3456032719836401,0.7023114968551574,1.0,9/13,30.65%,USP13;HERPUD1;TMEM259;RNFT1;SGTA;BAG6;NFE2L2;RNF185;CAV1
prerank,actin crosslink formation (GO:0051764),0.46008374027817833,1.0907006536638504,0.35471698113207545,0.9550913870988083,1.0,2/12,1.74%,LCP1;GAS2L1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4640731243380124,1.0906233689841518,0.352059925093633,0.9540480849106214,1.0,4/11,11.94%,NEDD4L;GOPC;LEPROTL1;PICALM
prerank,negative regulation of cartilage development (GO:0061037),-0.43175138532761625,-1.090566111938202,0.34324942791762014,0.7021249115556105,1.0,3/13,4.69%,ADAMTS12;TGFBR1;EFEMP1
prerank,regulation of calcium ion import (GO:0090279),0.41244251552461497,1.0905401612464596,0.3591549295774648,0.9529796141146973,1.0,6/21,17.18%,CXCL12;PSEN2;FYN;PRNP;TRIM27;SLC30A1
prerank,histone methylation (GO:0016571),0.3906914430084233,1.0905113110954423,0.3391304347826087,0.9517381075588858,1.0,5/26,10.86%,CTCFL;EZH2;SMYD3;CREBBP;CARM1
prerank,regulation of blood coagulation (GO:0030193),-0.3579603808684669,-1.0905064551289694,0.32786885245901637,0.7014256042296073,1.0,10/27,25.88%,TFPI;THBS1;VTN;FAP;EPHB2;CD34;ST3GAL4;ENPP4;DMTN;SERPINE1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.31378053019399627,1.0899145594133803,0.302158273381295,0.9524248586426248,1.0,23/88,13.35%,HSPA8;SH3D19;SORT1;EXOC8;EXOC6B;MYO5A;GOPC;DTNBP1;CLTA;AP1G1;AP1S2;NAPA;RAB14;ARF1;AP4S1;RABEP1;DOP1B;CHMP2A;CLVS1;APP;SCFD1;SCAMP1;CCDC93
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3732177458828864,1.089836124472251,0.34305317324185247,0.9513974962074927,1.0,12/31,21.23%,GSK3A;MAPK8;YWHAB;ZNF205;BAD;PPP3R1;YWHAH;BAX;YWHAQ;YWHAE;YWHAZ;TFDP2
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.4677902853161718,1.088992770932639,0.36363636363636365,0.9529948628193249,1.0,3/12,12.77%,NEK9;CNEP1R1;NEK6
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3448693569993967,1.0888977341404888,0.3261538461538461,0.9520012866314754,1.0,12/45,17.69%,FAM83B;CBL;SRC;RPS6KA5;PLCG1;ERBIN;PIK3C2A;BRAF;PTK2B;SHC1;PTPN11;KIF16B
prerank,response to calcium ion (GO:0051592),-0.2724762718670809,-1.0884053656379302,0.27364864864864863,0.7063856762479508,1.0,26/102,16.10%,KCNMA1;CPNE8;RYR3;IQGAP1;SEC31A;STIM1;ADCY1;CLIC4;ADGRV1;SLC25A13;ANXA11;SYT9;NLGN1;TRPC1;THBS1;LGMN;CAMK2D;SYT12;SYT11;SYT4;RASGRP2;CPNE2;SYT7;D2HGDH;GPLD1;PEF1
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.4944616410246392,1.0880586678719564,0.3619744058500914,0.9524144975885056,1.0,4/10,15.40%,ALKBH2;ASCC3;MPG;FTO
prerank,DNA dealkylation (GO:0035510),0.4944616410246392,1.0880586678719564,0.3619744058500914,0.9524144975885056,1.0,4/10,15.40%,ALKBH2;ASCC3;MPG;FTO
prerank,brain development (GO:0007420),-0.2556890572942076,-1.0878686468421899,0.24723247232472326,0.7069444444444445,1.0,57/136,31.38%,ROBO2;CNTN4;ZIC1;CTNNA2;ARNT2;PBX1;GRIN2B;NFIB;AFF2;NCOA6;TGFBR2;EPHA7;MEIS2;FBXW11;RELN;HSPG2;NIPBL;SMARCA1;ZIC2;NNAT;SCYL2;CTNS;ATXN1;CIC;BBS2;PLXNB2;RAPGEF2;NES;PBX4;SOX6;BPTF;PBX2;APOD;SMG9;GRIN2D;BAG6;GRIN1;IER3IP1;PCDH18;PAX2;NDRG4;ADGRG1;PTCH1;DDIT4;CX3CR1;POU6F1;EEF1AKMT4-ECE2;SLC6A17;QARS1;UTP3;AATK;MDGA1;TMX2;CLN5;MFSD2A;CDK5RAP3;VPS51
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.31314637262339,1.0878327125095857,0.3071104387291982,0.9518970522499159,1.0,9/87,6.09%,POLR2J;MAPK3;NCBP1;CBL;POLR2B;SHCBP1;ZFP36L1;SPRED1;TBX1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.43241112228076606,1.0877350096264071,0.3498168498168498,0.9509307039843327,1.0,3/18,4.43%,PSEN2;APOE;TMCC2
prerank,bile acid metabolic process (GO:0008206),-0.35172911783255195,-1.0872519559448228,0.325635103926097,0.7079334937658553,1.0,5/27,9.99%,OSBPL9;OSBPL6;CYP27A1;CYP7B1;OSBP
prerank,regulation of anatomical structure morphogenesis (GO:0022603),-0.2609822401476369,-1.0870831523674618,0.23943661971830985,0.7075695198904648,1.0,17/118,5.70%,LRRC4C;FGFR2;PHLDB2;ADGRB3;PDLIM5;EFNA5;ADGRA2;PDZD8;BMPER;PHLDB1;SDC2;PID1;MAPT;CTNNB1;STAT2;ZMYM6;HECW1
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.32351816781286036,-1.0869719949619197,0.2942708333333333,0.7070141358513283,1.0,8/39,10.03%,PKD1;GLI2;NRP1;TGFBR2;CTNNB1;BMP4;LRP5;SALL1
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.32270448892738696,-1.0869513138585398,0.300531914893617,0.7062193338628385,1.0,12/41,20.79%,ANK3;JAK1;BMP7;PLPP3;ADAM19;AFDN;DENND6A;PTPRU;MEGF10;PTPN23;FLOT1;CX3CL1
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.26208320864421214,-1.086586577935232,0.2326388888888889,0.7063217059292347,1.0,29/117,17.24%,IGF1;ALDH1A2;ME1;ABAT;MCCC2;VDAC1;PER2;CPT1A;PPARA;HLCS;PCCB;PDHX;DLD;SCPEP1;ACOT11;CKB;LDHB;CPT1C;ALDH4A1;MSMO1;ACADSB;CYP26B1;GGT5;GLO1;PCCA;ACSF2;ACOT7;AASDH;SLC5A6
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.44237471039736187,-1.0865682495172908,0.358974358974359,0.7055130398080682,1.0,9/12,51.86%,B3GALT5;B3GALNT1;B3GALT1;B3GALT2;B3GNT9;B3GNT3;B3GNT8;B3GNT6;B4GAT1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.49201713030278554,1.086514273158521,0.36470588235294116,0.9540510088520119,1.0,1/10,0.92%,SEMA6A
prerank,cytoplasmic translational initiation (GO:0002183),0.42764291818120814,1.0861152753823016,0.3522935779816514,0.9541636863960581,1.0,9/17,18.87%,MCTS1;EIF2B3;EIF4H;EIF4B;EIF5;EIF3M;EIF2S2;EIF3A;EIF4G1
prerank,cilium organization (GO:0044782),-0.24128423475153088,-1.0857383043850186,0.21428571428571427,0.7068363181191227,1.0,63/209,19.66%,GSN;PARVA;AHI1;PKD1;CC2D2A;EXOC3;RILPL1;FLNA;PIBF1;IFT81;DZIP1;TTC8;WDR35;DYNC2I1;DCDC2;RAB8B;CCDC66;NUDCD3;CCDC57;CFAP20;EXOC6;IFT46;TTC39C;IFT52;ACTR3;CEP89;CEP126;IFT172;CEP20;CFAP44;IFT74;RP2;ARL13B;ABLIM3;TTBK2;DISC1;BBS9;KIF3A;DZIP1L;RAB11A;WDR19;WDR11;INTU;RAB23;CCP110;BBS2;ARF4;CYS1;EXOC1;EXOC7;CEP250;PTPN23;EHD3;EHD1;DYNLL2;RAB8A;IFT20;ACTR2;BBS5;SNAP29;TMEM237;CCDC28B;TTLL3
prerank,translational termination (GO:0006415),0.30894142857722634,1.0853216421467387,0.3188202247191011,0.9557094027919157,1.0,13/95,12.31%,MRPS22;MRPS2;MRPS33;MRPL24;MRPL23;MRPL18;MRPL38;MRPS12;MRPL20;MRPL52;MRPL48;MRPS15;MRPS24
prerank,positive regulation of transferase activity (GO:0051347),0.2955745758362007,1.0852498951348843,0.3113207547169811,0.9546302238716661,1.0,28/142,11.75%,SERINC1;MAP2K7;MAPK3;GSK3A;TRIB3;PIN1;PNKP;GREM1;CCT2;DCUN1D4;TEK;MAP3K4;UBE2I;DBI;RET;EPHA5;BMI1;AXIN1;EPM2AIP1;MAGEC2;MERTK;ACD;CSF1R;TIE1;SERINC5;NEK7;FLT1;TNKS
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.45450920109083603,-1.0850488968181446,0.3616161616161616,0.7079015209153561,1.0,1/11,1.32%,AKAP6
prerank,heart looping (GO:0001947),-0.32091159469671754,-1.085019163651728,0.2975871313672922,0.7071215541759348,1.0,14/39,35.47%,AHI1;MICAL2;TGFBR2;SMO;TBX3;SETDB2;BBS5;CCDC39;NDRG4;TBX2;ZIC3;VANGL2;MKKS;SOX18
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3266990459379459,1.0848088453113327,0.31846153846153846,0.9549358136818987,1.0,13/59,11.57%,TRIM28;LEF1;CCNC;CDKN1A;MED23;MED12;MED15;CDK4;RELA;CSF1R;BCLAF1;AGO4;MED4
prerank,ion homeostasis (GO:0050801),0.37702563020444924,1.0844606855941625,0.3299145299145299,0.9548389803473197,1.0,4/30,4.26%,SLC4A4;SLC4A5;KLHL3;NEDD4L
prerank,positive regulation of interleukin-8 production (GO:0032757),0.34769826748357924,1.0844291501845669,0.334384858044164,0.9536167839486213,1.0,8/49,13.25%,TIRAP;PRKD2;SYK;RELA;RAB1A;PARK7;NOD1;DDIT3
prerank,cellular response to exogenous dsRNA (GO:0071360),0.46165083682033825,1.0843118409047496,0.352,0.9526724161729623,1.0,2/12,3.76%,RALB;IFIT1
prerank,determination of bilateral symmetry (GO:0009855),0.39353631323660854,1.0840088201335334,0.34912280701754383,0.952407154161951,1.0,5/24,17.71%,TBX1;NOTCH1;CITED2;KIF3B;BBS7
prerank,lipid biosynthetic process (GO:0008610),0.3140216146861147,1.0839355727368793,0.3196480938416422,0.9513662523760028,1.0,13/77,12.44%,ACSL5;MLYCD;GPAM;FITM2;HMGCR;GPAT4;MBOAT1;AGPS;PRKAA2;AGPAT3;PAM;LSS;PDSS2
prerank,negative regulation of coagulation (GO:0050819),-0.4255626211005382,-1.0838762885464308,0.3603238866396761,0.7093941124456562,1.0,4/14,11.40%,HS3ST5;TFPI;VTN;CD34
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.3556463186414153,1.0832039447369117,0.34565916398713825,0.9526926285803109,1.0,6/39,6.50%,PTPN18;CBL;PTPRJ;PTPN12;EPS15L1;ARHGEF7
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.32950444403067014,-1.0831996719257466,0.3065326633165829,0.7104785262979713,1.0,16/34,24.73%,GRID2;GRIN2B;GABRA2;GABRG2;GLRA1;GSK3B;GABRA5;GABRG3;GABRA4;GRIN2D;GRIN1;GABRG1;NLGN3;MPP2;GABRA1;AKT1
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.47452054357856877,1.0830801585407195,0.37572254335260113,0.9518291304551122,1.0,1/11,1.14%,SAG
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2895735072939875,1.0825639787704473,0.30707610146862485,0.9523037220101982,1.0,28/138,14.20%,POLR2J;MAZ;ERCC3;NR4A2;POLR2B;HDAC9;HDAC7;HDAC3;NR5A1;CCNH;MED23;PPARD;NOTCH1;NRBF2;GTF2H1;NRBP1;TAF15;RBPJ;ESR1;THRB;CREBBP;GTF2A2;E2F3;TAF4B;TBP;HDAC5;THRA;DR1
prerank,eosinophil migration (GO:0072677),-0.42361395355429865,-1.082535264776811,0.36026200873362446,0.7105374009316736,1.0,3/14,21.82%,SCG2;CX3CL1;CCL13
prerank,eosinophil chemotaxis (GO:0048245),-0.42361395355429865,-1.082535264776811,0.36026200873362446,0.7105374009316736,1.0,3/14,21.82%,SCG2;CX3CL1;CCL13
prerank,neuronal action potential (GO:0019228),-0.36703879423879193,-1.0822990144692817,0.3372365339578454,0.7103171838793888,1.0,6/22,12.92%,ANK3;SCN8A;SCN3A;SCN1A;KCNA1;CACNA1G
prerank,negative regulation of cilium assembly (GO:1902018),0.4636289135461798,1.081937424596031,0.36750483558994196,0.9533425107648016,1.0,3/12,7.44%,EVI5L;TBC1D30;MAP4
prerank,fatty acid transmembrane transport (GO:1902001),-0.384671372769187,-1.0818708732353148,0.3561320754716981,0.7106358143367206,1.0,6/19,14.92%,PRKAG2;CPT1A;PRKAB2;SLC27A1;ABCD2;CPT2
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.3568969361764853,1.081738598339942,0.3463414634146341,0.9527559812866168,1.0,9/39,12.19%,JAG2;TM2D3;SRC;EP300;NOTCH1;RBPJ;CREBBP;NOS3;PRKCI
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.4132442021216391,1.080834436120619,0.3534971644612476,0.9547242627447602,1.0,4/18,16.32%,CAMK1D;LYN;MTUS1;PTK2B
prerank,peroxisomal membrane transport (GO:0015919),-0.3492401670707369,-1.0806722880241242,0.3046683046683047,0.7130796324879484,1.0,10/27,18.35%,ACBD5;RAB8B;PEX14;FIS1;ALDH3A2;PXMP4;ABCD2;PEX2;PEX5;PEX6
prerank,intestinal lipid absorption (GO:0098856),-0.44712766228313744,-1.0802437909281495,0.3717948717948718,0.7133736031300116,1.0,2/11,7.95%,LIMA1;LDLR
prerank,protein K63-linked deubiquitination (GO:0070536),0.3700035707260319,1.080053801470886,0.34223706176961605,0.9562312296820673,1.0,9/31,13.42%,ABRAXAS1;TNFAIP3;YOD1;OTUD1;SPATA2;OTUD5;PSMD14;USP33;BRCC3
prerank,negative regulation of protein transport (GO:0051224),0.39253459644365424,1.0799354603928246,0.3537190082644628,0.9553834946054974,1.0,3/25,4.37%,RSC1A1;HMGCR;APOE
prerank,glycine transport (GO:0015816),0.47937505130721025,1.0798275312073364,0.3950850661625709,0.9544778315921562,1.0,3/10,16.38%,SLC7A8;SLC38A5;SLC25A38
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.31675079137179213,1.079436311489907,0.3215796897038082,0.9545515979901598,1.0,15/76,11.30%,GSK3A;SAE1;HDAC3;DCUN1D4;BIRC2;UBE3A;WFS1;PTTG1IP;SMAD7;UBA2;AXIN1;SPRTN;MYCBP2;UBQLN1;PIAS1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.35130610744187,1.0794063840680896,0.36,0.9533896520783329,1.0,7/46,9.34%,SEMA6A;PTPRR;PTPRC;PIN1;SPRED1;CNKSR3;LYN
prerank,regulation of Notch signaling pathway (GO:0008593),0.3161564705893189,1.0784404216255765,0.3381294964028777,0.9555541491937416,1.0,14/76,12.19%,JAG2;TM2D3;SRC;HEY1;EGFL7;TSPEAR;EP300;NOTCH1;LFNG;BEND6;RBPJ;CREBBP;NOS3;PRKCI
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.3101657934491497,1.0783321397781431,0.3206214689265537,0.9546873596362674,1.0,17/93,11.27%,PDE4D;MTCP1;RPTOR;STOX1;BCAR3;PRKD2;CNKSR3;RAPGEF3;BDNF;SMAD7;TXN;AXIN1;PAK1;PARK7;DOCK7;APP;DMD
prerank,positive regulation of protein catabolic process (GO:0045732),0.30643106046162705,1.0783061688978868,0.32056737588652484,0.9535238126889801,1.0,18/84,14.92%,GSK3A;SH3D19;TNFAIP3;PLK2;NEDD4L;APOE;VPS11;RAB7A;TNFRSF1B;PTTG1IP;AXIN1;WNT5A;ATG7;EGLN2;NDUFA13;FAF1;APC;VPS35
prerank,cholesterol efflux (GO:0033344),0.4083758682110893,1.0781193057965313,0.36496350364963503,0.9528876137826331,1.0,5/20,13.68%,APOE;SOAT1;SCARB1;NPC2;NPC1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.43864297361984683,1.0777720920106333,0.37453874538745385,0.9529568310827136,1.0,2/14,8.24%,OXSR1;WNT5A
prerank,cellular response to increased oxygen levels (GO:0036295),0.4721338668541025,1.0776020696022617,0.36174242424242425,0.9522610855437064,1.0,6/11,22.63%,ATP6V0D1;ATP6AP1;ATG7;ATP6V1A;FAS;FOXO1
prerank,regulation of GTPase activity (GO:0043087),0.2836594817261607,1.077497139933405,0.33163265306122447,0.9513632084667493,1.0,34/177,13.57%,EZH2;PIN1;VAV3;SOD1;EVI5L;CHN2;TBC1D30;BCAR3;LRCH1;PRKG1;RGS8;TBC1D10B;USP6NL;ARHGEF7;EPHA5;RAPGEF3;F11R;RGS10;RAP1GDS1;CCL25;RAPGEF6;FGD5;ITGA6;DOCK9;RASIP1;PLXNA4;RAB11FIP2;NF1;MAP4K4;PICALM;AGRN;LARS1;RABGAP1;ARHGAP15
prerank,cellular protein modification process (GO:0006464),0.25233769692793373,1.0773916733774263,0.2294238683127572,0.9504471144554109,1.0,204/982,17.15%,CISH;PHPT1;PSMB10;PSMC4;JMJD4;PSMB6;MAP3K11;MAPK3;ILF3;CAND1;SNRK;PTPRR;PTPN18;ELOC;GSK3A;PTPRG;RNF7;DUSP7;PSMD8;PSMD5;PSMD12;PTPRJ;CDK17;KLHL5;PTPRC;OXSR1;CDK19;CHML;KLHL3;CTDSP1;FEM1C;PPP3CB;PLK2;NEK11;PTPRM;RPS6KA4;BTBD1;PRKCH;ENGASE;CHM;HIPK2;PTPRB;DUSP12;MEX3B;PRKG1;PRKD2;RPS6KA5;PTPRE;PPP2CA;PSMD11;CDH2;NEURL2;SIRT3;APOE;MAP3K9;PTP4A2;PKN3;PSMB4;PTPN12;FYN;FBXL5;METAP2;RAB11B;WFS1;PDIA6;PSMC1;VWA1;UBE2I;FBXW2;UGCG;DCAF6;MAPK8;COP1;RET;SSH2;PAK3;ST8SIA1;PTPRT;SIK3;CSNK1G3;CDK11B;SYK;PPP2CB;PIM1;SIRT1;ATG4B;LMO7;PEAK1;KLHL2;FBXO32;SLC35A1;MINK1;MERTK;SERP2;CDK4;ACVRL1;PIGH;LATS2;FBXO11;CDKL4;LYN;RAB1A;NRBP1;PSMC2;PKN1;PAK1;PARK7;FBXO7;PSMD2;ERG;PIGT;PPP1R12A;UBE2M;MBTPS1;ICMT;DUSP11;NIM1K;ACVR2A;YES1;METAP1;PRKAA2;SRPK2;SETD3;NAE1;NLK;STT3B;NEK7;CTBP1;COPS7B;APP;PLAT;PIK3CD;ATG7;TNKS;ELOB;PPP3CA;MAP4K4;STRADB;ADPRH;TYK2;PRKCI;ST3GAL6;MAPK6;DCAF10;IKBKB;CTTNBP2NL;NEK6;CUL3;CHUK;NAA80;PSMD14;UBE2F;ST3GAL1;PSMC6;CHEK2;TLK2;PPP5C;COG3;EPAS1;NPC1;BRD2;PSMD1;PSMB1;PGGT1B;PROC;PTPRA;ST6GALNAC2;MSRA;B3GALNT2;CAMKK2;ST8SIA6;QPCT;COPS8;FBXO22;BMP2K;KLHL11;GAS6;DYRK2;MAN2A1;CDKL5;TAF1;CALU;PPP2R3A;NTAQ1;BRAF;MTMR2;CDK14;PIGU;PTK2B;KLHL13;PPM1L;KLHL42;PIK3R4;PSMA4;FBXL20;PRKDC;WNK2;DCUN1D1;LCMT1;PPP2R5A;MELTF;CKAP4;TIPARP;PRSS23
prerank,regulation of cellular response to stress (GO:0080135),0.2961518865192287,1.0772153281164119,0.31232876712328766,0.9497720301761072,1.0,34/115,19.50%,ATF3;MAPK3;CHCHD2;HSPA8;RPTOR;MANF;SMG1;EP300;AKT1S1;BAG1;NUP54;SIRT1;NUP50;CCAR2;ING2;CREBBP;FKBP4;NUP35;NEK6;CORO2B;NDC1;ATR;CAMK2G;RSL1D1;HIKESHI;NUP160;NPM1;POM121;NUP42;NUAK1;EIF4G1;YWHAE;HSPB8;NUP133
prerank,epithelial cell differentiation (GO:0030855),-0.27259008069979374,-1.0769102253472176,0.25259515570934254,0.721858717544551,1.0,27/88,24.73%,ERBB4;FGFR2;DAB2;FSTL1;MAF;HDAC1;BMP4;ANXA4;VDAC1;CPT1A;AKT2;PTER;ANXA1;SCUBE1;TOLLIP;ANXA7;SIX1;TAGLN2;FZD7;PCK2;PGK1;GLI1;KDM6B;VEGFA;PAX2;BASP1;AKT1
prerank,positive regulation of cellular process (GO:0048522),0.2568932249091187,1.0766382580448401,0.25775401069518716,0.9504822819306112,1.0,95/565,15.07%,FRMD5;MAZ;RAD18;ROMO1;NCBP1;PTPRJ;EZH2;TAL1;LEF1;TIAM1;ACER2;RPL23;FCGR2B;CXCL12;DERL2;RPS6KA1;RPTOR;CAMK1D;GREM1;CRLF1;STOX1;MCTS1;TBC1D8;ZFP36L1;PRKD2;TSHR;CSPP1;LMAN2;MEIS1;SLC35F6;TNFRSF1B;SINHCAF;CIB1;SLC6A6;MAPK8;FXR1;TBX1;CHTOP;FBXO5;ACTN4;SIRT1;IRS2;RNF187;NOTCH1;WNT5A;USP47;CNOT7;MERTK;CDK4;EXOSC9;ACACB;TJP1;RELA;CD47;RAD23A;MDM2;CSF1R;BCLAF1;LYN;LGI1;PAK1;CLDN5;EIF4G2;TRPM4;CITED2;ESM1;RPS9;PRKAA2;SRPK2;DDX3X;P2RX7;CD81;RHOG;FLT1;PA2G4;ACER3;PPP3CA;CRKL;DOT1L;TENM4;CUL3;DHPS;CNOT6;ANKRD17;RPS15A;FAF1;HES1;APC;HCFC1;CYBA;INO80;PARD3;VEGFC;S100A13;CNOT6L
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.41433231648166435,1.076081588318756,0.3570057581573896,0.9511942680526344,1.0,4/18,9.50%,GSK3A;SLC35F6;ZNF205;FZD9
prerank,alpha-amino acid metabolic process (GO:1901605),-0.31109488972086025,-1.075180493144709,0.3219895287958115,0.7258996024037988,1.0,23/45,30.80%,ASPA;SRR;SLC25A13;ATP7A;GLUL;GLUD1;MTHFR;DDAH1;NOX4;MTHFD1;NAALAD2;KYAT1;GPT2;GOT1;KYAT3;ASPG;RIMKLB;OAT;MTRR;DDAH2;ALDH18A1;ASS1;RIMKLA
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.328255867166537,1.0750974394057402,0.34335443037974683,0.95323356725596,1.0,5/57,6.94%,HRH4;MTNR1A;HTR1F;INSL3;GRM7
prerank,negative regulation of protein metabolic process (GO:0051248),-0.3012307930660178,-1.0748262291899207,0.32707774798927614,0.7260050777126634,1.0,18/48,18.96%,EGFR;FLNA;SIRT2;FLOT2;FMN2;ROCK1;LDLR;IRAK3;BANP;AZIN1;EIF2AK1;NFKB1;VBP1;PFDN2;CYP51A1;CRYAB;SNX3;MDM4
prerank,positive regulation of lymphocyte migration (GO:2000403),0.45634526038095097,1.0746786958302965,0.3707865168539326,0.9534365036927812,1.0,4/12,17.85%,CXCL12;APP;DOCK8;JAM2
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.2981664812239689,-1.0746442477877403,0.29658792650918636,0.7256276789512144,1.0,20/55,21.68%,GPC6;SDC2;CEMIP;OGN;VCAN;GPC3;HEXA;CEMIP2;HSPG2;HEXB;ARSB;GPC5;CSPG4;PRELP;TGFB1;GNS;GUSB;LUM;SDC3;GPC4
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.2861097732797077,-1.0746114819475896,0.29526462395543174,0.7248494872763188,1.0,25/65,23.25%,LDLRAD4;FBN1;SMAD3;SMURF2;TGFBR1;TGFBR2;FBN2;PPARA;SKI;HTRA3;SMAD6;LTBP1;UBC;SNX25;PPM1A;MTMR4;TGFB1;PRDM16;CD109;STUB1;SPRED3;ASPN;SNX6;EMILIN1;NRROS
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.3988507451295345,-1.0745658873637387,0.37100213219616207,0.724133006676991,1.0,7/16,20.40%,APPL2;PPARA;ADCY7;SIRPA;ABCD2;CHID1;APOD
prerank,ribosomal small subunit assembly (GO:0000028),0.4314797573408919,1.0744930705493159,0.3625,0.9528088469030697,1.0,7/16,21.89%,RPS14;RPS28;RRP7A;PRKDC;RPSA;RPS27;RPS5
prerank,regulation of transmembrane transport (GO:0034762),0.36974573424246765,1.0743882695688147,0.37435008665511266,0.951908934127179,1.0,5/31,8.55%,TRIB3;ACTB;NEDD4L;PIM1;SLC2A1
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.309803791595674,-1.0741931146911097,0.3013698630136986,0.7243569192983981,1.0,21/46,23.76%,ZIC1;SMAD3;KHDRBS1;FLNA;BAG3;PRKCD;ANP32B;UBR5;EFCAB7;CDH1;GSK3B;TP53;CAMK1;TGFB1;MAVS;TCF7L2;NEDD4;PIK3R1;NRDE2;EMD;NCBP2
prerank,sterol biosynthetic process (GO:0016126),0.3619116272686295,1.073885673102346,0.3464052287581699,0.9524343628159504,1.0,8/33,11.99%,EBP;INSIG1;HMGCR;PLPP6;SC5D;IDI1;NSDHL;LSS
prerank,regulation of endothelial cell proliferation (GO:0001936),0.3068473267400266,1.0735977361224813,0.35600578871201155,0.9522095188577586,1.0,16/88,11.85%,PTPRM;PDCL3;PRKD2;NRAS;PPP1R16B;APOE;EGFL7;TEK;KRIT1;RGCC;SIRT1;WNT5A;ACVRL1;TIE1;PIK3CD;NF1
prerank,protein methylation (GO:0006479),0.3519240008210668,1.0735619741419,0.33814102564102566,0.9510865911944252,1.0,9/40,14.46%,CTCFL;EZH2;PRMT3;RAB6A;ICMT;SETD3;CARM1;ETFBKMT;NTMT1
prerank,sphingoid metabolic process (GO:0046519),0.45017212964674747,1.0734641043524498,0.35804701627486435,0.9501387079438876,1.0,4/12,13.99%,KDSR;PLPP1;SGPP2;SGPP1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.29147661928278096,-1.0733930246819914,0.32471264367816094,0.7256562403893121,1.0,15/63,18.20%,IGF1;CFLAR;CYLD;TGFBR1;BMP4;PML;HTT;THBS1;ACVR1;DEPTOR;SIAH2;MADD;TRAF2;SCG2;TCF7L2
prerank,ATP synthesis coupled proton transport (GO:0015986),0.4165139494906268,1.0731642727394306,0.36731107205623903,0.9499046385514093,1.0,4/17,6.91%,ATP5F1E;ATP5MG;ATP5PF;ATP5MC2
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.35259829993988223,-1.0730785994302086,0.3555045871559633,0.7256054040966189,1.0,10/27,23.50%,AMBRA1;PDGFRB;KIT;PDGFRA;PTK2;TGFB1;PRKD1;P2RY12;EPHA8;TNFAIP8L3
prerank,negative regulation of angiogenesis (GO:0016525),-0.274177774234342,-1.0729845352138077,0.31756756756756754,0.7250132648972918,1.0,17/84,9.17%,SULF1;COL4A3;CTNNB1;GTF2I;ROCK2;ADAMTS9;SLC12A2;HOXA5;ROCK1;PML;HSPG2;FOXC1;ADAMTS1;SPARC;NIBAN2;THBS2;THBS1
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.3882070493508173,-1.0729343332690924,0.34725274725274724,0.7242941040745842,1.0,12/16,36.65%,GPR137C;KLHL22;SEH1L;FLCN;TELO2;LAMTOR5;PIP4P1;GPR137B;PIH1D1;RRAGD;GPR137;RRAGA
prerank,endothelial cell proliferation (GO:0001935),0.4158157475800639,1.0727351081706114,0.3644859813084112,0.9501515305820822,1.0,3/17,8.79%,PRKX;TEK;ACVRL1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.322578777003429,1.0724427129632583,0.33677991137370755,0.9499013928095577,1.0,11/69,9.70%,FOXQ1;SOD1;PPT1;CRLF1;APOE;TOX3;WFS1;BDNF;SOD2;FZD9;PARK7
prerank,manganese ion transport (GO:0006828),-0.41887570794025,-1.0722552127949296,0.38562091503267976,0.7253023848704939,1.0,7/14,22.73%,TRPC5;SLC39A14;SLC30A10;TRPC1;SLC39A8;SLC11A2;TRPC6
prerank,proteoglycan metabolic process (GO:0006029),-0.34647377156594583,-1.0721280167257123,0.3364485981308411,0.7247963422529132,1.0,11/26,24.77%,IGF1;SULF1;ADAMTS12;SULF2;CSGALNACT2;CHST11;BMPR1B;CHST8;BMPR2;CANT1;FOXL1
prerank,dendritic cell differentiation (GO:0097028),-0.3707318208914333,-1.071927468365851,0.3842696629213483,0.7245137783749025,1.0,3/22,6.96%,TGFBR2;AXL;CAMK4
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.39602371180889484,1.0715933784543907,0.36925795053003535,0.951589666850476,1.0,7/23,16.11%,DYNC1I1;TUBB;KIF1B;CCDC88C;DYNC1I2;TUBA1B;HOOK3
prerank,regulation of viral entry into host cell (GO:0046596),0.3768618549872658,1.0715823690153246,0.36185383244206776,0.9503801891546434,1.0,6/30,8.84%,LY6E;IFITM2;TRIM14;IFITM3;TRIM25;IFITM1
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.47748195849150626,1.0715208674447108,0.37450980392156863,0.9493197109609087,1.0,3/10,9.39%,ACER2;NEXMIF;CYP1B1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),-0.46813863504555897,-1.071317214458518,0.41379310344827586,0.7253177228724588,1.0,1/10,0.36%,ANK3
prerank,positive regulation of developmental growth (GO:0048639),0.3417500010148463,1.0712613707173577,0.35932721712538224,0.9489428889610282,1.0,9/49,12.33%,CPNE5;SEMA7A;PPIB;NEDD4L;BDNF;RUFY3;PLCB1;AGRN;PLAA
prerank,negative regulation of cellular protein localization (GO:1903828),-0.3306526260239539,-1.0711655869694159,0.3419811320754717,0.724906193891045,1.0,12/34,14.75%,GPM6B;CTNNA1;MAPT;ROCK2;ILRUN;UBXN2B;ACTN2;GSK3B;TTBK2;NSFL1C;MAP1A;COMMD1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),-0.3236139192706172,-1.0708986179399997,0.32558139534883723,0.7247869267335806,1.0,10/39,13.02%,ANK3;FGF12;FGF14;WNK1;OSR1;HECW1;PTPN3;WNK4;CAMK2D;WNK3
prerank,positive regulation of gene expression (GO:0010628),-0.21603220412998692,-1.0702203248998996,0.1262135922330097,0.725725790593325,1.0,83/442,15.20%,ANK2;DDX5;BMP6;NTRK3;ANK3;RIMS1;SLC24A3;IGF1;ROBO1;PLD1;SAMD4A;EGFR;GSN;SMAD3;FOXD1;ITGB8;NTRK2;FGF1;TGFBR1;MAPK14;PID1;OCLN;MED26;BMP7;VIM;ELAVL4;PRKAG1;BMP4;MED1;PPARGC1A;ROCK2;OSR1;SMO;F3;EPB41L4B;DEK;ERCC6;ADAM19;HOXA5;ROCK1;PIK3R3;FUBP3;PLA2R1;POLDIP3;EIF3C;YTHDF1;EZR;MAP2K2;NIBAN1;THBS1;PRR16;UBR5;EIF2AK2;AFDN;AGO3;PLSCR1;TLE1;GJA1;EPHB2;GSK3B;CAMK2N1;FN1;EEF2;CUX2;TP53;CD34;FAM98A;DDRGK1;RBM3;IFNGR1;RPS7;SNF8;PDCD5;POLR2A;IL33;HINFP;DDX21;ATM;VSTM2A;SETX;PTPN22;SCAMP5;PLXNB2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.39193178432481457,1.0702129841566146,0.3784246575342466,0.9513580226627899,1.0,2/24,1.79%,PRKAR1A;PDE4D
prerank,protein ADP-ribosylation (GO:0006471),-0.34476656363403557,-1.0701798032405265,0.3378684807256236,0.7249938398577276,1.0,13/28,21.51%,PARP4;ZC3HAV1;PARP14;SIRT2;PARP6;PARP3;ART3;ARF4;PARP12;PARP1;SIRT5;PARP16;PARP2
prerank,cellular response to organic substance (GO:0071310),-0.2535495465852764,-1.0701276484844957,0.2713178294573643,0.7242850187439586,1.0,33/116,20.00%,ROBO2;NFAT5;PTPN13;AKAP6;SMAD3;DPYSL3;IGFBP5;PTPN14;TGFBR1;TGFBR2;PID1;CTNNB1;RHOA;GHR;CLEC3B;ACVR1;SOCS2;IL1RAPL1;RAMP1;ACVR1B;IL18;NCOA1;RACK1;TGFB1;BMPR1B;PTPN23;PTPN2;TWF2;CDK9;BMPR1A;RPS6KB1;CPNE3;BMPR2
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.37128745145170644,1.0701047114081144,0.35181975736568455,0.9504846582414925,1.0,8/28,13.74%,TNFAIP3;MAP3K7;TAB2;TAB3;RELA;UBE2V1;NOD1;MAP2K6
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.3778215886360817,1.070030008555556,0.3889845094664372,0.9495015055680807,1.0,5/29,11.67%,LPCAT2;PLAAT3;DBI;LPCAT3;PNPLA8
prerank,negative regulation of multicellular organismal process (GO:0051241),0.2775246741039074,1.0696676999486094,0.32170542635658916,0.9494962993552872,1.0,28/199,11.33%,CIDEA;RGS2;PTPRR;GSK3A;PTPRG;FCGR2B;RPS6KA4;HMGCR;HDAC9;EVL;RPS6KA5;PPP2CA;HEY1;SPRED1;NPTN;RGCC;SMAD7;PPP1R11;HEY2;RAB11FIP5;NOTCH1;EFNA1;NOVA2;HOXA7;DOCK7;RBPJ;ADIPOR1;NOS3
prerank,regulation of mitotic nuclear division (GO:0007088),-0.2992922623911977,-1.0695527535796416,0.336283185840708,0.7250167445704839,1.0,11/55,15.81%,IGF1;PDGFRB;TOM1L2;BMP7;CUL9;BMP4;LRP5;OBSL1;IGF2;CAV2;TOM1L1
prerank,central nervous system myelination (GO:0022010),-0.45040448720137843,-1.0689790115795863,0.37894736842105264,0.7257374056558453,1.0,8/11,38.24%,PLP1;B4GALT6;CNTNAP1;ABCA2;MYRF;B4GALT5;CLU;SOX10
prerank,regulation of coagulation (GO:0050818),-0.45288164896738475,-1.0684238894103726,0.3895582329317269,0.7265043540074639,1.0,2/11,10.73%,HS3ST5;EPHB2
prerank,epidermis development (GO:0008544),-0.2943970356446599,-1.0682840603857033,0.32831325301204817,0.7260313972188397,1.0,8/56,12.08%,FGFR2;SVEP1;CCN2;HDAC1;FLOT2;PLOD1;EMP1;ALDH3A2
prerank,myeloid cell development (GO:0061515),-0.3880576086983035,-1.0681381580011247,0.37037037037037035,0.7255848155397643,1.0,4/18,4.74%,FOXP1;ANXA2;KIT;MED1
prerank,regulation of cellular protein metabolic process (GO:0032268),0.3396571140137115,1.0679817762705441,0.3836065573770492,0.954164119839272,1.0,17/47,20.51%,EIF2A;APOE;GEMIN5;EDNRB;TSC1;METAP1;APP;NANOS3;NFKBIA;VPS35;RBM4B;CYFIP1;RPL10;EIF4G1;NR1H3;EIF4E;MTPN
prerank,negative regulation of cellular component organization (GO:0051129),-0.27925077511545193,-1.0677415155296412,0.3333333333333333,0.7258405556362297,1.0,24/74,22.43%,BMP6;TMEFF2;WASL;PRKCZ;SORL1;IRAK3;FAP;EPHA3;GSK3B;HSF1;SYT11;SACS;SCAMP5;RAF1;LRSAM1;PEX5;CDC42;CRYAB;RIOK3;DNAJB2;RTEL1;PRKD1;IMPACT;VEGFA
prerank,positive regulation of cyclase activity (GO:0031281),-0.4180507919435552,-1.0675687816751558,0.3668763102725367,0.7254881064406348,1.0,4/14,3.50%,CACNA1C;CACNA1D;STIM1;MAPK14
prerank,regulation of fibroblast migration (GO:0010762),0.40887773053708665,1.067542767132836,0.368705035971223,0.9544724862089368,1.0,4/20,8.41%,PRR5L;RFFL;ARHGEF7;GNA12
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.3992937275511624,-1.0674328504451267,0.3651804670912951,0.7250159007791381,1.0,3/16,6.94%,NFAT5;RHOA;IRAK1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.37087940966112376,-1.0674096472462034,0.3659147869674185,0.7242417130191715,1.0,5/22,24.81%,ALDH1A2;LGMN;RBP1;PIAS4;CUBN
prerank,establishment of spindle orientation (GO:0051294),-0.3430577127772591,-1.0672768706452787,0.35071090047393366,0.7237680978048204,1.0,8/28,19.98%,FBXW11;HTT;UBXN2B;GJA1;NSFL1C;DCTN1;NDE1;ZW10
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.4058179051208914,-1.0672514583981896,0.35668789808917195,0.7229879259713097,1.0,8/17,21.78%,SULF1;FSTL1;XIAP;PCSK6;TMEM204;SFRP4;TWSG1;DOK5
prerank,negative regulation of locomotion (GO:0040013),0.46193803800539013,1.066812531561637,0.3896353166986564,0.9557352430087425,1.0,2/12,2.05%,FRMD5;PIN1
prerank,sphingoid biosynthetic process (GO:0046520),0.46127209345928133,1.066680502772198,0.4007707129094412,0.953740177585747,1.0,2/11,11.69%,ACER2;ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.46127209345928133,1.066680502772198,0.4007707129094412,0.953740177585747,1.0,2/11,11.69%,ACER2;ACER3
prerank,negative regulation of cellular component movement (GO:0051271),-0.40663375587440553,-1.0657853320033868,0.3832199546485261,0.7260897586950329,1.0,3/15,2.98%,SPOCK3;TGFBR3;FBLN1
prerank,morphogenesis of an epithelium (GO:0002009),0.3710027870311019,1.065486666135811,0.37809187279151946,0.9566845811304637,1.0,5/25,10.76%,PRKX;ACTB;DAG1;LIN7C;TRAF3IP1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.44498046202026975,1.065443698974792,0.3787878787878788,0.9555903296356356,1.0,2/13,6.89%,SYK;AP1G1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.368529332852662,-1.0651643937568558,0.3471264367816092,0.7261492468183205,1.0,2/21,0.71%,EYA2;EYA1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.368529332852662,-1.0651643937568558,0.3471264367816092,0.7261492468183205,1.0,2/21,0.71%,EYA2;EYA1
prerank,positive regulation of proteolysis (GO:0045862),-0.29357228846028666,-1.0650975326437024,0.33798882681564246,0.7255000490673695,1.0,23/55,30.05%,NRDC;OGT;CYFIP2;FBXW11;RHBDD1;BTRC;IST1;CCBE1;TBC1D10A;RCN3;TNIP1;GPLD1;TANK;ATP5IF1;STUB1;PINK1;NKD2;ADRA2A;PERP;ZC3H12A;CTSC;PACSIN3;FGFR4
prerank,regulation of peptidase activity (GO:0052547),-0.371692094712879,-1.0647606197157018,0.35135135135135137,0.7255993285559752,1.0,5/19,19.69%,NRDC;HDAC1;ECM1;RCN3;PINK1
prerank,inflammatory response (GO:0006954),0.27756010133492137,1.0646679090903959,0.32747804265997493,0.9571688373028624,1.0,21/195,13.02%,HRH4;PTGER2;PIK3CG;TACR1;FCGR2B;HDAC9;LY75;NFX1;ABCF1;F11R;CCL25;RELA;CSF1R;PJA2;IL10RB;MFHAS1;NOD1;PIK3CD;IKBKB;CHUK;HDAC5
prerank,determination of left/right symmetry (GO:0007368),0.3541378275736898,1.0644168427081855,0.34811165845648606,0.9567847394206398,1.0,6/36,13.19%,RFX3;TBX1;NOTCH1;CITED2;DAND5;KIF3B
prerank,hemopoiesis (GO:0030097),0.3040795190409952,1.0641947600862622,0.3488700564971751,0.956371388931643,1.0,12/87,9.27%,PRKX;MECOM;SNRK;TAL1;PTPRC;TIRAP;CD164;MEIS1;TEK;BMI1;WNT5A;CSF1R
prerank,protein phosphorylation (GO:0006468),0.2567402981775168,1.0641220369926252,0.29625550660792954,0.955437607199395,1.0,101/478,16.42%,PCK1;PRKX;STK32A;MAP3K11;MAPK3;ILF3;SNRK;GSK3A;CDK17;OXSR1;MAP3K7;CDK19;PPP3CB;PLK2;NEK11;RPS6KA1;RPS6KA4;CAMK1D;PRKCH;SRC;HIPK2;MEX3B;PRKG1;PRKD2;RPS6KA5;MAP3K9;CCNH;PKN3;TEK;SMG1;FYN;SLK;MAPK8;RET;PAK3;SIK3;CSNK1G3;CDK11B;SYK;SBK1;PIM1;SMAD7;PEAK1;MINK1;DCLK3;MERTK;CDK4;GTF2H1;ACVRL1;LATS2;CDKL4;CSF1R;LYN;NRBP1;PKN1;PAK1;ERG;NIM1K;ACVR2A;PRKAA2;SRPK2;NLK;NEK7;USP15;CTBP1;APP;FLT1;PIK3CD;TNKS;MAP4K4;MAST4;STRADB;TYK2;PRKCI;MAPK6;IKBKB;NEK6;ERC1;MAPK12;CHUK;CHEK2;TLK2;MAP2K6;BRD2;CSNK2A2;MAP3K3;CAMKK2;MAP3K10;COPS8;BMP2K;GAS6;DYRK2;ATR;TOP1;CDKL5;TAF1;BRAF;ABI2;CDK14;PTK2B;PIK3R4
prerank,positive regulation of B cell activation (GO:0050871),0.3303587455204455,1.0632348765015556,0.3656597774244833,0.9573249153125315,1.0,8/50,12.17%,PTPRC;VAV3;TIRAP;SYK;IRS2;CD81;KMT5B;TNIP2
prerank,T cell migration (GO:0072678),0.44407601960397847,1.0632343633113124,0.40636704119850187,0.9561038376144287,1.0,2/13,11.64%,PIK3CG;PIK3CD
prerank,Golgi to plasma membrane transport (GO:0006893),-0.30824867119098714,-1.062656510141416,0.32124352331606215,0.7305618496139644,1.0,16/47,16.71%,ANK3;ARFGEF2;VAMP5;MACF1;EXOC6;RAB31;GGA2;OPTN;OSBPL5;VPS35L;VAMP2;BBS2;COMMD1;GOLGA7;EXOC1;GGA3
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.39821282800714153,-1.0626220878327917,0.37447698744769875,0.7298024029478023,1.0,6/16,25.10%,VIM;BMP4;WNT4;TGFB1;TGFB3;CREB3L1
prerank,regulation of inclusion body assembly (GO:0090083),-0.4474545117852712,-1.0624230814590248,0.3706896551724138,0.7294803520718935,1.0,9/11,49.44%,SNCAIP;SACS;DNAJB2;BAG5;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.3821571756025349,1.0620080320817895,0.38137082601054484,0.9592015013477024,1.0,7/24,13.74%,TNFAIP3;MAP3K7;TAB2;TAB3;UBE2V1;NOD1;MAP2K6
prerank,histone H3 acetylation (GO:0043966),0.3486636901627256,1.061605211775945,0.37152209492635024,0.9593781831487477,1.0,5/40,3.32%,JADE3;LEF1;MAP3K7;PHF14;ING4
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.3554040866457089,-1.0611743083862666,0.3669724770642202,0.7320848012210037,1.0,7/24,19.38%,PLA2G4A;LPGAT1;CDS2;SLC27A1;CRLS1;PGS1;LPCAT1
prerank,phospholipid transport (GO:0015914),0.33578099129663413,1.0610214880730344,0.3793103448275862,0.9601291404072584,1.0,17/52,19.14%,ATP8A1;APOE;ATP11A;PRELID3B;TMEM30B;PRELID2;PITPNA;SCARB1;ATP11C;NPC2;OSBPL2;ATP10A;TMEM30A;ATP9B;PLTP;PITPNB;ABCG1
prerank,membrane organization (GO:0061024),-0.22781389647457798,-1.0605483541964167,0.27225130890052357,0.733071303270358,1.0,83/227,26.43%,ANK2;ANK3;RIMS1;DNAJC6;DAB2;EGFR;AMPH;STX18;CHRM2;AP2B1;A4GALT;SH3GL2;TOR1AIP2;STAM2;WASL;AP2A2;UBXN2A;STON2;ARPC1A;CTTN;NUP155;SYT9;AP2A1;LDLR;ACTR3;UBXN2B;PLEKHA8;TOR1AIP1;BIN1;HUWE1;MYOF;TMEM33;DMPK;UBC;IGF2R;TLCD2;NUP93;NSFL1C;MITD1;GRB2;HIP1R;M6PR;MYADM;EPN1;DNM1;VAMP2;TOR1B;USO1;NEMP1;MTCH1;FZD4;CHMP2B;SUN1;ACTR2;SYT2;SNX3;CHMP5;SNAP29;GLTP;STAM;ARPC2;VPS4A;CNTN2;HGS;GCA;VPS33B;COX18;CTDNEP1;EMD;VAPB;CLN3;VAMP8;SGCZ;TMEM170A;LEMD2;SERP1;SPTBN1;PICK1;SYP;HIP1;FNBP1;OCRL;TMEM43
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.3045717305626871,1.060465801080311,0.3438914027149321,0.9608516818684482,1.0,17/83,14.43%,CDK17;PLK2;CCNH;CDKN1A;NPAT;POLE;CDC45;FBXO5;CDK4;LATS2;POLA1;USP37;E2F3;CUL3;BACH1;PHF8;RCC1
prerank,positive regulation of cell cycle (GO:0045787),-0.2878691641558322,-1.0601981121915665,0.3424657534246575,0.7332042073571385,1.0,17/62,16.18%,FGFR2;EGFR;PKD1;NUPR1;MEIS2;CCDC57;CDKN1B;SMOC2;LGMN;CCND3;TBX3;RARA;HSF1;USP19;TTL;LRP6;CCPG1
prerank,innate immune response in mucosa (GO:0002227),-0.4480502977791512,-1.0597375873163881,0.4065040650406504,0.7336701739764558,1.0,2/10,15.72%,RNASE3;DEFA6
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.39253700572301864,1.0597089287990398,0.38235294117647056,0.9622653779460209,1.0,4/21,9.42%,RPL23;RPL5;FBXO5;RAB1A
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2763922375836561,-1.059632166640249,0.33035714285714285,0.7331140023794576,1.0,23/72,17.73%,CFLAR;JAK1;CYLD;AXL;IFNAR2;CBFB;IRAK1;TAX1BP1;IRAK3;BIRC3;ELF1;OTULIN;HIPK1;VRK2;IFNGR1;CLIP3;IKBKG;RACK1;MADD;TRAF2;PTPN2;RNF31;IFNGR2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.35647860667742387,1.0595697136514721,0.3954248366013072,0.9615140916619621,1.0,6/36,8.79%,PTPRM;APOE;KRIT1;RGCC;NOTCH1;ACVRL1
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.36395174078352865,-1.0595129966163304,0.3764988009592326,0.7325669017988303,1.0,5/22,7.97%,NRDC;TIMP3;TIMP2;ROCK1;PTPN3
prerank,triglyceride catabolic process (GO:0019433),0.414188651476721,1.0593535782630983,0.3992740471869328,0.9610862091389771,1.0,1/19,3.42%,FABP7
prerank,presynaptic endocytosis (GO:0140238),-0.351661290242371,-1.059312910600795,0.3627684964200477,0.7323234289511115,1.0,10/24,23.10%,AMPH;NLGN2;STON2;NLGN1;STON1;VAMP2;STX1A;SYT2;PACSIN1;NLGN3
prerank,regulation of neurotransmitter transport (GO:0051588),-0.40059875489936725,-1.0589403628033873,0.38095238095238093,0.7325653141786556,1.0,6/16,24.92%,RIMS1;SNCAIP;SYN1;FLOT1;CPLX1;CAMK2A
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.398753844108356,1.0589261541640722,0.3813084112149533,0.9613910523923737,1.0,11/20,20.96%,CNOT7;AGO4;HELZ;CNOT6;CNOT1;MOV10;WTIP;EIF6;AGO1;TNRC6A;CNOT8
prerank,axonal transport (GO:0098930),0.350099649005909,1.0581327569506909,0.367047308319739,0.9629378134237684,1.0,10/36,14.22%,SOD1;KIF1B;AP3S1;DST;DTNBP1;TMEM108;AP3M2;KIF3B;AP3M1;SNAPIN
prerank,ribonucleoprotein complex assembly (GO:0022618),0.287247045008168,1.0581217972731838,0.3472409152086137,0.9617627937931545,1.0,38/132,18.82%,SNRPD2;NCBP1;RSL24D1;RPL3;SNRPD1;MCTS1;SF1;RPS14;RPL5;SRSF10;GEMIN5;YTHDC1;MRPL20;COIL;EIF4H;RPLP0;RPS28;CPSF6;RRP7A;SRPK2;RPL24;EIF4B;STRAP;RPL23A;USP39;EIF5;PRKDC;EIF2S2;RPL38;EIF6;EIF3A;RPSA;PRPF18;DDX23;LUC7L2;CLP1;RPL10;SNRPD3
prerank,negative regulation of protein polymerization (GO:0032272),-0.3428790130639558,-1.0581126351819443,0.37857142857142856,0.7339240397065171,1.0,13/27,21.95%,MAP2;EML2;PRKCD;STMN2;CLIP3;HIP1R;KANK4;MYADM;STMN1;TUBB4A;TWF2;SSH1;PFN2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.41500794323947043,-1.0576731288863632,0.3830275229357798,0.7342825290733767,1.0,3/14,4.69%,ADAMTS12;TGFBR1;EFEMP1
prerank,regulation of centrosome duplication (GO:0010824),0.365383742930191,1.0575239193139396,0.38632478632478634,0.9626711351743937,1.0,5/29,10.29%,ALMS1;PLK2;CHMP1A;SIRT1;CHMP2A
prerank,regulation of dendrite extension (GO:1903859),0.41078146417504846,1.0572595803648934,0.3664259927797834,0.9623654345538113,1.0,2/18,4.26%,CPNE5;NEDD4L
prerank,cellular response to glucose stimulus (GO:0071333),0.36706229161164605,1.0562664789096217,0.375,0.964654196662677,1.0,6/30,10.58%,PCK1;SELENOT;RAB11B;RAB11FIP5;RAB11FIP2;PRKAA2
prerank,histone H4-K8 acetylation (GO:0043982),0.4227051430505048,1.0562082800600343,0.3940520446096654,0.9624316506519559,1.0,5/15,14.02%,JADE3;ING4;KANSL2;KANSL3;HCFC1
prerank,histone H4-K5 acetylation (GO:0043981),0.4227051430505048,1.0562082800600343,0.3940520446096654,0.9624316506519559,1.0,5/15,14.02%,JADE3;ING4;KANSL2;KANSL3;HCFC1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.434954689555229,-1.056098297760723,0.4085106382978723,0.7377909620479044,1.0,4/12,15.65%,BICD1;NINL;KIF3A;DCTN1
prerank,Ras protein signal transduction (GO:0007265),0.2866847408980017,1.0560786721722453,0.3578231292517007,0.9616293760898091,1.0,38/137,16.89%,RAC2;RALB;TRIM28;RAP2A;TIAM1;PLK2;RERG;NRAS;RALA;CFL1;CDKN1A;RASGRP3;GNB1;GRAP;RAPGEF3;GNA12;RAPGEF6;PARK7;CELSR1;RHOG;NF1;CDC42EP3;G3BP2;CRKL;MYO9B;RAP2C;RIT1;EPS8L1;RGL2;ELMO1;GNA13;MRAS;ABI2;CDH13;KPNB1;SHC1;CYFIP1;USP28
prerank,protein deacylation (GO:0035601),0.3880074025384,1.0559284272880023,0.36363636363636365,0.9609742431741193,1.0,5/23,7.36%,PPT1;HDAC7;HDAC3;SIRT3;SIRT1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.3646339272771845,-1.055922429817202,0.365296803652968,0.7374306649966623,1.0,7/20,23.39%,IGF1;FOXC1;NIBAN2;DDRGK1;TGFB1;GTF2B;LAMTOR5
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.4419663043021428,1.0554967662404322,0.39245283018867927,0.9612708950762104,1.0,3/12,10.75%,TRIB3;SIRT1;ERLIN2
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.30629445341460904,-1.0554397715396215,0.3360655737704918,0.7378702968561501,1.0,7/43,13.26%,AHI1;MICAL2;TGFBR2;SMO;ACVR1;TBX3;SETDB2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.4077241447858572,1.0551931073319711,0.3767605633802817,0.9610861033245806,1.0,4/18,9.56%,STOX1;FBXO5;CDK4;RAD51B
prerank,epithelial tube morphogenesis (GO:0060562),0.3602026694425419,1.0551768248092843,0.3651315789473684,0.9599505947540337,1.0,7/32,9.69%,PRKX;PRKD2;ACVRL1;RASIP1;CSF1R;PAK1;PODXL
prerank,sarcomere organization (GO:0045214),-0.33870353514122065,-1.0544910469141353,0.38875878220140514,0.7397044939577039,1.0,4/27,14.28%,TPM1;ACTN2;CSRP2;WDR1
prerank,activation of GTPase activity (GO:0090630),0.3045666283405684,1.0537165345739732,0.35724743777452417,0.9638691273118304,1.0,24/89,14.77%,TIAM1;ARHGEF26;EVI5L;TBC1D30;TBC1D8;RALGAPA2;TBC1D9;TBC1D10B;ARHGAP25;USP6NL;TBC1D4;RALGAPB;RABGAP1L;TBC1D12;TSC1;TBC1D25;DOCK7;RHOG;ADPRH;TBC1D14;RABGAP1;SYDE1;ARHGEF10;RALGAPA1
prerank,positive regulation of RNA splicing (GO:0033120),0.3642918235111301,1.053689974316048,0.38879456706281834,0.9627712967427283,1.0,4/29,6.90%,NCBP1;RBMXL1;RBM22;RBM20
prerank,cellular response to catecholamine stimulus (GO:0071870),0.38258264539258663,1.0536040667934126,0.3823008849557522,0.9618281245576248,1.0,3/23,6.25%,MAPK3;GABPA;GNB1
prerank,regulation of intracellular transport (GO:0032386),-0.32009738458297987,-1.0533721580207782,0.35714285714285715,0.7420231918549026,1.0,15/38,26.22%,MAP2;DYNC1H1;ATP9A;TTC21B;GAS1;RBM4;ATPSCKMT;RNF139;RINT1;CRYAB;AAAS;NUP214;DYNLT2B;CAPN10;INPP5F
prerank,positive regulation of protein maturation (GO:1903319),-0.441159395264431,-1.052817495022206,0.37344398340248963,0.7427310047886224,1.0,6/11,44.49%,RHBDD1;CCBE1;NKD2;SOX4;BAG2;ADAM8
prerank,mRNA splice site selection (GO:0006376),-0.33490789534457843,-1.0525593388385641,0.35664335664335667,0.7426147813858961,1.0,6/30,7.38%,CELF2;SRSF5;CELF4;PSIP1;SRSF6;SRSF1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.3833886819497795,1.0524153349033563,0.39928698752228164,0.9647271131821158,1.0,9/24,18.57%,ABCB10;ABCG2;TSPO;COX15;COX10;SLC25A38;ALAS1;FECH;NFE2L1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.41630764995189784,-1.0523903438057374,0.3924050632911392,0.7422553177673579,1.0,6/13,26.21%,RNF168;RNF8;NELFB;NELFA;LARP7;SUPT4H1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.3487882201201867,1.0517843488194873,0.38870967741935486,0.9656699599618798,1.0,11/36,16.89%,TIPRL;RAD1;CDC45;CLOCK;HUS1;NBN;DOT1L;CHEK2;BRIP1;ATR;USP28
prerank,regulation of platelet aggregation (GO:0090330),0.4165336832278706,1.0517686409472704,0.3786764705882353,0.9645315970065352,1.0,4/17,9.34%,PRKG1;SYK;F11R;LYN
prerank,positive regulation of cell growth (GO:0030307),0.29907784597796183,1.0515621691153847,0.3441011235955056,0.9640388713149576,1.0,15/96,10.75%,CPNE5;NCBP1;SEMA7A;DERL2;RPS6KA1;RPTOR;NEDD4L;CIB1;BDNF;RUFY3;USP47;EXOSC9;LGI1;EIF4G2;DDX3X
prerank,action potential (GO:0001508),-0.3065697522703684,-1.050666735840993,0.3675675675675676,0.7462171642173179,1.0,10/44,12.92%,ANK3;AKAP6;KCND2;SCN8A;SCN3A;KCNJ2;SCN1A;KCNA1;SRI;CACNA1G
prerank,negative regulation of calcium ion transport (GO:0051926),-0.39596888727611246,-1.0506164908098996,0.36971046770601335,0.7454925732952337,1.0,1/15,0.15%,ATP1A2
prerank,regulation of neuron apoptotic process (GO:0043523),0.2973912717051975,1.0505734244779585,0.3714689265536723,0.9662072321671538,1.0,20/96,13.25%,FOXQ1;SOD1;PPT1;CRLF1;SIGMAR1;APOE;TOX3;WFS1;AKT1S1;BDNF;SOD2;FZD9;PARK7;SRPK2;NAE1;EGLN2;NF1;PRNP;PRKCI;DDIT3
prerank,signal peptide processing (GO:0006465),0.4535374789402833,1.0505705862515715,0.4121338912133891,0.9650254883339427,1.0,4/11,13.70%,SEC11A;SPCS3;SPPL3;SPCS2
prerank,focal adhesion assembly (GO:0048041),-0.36131566396753356,-1.050557173988664,0.3738095238095238,0.744821983875857,1.0,5/21,9.72%,SORBS1;BCR;PIP5K1A;CTTN;ACTN2
prerank,anion transport (GO:0006820),-0.3257430140304535,-1.050478125475527,0.3568181818181818,0.7442179717481832,1.0,9/33,15.61%,SLC13A3;LRRC8D;SLC26A7;LRRC8B;VDAC1;SLC13A4;SLC22A6;SLC4A2;SLC19A1
prerank,DNA damage checkpoint signaling (GO:0000077),0.364387551440169,1.0504103339803468,0.39661016949152544,0.9643878039546216,1.0,10/28,16.89%,TIPRL;RAD1;CLOCK;HUS1;NBN;DOT1L;CHEK2;BRIP1;ATR;USP28
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.4241435027690171,1.0501689140440589,0.4148550724637681,0.9640681786776042,1.0,6/14,16.25%,SFSWAP;SRSF10;SRSF4;PTBP1;SRSF7;U2AF2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.275136972942632,1.0500534128623535,0.34102564102564104,0.9632840816425978,1.0,35/186,13.97%,SOX30;PSMB10;PSMC4;PSMB6;GSK3A;PSMD8;PSMD5;PSMD12;FRZB;RUVBL2;GREM1;TPBG;PSMD11;APOE;SOX2;PSMB4;PSMC1;CCDC88C;PFDN5;AXIN1;WNT5A;LATS2;SOX13;PSMC2;PSMD2;TMEM131L;NLK;TLE4;CUL3;PSMD14;DDIT3;PSMC6;PSMD1;PSMB1;APC
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.38410615988469443,-1.049558520089387,0.3777292576419214,0.7459334293938333,1.0,4/16,10.03%,FOXD1;FGF1;BMP4;SALL1
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.445315472162757,-1.0490097718257996,0.4274028629856851,0.7466648562408772,1.0,7/10,32.06%,SIRT2;BAG3;JUN;IMPACT;VHL;HIF1AN;NCK1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.4573336770570916,1.0489818809780196,0.41967871485943775,0.9657747142488158,1.0,3/11,11.64%,SIRT1;LYN;PIK3CD
prerank,negative regulation of response to external stimulus (GO:0032102),-0.2555683087712297,-1.0489721313406446,0.3391003460207612,0.7459361998636923,1.0,23/105,17.66%,LRFN5;CTNNA2;GRID2;PTPRS;PPM1B;SIRT2;ILRUN;PRKCD;PPARA;PTGIS;IRAK3;TRAFD1;OTULIN;SIRPA;CCN3;AJAP1;SELENOS;ENPP3;PTPN2;RORA;TNFAIP6;CERS2;CD109
prerank,methylguanosine-cap decapping (GO:0110156),0.46847781548576733,1.048823179686171,0.4137254901960784,0.9651525561569464,1.0,5/10,19.38%,PATL2;PATL1;DCP1A;LSM1;DCP1B
prerank,positive regulation of dendrite extension (GO:1903861),0.4124955695751123,1.048806469426154,0.3898916967509025,0.9640251164883102,1.0,2/17,4.26%,CPNE5;NEDD4L
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.41944126815246174,1.0484539709256844,0.41834862385321103,0.9640767202709238,1.0,2/16,0.94%,NCBP1;RBMXL1
prerank,negative regulation of chemotaxis (GO:0050922),0.365232907668265,1.0483647759826131,0.3798977853492334,0.963196717337974,1.0,7/31,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;NOTCH1;SEMA4C
prerank,positive regulation of JUN kinase activity (GO:0043507),0.3854025548568359,1.0480912850564108,0.3996478873239437,0.9629409289532377,1.0,6/23,14.80%,MAP3K11;MAP3K7;MAP3K4;PAK1;RPS3;MAP3K10
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.44318289714103176,1.0478181644679068,0.4306569343065693,0.9626537582443592,1.0,2/13,2.93%,UTP20;RPS21
prerank,ncRNA catabolic process (GO:0034661),-0.3369085218428253,-1.0477941619735496,0.3501259445843829,0.748312035142861,1.0,15/28,35.05%,LIN28B;EXOSC10;SND1;DIS3L;MTREX;DIS3;TRIR;RBM7;ZCCHC8;EXOSC8;EXOSC2;DEDD2;EXOSC3;EXOSC5;TENT4B
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.4327753387574403,-1.0477180763119283,0.39375,0.7477163774641978,1.0,3/11,16.33%,IL34;HSF1;TGFB1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.45546471142613854,-1.0475972468569161,0.39173228346456695,0.7472094932987287,1.0,5/10,39.57%,CBFB;NCKAP1L;HMGB1;ZBTB7B;SH3RF1
prerank,ephrin receptor signaling pathway (GO:0048013),0.3032046437186939,1.0475900090820474,0.3652173913043478,0.9622239927941475,1.0,17/82,10.48%,ARPC3;TIAM1;VAV3;PSEN2;AP2S1;ACTB;SRC;ITSN1;ARPC4;FYN;ARHGEF7;PAK3;EPHA5;EFNA1;LYN;PAK1;YES1
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.3122385297501886,1.0475086535146831,0.37925925925925924,0.9613471995476526,1.0,17/73,16.00%,MTCP1;RPTOR;STOX1;BCAR3;PRKD2;RAPGEF3;BDNF;TXN;AXIN1;PAK1;PARK7;DOCK7;APP;CD44;TERF2IP;GAS6;BRAF
prerank,membrane fusion (GO:0061025),-0.3256344335223389,-1.0474656874271497,0.41133004926108374,0.746721463653395,1.0,12/33,22.37%,RIMS1;UBXN2A;UBXN2B;HUWE1;MYOF;NSFL1C;DNM1;VAMP2;USO1;SNAP29;GCA;VPS33B
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3092555919203076,-1.0473266825367973,0.3604336043360434,0.746235787791325,1.0,5/41,4.63%,FGFR2;TGFBR3;TGFBR2;TPM1;BMP4
prerank,neural crest cell migration (GO:0001755),0.35493329895863607,1.0470627852239898,0.3665086887835703,0.9616721660671613,1.0,7/36,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;TBX1;SEMA6B;SEMA4C
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.34954490925672455,1.0470300419671563,0.3711864406779661,0.9606290306463948,1.0,9/35,13.89%,PTPRC;OCIAD1;NOTCH1;CYP1B1;IL10RB;NLK;ADIPOR1;DOT1L;HES1
prerank,synaptic vesicle endocytosis (GO:0048488),-0.32216984254108816,-1.0467673497478711,0.3605263157894737,0.7470079014640948,1.0,13/33,19.68%,DNAJC6;AMPH;SNAP91;NLGN2;STON2;NLGN1;STON1;DNM1;VAMP2;ITSN2;STX1A;SYT2;PACSIN1
prerank,lipoprotein catabolic process (GO:0042159),0.46337403830823987,1.0465940361434949,0.42034548944337813,0.9609990532733119,1.0,2/11,4.37%,PPT1;APOE
prerank,ncRNA transcription (GO:0098781),0.4311872349084471,1.0463072377594638,0.38996138996138996,0.9608269586545067,1.0,3/13,6.81%,GTF3C1;SPIN1;POLR1G
prerank,metal ion transport (GO:0030001),-0.26839648366983615,-1.046272182446777,0.3059210526315789,0.7476193319831247,1.0,16/86,13.25%,CACNA1C;ITPR1;CALCRL;CACNA1D;RYR3;SLC41A1;TRPC5;NIPA2;MRS2;CACNA1B;TRPC1;NDFIP1;CACNG7;RAMP1;NIPAL2;SLC39A8
prerank,telomere organization (GO:0032200),0.34049295739800883,1.0462291930555212,0.4128,0.9599275850097256,1.0,13/43,16.71%,CTC1;ERCC4;DCLRE1B;POLD3;ACD;TERT;HUS1;NBN;DOT1L;LTO1;TERF2IP;ATR;PRKDC
prerank,negative regulation of catabolic process (GO:0009895),-0.29281156261161284,-1.0461038740535789,0.3651226158038147,0.747288023954108,1.0,10/47,9.21%,EGFR;HDAC4;FLNA;SIRT2;NUPR1;FMN2;PPARA;IRAK3;BANP;AZIN1
prerank,regulation of vasculature development (GO:1901342),-0.3425924855204232,-1.0460316347558316,0.3811764705882353,0.7466540785498489,1.0,12/26,37.31%,ADGRA2;BMPER;CTNNB1;PLXND1;EMP2;ERBB2;SFRP1;EGLN1;HTATIP2;ETS1;EPHA2;VASH1
prerank,protein homooligomerization (GO:0051260),0.2887936351652762,1.0457445377840688,0.38189533239038187,0.9603648793983884,1.0,18/114,12.51%,THG1L;RS1;GLS;EHD4;ATL1;SIGMAR1;MLKL;B2M;BEND3;SSBP1;SLC1A2;ACACB;SOD2;TRMT61B;CHMP2A;TRPM4;G3BP2;LETM1
prerank,negative chemotaxis (GO:0050919),0.35151303189177047,1.0456576551370922,0.3918032786885246,0.9595064306957356,1.0,6/33,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;SEMA4C
prerank,regulation of epithelial cell migration (GO:0010632),0.3229643708069828,1.045549007538413,0.3856920684292379,0.9587350892468296,1.0,7/51,4.80%,PTPRR;PTPRG;SRC;CLASP2;EVL;INSL3;PFN1
prerank,regulation of dendrite morphogenesis (GO:0048814),-0.324344238694383,-1.0455426735638504,0.3698630136986301,0.7471695598378437,1.0,14/32,20.74%,ADGRB3;CUX1;SDC2;HECW1;GSK3B;CUX2;SEMA4D;IL1RAPL1;OBSL1;RAPGEF2;HECW2;KNDC1;NEDD4;NSMF
prerank,cellular calcium ion homeostasis (GO:0006874),-0.2499316453706403,-1.0455152067405504,0.34375,0.7464052692573067,1.0,24/133,14.25%,ANK2;SLC24A3;HTR2C;STIM2;MCU;PDZD8;ATP1B1;STIM1;PACS2;ATP13A5;TRPC5;MICU2;PML;HERPUD1;TRPC1;SLC24A2;PRKACA;DMPK;CAMK2D;CCL14;TMCO1;AFG3L2;SLC35G1;CAV2
prerank,programmed necrotic cell death (GO:0097300),0.41438488827952524,1.0455015851605602,0.41894353369763204,0.9577281894486568,1.0,5/18,16.21%,MLKL;TRPM7;ALKBH7;ITPK1;DNM1L
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.34888605872599976,1.0454782290738127,0.36757624398073835,0.9566595256878789,1.0,13/37,18.25%,EIF5A;SOD1;SFPQ;BCLAF1;BAD;RPS3;BMF;DDIT3;DNM1L;BECN1;BCAP31;BAX;FBH1
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3136640389674792,1.0449590827309294,0.38080495356037153,0.9572121882144532,1.0,19/63,18.03%,PLK2;CNOT11;CDKN1A;EP300;CRADD;CNOT2;RGCC;CNOT7;MDM2;RFWD3;CARM1;CNOT6;CHEK2;CNOT1;CNOT6L;PRKDC;CNOT10;BAX;RPL26
prerank,regulation of protein transport (GO:0051223),0.3706042192971904,1.044587692971759,0.40476190476190477,0.9573283951948857,1.0,5/27,11.48%,LCP1;HSPA8;STXBP5L;RHBDF2;SCFD1
prerank,negative regulation of viral release from host cell (GO:1902187),0.4316057908684238,1.0444669384770484,0.40148698884758366,0.956581596384949,1.0,2/13,3.56%,TRIM28;TRIM8
prerank,negative regulation of cell development (GO:0010721),-0.3412895284851233,-1.04432224567552,0.3878048780487805,0.7490364444801317,1.0,5/25,10.74%,IGF1;FBN1;APPL2;SORL1;GSK3B
prerank,regulation of protein localization to nucleus (GO:1900180),-0.3148968958106031,-1.0440876097656857,0.38181818181818183,0.7488495241023448,1.0,18/43,25.27%,CTNNA1;KAT7;BMP4;GLUL;ILRUN;GSK3B;WWTR1;TGFB1;LIMK2;CARD10;DTX3L;FLCN;LAMTOR5;OTUD7B;SESN2;AKT1;YAP1;EIF2AK3
prerank,sensory perception of chemical stimulus (GO:0007606),-0.39829045506273086,-1.0439993849707512,0.41041666666666665,0.7482611707365927,1.0,6/15,33.54%,GNAL;ADCY3;SYT10;SLC24A4;DRD2;MKKS
prerank,cellular response to gamma radiation (GO:0071480),-0.3746108693148987,-1.0434282160675283,0.388646288209607,0.7490058722314479,1.0,8/17,25.01%,MAP3K20;TP53;HSF1;ATM;KDM1A;CRYAB;TMEM109;YAP1
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.28814148545531637,-1.0433441274199522,0.35142118863049093,0.7483999074003137,1.0,9/59,10.53%,ALDH1A2;OSBPL9;OSBPL6;CYP27A1;SRR;PER2;CYP7B1;OSBP;ACLY
prerank,mitotic spindle organization (GO:0007052),0.27978001797959867,1.0430281497819751,0.357429718875502,0.9601937928166235,1.0,36/153,17.75%,ABRAXAS1;DYNC1I1;EML1;KIF18A;NUDC;PLK2;CLASP2;NEK9;DCTN2;MAP4;CDCA8;CENPC;MZT1;KIF2A;BCCIP;MIS12;DYNLL1;TNKS;NEK6;XPO1;KIF3B;CHEK2;PTPA;EFHC2;RCC1;ARHGEF10;DYNC1I2;CENPP;CLIP1;STAG2;CENPO;KPNB1;NUP160;CLASP1;RANGAP1;PAFAH1B1
prerank,negative regulation of DNA binding (GO:0043392),0.3638089286207629,1.0428091669628954,0.39792387543252594,0.9598075793800595,1.0,7/28,13.81%,LEF1;HEY1;HEY2;RSF1;TFAP4;TNKS;NFKBIA
prerank,sterol metabolic process (GO:0016125),0.316248481748871,1.042372017920376,0.40435458786936235,0.9600821420978018,1.0,10/60,10.16%,EBP;INSIG1;HMGCR;APOE;SOAT1;PPARD;SC5D;OSBPL1A;CYP1B1;NSDHL
prerank,inorganic cation import across plasma membrane (GO:0098659),-0.27544384833756386,-1.0421669545751202,0.36333333333333334,0.750937038343293,1.0,28/75,27.27%,ATP1A2;ATP1B1;SLC6A1;ATP1B3;SLC12A2;SLC39A14;ATP1A1;KCNJ2;SLC24A2;ATP1B2;KCNJ6;SLC9A2;ABCC9;SLC39A8;SLC12A6;KCNJ13;SLC12A4;ATP1A3;KCNJ10;SLC12A9;SLC39A6;CACNA2D1;SLC12A7;KCNK9;TRPV2;HCN2;SLC12A8;SLC12A5
prerank,positive regulation of protein phosphorylation (GO:0001934),0.2577008862129656,1.0418068750228078,0.3506787330316742,0.9607702661025117,1.0,52/348,12.66%,LRP8;GDF1;MAPK3;RALB;PTPRJ;LIMCH1;RAP2A;PTPRC;PIN1;MTCP1;PECAM1;TAB2;RPTOR;RPS6KA4;SRC;STOX1;BCAR3;HDAC3;PRKD2;RPS6KA5;TEK;NPTN;CDKN1A;CIB1;FXR1;TBX1;CALM3;LCP2;RAPGEF3;BDNF;SIRT1;TXN;AXIN1;EFNA1;ACVRL1;AKTIP;CDK2AP1;CSF1R;LYN;PAK1;PARK7;DOCK7;ACVR2A;DDX3X;CD81;MMD;APP;PRNP;WDFY2;CRKL;RAP2C;NBN
prerank,regulation of lymphocyte migration (GO:2000401),-0.4393223231256571,-1.0415365314855831,0.4158215010141988,0.7518545661212647,1.0,3/10,24.73%,WASL;MSN;AKT1
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.2901532482713633,-1.0415281199069328,0.3816155988857939,0.7510607217555859,1.0,8/48,12.06%,ANK2;AKAP6;CEMIP;UBASH3B;TRPC1;PRKACA;CAMK2D;SRI
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3673003875521611,1.0415198620554929,0.39713774597495527,0.9605840624957152,1.0,4/27,7.85%,MAP3K7;TAB2;TIRAP;TAB3
prerank,COPII-coated vesicle budding (GO:0090114),0.31061889231946654,1.0414715064040083,0.38823529411764707,0.9596030439346861,1.0,15/68,15.49%,TRAPPC2;CNIH1;ANKRD28;SEC23IP;F8;GOSR2;NAPA;TMED10;RAB1A;SCFD1;TRAPPC6B;MCFD2;CUL3;PPP6R1;TRAPPC10
prerank,mitotic cytokinesis (GO:0000281),-0.2973369405623028,-1.041453024618012,0.3871866295264624,0.7504576492085654,1.0,17/47,27.68%,ANK3;SON;ROCK2;CIT;ROCK1;KLHDC8B;RHOB;MITD1;TRIM36;STMN1;JTB;SNX18;RHOC;CNTROB;SPTBN1;EFHC1;RAB35
prerank,positive regulation of nervous system process (GO:0031646),-0.3722497379153167,-1.0414448131854555,0.40397350993377484,0.749657139449833,1.0,7/18,23.35%,RIMS1;NLGN2;UNC13B;DICER1;ATPSCKMT;RNF10;TPPP
prerank,response to interleukin-6 (GO:0070741),0.46835640522665656,1.041267362545952,0.42638623326959846,0.959147799863019,1.0,4/10,12.36%,SBNO2;PTPRT;RELA;ST3GAL6
prerank,mesenchyme morphogenesis (GO:0072132),0.4041986236250499,1.0412623310561695,0.41404805914972276,0.9580226440645466,1.0,5/17,15.94%,HEY1;NOTCH1;ACVRL1;NOS3;HEYL
prerank,Notch signaling involved in heart development (GO:0061314),0.45802788019983315,1.0412027414440046,0.41025641025641024,0.9570663536170001,1.0,5/11,15.94%,HEY1;HEY2;NOTCH1;RBPJ;HEYL
prerank,energy reserve metabolic process (GO:0006112),-0.3788957459544588,-1.0410842161758846,0.41739130434782606,0.7498250348275828,1.0,8/19,25.75%,PRKAG2;LEPR;PID1;GSK3B;PYGM;PHKG2;GFPT1;GFPT2
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.24233153180850026,1.040988083167363,0.29969727547931385,0.9566499850169773,1.0,293/1646,16.30%,TBX4;SOX30;LRRFIP1;DBX2;ATF3;IRX1;PRKAR1A;TOX4;MAZ;ZBTB42;CTCFL;MAP2K7;FOXQ1;CCDC85B;GCLC;DACH1;ILF3;MECOM;SIM1;ARID5A;SS18L1;ELOC;ONECUT1;KLF8;TRIB3;FOXN2;TRAPPC2;L3MBTL4;TFCP2;MTERF3;NR4A2;EZH2;CDK17;TAL1;ATF6;ACTL6A;TRIM28;ZFAT;HSPA8;LEF1;CIPC;HES6;EED;CTDSP1;RUVBL2;PPP3CB;GTF2IRD1;BTAF1;RPS6KA1;RPS6KA4;DMAP1;PHF14;KLF2;CCNC;HIPK2;ING4;ELK3;PAX8;ATXN1L;BCL11B;ZHX3;GABPA;ZBTB24;ZBTB33;BACH2;HDAC9;SBNO2;BCL6B;HDAC3;ZKSCAN1;SMAD1;RPS6KA5;PHF5A;PRDM15;PPP2CA;HNRNPAB;HEY1;NR5A1;RLF;APOE;ZBTB41;CCNH;IRF9;BBX;MEIS1;SOX2;HNRNPK;MYBL2;SMARCA2;YY1;FLI1;PHB2;GMEB2;TOX3;ZNF83;KDM3A;KDM2A;ZNF740;SPIN1;CDKN1A;UBE2I;USF2;NPAT;ZSCAN2;IRF2BPL;VEZF1;EP300;RFX3;ZNF260;NFX1;CARF;TBX1;MED23;PCGF3;RET;CALCOCO1;TGFBRAP1;SRSF10;CNOT2;CEBPG;MED12;ACTR8;MAMLD1;FOXF2;CDK11B;PPARD;CHMP1A;ZNF205;SFPQ;CDC45;FBXO5;UXT;SMAD7;DRAP1;SIRT1;CLOCK;ACTR5;ZNF3;PFDN5;RNF187;AXIN1;HEY2;SETD5;ZBTB14;NOTCH1;WNT5A;RUVBL1;CAND2;USP47;CNOT7;LCORL;ATXN7L3;ATAD2;GTF2H1;ZXDC;ACVRL1;RSF1;RELA;SOX13;TRPS1;SOD2;NAB2;PCID2;POLA1;MDM2;BCLAF1;RAI1;JUND;HOXA7;PIAS2;PKN1;PLCB1;TFAP4;RNF6;ERG;KLF6;ZKSCAN3;TSFM;UBE2V1;CIR1;TAF15;CCAR2;RYBP;WBP2;ING2;YEATS4;CITED2;MGA;CHD1;PBXIP1;HIC2;RBPJ;ESR1;SETD3;NLK;CREBBP;CARM1;USP22;HP1BP3;DACH2;RHOG;CTBP1;PIAS1;NFIC;MED4;POLR3F;PA2G4;JMJD1C;MDFIC;HDGF;PICALM;LANCL2;E2F3;ILF2;MZF1;SP1;IKBKB;SMARCD1;NUP35;ZSCAN12;IRF2;CHD3;ERC1;CHUK;HDAC5;RRP8;YWHAH;PITHD1;ACTA2;ZBTB45;TRRAP;SP110;ING5;NDUFA13;DDIT3;EDRF1;TGIF1;CHEK2;CTBP2;THRA;EPAS1;ZKSCAN5;BRD2;YBX1;HES1;KDM5C;HCFC1;SP8;CREBRF;RNF20;GRHL1;BRIP1;BACH1;PURG;NCOA7;SIX5;PHF8;BAZ2A;E2F6;AEBP2;NSD2;CAMKK2;FUS;MAP3K10;TMPRSS6;TSHZ1;PHF10;TERF2IP;TFAM;ZFP62;BCL6;TCF20;GAS6;FOXJ3;NKAP;TFEB;ELK4;TAF6L;TRIM33;SMARCA4;TCF7L1;TCF3;APBB2;WIZ;HEYL;ID2;ZNF483;PURB;TSHZ2;ZBTB18;NAA15;CDK14;TP53INP2
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.4395563613879687,1.0404538599372506,0.40388349514563104,0.9572680116532587,1.0,3/12,10.70%,BCDIN3D;TERT;ESR1
prerank,proteasome assembly (GO:0043248),0.44853249979678733,1.0402244258279647,0.41015625,0.9569036748712321,1.0,3/11,7.73%,PSMD5;PSMD11;PSMG1
prerank,amyloid fibril formation (GO:1990000),-0.2956194480587861,-1.0401206862734333,0.39255014326647564,0.7516287425545558,1.0,14/51,25.45%,GSN;SNCAIP;MAPT;SORL1;HSPG2;GGA2;BACE1;UBC;SIAH2;GGA3;TGFBI;TSPAN15;MFGE8;APH1B
prerank,regulation of TOR signaling (GO:0032006),0.30635815402743755,1.0400558567026468,0.37767584097859325,0.9563438161190388,1.0,15/67,15.42%,GSK3A;RPTOR;HDAC3;RFFL;EPM2A;AKT1S1;LAMTOR1;SIRT1;GNA12;TSC1;PRKAA2;LARS1;RRAGC;TMEM127;GAS6
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.46402905118033716,-1.0399007998229497,0.4433198380566802,0.7513867564756574,1.0,6/10,20.43%,OSR1;HECW1;CAMK2D;COMMD1;HECW2;NEDD4
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.45189659777003643,1.039793793568557,0.4064885496183206,0.9561082757397538,1.0,5/11,19.71%,CCT2;CCT5;TCP1;DKC1;CCT8
prerank,regulation of sprouting angiogenesis (GO:1903670),0.35460544988889475,1.039791758910879,0.39384116693679094,0.954999110987701,1.0,5/33,4.15%,SEMA6A;JMJD8;KLF2;SMAD1;PPP1R16B
prerank,nuclear membrane organization (GO:0071763),-0.36427266733379704,-1.0397701538615138,0.4,0.7509239073074843,1.0,13/19,35.85%,UBXN2A;UBXN2B;TOR1AIP1;NSFL1C;TOR1B;DCTN1;NEMP1;VPS4A;EMD;TMEM43;TOR1A;GPER1;CHMP7
prerank,response to UV-B (GO:0010224),0.4440881549385177,1.0396685169841433,0.4311023622047244,0.9542722217949183,1.0,3/12,8.95%,MME;CDKN1A;RELA
prerank,fatty acid transport (GO:0015908),0.4125454067974978,1.0395797823514579,0.43439716312056736,0.9534301821413145,1.0,3/17,6.79%,GOT2;APOE;PPARD
prerank,regulation of apoptotic process (GO:0042981),0.2458113433147014,1.039508256766637,0.35591397849462364,0.9525688890921716,1.0,107/676,14.01%,LRP8;CIDEA;HIGD2A;ERCC3;GCLC;MAP3K11;CBL;ATF6;FRZB;LEF1;TIAM1;ACER2;VAV3;SOD1;PSEN2;PLK2;RPS6KA1;BCL2L2;GLS2;CHM;ARHGEF26;GREM1;SRC;PPT1;DNAJA3;ING4;PAX8;MCF2L;HDAC3;BIRC2;NME1;ITSN1;SIGMAR1;TNFRSF10B;TEK;HNRNPK;CIAPIN1;SLK;PHB2;TOX3;CASP6;WFS1;CFL1;CIB1;AKT1S1;MAPK8;BAG1;ARHGEF6;CRADD;ARHGEF7;TRIO;PIM1;ACTN4;OMA1;SIRT1;NAA35;ARHGEF18;WNT5A;USP47;ITGA6;LATS2;PHLPP1;TJP1;FBXO11;RELA;PCID2;BCLAF1;CYP1B1;FZD9;PARK7;TFAP4;TARDBP;AIFM1;CCAR2;RYBP;TMBIM4;ING3;CITED2;PRKAA2;BAD;NAE1;DDX3X;CREBBP;ANKLE2;HIGD1A;RPS3;PA2G4;ATG7;EGLN2;NF1;MAP4K4;IP6K2;BMF;BNIP3L;PRKCI;API5;IKBKB;ERC1;ING5;UTP11;AVEN;DIABLO;FAF1;NFKBIA;PROC;APC;PTPA
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),-0.2853303798625298,-1.0392028036512613,0.3770949720670391,0.7516308269116093,1.0,13/57,13.30%,UACA;GRIN2B;CYFIP2;MALT1;FIS1;LGMN;MAP3K5;GRAMD4;AIM2;CTSD;USP50;PDCD5;TBC1D10A
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.36405741417702486,1.039109445038479,0.4102112676056338,0.9516526016242891,1.0,4/29,6.67%,MLYCD;ACAT1;DBI;GPAT4
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.36405741417702486,1.039109445038479,0.4102112676056338,0.9516526016242891,1.0,4/29,6.67%,MLYCD;ACAT1;DBI;GPAT4
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.38244587225069865,1.0385814693136728,0.3996655518394649,0.9522227285493654,1.0,6/24,11.75%,CTC1;SRC;ERCC4;HNRNPC;ACD;TNKS
prerank,neural tube closure (GO:0001843),-0.31913381114383865,-1.0383375886295205,0.373134328358209,0.7532815492763065,1.0,17/34,31.66%,LMO4;SKI;COBL;MTHFR;DVL3;MTHFD1;PLXNB2;LRP6;TGFB1;DVL1;TSC2;PAX2;BCL10;FUZ;SCRIB;KDM2B;VANGL2
prerank,positive regulation of lamellipodium assembly (GO:0010592),-0.3445280724544222,-1.0376789459250353,0.375,0.7542913287462728,1.0,10/24,21.10%,WASF2;AUTS2;OCLN;PLCE1;ACTR3;TWF2;ACTR2;CDC42;PIK3R1;ARPC2
prerank,MAPK cascade (GO:0000165),0.25940972282841,1.0374618447959776,0.3788235294117647,0.9546397113016593,1.0,56/295,14.83%,GFRA3;PSMB10;PSMC4;MAP2K7;PSMB6;MAPK3;DUSP7;PSMD8;SPTB;PSMD5;PSMD12;MAP3K7;SHANK3;ZFP36L1;NRAS;PSMD11;TEK;SPRED1;PSMB4;FYN;PSMC1;RASGRP3;MAPK8;RET;FGF13;YWHAB;IRS2;MINK1;PSMC2;PAK1;PSMD2;ICMT;RASA2;NF1;MAP4K4;TNIP2;PDE6D;IKBKB;ARTN;ZDHHC9;CUL3;MAPK12;CHUK;NRG2;PSMD14;PSMC6;PPP5C;PSMD1;PSMB1;PTPRA;RGL2;MAP3K3;RGL3;GFRA1;CAMKK2;ABHD17B
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3786539739358493,-1.0370497416588709,0.3934065934065934,0.7551893143307501,1.0,2/17,1.07%,BMP6;SASH1
prerank,carnitine shuttle (GO:0006853),-0.42989770956145135,-1.0367892613315148,0.4592274678111588,0.7550705098556344,1.0,4/11,14.92%,PRKAG2;CPT1A;PRKAB2;CPT2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.44875470735671674,1.0364203688910842,0.4174573055028463,0.9570257626386558,1.0,4/12,17.75%,JMJD4;FYCO1;BNIP3;INSR
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.4449587008333379,-1.0363063842478388,0.41513292433537835,0.7555884685204239,1.0,3/10,15.70%,RYK;CTNNB1;LRP6
prerank,telomere capping (GO:0016233),0.41018233443962365,1.0361056411809886,0.4117647058823529,0.9569481043392422,1.0,7/16,17.17%,CTC1;DCLRE1B;ACD;NBN;TERF2IP;PRKDC;DCLRE1C
prerank,regulation of lamellipodium organization (GO:1902743),-0.4023188049085703,-1.0358863496387472,0.41014799154334036,0.7559899251423017,1.0,6/14,25.32%,PDPN;FER;TWF2;CDC42;CAPZB;DMTN
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.4439591047349053,1.0358604755183685,0.4442231075697211,0.9566580346367272,1.0,3/13,11.00%,TDG;UPP2;SMUG1
prerank,positive regulation of inflammatory response (GO:0050729),-0.2618132409119861,-1.0357438031098556,0.3569023569023569,0.755597216227881,1.0,26/86,29.17%,OSMR;SNX4;NUPR1;LBP;NAPEPLD;IL17RA;IL16;GPR4;IL18;IL33;IL6ST;TNIP1;GPRC5B;AGTR1;SETD4;CX3CL1;VAMP8;PLA2G7;FEM1A;TLR3;SERPINE1;PDE2A;CCN4;KARS1;SNCA;MDK
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2532474035671634,1.0354309307652518,0.38175675675675674,0.9569152679116542,1.0,57/417,10.65%,CCDC85B;GCLC;DACH1;ILF3;MECOM;ARID5A;TRIB3;L3MBTL4;MTERF3;EZH2;TRIM28;HSPA8;LEF1;CIPC;EED;BTAF1;DMAP1;ING4;ELK3;ZHX3;ZBTB33;HDAC9;SBNO2;HDAC3;RPS6KA5;HEY1;SMARCA2;PHB2;UBE2I;RFX3;PPARD;CHMP1A;SFPQ;SIRT1;CLOCK;PFDN5;HEY2;ZBTB14;NOTCH1;WNT5A;USP47;CNOT7;RSF1;RELA;SOX13;MDM2;BCLAF1;HOXA7;PLCB1;TFAP4;ZKSCAN3;CIR1;CCAR2;CITED2;PBXIP1;HIC2;RBPJ
prerank,positive regulation of protein polymerization (GO:0032273),-0.2797569522405393,-1.0354184273957259,0.38526912181303113,0.7556891483628644,1.0,25/65,27.97%,NAV3;MAPT;OCLN;FER;CTTN;AKAP9;SLAIN2;BIN1;BAIAP2L1;FCHSD2;DCTN1;CDC42EP5;CDC42EP1;MET;PINK1;PFN2;TPPP;HSP90AA1;TTBK1;TPPP3;CDC42EP2;NCKAP1L;ARL2;TOGARAM1;MAPRE1
prerank,nitrogen compound transport (GO:0071705),0.27544743266476424,1.0353942200854112,0.38376891334250346,0.9559371073868093,1.0,14/141,7.87%,SLC18A1;SLC5A7;SLC7A8;ABCG2;PPT1;SLC3A2;SLC52A2;RAB7A;RAMP2;SLC52A3;SLC6A6;CHMP1A;TMEM30B;SLC44A1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.3969142490796713,1.0353547360722113,0.4010989010989011,0.9549633034666276,1.0,4/18,11.70%,RPS26;TERT;ESR1;PTBP1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.4092470215078195,-1.0353462901544854,0.43817787418655096,0.7550651537000906,1.0,3/14,7.70%,PUM1;PUM2;ZDHHC5
prerank,regulation of chromatin binding (GO:0035561),0.4571349296221533,1.0350876642851266,0.4109311740890688,0.95472609742792,1.0,2/10,8.25%,BTAF1;KDM4D
prerank,cAMP-mediated signaling (GO:0019933),-0.3438407243505226,-1.034967081104641,0.40572792362768495,0.7552747875908056,1.0,4/24,3.18%,KSR1;AKAP6;ADCY2;ADCY1
prerank,lipoprotein transport (GO:0042953),0.4531198625270176,1.0349391443304936,0.40674603174603174,0.9541378575748667,1.0,5/10,20.79%,ZDHHC17;VMP1;UNC119B;MIA3;PPARG
prerank,cell part morphogenesis (GO:0032990),-0.4093485474726611,-1.0348846107799416,0.4230769230769231,0.754680663350349,1.0,3/13,7.76%,PID1;WASF1;FIS1
prerank,acidic amino acid transport (GO:0015800),-0.38069546856646486,-1.0345918783233086,0.4194260485651214,0.7546805030260261,1.0,6/17,10.49%,SLC1A3;SLC6A13;LRRC8D;SLC6A1;SLC25A13;GJA1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.41869149848365206,1.0345617413196457,0.41263940520446096,0.9542784071218493,1.0,4/15,13.23%,TTLL12;CNOT7;USP18;NLRC5
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.26359108987966434,1.0338916184333125,0.3806532663316583,0.9553602897314578,1.0,40/208,14.19%,ZDHHC17;JMJD8;TNFAIP3;MAP3K7;TAB2;PLK2;EEF1D;TIRAP;TRIM8;BIRC2;ZDHHC13;TNFRSF10B;TMED4;EDAR;TRIM14;GPR89A;CARD16;TRAF5;SIRT1;NLRC3;TAB3;WNT5A;TRIM25;TRAF3;RELA;RBCK1;LURAP1;UBE2V1;ESR1;NOD1;TNIP2;IKBKB;NEK6;MAPKBP1;CHUK;ANKRD17;PPP5C;ATP2C1;TRIM27;MAP3K3
prerank,long-chain fatty acid transport (GO:0015909),-0.3222655471770216,-1.0335018381931407,0.4014251781472684,0.7567671279602378,1.0,7/30,14.92%,PRKAG2;ACSL1;CPT1A;PRKAB2;SLC27A1;ABCD2;CPT2
prerank,mismatch repair (GO:0006298),0.37175455388841566,1.03347586381454,0.4249146757679181,0.9556117318071985,1.0,6/27,9.74%,TDG;PMS2;POLD3;MLH1;PMS1;MSH3
prerank,response to UV-A (GO:0070141),0.42392788258743264,1.0333957295214302,0.4399260628465804,0.9547689483745608,1.0,2/14,4.46%,CERS1;MME
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.31221929198714854,1.0332588634580389,0.4012539184952978,0.9541257673850015,1.0,13/59,13.81%,MAP3K7;TAB2;BIRC2;NLRC3;TAB3;RELA;RBCK1;NFKBIL1;IKBKB;ERC1;CHUK;FAIM;NFKBIA
prerank,negative regulation of apoptotic process (GO:0043066),0.24968022291771,1.0332586900829785,0.3649393605292172,0.9530351294924494,1.0,69/444,13.96%,CIDEA;HIGD2A;MAZ;FOXQ1;GCLC;MAPK3;CBL;NR4A2;LEF1;SOD1;PSEN2;PLK2;RPS6KA1;BCL2L2;PRKCH;GREM1;SRC;PPT1;CRLF1;MAP2K5;HDAC3;BIRC2;APOE;TEK;HNRNPK;CIAPIN1;PHB2;TOX3;WFS1;CFL1;CIB1;MAPK8;TBX1;CARD16;BAG1;SFPQ;PIM1;BDNF;SIRT1;NAA35;NOTCH1;WNT5A;USP47;MERTK;TJP1;RELA;SOD2;PCID2;FZD3;FZD9;PARK7;TMBIM4;CITED2;PRKAA2;DDX3X;ANKLE2;HIGD1A;PA2G4;MAP4K4;BNIP3L;PRKCI;API5;IKBKB;ERC1;AVEN;NFKBIA;TRIM27;CSNK2A2;PROC
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.4209495025251944,-1.0332501360487418,0.3974358974358974,0.7566296513835299,1.0,4/12,19.95%,KAT7;WRNIP1;METTL4;BLM
prerank,lysine metabolic process (GO:0006553),0.43714999891237905,1.032857049089041,0.4351851851851852,0.9521376421877128,1.0,3/12,15.27%,AASS;PHYKPL;SLC25A21
prerank,lysine catabolic process (GO:0006554),0.43714999891237905,1.032857049089041,0.4351851851851852,0.9521376421877128,1.0,3/12,15.27%,AASS;PHYKPL;SLC25A21
prerank,cellular iron ion homeostasis (GO:0006879),0.32556064705106436,1.0327757312098864,0.39593114241001565,0.9513222663880083,1.0,10/55,11.99%,CAND1;HMOX2;SOD1;ABCG2;FBXL5;ATP6V0D1;ISCU;GLRX3;ATP6AP1;ACO1
prerank,activation of phospholipase C activity (GO:0007202),-0.32901674705757666,-1.0323888144933264,0.40145985401459855,0.7581870032286088,1.0,5/29,6.33%,LPAR1;EGFR;NTRK2;ARHGAP6;EDNRA
prerank,epiboly involved in wound healing (GO:0090505),-0.3794973257278503,-1.0318501519493113,0.42332613390928725,0.7588375865787198,1.0,5/16,6.22%,TMEFF2;PDPN;RHOA;FLNA;DDR1
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.3197776298005545,1.0310945712523554,0.41849529780564265,0.9557441120355974,1.0,8/50,10.75%,RPS6KA1;SRC;MAP2K5;RFFL;CARD16;USP47;PARK7;DDX3X
prerank,B cell activation (GO:0042113),0.30670780903981476,1.0309046500335786,0.41063515509601184,0.955263336408517,1.0,9/68,13.02%,DCAF1;PTPRJ;PTPRC;HDAC9;PHB2;CEBPG;KLF6;PIK3CD;HDAC5
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.43078823525043863,1.0306182379972373,0.4448818897637795,0.955159338388741,1.0,6/13,20.96%,PRR5L;CNOT7;CNOT1;MOV10;RC3H1;CNOT8
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.2411406514184379,1.0303625288343872,0.37716615698267075,0.9549071225456293,1.0,191/1082,14.95%,SOX30;ATF3;MAZ;CTCFL;MAP2K7;MAPK3;ILF3;CHCHD2;MECOM;SS18L1;ONECUT1;EIF5A;TFCP2;NR4A2;TAL1;ATF6;TRIM28;PIN1;LEF1;RUVBL2;PPP3CB;RPS6KA1;RPTOR;RPS6KA4;KLF2;MRTFA;CCNC;PCBP1;GREM1;HIPK2;ELK3;PAX8;BCL11B;MAP2K5;GABPA;SBNO2;HDAC3;PRKD2;SMAD1;RPS6KA5;MRTFB;PHF5A;PRDM15;HNRNPAB;HEY1;NR5A1;RLF;APOE;MMP12;PRDM4;MEIS1;CCDC62;SOX2;MYBL2;SMARCA2;YY1;FLI1;TOX3;KDM3A;SPIN1;IER2;USF2;NPAT;IRF2BPL;DCAF6;VEZF1;EP300;RFX3;ICE1;TBX1;ASXL3;RET;CALCOCO1;CEBPG;MED12;FOXF2;PPARD;RGCC;SFPQ;SMAD7;DRAP1;SIRT1;CLOCK;PAXBP1;TET3;RNF187;LMO7;AXIN1;HEY2;NOTCH1;WNT5A;CAND2;GLMP;ATXN7L3;ATAD2;GTF2H1;ITGA6;ZXDC;ACVRL1;RSF1;RELA;PCID2;BCLAF1;ECD;RAI1;JUND;HOXA7;PARK7;PLCB1;AKAP8L;TFAP4;KANSL3;RNF6;RHOQ;ERG;KLF6;PPP1R12A;ZKSCAN3;UBE2V1;TAF15;RYBP;WBP2;LMO2;ACVR2A;ING2;YEATS4;CITED2;RBPJ;ESR1;SETD3;THRB;DDX3X;CREBBP;CD81;USP22;RHOG;APP;ZBED3;NFIC;MED4;ATAD2B;ZBED4;MDFIC;TNKS;PPP3CA;PICALM;PPP3R1;TNIP2;E2F3;ILF2;AGRN;MZF1;SP1;IKBKB;SMARCD1;SS18;IRF2;DOT1L;CHUK;HDAC5;YWHAH;PITHD1;ACTA2;NLRC5;ING5;DDIT3;EDRF1;CHEK2;CTBP2;THRA;EPAS1;SSBP4;POGZ;NFKBIA;YBX1;HES1;HCFC1;CREBRF;RNF20;DR1;GRHL1;NCOA7;PHF8;HEATR1;CRTC3;INO80;SCAF8;CAMKK2;TMPRSS6;PRDM10;PHF10
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.3636890796347355,1.030293306248642,0.4097222222222222,0.9540520386131167,1.0,7/26,13.74%,TNFAIP3;MAP3K7;TAB2;TAB3;UBE2V1;NOD1;MAP2K6
prerank,protein insertion into membrane (GO:0051205),0.3586971423727199,1.0300905642234666,0.4305993690851735,0.9536638163441928,1.0,2/32,0.34%,RTP3;REEP1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.377815020953989,1.0299865419126892,0.4336283185840708,0.9529240634605034,1.0,3/22,4.86%,EIF5A;RPL23;SPRED1
prerank,cellular protein catabolic process (GO:0044257),-0.28023606343633,-1.0299100024663088,0.391812865497076,0.763422921909469,1.0,17/59,16.94%,ADAMTS12;AP2B1;CAPN2;AP2A2;AFG1L;MALT1;AP2A1;PSMA6;LGMN;CLPP;FAP;TCIRG1;CTSO;VLDLR;SIAH2;RNF123;CTSZ
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.24823982445514503,1.0298014281396823,0.3799126637554585,0.952454865176711,1.0,94/497,16.20%,CCDC85B;GCLC;DACH1;ILF3;MECOM;ARID5A;GSK3A;TRIB3;L3MBTL4;MTERF3;EZH2;TRIM28;HSPA8;LEF1;CIPC;PATL2;EED;BTAF1;DMAP1;ING4;ELK3;ZHX3;ZBTB33;HDAC9;SBNO2;HDAC3;RPS6KA5;HEY1;SMARCA2;PHB2;CDKN1A;UBE2I;DBI;RFX3;FXR1;PAIP2B;PPARD;CHMP1A;SFPQ;SIRT1;CLOCK;PFDN5;HEY2;ZBTB14;NOTCH1;WNT5A;USP47;CNOT7;ACVRL1;RSF1;TSC1;RELA;SOX13;MDM2;BCLAF1;HOXA7;PLCB1;TFAP4;ZKSCAN3;CIR1;CCAR2;CITED2;PBXIP1;HIC2;RBPJ;DDX3X;CTBP1;NANOS3;RPS3;PA2G4;MDFIC;LANCL2;HDAC5;NDUFA13;DDIT3;CTBP2;THRA;YBX1;HES1;KDM5C;CAPRIN1;CNOT1;MAP3K10;TMPRSS6;PHF10;BCL6;GAS6;NKAP;ATR;TRIM33;SMARCA4;HEYL;ID2;ZBTB18
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.4103287243355981,-1.02963932221036,0.41014799154334036,0.7633613099180898,1.0,7/13,20.73%,BMP7;RREB1;NAPEPLD;VSTM2A;SIX1;PTGS2;TFE3
prerank,cellular response to oxidative stress (GO:0034599),0.28132009675285824,1.0294046141457516,0.3782668500687758,0.9526766264546801,1.0,17/118,11.45%,MAPK3;ROMO1;CHCHD2;PRR5L;TXNRD2;SLC25A24;SOD1;EIF2S1;CYCS;ZFAND1;MAPK8;LONP1;GPX7;SOD2;PARK7;PRKAA2;RPS3
prerank,nucleotide-sugar metabolic process (GO:0009225),0.44160629524500433,1.029360308789239,0.4514851485148515,0.951756176361907,1.0,4/12,12.53%,CSGALNACT1;EXTL2;UGP2;SLC35A3
prerank,negative regulation of MAP kinase activity (GO:0043407),0.33203781531802834,1.0289337164184198,0.4354587869362364,0.9520815281184759,1.0,4/44,4.37%,RGS2;DUSP7;PTPRJ;APOE
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4503364127990586,1.028480511255645,0.43833017077798864,0.952407169577836,1.0,4/11,16.43%,PCBP1;NOVA2;PCBP3;ZNF445
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.3543094316413617,1.028098335230888,0.43109540636042404,0.9526392133195422,1.0,13/29,20.96%,HBS1L;CNOT7;EXOSC9;PATL1;NT5C3B;EXOSC1;CNOT6;DCP1A;LSM1;DCP1B;EXOSC7;DDX6;CNOT8
prerank,regulation of cell growth (GO:0001558),0.26546458531278044,1.0277367633401346,0.3933415536374846,0.95275962601683,1.0,29/204,12.46%,CISH;CCDC85B;NCBP1;PTPRJ;FRZB;ST7L;DERL2;RPS6KA1;RPTOR;RERG;PPT1;LTBP4;PPP2CA;SMARCA2;CDKN1A;CIB1;LAMTOR1;CDK11B;SIRT1;USP47;ACVRL1;EXOSC9;LGI1;CCAR2;EIF4G2;DDX3X;EGLN2;IP6K2;EI24
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3527445025327033,1.0275984223188748,0.41638795986622074,0.9521425798412885,1.0,6/33,8.79%,MAP2K5;APOE;MMRN2;RGCC;NOTCH1;ACVRL1
prerank,UV-damage excision repair (GO:0070914),0.4368450032156431,1.0274795574416171,0.44204322200392926,0.9514801301100997,1.0,5/12,14.62%,SIRT1;ACTR5;POLD3;POLA1;INO80
prerank,receptor-mediated endocytosis (GO:0006898),-0.24385744888761832,-1.0274583654094607,0.3969465648854962,0.7687115094120381,1.0,31/132,14.59%,DNAJC6;LRP1;DAB2;CALCRL;AP2B1;SNAP91;AP2A2;PDLIM7;SORL1;LRP1B;HSPG2;CTTN;WASF1;GPR107;RAB31;AP2A1;LDLR;SPARC;GRK3;ACKR3;IGF2R;RAMP1;GRB2;HIP1R;M6PR;FCHSD2;DNM1;VLDLR;DNAJC13;CAV2;LMBR1L
prerank,cellular response to insulin stimulus (GO:0032869),0.28343064743011326,1.0274509878916982,0.3933333333333333,0.9505204763597825,1.0,33/124,18.18%,PCK1;GSK3A;TRIB3;INSIG1;BCAR3;HDAC9;ZFP36L1;ATP6V1D;MYO5A;ATP6V0D1;AP3S1;TBC1D4;IRS2;ATP6V0E1;RHOQ;ATP6AP1;PRKCI;HDAC5;GRB14;APC;ZDHHC7;DENND4C;PIK3C2A;ATP6V1B2;NAMPT;PRKDC;SHC1;BAIAP2;INSR;C2CD5;SYAP1;IRS1;ATP6V1A
prerank,positive regulation of viral process (GO:0048524),0.312605722866403,1.0274199737002185,0.4009146341463415,0.9495578930687151,1.0,12/60,12.24%,POLR2J;POLR2B;IFIT1;RAB7A;ADAR;CNOT7;RSF1;RAD23A;SRPK2;DDX3X;MDFIC;TMEM39A
prerank,mRNA processing (GO:0006397),0.2560790130450988,1.0272953336143513,0.40700483091787437,0.9488934503586258,1.0,46/287,10.88%,POLR2J;ERCC3;SNRPD2;NCBP1;RBM22;HSPA8;POLR2B;PRPF31;PRPF3;SNRPD1;HNRNPH2;PCBP1;PHF5A;SF1;CCNH;PRPF40A;HNRNPK;CPSF4;CHTOP;PPIL3;PLRG1;SNRNP27;SRSF10;PRCC;SFPQ;HNRNPC;GEMIN5;SMNDC1;YTHDC1;SF3B3;SRSF4;DNAJC8;SNU13;GTF2H1;SARNP;NOVA2;SF3A1;PRMT9;RSRC1;AKAP8L;BUD31;SYF2;U2AF1;CPSF6;PAPOLA;EFTUD2
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.43968288080592083,1.0269364438400785,0.43410852713178294,0.9489605312011634,1.0,5/12,17.02%,EZH2;KLF2;CTBP2;CNOT1;CALR
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4514150039123097,1.0268166859566201,0.4391634980988593,0.948258788407338,1.0,3/11,10.91%,FYN;PARK7;UBQLN1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.24222058521552842,1.02679921404655,0.395615866388309,0.9472575408258003,1.0,156/834,15.94%,SOX30;ATF3;CTCFL;MAPK3;CHCHD2;SS18L1;ONECUT1;EIF5A;TFCP2;NR4A2;TAL1;ATF6;PIN1;LEF1;RUVBL2;PPP3CB;RPS6KA1;RPS6KA4;KLF2;MRTFA;CCNC;PCBP1;GREM1;HIPK2;ELK3;PAX8;BCL11B;MAP2K5;GABPA;SBNO2;HDAC3;PRKD2;SMAD1;RPS6KA5;MRTFB;PRDM15;HEY1;NR5A1;RLF;MMP12;PRDM4;MEIS1;CCDC62;SOX2;MYBL2;SMARCA2;YY1;TOX3;IER2;USF2;NPAT;IRF2BPL;DCAF6;VEZF1;EP300;RFX3;TBX1;ASXL3;CALCOCO1;CEBPG;MED12;FOXF2;PPARD;RGCC;SFPQ;SMAD7;DRAP1;SIRT1;CLOCK;PAXBP1;TET3;LMO7;HEY2;NOTCH1;WNT5A;GLMP;ATAD2;ITGA6;ACVRL1;RSF1;RELA;BCLAF1;ECD;JUND;HOXA7;PARK7;AKAP8L;KANSL3;RHOQ;ERG;KLF6;PPP1R12A;WBP2;TERT;LMO2;ACVR2A;YEATS4;CITED2;RBPJ;ESR1;SETD3;THRB;DDX3X;CREBBP;CD81;APP;ZBED3;NFIC;MED4;ATAD2B;ZBED4;TNKS;PPP3CA;PPP3R1;TNIP2;E2F3;AGRN;MZF1;SP1;IKBKB;SMARCD1;SS18;IRF2;DOT1L;CHUK;HDAC5;NLRC5;DDIT3;CTBP2;THRA;EPAS1;SSBP4;POGZ;NFKBIA;YBX1;HES1;HCFC1;CREBRF;DR1;GRHL1;NCOA7;CRTC3;INO80;TMPRSS6;PRDM10;PHF10;TCF20;TCERG1;FOXJ3;TFEB;ELK4;TAF6L;NAMPT;SMARCA4;TCF3;HEYL
prerank,chemokine-mediated signaling pathway (GO:0070098),0.3307681384158353,1.0267744344128917,0.4214618973561431,0.9462756740588942,1.0,4/42,8.53%,OXSR1;CXCL12;CIB1;CCL25
prerank,regulation of rRNA processing (GO:2000232),-0.38603673354797213,-1.0267061318518975,0.4227467811158798,0.7698692071824007,1.0,8/16,32.56%,RIOK1;RIOK2;WDR43;SIRT7;UTP15;BUD23;KAT2B;YTHDF2
prerank,protein K63-linked ubiquitination (GO:0070534),-0.29843439821496076,-1.0260385818367361,0.41534391534391535,0.7708698361880711,1.0,17/41,26.85%,RNF152;UBE2N;HECTD1;WWP2;RNF4;RNF135;RNF168;RNF8;TRAF3IP2;TRAF2;TRIM5;STUB1;NEDD4;ARIH2;UBE2B;UBE2S;UBE2E2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.2461682386233099,1.0258929170297164,0.401330376940133,0.9479592438840249,1.0,80/509,13.44%,RAC2;MAZ;CBL;PIK3CG;TRIB3;PIK3AP1;ZDHHC17;PTPRJ;JMJD8;PTPRC;MAP3K7;RPL23;TAB2;PLK2;RPTOR;EEF1D;TIRAP;SRC;TRIM8;BCAR3;HDAC3;PRKD2;IFI35;BIRC2;ZDHHC13;TNFRSF10B;SOX2;TEK;FYN;TMED4;PHB2;EDAR;TRIM14;GPR89A;EP300;TBX1;CARD16;RET;TRAF5;LAMTOR1;SELP;ACTN4;SIRT1;TXN;IRS2;TAB3;VWF;WNT5A;TRIM25;RELA;RBCK1;BCLAF1;LYN;LURAP1;PARK7;UBE2V1;RNF13;MFHAS1;BAD;ESR1;DDX3X;USP15;NOD1;RHOG;APP;RPS3;FLT1;PIK3CD;PIK3R5;BMF;TNIP2;IKBKB;LARS1;NEK6;RRAGC;CHUK;NRG2;DDIT3;ANKRD17;PPP5C
prerank,protein localization to nucleus (GO:0034504),-0.25286614205560987,-1.0256136475580637,0.3816793893129771,0.7712481781415595,1.0,48/102,32.16%,COL1A1;TOR1AIP2;BMP7;IPO9;BMP4;LMNA;TNPO3;APPL2;PML;NUP155;NUP188;BANP;TOR1AIP1;IPO11;NUP93;NUP88;TNPO2;TAF8;TOPORS;TOR1B;FAM53C;PAF1;NUTF2;IPO13;DVL1;TSC2;NUP85;SIX1;APPL1;TBRG1;NUP214;GBP2;CTDNEP1;PPP1R10;NOP53;AKT1;SEC13;SUPT7L;RPF2;ARL2;NUP153;ABCA7;BCL3;NXT2;RPAIN;RAN;TOR1A;EIF4ENIF1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.44054073359705015,-1.0253864459031854,0.4460285132382892,0.7710423764221893,1.0,5/10,13.10%,PTPRS;PPM1B;REL;SIRPA;RELB
prerank,response to hydrogen peroxide (GO:0042542),0.32538078687477884,1.0252749890223292,0.4096774193548387,0.9488436074095412,1.0,9/45,11.45%,TNFAIP3;SOD1;FYN;SIRT1;RELA;CYP1B1;PARK7;APTX;RPS3
prerank,gluconeogenesis (GO:0006094),0.34297109372270385,1.0251194721980699,0.4327390599675851,0.9482726121781291,1.0,4/39,5.74%,PCK1;SLC25A1;GOT2;TPI1
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.3057500825534868,-1.0250904976720678,0.40318302387267907,0.7710452979571132,1.0,7/39,7.97%,ANK2;FGF12;CACNA1D;FHL1;WWP2;CHRM3;PTPN3
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.34814512947434273,1.0248482450519103,0.42387543252595156,0.9480585442041196,1.0,14/31,20.96%,HBS1L;CNOT7;EXOSC9;PATL1;NT5C3B;EXOSC1;CNOT6;DCP1A;LSM1;DIS3L2;DCP1B;EXOSC7;DDX6;CNOT8
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.4070760222785507,-1.0245818621858602,0.4155844155844156,0.7716435430176843,1.0,3/13,6.61%,NFIB;BMP4;PPARA
prerank,regulation of protein kinase C signaling (GO:0090036),-0.39502723421075536,-1.024462297629218,0.4451345755693582,0.7711580480115848,1.0,10/14,39.96%,ADGRV1;ULK4;MYADM;GPD1L;ADRA1A;VEGFA;FLT4;WNT11;CD40;SPHK2
prerank,protein maturation (GO:0051604),-0.25417570696915054,-1.0244347019772762,0.4105960264900662,0.7704095511802959,1.0,35/95,27.85%,AEBP1;OGT;PCSK2;PCSK5;MMP16;MMP14;F3;SORL1;ADAM19;CCS;BACE1;NAA40;ADAMTS3;CPM;NNAT;PCSK6;AFG3L2;NFU1;DDI2;MMS19;HSPD1;PITRM1;ISCA1;STUB1;CASP2;NAA60;CPXM2;CIAO1;CLN3;TSPAN15;APH1B;PTCH1;CPXM1;SDE2;EEF1AKMT4-ECE2
prerank,stem cell development (GO:0048864),0.40914118010185174,1.0242047977020567,0.4426229508196721,0.9490803690670107,1.0,2/16,4.14%,PTPRC;CDH2
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.43862984714705916,-1.0236598124684273,0.43067226890756305,0.7717522658610271,1.0,8/10,49.44%,SORL1;SACS;DNAJB2;DNAJA4;DNAJB1;HSPA1A;HSPA1B;HSPA2
prerank,cellular response to chemokine (GO:1990869),0.32589213860076865,1.022900666562469,0.4165366614664587,0.9521921195676004,1.0,5/46,8.53%,OXSR1;CXCL12;LRCH1;RIPOR2;CCL25
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.3299058763495732,-1.022860952054358,0.41927710843373495,0.7731508242688246,1.0,10/27,19.24%,TNS2;PID1;PRKCZ;ENPP1;PRKCD;PIP4K2B;GRB10;PTPN2;TSC2;RPS6KB1
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3599779340344945,1.022675258831044,0.4175257731958763,0.9519153569829638,1.0,5/27,9.31%,CSGALNACT1;XYLT1;CHSY3;PXYLP1;B3GAT2
prerank,pore complex assembly (GO:0046931),-0.3587169094031296,-1.0226319144515532,0.41416309012875535,0.7730079404830646,1.0,10/19,31.44%,NUP205;AFDN;AHCTF1;NUP93;ANO6;GSDMD;PLEKHA7;TMEM170A;NUP153;PDZD11
prerank,regulation of monocyte differentiation (GO:0045655),-0.390488532034695,-1.0222627150820958,0.430062630480167,0.773180857776588,1.0,3/14,10.11%,FOXP1;IL34;CDK6
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.4241812385751339,1.0221000121410602,0.4367588932806324,0.9526804898175713,1.0,5/12,17.03%,ACTB;CELSR1;TRAF3IP1;ZDHHC7;LAMA5
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.23739158414103156,1.0220379489759717,0.3963782696177062,0.9518112886447284,1.0,294/1668,16.20%,TBX4;SOX30;LRRFIP1;DBX2;ATF3;IRX1;PRKAR1A;TOX4;MAZ;ZBTB42;CTCFL;DCAF1;FOXQ1;DACH1;MAPK3;AASS;CHCHD2;MECOM;SIM1;ARID5A;SS18L1;ELOC;ONECUT1;EIF5A;KLF8;TRIB3;TFCP2;NR4A2;EZH2;TAL1;ATF6;ACTL6A;TRIM28;PIN1;LEF1;HES6;RPL23;EED;CTDSP1;RUVBL2;JAZF1;PPP3CB;GTF2IRD1;RPS6KA1;RPS6KA4;DMAP1;PHF14;KLF2;MRTFA;CCNC;PCBP1;GREM1;DNAJA3;HIPK2;ELK3;PAX8;BCL11B;MAP2K5;ZHX3;GABPA;ZBTB24;ZBTB33;BACH2;HDAC9;SBNO2;BCL6B;HDAC3;PRKD2;ZKSCAN1;SMAD1;RPS6KA5;MRTFB;PRDM15;HEY1;NEDD4L;NR5A1;RLF;APOE;MMP12;ZBTB41;CCNH;IRF9;PRDM4;BBX;MEIS1;CCDC62;SOX2;HNRNPK;MYBL2;SMARCA2;YY1;FLI1;GMEB2;TOX3;ZNF83;WFS1;KDM3A;KDM2A;ZNF740;VPS72;IER2;CDKN1A;UBE2I;USF2;NPAT;ZSCAN2;IRF2BPL;DCAF6;BEND3;VEZF1;EP300;RFX3;ZNF260;RPS14;NFX1;CARF;TBX1;MED23;ASXL3;PCGF3;CALCOCO1;CNOT2;CEBPG;MED12;MAMLD1;FOXF2;PPARD;RGCC;ZNF205;SFPQ;UXT;SMAD7;DRAP1;BMI1;SIRT1;CLOCK;ZNF3;PAXBP1;TET3;LMO7;HEY2;ZBTB14;MED15;NOTCH1;SAP130;WNT5A;RUVBL1;EDNRB;GLMP;LCORL;ATXN7L3;CDK4;EFNA1;ATAD2;GTF2H1;ITGA6;ZXDC;ACVRL1;RSF1;RELA;SOX13;TRPS1;SOD2;MDM2;CSF1R;BCLAF1;ECD;RAI1;JUND;HOXA7;PIAS2;PKN1;PARK7;AKAP8L;TFAP4;KANSL3;RHOQ;ERG;BUD31;KLF6;PPP1R12A;ZKSCAN3;CIR1;WBP2;LMO2;ACVR2A;YEATS4;CITED2;MGA;CHD1;HIC2;RBPJ;ESR1;SETD3;THRB;DDX3X;CREBBP;CD81;DACH2;CTBP1;AGO4;APP;ZBED3;PIAS1;ORC2;NFIC;MED4;ATAD2B;ZBED4;JMJD1C;TNKS;PPP3CA;IFI27;HDGF;PPP3R1;TNIP2;E2F3;AGRN;N4BP2L2;MZF1;SP1;IKBKB;SMARCD1;SS18;ZSCAN12;IRF2;DOT1L;CHD3;CHUK;HDAC5;ZBTB45;SP110;NLRC5;DDIT3;TGIF1;CTBP2;THRA;EPAS1;SSBP4;ZKSCAN5;POGZ;BRD2;NFKBIA;YBX1;HES1;USP9X;TRIM27;HCFC1;SP8;CREBRF;DR1;GRHL1;BRIP1;BACH1;PURG;NCOA7;SIX5;PHF8;CRTC3;E2F6;AEBP2;CNOT1;INO80;FUS;TMPRSS6;PRDM10;TSHZ1;PHF10;EZH1;ZFP62;BCL6;MOV10;TCF20;TCERG1;FOXJ3;NKAP;TFEB;ELK4;TAF6L;TAF1;TRIM33;NAMPT;SMARCA4;TCF7L1;TCF3;WIZ;HEYL;ID2;ZNF483;PURB;AKIRIN1;TAF3;TSHZ2;ZBTB18
prerank,regulation of endothelial cell migration (GO:0010594),-0.25857821374889206,-1.0218856477980003,0.39009287925696595,0.7733760931366775,1.0,18/85,11.96%,FOXP1;ANXA3;SASH1;NR2F2;BMPER;FGF1;NRP1;BMP4;ROCK2;ADAMTS9;GLUL;SPARC;SMOC2;THBS1;NRP2;FOXC2;RHOJ;RHOB
prerank,cellular response to estradiol stimulus (GO:0071392),0.40074113315464854,1.0218546424908912,0.43936731107205623,0.9513452244155205,1.0,3/18,10.70%,RUVBL2;CCDC62;ESR1
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.4388876545315137,1.021492045557924,0.44083969465648853,0.9514903354845027,1.0,3/12,7.53%,APOE;PFDN6;PFDN5
prerank,neutrophil activation involved in immune response (GO:0002283),0.24687941850857523,1.0214156412892743,0.417607223476298,0.9506671257899688,1.0,72/428,14.82%,SURF4;IMPDH1;CAND1;ATP8A1;PSMD12;PTPRJ;HMOX2;EEF1A1;HSPA8;GLB1;PTPRC;GYG1;PRCP;PECAM1;PTGES2;RAB5C;SVIP;CCT2;PYGL;PTPRB;ATP6V1D;NRAS;TUBB;PSMD11;ATP11A;MME;RAB7A;TNFRSF1B;B2M;FUCA1;LAMTOR1;SYK;ATP6AP2;STOM;RAB6A;RAB14;CD47;NFASC;PSMC2;PSMD2;HRNR;MGAM;VAT1;DYNLL1;PNP;DDX3X;GPI;RHOG;PA2G4;ATG7;RAB5B;HGSNAT;ILF2;GALNS;RAP2C;GM2A;CD55;NPC2;SCAMP1;PSMD14;OSTF1;NDUFC2;ARPC5;PSMD1;PSMB1;ERP44;CD93;APAF1;CYBA;CD44;NHLRC3;QPCT
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.34832825504950865,1.0212915117375145,0.42016806722689076,0.9500327411630608,1.0,11/33,18.26%,PIK3CG;PIK3C2G;ZFP36L1;HTR2A;PIK3CD;PIK3R5;NF1;PIK3C2A;PLEKHA1;IRS1;NYAP2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.35107584048007356,-1.0211904288289841,0.4659090909090909,0.7744891874701859,1.0,5/22,14.83%,AHNAK;CACNB4;SRI;GNB5;PDE4B
prerank,regulation of dopamine secretion (GO:0014059),-0.34340326299267204,-1.0207646650772277,0.43132530120481927,0.7748101060737465,1.0,11/25,30.26%,SYT9;SYT12;SYT11;SYT4;SYT7;SYT2;KCNA2;SYT10;SYT6;SNCA;DRD2
prerank,positive regulation of secretion (GO:0051047),-0.419392499681035,-1.020593582811488,0.41,0.7744496401279545,1.0,2/11,16.34%,GPLD1;NPR1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.3759946799460213,-1.0205767425245575,0.42342342342342343,0.7736833595926998,1.0,3/16,17.52%,SOX5;FOXC1;SOX6
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.4019218302368778,1.0205641281239446,0.43243243243243246,0.9513126329705478,1.0,5/18,13.02%,GSK3A;HDAC3;BDNF;NOTCH1;HDAC5
prerank,negative regulation of fibroblast proliferation (GO:0048147),-0.36948691769466935,-1.020334515630876,0.4178082191780822,0.773539778449144,1.0,10/18,33.38%,SKI;CDC73;TP53;MED25;PEX2;EMD;SFRP1;B4GALT7;CD300A;TRIM32
prerank,tRNA wobble base modification (GO:0002097),0.418090899746775,1.0200554457979505,0.4489402697495183,0.9518790097196425,1.0,1/14,0.85%,MOCS3
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.3484611420317108,1.0197143661534567,0.41068447412353926,0.9518888882608981,1.0,9/32,14.65%,MAP2K5;HDAC9;HDAC7;CIB1;MMRN2;NOTCH1;HDAC5;MAP3K3;PIK3C2A
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.2568282629676462,1.019435773994146,0.4261294261294261,0.9517363102684903,1.0,53/241,16.25%,POLR2J;SNRPD2;NCBP1;RBM22;HSPA8;POLR2B;PRPF31;PRPF3;SNRPD1;HNRNPH2;PCBP1;PHF5A;SF1;PRPF40A;HNRNPK;CPSF4;PPIL3;PLRG1;SNRNP27;SRSF10;PRCC;SFPQ;HNRNPC;GEMIN5;SMNDC1;YTHDC1;SF3B3;SRSF4;DNAJC8;SNU13;NOVA2;SF3A1;RSRC1;BUD31;SYF2;U2AF1;PAPOLA;EFTUD2;PTBP1;RBM10;YBX1;SRSF7;FUS;SNRPA;USP39;RBM4B;SF3B6;HNRNPL;TRA2B;GTF2F2;RBM41;UPF3B;U2AF2
prerank,sulfur compound biosynthetic process (GO:0044272),-0.24737639358426192,-1.0188693356524863,0.419672131147541,0.7768486737001946,1.0,42/104,28.80%,UST;DSE;GLCE;B4GALT1;CHSY1;OGN;VCAN;SLC26A2;SLC35B3;CSGALNACT2;GGTA1;CHST15;B4GALT6;GSTT1;CHST11;GSTZ1;SLC35D2;UGDH;CSPG4;GGT5;ST3GAL4;PAPSS2;PRELP;DSEL;ESD;B4GALT4;LUM;GSTA4;GSTM1;CDO1;CHST2;BGN;CHPF2;CHAC2;OPLAH;CHST3;HPGDS;CSPG5;OMD;CHST12;DCN;MGST1
prerank,positive regulation of vascular permeability (GO:0043117),-0.41425544596477853,-1.0186908603489966,0.43956043956043955,0.7764982492510335,1.0,2/12,3.80%,BMP6;OCLN
prerank,regulation of cellular amide metabolic process (GO:0034248),0.3490835293520762,1.0184636592425635,0.43356643356643354,0.95375673947277,1.0,14/32,20.66%,EIF2A;GEMIN5;TMED10;TSC1;METAP1;APP;NANOS3;PICALM;RBM4B;CYFIP1;RPL10;EIF4E;MTPN;SAMD8
prerank,response to prostaglandin E (GO:0034695),0.4615589003943718,1.0184098278273992,0.45614035087719296,0.9528908838011252,1.0,2/10,6.25%,PTGER2;GNB1
prerank,regulation of centriole replication (GO:0046599),0.4057195038484076,1.0183675613603154,0.41366223908918404,0.9520091403295279,1.0,2/17,2.58%,ALMS1;PLK2
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.4166144782746667,1.0181331866319006,0.43859649122807015,0.9517170603393909,1.0,2/14,6.13%,RFFL;CARD16
prerank,cellular response to cytokine stimulus (GO:0071345),0.24849369716644107,1.0180493950652745,0.4123006833712984,0.950943906873118,1.0,45/416,9.90%,LRP8;MT1X;PTPN18;GSK3A;CBL;PTPRJ;IL1R1;HSPA8;OXSR1;SMPD4;LEF1;CXCL12;IFNLR1;IFITM2;CRLF1;LRCH1;SBNO2;IFIT1;ZFP36L1;GBP3;MME;SOX2;PTPN12;FYN;TNFRSF1B;CDKN1A;CIB1;RIPOR2;MAPK8;GBP4;ICAM1;PTPRT;SYK;RO60;PIM1;SIRT1;WNT5A;CCL25;ERBIN;RELA;CD47;CSF1R;IL10RB;INPP5D;IFNAR1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.31042118860608686,-1.017920640978373,0.4090909090909091,0.7778710377027909,1.0,12/34,21.10%,WASF2;AUTS2;OCLN;PLCE1;FER;ACTR3;TWF2;ACTR2;CDC42;CAPZB;PIK3R1;ARPC2
prerank,regulation of epithelial cell differentiation (GO:0030856),0.4011012751175325,1.0176973300470018,0.44808743169398907,0.9510324610886077,1.0,1/17,0.25%,PRKX
prerank,negative regulation of interleukin-2 production (GO:0032703),0.4001665730534738,1.017539415460857,0.4501779359430605,0.9504897673003563,1.0,3/18,3.68%,TNFAIP3;PTPRC;HDAC7
prerank,double-strand break repair (GO:0006302),0.27096710165132115,1.0174983550270877,0.42575558475689884,0.9495967298798557,1.0,34/158,14.69%,ABRAXAS1;ZSWIM7;ERCC4;YY1;HPF1;KDM2A;XRCC1;APLF;TENT4A;CIB1;MAPK8;ACTR8;SFPQ;ACTR5;DCLRE1B;UBE2V2;EYA3;KDM4D;POLA1;SEM1;RAD51B;EXD2;RFWD3;APTX;HUS1;NBN;PSMD14;CHEK2;BRCC3;PPP5C;RMI1;BRIP1;INO80;NSD2
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.39337954985527646,-1.0172564119879086,0.4394250513347023,0.778868441302058,1.0,4/13,19.73%,DDX5;PLA2R1;ATM;SPRED3
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.42274371587544024,1.0170818617549866,0.43653846153846154,0.9498561357608782,1.0,4/15,19.14%,APOE;SCARB1;PLTP;ABCG1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.3027109036693855,-1.0170090901389346,0.4289340101522843,0.7787202019979271,1.0,16/41,23.05%,PRKAG2;OGT;PRKAG1;NUP205;NUP155;NUP188;NUP93;NUP88;SEH1L;LACC1;NUP85;AAAS;RAE1;NUP37;NUP214;PGAM1
prerank,negative regulation of mRNA processing (GO:0050686),0.40556576681206896,1.0168466663164986,0.44385026737967914,0.9495565115344698,1.0,6/15,16.25%,SFSWAP;SRSF10;SRSF4;PTBP1;SRSF7;U2AF2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.4240391004578523,1.0167802625627151,0.4521575984990619,0.9487662171600523,1.0,4/13,13.32%,SOD1;APOE;ERLIN2;PLEK
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.4108665157701382,1.0167026952719485,0.45108695652173914,0.9480010880943702,1.0,4/14,12.87%,RGCC;PLCG1;PRKCI;ECSCR
prerank,negative regulation of DNA recombination (GO:0045910),0.3278745226234078,1.0164211408893404,0.45819935691318325,0.9478587297914737,1.0,8/43,15.33%,POLR2J;ZRANB3;POLR2B;ACD;MSH3;HELB;TERF2IP;UBQLN4
prerank,neuromuscular junction development (GO:0007528),-0.3399014249979305,-1.0163925307617407,0.40707964601769914,0.77970166163142,1.0,4/24,2.52%,ANK3;PDZRN3;CACNB4;PPFIBP1
prerank,regulation of gastrulation (GO:0010470),-0.3926752478143693,-1.0160399891500216,0.4282700421940928,0.7798994627323628,1.0,3/14,5.43%,PHLDB2;PHLDB1;OSR1
prerank,ion transport (GO:0006811),-0.2503028007516973,-1.0158952961793837,0.42105263157894735,0.7794632594481538,1.0,23/111,14.56%,TRPM3;SLC24A3;GABRB1;SLC1A3;GLRB;WNK1;SLC26A7;VDAC1;PIEZO2;SLC12A2;SLC26A2;GLRA1;SLC24A2;WNK4;ANO1;LASP1;SLC20A1;SLC9A2;CTNS;ANO6;SLC26A11;SLC12A6;SLC4A2
prerank,regulation of cellular biosynthetic process (GO:0031326),0.35438606013128676,1.0158595262313308,0.4312393887945671,0.948605415338023,1.0,7/28,11.20%,FITM2;TNFRSF1B;SIRT1;ADIPOR2;CD47;PRKAA2;ADIPOR1
prerank,RNA catabolic process (GO:0006401),0.3355071597230528,1.015695241426046,0.4247226624405705,0.948086550770868,1.0,7/46,11.23%,ZC3H12D;NCBP1;NUDT12;RNASE6;XRN2;DXO;AGO4
prerank,cellular response to peptide (GO:1901653),0.3139009648801356,1.0156433960009135,0.44019138755980863,0.9472407384190512,1.0,11/56,12.00%,CACNA1A;RPL23;FCGR2B;SRC;ZFP36L1;FYN;ICAM1;MDM2;NOD1;APP;PRNP
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.3746152753009987,1.0153625136601967,0.4172661870503597,0.9471085557334318,1.0,7/22,16.55%,TIPRL;BOD1;PPP1R11;MGAT5;IKBKB;PTPA;FKBP1A
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.4159524813514883,-1.015143464515193,0.45790554414784396,0.7807750044705462,1.0,1/12,5.47%,ZBTB1
prerank,positive regulation by host of viral transcription (GO:0043923),0.40626691362669576,1.0148462274894747,0.45124282982791586,0.9477576530457751,1.0,6/15,15.88%,LEF1;EP300;TFAP4;CHD1;SP1;SMARCA4
prerank,lamellipodium organization (GO:0097581),-0.3295735295941296,-1.0147708727344023,0.41379310344827586,0.7810110347118627,1.0,12/29,21.40%,SNX2;KIT;VCL;CTTN;WASF1;SPATA13;ABLIM2;ABLIM3;PTPRO;ARFIP2;ARHGEF4;P2RY12
prerank,response to organophosphorus (GO:0046683),-0.38014429777371206,-1.0142535680921856,0.4356223175965665,0.7816293067013134,1.0,9/16,40.83%,P2RX4;ABCC9;STAT1;DGKQ;TRIM16;TRPC3;RFC3;TYMS;VGF
prerank,activation of protein kinase B activity (GO:0032148),-0.3234277344624254,-1.0139284249521197,0.43859649122807015,0.7816880430091384,1.0,3/29,3.10%,NTRK3;IGF1;FGF1
prerank,positive regulation of translational initiation (GO:0045948),-0.3550933158461172,-1.0138616371020863,0.42139737991266374,0.7810565895081496,1.0,9/18,32.78%,KHDRBS1;YTHDF1;HABP4;RPS6KB1;EIF2B5;RPS6KB2;POLR2G;YTHDF2;MTOR
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.40000523286038775,1.0137082794353303,0.4604051565377532,0.9502917273172558,1.0,2/16,6.50%,TUBB;CEBPG
prerank,regulation of isotype switching (GO:0045191),-0.399020960627218,-1.0135021190051225,0.4707112970711297,0.7812913535242566,1.0,5/14,20.18%,PAXIP1;SHLD1;PARP3;RIF1;SLC15A4
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.36853655228946863,-1.013444646739172,0.44849785407725323,0.7806253682901052,1.0,8/18,25.90%,FLNA;WDR43;SIRT7;ATF4;UTP15;ERBB2;EIF2AK3;POLR2K
prerank,negative regulation of vascular permeability (GO:0043116),0.4375143125161613,1.0130379982175968,0.47248576850094876,0.9513354002358935,1.0,3/12,10.04%,PTPRJ;RAMP2;CLDN5
prerank,regulation of macroautophagy (GO:0016241),0.28260127783494227,1.0127526332817172,0.44035346097201766,0.9512468617766631,1.0,32/105,19.41%,MAP3K7;RPTOR;EXOC8;ATP6V1D;EPM2A;SMG1;VPS26A;ATP6V0D1;MAPK8;LAMTOR1;SIRT1;ATP6V0E1;TSC1;TBC1D25;PRKAA2;UBQLN1;BNIP3L;RRAGC;SCOC;ATP6V1B2;VPS35;ATG13;SESN3;BNIP3;UBQLN2;ATP6V1A;USP36;SH3GLB1;ULK1;SESN1;LZTS1;LARP1
prerank,transcription by RNA polymerase II (GO:0006366),-0.21677948497713284,-1.012602334691223,0.4027777777777778,0.7822079297349487,1.0,87/305,20.01%,DDX5;NOTCH2;TEAD1;GLIS3;PABPN1;PRRX1;RARB;MAF;TBL1XR1;CCN2;ELP4;SOX5;MED26;RPRD1B;GTF2I;MAML1;HDAC1;MED1;PPARGC1A;CBFB;RREB1;ZBTB1;POU2F1;RBMX;DEK;ERCC6;PIR;ELL;PPARA;NOTCH3;CSTF3;RNGTT;MED17;CDC73;PHAX;SNW1;SRRT;GTF2A1;ELP2;RXRA;SYMPK;NFKB1;NR2C2;ESRRA;TBL1X;NR3C2;RARA;NELFB;CDK7;CSTF2;NFYA;CCNT1;POLR2A;ELOA;SNAPC3;DDX21;TAF8;INTS10;SETX;CCNK;PAF1;INTS8;INTS11;TEAD3;MLLT1;TAF6;WWTR1;RPAP1;CTDP1;NR3C1;GTF2E2;RORA;CDK9;EAF1;TAF5L;TAF12;KLF13;MAML2;COPS2;PARP1;MED20;NELFA;TEAD2;NR2F1;CDK12;CPSF3;NABP2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.4344745292938104,-1.0125137150182417,0.492,0.7816450477752092,1.0,4/10,21.80%,SOX5;BMPR1B;SOX6;PKDCC
prerank,establishment of vesicle localization (GO:0051650),-0.3627119976561589,-1.012456953463942,0.42924528301886794,0.7810040654955056,1.0,7/18,16.86%,KIF5C;CCDC186;SYT11;RAB11A;IKBKG;KIF5A;LIMK2
prerank,protein K48-linked deubiquitination (GO:0071108),0.36757401533733103,1.0120800168852788,0.4427083333333333,0.9523501659240988,1.0,9/23,17.35%,TNFAIP3;YOD1;OTUD3;USP37;OTUD5;USP33;MINDY2;OTUD4;ATXN3
prerank,"base-excision repair, gap-filling (GO:0006287)",0.34505252844549283,1.0119100963300114,0.43333333333333335,0.951896470366176,1.0,7/35,12.39%,PNKP;XRCC1;TDG;POLE;POLD3;SMUG1;MPG
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.4075733565427671,1.0113941654687422,0.4616822429906542,0.9524745682594432,1.0,2/15,3.55%,AMDHD2;EXTL2
prerank,peptide hormone secretion (GO:0030072),0.35836486328778605,1.0113678756526128,0.443859649122807,0.9515386541158194,1.0,4/26,9.72%,LTBP4;RAB1A;PARK7;CYB5R4
prerank,regulation of axon regeneration (GO:0048679),-0.4027880769637985,-1.0112711176795177,0.4418604651162791,0.7834068955452815,1.0,4/12,26.22%,PTPRS;CERS2;SCARF1;INPP5F
prerank,endosome organization (GO:0007032),0.32956223651210387,1.0112689187199313,0.43127147766323026,0.9508358806497683,1.0,14/41,18.96%,EXOC8;CLCN3;VPS11;TMEM9;LAMTOR1;AKTIP;RAB22A;LAPTM4B;HOOK3;VPS18;CORO1C;RAB27A;ALS2;PI4K2B
prerank,protein O-linked glycosylation (GO:0006493),-0.2536158605838184,-1.011146679945982,0.4,0.7829340806590693,1.0,19/96,17.48%,GALNT13;GXYLT2;OGT;PLOD2;TMTC4;TET1;POFUT1;TRAK1;PLOD1;TMTC1;DPM1;RXYLT1;XXYLT1;LARGE1;FKTN;ST3GAL4;GALNT14;POGLUT3;GALNTL6
prerank,gas transport (GO:0015669),0.46599470908236357,1.010758442186959,0.47443762781186094,0.9514026814601945,1.0,1/10,4.03%,CA2
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.32755574765566586,-1.010694871574347,0.42452830188679247,0.783409249360911,1.0,10/26,26.84%,LGR4;FLOT2;APPL2;IRAK3;BIRC3;FLOT1;APPL1;GPR108;TLR3;LRRC14
prerank,cellular response to calcium ion (GO:0071277),-0.26738307493497065,-1.010500488456719,0.4353932584269663,0.7831254488385914,1.0,17/67,15.98%,CPNE8;RYR3;IQGAP1;ADCY1;CLIC4;ADGRV1;SYT9;NLGN1;LGMN;CAMK2D;SYT12;SYT11;SYT4;RASGRP2;CPNE2;SYT7;GPLD1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.2857947517103145,1.0104174701023465,0.4395448079658606,0.951447360874638,1.0,16/100,11.67%,MAZ;MAPK3;CBL;PIK3CG;PIK3AP1;SRC;PPP1R16B;TEK;SELP;SIRT1;IRS2;NLRC3;LYN;FLT1;PIK3CD;PIK3R5
prerank,negative regulation of heart contraction (GO:0045822),0.4410402161827113,1.010275704339341,0.4576923076923077,0.9508890065515206,1.0,2/11,1.79%,PIK3CG;PDE4D
prerank,protein targeting to peroxisome (GO:0006625),-0.31829591015740333,-1.0102450204242197,0.4326241134751773,0.7830602343322397,1.0,10/29,18.35%,ACBD5;RAB8B;PEX14;FIS1;ALDH3A2;PXMP4;ABCD2;PEX2;PEX5;PEX6
prerank,positive regulation of protein dephosphorylation (GO:0035307),-0.31671369894347245,-1.0102251891821492,0.4207920792079208,0.7823047374566753,1.0,3/32,2.14%,MAGI2;PDGFRB;CAMTA1
prerank,regulation of cellular respiration (GO:0043457),0.392154816596066,1.0101857023127707,0.4608208955223881,0.9501707059001896,1.0,3/17,9.90%,IFNLR1;IL10RB;IFNAR1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.29687880892390744,-1.009928029278387,0.42346938775510207,0.7823157145987181,1.0,21/40,41.25%,IGF1;FAM162A;BCL2L11;TP53;GHITM;PDCD5;PINK1;AKT1;BCL2L1;GPX1;BID;FXN;PRELID1;GPER1;PLSCR3;CLU;HGF;OPA1;PLAUR;BBC3;PPIF
prerank,regulation of nervous system development (GO:0051960),0.3359945284406033,1.0098418112192131,0.4336569579288026,0.9501619335504286,1.0,9/37,15.94%,HES6;HEY1;TNFRSF1B;HEY2;PRUNE1;DOCK7;TENM4;HES1;HEYL
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.38989674205987623,-1.0095851893149117,0.43544857768052514,0.7824330260805229,1.0,9/14,29.76%,DDB1;PPARGC1A;AKT2;ARPP19;GPLD1;PTPN2;AKT1;NNMT;SLC45A3
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.4328661851195626,-1.009253706827909,0.4726930320150659,0.7825119875828045,1.0,3/10,5.59%,BMP5;BMP7;ARHGAP12
prerank,fatty acid beta-oxidation (GO:0006635),0.3157673141201618,1.0088618660163804,0.4428794992175274,0.9521132371750595,1.0,12/51,16.61%,CRAT;ACOX3;ACAT1;PPARD;ETFA;HSD17B4;ACOT8;BDH2;ECHDC1;ECHS1;ACAA2;ACADL
prerank,maintenance of blood-brain barrier (GO:0035633),0.348658587596869,1.008843537771812,0.43537414965986393,0.9511731560876521,1.0,10/30,13.59%,SLC1A1;PECAM1;ACTB;F11R;TJP1;ESAM;CLDN5;DMD;CDH5;LSR
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.3662349547147719,-1.008654978377189,0.4352078239608802,0.7833926077245401,1.0,7/18,35.42%,FBN1;TCTA;TLR3;GPR137B;TMEM178A;MAFB;GPR137
prerank,regulation of amyloid fibril formation (GO:1905906),0.40847478174673973,1.008559491672973,0.4585635359116022,0.9510898187233701,1.0,4/15,11.24%,APOE;PFDN6;PFDN5;APP
prerank,regulation of protein polymerization (GO:0032271),-0.31110323271980866,-1.0084640121656436,0.4494949494949495,0.7831154551852797,1.0,18/35,30.30%,MAP2;MAPT;ARHGAP28;PLEKHG2;CTTN;FCHSD2;DBNL;PFN2;TPPP;HSP90AA1;TTBK1;TPPP3;ARL2;DBN1;HAX1;COTL1;GBA2;ARHGAP18
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.34586354584122636,1.0083364177600551,0.4427350427350427,0.9508072613718949,1.0,9/36,16.06%,EZH2;EED;UXT;BMI1;RYBP;MGA;APAF1;E2F6;RBBP4
prerank,embryonic axis specification (GO:0000578),-0.38005446029917733,-1.008212788977099,0.430062630480167,0.7830127201385306,1.0,3/15,11.84%,COBL;SMAD6;TBX3
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.38060399484318064,-1.0081528707703071,0.4194260485651214,0.7823822595733587,1.0,4/16,6.59%,PDGFRB;NRP1;FER;PDGFRA
prerank,monocyte differentiation (GO:0030224),0.4484027181727872,1.008045572314549,0.4438095238095238,0.9506949385315551,1.0,1/10,0.10%,MT1G
prerank,negative regulation of T cell proliferation (GO:0042130),0.3606524767039283,1.008016271249446,0.4757929883138564,0.9497964634149881,1.0,3/28,13.15%,PRKAR1A;PRNP;CD274
prerank,striated muscle cell development (GO:0055002),0.40996297334367615,1.0079311398505717,0.46065259117082535,0.9490663030384826,1.0,2/14,4.85%,PGM5;FLII
prerank,negative regulation of binding (GO:0051100),0.29234287374285106,1.0079154102522412,0.43859649122807015,0.9481220084892961,1.0,13/81,9.80%,RALB;PIN1;LEF1;BTAF1;ACTB;PSME3IP1;IFIT1;CDKN1A;MAPK8;CARD16;RSF1;PARK7;TFAP4
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.37819062213109234,1.007707974818616,0.4537521815008726,0.9477899322111841,1.0,7/20,16.87%,RSC1A1;RHOQ;PICALM;TMEM59;AP2M1;LZTFL1;PPP2R5A
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.38635778131226217,-1.007456229275397,0.45054945054945056,0.7834938382061857,1.0,4/15,25.16%,GSTZ1;KYAT1;QDPR;FAH
prerank,neutrophil degranulation (GO:0043312),0.24373791123696853,1.0074482207705906,0.45310734463276836,0.9476453186298986,1.0,71/425,14.82%,SURF4;IMPDH1;CAND1;ATP8A1;PSMD12;PTPRJ;HMOX2;EEF1A1;HSPA8;GLB1;PTPRC;GYG1;PRCP;PECAM1;PTGES2;RAB5C;SVIP;CCT2;PYGL;PTPRB;ATP6V1D;NRAS;TUBB;PSMD11;ATP11A;MME;RAB7A;TNFRSF1B;B2M;FUCA1;LAMTOR1;ATP6AP2;STOM;RAB6A;RAB14;CD47;NFASC;PSMC2;PSMD2;HRNR;MGAM;VAT1;DYNLL1;PNP;DDX3X;GPI;RHOG;PA2G4;ATG7;RAB5B;HGSNAT;ILF2;GALNS;RAP2C;GM2A;CD55;NPC2;SCAMP1;PSMD14;OSTF1;NDUFC2;ARPC5;PSMD1;PSMB1;ERP44;CD93;APAF1;CYBA;CD44;NHLRC3;QPCT
prerank,positive regulation of chromosome organization (GO:2001252),-0.3801799598974116,-1.0074017694113901,0.46,0.7828320278423126,1.0,7/15,26.46%,PML;RAD50;MRE11;GNL3;RTEL1;PPP1R10;RAD21
prerank,endothelial cell migration (GO:0043542),-0.30219415276422684,-1.0073176530435144,0.43005181347150256,0.7822667325122009,1.0,18/37,26.44%,FSTL1;ADGRA2;NRP1;RHOA;PXN;DPP4;STARD13;PLEKHG5;FAP;PLXND1;CCN3;SCG2;STAT1;TNFSF12;VEGFA;EMP2;NR4A1;RAB13
prerank,endothelial tube morphogenesis (GO:0061154),-0.43558347619584115,-1.007126158196547,0.45869565217391306,0.7820221835966018,1.0,5/10,11.96%,CTNNB1;RHOA;BMP4;STARD13;RHOB
prerank,regulation of trans-synaptic signaling (GO:0099177),0.3427519162654027,1.0069172495746648,0.4475043029259897,0.9482975005478627,1.0,4/33,3.02%,LRP8;CACNA1A;GRIK5;GRIK2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.3536959434373075,1.0068796309159442,0.4660033167495854,0.9474307905573831,1.0,9/29,15.49%,COG5;COPG2;GOSR2;RAB6B;NAPA;RAB6A;COPG1;COG3;TRAPPC10
prerank,positive regulation of cellular catabolic process (GO:0031331),0.2710048579794316,1.0065534472258548,0.44598337950138506,0.9474240428762957,1.0,39/132,18.94%,SLC4A4;GSK3A;PRR5L;ATF6;SH3D19;PLK2;SVIP;TRIM8;APOE;VPS11;TNFRSF1B;TRIM14;PTTG1IP;IRS2;CNOT7;DXO;PRKAA2;BAD;P2RX7;PFKFB3;APP;TMEM59;FAF1;TRIM27;CNOT1;PIK3C2A;VPS35;DAGLB;MOV10;TFEB;BNIP3;ADAM9;INSR;IRS1;RDX;SH3GLB1;ULK1;RC3H1;MID2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.39072068585844644,1.0062859589612358,0.4542056074766355,0.9472775785629692,1.0,2/16,2.29%,RBM22;SFSWAP
prerank,regulation of actin cytoskeleton organization (GO:0032956),-0.2546435538016306,-1.0058836576088945,0.42244224422442245,0.7846711068387805,1.0,24/87,17.28%,NOTCH2;LRP1;GPM6B;IQGAP1;EFNA5;PDGFRB;RHOA;ROCK2;PRKCD;ROCK1;PDGFRA;EZR;RND3;RHOBTB2;EPHA3;RHOB;RHOBTB1;HIP1R;TAOK1;ARHGDIA;ARHGEF5;IQGAP2;ABL2;TWF2
prerank,negative regulation of protein depolymerization (GO:1901880),-0.3380486272062637,-1.0055978064393372,0.44419134396355353,0.7846727038817637,1.0,7/24,14.10%,NAV3;HDGFL3;PLEKHH2;LIMA1;STMN2;TTBK2;TAOK1
prerank,synaptic vesicle recycling (GO:0036465),-0.3168602341013692,-1.0047659243977534,0.43544303797468353,0.7861863944790956,1.0,10/31,19.68%,AMPH;NLGN2;STON2;NLGN1;STON1;VAMP2;SYT7;STX1A;SYT2;PACSIN1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.33233724562170636,1.004734940190021,0.44875776397515527,0.9511228109709992,1.0,13/37,16.80%,RPL23;PDCL3;HIPK2;RPL5;PARK7;CCAR2;RYBP;TLK2;GIPC1;CSNK2A2;UCHL5;TAF1;N4BP1
prerank,mitotic recombination (GO:0006312),-0.3763691792143967,-1.0046707556343786,0.44372294372294374,0.7856468086271575,1.0,8/15,32.98%,SMC6;RAD50;TPRKB;RAD51D;NSMCE2;DMC1;RAD54B;ERCC1
prerank,actin filament organization (GO:0007015),-0.23177803106088254,-1.0046363823949451,0.4187725631768953,0.7849681168582493,1.0,28/151,12.89%,SVIL;MCU;PPP1R9A;GSN;DPYSL3;CGNL1;TMOD2;SPIRE1;WASL;SHROOM3;ABI1;TPM1;RHOA;FLNA;NEDD9;GAS2;ARHGAP12;COBL;RND3;RHOBTB2;BIN3;FHOD1;BAIAP2L1;RHOB;RHOBTB1;INPPL1;HIP1R;DLG1
prerank,vitamin D metabolic process (GO:0042359),-0.3969917256477642,-1.0043100591415894,0.46021505376344085,0.7850809940943387,1.0,4/13,34.28%,LGMN;PIAS4;CUBN;CYP2R1
prerank,regulation of protein acetylation (GO:1901983),0.4329290896777378,1.0041057127442885,0.4657258064516129,0.9521015300759947,1.0,5/12,15.09%,RAPGEF3;SIRT1;PARK7;DDX3X;TERF2IP
prerank,regulation of protein phosphorylation (GO:0001932),0.2549075396623371,1.0040975013030917,0.4651442307692308,0.9511459556683681,1.0,41/256,12.34%,ROPN1;ATF3;MAPK3;PRR5L;RALB;LIMCH1;RAP2A;PIN1;SOD1;PECAM1;SMG8;PDCL3;HDAC3;PPP2CA;TEK;FYN;NPTN;CIB1;FXR1;TBX1;CCDC88C;SIRT1;AXIN1;KDM4D;EFNA1;AKTIP;CDK2AP1;MOB1B;CSF1R;LYN;PAK1;PARK7;AKAP8L;TARDBP;ACVR2A;TRAF3IP1;APP;ZBED3;PRNP;WDFY2;CRKL
prerank,regulation of interferon-gamma production (GO:0032649),0.29885750150045776,1.0040057129341953,0.4481707317073171,0.9504612616406825,1.0,11/71,15.42%,IL1R1;PDE4D;CYRIB;CEBPG;CD47;VSIR;PRNP;CD274;DDIT3;TRIM27;GAS6
prerank,kinetochore organization (GO:0051383),0.4177962969212651,1.0037356093383933,0.44083969465648853,0.9502767224872463,1.0,3/13,13.69%,CENPC;MIS12;POGZ
prerank,gland development (GO:0048732),-0.2709434084764731,-1.0035452326373808,0.43874643874643876,0.786408473774251,1.0,12/59,12.16%,FGFR2;TGFBR3;GLI2;TGFBR1;ZBTB1;WNT4;COBL;DKK3;EZR;SALL1;TBX3;ANXA1
prerank,dendrite self-avoidance (GO:0070593),-0.366930654999376,-1.0033661199998578,0.4665271966527197,0.7860912798819418,1.0,4/16,7.13%,CNTN4;CNTN6;DSCAM;PALLD
prerank,regulation of macromolecule metabolic process (GO:0060255),0.2636806348782727,1.003307990715045,0.4374193548387097,0.9505936029634938,1.0,25/170,9.97%,CAVIN4;PTPRC;PIN1;PCBP1;SORT1;STOX1;ZFP36L1;HNRNPAB;APOE;PRDM4;SOX2;HNRNPK;TRIM14;NPAT;LAMTOR1;RO60;BMI1;RNF187;KDM6A;CDK4;TOB2;NOVA2;ARF1;MARF1;TARDBP
prerank,canonical Wnt signaling pathway (GO:0060070),-0.26558561626829097,-1.002869391142913,0.42120343839541546,0.7866215815316433,1.0,20/68,18.74%,WNT5B;FZD6;RYK;CTNNB1;PLPP3;DIXDC1;CSNK1A1;WNT4;LRP5;CSNK1E;DVL3;FZD2;GSK3B;SCYL2;WNT9A;LRP6;FZD4;DVL1;TCF7L2;SFRP4
prerank,anterograde synaptic vesicle transport (GO:0048490),0.40539513647095005,1.0026737345142465,0.4645390070921986,0.9505390669926109,1.0,6/15,16.55%,AP3S1;DTNBP1;AP3M2;AP3M1;SNAPIN;BLOC1S5
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.40539513647095005,1.0026737345142465,0.4645390070921986,0.9505390669926109,1.0,6/15,16.55%,AP3S1;DTNBP1;AP3M2;AP3M1;SNAPIN;BLOC1S5
prerank,cell cycle G1/S phase transition (GO:0044843),0.30336065434988907,1.0025989135313078,0.4371165644171779,0.949795853558218,1.0,12/61,14.43%,MAP3K11;PLK2;CCNH;CDKN1A;POLE;CDK4;LATS2;USP37;E2F3;CUL3;PHF8;RCC1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.4154750271887123,1.0019258980952763,0.477859778597786,0.9500100929264216,1.0,4/15,14.60%,ZFP36L1;CNOT7;NANOS3;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.4154750271887123,1.0019258980952763,0.477859778597786,0.9500100929264216,1.0,4/15,14.60%,ZFP36L1;CNOT7;NANOS3;CNOT1
prerank,nucleotide biosynthetic process (GO:0009165),0.39147500622637826,1.0017672432680014,0.4711191335740072,0.9495681098704556,1.0,9/18,20.44%,RRM2B;PRPS1L1;PRPS1;PNP;RRM1;NMNAT1;HPRT1;GART;PPAT
prerank,tRNA wobble uridine modification (GO:0002098),0.4113708739222056,1.0017117011268775,0.4573055028462998,0.9487441714361307,1.0,2/14,7.96%,MOCS3;ELP1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.3361479423192494,-1.0016190918322674,0.4525862068965517,0.7892862651170809,1.0,14/23,41.58%,DDB1;DDB2;UBC;XPC;COPS2;PARP1;COPS5;COPS7A;RBX1;COPS6;XPA;GPS1;UBA52;CETN2
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.23511913534929543,1.0014360115534815,0.47772020725388603,0.9485491345400398,1.0,143/807,16.20%,SOX30;LRRFIP1;ATF3;IRX1;MAZ;DCAF1;CCDC85B;GCLC;DACH1;ILF3;AASS;MECOM;ARID5A;KLF8;TRIB3;L3MBTL4;MTERF3;NR4A2;EZH2;TRIM28;HSPA8;LEF1;CIPC;RPL23;EED;JAZF1;GTF2IRD1;BTAF1;DMAP1;KLF2;DNAJA3;ING4;ELK3;MAP2K5;ZHX3;ZBTB33;HDAC9;SBNO2;BCL6B;HDAC3;RPS6KA5;HEY1;NEDD4L;SOX2;SMARCA2;YY1;PHB2;WFS1;KDM2A;VPS72;UBE2I;IRF2BPL;BEND3;EP300;RFX3;RPS14;NFX1;CNOT2;PPARD;CHMP1A;ZNF205;SFPQ;UXT;SMAD7;DRAP1;BMI1;SIRT1;CLOCK;ZNF3;PFDN5;HEY2;ZBTB14;NOTCH1;SAP130;WNT5A;EDNRB;USP47;CNOT7;EFNA1;RSF1;RELA;SOX13;TRPS1;NAB2;MDM2;BCLAF1;HOXA7;PLCB1;TFAP4;ZKSCAN3;CIR1;CCAR2;CITED2;PBXIP1;HIC2;RBPJ;ESR1;THRB;CREBBP;CTBP1;ORC2;NFIC;PA2G4;MDFIC;IFI27;HDGF;LANCL2;N4BP2L2;MZF1;IRF2;CHD3;HDAC5;NDUFA13;DDIT3;TGIF1;CTBP2;THRA;HES1;USP9X;TRIM27;KDM5C;HCFC1;DR1;BACH1;E2F6;CNOT1;MAP3K10;TMPRSS6;PHF10;EZH1;BCL6;GAS6;TCERG1;NKAP;ELK4;TAF1;TRIM33;SMARCA4;TCF3;HEYL;ID2;TAF3;ZBTB18
prerank,blood vessel diameter maintenance (GO:0097746),0.33441167740904,1.0010582545584092,0.448566610455312,0.94868637509728,1.0,6/34,11.33%,GCLC;KLF2;GCLM;EDNRB;KCNMB2;NOS3
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.40658392131793974,-1.0009116400221856,0.44948453608247424,0.7903980362537765,1.0,4/12,33.80%,IL18;IL17D;CD80;PAEP
prerank,positive regulation of programmed cell death (GO:0043068),0.2516105817695804,1.0008538811547887,0.46616541353383456,0.9483450646650037,1.0,54/272,16.78%,ERCC3;MAP3K11;ATF6;FRZB;TIAM1;VAV3;SOD1;PSEN2;ARHGEF26;ING4;MCF2L;ITSN1;TNFRSF10B;MAPK8;ARHGEF6;CRADD;ARHGEF7;SYK;TRIO;OMA1;SIRT1;ARHGEF18;ITGA6;LATS2;BCLAF1;CYP1B1;FZD9;TFAP4;AIFM1;CCAR2;RYBP;ING3;BAD;DDX3X;ATG7;NF1;IP6K2;BMF;BNIP3L;ING5;UTP11;DIABLO;FAF1;APC;PTPA;APAF1;MAP3K10;BCL6;GNA13;APH1A;DNM1L;QRICH1;BNIP3;RASGRF2
prerank,cellular component assembly (GO:0022607),-0.22093504071483677,-1.0007364174209488,0.4371859296482412,0.7901166054489318,1.0,61/253,20.06%,CALD1;ANK3;RIMS1;TEAD1;PAWR;GSN;GPM6B;PARVA;DPYSL3;LRRTM3;KMT2A;PCLO;LIMA1;WASL;DLG4;OCLN;WIPF1;RHOA;NLGN2;FLNA;NEDD9;PPARGC1A;TAPBP;TUBGCP4;PEX14;PML;WASF1;DARS1;NLGN1;YTHDF1;EZR;DCX;TP53;TLCD2;ILK;PPID;RHOJ;STK25;BAIAP2L1;IKBKG;WDR19;AFG3L2;BSN;RANBP9;VAMP2;QSOX1;TGFB1;TRAF2;DVL1;MYO1B;CARD10;CLDN14;ZFYVE27;CDC42;ADD2;MDM4;TEAD2;SHANK1;TTLL3;ZW10;SPG7
prerank,regulation of establishment of protein localization (GO:0070201),-0.3981678359891256,-1.000626724921318,0.4839357429718876,0.7896423919532536,1.0,4/13,15.18%,SPIDR;CEP120;CTSD;CEP295
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.42714652312495427,0.9994509508659576,0.4602272727272727,0.9516560033070397,1.0,2/12,6.67%,PDE4D;CALM3
prerank,regulation of platelet activation (GO:0010543),0.37580121182843096,0.9994464820487607,0.43253234750462105,0.9506979007425653,1.0,6/21,13.32%,APOE;SELP;SYK;LYN;NOS3;PLEK
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.38230061659329984,0.9992689662628508,0.475,0.9502879972492878,1.0,8/19,19.55%,GSK3A;PARK7;FBXO7;CSNK2A2;CAMKK2;DNM1L;USP36;FBXW7
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.3861030911335067,0.9992405103884054,0.4605263157894737,0.9494164798657561,1.0,3/18,4.50%,MAPK3;SRC;VPS11
prerank,positive regulation of protein import (GO:1904591),-0.32119143087726826,-0.9991208656684931,0.45897435897435895,0.7930524890585042,1.0,12/30,17.29%,ZIC1;SMAD3;FLNA;BAG3;PRKCD;UBR5;EFCAB7;CDH1;PDCD5;ARHGEF5;TGFB1;MAVS
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.25618870754567236,-0.9990563687434952,0.4402332361516035,0.7924408860028165,1.0,17/76,25.35%,LPAR1;HTR2C;GRM5;CHRM2;PLCE1;ADRA1B;ACTN2;ANO1;GPR4;OPRM1;GNA14;AGTR1;ADRA1A;P2RY12;ADRA2A;LPAR6;CMKLR1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.3837461327056397,0.998968141409009,0.46830985915492956,0.9493163914720811,1.0,3/19,9.27%,MAPK3;CAMK1D;CSF1R
prerank,lipid catabolic process (GO:0016042),0.3901388481542032,0.99850005887698,0.46617915904936014,0.9498256981100254,1.0,2/18,4.72%,PPT1;PLAAT3
prerank,positive regulation of protein modification process (GO:0031401),0.2588754318424568,0.9984067150309138,0.47388059701492535,0.9491112918772144,1.0,43/203,15.42%,MAPK3;RALB;LIMCH1;RAP2A;PIN1;PECAM1;SVIP;HDAC3;PPP1R16B;TEK;NPTN;CIB1;FXR1;TBX1;CNEP1R1;CALM3;RAPGEF3;SPPL3;SIRT1;TXN;AXIN1;EFNA1;AKTIP;CDK2AP1;CSF1R;LYN;PAK1;ACVR2A;DDX3X;ANKLE2;APP;ATG7;PTBP1;WDFY2;CRKL;CDH5;PTPA;CAMKK2;VEGFC;TERF2IP;ATG14;RAB3GAP1;GAS6
prerank,sulfur amino acid metabolic process (GO:0000096),0.3745475373790216,0.9980668800363665,0.4706896551724138,0.9492089426338218,1.0,2/24,2.90%,GCLC;MTR
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.41904552168423903,-0.9979918930808146,0.4677754677754678,0.7945427695360058,1.0,3/11,15.10%,NRP1;SIRT2;STMN1
prerank,regulation of feeding behavior (GO:0060259),-0.417776609719324,-0.9973859068797222,0.4703476482617587,0.7953971788603725,1.0,2/11,6.89%,LEPR;CFAP20
prerank,chemical homeostasis (GO:0048878),0.307242963395327,0.9973392161003429,0.47730829420970267,0.9504023680694123,1.0,8/61,7.51%,SLC4A4;SLC4A5;KLHL3;FITM2;NEDD4L;ACOX3;USF2;IRS2
prerank,phosphorylation (GO:0016310),0.24521965997082643,0.9972496078143448,0.47520184544405997,0.9497235607967561,1.0,81/384,16.72%,MAP3K11;MAPK3;ILF3;SNRK;GSK3A;PIK3CG;CDK17;DGKB;OXSR1;CDK19;PPP3CB;PLK2;PNKP;NEK11;RPS6KA4;PRKCH;HIPK2;MEX3B;PRKG1;PRKD2;RPS6KA5;PANK2;MAP3K9;PKN3;FYN;CERKL;MAPK8;RET;PAK3;SIK3;CDK11B;SYK;PIM1;PEAK1;MINK1;MERTK;CDK4;ACVRL1;LATS2;CDKL4;LYN;NRBP1;PKN1;PAK1;ERG;NIM1K;ACVR2A;PRKAA2;SRPK2;NLK;NEK7;CTBP1;PI4KA;APP;PIK3CD;MAP4K4;STRADB;TYK2;PRKCI;MAPK6;IKBKB;NEK6;CHUK;CHEK2;TLK2;BRD2;CAMKK2;COPS8;BMP2K;GAS6;DYRK2;TOP1;CDKL5;TAF1;CERK;BRAF;CDK14;PTK2B;PIK3R4;PRKDC;WNK2
prerank,negative regulation of protein kinase activity (GO:0006469),0.28667290183750627,0.9972092917110459,0.46,0.9488661294117003,1.0,11/88,7.91%,PTPRQ;TRIB3;PTPRC;GNAQ;PTPRB;SPRED1;CDKN1A;DTNBP1;AKT1S1;PTPRT;ADAR
prerank,autophagosome assembly (GO:0000045),0.31367552245976027,0.9971789343070989,0.4782608695652174,0.9479975862818445,1.0,19/52,18.78%,MAP1LC3B;ATP2A2;RAB7A;RAB43;TRAPPC8;VMP1;RAB1A;UBQLN1;ATG7;ATG16L1;ATG14;TMEM41B;GABARAPL1;ATG13;TP53INP2;UBQLN2;BECN1;GABARAP;ULK1
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.42761905556034113,0.9969683031104906,0.45614035087719296,0.9476999411319104,1.0,3/12,8.14%,PCGF3;YTHDC1;CDYL
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4296647540764693,0.9969240807295812,0.46395563770794823,0.9468993304359701,1.0,1/12,0.62%,IMPDH1
prerank,protein import into nucleus (GO:0006606),0.30160079726558126,0.9966174824586742,0.44296296296296295,0.9468613225943701,1.0,18/66,17.60%,RPL23;MMP12;PHB2;KPNA3;PTTG1IP;NUP54;SYK;NXT1;NUP50;RANBP17;KPNA1;E2F3;NUP35;IPO8;HIKESHI;KPNB1;STAT3;POM121
prerank,regulation of protein catabolic process (GO:0042176),0.28006979320851777,0.9966083913423914,0.4584527220630373,0.945944381346773,1.0,19/99,13.97%,GSK3A;EEF1A1;TNFAIP3;PIN1;PLK2;HMGCR;NEDD4L;RAB7A;TMEM9;AXIN1;SF3B3;WNT5A;MDM2;ATG7;EGLN2;NDUFA13;CHEK2;FAF1;APC
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.38083310421372024,0.9966081682956418,0.4660714285714286,0.9449936834760728,1.0,3/20,11.10%,GSK3A;EP300;PGP
prerank,transepithelial transport (GO:0070633),0.40879355400695083,0.9963406384828493,0.47201492537313433,0.944818183193144,1.0,3/15,8.27%,SLC1A1;ABCG2;SLC1A2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.4176508693107852,-0.9960243990768199,0.47357293868921774,0.7982997416873427,1.0,3/11,7.94%,FGFR2;TGFBR2;LRP5
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.42752407694049965,-0.9959160985511383,0.4732334047109208,0.7978382157243562,1.0,2/10,6.94%,WNK1;DPP4
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.3175761673000196,-0.9958831228497829,0.46190476190476193,0.797133951535875,1.0,10/29,23.50%,AMBRA1;PDGFRB;KIT;PDGFRA;PTK2;TGFB1;PRKD1;P2RY12;EPHA8;TNFAIP8L3
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4292393685657222,0.9957996705118148,0.4470588235294118,0.9454647409484741,1.0,1/11,0.14%,CIDEA
prerank,Notch signaling pathway (GO:0007219),0.30246379314037636,0.9957655944448154,0.45709828393135726,0.9446138488485357,1.0,14/59,15.94%,SORBS2;JAG2;PSEN2;HEY1;EP300;HEY2;NOTCH1;RBPJ;CREBBP;DTX4;YBX1;HES1;APH1A;HEYL
prerank,cardiac ventricle development (GO:0003231),0.3713266046088838,0.9956262143971778,0.46113074204946997,0.9441028671807582,1.0,7/20,15.94%,HEY1;HEY2;NOTCH1;MATR3;DAND5;HES1;HEYL
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.2655908823279348,-0.995493982679016,0.439873417721519,0.797411459423888,1.0,14/66,12.89%,EGFR;KANK2;PKD1;FHL1;RBL2;APPL2;MYO16;CDC73;ADAMTS1;BRD7;CCND3;CDK6;ANXA1;DLG1
prerank,neutrophil mediated immunity (GO:0002446),0.24078071596343106,0.9949337684428395,0.48755656108597284,0.9452431964443007,1.0,71/432,14.82%,SURF4;IMPDH1;CAND1;ATP8A1;PSMD12;PTPRJ;HMOX2;EEF1A1;HSPA8;GLB1;PTPRC;GYG1;PRCP;PECAM1;PTGES2;RAB5C;SVIP;CCT2;PYGL;PTPRB;ATP6V1D;NRAS;TUBB;PSMD11;ATP11A;MME;RAB7A;TNFRSF1B;B2M;FUCA1;LAMTOR1;ATP6AP2;STOM;RAB6A;RAB14;CD47;NFASC;PSMC2;PSMD2;HRNR;MGAM;VAT1;DYNLL1;PNP;DDX3X;GPI;RHOG;PA2G4;ATG7;RAB5B;HGSNAT;ILF2;GALNS;RAP2C;GM2A;CD55;NPC2;SCAMP1;PSMD14;OSTF1;NDUFC2;ARPC5;PSMD1;PSMB1;ERP44;CD93;APAF1;CYBA;CD44;NHLRC3;QPCT
prerank,embryonic hemopoiesis (GO:0035162),-0.4014440657370709,-0.9944953031750166,0.4666666666666667,0.7993244999865528,1.0,3/12,4.62%,KMT2A;TGFBR2;KIT
prerank,amino acid import across plasma membrane (GO:0089718),0.3596817171105517,0.9943209981615332,0.44905008635578586,0.9461652999430058,1.0,5/24,8.27%,SLC7A8;SLC1A1;SLC3A2;SLC6A6;SLC1A2
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3200781191435902,-0.9940162097698657,0.45727482678983833,0.7998590180671817,1.0,6/26,7.91%,DNAJC6;AP2B1;SNAP91;AP2A2;GPR107;AP2A1
prerank,positive regulation of signaling (GO:0023056),-0.29896510135365273,-0.9939642513624878,0.45792079207920794,0.7992248801829988,1.0,17/37,33.01%,RIMS1;WLS;ANXA2;DLG4;CLSTN2;ILK;PTPN23;KCTD13;CLSTN3;RAB29;INPP5F;CD80;SNCA;SCRIB;CDKN2AIP;EDN1;NMU
prerank,positive regulation of cell motility (GO:2000147),0.258760234719601,0.9938975132905699,0.489769820971867,0.9465353560078607,1.0,30/205,11.87%,PHPT1;SPOCK2;MAZ;SEMA6A;SEMA6D;SEMA7A;LEF1;TIAM1;CXCL12;PECAM1;SEMA3C;CIB1;RET;SEMA6B;ACTN4;RUFY3;NOTCH1;ITGA6;TJP1;SEMA4C;SOD2;CSF1R;PAK1;PODXL;VSIR;MGAT5;FLT1;PIK3CD;PPP3CA;MAP4K4
prerank,cardiac muscle cell development (GO:0055013),-0.34617361759754667,-0.9935761997884424,0.4669811320754717,0.7995327499597775,1.0,4/20,6.59%,PDLIM5;PDGFRB;CXADR;PDGFRA
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.44477925582719813,-0.9933645638450448,0.4762886597938144,0.7985364827413944,1.0,3/10,12.94%,MBP;WNK1;MYADM
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.44477925582719813,-0.9933645638450448,0.4762886597938144,0.7985364827413944,1.0,3/10,12.94%,MBP;WNK1;MYADM
prerank,cellular response to hydrogen peroxide (GO:0070301),0.3379836724992341,0.9933215777884871,0.4774305555555556,0.9473022030279759,1.0,7/33,11.45%,TNFAIP3;SIGMAR1;SIRT1;RELA;CYP1B1;PARK7;RPS3
prerank,glycerol metabolic process (GO:0006071),0.4399482854709006,0.9932033928794057,0.4842300556586271,0.9467214318766208,1.0,3/10,11.10%,TPI1;COQ2;PGP
prerank,regulation of DNA biosynthetic process (GO:2000278),0.35316440404894345,0.9930430415875158,0.4648370497427101,0.9462954506977596,1.0,6/27,11.75%,DACH1;PRKD2;CDKN1A;RGCC;ACVRL1;TNKS
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.2656212663733538,-0.9928184661368238,0.4393063583815029,0.799245158587992,1.0,12/61,9.57%,EYA2;EYA1;EGFR;PDGFRB;UBE2N;TOX;ERCC6;PML;RAD50;SMOC2;MRE11;RNF168
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.33211442396268476,0.9927234997387557,0.4696969696969697,0.9463081900657748,1.0,7/35,9.12%,SEMA6A;SEMA6D;SEMA7A;SEMA3C;SEMA6B;PLXNA4;SEMA4C
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.31608874929096203,0.9926326500788598,0.47266881028938906,0.9456471581312307,1.0,12/48,17.44%,AEN;BCL2L2;HIPK2;TNFRSF1B;EP300;SIRT1;CDIP1;CHEK2;DYRK2;PRKDC;USP28;BAX
prerank,regulation of cell division (GO:0051302),0.2929490034312104,0.9926083994389572,0.46200607902735563,0.9447621775263102,1.0,8/72,6.67%,TAL1;PIN1;PLK2;PRDM15;CSPP1;PRPF40A;CIB1;CALM3
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.373979170261473,0.9925347232461602,0.48484848484848486,0.9440652817233299,1.0,5/21,11.29%,FCGR2B;PRKCH;LYN;CD81;SLC39A10
prerank,calcium ion import (GO:0070509),-0.3188960980895981,-0.9924582245838456,0.46582278481012657,0.7994972667216687,1.0,8/28,15.92%,CACNA1C;MCU;CACNA1D;MICU2;CACNA1B;CACNA1G;AFG3L2;MCUR1
prerank,glucan catabolic process (GO:0009251),-0.3765319990141065,-0.992170168735235,0.4514038876889849,0.7994809347473532,1.0,7/15,19.45%,PYGB;AGL;PHKA2;PYGM;PGM2;GAA;PHKG2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.39802737925049053,-0.9920876753047079,0.47216494845360824,0.7989259374444643,1.0,5/12,25.15%,RNF168;RNF8;NELFB;NELFA;LARP7
prerank,protein stabilization (GO:0050821),0.25913442136093195,0.9920351260757642,0.49466666666666664,0.9446593000587876,1.0,32/168,14.02%,ZSWIM7;CDC37L1;PIN1;RPL23;GNAQ;PDCL3;CDC37;CCT2;PPIB;CCNH;CCT5;PFN1;PHB2;WFS1;CDKN1A;EP300;BAG1;RPL5;SMAD7;GLMP;EFNA1;TSC1;PARK7;OTUD3;NLK;ZBED3;TNIP2;USP33;CHEK2;COG3;USP9X;HCFC1
prerank,aerobic respiration (GO:0009060),0.37476223427694694,0.9914967279911925,0.4748700173310225,0.9453132322571044,1.0,3/20,4.30%,ME3;MTFR1;SIRT3
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.39907898768558114,-0.9914640753515798,0.4787018255578093,0.7998556003681007,1.0,4/13,6.88%,ASPA;DDO;GLUL;GLUD1
prerank,sensory perception of smell (GO:0007608),-0.41873632453165543,-0.9912782366924937,0.5020408163265306,0.7996172571996145,1.0,5/11,33.54%,ADCY3;SYT10;SLC24A4;DRD2;MKKS
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3491528564584856,-0.991249289465625,0.46938775510204084,0.7981539723376133,1.0,2/20,0.57%,ZBTB20;IGF1
prerank,positive regulation of glycolytic process (GO:0045821),-0.3491528564584856,-0.991249289465625,0.46938775510204084,0.7981539723376133,1.0,2/20,0.57%,ZBTB20;IGF1
prerank,"transcription, DNA-templated (GO:0006351)",0.2549250577811934,0.9911349747670518,0.48370927318295737,0.9454785407091035,1.0,41/207,16.18%,POLR2J;ERCC3;NCBP1;ELOC;NR4A2;POLR2B;POLR1C;GTF3C1;PAX8;CCNH;IRF9;GMEB2;NFX1;GTF3C5;TRIP11;PWP1;RO60;DRAP1;IVNS1ABP;GTF2H1;RSF1;TAF15;THRB;GTF2A2;NFIC;MED4;ELOB;TSC22D1;TAF4B;TBP;RRAGC;RNMT;PPP5C;THRA;BAZ2A;TFAM;NOCT;TAF1;GTF2F2;GTF3C2;TAF3
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.41507710967846967,-0.9908960831971292,0.4778761061946903,0.7983269471667527,1.0,7/11,45.12%,CAMK4;MAVS;TICAM1;TYROBP;ITGB2;SPI1;ITGAM
prerank,establishment of mitotic spindle localization (GO:0040001),-0.31475619976220565,-0.9904521012764167,0.4709976798143852,0.7987491387077967,1.0,8/28,19.98%,FBXW11;HTT;UBXN2B;GJA1;NSFL1C;DCTN1;NDE1;ZW10
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3299165935372321,0.9904060559418838,0.4739413680781759,0.9467535056365258,1.0,7/38,12.39%,LRP8;PTPRC;EFNA1;CSF1R;APP;PRNP;RAP2C
prerank,apoptotic process (GO:0006915),0.2559876921937306,0.9902261644953688,0.4796547472256473,0.9463303780154116,1.0,36/203,14.80%,ERCC3;SEMA6A;BNIPL;AHCYL1;MAP3K7;FASTKD2;MAL;MAGI3;ING4;PPP2CA;TNFRSF10B;SCN2A;CASP6;CIB1;EP300;FXR1;TBX1;ARHGEF6;BCL2L13;CDK11B;PPARD;MDM2;BCLAF1;AIFM1;BAD;NAE1;CDIP1;APP;IFI27;BMF;RRAGC;DIABLO;NFKBIA;ELMO1;APAF1;MAP3K10
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.28332367221108423,0.9902041531200241,0.49277456647398843,0.9454678293128994,1.0,14/86,12.39%,LRP8;PTPRJ;PTPRC;PECAM1;PDCL3;SRC;FYN;SAMSN1;CNOT7;EFNA1;CD81;APP;PRNP;RAP2C
prerank,negative regulation of wound healing (GO:0061045),-0.3250881503029271,-0.9901733746207482,0.4872389791183295,0.7987160120845921,1.0,7/28,17.66%,PHLDB2;TFPI;SLC12A2;VTN;CD34;AJAP1;CD109
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.35787218857864644,0.9901071701371879,0.46371681415929206,0.9448429803260718,1.0,5/25,8.20%,PRPF3;SRSF10;SMNDC1;SF3B3;SRSF4
prerank,regulation of cellular protein localization (GO:1903827),-0.28702310821995936,-0.9899222449009816,0.4645669291338583,0.7986587043154219,1.0,11/45,9.75%,MAP2;GPC6;SPIDR;MAPT;CTNNB1;GPC3;VCP;CCDC66;CSNK1E;GPC5;DVL3
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.35507678207732957,0.9898212659444559,0.4616724738675958,0.9447784201851525,1.0,6/24,16.66%,CXCL12;SIRT1;CCAR2;ING2;CD44;TMEM161A
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.33223594281334595,0.9897903902792472,0.4872665534804754,0.9439413504482634,1.0,4/34,10.79%,PTPRC;PHB2;WNT5A;GPI
prerank,protein import (GO:0017038),-0.2534571269830874,-0.9896261588786966,0.4521452145214521,0.798665366016929,1.0,32/84,25.00%,ACBD5;IPO9;TNPO3;APPL2;RAB8B;PEX14;HSPA4;NUP155;FIS1;NUP188;IPO11;NUP93;NUP88;ALDH3A2;TNPO2;PXMP4;ABCD2;FAM53C;PEX2;NUTF2;PEX5;IPO13;TSC2;NUP85;GDAP1;APPL1;NUP214;PPP1R10;AKT1;ABCD3;SAMM50;SEC13
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.3472771810926735,-0.9895606500516142,0.47368421052631576,0.7980670518874843,1.0,6/20,8.94%,CFLAR;OGT;CYLD;NUPR1;FLOT2;BIRC3
prerank,regulation of fatty acid metabolic process (GO:0019217),0.3942902851944458,0.9890349777119072,0.4706959706959707,0.9452317082940005,1.0,5/17,11.20%,PANK2;PPARD;ADIPOR2;PRKAA2;ADIPOR1
prerank,cellular response to ATP (GO:0071318),-0.3861319176734043,-0.9889535165207971,0.45665961945031713,0.7989676523247603,1.0,4/14,21.40%,RYR3;P2RX4;SSH1;P2RY12
prerank,negative regulation of response to stimulus (GO:0048585),0.30420974635737613,0.9886203389023034,0.46616541353383456,0.945579230874431,1.0,13/60,14.19%,FCGR2B;MAP2K5;WFS1;LPCAT3;FBXO5;SIRT1;LYN;ZKSCAN3;TERT;MCTP1;HHIP;YBX1;MAP3K3
prerank,negative regulation of translation (GO:0017148),-0.24977747537662215,-0.9884169464867911,0.49691358024691357,0.7996656098503478,1.0,18/87,14.78%,SAMD4A;CPEB4;CPEB1;CPEB2;IGFBP5;PUM1;ROCK2;ROCK1;SYNCRIP;EIF4E2;YTHDF1;CNOT9;EIF2AK2;PUS7;RBM4;UNK;RACK1;TOB1
prerank,negative regulation of cell adhesion (GO:0007162),-0.260975606731229,-0.9882870899215755,0.4599406528189911,0.7992358659698238,1.0,31/72,25.88%,PLXNA2;ADAM22;SPOCK1;FBLN1;RHOA;DSCAM;JAM3;CDH1;EPHB2;SEMA4D;SIPA1;PLXND1;NF2;ARHGDIA;PTK2;PTPRO;PLXNB2;CBLL1;TGFB1;PLXNC1;FZD4;SEMA5A;TGFBI;FZD7;CX3CL1;ARHGDIB;DUSP1;ITGB1BP1;PLXNB1;DMTN;SERPINE1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.34007158487925593,-0.9882133249577577,0.49411764705882355,0.798664515243065,1.0,7/20,19.96%,GSN;PLA2R1;THBS1;ANO6;ITGA4;SFRP4;PIAS4
prerank,negative regulation of viral transcription (GO:0032897),0.4100188242669871,0.9880978688153428,0.4667931688804554,0.9461689248674173,1.0,6/13,18.94%,TRIM14;IFITM3;TRIM27;UBP1;HEXIM1;MID2
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.28047509054057923,0.9880938108235315,0.4809590973201692,0.9452528992484069,1.0,16/101,11.67%,PIK3CG;RALB;EZH2;MTCP1;RPTOR;SRC;PPP2CA;CIB1;CALM3;RGCC;SIRT1;WNT5A;CSF1R;DDX3X;FLT1;PIK3R5
prerank,cation transport (GO:0006812),-0.22752448130865535,-0.9880152297637194,0.48068669527896996,0.7984314111826262,1.0,44/167,23.77%,TRPM3;ATP1A2;KCNB2;KCNMA1;ATP1B1;TRPM6;SLC41A1;SLC47A1;SCN8A;SCN3A;PIEZO2;SLC12A2;SLC6A9;KCNK5;KCNJ2;SCN1A;KCNA1;SLC22A4;ANO1;SGK1;NDFIP1;KCNJ6;SLC9B2;ABCC9;ANO6;KCNJ13;NDUFA9;KCNS3;KCNQ4;SLC5A6;SLC38A7;SLC5A5;ANO10;KCNJ10;KCNA2;KCNA6;SLC11A2;SLC22A18;GRIN1;MCOLN1;TRPC6;KCNC1;PANX1;CLN3
prerank,regulation of cell junction assembly (GO:1901888),-0.32603725001865247,-0.987976920772942,0.4845814977973568,0.7977580515344865,1.0,6/27,9.47%,PDLIM5;OCLN;CBFB;ROCK2;ROCK1;PRKACA
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.37914787593563987,-0.9879597295748538,0.46813186813186813,0.7970215325989739,1.0,9/14,37.75%,ME1;NMNAT2;NMNAT3;AK5;AK3;AK4;CMPK2;AK1;NME2
prerank,termination of RNA polymerase II transcription (GO:0006369),0.33817878750368563,0.9879075543562725,0.4715447154471545,0.9448837916333259,1.0,9/33,18.82%,MAZ;NCBP1;CPSF4;PAPOLA;SCAF8;SLBP;WDR33;CLP1;SNRPD3
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.40713889092771105,-0.9876010583882927,0.5,0.797252370640728,1.0,2/12,2.75%,FOXP1;MBP
prerank,atrial septum morphogenesis (GO:0060413),-0.4243866603280639,-0.9875459699901641,0.45102040816326533,0.7966115309573172,1.0,2/10,9.38%,NOTCH2;ACVR1
prerank,microtubule polymerization or depolymerization (GO:0031109),0.36439193208030884,0.9870066510283416,0.4856115107913669,0.9466183923115359,1.0,5/24,9.81%,KIF18A;PIN1;FGF13;TRPV4;KIF2A
prerank,protein-containing complex assembly (GO:0065003),0.2482105475165494,0.9868082097096396,0.5018315018315018,0.9463204465647633,1.0,57/259,17.02%,SH3BGR;CAND1;TRAPPC2;CAPZA2;LEF1;TIAM1;CXCL12;CNIH1;KIFAP3;SKAP2;NDUFAF1;ANKRD28;SEC23IP;KPNA3;EP300;F8;GOSR2;MAGI1;NAPA;GEMIN5;PDE4DIP;AXIN1;TMED10;RUVBL1;CAND2;SLC2A1;MDM2;RAB1A;TFAP4;TERT;BAD;P2RX7;CREBBP;TLE4;DMD;SCFD1;TRAPPC6B;ELOB;HGSNAT;PICALM;MCFD2;CUL3;TRRAP;HES1;APC;AP2M1;PARD3;PPP6R1;TRAPPC10;SMARCA4;TCF7L1;DNM1L;PTK2B;TUBGCP2;DNAJB14;LIN7A;CD2AP
prerank,negative regulation of neuron death (GO:1901215),0.2840490845738233,0.9867992187547878,0.4738372093023256,0.9454335162774461,1.0,13/93,9.73%,FOXQ1;SOD1;PPT1;CRLF1;APOE;TNFRSF1B;TOX3;WFS1;BDNF;SOD2;FZD9;PARK7;FBXO7
prerank,import into nucleus (GO:0051170),0.2952423466076627,0.986797562586587,0.4684287812041116,0.9445226664487815,1.0,11/73,8.68%,SNRPD2;SNRPD1;BACH2;MMP12;PHB2;PTTG1IP;SYK;NXT1;GEMIN5;NUP50;RANBP17
prerank,peptidyl-lysine modification (GO:0018205),-0.24620616954408064,-0.9863191306022919,0.45544554455445546,0.7991212526144549,1.0,38/99,23.23%,EYA1;HDAC4;PLOD2;LOXL1;SIRT2;SENP3;ATP7A;NUP205;NUP155;NUP188;IFIH1;PLOD1;BCL11A;USPL1;NUP93;NUP88;LOXL3;NNAT;P3H3;SEH1L;TOPORS;PIAS3;ATPSCKMT;SIRT7;SENP7;EEF1AKMT1;STX1A;NUP85;AAAS;SIRT5;NSMCE2;PIAS4;RAE1;NUP37;LOX;VPS33B;NUP214;METTL21A
prerank,mitochondrial transport (GO:0006839),0.3096280845067048,0.9861898932843594,0.48043818466353677,0.9453373186367467,1.0,8/53,10.66%,TOMM20;ABCB10;SLC25A24;TIMM17B;TSPO;FBXO7;MAIP1;BAD
prerank,mitochondrial fission (GO:0000266),0.39485856753523746,0.9859449848445158,0.48188405797101447,0.9451476943399193,1.0,2/16,3.83%,DNM3;MTFR1
prerank,microtubule anchoring (GO:0034453),0.4241716978083913,0.9859423785380881,0.4632352941176471,0.9442371295826529,1.0,6/12,17.26%,CLASP2;DAG1;GCC2;BCCIP;BICD2;CLASP1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.24249450084696134,-0.985866671389257,0.51875,0.7995768651453546,1.0,20/95,12.13%,LDLRAD4;TGFBR3;DAB2;SMAD3;SMURF2;TGFBR1;TGFBR2;SMAD4;ZEB2;PPARA;SKI;HTRA3;DKK3;SNW1;SMAD6;THBS1;UBC;SNX25;STK11;PPM1A
prerank,cellular response to interleukin-6 (GO:0071354),-0.3312631732568538,-0.9856180370476317,0.47883597883597884,0.7994868832305988,1.0,7/26,7.13%,ST18;JAK1;PID1;SMAD4;FER;IL6R;PTGIS
prerank,negative regulation of B cell proliferation (GO:0030889),0.43481562370076776,0.9848672179872446,0.4861111111111111,0.9464221930034296,1.0,2/11,9.34%,FCGR2B;LYN
prerank,very long-chain fatty acid metabolic process (GO:0000038),-0.3198087494433203,-0.9843982577081267,0.46568627450980393,0.8021202347400161,1.0,7/30,15.07%,ACSL1;HACD3;HACD1;HACD4;TECR;ABCD2;PEX2
prerank,neuron projection organization (GO:0106027),-0.3718820234844844,-0.9843811969041046,0.4849137931034483,0.8014159461054972,1.0,9/15,26.53%,LGMN;GSK3B;MAP1A;ABCD2;DCTN1;ATP1A3;PLS1;PICK1;CHRNA7
prerank,regulation of synapse organization (GO:0050807),-0.3192591393890497,-0.9842941486271458,0.47619047619047616,0.8008918891571143,1.0,10/26,29.70%,CTNNA2;PDLIM5;ARHGAP22;IL1RAPL1;NEDD4;CAMK2B;CLN3;SLITRK4;ABHD17A;MDGA1
prerank,positive regulation of response to wounding (GO:1903036),-0.3335059149284968,-0.9841370479844666,0.45913461538461536,0.8005778739898216,1.0,11/24,30.59%,OCLN;VTN;ANXA1;PTK2;SCARF1;ADRA2A;DMTN;HBEGF;MDK;MYLK;CLDN1
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3818851737918373,0.9839512106595397,0.4905335628227194,0.9481797001863537,1.0,4/19,8.61%,CTC1;SRC;HNRNPC;ACD
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),-0.30878014114279423,-0.983914840370849,0.4713216957605985,0.8004300158415498,1.0,4/32,8.47%,AKAP6;P2RX4;CEMIP;TRPC1
prerank,protein ubiquitination (GO:0016567),0.23750194906876984,0.9838840554911535,0.5273522975929978,0.9474719478932104,1.0,96/471,16.71%,PSMB10;PSMC4;PSMB6;RAD18;CAND1;ELOC;RNF7;CBL;PSMD8;PSMD5;PSMD12;ARIH1;KLHL3;RNF38;SPOP;UBA1;BIRC2;PSMD11;NEDD4L;VPS11;NHLRC1;RBBP6;PSMB4;FBXL5;UBE3A;TRIM14;PSMC1;FBXW2;NFX1;SIRT1;RNF187;LMO7;UBE2V2;KLHL2;FBXO32;CAND2;TRIM25;AKTIP;FBXO11;RBCK1;CRBN;ANAPC7;MDM2;PJA2;MYCBP2;RFWD3;PSMC2;UBE3D;KLHL24;FBXO7;PSMD2;EIPR1;RNF6;ZNRF1;UBE2V1;RNF13;RNF25;CHFR;USP22;ANAPC11;DTX4;TNKS;ELOB;RNF11;CUL3;PSMD14;UBE2R2;PSMC6;RNF146;EPAS1;TSPAN17;PSMD1;PSMB1;USP9X;TRIM27;RNF20;FANCL;TRIM3;UBA6;NHLRC3;FBXO22;UBE2G1;RMND5A;RNF114;TAF1;TRIM33;PELI1;KLHL7;KLHL13;KLHL42;RNF125;UBE2H;PSMA4;VPS18;FBXL20;PRKDC
prerank,maintenance of protein localization in organelle (GO:0072595),-0.35479573363741657,-0.9837661670169261,0.5054466230936819,0.8000932577661953,1.0,10/19,30.02%,TAPT1;PML;TAF8;TOPORS;PINK1;HK2;AKT1;SUPT7L;ARL2;BCL3
prerank,peptidyl-threonine modification (GO:0018210),-0.26192538076530014,-0.9836346422310374,0.4633431085043988,0.7996858610847908,1.0,17/66,14.49%,GALNT13;TGFBR1;TGFBR2;WNK1;CDC42BPB;ROCK2;CIT;PRKCD;ROCK1;HIPK3;ACVR1;HIPK1;GSK3B;CAMK2D;ACVR1B;WNK3;MAP3K12
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3292223019621009,-0.9836185481870915,0.4742990654205608,0.7989674147604662,1.0,7/24,17.52%,ADAMTS12;TGFBR1;SOX5;EFEMP1;WNT9A;BMPR1B;SOX6
prerank,lipoprotein localization (GO:0044872),0.4238963766897982,0.9830380066161702,0.49206349206349204,0.9490080795007182,1.0,2/11,6.79%,ZDHHC17;VMP1
prerank,osteoclast differentiation (GO:0030316),-0.3357851060436198,-0.9827879802124966,0.47029702970297027,0.8004342720642978,1.0,3/22,3.50%,FOXP1;ANXA2;MAPK14
prerank,acyl-CoA metabolic process (GO:0006637),0.32795894579404955,0.9819270334931752,0.4915254237288136,0.9513845544016897,1.0,6/35,11.93%,MLYCD;DBI;GPAT4;ACACB;HMGCS2;ACOT8
prerank,T-helper cell differentiation (GO:0042093),-0.37858131074350043,-0.9818782511463666,0.4797297297297297,0.8021298806474217,1.0,2/14,5.68%,FOXP1;ATP7A
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.3810509063872517,0.9818555598763063,0.47079646017699117,0.9506643611450682,1.0,5/17,12.40%,KLHDC10;SEMA4C;LYN;RNF13;MID1
prerank,response to peptide (GO:1901652),0.33321107889557794,0.9818309582783284,0.4796747967479675,0.9498255663775267,1.0,7/33,12.00%,CACNA1A;MMP12;FYN;EIF2B3;ERBIN;GNAI1;PRNP
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.38261877028827446,0.9817577176485699,0.49168207024029575,0.9491353876706785,1.0,8/18,18.60%,APOE;VPS11;PTTG1IP;CD81;FAF1;VPS35;RNF128;RDX
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.3113878889156159,0.9815332124564724,0.49838187702265374,0.9488748745188696,1.0,9/44,15.42%,RPS6KA1;SRC;MAP2K5;CARD16;USP47;PCID2;DDX3X;CD44;GAS6
prerank,lysosome organization (GO:0007040),0.3238089117925507,0.9813665262449723,0.49747899159663866,0.9484742583765801,1.0,15/36,20.68%,LAMTOR1;TMEM165;TPP1;AKTIP;ZKSCAN3;MBTPS1;CLVS1;SNAPIN;TFEB;HOOK3;VPS18;VPS33A;GRN;TPCN2;LRRK2
prerank,regulation of chemokine production (GO:0032642),-0.2955895180293159,-0.9812937102955216,0.4894179894179894,0.8029238860054569,1.0,5/36,13.49%,FOXP1;IL6R;EIF2AK2;IL18;IL33
prerank,membrane depolarization (GO:0051899),-0.3057469105416181,-0.9806107279064087,0.43243243243243246,0.8039808068242402,1.0,10/32,17.51%,CACNB4;P2RX4;SCN8A;SCN3A;CACNA1B;SCN1A;CACNA1G;CACNG4;CACNG2;ATP5IF1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.3467605174162873,0.980415950167671,0.4904679376083189,0.9504248668562755,1.0,3/25,10.65%,CBL;BCAR3;RBPJ
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.27018389745341703,0.9802938281352768,0.5148095909732017,0.9498692517838825,1.0,30/129,13.85%,PSMB10;PSMC4;PSMB6;PSMD8;PSMD5;PSMD12;PIN1;PRDM15;PSMD11;PSMB4;TMEM9;PSMC1;CSNK1G3;ATP6AP2;AXIN1;RUVBL1;USP47;FZD9;PSMC2;PSMD2;CCAR2;TRPM4;DDX3X;ZBED3;TNKS;PSMD14;PSMC6;RNF146;PSMD1;PSMB1
prerank,primary alcohol metabolic process (GO:0034308),-0.3223953260448331,-0.9802485826017098,0.4904306220095694,0.8042217322203291,1.0,5/25,12.08%,IGF1;DHRS3;RBP4;NAPEPLD;ALDH3A2
prerank,regulation of viral transcription (GO:0046782),0.3208882134299003,0.9802424464341838,0.4739413680781759,0.9490961301508398,1.0,11/39,18.94%,POLR2J;POLR2B;TRIM14;IFITM3;RSF1;MDFIC;TRIM27;GTF2F2;UBP1;HEXIM1;MID2
prerank,positive regulation of multicellular organismal process (GO:0051240),-0.20960187811856237,-0.9798118311818342,0.5632911392405063,0.8046606787283713,1.0,59/308,16.37%,LRP1;DAB2;LEPR;COL1A1;SMAD3;ACSL1;OGT;FOXD1;EBF2;SMURF2;TGFBR1;DYNC1H1;TGFBR2;SNX4;SOX5;CTNNB1;PDPN;SMAD4;TAPT1;BMP4;MED1;PPARGC1A;RREB1;GHR;SMO;APPL2;SORL1;PER2;ROCK1;ADRA1B;LBP;PLA2R1;STAT6;LPIN1;FOXC1;NLGN1;PAXIP1;SHLD1;NIBAN2;KSR2;ACVR1;EIF2AK2;GJA1;NR2C2;PRKAB2;HSF1;ACVR1B;SLC27A1;IL18;IL33;ABCA1;GRB10;KDM1A;CPT2;SCAMP5;WWTR1;TGFB1;NPR1;BMPR1B
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3195638723605717,0.9798098386881177,0.46801872074882994,0.9494815504764771,1.0,6/41,9.27%,LRP8;SRC;FYN;BDNF;EFNA1;CSF1R
prerank,regulation of cellular component biogenesis (GO:0044087),0.31649806572124956,0.9798050006920384,0.4737704918032787,0.9485912075910288,1.0,7/39,10.00%,HSPA8;APOE;VPS11;HJURP;NOTCH1;TJP1;TIE1
prerank,regulation of immune response (GO:0050776),0.26671771694063995,0.9795540044145598,0.49386084583901774,0.9484215254145301,1.0,11/135,9.34%,LRP8;SH2D1A;FCGR2B;TIRAP;BIRC2;B2M;ICAM1;SYK;IFITM1;TRAF3;LYN
prerank,cytosolic calcium ion transport (GO:0060401),-0.3191234557694238,-0.9793790235503858,0.47619047619047616,0.8050837889826706,1.0,10/28,22.75%,CACNA1C;MCU;MICU2;AFG3L2;SLC35G1;MCUR1;ADRA1A;MCUB;ATP2B3;CACNA2D1
prerank,Wnt signaling pathway (GO:0016055),-0.24961139456559134,-0.9793763305743369,0.5045871559633027,0.8043314068041509,1.0,26/92,18.74%,WLS;NXN;WNT5B;FZD6;RYK;CTNNB1;PLPP3;DIXDC1;BTRC;CSNK1A1;WNT4;LRP5;CSNK1E;DVL3;CSNK1G2;FZD2;GSK3B;UBC;USP34;WNT9A;LRP6;FZD4;DVL1;TCF7L2;SNX3;SFRP4
prerank,snRNA processing (GO:0016180),-0.3698455928197526,-0.9792759583913039,0.4845814977973568,0.803867155071335,1.0,10/16,37.35%,INTS10;INTS8;INTS11;INTS7;TUT1;INTS12;INTS9;INTS3;INTS1;TOE1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3419355346110853,-0.9792149727379813,0.47045454545454546,0.8032851422219688,1.0,4/20,9.17%,SULF1;SULF2;SMOC2;THBS1
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.40858864892014063,0.9790832137041361,0.45778611632270166,0.9488420522968348,1.0,14/14,59.18%,ATP6AP1;CSF1;IFNG;POU4F2;IL23R;IL12B;TNFSF11;TNF;IL23A;OCSTAMP;CCR1;POU4F1;TRAF6;TYROBP
prerank,sensory perception of light stimulus (GO:0050953),-0.25232423424852257,-0.9787261506370164,0.5066225165562914,0.8038862755594534,1.0,9/87,6.38%,PCDH15;SLC4A10;COL1A1;EML2;COL11A1;ADGRV1;EFEMP1;DHRS3;DNAJC19
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.30227922868104995,-0.9785844629794083,0.4743935309973046,0.8035101643709356,1.0,14/30,24.60%,OGT;WAC;FHIT;CAMLG;DDRGK1;TRIM39;MAP1A;USP7;SGTA;STYX;BAG6;EIF3H;UBXN1;NOP53
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.22867822220119444,-0.9785111220505751,0.54,0.8029525114181206,1.0,48/150,22.58%,NTRK3;LDLRAD4;PRKAG2;PTPN13;DNAJC3;ERRFI1;SH3GL2;FBLN1;RASSF2;PID1;OCLN;PLPP3;SIRT2;PRKCZ;ENPP1;PRKCD;PPM1E;XDH;UBASH3B;SMAD6;NIBAN1;EPHB2;CAMK2N1;SNX25;SEMA4D;DEPTOR;SIRPA;MYADM;TAB1;RACK1;LRP6;WWTR1;TGFB1;RTRAF;DVL1;GPD1L;TSC2;PPP1R15B;SPRED3;PAQR3;HSPB1;CADM4;FKBP8;PPM1F;DBNDD2;DGKQ;IMPACT;EMILIN1
prerank,response to ionizing radiation (GO:0010212),0.2911034347907688,0.9785061084383369,0.49853372434017595,0.9495971702317932,1.0,11/70,9.63%,AEN;ABRAXAS1;EEF1D;RAD1;CDKN1A;COP1;SIRT1;CLOCK;EYA3;KDM4D;RFWD3
prerank,mitochondrion distribution (GO:0048311),-0.4046320751315412,-0.9781511211135723,0.500998003992016,0.8031795879426664,1.0,3/12,10.34%,MAPT;TRAK1;ARMC1
prerank,positive regulation of catabolic process (GO:0009896),0.2901260488755031,0.9781492801755475,0.48401162790697677,0.9497551616172382,1.0,12/65,13.97%,GSK3A;TNFAIP3;PLK2;NEDD4L;RAB7A;AXIN1;WNT5A;VSIR;ATG7;EGLN2;NDUFA13;APC
prerank,sodium ion import across plasma membrane (GO:0098719),0.3883222042723551,0.9778324105603974,0.48845470692717585,0.9497606121849772,1.0,3/17,10.43%,SLC9A7;SLC9A6;TRPM4
prerank,regulation of interleukin-13 production (GO:0032656),-0.3853059126783168,-0.977195246335514,0.48541666666666666,0.8049965958895368,1.0,4/13,13.16%,PRKCZ;RARA;TNFRSF21;IL18
prerank,regulation of exit from mitosis (GO:0007096),0.3149238811936643,0.9771057627520892,0.4831649831649832,0.95100960208055,1.0,7/38,12.50%,ANAPC2;PHB2;RGCC;ANAPC7;ANAPC11;ANAPC10;ANAPC4
prerank,regulation of endocytosis (GO:0030100),-0.2647714056387711,-0.9767131263393576,0.4807692307692308,0.8055337881115273,1.0,22/61,21.09%,LRP1;DAB2;RUFY2;ARFGAP1;STON2;GPC3;ROCK1;ZFYVE16;STON1;EPHA3;RIT2;CLIP3;SYT11;HIP1R;SCAMP5;CBLL1;LRSAM1;ABL2;TSC2;PACSIN1;FLOT1;PRKD1
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.4324712237103169,0.9765873651979055,0.48906560636182905,0.9516354653387765,1.0,4/10,18.64%,SSBP1;INO80;WIZ;ATRX
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.2365618022318621,0.976419472484084,0.5514950166112956,0.9512276855467158,1.0,80/476,13.36%,MAZ;CTCFL;MAP2K7;ILF3;MECOM;SS18L1;TAL1;TRIM28;LEF1;PPP3CB;RPS6KA1;KLF2;HIPK2;PAX8;PHF5A;HNRNPAB;HEY1;RLF;APOE;SOX2;SMARCA2;FLI1;KDM3A;SPIN1;NPAT;EP300;RFX3;TBX1;RET;CALCOCO1;MED12;FOXF2;PPARD;CLOCK;RNF187;AXIN1;HEY2;NOTCH1;WNT5A;CAND2;ATXN7L3;ATAD2;GTF2H1;ZXDC;ACVRL1;RSF1;RELA;PCID2;RAI1;PLCB1;TFAP4;RNF6;KLF6;ZKSCAN3;UBE2V1;TAF15;RYBP;WBP2;ING2;YEATS4;CITED2;ESR1;SETD3;CREBBP;USP22;RHOG;MED4;MDFIC;PICALM;ILF2;SP1;IKBKB;CHUK;YWHAH;PITHD1;ACTA2;ING5;DDIT3;EDRF1;CHEK2
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.25068956731247355,-0.9763513458853231,0.48773006134969327,0.8057514362486798,1.0,24/84,17.43%,CELF2;DDX5;TIA1;SON;DDX17;KHDRBS1;CELF4;KHDRBS2;RBM39;RBMX;SRSF6;RBM15;SNW1;RBFOX3;HNRNPA1;SMU1;RBM4;RBM3;DAZAP1;SRRM4;NOVA1;RBM7;SRPK1;RNPS1
prerank,glycine metabolic process (GO:0006544),-0.39817000277415104,-0.9762405114197541,0.47401247401247404,0.8052865847448997,1.0,9/12,55.80%,DLD;RIDA;AMT;GCSH;SHMT2;GCAT;SHMT1;GLDC;GLYAT
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.27614415727315805,-0.976106335427244,0.5264623955431755,0.8048904303934841,1.0,10/47,12.58%,PDGFRB;MAPK14;TGFBR2;PID1;MAPT;PRKCD;XDH;THBS1;TP53;GRB2
prerank,detection of calcium ion (GO:0005513),0.4112771755668533,0.9760137528136417,0.49070631970260226,0.9514721372785406,1.0,5/13,19.01%,CALM3;KCNMB2;KCNMB3;RYR2;CALM1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.28456767129198235,0.9755134389686988,0.5089285714285714,0.9520656509156505,1.0,13/72,7.53%,HSPA8;SHANK3;CLASP2;APOE;PFN1;CYRIB;CIB1;KANK3;PFDN6;SSH2;FGF13;CAMSAP2;PFDN5
prerank,detection of visible light (GO:0009584),0.3890852321544619,0.9754942008400028,0.502,0.9512087979917822,1.0,2/16,8.98%,GNAQ;GNA11
prerank,membrane lipid metabolic process (GO:0006643),0.36484826965683814,0.9753094465639685,0.5018115942028986,0.9508545212689562,1.0,5/22,12.36%,SERINC1;CERKL;TEX2;CYP1B1;ST3GAL6
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.36247443029717613,-0.9752592053830069,0.46943231441048033,0.8064284100855521,1.0,7/16,19.45%,PYGB;AGL;PHKA2;PYGM;PGM2;GAA;PHKG2
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.29414789415398795,-0.975097189283213,0.4908616187989556,0.8061006880093428,1.0,13/37,17.66%,IFT81;WDR35;DYNC2I1;TTC21B;IFT46;IFT57;IFT52;IFT172;IFT74;KIF3A;WDR19;DYNLL2;IFT20
prerank,regulation of T cell mediated immunity (GO:0002709),0.4301281849217725,0.975024752123816,0.49523809523809526,0.9507842056242102,1.0,2/10,10.43%,TNFRSF1B;TRPM4
prerank,protein palmitoylation (GO:0018345),0.33532821148584246,0.9746601759790177,0.4991023339317774,0.9509644560089863,1.0,7/30,14.14%,ZDHHC17;ZDHHC13;ZDHHC14;SELENOK;ZDHHC15;ZDHHC9;ZDHHC7
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.2632240527144533,0.9745698773646166,0.5217391304347826,0.9503509334245034,1.0,27/140,13.87%,RAC2;TIAM1;VAV3;ARHGEF26;SRC;CHN2;MCF2L;ITSN1;ARAP2;CYRIB;ARHGAP25;ARHGEF6;ARHGEF7;TRIO;ARHGEF18;MYO9A;FAM13A;OPHN1;RHOQ;ARHGAP39;RHOG;A2M;ARHGAP23;MYO9B;DEPDC1B;ARHGAP15;SYDE1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.29206455544287246,-0.9744921752956649,0.4639175257731959,0.8069794297019435,1.0,4/35,7.04%,MAGI2;PDGFRB;CRY2;HTT
prerank,regulation of DNA binding (GO:0051101),0.31204900630083965,0.9743677764844234,0.5007974481658692,0.950054442918074,1.0,11/44,13.89%,LEF1;NME1;MAPK8;CEBPG;TXN;HJURP;RSF1;TFAP4;DOT1L;NFKBIA;HES1
prerank,regulation of G0 to G1 transition (GO:0070316),0.3319628733480614,0.9742442553058476,0.48223350253807107,0.9495122058807749,1.0,9/38,16.06%,EZH2;EED;UXT;BMI1;RYBP;MGA;APAF1;E2F6;RBBP4
prerank,regulation of hydrolase activity (GO:0051336),0.292687971648817,0.9736130350636668,0.5170876671619614,0.9504901492005556,1.0,12/71,9.10%,CFAP73;VAV3;SOD1;CHN2;PRKG1;TBC1D10B;TDG;EPHA5;RAPGEF6;FGD5;RASIP1;PLXNA4
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.2597012331997029,0.9733660054645794,0.5174731182795699,0.95031130945454,1.0,18/150,11.67%,RAC2;MAZ;PIK3CG;TRIB3;PIK3AP1;PTPRJ;SRC;TEK;FYN;RET;TXN;IRS2;PARK7;MFHAS1;ESR1;RHOG;PIK3CD;PIK3R5
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.4159807597421864,0.9731700892351628,0.49521988527724664,0.9499972077758274,1.0,2/12,6.20%,SOAT1;LPCAT3
prerank,regulation of organelle organization (GO:0033043),0.283385107214032,0.9731359561902947,0.5014577259475219,0.9491861179314567,1.0,13/80,10.96%,SURF4;MAPK3;STOX1;VPS11;MYO5A;EP300;USP6NL;CAMSAP2;F11R;PDE4DIP;TJP1;TBC1D25;RBSN
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.36082032896876154,-0.9725688130622928,0.495850622406639,0.8113218437731406,1.0,2/17,3.12%,NTRK3;NRP1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3634140291705385,0.9724950871015967,0.49822695035460995,0.9501853860349384,1.0,2/21,3.77%,MAPK3;ZFP36L1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.24203844690767434,-0.9724875768903478,0.5187713310580204,0.8107805616972438,1.0,18/92,13.00%,FOXP1;ANXA3;SASH1;DOCK5;DOCK1;FGF1;NRP1;BMP4;RREB1;ROCK2;EPB41L4B;SPARC;SMOC2;THBS1;NRP2;FOXC2;RHOB;RAB11A
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.26964856480306215,-0.9724624247329645,0.5040431266846361,0.8100906344410875,1.0,16/53,19.73%,EYA2;DDX5;EYA1;EGFR;UBE2N;PRKCD;ERCC6;PLA2R1;RNF168;RNF8;ATM;NACC2;NPAS2;BABAM1;SMCHD1;SPRED3
prerank,intracellular lipid transport (GO:0032365),-0.33618303095479735,-0.9724022935080987,0.4939759036144578,0.8094704286885522,1.0,6/21,14.92%,PRKAG2;CPT1A;PLEKHA8;PRKAB2;ABCD2;CPT2
prerank,vasculature development (GO:0001944),-0.36383103657529614,-0.9723868537518954,0.5188470066518847,0.808758804668894,1.0,7/16,25.82%,PDGFRB;ERRFI1;PDGFRA;STK11;BMPR2;STRA6;NOTCH4
prerank,secondary palate development (GO:0062009),-0.3814543884405923,-0.9719815029356218,0.503370786516854,0.8090973549540661,1.0,3/14,4.04%,TGFBR3;TGFBR2;SMAD4
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.3528122471626526,0.9718764949132654,0.5,0.9511615223326447,1.0,3/25,3.85%,EVI5L;TBC1D30;EVL
prerank,serine family amino acid catabolic process (GO:0009071),-0.41850916427163876,-0.971771094673572,0.4970414201183432,0.8088955869959037,1.0,8/10,51.91%,DLD;AMT;CBS;GCSH;THNSL2;SHMT2;SHMT1;GLDC
prerank,cardiolipin metabolic process (GO:0032048),-0.39633761899866693,-0.9717509298011402,0.5070993914807302,0.8082064031554212,1.0,5/13,21.20%,PLA2G4A;SLC27A1;CRLS1;PGS1;PLA2G6
prerank,hexose biosynthetic process (GO:0019319),0.3201307376474022,0.9716114771879002,0.5219512195121951,0.9510525602926551,1.0,4/42,5.74%,PCK1;SLC25A1;GOT2;TPI1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3566314159850658,0.9711862804145297,0.5090252707581228,0.951391135918316,1.0,3/23,10.53%,SAG;METAP2;METAP1
prerank,negative regulation of protein modification process (GO:0031400),0.28232140951100104,0.9710085773214413,0.5135542168674698,0.9510294474738009,1.0,27/79,17.17%,PRR5L;PNKP;PPP1R16B;XRCC1;CIB1;DBI;YWHAB;SIRT1;CDYL;LYN;PARK7;TARDBP;PRKAA2;MFHAS1;TRAF3IP1;DMD;ZBED3;PRNP;CRKL;PTPA;TERF2IP;ATG14;DNAJC10;PPP1R8;PRKDC;WARS1;CORO1C
prerank,rRNA methylation (GO:0031167),-0.32985384280371877,-0.9708851353168775,0.49213483146067416,0.8097476740513847,1.0,17/22,45.67%,METTL15;NSUN4;NSUN3;METTL5;BUD23;MTERF4;FTSJ3;NOP2;NSUN5;ZCCHC4;FBL;MRM1;FDXACB1;MRM2;TRMT112;MRM3;METTL16
prerank,positive regulation of DNA replication (GO:0045740),-0.35682783523915484,-0.9706102259471258,0.49256900212314225,0.8097385255010582,1.0,6/16,14.08%,EGFR;GLI2;KAT7;STN1;BRPF3;ATAD5
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.3920107756316409,-0.9705708123236992,0.5030425963488844,0.8090891782644718,1.0,3/12,3.68%,NBL1;WASL;BMP5
prerank,blood circulation (GO:0008015),0.30630290345555805,0.9704043926147684,0.4944,0.9518452605655325,1.0,5/49,4.39%,GCLC;SOD1;CXCL12;TBC1D8;GCLM
prerank,regulation of ion transport (GO:0043269),-0.24935026888571277,-0.9703494614030409,0.49107142857142855,0.8089583728163565,1.0,30/76,30.26%,ANK3;WNK1;P2RX4;WWP2;ATP1A1;SYT9;KCNJ2;SIK1;PER1;KCNJ6;SYT12;SYT11;SYT4;NKAIN4;VAMP2;SYT7;KCNJ13;SYT2;KCNJ10;KCNA2;NEDD4;SNX6;SYT10;SYT6;SPTBN4;ITGB3;SNCA;KCNJ12;NOS1;DRD2
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",0.36074527508785736,0.9703004928731797,0.511744966442953,0.9512442754778834,1.0,8/24,16.06%,EZH2;EED;BMI1;PPHLN1;TRIM27;AEBP2;TASOR;RBBP4
prerank,neuron remodeling (GO:0016322),-0.42066751167785954,-0.9700562201244133,0.501123595505618,0.8089687721887312,1.0,4/10,21.60%,ADGRB3;SCARF1;CX3CL1;EPHA8
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.3886358859616541,-0.9696582229607903,0.5043859649122807,0.8092211780808198,1.0,4/12,18.87%,SNAP25;STX3;STX1A;SNAP29
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3034184758872802,0.9692405206858129,0.49837662337662336,0.9534198976104428,1.0,16/53,17.73%,PSME3IP1;APOE;FOXF2;DESI1;GNA12;RAD23A;PSMC2;OPHN1;ECSCR;XPO1;PSMD14;PSMC6;UCHL5;UBQLN4;TMTC3;RAD23B
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.38742760773145835,-0.9691691307497482,0.4797570850202429,0.8097305563970795,1.0,4/13,7.14%,HACD3;HACD1;HACD4;TECR
prerank,positive regulation of DNA repair (GO:0045739),-0.28153324484791786,-0.9688293382445943,0.49868766404199477,0.8098391405278124,1.0,10/46,9.57%,EYA2;EYA1;EGFR;SPIRE1;UBE2N;SPIDR;FMN2;ERCC6;MGMT;RNF168
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.276986697261722,-0.9687766747273817,0.525065963060686,0.8092348921791382,1.0,16/48,23.05%,PRKAG2;OGT;PRKAG1;NUP205;NUP155;NUP188;NUP93;NUP88;SEH1L;PRDM16;NUP85;AAAS;RAE1;NUP37;NUP214;PGAM1
prerank,cellular response to interleukin-4 (GO:0071353),0.43855192866659043,0.9687115316391414,0.5218295218295218,0.9540335077028168,1.0,1/10,2.08%,LEF1
prerank,cell-substrate junction assembly (GO:0007044),-0.30035164181058716,-0.9685591145795018,0.5158730158730159,0.8091192244796142,1.0,7/33,10.78%,SORBS1;PLEC;BCR;PIP5K1A;CTTN;ACTN2;FN1
prerank,response to molecule of bacterial origin (GO:0002237),0.2867974067251524,0.9684703020930683,0.5037821482602118,0.9538727836187177,1.0,13/69,16.09%,TNFAIP3;FCGR2B;TAB2;TIRAP;CYRIB;SELP;ERBIN;IFNAR1;NOS3;OTUD5;GCH1;NOCT;PELI1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.43259586841265674,0.9682245104904879,0.47731755424063116,0.9536912751481815,1.0,3/10,9.85%,RAP2A;MYO9A;OPHN1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.34966533781932574,-0.9681492465399832,0.4790697674418605,0.8079909089150125,1.0,14/20,49.18%,ZWINT;KLHL22;BUB3;ATM;ZW10;TEX14;MAD2L2;BUB1B;MAD2L1;TTK;IK;CENPF;KNTC1;TRIP13
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.34966533781932574,-0.9681492465399832,0.4790697674418605,0.8079909089150125,1.0,14/20,49.18%,ZWINT;KLHL22;BUB3;ATM;ZW10;TEX14;MAD2L2;BUB1B;MAD2L1;TTK;IK;CENPF;KNTC1;TRIP13
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.34966533781932574,-0.9681492465399832,0.4790697674418605,0.8079909089150125,1.0,14/20,49.18%,ZWINT;KLHL22;BUB3;ATM;ZW10;TEX14;MAD2L2;BUB1B;MAD2L1;TTK;IK;CENPF;KNTC1;TRIP13
prerank,cellular response to dsRNA (GO:0071359),0.39384579137543907,0.9680887167514148,0.5174418604651163,0.953231225397946,1.0,2/15,3.76%,RALB;IFIT1
prerank,regulation of focal adhesion assembly (GO:0051893),-0.267469121520333,-0.9676896140684945,0.5057803468208093,0.8085126507122067,1.0,11/54,6.54%,PHLDB2;GPM6B;EFNA5;NRP1;MACF1;RHOA;ROCK2;VCL;ARHGAP6;ROCK1;LDB1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.38264531933536106,0.9673396837174322,0.5,0.9545548569314072,1.0,1/16,1.03%,GSK3A
prerank,amino acid transport (GO:0006865),0.3037804327366095,0.9669796356821331,0.5138211382113821,0.9547104507008402,1.0,5/49,5.75%,SLC7A8;SLC36A4;SLC25A44;SLC3A2;SLC6A6
prerank,multivesicular body assembly (GO:0036258),-0.305165628816109,-0.9668504760297502,0.5241379310344828,0.8101291230393577,1.0,10/30,22.20%,STAM2;IST1;SNF8;RAB11A;TSG101;CHMP2B;CHMP5;STAM;VPS4A;HGS
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.3961308090415663,0.9668372249415138,0.5293040293040293,0.9542465339082602,1.0,1/15,0.78%,ZC3H12D
prerank,glucan biosynthetic process (GO:0009250),0.4101190449766958,0.9667829788874458,0.4844606946983547,0.9526302294848206,1.0,3/12,10.01%,GYG1;NHLRC1;UGP2
prerank,glycogen biosynthetic process (GO:0005978),0.4101190449766958,0.9667829788874458,0.4844606946983547,0.9526302294848206,1.0,3/12,10.01%,GYG1;NHLRC1;UGP2
prerank,B cell receptor signaling pathway (GO:0050853),0.3335799260894554,0.9667486179325016,0.520618556701031,0.9518419090921212,1.0,6/32,17.44%,PTPRC;VAV3;SYK;PIK3CD;PLEKHA1;BAX
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.24222366661820086,0.9662433832606543,0.5408038976857491,0.9523876988538204,1.0,56/264,16.25%,POLR2J;SNRPD2;NCBP1;RBM22;HSPA8;POLR2B;PRPF31;PRPF3;SNRPD1;HNRNPH2;PCBP1;PHF5A;SF1;PRPF40A;HNRNPK;CPSF4;PPIL3;PLRG1;SNRNP27;SRSF10;PRCC;SFPQ;HNRNPC;GEMIN5;SMNDC1;YTHDC1;SF3B3;SRSF4;DNAJC8;COIL;SNU13;NOVA2;SF3A1;RSRC1;BUD31;SYF2;U2AF1;SRPK2;PAPOLA;EFTUD2;PTBP1;RBM10;STRAP;YBX1;SRSF7;FUS;SNRPA;USP39;RBM4B;SF3B6;HNRNPL;TRA2B;GTF2F2;RBM41;UPF3B;U2AF2
prerank,regulation of dendrite development (GO:0050773),0.32324957076158445,0.9661912371078375,0.524701873935264,0.9516562510438548,1.0,6/37,9.78%,LRP8;RAP2A;CAMK1D;NEDD4L;CAMSAP2;ZDHHC15
prerank,apical junction assembly (GO:0043297),0.30154943836914305,0.9661613019547953,0.5158730158730159,0.9508609756815933,1.0,11/53,14.68%,MARVELD2;PECAM1;RAMP2;F11R;ESAM;CLDN5;PRKCI;CDH5;APC;PATJ;PARD3
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.359970951214849,-0.9660003864450322,0.4978165938864629,0.8116857923346638,1.0,7/18,20.59%,KMT2A;SETD7;EHMT2;KMT2B;SMYD2;KMT2D;SETD4
prerank,positive regulation of cytokine production (GO:0001819),0.2423227256703099,0.9659734310492437,0.5542312276519666,0.9505012519588809,1.0,33/292,11.64%,LRRFIP1;CADM1;PIK3CG;IL1R1;PDE4D;PTPRC;MAP3K7;SOD1;POLR1C;TIRAP;PRKD2;RAB7B;CYRIB;EP300;CEBPG;RGCC;SYK;TMED10;WNT5A;RELA;CSF1R;CYP1B1;RAB1A;LURAP1;PARK7;PLCB1;PNP;CREBBP;NOD1;APP;RPS3;POLR3F;PIK3CD
prerank,limb development (GO:0060173),0.34275021824694885,0.9659122867998937,0.4864864864864865,0.9497944019658904,1.0,2/28,3.13%,TBX4;GREM1
prerank,negative regulation of protein binding (GO:0032091),0.2894052123332559,0.9659026076982323,0.518463810930576,0.9489455288732149,1.0,10/71,6.13%,RALB;PIN1;ACTB;PSME3IP1;IFIT1;ATP2A2;B2M;CDKN1A;MAPK8;CARD16
prerank,determination of heart left/right asymmetry (GO:0061371),-0.28422212197200203,-0.9657974215402224,0.536,0.8114911720236735,1.0,10/42,25.99%,AHI1;MICAL2;TGFBR2;SMO;TBX3;SETDB2;BBS5;CCDC39;NDRG4;TBX2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.32882376781529377,0.9656871411104376,0.506872852233677,0.9486809566533977,1.0,2/33,3.77%,LEF1;ZFP36L1
prerank,negative regulation by host of viral process (GO:0044793),-0.4112607988835797,-0.965455207083751,0.5010438413361169,0.8116858996582635,1.0,3/10,27.52%,CCNK;PSMC3;ZC3H12A
prerank,lipoprotein biosynthetic process (GO:0042158),0.4165119459085388,0.9653593838775273,0.4969939879759519,0.9487487293172053,1.0,3/11,11.69%,APOE;UGCG;ATG7
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.36381271810169813,0.9651610207017328,0.5209471766848816,0.948426653431684,1.0,3/22,10.43%,TNFRSF1B;WNT5A;TRPM4
prerank,regulation of angiogenesis (GO:0045765),-0.21785967051543234,-0.9649999590221763,0.5625,0.8121575780234159,1.0,33/192,12.29%,SULF1;ANXA3;SASH1;ADAM12;ADGRA2;ITGB8;BMPER;STIM1;FGF1;COL4A3;CTNNB1;GTF2I;ROCK2;F3;GLUL;HOXA5;ROCK1;CEMIP2;PML;HSPG2;PTGIS;FOXC1;ADAMTS1;SPARC;NIBAN2;THBS2;SMOC2;THBS1;HIPK1;CD34;RHOJ;RHOB;ECM1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.33035465081742243,-0.9647013558937201,0.4955947136563877,0.81217007690195,1.0,9/22,20.57%,IGF1;SMAD4;P2RX4;ROCK2;ROCK1;CAMK2D;IL6ST;PARP1;LMCD1
prerank,protein export from nucleus (GO:0006611),-0.3097246265226966,-0.9646965630969794,0.5,0.8114519620998213,1.0,8/27,16.33%,RANBP3L;PKD1;XPO6;DUSP16;STRADA;RANBP3;NUTF2;TGFB1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.3720913553588248,0.964556432519174,0.49816176470588236,0.9491744763057607,1.0,5/18,14.65%,HDAC9;HDAC7;CIB1;MAP3K3;PIK3C2A
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.3164534877171293,-0.9644530576357988,0.5036144578313253,0.8113725525136939,1.0,11/27,26.50%,RIMS1;SYT9;SYT12;SYT11;SYT4;VAMP2;SYT7;SYT2;ARHGAP17;SYT10;SYT6
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.24876872453739046,0.9639465477833717,0.5433673469387755,0.9500387153935921,1.0,36/190,13.32%,GSK3A;TRIB3;PTPRJ;PDE4D;TNFAIP3;BCL2L2;SRC;HDAC7;RFFL;IFI35;PRDM15;EPM2A;SPRED1;CYRIB;CIB1;AKT1S1;ARHGAP25;SIRT1;DAG1;NLRC3;PHLPP1;TSC1;RELA;MDM2;LYN;OTUD3;PRKAA2;ESR1;DDX3X;P2RX7;ADIPOR1;NF1;MAPKBP1;NDUFA13;DDIT3;PLEK
prerank,regulation of neurogenesis (GO:0050767),0.29536940013175744,0.9638673443561344,0.5121580547112462,0.9493865236525926,1.0,12/55,16.11%,HES6;HEY1;MME;B2M;HEY2;NOTCH1;PRUNE1;DOCK7;FAIM;HES1;HEYL;HOOK3
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.32818018631732393,-0.9636828854391402,0.4803921568627451,0.8127240867395431,1.0,7/24,16.12%,SORBS1;IGF1;ENPP1;AKT2;GSK3B;IGF2;SELENOS
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.35522218128196814,0.962995514175733,0.5262206148282098,0.9510313963390717,1.0,6/22,13.89%,OCIAD1;NOTCH1;CYP1B1;IL10RB;MGAT5;HES1
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.2483677551866351,-0.962956039063511,0.5474683544303798,0.8138545908314725,1.0,29/78,25.34%,SORBS1;LRP1;DAB2;EGFR;PID1;PPFIA1;MMP14;STX8;ZDHHC5;STX3;DPP10;EPHA3;EPHB2;CLIP3;DLG1;WNK3;TGFB1;TMBIM1;ZDHHC8;PIK3R1;VPS4A;APPL1;CLN3;VAMP8;PLS1;NKD2;AKT1;BCL2L1;SPTBN1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.32923709353637987,0.9628124785151573,0.5212947189097104,0.9507260790579117,1.0,9/35,11.84%,DDX54;SRC;UBE3A;KDM3A;CALCOCO1;PLPP1;WBP2;ESR1;EGLN2
prerank,glycosaminoglycan metabolic process (GO:0030203),0.30189268734316316,0.962590164116664,0.5296950240770465,0.950509745679451,1.0,12/54,12.23%,XYLT1;SGSH;GLB1;EXT2;HS6ST1;PXYLP1;FUCA1;HS3ST2;B3GAT2;HGSNAT;IDS;AGRN
prerank,regulation of protein autophosphorylation (GO:0031952),-0.29254918366103566,-0.962583393110127,0.5431235431235432,0.8140756790747904,1.0,14/36,22.67%,ERRFI1;RASSF2;EPHA7;ENPP1;RAD50;TNKS1BP1;MRE11;PPP2R5E;PDGFD;TOM1L1;PDGFA;IMPACT;VEGFA;PPP2R5D
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.3835055056007549,-0.9621653497905377,0.5256673511293635,0.8137091756113936,1.0,2/12,10.74%,FHL2;GSK3B
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.3835055056007549,-0.9621653497905377,0.5256673511293635,0.8137091756113936,1.0,2/12,10.74%,FHL2;GSK3B
prerank,IRE1-mediated unfolded protein response (GO:0036498),0.29692458420485646,0.9620436879618286,0.5007518796992482,0.9511310463476373,1.0,12/52,13.83%,GSK3A;EXTL2;WFS1;PDIA6;ATP6V0D1;GOSR2;TPP1;HYOU1;HDGF;TATDN2;FKBP14;PDIA5
prerank,protein targeting (GO:0006605),0.2704131466067988,0.9617263084390593,0.5353535353535354,0.9511968646114687,1.0,21/118,14.68%,RTP3;TOMM20;CHM;CDC37;TIMM17B;TSPO;PEX1;SPCS3;ZDHHC14;PIKFYVE;AP4S1;FBXO7;ZDHHC15;ICMT;VPS37B;PRKCI;ZDHHC9;GIPC1;SPCS2;ZDHHC7;PARD3
prerank,rRNA catabolic process (GO:0016075),-0.35302512529850333,-0.9616876059202045,0.5112612612612613,0.8142396141219584,1.0,9/16,34.86%,EXOSC10;DIS3L;DIS3;TRIR;EXOSC8;EXOSC2;DEDD2;EXOSC3;EXOSC5
prerank,organelle assembly (GO:0070925),-0.20180195125718992,-0.961627573013961,0.6375838926174496,0.8136688560228181,1.0,97/384,19.66%,BICD1;AMBRA1;GSN;ULK2;PARVA;AHI1;PKD1;CC2D2A;EXOC3;TMOD2;PACS2;STAM2;DYNC1H1;MAPT;RILPL1;FLNA;PIBF1;IFT81;DZIP1;TTC8;WDR35;UBXN2A;PIK3C3;WIPI1;DYNC2I1;DCDC2;RAB8B;TUBGCP4;CCDC66;NUDCD3;CCDC57;CFAP20;IST1;OGFOD1;EXOC6;IFT46;TTC39C;GOLGA2;IFT52;ACTR3;YTHDF1;UBXN2B;CEP89;CEP126;IFT172;CEP20;CFAP44;IFT74;RP2;CD34;ARL13B;ABLIM3;TTBK2;NSFL1C;DISC1;LIMD1;STX12;BBS9;KIF3A;DZIP1L;TUBGCP6;G3BP1;CCDC61;CDS2;SNF8;RAB11A;WDR19;WDR11;ATXN2L;INTU;RAB23;DHX29;BBS2;CDS1;TSG101;ARF4;CYS1;EXOC1;EXOC7;HPS4;CEP250;PTPN23;EHD3;EHD1;DYNLL2;RAB8A;CHMP2B;IFT20;ACTR2;CHMP5;BBS5;SNAP29;CIRBP;TMEM237;IRGM;CCDC28B;TTLL3
prerank,macroautophagy (GO:0016236),0.26744183438920666,0.961418941517534,0.5161290322580645,0.9511966288098894,1.0,34/118,18.78%,TOMM20;MTERF3;MAP1LC3B;KLHL3;SRC;MTMR14;YOD1;ATG4B;EPG5;TECPR1;CHMP2A;PRKAA2;DYNLL1;VPS37B;UBQLN1;NBR1;ATG7;PLAA;EI24;CSNK2A2;ATG16L1;ATG14;GABARAPL1;ATG13;PIK3R4;VPS37C;ZFYVE1;PIP4K2A;BECN1;VPS4B;VPS33A;GABARAP;LAMP2;ULK1
prerank,positive regulation of protein import into nucleus (GO:0042307),0.34095324869632726,0.9613842246781116,0.5157545605306799,0.9504240109896568,1.0,4/28,3.74%,RBM22;TRIM28;DMAP1;HDAC3
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.41271389148780296,-0.9613041833123049,0.5043859649122807,0.8137931738384909,1.0,5/10,33.53%,LPGAT1;ABCD2;NR1H2;SLC45A3;MID1IP1
prerank,RNA 3'-end processing (GO:0031123),-0.25425924782606146,-0.9610615344559101,0.5413105413105413,0.8137194384090977,1.0,25/69,24.32%,SRSF5;SRSF11;PABPN1;CASC3;RPRD1B;SRSF2;SRSF6;LIN28B;SRSF1;POLDIP3;DDX39B;CSTF3;SYMPK;CSTF2;THOC5;SLU7;CDC40;RNPS1;CPSF3;SUPV3L1;EIF4A3;TUT1;NCBP2;THOC1;RBM8A
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.35756152089726856,-0.9609485846097361,0.5258620689655172,0.8132647960181703,1.0,2/16,2.12%,DDX5;DDX17
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.390483839846023,0.9607780318701293,0.51171875,0.9512159030381401,1.0,4/15,15.54%,SYK;PNP;CD55;NKAP
prerank,Golgi to lysosome transport (GO:0090160),0.4170867084931192,0.9606098034909495,0.50187265917603,0.950805500061046,1.0,3/11,10.96%,SORT1;AP1G1;RBSN
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.34983282349552525,0.9604921208919125,0.5109489051094891,0.9502562349012218,1.0,6/22,12.66%,RAP2A;GREM1;CALM3;DDX3X;RAP2C;NBN
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.2841468229389988,-0.9603429244765398,0.5695876288659794,0.8141841271650881,1.0,16/38,27.52%,OTUD7A;PPM1B;TLE1;PER1;PPM1A;TRIM39;TNIP1;USP10;TANK;RORA;RIOK3;STAT1;OTUD7B;TRIM59;RHOH;ZC3H12A
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.28856403150537385,0.9602728593699987,0.5170876671619614,0.950077169120634,1.0,7/63,13.15%,PTPRC;VAV3;TIRAP;IRS2;PNP;CD81;CD274
prerank,DNA strand elongation (GO:0022616),0.37725709095278304,0.9598858132704369,0.5370370370370371,0.9503336976603572,1.0,5/18,12.66%,DCLRE1B;POLD3;POLA1;TERT;NBN
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.29649033016488896,-0.9598765106157732,0.5152284263959391,0.8146299229254692,1.0,11/35,19.85%,SULF1;NR2F2;COL4A3;XDH;SPARC;THBS1;AIMP1;CAV2;SCG2;ATP5IF1;STAT1
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.3628429193510504,0.9598092051767418,0.4990825688073395,0.9496995318446901,1.0,4/19,11.87%,PTPRJ;TEK;TSC1;MAP4K4
prerank,negative regulation of cell growth (GO:0030308),0.2626838593935995,0.9594164044248175,0.5443548387096774,0.9499723032367426,1.0,20/121,13.25%,CCDC85B;GSK3A;PTPRJ;FRZB;ST7L;RERG;PPT1;PPP2CA;SMARCA2;CDKN1A;DIP2B;FGF13;SIRT1;ACVRL1;RNF6;CCAR2;DDX3X;IP6K2;EI24;NDUFA13
prerank,calcium ion transport into cytosol (GO:0060402),-0.3310695461031995,-0.959278334426253,0.48259860788863107,0.8155026892281848,1.0,11/21,37.52%,CACNA1C;GRIN2B;ADRA1A;GRIN2D;GRIN1;CACNA2D1;JPH2;JPH4;ATP2B4;TRPM2;CACNB3
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.3203602804128638,-0.9592673909728562,0.5289855072463768,0.8147942858071013,1.0,9/25,25.20%,ERRFI1;PPARA;SLC6A9;EPHB2;ZGPAT;TSG101;SOCS5;SNX6;SOCS4
prerank,regulation of mitochondrial translation (GO:0070129),0.3596437669770469,0.9591733280325165,0.5106761565836299,0.9497998602642986,1.0,5/21,17.64%,FASTKD2;NGRN;TSFM;MTG2;RCC1L
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3286822403180805,-0.9591472583376414,0.5104408352668214,0.8143579587100752,1.0,8/21,23.37%,MCU;PDZD8;MICU2;FIS1;AFG3L2;MCUR1;MCUB;ANXA6
prerank,limb morphogenesis (GO:0035108),0.36814451201623793,0.9590401384203164,0.5456238361266295,0.9493067364584308,1.0,1/20,0.04%,TBX4
prerank,acylglycerol metabolic process (GO:0006639),0.3201122283549228,0.9583736004658869,0.5183946488294314,0.9503576249287391,1.0,4/37,5.12%,DGKB;APOE;PLAAT3;LMF1
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.2880063880377772,-0.9580442395940244,0.5205128205128206,0.8165105199725448,1.0,15/41,23.05%,PRKAG2;OGT;PRKAG1;NUP205;NUP155;NUP188;NUP93;NUP88;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;PGAM1
prerank,cellular respiration (GO:0045333),0.3128760444439628,0.9579832222590936,0.5431309904153354,0.9505424038577195,1.0,9/41,14.53%,CYCS;ME3;MTFR1;SIRT3;ETFA;SDHA;COX15;UQCRB;COX10
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.2537923778490551,0.9579534247047485,0.5623342175066313,0.9497762442356138,1.0,10/152,4.66%,MTNR1A;HTR1F;PTGER2;ADGRE1;ADGRL4;GNAQ;ADGRL3;TSHR;INSL3;RAMP2
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.38996675734733033,-0.9578979536381589,0.5077262693156733,0.8161645594226611,1.0,3/12,8.37%,NOTCH2;DOCK10;DOCK11
prerank,organophosphate ester transport (GO:0015748),0.34757660148658664,0.9576152834682545,0.5017182130584192,0.9498016996530587,1.0,7/24,13.86%,PRELID3B;EPG5;PRELID2;PITPNA;SCARB1;NPC2;OSBPL2
prerank,selective autophagy (GO:0061912),0.2930511204567504,0.9574920417639081,0.5230769230769231,0.9493099684437406,1.0,17/56,16.99%,DYNC1I1;MAP1LC3B;KLHL3;UFC1;RAB7A;PHB2;AUP1;PARK7;UBE2V1;DYNLL1;UBQLN1;NBR1;LGALS8;DYNC1I2;ATG14;ATG13;BECN1
prerank,sensory perception of taste (GO:0050909),0.4350364047200601,0.9574579323865207,0.5080645161290323,0.9485591528768198,1.0,10/10,56.52%,ASIC2;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;CD36;ASIC1;PKD1L3;PKD2L1
prerank,positive regulation of mitochondrial translation (GO:0070131),0.3996920559901743,0.9571291097260524,0.5508317929759704,0.9486042959250766,1.0,2/14,8.96%,FASTKD2;NGRN
prerank,regulation of DNA replication (GO:0006275),0.3007310802283084,0.9565852532741714,0.5320813771517997,0.9492299891596881,1.0,11/49,13.78%,CTC1;BCAR3;PPP2CA;ORC3;RBBP6;FBXO5;ACVRL1;ESCO1;USP37;ANKRD17;FAF1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.3135931950835053,-0.9563172993817481,0.5400943396226415,0.8196873651273199,1.0,9/26,21.53%,ADCY5;EFNA5;LRP5;CDK16;ANO1;STXBP4;GPLD1;PLA2G6;ADCY8
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.3405168603627941,-0.9563042582716009,0.5167037861915368,0.8189955693422198,1.0,13/18,43.58%,COX16;COX19;COX17;COX18;PET100;COX20;COX14;BCS1L;COA5;SCO1;COA3;SURF1;FASTKD3
prerank,regulation of biomineral tissue development (GO:0070167),0.34303721716216035,0.956295647155999,0.5190082644628099,0.9492185485115172,1.0,8/26,15.42%,HEY1;FBXO5;HEY2;NOTCH1;NOS3;NBR1;BMP2K;GAS6
prerank,nuclear membrane reassembly (GO:0031468),-0.2688458108812961,-0.9562867415158851,0.543661971830986,0.8183161138665849,1.0,22/54,25.00%,SIRT2;PPP2R2A;LMNA;UBXN2A;NUP205;IST1;NUP155;NUP188;UBXN2B;AHCTF1;NUP93;NSFL1C;SEH1L;CHMP2B;NUP85;NUP37;CC2D1B;VPS4A;EMD;LBR;LEMD2;SEC13
prerank,regulation of cell development (GO:0060284),0.31673588998846053,0.95619717171481,0.5190713101160862,0.9486615310869191,1.0,10/36,15.94%,HES6;HDAC9;HEY1;CLOCK;HEY2;PRUNE1;DOCK7;HES1;FBXO22;HEYL
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.34931871766216005,-0.9559104809674986,0.5309168443496801,0.8186043399074017,1.0,8/17,27.42%,EMC7;CAMLG;SGTA;BAG6;EMC1;EMC8;EMC9;GET4
prerank,T cell homeostasis (GO:0043029),-0.40033410438564887,-0.9553837563689693,0.525691699604743,0.8192327386008106,1.0,4/10,27.92%,PPP2R3C;AKT1;NCKAP1L;ZC3H8
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.43381764988700566,0.9552996057087513,0.49203187250996017,0.9502899948547628,1.0,3/10,15.42%,CXCL12;LYN;GAS6
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.3230723950542062,-0.9552611019727623,0.5260663507109005,0.8187703927492447,1.0,2/23,0.57%,ZBTB20;IGF1
prerank,regulation of protein secretion (GO:0050708),-0.22796108508760454,-0.9547446207635294,0.583011583011583,0.8193120046363622,1.0,34/119,26.00%,BMP6;IGF1;CACNA1C;ITPR1;SNAP25;CACNA1D;KCNC2;SERGEF;SLC12A2;PER2;DPP4;ENSA;EZR;STXBP5;PPID;UNC13B;SYT7;EXOC1;TGFB1;STX1A;KCNS3;CYP51A1;ITPR2;RHBDF1;P3H1;IER3IP1;TGFB3;LLGL1;UQCC2;ADRA2A;APBB1;PICK1;PPIA;SYTL4
prerank,regulation of cholesterol transport (GO:0032374),-0.34242662852752354,-0.9547349947388436,0.5011135857461024,0.8186061302230074,1.0,5/20,12.71%,LRP1;OSBPL6;ABCA5;NFKB1;TTC39B
prerank,regulation of autophagy (GO:0010506),0.24232038860844585,0.9545522621278821,0.559748427672956,0.9515834520500552,1.0,57/216,18.94%,GSK3A;TRIB3;ATF6;EEF1A1;ACER2;TAB2;PLK2;RPTOR;EXOC8;SVIP;TRIM8;ATP6V1D;VPS29;VPS26A;ATP6V0D1;TRIM14;EP300;MAPK8;LAMTOR1;TAB3;DRAM2;ATP6V0E1;RASIP1;ZKSCAN3;EIF4G2;PRKAA2;BAD;UBQLN1;CISD2;TMEM59;BMF;TBC1D14;RRAGC;USP33;DDIT3;TLK2;TRIM27;CSNK2A2;PIK3C2A;ATP6V1B2;VPS35;TFEB;ATG13;DNM1L;BNIP3;UBQLN2;PIP4K2A;WDR41;DAPL1;STAT3;FOXK2;ATP6V1A;USP36;SH3GLB1;ULK1;EIF4G1;MID2
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.37654855428390765,0.9544218711603006,0.5183823529411765,0.9511041291412753,1.0,4/17,10.66%,VEZF1;RFX3;TMEM100;BAD
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.37913653246842266,0.9541128155755385,0.5113207547169811,0.9511273725797018,1.0,6/15,18.77%,GRM7;HOMER1;GRM3;DAGLB;GRM8;HOMER3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.29663056310894476,0.9540497579758379,0.5117370892018779,0.9504470240741031,1.0,10/48,14.65%,HDAC9;HDAC7;PRKD2;CIB1;SIRT1;PLCG1;NOS3;SP1;MAP3K3;PIK3C2A
prerank,apoptotic cell clearance (GO:0043277),-0.3076911273657935,-0.9539925188466992,0.5172413793103449,0.819762606865077,1.0,9/30,12.30%,XKR4;LRP1;TXNDC5;XKR6;THBS1;RHOBTB2;RARA;ANXA1;RHOBTB1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.35609539542648055,0.953895870796086,0.5305755395683454,0.950023125677854,1.0,6/24,13.57%,TTLL1;CEP41;AGTPBP1;AGBL5;NAA80;TTLL7
prerank,response to interferon-gamma (GO:0034341),0.28609115243850297,0.9532701663276287,0.5317577548005908,0.95089759212546,1.0,8/67,9.14%,IFITM2;GBP3;GBP4;IFITM3;WNT5A;CCL25;IFITM1;CD47
prerank,calcium import into the mitochondrion (GO:0036444),-0.4135494656991724,-0.9529994469203333,0.5394456289978679,0.821658607595953,1.0,5/10,21.38%,MCU;MICU2;AFG3L2;MCUR1;MCUB
prerank,regulation of viral release from host cell (GO:1902186),0.3554305022506962,0.9527702348504378,0.5290806754221389,0.9514811570873215,1.0,5/21,10.64%,TRIM28;TRIM8;TRIM25;CHMP2A;VPS37B
prerank,epidermal cell differentiation (GO:0009913),-0.28026430736406155,-0.9526469420407548,0.5130890052356021,0.821912012405422,1.0,6/41,6.12%,CLIC4;CTNNB1;HDAC1;MED1;BCR;PIP5K1A
prerank,dendritic spine morphogenesis (GO:0060997),-0.36389414268313863,-0.9524792606279168,0.5057471264367817,0.8216440815149013,1.0,6/15,10.73%,EPHB1;WASL;DLG4;CTNND2;DOCK10;EPHB2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.24640503731600844,0.9523253214946155,0.5802005012531328,0.951887822203556,1.0,28/214,11.24%,MAP2K7;MAPK3;SEMA6A;PTPRR;ZDHHC17;SEMA7A;PTPRC;PIN1;TIRAP;PRKD2;APOE;TEK;SPRED1;PHB2;CIB1;ICAM1;HTR2A;SYK;CNKSR3;MTURN;NOTCH1;CCL25;CSF1R;LYN;MFHAS1;ATP6AP1;NPNT;APP
prerank,glucose import (GO:0046323),0.39921616290076006,0.9514607663893354,0.5318761384335154,0.9534106266198066,1.0,3/13,14.14%,SORT1;SLC2A1;ZDHHC7
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.33816590494705245,0.9512908331577246,0.5272407732864675,0.9530276680759369,1.0,6/26,12.85%,FBXO5;ANAPC7;ANAPC11;ANAPC4;NEK6;CUL3
prerank,protein modification by small protein conjugation (GO:0032446),0.2343276681113171,0.9512483237674036,0.6009334889148191,0.9523097972416974,1.0,92/361,19.55%,RAD18;MOCS3;CAND1;ELOC;RNF7;CBL;ARIH1;TRIM28;SAE1;KLHL3;RNF38;UFC1;UBA1;DCUN1D4;NEDD4L;VPS11;FBXL5;TRIM14;UBE2I;NFX1;NUP54;SIRT1;UBA2;RNF187;LMO7;NUP50;UBE2V2;KLHL2;FBXO32;CAND2;FBXO11;CRBN;ANAPC7;MDM2;PJA2;PIAS2;MYCBP2;RFWD3;KLHL24;FBXO7;EIPR1;RNF6;UBE2M;TRPM4;RNF25;NAE1;CHFR;ANAPC11;PIAS1;DTX4;ATG7;ELOB;NUP35;CUL3;UBE2R2;UBE2F;EPAS1;TSPAN17;USP9X;TRIM27;RNF20;UBA6;UBE2G1;NDC1;TRIM33;KLHL7;KLHL13;UBE2H;VPS18;PRKDC;DCUN1D1;DCUN1D2;NUP160;UBR3;MSL2;UVSSA;PEX13;RANGAP1;POM121;KCTD10;FBH1;KLHL9;NUP42;UBE2D3;TRPC4AP;HIF3A;BRAP;KLHL18;HACE1;DERL1;NUP133;FBXW7
prerank,regulation of interleukin-12 production (GO:0032655),-0.2722119465123664,-0.9512058287350967,0.5516372795969773,0.8241949387763817,1.0,7/47,15.06%,FOXP1;MAPK14;PIBF1;IRAK3;THBS1;IL16;HSPD1
prerank,cognition (GO:0050890),-0.2793308011486004,-0.9507294332454276,0.5433673469387755,0.8246374222381028,1.0,15/42,27.07%,GRM5;SOBP;TTC8;NIPBL;CUX2;CTNS;ST3GAL4;MAGT1;CHMP2B;DGCR2;LINS1;STRA6;FAM107A;CHRNA7;SLC1A4
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3039863380570681,0.9505106296649108,0.5257903494176372,0.9535017152258635,1.0,8/43,15.42%,CIDEA;TNFAIP3;NLRC3;VSIR;NFKBIL1;CD274;TRIM27;GAS6
prerank,mRNA export from nucleus (GO:0006406),-0.2353667249294173,-0.9502482886582643,0.5603715170278638,0.8251340734346777,1.0,39/102,25.47%,SRSF5;SRSF11;PABPN1;CASC3;SRSF2;ALKBH5;SRSF6;NUP205;ENY2;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;NUP93;NUP88;DDX19B;SEH1L;THOC5;SLU7;CDC40;DDX19A;UPF1;RNPS1;NUP85;AAAS;CPSF3;RAE1;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13;ZC3H11A
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.2969935386655886,0.94987644529402,0.5315457413249212,0.9544212986171717,1.0,9/48,12.84%,POLR1C;ACTB;EP300;POLR1G;ATAD2;WBP2;ATAD2B;SMARCD1;TBP
prerank,regulation of regulated secretory pathway (GO:1903305),-0.291521076400981,-0.9491821310708394,0.5304136253041363,0.8271021600543008,1.0,8/34,14.39%,RIMS1;SYT9;SYN1;GSK3B;SYT12;SYT11;SYT4;SYT7
prerank,regulation of protein localization to Cajal body (GO:1904869),0.42228468115812207,0.9491808815525314,0.52465483234714,0.9546027309629536,1.0,5/11,19.71%,CCT2;CCT5;TCP1;DKC1;CCT8
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.42228468115812207,0.9491808815525314,0.52465483234714,0.9546027309629536,1.0,5/11,19.71%,CCT2;CCT5;TCP1;DKC1;CCT8
prerank,long-term synaptic potentiation (GO:0060291),-0.3326074494058747,-0.9488800627547362,0.5560747663551402,0.8272108101782902,1.0,9/21,24.26%,GRIN2B;TSHZ3;PRKCZ;SLC24A2;VAMP2;SHANK2;NFATC4;GRIN2D;MPP2
prerank,regulation of protein kinase activity (GO:0045859),0.26577026903278267,0.9483805911961546,0.5611510791366906,0.9560029531214344,1.0,22/106,16.74%,TRIB3;PTPRC;SOD1;TAB2;SMG8;GNAQ;SPRED1;CDKN1A;DTNBP1;AKT1S1;LCP2;SIRT1;PARK7;MMD;NF1;RAP2C;TRIM27;CAMKK2;GAS6;PRKRIP1;PTK2B;WARS1
prerank,negative regulation of programmed cell death (GO:0043069),-0.19802318348039652,-0.9480968903204723,0.6507936507936508,0.8284850815869397,1.0,70/355,15.71%,NOTCH2;IGF1;DAB2;EGFR;FHL2;SON;CFLAR;AHI1;FSTL1;KANK2;DNAJC3;ARHGAP10;AXL;CTNNB1;PDPN;ERCC5;FLNA;HDAC1;TNFAIP8;BMP4;MED1;MALT1;NUPR1;ANXA4;AATF;OSR1;FMN2;BAG3;VDAC1;HIPK3;RHBDD1;IRAK1;IL31RA;AKT2;KLHL20;TAX1BP1;TXNDC5;CAT;SMAD6;BIRC3;NIBAN2;THBS1;GRK5;MGMT;MRE11;RNF157;XIAP;SOCS2;GSK3B;NFKB1;UBC;SEMA4D;TP53;DDRGK1;TBX3;ANXA1;ANXA5;TM7SF3;WNK3;SIAH2;IL6ST;TOPORS;ARHGDIA;SETX;PTK2;GLO1;HSPD1;RAF1;ARF4;NGF
prerank,regulation of cilium movement (GO:0003352),-0.40297752182312374,-0.948083575991678,0.5353535353535354,0.827789916055623,1.0,9/10,55.78%,CCDC39;DNAH11;CFAP43;CFAP298;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.36763333365627054,-0.9477742600963386,0.5670995670995671,0.8279295056616685,1.0,7/15,27.32%,NTRK3;F3;IL16;SCG2;VEGFA;VEGFB;PGF
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.3414247902839604,-0.9477633010715629,0.5054945054945055,0.8272300842741295,1.0,12/18,35.64%,CTNNA1;ILRUN;GSK3B;RAB23;APOD;FLCN;CABP1;OTUD7B;SUFU;CHP1;POLR1A;LATS1
prerank,cellular response to retinoic acid (GO:0071300),-0.275733799035877,-0.9475434992745411,0.5572519083969466,0.827067076900265,1.0,12/42,17.28%,WNT5B;BRINP1;PTK7;BRINP2;SNW1;EPHA3;WNT9A;ATM;SETX;ABL2;FZD4;TWF2
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3817327824104466,-0.947393090288612,0.5376344086021505,0.8267208242284432,1.0,3/13,5.94%,SLC4A10;SHISA9;SHISA6
prerank,vasculogenesis (GO:0001570),0.325168809855779,0.9473256543719141,0.5171232876712328,0.9580580044234153,1.0,6/32,9.08%,EGFL7;RAMP2;SPRED1;HEY2;NOTCH1;RASIP1
prerank,regulation of embryonic development (GO:0045995),0.31928265211796414,0.946968632941555,0.530278232405892,0.9581735531954538,1.0,12/34,19.82%,CLASP2;CFL1;TDG;DAG1;RAB14;PLCB1;ZBED3;SOX17;CLASP1;INSR;DHX36;POGLUT1
prerank,regulation of establishment of cell polarity (GO:2000114),0.3693184365077363,0.9465783129339135,0.5205223880597015,0.9583612732356618,1.0,7/16,18.16%,CYRIB;RIPOR2;KRIT1;RUFY3;CDH5;PTK2B;ARFGEF1
prerank,aortic valve development (GO:0003176),-0.2919109228936199,-0.9465471421565383,0.5497630331753555,0.8281603111544591,1.0,6/34,8.64%,ROBO2;ROBO1;BMP4;ROCK2;ROCK1;SMAD6
prerank,histone lysine demethylation (GO:0070076),0.34554552250095916,0.9465064628350244,0.5353356890459364,0.9577016011604315,1.0,7/25,14.40%,KDM3A;KDM2A;KDM6A;KDM4D;JMJD1C;KDM5C;PHF8
prerank,cellular response to amino acid stimulus (GO:0071230),-0.2860927265252544,-0.9461847623581335,0.581081081081081,0.8283286766103987,1.0,6/33,7.68%,CPEB4;CPEB1;CAPN2;KLHL22;CASTOR2;GLRA1
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.40122919080285224,-0.9461843748899099,0.5267665952890792,0.8276072243697147,1.0,3/10,18.57%,ACTN2;WDR1;SEMA5A
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.3748173275449701,-0.9458154123354817,0.520242914979757,0.8278795811518325,1.0,8/12,32.70%,WAC;TP53;SDE2;FBXO31;CDK2;RPS27L;CCND1;PLK5
prerank,regulation of neuron differentiation (GO:0045664),-0.2426052044188301,-0.9456561390897494,0.6136363636363636,0.8275687001688367,1.0,12/76,9.26%,CNTN4;NRCAM;NBL1;BRINP1;BMP7;RHOA;MED1;ZEB1;ROCK1;NLGN1;BRINP2;BIN1
prerank,necroptotic process (GO:0070266),0.3845073380961012,0.9453438489639997,0.5452865064695009,0.9600766667584334,1.0,4/16,16.21%,MLKL;TRPM7;ITPK1;DNM1L
prerank,protein modification process (GO:0036211),0.2749640006687804,0.9444319847382519,0.5481481481481482,0.9617368489511888,1.0,22/76,18.58%,DUSP12;UBE2I;FBXW2;CSNK1G3;SLC35A1;PIGH;FBXO11;UBE2M;ICMT;YES1;PLAT;ADPRH;ST3GAL6;ST3GAL1;MSRA;QPCT;FBXO22;NTAQ1;PRKDC;LCMT1;SEPHS1;UBE2D3
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.2973872133726636,-0.9444201226667925,0.5049019607843137,0.8299248923650221,1.0,4/29,5.19%,NOTCH2;IGF1;RASGRF1;RELN
prerank,regulation of myoblast fusion (GO:1901739),-0.402095970517402,-0.9442763024956258,0.5654008438818565,0.8295940381627002,1.0,4/11,20.58%,CFLAR;MAPK14;EHD1;FLOT1
prerank,maturation of SSU-rRNA (GO:0030490),-0.2885979852654583,-0.9438309423061135,0.556930693069307,0.8300499146197293,1.0,18/34,28.83%,RIOK1;BMS1;RIOK2;UTP6;NOL11;DDX52;RPS16;UTP4;NAT10;NOB1;RIOK3;WDR3;NOP14;LSM6;RRP36;TSR2;NOL10;UTP3
prerank,regulation of macrophage differentiation (GO:0045649),0.37930873833770296,0.9434708178585784,0.5239786856127886,0.9635780027599327,1.0,1/15,0.78%,C1QC
prerank,regulation of actin filament bundle assembly (GO:0032231),0.33344202423366465,0.942640659737539,0.5532646048109966,0.965056447338258,1.0,4/26,8.90%,ALMS1;SHANK3;PFN1;TSC1
prerank,regulation of protein localization to membrane (GO:1905475),-0.30449861728061794,-0.9426396346801451,0.5612009237875288,0.8323732023381744,1.0,6/28,8.98%,GPC6;GSN;MMP14;GPC3;STX8;GPC5
prerank,tryptophan metabolic process (GO:0006568),-0.39246824250656454,-0.9423028543983979,0.5186721991701245,0.8325200229733132,1.0,2/11,17.93%,ATP7A;KYAT1
prerank,telomere maintenance via recombination (GO:0000722),-0.38786052767894336,-0.9421164680522798,0.5289079229122056,0.8322617603362306,1.0,5/11,19.44%,SMC6;RAD50;TPRKB;RAD51D;NSMCE2
prerank,positive regulation of cell junction assembly (GO:1901890),-0.2620608724881787,-0.9419779688416748,0.5765027322404371,0.8318645379004854,1.0,12/56,11.94%,NRXN1;GRID2;EPHB1;NRP1;NLGN2;SYNDIG1;ROCK1;CLSTN2;NLGN1;EPHB2;CUX2;IL1RAPL1
prerank,keratan sulfate metabolic process (GO:0042339),-0.2935956952934688,-0.9418208171038739,0.586046511627907,0.8315396084278259,1.0,11/31,21.48%,B4GALT1;OGN;HEXA;HEXB;B4GALT6;SLC35D2;ST3GAL4;PRELP;GNS;B4GALT4;LUM
prerank,regulation of cell-matrix adhesion (GO:0001952),0.28048549011773766,0.9418084598942066,0.5705329153605015,0.9664880113855335,1.0,19/64,17.90%,LIMCH1;ACER2;SLK;CIB1;NEXMIF;PEAK1;MINK1;CCL25;TSC1;HOXA7;NF1;MAP4K4;PTPRA;SEMA3E;PTK2B;CDH13;CORO1C;CLASP1;CASK
prerank,monoacylglycerol metabolic process (GO:0046462),-0.3772984973862866,-0.9415413389839916,0.5400410677618069,0.8315278750561892,1.0,1/13,1.27%,PLA2G4A
prerank,central nervous system neuron axonogenesis (GO:0021955),-0.37984529373032344,-0.9414631002733682,0.5485961123110151,0.8310060005170158,1.0,3/12,10.73%,EPHB1;B4GALT6;EPHB2
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.39824334669651096,-0.9411689171608063,0.5373737373737374,0.8310123585304384,1.0,6/10,22.02%,OGT;SIRT7;USP7;SELENOS;ZNF692;DGKQ
prerank,regulation of mitochondrial depolarization (GO:0051900),0.42329348955811985,0.9408528303000852,0.5497076023391813,0.968224576170355,1.0,2/10,9.50%,SRC;FZD9
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.36384159819942147,-0.9407311085860766,0.5534188034188035,0.8314722687805145,1.0,4/14,18.69%,ERCC6;MMS19;ACTR2;PARP1
prerank,myeloid leukocyte differentiation (GO:0002573),0.2843700227333465,0.9393635430090567,0.555052790346908,0.9713820977797786,1.0,8/65,9.27%,MT1G;LEF1;SBNO2;CDKN1A;EP300;SIRT1;CDK4;CSF1R
prerank,regulation of fibroblast proliferation (GO:0048145),-0.2717228549992158,-0.9391158976624314,0.544,0.8348330555266175,1.0,10/45,15.07%,IGF1;CTNNB1;PDGFRA;SKI;CDC73;CDK6;FN1;TP53;MED25;PEX2
prerank,keratinocyte differentiation (GO:0030216),-0.2974634172313295,-0.9387043477077546,0.5439429928741093,0.8351005488028604,1.0,5/29,12.16%,CLIC4;MED1;BCR;PIP5K1A;ANXA1
prerank,chromosome condensation (GO:0030261),0.3162263352777038,0.9386586555968862,0.5489891135303266,0.9724256687741344,1.0,7/36,14.40%,BANF1;TENT4A;CHMP1A;AKAP8L;AIFM1;CSNK2A2;PHF8
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.40667961396049,-0.9386452428577575,0.5480572597137015,0.8345505457306134,1.0,5/10,31.60%,GFPT1;HK2;GFPT2;PFKM;PFKL
prerank,entry into host (GO:0044409),0.39712050244487296,0.9386348548317894,0.5464684014869888,0.9716517178352718,1.0,2/13,3.17%,CBL;SRC
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.33176108988770425,0.9384813602303532,0.5564924114671164,0.971260369290497,1.0,6/29,13.23%,TTLL12;CDC37;WNT5A;CNOT7;USP18;NLRC5
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.3339092979780887,-0.9381781793383451,0.5484581497797357,0.8350029094460882,1.0,9/19,25.82%,BMP6;ADAM19;AFDN;DENND6A;PTPRU;FLOT1;PPM1F;VEGFA;NOTCH4
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),-0.3574808955628662,-0.9378032916334654,0.5327313769751693,0.8351732098919238,1.0,3/15,8.27%,ATP1B1;ATP1A1;KCNJ2
prerank,glycoprotein catabolic process (GO:0006516),-0.3516667478607311,-0.937661967716641,0.5384615384615384,0.8348297524733218,1.0,3/17,5.60%,ADAMTS12;NGLY1;ADAMTS9
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.35236413627231,0.9375972371807482,0.5388692579505301,0.9727680502043543,1.0,4/21,9.56%,STOX1;FBXO5;CDK4;RAD51B
prerank,regulation of protein import into nucleus (GO:0042306),-0.28427991071857556,-0.9370499219653523,0.5674300254452926,0.8357160069025201,1.0,14/36,20.68%,ZIC1;SMAD3;FLNA;BMP4;BAG3;PRKCD;UBR5;EFCAB7;CDH1;RAB23;TGFB1;MAVS;APOD;PIK3R1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),-0.3597387912892417,-0.9370127867686324,0.5421412300683371,0.8350969640957138,1.0,3/14,7.08%,ZEB1;OSR1;XDH
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3166206901735767,-0.9365840767841882,0.572354211663067,0.8355333438521706,1.0,13/21,28.41%,CHSY1;VCAN;CSGALNACT2;CHST15;CHST11;UGDH;CSPG4;BGN;CHPF2;CHST3;CSPG5;CHST12;DCN
prerank,positive regulation of fat cell differentiation (GO:0045600),0.29765938070361964,0.9363745557744412,0.5511811023622047,0.9752961787114838,1.0,10/47,12.28%,FRZB;CCDC71L;ZFP36L1;PPARD;PIM1;AAMDC;SOX13;TRPM4;CARM1;WDFY2
prerank,regulation of inflammatory response (GO:0050727),0.24651664595720416,0.936100593663492,0.6090794451450189,0.9752051809998532,1.0,29/190,15.22%,PIK3AP1;IL1R1;SEMA7A;TNFAIP3;SBNO2;BCL6B;IFI35;BIRC2;APOE;TEK;TNFRSF1B;SPATA2;LPCAT3;PPARD;NLRC3;WNT5A;RELA;CD47;PARK7;MFHAS1;NLRP6;APP;USP18;CDH5;NFKBIA;PROC;VPS35;DAGLB;BCL6
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.3553908962885167,-0.9359142777580016,0.5409090909090909,0.8365242971114311,1.0,3/16,3.21%,OGT;AUTS2;RASGRF1
prerank,UV protection (GO:0009650),-0.40157000413776733,-0.9354359280164833,0.5623762376237624,0.8369780773104035,1.0,3/10,8.19%,SCARA3;ERCC5;CAT
prerank,regulation of mitochondrial fission (GO:0090140),-0.3109444178160966,-0.935334018138667,0.5845070422535211,0.8365080972443312,1.0,5/24,7.76%,MCU;SPIRE1;MAPT;STAT2;FIS1
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.27319936876035456,0.934922277820125,0.5806916426512968,0.9776726676840563,1.0,11/78,10.46%,ACTB;CDC37;CDK5RAP1;CCNH;CDKN1A;RGCC;GTF2H1;LATS2;CCNG2;TFAP4;BCCIP
prerank,positive regulation of neuron differentiation (GO:0045666),-0.26939627638528535,-0.9345035994351125,0.5654450261780105,0.8378717146303991,1.0,6/40,8.28%,NRCAM;NBL1;BRINP1;RHOA;ZEB1;BRINP2
prerank,regulation of gene expression (GO:0010468),0.21980679449511178,0.9340553112625819,0.7126673532440783,0.9792205845064534,1.0,164/903,16.08%,TBX4;MAZ;CTCFL;MAPK3;GSK3A;ONECUT1;CAVIN4;FOXN2;TRAPPC2;EZH2;ZFAT;DIP2A;PTPRC;PIN1;LEF1;HES6;RPL23;GTF2IRD1;RPS6KA4;PDCL3;NWD1;HNRNPH2;PCBP1;SORT1;ATXN1L;STOX1;GABPA;SBNO2;BCL6B;ZFP36L1;SMAD1;RPS6KA5;PPP2CA;HNRNPAB;HEY1;NR5A1;APOE;PRDM4;RAMP2;SOX2;HNRNPK;MYBL2;SMARCA2;YY1;FAM50A;TRIM14;SPIN1;NPAT;CPSF4;EP300;RFX3;DTNBP1;MAPK8;TDG;NFX1;MED23;CALCOCO1;RPL5;TGFBRAP1;SRSF10;ACTR8;CDK11B;RGCC;ZNF205;RO60;RBM20;SFPQ;DRAP1;BMI1;SIRT1;CLOCK;ACTR5;PFDN5;RNF187;KDM6A;HEY2;YTHDC1;NOTCH1;WNT5A;CNOT7;CDK4;TOB2;ACVRL1;NOVA2;TRAF3;RELA;SOX13;NAB2;LYN;MARF1;PARK7;RNF6;TARDBP;CLDN5;UBE2V1;VSIR;CCAR2;RYBP;TERT;ING2;CITED2;PRKAA2;SRPK2;RBPJ;ESR1;DDX3X;NLK;P2RX7;CREBBP;CARM1;HP1BP3;AGO4;APP;MATR3;NOS3;RPS3;PIK3CD;PTBP1;JMJD1C;PICALM;PCBP3;CRKL;MZF1;SP1;NUP35;IRF2;CHD3;CDH5;ERC1;HDAC5;ACTA2;TRRAP;DDIT3;CHEK2;ZKSCAN5;POGZ;YBX1;TRIM27;HCFC1;RNF20;BACH1;BAZ2A;NSD2;FUS;PRDM10;VPS35;TERF2IP;ATG14;BCL6;MOV10;GAS6;HNRNPL;NKAP;TFEB;TRA2B;NOCT;TAF6L;TAF1;TCF7L1;TCF3;APBB2;BRAF;TDRD7;ID2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.3940865310463888,0.9340336730417871,0.5551470588235294,0.9784399597071758,1.0,3/14,8.24%,SEMA7A;SIRT1;WNT5A
prerank,anterior/posterior pattern specification (GO:0009952),-0.2602379615623295,-0.9339615915719727,0.5745257452574526,0.8385366362491404,1.0,9/53,8.57%,WLS;PCSK5;HOXC6;TGFBR1;HOXA3;HOXA5;SKI;LRP5;BHLHE40
prerank,positive regulation of heart rate (GO:0010460),0.3732946105266771,0.9337906705754472,0.5444015444015444,0.9783081999217723,1.0,3/17,10.43%,PDE4D;ATP2A2;TRPM4
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3432664604987583,0.9334974479878371,0.5387263339070568,0.9782940119828252,1.0,6/22,13.33%,PSMC4;MED12;PSMC2;ESR1;MED4;PSMC6
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.35668562059066755,-0.933442715857197,0.5736961451247166,0.8391376989866028,1.0,5/15,10.59%,BMPER;FGF1;JAK1;ITGA5;PKM
prerank,heterochromatin organization (GO:0070828),0.38705758454751693,0.9328455701655134,0.5515370705244123,0.9791982588948562,1.0,4/14,15.02%,MECOM;SIRT1;HP1BP3;EZH1
prerank,glycolipid metabolic process (GO:0006664),0.29527902337559214,0.9325300017356737,0.5538221528861155,0.9792051967488148,1.0,6/47,5.93%,GLB1;SMPD4;ST6GALNAC3;ESYT2;UGCG;FUCA1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.305347444104894,-0.9315248115407595,0.5772946859903382,0.8431857041846114,1.0,2/26,0.71%,EYA2;EYA1
prerank,protein N-linked glycosylation (GO:0006487),0.28327800017913035,0.9314329080855536,0.5770392749244713,0.9812915766078892,1.0,10/66,13.27%,NUDT14;ALG6;ASGR1;ALG8;TMEM165;OST4;STT3B;MGAT5;MCFD2;ST3GAL1
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.2916649899713136,-0.9305145702914706,0.5829383886255924,0.8449551837351255,1.0,14/30,26.38%,PARP14;PIBF1;PRKCZ;PRKCD;SRCIN1;SEMA4D;NF2;PTPN2;CADM4;SH3BP5;SH3BP5L;DMTN;INPP5F;SFRP1
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.23148698403450185,-0.9304665715387209,0.6223021582733813,0.8443605022754865,1.0,18/98,13.03%,SORBS1;ANK3;LRP1;EGFR;CEMIP;AKT2;ZDHHC5;FIS1;STX3;EFCAB7;DPP10;EPHA3;EPHB2;TP53;CLIP3;DLG1;WNK3;PDCD5
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.3346133719421759,0.9302039199200343,0.5575539568345323,0.9838265503133614,1.0,8/25,19.57%,SORT1;LEPROTL1;CHMP1A;CHMP2A;LAPTM4B;VPS4B;LEPROT;DENND10
prerank,adherens junction organization (GO:0034332),-0.26499247632104844,-0.9300727173580717,0.5835616438356165,0.8446593258069646,1.0,21/48,24.18%,CDH10;CTNNA1;CTNNB1;JAM3;VCL;CDH11;CDH7;AFDN;CDH1;CSK;CDH4;CTNND1;CADM2;NECTIN3;CDH9;CADM3;CDH8;CDH19;NECTIN2;DCHS1;PVR
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.25661495325967526,0.9300629963752203,0.5963687150837989,0.9833753762945625,1.0,31/119,17.19%,CISH;PIK3CG;PIK3C2G;MTMR14;EFR3B;SMG1;PIKFYVE;RAB14;PIGH;ARF1;INPP5D;PI4KA;PIGB;PIK3CD;PIK3R5;IP6K2;PGAP2;INPP4B;SYNJ2;RUFY1;PIK3C2A;IMPA1;PIGN;MTMR2;MBOAT7;PIGU;PIK3R4;PLEKHA1;ITPKB;PIP4K2A;PLEKHA3
prerank,cellular amino acid catabolic process (GO:0009063),0.264362428173233,0.9297345445920162,0.5785714285714286,0.9833903851601756,1.0,8/87,5.45%,AASS;BCKDHB;ALDH5A1;SLC25A44;GLS2;GLS;GOT2;ACAT1
prerank,positive regulation of apoptotic process (GO:0043065),0.23026463349725615,0.9294794604094352,0.6485507246376812,0.9832304059187863,1.0,58/293,16.78%,ERCC3;MAP3K11;ATF6;FRZB;TIAM1;VAV3;SOD1;PSEN2;ARHGEF26;ING4;MCF2L;ITSN1;TNFRSF10B;MAPK8;ARHGEF6;CRADD;ARHGEF7;TRIO;OMA1;SIRT1;ARHGEF18;ITGA6;LATS2;BCLAF1;CYP1B1;FZD9;TFAP4;AIFM1;CCAR2;RYBP;ING3;SRPK2;BAD;DDX3X;RPS3;ATG7;NF1;IP6K2;PRNP;BMF;BNIP3L;ING5;DDIT3;UTP11;DIABLO;FAF1;APC;PTPA;APAF1;MAP3K10;BCL6;GNA13;TPD52L1;APH1A;DNM1L;QRICH1;BNIP3;RASGRF2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.2519163479620478,0.9293056456541311,0.5986394557823129,0.9828888951321324,1.0,30/136,16.18%,TNFAIP3;HES6;NWD1;MAP2K5;PHB2;WFS1;CEBPG;PIM1;SMAD7;SIRT1;NLRC3;MTURN;ERBIN;TRAF3;RBCK1;CYP1B1;NFKBIL1;ESR1;PRNP;CHUK;NLRC5;DDIT3;NFKBIA;HES1;MAP3K10;GAS6;TAF1;HEYL;ID2;TAF3
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.28070654944476936,-0.9292653188750714,0.5785536159600998,0.8459454732747554,1.0,15/39,28.03%,BMP6;MBP;WNK1;PPARA;CDH1;MYADM;NF2;PTK2;TGFB1;PPM1F;VEGFA;AKT1;NOTCH4;AKNA;BMP2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.24804920939331507,0.9290673221146364,0.6112565445026178,0.982705553258592,1.0,20/151,11.24%,MAP2K7;MAPK3;SEMA7A;PTPRC;TIRAP;PRKD2;APOE;TEK;PHB2;CIB1;ICAM1;HTR2A;MTURN;NOTCH1;CCL25;CSF1R;MFHAS1;ATP6AP1;NPNT;APP
prerank,regulation of phosphorylation (GO:0042325),-0.2254806139611149,-0.929039394834308,0.6436781609195402,0.8457940754774951,1.0,26/120,13.25%,PRKAG2;EGFR;GRM5;OGT;NRP1;BMP7;FER;DSCAM;PRKAG1;SIRT2;STAT2;BMP4;NUP205;ROCK1;LDB1;PML;NUP155;CDKN1B;NUP188;THBS1;FN1;NUP93;ILK;NUP88;FNIP1;SEH1L
prerank,platelet degranulation (GO:0002576),0.2578619633128838,0.9289709863286992,0.5994475138121547,0.9821385933517495,1.0,18/118,11.44%,ABCC4;CDC37L1;SOD1;PECAM1;MANF;NHLRC2;CYRIB;F8;SELENOP;SELP;ACTN4;VWF;LGALS3BP;LYN;GTPBP2;APP;A2M;OLA1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.34799799168820705,0.9289476942225968,0.5335689045936396,0.9813680123750124,1.0,5/21,16.32%,MAPK3;CSF1R;MTUS1;AKIRIN1;PTK2B
prerank,positive regulation of mRNA processing (GO:0050685),0.3493407950133284,0.9285852787461186,0.5648312611012434,0.9814853142662026,1.0,2/21,0.94%,NCBP1;RBMXL1
prerank,DNA packaging (GO:0006323),0.3694522838613528,0.9284996534246808,0.5367647058823529,0.980862046158624,1.0,4/16,18.94%,BANF1;AIFM1;RBBP4;HAT1
prerank,negative regulation of gene expression (GO:0010629),0.23252936048691014,0.9284241417172594,0.6514084507042254,0.980227471282964,1.0,51/302,14.60%,CIDEA;ZC3H12D;ILF3;EZH2;DIP2A;PATL2;FCGR2B;EED;RPS6KA4;STOX1;HDAC9;RPS6KA5;NUDT12;APOE;YY1;NPTN;FXR1;PAIP2B;RGCC;RPS26;BMI1;SIRT1;PPP1R11;HEY2;NOTCH1;CNOT7;ACVRL1;TSC1;DXO;PARK7;TARDBP;CLDN5;TERT;CITED2;PRKAA2;ESR1;DDX3X;AGO4;APP;NANOS3;RPS3;PTBP1;PICALM;CRKL;PPHLN1;YBX1;TRIM27;CAPRIN1;AEBP2;TASOR;CNOT1
prerank,GTP metabolic process (GO:0046039),0.37710892739396673,0.9283754098733619,0.5625,0.979522922100045,1.0,3/15,12.60%,IMPDH1;RHOQ;EFL1
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.3209982935158729,0.9280914474205769,0.5773710482529119,0.9794615951017768,1.0,8/29,14.48%,SHANK3;PFN1;CYRIB;KANK3;SSH2;TJP1;FKBP4;TWF1
prerank,regulation of cell cycle (GO:0051726),0.23218980396179953,0.927290031174332,0.6397146254458977,0.9807843344341566,1.0,48/271,14.15%,DYNLT3;FBXL6;MECOM;CKS2;GAS2L1;PTPRC;RPL23;TTLL12;HIPK2;ING4;BIRC2;SOX2;MYBL2;CDKN1A;EP300;CDK11B;RGCC;CHMP1A;PRCC;FBXO5;SIRT1;NOTCH1;CDK4;TSC1;RAD23A;MDM2;JUND;FZD9;TFAP4;TARDBP;EIF4G2;CITED2;SRPK2;NEK7;CTBP1;NANOS3;WDR12;NBN;NEK6;MAPK12;RRP8;ANKRD17;RPS15A;MAP2K6;CSNK2A2;APC;HCFC1;RNF20
prerank,secondary alcohol metabolic process (GO:1902652),0.2985023498155861,0.9271342227865049,0.5619967793880838,0.9803992625565795,1.0,7/42,12.81%,EBP;APOE;SOAT1;PPARD;OSBPL1A;NSDHL;LDLRAP1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.29564171508804943,0.9270043993930974,0.5818759936406995,0.9799301760360939,1.0,9/47,12.40%,MAPK3;RAP2A;GREM1;KLHDC10;PHLPP1;SEMA4C;NBR1;MAP4K4;MID1
prerank,protein homotetramerization (GO:0051289),0.29568823414120443,0.9270030559861852,0.5633802816901409,0.9791019680111597,1.0,7/49,10.43%,THG1L;GLS;B2M;SSBP1;ACACB;SOD2;TRPM4
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3414630269357679,0.9269433577775619,0.5472027972027972,0.9775971606786883,1.0,9/23,21.23%,MAPK8;YWHAB;BAD;PPP3R1;YWHAH;YWHAQ;YWHAE;YWHAZ;TFDP2
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3414630269357679,0.9269433577775619,0.5472027972027972,0.9775971606786883,1.0,9/23,21.23%,MAPK8;YWHAB;BAD;PPP3R1;YWHAH;YWHAQ;YWHAE;YWHAZ;TFDP2
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.3234968173896322,0.9268780847872534,0.5390199637023594,0.976952523578019,1.0,6/26,12.85%,TNFAIP3;CARD16;NLRC3;NFKBIL1;TRAF3IP1;MAPKBP1
prerank,positive regulation of metabolic process (GO:0009893),0.25825732789715106,0.9267023223107789,0.6059743954480796,0.9766140236025694,1.0,13/103,8.93%,ALMS1;UCP2;CAMK1D;HDAC3;TSHR;KDM3A;ELOVL6;BEND3;GATM;SYK;OMA1;ADIPOR2;ACACB
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.36883948748595957,0.9266596927347356,0.5647279549718575,0.9759000823087258,1.0,5/16,18.25%,CXCL12;CCAR2;RPS3;TMEM161A;FBH1
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3969608899216707,-0.9266184330039191,0.5587628865979382,0.8512068603851004,1.0,6/10,24.24%,DDX39B;CRY1;THOC5;WDR76;ETAA1;THOC1
prerank,positive regulation of viral transcription (GO:0050434),0.33529290365287967,0.9265796160735184,0.5676625659050967,0.9752975275195039,1.0,4/25,11.73%,POLR2J;POLR2B;RSF1;MDFIC
prerank,actin filament network formation (GO:0051639),0.39899135399233454,0.9262563035691901,0.5618860510805501,0.9753741160246759,1.0,1/11,0.55%,LCP1
prerank,response to growth factor (GO:0070848),-0.27184339086343834,-0.9262095866343549,0.6051948051948052,0.8515420123606361,1.0,26/41,36.34%,TGFBR1;TGFBR2;CTNNB1;ACVR1;ACVR1B;RACK1;BMPR1B;TWF2;BMPR1A;RPS6KB1;CPNE3;BMPR2;EMD;AKT1;ERBB2;SFRP1;HDAC6;TBC1D7;NOS1;SPHK1;GATA6;PLK5;MAPK7;URI1;EPHA2;HTRA2
prerank,anion transmembrane transport (GO:0098656),0.2754671004617307,0.9260441232082092,0.5670731707317073,0.9751274558935527,1.0,16/67,16.38%,SLC7A8;SLC1A1;SLC36A4;SLC25A1;SLC3A2;LRRC8C;SLC1A2;SLC35A1;SLC35B1;SFXN1;SLC35A3;SLC25A12;SLC38A5;SLC25A21;SLC25A42;SLC25A38
prerank,amino acid import (GO:0043090),-0.3154325677283761,-0.9259124927481082,0.5704387990762124,0.8515672684275983,1.0,6/21,9.28%,SLC1A3;SLC6A13;SLC47A1;SLC6A1;SFXN2;SLC22A4
prerank,polarized epithelial cell differentiation (GO:0030859),0.3878699284862111,0.9258010404343507,0.5486381322957199,0.9749621131955991,1.0,4/13,14.14%,RAP2A;MYO9A;OPHN1;ZDHHC7
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.3843792893689499,-0.9253334997711853,0.5720250521920668,0.8523120458071365,1.0,4/11,13.98%,MPV17L;SLC30A10;PPARA;ABCD2
prerank,regulation of autophagosome assembly (GO:2000785),0.31731523228344943,0.924967425624951,0.5824742268041238,0.9763260488525857,1.0,15/33,21.42%,RALB;PIKFYVE;TBC1D12;SCFD1;ADPRH;FEZ2;TMEM39A;TBC1D14;RAB3GAP1;UBQLN2;PIP4K2A;SH3GLB1;LRRK2;RAB5A;PIP4K2C
prerank,positive regulation of superoxide anion generation (GO:0032930),0.38609957848744736,0.9249037553948158,0.5621414913957935,0.9756715654622709,1.0,2/13,6.82%,SOD1;SYK
prerank,response to gamma radiation (GO:0010332),-0.3015672122699773,-0.9245072483390206,0.5483146067415731,0.8537123790584726,1.0,15/24,40.93%,MAP3K20;TP53;HSF1;ATM;KDM1A;CRYAB;TMEM109;YAP1;PRKAA1;MEN1;DCUN1D3;HRAS;TRIM13;TSPYL5;FANCD2
prerank,axoneme assembly (GO:0035082),-0.2884991456359594,-0.9244706365972287,0.590047393364929,0.8530899899634712,1.0,19/30,51.48%,DCX;SPAG1;TTLL3;CCDC39;CFAP74;RP1;TOGARAM1;SPAG16;GAS8;RSPH9;CFAP46;DNAAF3;LRGUK;DRC1;SPAG17;JHY;FOXJ1;CCDC65;DNAAF2
prerank,regulation of ossification (GO:0030278),-0.27577827775724767,-0.9244180642907488,0.6,0.8524896474139532,1.0,14/36,29.17%,BMP4;CHSY1;ENPP1;ANKH;SMAD6;ACVR1;ECM1;LRP6;BMPR2;TXLNG;NOTUM;SFRP1;BMP2;MDK
prerank,phosphatidylcholine metabolic process (GO:0046470),0.27173246365004083,0.9243367642872666,0.5701357466063348,0.9763063249663072,1.0,13/70,16.56%,LPCAT2;PLAAT3;DBI;LPCAT3;GPAT4;SLC44A1;MBOAT1;PNPLA8;CEPT1;ABHD4;CSNK2A2;MBOAT7;SLC44A2
prerank,positive regulation of defense response (GO:0031349),-0.23412110189833957,-0.9242574330021412,0.6401384083044983,0.8521878528487289,1.0,28/89,29.17%,NAPEPLD;OPTN;PLSCR1;POLR3C;IL17RA;IL16;GPR4;IL18;IL33;TNIP1;LRSAM1;NPAS2;GPRC5B;GBP5;RIOK3;AGTR1;SLC15A4;SETD4;CX3CL1;PLA2G7;FEM1A;TLR3;SERPINE1;PDE2A;CCN4;POLR3G;SNCA;MDK
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.3658538619036925,0.9242322794360324,0.5531135531135531,0.9757419536849672,1.0,5/17,14.53%,CYCS;COX6B1;COX5A;COX15;COX10
prerank,"phagocytosis, engulfment (GO:0006911)",0.3063764841940139,0.924232211782984,0.5557404326123128,0.9749261932628831,1.0,4/36,5.97%,RAC2;XKR8;FCGR2B;ARHGAP25
prerank,RNA metabolic process (GO:0016070),-0.219924200418551,-0.9239800860970833,0.6557971014492754,0.8521895700517584,1.0,32/127,16.84%,CELF2;RBMS1;BICD1;HNRNPH1;DDX17;PABPN1;ELAVL4;RBM39;RBMX;SYNCRIP;SNRNP40;DDX39B;RNGTT;DDX24;HNRNPA2B1;SIDT2;AGO3;HNRNPA1;RNASEH2B;RBM4;RBM3;TP53RK;POLR2A;SND1;ATXN1;DICER1;SETX;RNASE3;MTREX;PABPC4;PRPF4;NOVA1
prerank,regulation of membrane repolarization (GO:0060306),-0.3621828489946456,-0.9239254725497681,0.5403726708074534,0.8516076823478635,1.0,3/13,8.27%,AKAP6;AKAP9;KCNJ2
prerank,response to tumor necrosis factor (GO:0034612),0.265331896869656,0.9236144535956828,0.6037463976945245,0.9758417233203658,1.0,13/91,12.92%,MAP2K7;SMPD4;ZFP36L1;GBP3;CIB1;SIRT1;CCL25;ERBIN;RELA;NPNT;RPS3;IKBKB;CHUK
prerank,regulation of protein processing (GO:0070613),-0.3284010067561756,-0.923333001057191,0.5630841121495327,0.8523347310265054,1.0,6/21,24.38%,RHBDD1;GAS1;CCBE1;RNF139;CLN3;NKD2
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.32260561010522537,0.9232710521620769,0.5777777777777777,0.975915005025011,1.0,8/27,15.72%,GSK3A;FCGR2B;MBOAT1;FBXO7;EFHC2;HOMER1;VPS35;CAMK2G
prerank,nuclear body organization (GO:0030575),-0.37145828122744784,-0.9230378459254225,0.5505154639175258,0.8523306180173971,1.0,5/12,17.12%,AFF2;PML;USPL1;USP50;HABP4
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.33155665689946556,-0.922747195183674,0.5682926829268292,0.8523531020580779,1.0,7/19,20.71%,ROBO1;XDH;SMOC2;CCBE1;ADAMTS3;JCAD;CADM4
prerank,regulation of MAPK cascade (GO:0043408),0.24643136299893412,0.9223890616365291,0.6184895833333334,0.9774339335085162,1.0,26/157,11.87%,MAPK3;ZDHHC17;PTPRJ;PTPRC;GREM1;BCAR3;PRDM15;SOX2;TEK;SPRED1;TBX1;RET;PAK3;LAMTOR1;SYK;ATP6AP2;DAG1;MINK1;PHLPP1;LYN;PAK1;P2RX7;NBR1;FLT1;NF1;MAP4K4
prerank,receptor metabolic process (GO:0043112),-0.2563345341807844,-0.9223303613122156,0.6016260162601627,0.8527029027311784,1.0,15/53,16.65%,LRP1;ARFGEF2;CALCRL;RAB31;GRK3;LGMN;ACKR3;UVRAG;SNX25;RAMP1;GRB2;DNM1;TGFB1;EHD3;GRK4
prerank,mRNA destabilization (GO:0061157),0.30319619248369395,0.9223135738778928,0.5831960461285008,0.9768270399492671,1.0,12/38,20.08%,ZC3H12D;ZFP36L1;TARDBP;TUT7;CNOT1;TUT4;MOV10;FTO;RC3H1;DIS3L2;DHX36;METTL14
prerank,cell differentiation in spinal cord (GO:0021515),0.41630260150327103,0.922313250102277,0.5481927710843374,0.9760145311648001,1.0,2/10,10.08%,SOX13;ZC4H2
prerank,reticulophagy (GO:0061709),-0.38119801542883736,-0.9222805954311536,0.5785123966942148,0.8521192279007445,1.0,4/12,14.33%,ULK2;UFL1;DDRGK1;TEX264
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.31500047774741385,0.9215523043820021,0.5668896321070234,0.9772467472855173,1.0,6/33,13.08%,TAL1;ABCB10;RAB7B;MTURN;ACVR2A;PITHD1
prerank,regulation of MAP kinase activity (GO:0043405),0.26461686795362177,0.9213820765134629,0.6282051282051282,0.9768848322118824,1.0,6/92,1.46%,RGS2;PIK3CG;TRIB3;DUSP7;PTPRJ;EZH2
prerank,icosanoid secretion (GO:0032309),0.39484081298861884,0.9213551819983296,0.5678776290630975,0.9761392304709832,1.0,2/12,11.67%,ABCC4;PNPLA8
prerank,alcohol catabolic process (GO:0046164),0.4144514438170903,0.9213071305891659,0.5681381957773513,0.9754574791411469,1.0,2/10,7.67%,APOE;SNX17
prerank,positive regulation of cell migration (GO:0030335),0.2343834467914457,0.9208603896979896,0.6473489519112207,0.9758290718093917,1.0,38/253,12.34%,MAZ;SEMA6A;SEMA6D;SEMA7A;PTPRC;LEF1;TIAM1;CXCL12;PECAM1;SRC;CLASP2;INSL3;PFN1;SEMA3C;CIB1;RET;ARHGEF7;SEMA6B;FBXO5;ACTN4;RUFY3;NOTCH1;PLCG1;ITGA6;TJP1;SEMA4C;SOD2;CSF1R;PAK1;PODXL;VSIR;MGAT5;FLT1;PIK3CD;PPP3CA;MAP4K4;PLAA;CRKL
prerank,cellular response to arsenic-containing substance (GO:0071243),0.37405352756983656,0.9203839435056097,0.5657142857142857,0.9762565314027989,1.0,3/15,10.75%,ATF3;ZFAND1;DDX3X
prerank,angiogenesis involved in wound healing (GO:0060055),0.39961310134544714,0.920214646794519,0.5553435114503816,0.975906718261292,1.0,2/11,7.43%,PRCP;ADIPOR2
prerank,microtubule nucleation (GO:0007020),-0.3353242704618447,-0.919437544011988,0.5960264900662252,0.8584297860946356,1.0,8/19,17.67%,TUBGCP4;CCDC57;GOLGA2;AKAP9;SLAIN2;TUBGCP6;RANBP9;NDE1
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.38883959496481535,0.9188050370610032,0.572265625,0.9788401137669511,1.0,3/12,10.73%,GAS2L1;LMO2;THRB
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2906126845439853,0.9182902975264441,0.5799676898222941,0.9794045040446604,1.0,9/48,16.34%,PTPRC;TTLL12;RFFL;CARD16;CNOT7;USP18;NLRC5;GAS6;OTUD4
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.26194871157176025,0.9182316108986859,0.604992657856094,0.9787346940155033,1.0,24/94,17.98%,TRIB3;BCL2L2;HIPK2;TNFRSF10B;SCN2A;TNFRSF1B;CDKN1A;SELENOK;CYP1B1;AIFM1;BAD;DDX3X;CUL3;RRP8;DDIT3;CHEK2;DIABLO;APAF1;DNAJC10;QRICH1;BNIP3;PRKDC;BAX;GSKIP
prerank,dendritic spine organization (GO:0097061),0.3283383566139077,0.9181371201296065,0.5703001579778831,0.9781492401314661,1.0,7/26,12.06%,DIP2A;SHANK3;FYN;PAK3;ARF1;PRNP;ITGA3
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2584379234367635,0.9179810113432132,0.6080691642651297,0.9777685838677704,1.0,14/95,13.15%,TNFAIP3;FCGR2B;TIRAP;SBNO2;TNFRSF1B;CYRIB;MAPK8;CARD16;WNT5A;RELA;NFKBIL1;TNIP2;PLAA;CD274
prerank,intermediate filament organization (GO:0045109),-0.33442905530143724,-0.9178367431571511,0.5855263157894737,0.8616641679728022,1.0,10/17,43.72%,VIM;NEFL;GFAP;BFSP2;DES;PKP2;BFSP1;MTM1;DSP;TCHH
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.3035753858383036,0.9176965314430742,0.6039603960396039,0.977705281902568,1.0,5/37,8.70%,ERCC3;ERCC4;POLK;POLD3;GTF2H1
prerank,autophagosome organization (GO:1905037),0.29097728736399747,0.9173228338483297,0.5822368421052632,0.9778919650018392,1.0,18/50,18.78%,MAP1LC3B;ATP2A2;RAB7A;RAB43;VMP1;RAB1A;UBQLN1;ATG7;ATG16L1;ATG14;TMEM41B;GABARAPL1;ATG13;TP53INP2;UBQLN2;BECN1;GABARAP;ULK1
prerank,negative regulation of lymphocyte migration (GO:2000402),0.40842761496593233,0.9171293219415911,0.5753424657534246,0.9775774955138935,1.0,2/10,5.70%,LRCH1;RIPOR2
prerank,multivesicular body organization (GO:0036257),-0.2907683328366376,-0.917103437724883,0.6004672897196262,0.8628703302079499,1.0,10/31,22.20%,STAM2;IST1;SNF8;RAB11A;TSG101;CHMP2B;CHMP5;STAM;VPS4A;HGS
prerank,maintenance of protein location in nucleus (GO:0051457),0.34832477151237107,0.9169770512874629,0.5577617328519856,0.9771806356207621,1.0,10/20,22.05%,SYNE1;ARL2BP;PARK7;TAF3;RANGAP1;MORC3;SP100;BBS4;SKP1;SUN2
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.3847223757653261,-0.9164991643327028,0.5714285714285714,0.8637362076655017,1.0,7/11,26.40%,OGFOD1;P4HB;P4HTM;EGLN3;P4HA2;CRTAP;EGLN1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.2172810234821778,0.9160664533915054,0.7292340884573895,0.9787143643843185,1.0,99/572,16.20%,SOX30;LRRFIP1;ATF3;IRX1;MAZ;DCAF1;DACH1;AASS;ARID5A;KLF8;TRIB3;NR4A2;EZH2;RPL23;EED;JAZF1;GTF2IRD1;DMAP1;KLF2;DNAJA3;MAP2K5;HDAC9;BCL6B;HDAC3;HEY1;NEDD4L;SOX2;SMARCA2;YY1;WFS1;VPS72;UBE2I;IRF2BPL;BEND3;EP300;RPS14;NFX1;CNOT2;PPARD;ZNF205;SFPQ;UXT;SMAD7;DRAP1;BMI1;SIRT1;ZNF3;HEY2;NOTCH1;SAP130;EDNRB;EFNA1;RELA;SOX13;TRPS1;MDM2;HOXA7;ZKSCAN3;CIR1;CITED2;RBPJ;ESR1;THRB;CREBBP;CTBP1;ORC2;NFIC;IFI27;HDGF;N4BP2L2;MZF1;IRF2;CHD3;HDAC5;DDIT3;TGIF1;CTBP2;THRA;HES1;USP9X;TRIM27;HCFC1;DR1;BACH1;E2F6;CNOT1;TMPRSS6;EZH1;BCL6;TCERG1;NKAP;ELK4;TAF1;TRIM33;SMARCA4;TCF3;ID2;TAF3;ZBTB18
prerank,protein lipidation (GO:0006497),0.27900053518757906,0.9159418295769581,0.595679012345679,0.9782299771377118,1.0,14/59,16.31%,ZDHHC17;ZDHHC13;UGCG;ZDHHC14;SELENOK;PIGH;ZDHHC15;PIGB;ATG7;PGAP2;ZDHHC9;ZDHHC7;PIGN;PIGU
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3077185070011126,0.9158948603194106,0.579734219269103,0.9775504292758934,1.0,9/35,16.89%,SLC25A1;PPT1;ACAT1;FAR2;HMGCS2;PAM;BDH2;HPGD;ACACA
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.334598591821207,0.9158790890199321,0.5803108808290155,0.9767908485637724,1.0,2/23,2.44%,SURF4;DERL2
prerank,positive regulation of endocytosis (GO:0045807),0.2985388403676189,0.9158403089777694,0.6022727272727273,0.9760942521701298,1.0,7/45,5.39%,CBL;PPT1;NEDD4L;APOE;SGIP1;HNRNPK;B2M
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3190523694831541,0.9151478596962027,0.5716723549488054,0.9770517798547245,1.0,9/28,19.81%,SORT1;TNFRSF10B;CRADD;DDX3X;DIABLO;DELE1;BAX;GABARAP;TNFRSF1A
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.279773158310563,-0.9148327026790894,0.6220095693779905,0.86717333836858,1.0,4/32,8.47%,AKAP6;CEMIP;HTT;TRPC1
prerank,glycerophospholipid biosynthetic process (GO:0046474),-0.20987100989932944,-0.9145768039855485,0.7489539748953975,0.867073888577243,1.0,37/172,16.11%,PTPN13;PLD1;PLA2G4A;PLEKHA2;AGPAT4;ABHD5;PIK3C2B;MTMR7;PIK3C3;AGPAT5;PIP5K1A;DGKH;SACM1L;PIK3R3;VAC14;LPIN1;PLEKHA8;PLSCR1;MTMR12;PIP4K2B;HDHD5;CHKA;PITPNM3;AGK;PCYT1B;INPPL1;CDS2;SLC27A1;ETNK2;CDS1;MTMR9;MTMR4;PCYT2;PTDSS2;CRLS1;PGS1;ABHD3
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3435605950663095,0.9145669911210236,0.5798611111111112,0.9777671261601157,1.0,4/20,10.75%,TRIB3;PRMT3;ASXL3;ERLIN2
prerank,cellular response to starvation (GO:0009267),0.2438305271587489,0.9143896008478345,0.650730411686587,0.977427615692055,1.0,38/147,19.07%,MAPK3;RALB;GAS2L1;MAP1LC3B;HSPA8;EIF2S1;RPTOR;ATP6V1D;ATP6V0D1;XPR1;CDKN1A;MAPK8;LAMTOR1;SIRT1;ATP6V0E1;NIM1K;PRKAA2;ATG7;LARS1;RRAGC;RRP8;USP33;ATP6V1B2;ATG14;TFEB;KPTN;GABARAPL1;SESN3;PIK3R4;ZFYVE1;BECN1;DAPL1;ATP6V1A;GABARAP;NUAK1;LAMP2;SH3GLB1;SESN1
prerank,response to thyroid hormone (GO:0097066),0.37941912202930733,0.9139889339897628,0.5797665369649806,0.9776669733632547,1.0,3/13,10.73%,GAS2L1;LMO2;THRB
prerank,regulation of JUN kinase activity (GO:0043506),0.30955291593034334,0.9139309445263202,0.5829145728643216,0.9770362140793103,1.0,7/33,14.80%,MAP3K11;MAP3K7;MAP3K4;PAK1;RPS3;AIDA;MAP3K10
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.3373468932256362,0.9137966438977643,0.5788561525129983,0.9757896112642018,1.0,3/21,8.70%,ERCC3;ERCC4;GTF2H1
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.3373468932256362,0.9137966438977643,0.5788561525129983,0.9757896112642018,1.0,3/21,8.70%,ERCC3;ERCC4;GTF2H1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.3284251355691492,0.9136929505248107,0.5754560530679934,0.9752779445589205,1.0,4/25,12.87%,MAP3K7;B2M;WNT5A;CD55
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.26647203031777045,0.913622030322211,0.5935672514619883,0.9746762849025783,1.0,9/75,8.34%,PDCL3;PRKD2;NRAS;PPP1R16B;EGFL7;TEK;SIRT1;WNT5A;PLCG1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.3759776855396817,0.9131322719093466,0.5513078470824949,0.9751351039676969,1.0,2/14,7.36%,PRKAR1A;SIRT1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.2515836777864567,0.9129473105825693,0.646814404432133,0.9748390069075435,1.0,12/112,11.24%,CIDEA;PTPRJ;TNFAIP3;PTPRC;TIRAP;SYK;NLRC3;WNT5A;CD47;VSIR;NFKBIL1;APP
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.2604704017127751,-0.9128935192245673,0.6033057851239669,0.870548707843423,1.0,6/46,6.36%,PLD1;PLA2G4A;AGPAT4;ABHD5;AGPAT5;DGKH
prerank,amino acid transmembrane transport (GO:0003333),-0.2614324165588311,-0.91257921204635,0.6094986807387863,0.8706509782944452,1.0,8/45,11.05%,SLC7A11;SLC6A13;SLC47A1;LRRC8D;SLC25A13;SFXN2;SLC22A4;SLC38A11
prerank,regulation of RNA metabolic process (GO:0051252),-0.24733841313573032,-0.9122501904234821,0.6053412462908012,0.8707446101113107,1.0,7/59,4.74%,HNRNPH1;SNRNP70;AHNAK;SON;AFF2;CLK4;MED1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.29447683561726834,0.9120889071602829,0.5859766277128547,0.9762729678664076,1.0,5/41,10.38%,CIDEA;TNFAIP3;NLRC3;VSIR;NFKBIL1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.366074259624471,0.9119203274202067,0.5784671532846716,0.975908714724515,1.0,4/15,10.65%,PTPN18;PTPN12;RHBDF2;RBPJ
prerank,response to progesterone (GO:0032570),0.36048874918188506,0.9117475555170982,0.6068222621184919,0.9755649079285607,1.0,3/18,10.29%,SRC;UBE3A;WBP2
prerank,negative regulation of type I interferon production (GO:0032480),-0.26844111264622866,-0.9114324260277539,0.6135135135135135,0.8720170864098483,1.0,12/40,13.10%,CYLD;PTPRS;PPM1B;ILRUN;TAX1BP1;IFIH1;RNF135;REL;NPLOC4;IKBKE;SIRPA;RELB
prerank,DNA metabolic process (GO:0006259),0.22898715766672725,0.9114191285182214,0.6804733727810651,0.9756331619889769,1.0,46/270,15.71%,ERCC3;ZRANB3;RAD18;CTC1;TRIM28;PNKP;ORC3;ERCC4;RAD1;XRCC1;POLK;TDG;POLE;CDC45;LONP1;DCLRE1B;ORC4;UBE2V2;POLD3;ACD;GTF2H1;POLA1;RAD51B;EXD2;PARK7;MSH3;TERT;SRPK2;SMUG1;HUS1;ORC2;TOP3A;KMT5B;PWWP3A;MPG;NBN;HELB;DOT1L;TRRAP;LTO1;BACH1;FANCL;INO80;TERF2IP;ATR;TOP1
prerank,regulation of fibrinolysis (GO:0051917),-0.3645979537474785,-0.9112014775114898,0.5608108108108109,0.8718435766785408,1.0,2/13,10.47%,THBS1;FAP
prerank,mucosal immune response (GO:0002385),0.36789142879758546,0.9110622941580451,0.5817490494296578,0.9757350805275038,1.0,1/15,2.87%,IFNLR1
prerank,tube closure (GO:0060606),-0.2853900838260929,-0.9110061514925549,0.6004842615012107,0.8715877547138169,1.0,9/31,17.78%,LMO4;SKI;COBL;MTHFR;MTHFD1;PLXNB2;LRP6;TGFB1;TSC2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.24649980787902623,0.9107611528925788,0.6378600823045267,0.9757267880553345,1.0,25/124,14.74%,ROPN1;FAM161B;PTPRM;KIFAP3;MANF;APOE;CFAP126;CNTNAP2;DTNBP1;TMEM108;TTC17;MAP4;ODF2;CSF1R;LYN;LGI1;OPHN1;DOCK7;FRY;APP;TBC1D24;PLEK;SNAPIN;LRP12;TBC1D23
prerank,regulation of actomyosin structure organization (GO:0110020),-0.36234190421828616,-0.9107209490711935,0.5866935483870968,0.871584639663072,1.0,4/13,11.23%,AKAP13;ROCK2;ROCK1;FHOD1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.40358924061605567,0.9105974999016663,0.5802707930367504,0.9753446533271394,1.0,4/10,17.17%,DCLRE1B;ACD;TERF2IP;DCLRE1C
prerank,regulation of vasculogenesis (GO:2001212),0.37287514942710254,0.9095882403306826,0.6025641025641025,0.9771187621013409,1.0,3/14,7.78%,HEY1;TMEM100;HEY2
prerank,mitotic nuclear division (GO:0140014),0.2659161546417666,0.9093332837511306,0.614406779661017,0.9770200866976017,1.0,17/71,17.26%,ABRAXAS1;KIF18A;PPP2R2D;CLASP2;CDCA8;MZT1;KIF2A;CHMP2A;BCCIP;MIS12;KIF3B;CHEK2;INO80;ARHGEF10;STAG2;KPNB1;CLASP1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.27165604378236047,0.9091887386089555,0.5985185185185186,0.9766297896210197,1.0,21/69,19.64%,DERL2;YOD1;WFS1;FAM8A1;SGTB;TRIM25;AUP1;RHBDD2;ERLIN2;UBQLN1;STT3B;PSMC6;DNAJC10;UFD1;UBQLN2;DNAJB14;UBXN4;EDEM2;DNAJB9;DERL1;SEL1L
prerank,membrane protein proteolysis (GO:0033619),0.3044699695774214,0.9088406132882483,0.6013071895424836,0.976718723342512,1.0,12/37,18.22%,PSEN2;RET;NAPSA;SPPL3;DAG1;RELA;MBTPS1;TMPRSS6;MYH9;APH1A;ADAM9;SPPL2A
prerank,regulation of translation (GO:0006417),0.24115290461115588,0.9085410433198124,0.6481994459833795,0.9767052995329243,1.0,58/173,21.60%,ILF3;NCBP1;PATL2;EIF2A;RPS6KA1;LARP4B;EIF3B;FXR1;RPL5;PAIP2B;GEMIN5;PYM1;CNOT7;EIF4H;TSC1;TSFM;EIF4G2;METAP1;DDX3X;APP;NANOS3;RPS3;EIF4B;YBX1;CAPRIN1;CNOT1;RBM4B;EIF5;UPF3B;PRKDC;CYFIP1;LARP4;MTG2;CNOT10;CALR;NPM1;EIF6;RPL26;RPL10;EIF4G1;MRPL13;DHX36;MTIF2;EIF3E;LARP1;EIF1;METTL14;EIF4E;MTPN;DDX6;CNOT8;TRAP1;GSPT1;GLE1;EIF2AK4;DHX9;PAIP2;ATXN2
prerank,lipid modification (GO:0030258),0.29910131287248987,0.9084318127149158,0.610738255033557,0.9762162518740586,1.0,6/37,8.28%,DGKB;PLPP6;LPCAT3;PLPP1;MBOAT1;SGPP2
prerank,cellular response to mechanical stimulus (GO:0071260),0.2962029917808869,0.9083835414808707,0.6006339144215531,0.9755639794993587,1.0,6/46,10.66%,MAPK3;TNFRSF10B;MAPK8;CRADD;F11R;BAD
prerank,cellular response to purine-containing compound (GO:0071415),-0.3877266874524414,-0.908370056451219,0.5873684210526315,0.8767851386504539,1.0,6/10,41.19%,RYR3;P2RY1;GSTM2;TRPM2;P2RY6;CASQ2
prerank,regulation of wound healing (GO:0061041),-0.26692048541598373,-0.9081590974629143,0.6246648793565683,0.8765885995355921,1.0,16/42,30.65%,OCLN;SRSF6;VTN;EPHB2;ANXA1;PTK2;AJAP1;CD109;CADM4;ADRA2A;DMTN;SERPINE1;HBEGF;MYLK;CLDN1;CAV1
prerank,interstrand cross-link repair (GO:0036297),-0.2455378167582907,-0.9079701728353284,0.6472148541114059,0.8763203489662985,1.0,36/53,46.55%,VCP;RNF168;RPA1;UBC;RNF8;NUCKS1;MCM9;FAN1;FANCE;USP1;ATRIP;SLX4;POLN;DCLRE1A;FAAP100;MSH6;FANCC;ERCC1;FANCI;MUS81;FAAP20;RPA3;XPA;FANCB;UBA52;FANCD2;FANCG;NEIL3;MCM8;RPA2;EXO5;RAD51;RAD51AP2;CENPX;FANCA;WDR48
prerank,histone H3 deacetylation (GO:0070932),0.3636826625537022,0.9078459861309894,0.5546875,0.9761538573591918,1.0,4/15,7.36%,HDAC9;HDAC3;SFPQ;SIRT1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2922590163477958,0.9073131892470331,0.5807622504537205,0.9767900945526937,1.0,19/45,20.52%,EIF2A;GEMIN5;YTHDC1;TSC1;METAP1;APP;MATR3;NANOS3;RBM4B;ATG14;TDRD7;CYFIP1;LARP4;RPL10;RC3H1;LARP1;EIF4E;MTPN;GCNT2
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2606073733324295,0.9072048373021047,0.6278735632183908,0.9762807297735582,1.0,16/91,12.07%,MAPK3;PTPRC;AP2S1;SRC;RAB5C;STXBP5L;RAB11B;RALA;SYK;SNX17;OPHN1;MBTPS1;SCFD1;RAB5B;PICALM;SCARB1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.2713196495585922,-0.9071304852192276,0.618421052631579,0.8775799407735335,1.0,15/36,24.60%,OGT;WAC;FHIT;CAMLG;PSMF1;DDRGK1;TRIM39;MAP1A;USP7;BAG6;EIF3H;UBXN1;PRKCG;AQP11;NOP53
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.30705826411181747,0.9071009554003592,0.6033333333333334,0.975751108594438,1.0,2/33,3.64%,CBL;BCAR3
prerank,RNA processing (GO:0006396),0.23688166161959479,0.9068014222223055,0.6503856041131105,0.975741437445596,1.0,50/176,18.00%,SNRPD2;NCBP1;FASTKD2;PRPF3;SNRPD1;DDX54;PPP2CA;HNRNPK;PPIG;TENT4A;USB1;SFPQ;HNRNPC;IVNS1ABP;ADAR;SF3B3;SRSF4;YJU2;SF3A1;PRMT9;RSRC1;XRN2;AKAP8L;TARDBP;U2AF1;CPSF6;CCAR2;DUSP11;SRPK2;ADARB2;PTBP1;RRAGC;TUT7;SRSF7;FUS;USP39;TUT4;TSEN2;HNRNPL;TCERG1;ADARB1;U2AF2;DKC1;NONO;LSM1;HNRNPF;SNRPA1;DHX8;PRPF18;DDX23
prerank,phosphatidylinositol metabolic process (GO:0046488),-0.2223104008863049,-0.9064145005969757,0.7306397306397306,0.878667469483416,1.0,23/109,15.34%,PTPN13;PLA2G4A;PDGFRB;PLEKHA2;LPGAT1;PIK3C2B;MTMR7;PIP4P2;PIK3C3;PIP5K1A;SACM1L;PIK3R3;VAC14;PLEKHA8;MTMR12;PIP4K2B;PLCB3;PITPNM3;INPPL1;SLC27A1;CDS1;MTMR9;MTMR4
prerank,"base-excision repair, AP site formation (GO:0006285)",0.3587277687862947,0.9060748512155448,0.5810344827586207,0.9767909222968898,1.0,5/17,15.09%,TDG;ACD;SMUG1;MPG;TERF2IP
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.32846814850226347,-0.9056907467556888,0.579295154185022,0.8797877357316702,1.0,8/18,23.59%,ASPA;SLC25A13;MTHFR;MTHFD1;NAALAD2;SMS;GOT1;ASPG
prerank,lipid droplet formation (GO:0140042),0.3991216761798757,0.9056585793659105,0.5746691871455577,0.9770819783907287,1.0,3/10,16.74%,FITM2;AUP1;ZFYVE1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.3733092302187321,0.9050875106071498,0.5758157389635317,0.9777086370048461,1.0,3/14,11.18%,UPP1;UPP2;ERH
prerank,zinc ion transport (GO:0006829),-0.31100393376977536,-0.9046369744233782,0.6150234741784038,0.8816493230390512,1.0,8/21,24.91%,SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC39A8;SLC39A7;SLC39A6;SLC30A5
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.2157601128321307,-0.9045084768813035,0.7093023255813954,0.8812587578510097,1.0,16/142,10.65%,ATP1A2;LPAR1;CACNA1C;ADCY5;SMAD3;DLG4;TRPC5;PLCE1;EDNRA;PDGFRA;ADRA1B;FIS1;CCR9;TRPC1;PRKACA;ACKR3
prerank,barbed-end actin filament capping (GO:0051016),-0.32595333355206846,-0.9045046013321445,0.6137931034482759,0.8798163499174022,1.0,8/18,21.27%,SVIL;GSN;TRIOBP;ADD3;TWF2;ADD2;CAPZB;VILL
prerank,actin filament capping (GO:0051693),-0.32595333355206846,-0.9045046013321445,0.6137931034482759,0.8798163499174022,1.0,8/18,21.27%,SVIL;GSN;TRIOBP;ADD3;TWF2;ADD2;CAPZB;VILL
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.24808812324876683,-0.9044152361442576,0.6778711484593838,0.8792869818012385,1.0,16/55,19.88%,PDGFRB;MAPK14;TGFBR2;PID1;SIRT2;AATF;XDH;THBS1;TP53;MPV17;GRB2;ARF4;SIRT5;AGTR1;PINK1;SLC25A33
prerank,snRNA transcription (GO:0009301),-0.2380715081123814,-0.9042905318434544,0.6863354037267081,0.8788745604477242,1.0,41/70,33.55%,RPRD1B;POU2F1;ELL;PHAX;SRRT;USPL1;GTF2A1;CDK7;CCNT1;POLR2A;SNAPC3;TAF8;INTS10;CCNK;INTS8;INTS11;TAF6;GTF2E2;CDK9;NABP2;GTF2B;INTS7;SNAPC4;TAF13;NCBP2;POLR2K;INTS12;GTF2E1;INTS9;TAF11;POLR2H;INTS3;ZC3H8;NABP1;POLR2G;POLR2F;POU2F2;POLR2C;TAF5;GTF2F1;INTS1
prerank,microtubule polymerization (GO:0046785),-0.296634759545926,-0.9033367112071524,0.6266666666666667,0.8805375342384406,1.0,10/28,13.53%,HDGFL3;MAPT;TUBGCP4;CCDC57;GOLGA2;AKAP9;SLAIN2;CKAP5;TUBGCP6;RANBP9
prerank,receptor recycling (GO:0001881),-0.3857257425135369,-0.9032836170754546,0.5887265135699373,0.879956957293526,1.0,8/10,37.89%,ARFGEF2;SORL1;EHD3;LMTK2;NSG1;PHETA1;PLEKHJ1;REP15
prerank,DNA duplex unwinding (GO:0032508),-0.2596725639809192,-0.903129042979331,0.626984126984127,0.8796292979721501,1.0,17/50,22.49%,DDB1;DDB2;DDX1;RAD50;MRE11;RPA1;UBC;ANXA1;PURA;MCM9;XPC;PARP1;BLM;SUPV3L1;RECQL;RTEL1;MCM6
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3177103613120593,0.90280984061185,0.6055363321799307,0.9828965308658765,1.0,8/28,17.44%,TRIB3;TNFRSF10B;SELENOK;AIFM1;DDIT3;DNAJC10;QRICH1;BAX
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.30745401469725026,0.9025454177134639,0.5767857142857142,0.9827626161256221,1.0,5/29,11.20%,PPP2CA;SPRED1;SMAD7;EFNA1;ADIPOR1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3288439078774667,0.9022951922492183,0.5897887323943662,0.9826130182867224,1.0,4/24,9.70%,TXNDC12;WFS1;LPCAT3;PARK7
prerank,regulation of water loss via skin (GO:0033561),0.3657655729637938,0.9022777237366083,0.5888689407540395,0.9810982461805032,1.0,3/15,13.59%,UGCG;HRNR;LSR
prerank,establishment of skin barrier (GO:0061436),0.3657655729637938,0.9022777237366083,0.5888689407540395,0.9810982461805032,1.0,3/15,13.59%,UGCG;HRNR;LSR
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.31462023226015545,-0.9020573954315455,0.5940366972477065,0.8815606302944139,1.0,6/21,16.22%,MED13;MED1;MED17;PAXIP1;SETX;JUN
prerank,positive regulation of calcium ion import (GO:0090280),0.39167149776612126,0.9020334865846078,0.6051660516605166,0.9809171671478876,1.0,1/12,2.31%,CXCL12
prerank,regulation of cellular response to heat (GO:1900034),0.26448096671330135,0.9018500106898604,0.6248153618906942,0.9806132106598534,1.0,23/77,19.50%,MAPK3;HSPA8;RPTOR;EP300;AKT1S1;BAG1;NUP54;SIRT1;NUP50;CCAR2;CREBBP;FKBP4;NUP35;NDC1;ATR;CAMK2G;HIKESHI;NUP160;POM121;NUP42;YWHAE;HSPB8;NUP133
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.41089420181413516,0.901812170148644,0.5853174603174603,0.9799333377946305,1.0,2/10,8.24%,RUVBL2;RUVBL1
prerank,epithelial cell development (GO:0002064),-0.3188843373257695,-0.9013863935205071,0.6070588235294118,0.8824372649361861,1.0,2/20,4.35%,WNT5B;RILPL1
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3930691819331864,0.9013391581098467,0.588126159554731,0.9803612681042787,1.0,3/11,12.16%,CYCS;UQCC3;UQCRB
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3131523799414919,-0.9009290615495394,0.6428571428571429,0.8828781486720255,1.0,6/22,16.27%,TAFA1;TOX;APPL2;KDM1A;SLC16A2;NES
prerank,skeletal muscle contraction (GO:0003009),0.34437065926349264,0.9007435116904023,0.5836431226765799,0.9811190550712211,1.0,1/19,3.35%,STAC
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.36182021105404055,-0.9004092374579412,0.5974025974025974,0.8833949504723776,1.0,4/13,13.49%,IGF1;GOLGA2;RAMP1;IL33
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.3394416207306667,0.9001476152629152,0.598939929328622,0.9819452883683029,1.0,4/19,11.64%,RPTOR;ICE1;NAB2;POLR3F
prerank,negative regulation of defense response (GO:0031348),-0.23351824008930616,-0.900082310725107,0.7155963302752294,0.8834357809224834,1.0,17/77,17.14%,LRFN5;PPM1B;SIRT2;ILRUN;PRKCD;PPARA;PTGIS;IRAK3;TRAFD1;OTULIN;SIRPA;CCN3;SELENOS;ENPP3;PTPN2;RORA;TNFAIP6
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3740315699484192,-0.9000542530850086,0.6212765957446809,0.8827824060531122,1.0,5/11,18.94%,DAB2;SORL1;EZR;PTPN23;MSN
prerank,water-soluble vitamin metabolic process (GO:0006767),0.26720663691280383,0.8997773921511115,0.6344725111441307,0.9821776303669677,1.0,8/68,8.55%,ALDH1L1;MTR;FLAD1;PANK2;SLC52A2;SLC52A3;MTHFS;SLC2A1
prerank,primary neural tube formation (GO:0014020),-0.2879935682313275,-0.8997218781243553,0.6113861386138614,0.8828439319136394,1.0,9/30,17.78%,LMO4;SKI;COBL;MTHFR;MTHFD1;PLXNB2;LRP6;TGFB1;TSC2
prerank,positive regulation of peptidase activity (GO:0010952),-0.3133095828305652,-0.8995004785145865,0.5817757009345794,0.8826614694412472,1.0,11/20,35.06%,VCP;DDRGK1;RCN3;TANK;PINK1;APH1B;PSME2;PSME3;PSME1;PRELID1;PSENEN
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),-0.37097067236976744,-0.8989321929242122,0.5884861407249466,0.8833041722250559,1.0,3/11,9.72%,CAB39;BIN1;ACTN2
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.33395748939446307,-0.8988765267826595,0.6030042918454935,0.8827145860439132,1.0,5/16,17.54%,LRP1;HDAC1;ROCK1;IFNGR1;CYP51A1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.39526305605229917,0.8986594989060043,0.5949119373776908,0.9842382906498477,1.0,3/11,15.42%,CXCL12;MERTK;GAS6
prerank,regulation of exosomal secretion (GO:1903541),-0.3212069654539097,-0.8986410332172229,0.6100217864923747,0.8825381805539914,1.0,7/19,22.20%,ATP9A;SMPD3;SNF8;TSG101;STAM;VPS4A;HGS
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.3331462347140771,0.898534400220018,0.5855018587360595,0.9837829731366425,1.0,3/22,6.87%,DUSP7;PPP2CA;PPP2CB
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.3467703500560679,0.8982393766324123,0.5896980461811723,0.9837828557313898,1.0,5/18,12.85%,RIPOR2;SCAI;RASIP1;ITGA3;CUL3
prerank,lipid phosphorylation (GO:0046834),-0.3743786216474214,-0.8982197575874844,0.6041237113402061,0.8828244064728403,1.0,2/10,6.36%,DGKI;DGKH
prerank,steroid catabolic process (GO:0006706),0.4069600869682606,0.8977778031287884,0.6039215686274509,0.9842089720381781,1.0,2/10,13.06%,HSD17B11;YWHAH
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.34795541362878474,-0.8977351384435055,0.5916334661354582,0.8832760757340217,1.0,5/14,28.15%,PAXIP1;SHLD1;RIF1;NECTIN2;SHLD2
prerank,lytic vacuole organization (GO:0080171),0.30302476156158115,0.897653641594781,0.6061643835616438,0.9837540377050336,1.0,10/32,16.62%,LAMTOR1;TPP1;AKTIP;ZKSCAN3;MBTPS1;CLVS1;SNAPIN;TFEB;HOOK3;VPS18
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.22587617377477784,-0.8973752489109548,0.7308970099667774,0.88338722716249,1.0,34/85,26.91%,DAB2;HECTD1;RNF14;RCHY1;SIRT2;NUPR1;USP13;VCP;CSNK1A1;CSNK1E;GSK3B;TMEM259;DDRGK1;RACK1;RNFT1;KEAP1;RNF19B;DVL1;SOCS5;USP5;OSBPL7;STUB1;PSMC5;DNAJB2;PSMC3;ARIH2;SH3RF2;BAG6;NKD2;NOP53;RNF185;HSPBP1;DDA1;RNF144A
prerank,regulated exocytosis (GO:0045055),0.23768702439737716,0.8965282187368812,0.6913099870298314,0.9857725131008881,1.0,25/173,11.44%,ABCC4;CDC37L1;SOD1;PECAM1;PPP3CB;MANF;SDF4;NHLRC2;RAB11B;SYNGR2;CYRIB;F8;SELENOP;SELP;ACTN4;VWF;RAB11FIP5;TMED10;LGALS3BP;RAB11FIP2;LYN;GTPBP2;APP;A2M;OLA1
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.4058674443265736,0.8964469228138524,0.5890151515151515,0.9851943481699126,1.0,2/10,4.89%,PTPRJ;PTPN12
prerank,aspartate family amino acid catabolic process (GO:0009068),0.3397455838259245,0.8964305473094292,0.6067019400352733,0.9844616761617594,1.0,3/19,9.72%,AASS;GOT2;PHYKPL
prerank,phosphatidic acid metabolic process (GO:0046473),-0.25204716645123726,-0.8962892878646799,0.6422764227642277,0.8853504214477106,1.0,6/48,6.36%,PLD1;PLA2G4A;AGPAT4;ABHD5;AGPAT5;DGKH
prerank,response to lipid (GO:0033993),0.24963191117329112,0.8962070742740659,0.6638655462184874,0.9842779524292415,1.0,12/105,12.35%,PCK1;ACER2;TAB2;TIRAP;PAQR8;SELP;PPARD;ERBIN;IFNAR1;ESR1;NOS3;OTUD5
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.3588199390349769,0.8961399680298983,0.6003824091778203,0.9836695755765735,1.0,4/16,14.38%,APOE;TERT;SCARB1;GCH1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.36588018928758415,-0.8961347977316456,0.6025641025641025,0.8843052577721469,1.0,2/12,2.98%,EFNA5;FBLN1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.36588018928758415,-0.8961347977316456,0.6025641025641025,0.8843052577721469,1.0,2/12,2.98%,EFNA5;FBLN1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.304225523262841,0.8960440636296602,0.5845896147403685,0.9831211841938692,1.0,7/35,9.27%,PHPT1;TEK;RAPGEF3;F11R;TJP1;ESAM;CSF1R
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.28960315340451565,-0.8960120000498697,0.6430317848410758,0.8838930328577236,1.0,11/26,37.02%,SMAD3;P2RX4;DDAH1;PTGS2;AKT1;HSP90AA1;DDAH2;ASS1;EDN1;TMEM106A;CLU
prerank,heart contraction (GO:0060047),-0.2677666964411225,-0.8959972188803237,0.6442577030812325,0.8832123779499977,1.0,3/41,4.20%,ATP1A2;ATP1B1;TPM1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.375134791087221,0.8959916513283678,0.5612052730696798,0.9824919227907466,1.0,4/13,16.42%,PIK3AP1;EPG5;TNIP2;PIK3R4
prerank,positive regulation of developmental process (GO:0051094),0.23598142586065846,0.8959634325657535,0.6925133689839572,0.9817919227981546,1.0,23/164,12.11%,LRP8;ANAPC2;RPS6KA1;SHANK3;SRC;CLASP2;APOE;RALA;CFL1;SLC6A6;ARHGEF7;FBXO5;RAPGEF3;SIRT1;DAG1;DDHD1;WNT5A;PLCB1;ZDHHC15;TRPM4;ZBED3;PA2G4;KMT5B
prerank,negative regulation of defense response to virus (GO:0050687),-0.38600111086132904,-0.8956770626486509,0.6090534979423868,0.8833029922247364,1.0,2/10,6.05%,PPM1B;ILRUN
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.2810301070844347,-0.8956226640655205,0.6240409207161125,0.8827249953857064,1.0,6/31,12.74%,PACRG;BAG3;RHBDD1;OPTN;HSF1;TM7SF3
prerank,branched-chain amino acid catabolic process (GO:0009083),0.3434586208363913,0.8955428850347972,0.6028368794326241,0.9813147950493755,1.0,3/20,5.45%,BCKDHB;SLC25A44;ACAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.3434586208363913,0.8955428850347972,0.6028368794326241,0.9813147950493755,1.0,3/20,5.45%,BCKDHB;SLC25A44;ACAT1
prerank,regulation of myoblast differentiation (GO:0045661),0.3063878929254086,0.8953696587706907,0.6160558464223386,0.9809623726964934,1.0,5/32,9.71%,XKR8;ZFP36L1;RIPOR2;NOTCH1;PLCB1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.36287211184233553,-0.8953648695574027,0.584051724137931,0.8826475084628543,1.0,3/13,13.16%,AXL;ZBTB1;IL18
prerank,fat cell differentiation (GO:0045444),-0.2488276742645965,-0.8953244093959467,0.6613756613756614,0.8820300490269769,1.0,18/57,23.57%,WNT5B;OSBPL11;PID1;MED1;PPARGC1A;PER2;AKT2;SMAD6;BBS9;CLIP3;BBS2;TMEM120B;PRDM16;TCF7L2;ATF5;OSBPL8;TMEM120A;C1QTNF3
prerank,protein glycosylation (GO:0006486),-0.21196741317429127,-0.8951994364205246,0.7867647058823529,0.881625266197787,1.0,37/125,26.15%,MGAT4C;MAN1C1;OGT;PLOD2;B4GALT1;TET1;FUT8;POFUT1;TRAK1;PMM2;GOLGA2;ALG9;PLOD1;FUT10;DPM1;LARGE1;FKTN;B3GALT5;SLC39A8;ST3GAL4;B3GALNT1;MAGT1;ENTPD5;B3GALT1;ST8SIA2;ALG5;ALG10B;GFPT1;ALG11;C1GALT1C1;GAL3ST1;STT3A;SERP1;AQP11;GFPT2;ALG12;KRTCAP2
prerank,positive regulation of transmembrane transport (GO:0034764),0.3697637236727913,0.8951757284782543,0.5890151515151515,0.9807124388417436,1.0,5/13,17.82%,ACSL5;CA2;P2RX7;BRAF;C2CD5
prerank,chromatin assembly or disassembly (GO:0006333),-0.3747183023898524,-0.8950360312015792,0.6168032786885246,0.8813146351382757,1.0,7/11,43.39%,TP53;MTA2;NOC2L;CDAN1;HIRIP3;SUV39H2;CHAF1A
prerank,long-term memory (GO:0007616),-0.32009037539944,-0.8947744386051587,0.6181384248210023,0.8812448750541219,1.0,6/19,19.61%,RASGRF1;CAMK4;LDLR;SGK1;NFATC4;SHANK1
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.2731978829201577,-0.8947446192738854,0.6231884057971014,0.8806187311178247,1.0,12/36,22.38%,CYLD;TAOK3;EZR;PER1;DLG1;SIRPA;FKTN;DACT1;PTPN22;PINK1;SH3RF2;DUSP1
prerank,generation of neurons (GO:0048699),0.23213081863675003,0.8945908903886145,0.7150326797385621,0.9814333912016913,1.0,23/190,10.34%,IRX1;EML1;NR4A2;PIN1;HES6;ASTN2;ADGRL3;HEY1;POMGNT2;IER2;MYEF2;FGF13;HEY2;WNT5A;ITM2C;NGRN;FZD3;PRUNE1;OPHN1;CELSR1;ACSL4;NAV1;DOCK7
prerank,long-chain fatty acid import into cell (GO:0044539),-0.3843371615905212,-0.8942120448255286,0.6072874493927125,0.8811527817021307,1.0,3/10,19.24%,ACSL1;SLC27A1;RPS6KB1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.2495363262293586,0.8940047177287183,0.6748911465892597,0.9821348444282727,1.0,9/110,6.38%,PTGER2;ADGRE1;ADGRL4;GNAQ;ADGRL3;TSHR;RAMP2;GNB1;RXFP1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.26572535701316113,-0.8936945833245337,0.6574307304785895,0.8816217315135662,1.0,17/39,23.21%,RIOK1;RIOK2;NOL11;DDX52;RPS16;RPS7;RPS6;NOM1;UTP4;RPS17;NOB1;RIOK3;WDR3;NOP14;LSM6;METTL17;RRP36
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.32799918718764276,-0.8936333742852292,0.5995850622406639,0.8810483239017898,1.0,6/17,25.10%,VIM;BMP4;WNT4;TGFB1;TGFB3;CREB3L1
prerank,regulation of histone modification (GO:0031056),0.37783865374417025,0.8936207410361596,0.6156716417910447,0.9823372940319709,1.0,4/13,9.76%,HPF1;SETD5;PARK7;AKAP8L
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.3821340371570869,-0.8934707441117139,0.6284046692607004,0.8807089217826218,1.0,4/10,11.92%,RARB;SNW1;RXRA;RARA
prerank,autophagy of nucleus (GO:0044804),-0.33094097655661625,-0.8933650132686576,0.6113445378151261,0.8802508997243653,1.0,2/16,5.52%,ULK2;WIPI1
prerank,neuron differentiation (GO:0030182),0.23429396599184305,0.8928915161159658,0.7156208277703605,0.9833855758072444,1.0,17/165,9.92%,IRX1;ERCC3;NR4A2;PIN1;MANF;PPT1;HS6ST1;IER2;MYEF2;UGCG;EPHA5;WNT5A;ITM2C;NGRN;FZD3;OPHN1;ACSL4
prerank,regulation of protein localization (GO:0032880),-0.24419465894147221,-0.8922045901020018,0.7119565217391305,0.8823300724498241,1.0,17/58,21.15%,MAP2;UFL1;CSNK1E;AFDN;DVL3;RAB9A;DZIP1L;CTSD;DLG1;CAMK1;RACK1;KDM1A;DVL1;PARP1;TRIM5;PPM1F;VPS4A
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2422238863874711,-0.8921573752012295,0.6873239436619718,0.8817308870927039,1.0,16/59,14.49%,TGFBR1;TGFBR2;WNK1;CDC42BPB;ROCK2;CIT;PRKCD;ROCK1;HIPK3;ACVR1;HIPK1;GSK3B;CAMK2D;ACVR1B;WNK3;MAP3K12
prerank,positive regulation of angiogenesis (GO:0045766),0.24921860964997306,0.8920386236919919,0.6707317073170732,0.9847996194760341,1.0,19/108,12.86%,JMJD8;PDCL3;HIPK2;PRKD2;SMAD1;RAMP2;TEK;RAPGEF3;SIRT1;WNT5A;PLCG1;TJP1;CYP1B1;TIE1;NOS3;FLT1;PIK3CD;SP1;CDH5
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.24378161101131657,-0.8919852630354155,0.6728971962616822,0.8814559628048165,1.0,11/62,10.13%,KMT2A;HDAC1;MEIS2;CBFB;HOXA5;CDC73;RBM15;THBS1;AGO3;CDK6;RBBP5
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.26288923904095746,0.8919741088674731,0.6491754122938531,0.9841885182172412,1.0,11/70,11.81%,GSK3A;BCL2L2;SORT1;TNFRSF10B;TNFRSF1B;CIB1;CRADD;BAD;DDX3X;P2RX7;IFI27
prerank,renal absorption (GO:0070293),-0.3760364118630869,-0.8915453238826319,0.6321138211382114,0.8817618884214921,1.0,3/10,10.22%,GSN;WNK4;SGK1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.36699931902862715,-0.8914247898431665,0.6027667984189723,0.8813417134225291,1.0,1/11,4.77%,P2RX4
prerank,regulation of protein kinase A signaling (GO:0010738),-0.31485573112226456,-0.8914120565140651,0.5931818181818181,0.8806706421556766,1.0,3/20,4.30%,AKAP6;AKAP12;ADGRV1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.38816389644696137,0.8912557175140958,0.609942638623327,0.9852350392780743,1.0,3/11,19.58%,SIRT1;HDAC2;XBP1
prerank,regulation of small molecule metabolic process (GO:0062012),0.31923741115964804,0.8912545095153975,0.6252285191956124,0.984474696875208,1.0,5/28,11.20%,MLYCD;PANK2;APOE;SIRT1;ADIPOR1
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.26182905051562366,-0.8910790700490145,0.6565656565656566,0.8807951221147079,1.0,15/40,26.77%,PID1;MAPT;VCP;AKT2;SPART;SLC25A36;ATP5IF1;PINK1;SLC25A33;BCL2;STOML2;AKT1;BCL2L1;PRDX3;RNF122
prerank,transition metal ion homeostasis (GO:0055076),0.31694025176677987,0.8909265090615388,0.6146179401993356,0.9845218487645401,1.0,7/28,15.48%,HMOX2;FBXL5;B2M;PICALM;CUTC;TMPRSS6;BDH2
prerank,positive regulation of lipid transport (GO:0032370),0.3785878451989442,0.8908220304923562,0.6143911439114391,0.9840168132995003,1.0,2/12,5.66%,APOE;DBI
prerank,positive regulation of cell population proliferation (GO:0008284),0.21683780787707113,0.8905333851413377,0.785234899328859,0.9839730000972716,1.0,60/423,13.09%,MAZ;ROMO1;EZH2;PTPRC;LEF1;TIAM1;ACER2;RPL23;DERL2;PRKCH;GREM1;CRLF1;STOX1;MCTS1;TBC1D8;NME1;TSHR;MEIS1;SLC35F6;SINHCAF;CDKN1A;CIB1;TBX1;CHTOP;PIM1;FBXO5;BMI1;SIRT1;IRS2;RNF187;NOTCH1;WNT5A;CNOT7;CDK4;TJP1;RELA;CD47;MDM2;CSF1R;LYN;FZD9;PAK1;CLDN5;TERT;TRPM4;ESM1;RPS9;SRPK2;RBPJ;BAD;CD81;RHOG;FLT1;ACER3;PRKCI;CRKL;DOT1L;CUL3;DHPS;CNOT6
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.35816200968573136,-0.890395491936312,0.6416309012875536,0.8817096755674521,1.0,9/13,44.95%,SERTAD2;ARID1B;PADI2;SERTAD1;ZMIZ2;ELOF1;CDCA4;SPI1;CHEK1
prerank,positive regulation of cellular component organization (GO:0051130),0.2483956478766536,0.8901608585484967,0.6689560439560439,0.9841642070804019,1.0,26/107,17.90%,SURF4;TAL1;SLF1;ANAPC2;SHANK3;TIRAP;NEDD4L;APOE;ICE1;SYK;RAPGEF3;PARK7;RPS3;BMF;CDH5;FAF1;ASAP1;ATP10A;ADGRL1;LRP4;SLF2;BNIP3;WARS1;BAX;INSR;TMEM30A
prerank,aorta morphogenesis (GO:0035909),0.3512930764186029,0.8901186068646949,0.5960144927536232,0.9835190530895933,1.0,5/17,10.65%,HEY1;TBX1;HEY2;ACVRL1;RBPJ
prerank,pinocytosis (GO:0006907),0.39462461784336206,0.889234797147898,0.6091081593927894,0.9849070754753657,1.0,1/10,3.18%,PPT1
prerank,negative regulation of myotube differentiation (GO:0010832),0.3834394016306706,0.8889203048285558,0.5951940850277264,0.9849368827784092,1.0,4/12,13.02%,HDAC3;BDNF;NOTCH1;HDAC5
prerank,regulation of sodium ion transmembrane transport (GO:1902305),-0.2846812398966011,-0.8887885773016095,0.6112469437652812,0.8847828788863819,1.0,7/27,17.63%,FGF12;SNTA1;PTPN3;CAMK2D;DLG1;COMMD1;GPD1L
prerank,global genome nucleotide-excision repair (GO:0070911),0.31236280859280996,0.8886344781925821,0.6357267950963222,0.9849121072796266,1.0,3/26,8.70%,ERCC3;ERCC4;GTF2H1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),-0.3264580716664471,-0.8884287857911086,0.6353211009174312,0.8848984392725362,1.0,7/17,19.85%,PBX1;MAML1;NOTCH3;SNW1;PLXND1;MAML2;STAT1
prerank,ether lipid metabolic process (GO:0046485),0.3611425995808415,0.888284003878564,0.6055776892430279,0.9850096342250928,1.0,5/14,14.26%,PLAAT3;PEDS1;PEX7;AGPS;GNPAT
prerank,synaptonemal complex organization (GO:0070193),-0.33814668578730495,-0.8881133649982577,0.6182572614107884,0.8842625489714505,1.0,12/15,64.20%,BAG6;RAD21;P3H4;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3;SYCP2;RAD21L1;HORMAD1
prerank,synaptonemal complex assembly (GO:0007130),-0.33814668578730495,-0.8881133649982577,0.6182572614107884,0.8842625489714505,1.0,12/15,64.20%,BAG6;RAD21;P3H4;TEX11;REC8;TRIP13;SYCE2;TEX12;STAG3;SYCP2;RAD21L1;HORMAD1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3680710827595881,-0.8880099865348179,0.6257425742574257,0.8838001658295768,1.0,2/11,5.52%,PACS2;WIPI1
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.35669192055391014,-0.8879660585554126,0.6289308176100629,0.8832063808360653,1.0,6/12,21.51%,PARP6;PARP3;PARP12;PARP1;PARP16;PARP2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3354807550972884,0.8879101311510195,0.6336805555555556,0.9851670492454478,1.0,5/21,15.74%,TALDO1;RPIA;GPI;PGLS;PGM2L1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.3403583146094866,-0.8879026921395702,0.625,0.882650105859124,1.0,3/15,6.22%,EGFR;TEC;DDR1
prerank,regulation of intracellular signal transduction (GO:1902531),0.21743397264492137,0.8877240550388494,0.7914746543778802,0.9848868397361178,1.0,76/420,14.24%,RAC2;PRKAR1A;MAPK3;PIN1;TIAM1;VAV3;ARHGEF26;HIPK2;CHN2;MCF2L;RFFL;PRKD2;BIRC2;ITSN1;PPP1R16B;RAD1;TEK;SPRED1;SGMS1;ARAP2;EP300;ARHGAP25;ARHGEF6;RPL5;TRAF5;ARHGEF7;PAK3;TRIO;ATP6AP2;ARHGEF18;VWF;WNT5A;GNA12;MINK1;MYO9A;PHLPP1;TRAF3;RELA;MDM2;PJA2;LYN;FAM13A;PAK1;TTC5;OPHN1;RHOQ;TAF15;TMBIM4;ING2;ARHGAP39;PRKAA2;RHOG;A2M;GNAI1;HUS1;TOP3A;ARHGAP23;MAP4K4;PAK1IP1;MYO9B;TAF4B;NBN;PTPMT1;CHD3;TBP;RRAGC;ING5;CHEK2;DEPDC1B;ARHGAP15;MAP2K6;NFKBIA;SYDE1;CSNK2A2;RMI1;BRIP1
prerank,erythrocyte differentiation (GO:0030218),0.2850543135141464,0.8876924574992991,0.6285266457680251,0.9842125330037403,1.0,7/44,10.60%,TAL1;ABCB10;HIPK2;RPS14;CEBPG;LYN;MFHAS1
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.2928763769883108,0.8874488892798098,0.6363636363636364,0.9840651256814564,1.0,7/38,13.67%,TNFAIP3;RFFL;TNFRSF10B;ICAM1;DDX3X;NOS3;FAIM
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.33597420845895204,0.8871848827057198,0.5948275862068966,0.983968750553148,1.0,2/19,6.13%,TNFAIP3;CARD16
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.3167730062695868,-0.8868768958431422,0.6082004555808656,0.8844238544714654,1.0,6/19,24.44%,ENPP1;SLC26A2;SLC35B3;PAPSS2;BPNT1;ABHD14B
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.25630505199533765,0.8864971912880582,0.6553254437869822,0.9848802207371594,1.0,12/80,11.12%,CYCS;RPS6KA1;SRC;MAP2K5;SOX2;CARD16;SYK;SIRT1;USP47;BAD;DDX3X;NOD1
prerank,sensory organ development (GO:0007423),0.2789605664164142,0.8863531427137789,0.6336477987421384,0.9844734389293436,1.0,5/51,4.77%,ATF6;HIPK2;PAX8;MEIS1;SOX2
prerank,negative regulation of developmental process (GO:0051093),-0.23363127168867595,-0.8862742298406026,0.7251655629139073,0.8851242304622926,1.0,12/69,10.11%,DCC;NFIB;PTPRS;MAPT;BMP4;ROCK2;ROCK1;FOXC1;ANP32B;HUWE1;BCL11A;CDK6
prerank,regulation of protein ubiquitination (GO:0031396),0.24901003111304024,0.8862420559477924,0.6945205479452055,0.9840207556390268,1.0,18/108,11.45%,GSK3A;TNFAIP3;HDAC3;PRMT3;BIRC2;UBE3A;WFS1;PTTG1IP;FOXF2;SMAD7;IVNS1ABP;AXIN1;SPRTN;MYCBP2;PARK7;UBQLN1;SPOPL;RPS3
prerank,negative regulation of blood pressure (GO:0045776),0.3709640451062674,0.8861930419668141,0.6108007448789572,0.9833946077143922,1.0,2/13,11.33%,PRCP;NOS3
prerank,positive regulation of macroautophagy (GO:0016239),0.2807243992977593,0.8859605588213139,0.6368078175895765,0.9832339401890854,1.0,16/48,19.50%,RALB;MAP3K7;EPM2A;SIRT1;FYCO1;PRKAA2;BNIP3L;SCOC;RAB3GAP1;SESN3;BNIP3;PIP4K2A;SH3GLB1;SESN1;LARP1;HSPB8
prerank,sodium-independent organic anion transport (GO:0043252),-0.3783544366537094,-0.8853913250445867,0.6254826254826255,0.8864776332995541,1.0,1/10,0.92%,SLCO3A1
prerank,regulation of response to oxidative stress (GO:1902882),0.38554827994184054,0.8849133457879008,0.6166666666666667,0.9849669161853157,1.0,2/11,11.03%,STOX1;MCTP1
prerank,negative regulation of signal transduction (GO:0009968),0.22380557381176053,0.884871123106934,0.7481840193704601,0.9843276335787746,1.0,21/249,7.15%,SOX30;RGS2;MAZ;SEMA6A;PTPN18;GSK3A;PTPRJ;NR4A2;EZH2;FRZB;TNFAIP3;PTPRC;PTPRE;HEY1;EGFL7;PTPN12;MMRN2;CARD16;YWHAB;PTPRT;BDNF
prerank,acylglycerol homeostasis (GO:0055090),0.3385929428330917,0.8848624348564172,0.6225749559082893,0.9835959403937606,1.0,3/20,12.07%,APOE;PNPLA8;SCARB1
prerank,response to nutrient levels (GO:0031667),0.3431218549352272,0.8834819380921525,0.6119133574007221,0.9861907698433631,1.0,4/17,18.87%,RPTOR;PRKAA2;ULK1;EIF4G1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.24305888554772018,0.8834236634014819,0.6742857142857143,0.9855775702923778,1.0,14/107,11.00%,ATF3;TRIB3;ATF6;EIF2S1;GORASP2;UFC1;ATP2A2;TNFRSF10B;WFS1;SELENOK;MBTPS1;AIFM1;UBQLN1;HYOU1
prerank,regulation of cellular component organization (GO:0051128),0.24419790945238862,0.8833669589243011,0.6987951807228916,0.984953569951952,1.0,20/135,11.94%,CISH;HSPA8;AP2S1;RPTOR;RAB5C;LTBP4;APOE;LAMTOR1;CDK11B;CAMSAP2;HJURP;SNX17;SETD5;WNT5A;TJP1;PARK7;OPHN1;RAB5B;EGLN2;PICALM
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.2870729948009059,-0.8833299471659973,0.6488372093023256,0.8906407845499343,1.0,5/25,11.33%,EGFR;NRP1;DSCAM;THBS1;ILK
prerank,mononuclear cell differentiation (GO:1903131),0.32578038175653456,0.8832691819846508,0.6013986013986014,0.9844312039301811,1.0,5/24,15.44%,MT1G;CSF1R;LYN;GAS6;MYH9
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.36509533533043526,0.8830598803132029,0.5913978494623656,0.9841797623814458,1.0,5/13,17.44%,BAD;BMF;BNIP3L;BNIP3;BAX
prerank,hepaticobiliary system development (GO:0061008),-0.3053262520632382,-0.8829397023008075,0.6436781609195402,0.8908441443042474,1.0,4/20,8.00%,TGFBR3;WNT4;COBL;NIPBL
prerank,regulation of necroptotic process (GO:0060544),0.3237383751691119,0.8825902761588789,0.6286764705882353,0.9846172913994509,1.0,5/23,9.50%,CDC37;BIRC2;MLKL;SPATA2;FZD9
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.3841354508291255,0.8824223659570201,0.5868725868725869,0.9842890262709062,1.0,2/11,8.24%,NR4A2;WNT5A
prerank,gliogenesis (GO:0042063),-0.34042147226659814,-0.8823092629516566,0.6172566371681416,0.8915364053073711,1.0,4/15,12.16%,NFIB;RELN;CDK6;ANXA1
prerank,cranial nerve development (GO:0021545),-0.3737734775541557,-0.882226170426116,0.6316916488222698,0.891037871995117,1.0,9/11,59.43%,SALL1;PAX2;TMEM126A;ERBB3;CHRNB2;TFAP2A;POU4F1;TIFAB;ISL1
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.34753440866292895,-0.882153633070972,0.6423841059602649,0.8905028864019972,1.0,3/14,19.92%,OSMR;IL6ST;PTGS2
prerank,positive regulation of myoblast differentiation (GO:0045663),0.34489013052031736,0.8821340337767816,0.6065259117082533,0.984235589301889,1.0,3/16,9.71%,XKR8;RIPOR2;PLCB1
prerank,negative regulation of neuron differentiation (GO:0045665),-0.304810090491483,-0.8815588726400548,0.6529126213592233,0.8911716456162646,1.0,3/22,4.74%,CNTN4;BMP7;MED1
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.2996006456129885,-0.8814384603836313,0.6594202898550725,0.8907568801925981,1.0,9/24,22.58%,ITGA5;NIBAN2;VTN;GRB10;TMEM204;NEDD4;CADM4;HGS;EMILIN1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.32454460205259306,0.8814171316236167,0.6232638888888888,0.9852361321298448,1.0,4/24,8.16%,XRCC1;POLK;POLE;POLD3
prerank,cellular biogenic amine catabolic process (GO:0042402),0.39137337334678896,0.8809272484739845,0.6055226824457594,0.9856928215728739,1.0,2/10,7.87%,SMOX;SLC44A1
prerank,positive regulation of type 2 immune response (GO:0002830),-0.3427899797745526,-0.8809083289033647,0.6337078651685393,0.8912775847796401,1.0,3/14,13.16%,PRKCZ;RARA;IL18
prerank,autophagy of mitochondrion (GO:0000422),0.2914872251369105,0.8805380935765078,0.6179966044142614,0.9859375365736286,1.0,19/38,22.37%,MAP1LC3B;PHB2;FBXO7;CISD2;ATG7;ATG14;GABARAPL1;ATG13;BNIP3;BECN1;GABARAP;ULK1;WDR45B;ATG2B;FUNDC1;USP30;SQSTM1;ATG12;GABARAPL2
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.25799038822899323,0.880096908913561,0.6926536731634183,0.986236034415333,1.0,13/75,14.14%,RGS2;SAG;RGS5;GNG7;METAP2;YWHAB;RGS3;PLCB1;METAP1;USP33;PLEK;RPGRIP1L;ZDHHC7
prerank,response to purine-containing compound (GO:0014074),-0.32428350054806243,-0.8799647827247964,0.6411378555798687,0.89276691913598,1.0,9/17,40.83%,P2RX4;ABCC9;STAT1;DGKQ;TRPC3;P2RY1;TRPM2;P2RY6;VGF
prerank,axonemal dynein complex assembly (GO:0070286),0.31365249429623865,0.8799275820431263,0.626057529610829,0.9859032391983228,1.0,2/27,6.56%,CFAP73;DNAL1
prerank,mitotic cell cycle phase transition (GO:0044772),0.22793188621774166,0.8796118756017247,0.7330729166666666,0.9858981069452709,1.0,32/203,14.94%,FBXL6;ALMS1;PLK2;PPP2R2D;HAUS5;CEP41;HAUS4;CLASP2;TUBB;CCNH;DCTN2;CDKN1A;POLE;ODF2;CDK4;WEE1;LATS2;CCNG2;DCTN3;CEP164;ANAPC7;PLCB1;PPP1R12A;CHMP2A;DYNLL1;USP37;E2F3;CUL3;CHEK2;PHF8;RCC1;DYNC1I2
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.22016034972803913,-0.8790278636055211,0.7267267267267268,0.8942503997193134,1.0,36/96,25.47%,SRSF5;SRSF11;CASC3;SRSF2;ALKBH5;SRSF6;NUP205;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;NUP93;NUP88;DDX19B;SEH1L;THOC5;SLU7;CDC40;UPF1;RNPS1;NUP85;AAAS;CPSF3;RAE1;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13;ZC3H11A
prerank,cilium movement (GO:0003341),0.27874592435366696,0.8788682097553253,0.6511627906976745,0.9869756319946237,1.0,2/47,2.16%,CFAP73;CABYR
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.28514344276087,0.8786704639462727,0.6719745222929936,0.9867147893464524,1.0,5/39,8.70%,ERCC3;ERCC4;POLK;POLD3;GTF2H1
prerank,calcium ion homeostasis (GO:0055074),-0.22267463718523356,-0.878617694833093,0.7526501766784452,0.8944706990993025,1.0,7/95,3.45%,ANK2;SLC24A3;HTR2C;STIM2;ATP1B1;STIM1;ATP13A5
prerank,cellular response to oxygen-containing compound (GO:1901701),0.21933469278225615,0.878558997898896,0.7684210526315789,0.986209862816995,1.0,39/291,13.25%,CERS1;MAPK3;ROMO1;BRINP3;INSIG1;TNFAIP3;RUVBL2;RPTOR;ACTB;MTR;TIRAP;SBNO2;ZFP36L1;TSHR;CCDC62;TNFRSF1B;ZFAND1;MAPK8;TBX1;CARD16;GNB1;RET;LAMTOR1;RAPGEF3;WNT5A;RELA;LYN;NFKBIL1;ESR1;P2RX7;RPS3;IP6K2;TNIP2;PLAA;LARS1;RRAGC;CHUK;CD274;NDUFA13
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.2876635012718832,-0.8779971036677708,0.67,0.895142064490343,1.0,9/25,32.82%,SMAD3;P2RX4;DDAH1;PTGS2;AKT1;HSP90AA1;DDAH2;ASS1;EDN1
prerank,response to retinoic acid (GO:0032526),-0.23690233082644166,-0.8776671775228672,0.7277777777777777,0.8951842524420555,1.0,15/59,17.28%,WNT5B;BRINP1;PTK7;RBP4;BRINP2;SNW1;RXRA;EPHA3;RARA;WNT9A;ATM;SETX;ABL2;FZD4;TWF2
prerank,L-glutamate transmembrane transport (GO:0015813),0.39352753950589253,0.8776495367377781,0.6124031007751938,0.9876764117310994,1.0,3/10,12.68%,SLC1A1;SLC1A2;SLC25A12
prerank,cytoplasmic microtubule organization (GO:0031122),0.2725763901297743,0.8771749762422032,0.6511254019292605,0.9881029542458384,1.0,9/54,8.01%,TUBGCP5;SLK;CIB1;DST;CRIPT;CCDC88C;CLIP2;CAMSAP2;TRPV4
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3638494988873191,0.8769943801200181,0.6313725490196078,0.9877909468199171,1.0,4/14,14.30%,RAP2A;MYO9A;OPHN1;PATJ
prerank,substrate-dependent cell migration (GO:0006929),0.3660080506121335,0.8769045555481308,0.6209964412811388,0.9872615362760295,1.0,5/14,17.02%,PTPRC;ITGA2;OPHN1;VEGFC;CD2AP
prerank,cortical actin cytoskeleton organization (GO:0030866),0.32537948364262226,0.8765202120479197,0.6187943262411347,0.9874438705514456,1.0,6/20,16.92%,LCP1;RHOQ;IKBKB;PLEK;ARF6;STRIP1
prerank,placenta development (GO:0001890),0.368884590050882,0.8762328426904152,0.6337209302325582,0.9874253828130828,1.0,1/12,2.27%,SOD1
prerank,sulfur compound transport (GO:0072348),-0.28549576049554115,-0.8759905825320974,0.660377358490566,0.8983117838858021,1.0,14/27,32.46%,SLC6A13;LRRC8D;SLC26A7;SLC13A4;SLC35F3;SLC27A1;SLC26A11;SLC5A6;SLC25A30;SLC19A2;SLC25A11;MGST1;SLC36A1;SLC25A19
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.3039706336066008,0.875949755880601,0.6470588235294118,0.9873967329476148,1.0,8/29,18.23%,UTP20;RPS21;RPS14;NGDN;HELB;HEATR1;DCAF13;RPS8
prerank,cellular response to inorganic substance (GO:0071241),-0.2991058298018891,-0.8759485462803916,0.6280193236714976,0.8977269262164344,1.0,11/21,39.11%,KCNC2;SPIDR;DDI2;RTF2;BLM;GUCY1B1;CDK2;DDX11;NSMCE3;MT3;TIMELESS
prerank,positive regulation of immunoglobulin production (GO:0002639),0.3020100526887559,0.8758455587548006,0.6471631205673759,0.9869133224487093,1.0,9/31,21.31%,PTPRC;PHB2;GPI;KMT5B;DNAJB9;TFRC;XBP1;KMT5C;STX4
prerank,regulation of monooxygenase activity (GO:0032768),-0.298311499478831,-0.8758272585251878,0.6477832512315271,0.8972923927539325,1.0,12/23,30.89%,EGFR;WASL;ZDHHC21;DDAH1;NOSIP;AKT1;HSP90AA1;DDAH2;CYGB;SNCA;CAV1;POR
prerank,fatty acid catabolic process (GO:0009062),-0.22809450895121422,-0.8755566084189155,0.7300613496932515,0.8972273940841706,1.0,25/67,31.48%,ACBD5;ECI2;PCCB;LPIN1;ALDH3A2;ABCD2;ACAD11;CPT2;PHYH;PEX2;PCCA;ABHD3;EHHADH;ACAD10;LPIN2;ECHDC2;NUDT7;ACAT2;ABCD3;ECI1;LPIN3;SLC27A4;PECR;MCEE;PLA2G15
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.3380582972317675,-0.8755558025483139,0.6401766004415012,0.8965324077215957,1.0,8/15,45.20%,IL17RA;GBP5;APPL1;IL17D;TICAM1;NOD2;MYD88;TLR4
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.3842920156433265,0.8752702012545864,0.6268939393939394,0.9875505141948424,1.0,5/11,20.37%,SRC;ARHGEF7;CD44;CORO1C;ENPP2
prerank,regulation of mast cell degranulation (GO:0043304),0.3661255090655553,0.8748914358379785,0.623574144486692,0.9877793983219855,1.0,3/14,9.52%,SYK;LYN;CD84
prerank,positive regulation of protein sumoylation (GO:0033235),0.38849457196765763,0.8746199319269892,0.6210131332082551,0.9876869044224208,1.0,3/10,11.30%,SAE1;UBA2;PIAS1
prerank,positive regulation of cytokinesis (GO:0032467),-0.2743841042518385,-0.8743654699425416,0.6642335766423357,0.8985164923816561,1.0,3/32,5.99%,SVIL;RHOA;CIT
prerank,homotypic cell-cell adhesion (GO:0034109),-0.25944621751327995,-0.8739219572626683,0.7029702970297029,0.8988397319519701,1.0,11/39,16.25%,MEGF11;TLN1;FLNA;PLPP3;VCL;PDGFRA;UBASH3B;FN1;ILK;STXBP1;MEGF10
prerank,regulation of leukocyte activation (GO:0002694),0.35681261286484517,0.8738674553845276,0.6223908918406073,0.9888154736487544,1.0,3/14,10.60%,PJA2;LYN;MFHAS1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3232516362591177,0.8738174210090307,0.6384892086330936,0.9881847003176171,1.0,6/23,11.20%,HDAC7;IFI35;NLRC3;RELA;DDX3X;ADIPOR1
prerank,response to glucose (GO:0009749),0.2776017599825141,0.8735953846265904,0.6610169491525424,0.9879616856337351,1.0,6/46,11.28%,PCK1;SELENOT;IRS2;EIF2B3;PRKAA2;ZBED3
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.3193886557808514,0.8735089188944207,0.6296928327645052,0.9874324262284369,1.0,2/23,2.02%,CBL;PTPRC
prerank,iron ion transport (GO:0006826),-0.24462783769877267,-0.8728662404502188,0.6783783783783783,0.9006219735988085,1.0,9/47,12.78%,CP;ATP6V1E1;ATP6V0B;SLC39A14;SCARA5;TCIRG1;ATP6V0A4;STEAP3;ATP6V0C
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.25237737707456953,0.8728609815252306,0.6880466472303207,0.9882190928214001,1.0,11/77,10.75%,MAZ;NR4A2;BCL2L2;SRC;SLC35F6;BDNF;ITGA6;RELA;FZD9;PARK7;DDX3X
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.3044584780256677,-0.8725574634265474,0.6596244131455399,0.9006045212238566,1.0,10/20,24.23%,BICD1;MGRN1;GRK3;RNF157;GPRASP1;CRY1;STMN1;MET;GRK2;APLP1
prerank,positive regulation of ATPase activity (GO:0032781),-0.2570862658448746,-0.8722185698899642,0.6826196473551638,0.9006587781134608,1.0,9/41,12.77%,TOR1AIP2;ATP1B1;DNAJC24;TPM1;ATP1B3;TOR1AIP1;ATP1B2;PLSCR1;MSH2
prerank,positive regulation of cytoskeleton organization (GO:0051495),-0.22511102108891368,-0.8720292086203709,0.7631578947368421,0.9004308105854318,1.0,16/76,18.57%,NTRK3;NRP1;DYNC1H1;FER;CTTN;BIN1;SYNPO2;BAIAP2L1;FCHSD2;PFDN2;WDR1;CDC42EP5;NES;CDC42EP1;CDC42;SEMA5A
prerank,negative regulation of platelet activation (GO:0010544),0.3527119270770166,0.8719246921697693,0.6259541984732825,0.9896937010964155,1.0,6/16,21.02%,PRKG1;APOE;NOS3;CD9;THBD;PDGFB
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.29570390134270197,0.8718616042721163,0.686541737649063,0.9890969571460949,1.0,8/33,10.86%,GPAM;EP300;AXIN1;PKN1;PARK7;RNF6;ESR1;CARM1
prerank,carbohydrate derivative transport (GO:1901264),0.3389397412182596,0.8716932816914855,0.6173752310536045,0.9887791608951825,1.0,7/18,20.14%,SLC10A7;SLC29A1;SCARB1;NPC2;PLTP;ABCG1;SLC15A2
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.22955902798375438,-0.8714031403412801,0.7507692307692307,0.9011345016036756,1.0,40/69,33.55%,RPRD1B;POU2F1;ELL;PHAX;SRRT;GTF2A1;CDK7;CCNT1;POLR2A;SNAPC3;TAF8;INTS10;CCNK;INTS8;INTS11;TAF6;GTF2E2;CDK9;NABP2;GTF2B;INTS7;SNAPC4;TAF13;NCBP2;POLR2K;INTS12;GTF2E1;INTS9;TAF11;POLR2H;INTS3;ZC3H8;NABP1;POLR2G;POLR2F;POU2F2;POLR2C;TAF5;GTF2F1;INTS1
prerank,cellular response to hexose stimulus (GO:0071331),0.3259145351473039,0.8712038033139352,0.6282527881040892,0.9892113093157513,1.0,1/23,0.02%,PCK1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.3750353958653841,0.8712016857886193,0.618860510805501,0.9884864976450799,1.0,3/12,13.89%,NOTCH1;N4BP2L2;HES1
prerank,negative regulation of actin filament polymerization (GO:0030837),0.3253850383028435,0.8708293556912601,0.6583184257602862,0.9886253262979241,1.0,4/22,6.30%,PFN1;CYRIB;KANK3;SSH2
prerank,carboxylic acid metabolic process (GO:0019752),-0.26863468072831764,-0.8707902119041188,0.7004716981132075,0.9017778025857678,1.0,5/33,7.13%,PLA2G4A;DDO;GLUD1;CYB5A;PTGIS
prerank,cellular amide metabolic process (GO:0043603),0.2417094940215457,0.870715610548702,0.7157142857142857,0.9881443532094031,1.0,10/102,6.76%,ALDH1L1;MLYCD;PPP2CA;PANK2;MME;PLAAT3;DBI;MTHFS;GPAT4;PLPP1
prerank,erythrocyte development (GO:0048821),0.3862890775318827,0.8704892529366537,0.6215139442231076,0.9879350896194995,1.0,1/10,1.65%,ABCB10
prerank,DNA geometric change (GO:0032392),-0.29318550309996005,-0.8701443164698581,0.675990675990676,0.9025508366256101,1.0,10/24,20.94%,DDX1;RAD50;HNRNPA2B1;MRE11;ANXA1;MCM9;BLM;SUPV3L1;RECQL;RTEL1
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.29280393563480395,-0.8697209840864131,0.662870159453303,0.9021024475475795,1.0,6/23,11.69%,DAB2;SMAD4;ZEB2;SNW1;THBS1;STK11
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.29280393563480395,-0.8697209840864131,0.662870159453303,0.9021024475475795,1.0,6/23,11.69%,DAB2;SMAD4;ZEB2;SNW1;THBS1;STK11
prerank,positive regulation of DNA recombination (GO:0045911),-0.2866671168388695,-0.8696871896846976,0.6738095238095239,0.9014831564620802,1.0,7/27,19.62%,ERCC6;PAXIP1;SHLD1;MMS19;ACTR2;PARP1;RIF1
prerank,histone H4 deacetylation (GO:0070933),-0.3715800784327389,-0.8696003177132353,0.6702127659574468,0.9009803671714269,1.0,3/10,4.61%,HDAC4;HDAC1;SIRT2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.21554579313251332,0.8694439630451771,0.8243559718969555,0.9897350080684111,1.0,60/336,15.76%,ERCC3;ZRANB3;RAD18;MAPK3;TRIM28;SLF1;ACER2;VAV3;PNKP;BCL2L2;UBA1;ERCC4;RAD1;YY1;RBBP6;TNFRSF1B;HPF1;APLF;POLK;CDKN1A;CIB1;SIRT1;USP47;GTF2H1;AKTIP;SPRTN;POLA1;LYN;RAD51B;RFWD3;PAK1;PARK7;MSH3;SUSD6;ALKBH7;CHCHD6;APTX;HUS1;RPS3;KMT5B;PWWP3A;NBN;HELB;DOT1L;MAPK12;TRRAP;DDIT3;CHEK2;TLK2;MAP2K6;APC;BACH1;FANCL;UBA6;INO80;BCL6;UBQLN4;DYRK2;ATR;TAF1
prerank,histone H4-K16 acetylation (GO:0043984),0.3345441260924107,0.8693601812525087,0.6598513011152416,0.9892073947047313,1.0,7/19,18.88%,JADE3;ING4;KANSL2;KANSL3;HCFC1;MSL2;MSL3
prerank,cellular response to alkaloid (GO:0071312),-0.31584575800352627,-0.8692778247864091,0.6554054054054054,0.9009931590096191,1.0,5/17,22.55%,RYR3;SPIDR;CASP7;BLM;CASP3
prerank,negative regulation of ossification (GO:0030279),0.3151840334691899,0.869240865412356,0.650709219858156,0.9887461510223942,1.0,6/23,16.36%,GREM1;NOTCH1;TRPM4;RBPJ;PTK2B;LRP4
prerank,cell cycle G2/M phase transition (GO:0044839),0.23644832981521874,0.8688604487000494,0.7162726008344924,0.9889657703885124,1.0,17/129,10.64%,FBXL6;ALMS1;HAUS5;CEP41;HAUS4;TUBB;CCNH;DCTN2;CDKN1A;ODF2;WEE1;DCTN3;CEP164;PLCB1;AKAP8L;PPP1R12A;DYNLL1
prerank,negative regulation of protein localization to membrane (GO:1905476),0.3110946362637699,0.868833841142505,0.6423841059602649,0.9882875104013157,1.0,7/24,16.87%,RSC1A1;RHOQ;PICALM;TMEM59;AP2M1;LZTFL1;PPP2R5A
prerank,tRNA 5'-leader removal (GO:0001682),0.36564865480268194,0.868745252883185,0.6207584830339321,0.9877778732765283,1.0,3/13,15.03%,RPP25L;POP5;SSB
prerank,macrophage differentiation (GO:0030225),-0.3484439347266843,-0.8683678638429986,0.6434599156118144,0.9023288401660012,1.0,5/13,22.43%,BMP4;IL31RA;CDC42;PARP1;VEGFA
prerank,nucleotide catabolic process (GO:0009166),-0.32641382330073443,-0.8683288798643459,0.6339285714285714,0.9017086707179792,1.0,8/16,33.80%,VCP;XDH;DERA;NUDT3;ITPA;GPX1;NT5C;GDA
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.2875138412919115,0.868221566525975,0.6612641815235009,0.9883220470708186,1.0,8/39,13.07%,DYNC1I1;MYO5A;ACTN4;TANC2;RAB1A;MYO1D;PPFIA2;MYO1E
prerank,protein depolymerization (GO:0051261),-0.27892081620083936,-0.8681678086814002,0.6448598130841121,0.901383942182433,1.0,8/27,17.28%,GSN;MICAL2;MICAL3;STMN2;CKAP5;WDR1;STMN1;TWF2
prerank,prostaglandin biosynthetic process (GO:0001516),-0.31347594886647234,-0.8678596310042908,0.6729559748427673,0.9013626323915999,1.0,3/18,7.13%,PTGDS;PLA2G4A;PTGIS
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3706582894793319,0.8677145254828162,0.6044624746450304,0.9888194091551937,1.0,2/12,9.34%,PTPRC;LYN
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.24609294154714928,-0.867622674863798,0.7329842931937173,0.9011908742879546,1.0,8/50,11.62%,NFAT5;SASH1;EGFR;RHOA;IRAK1;EIF2AK2;ILK;NR3C2
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.3829386117393519,-0.8675835094369313,0.6407563025210085,0.9005864276479981,1.0,4/10,16.74%,PARP14;PIBF1;NF2;PTPN2
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3637713828011362,0.8674999912182484,0.6299810246679317,0.9885943730663924,1.0,2/13,5.66%,ALG6;ALG8
prerank,phagosome acidification (GO:0090383),0.31201790440939353,0.8674751231874637,0.6554621848739496,0.987934186708983,1.0,4/26,8.45%,ATP6V1D;RAB7A;ATP6V0D1;ATP6V0E1
prerank,purine-containing compound salvage (GO:0043101),-0.3510800585268694,-0.8671240419731326,0.6447368421052632,0.9008826841242354,1.0,3/12,9.79%,AMPD3;DGUOK;ADK
prerank,prostaglandin metabolic process (GO:0006693),-0.2839187377722475,-0.8670559460953778,0.6597701149425287,0.9003441071506639,1.0,8/26,27.52%,PTGDS;PLA2G4A;PTGIS;PTGES;PTGS2;GSTM1;TBXAS1;HPGDS
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.24952492111504998,0.8669407748548228,0.7096317280453258,0.988481309028146,1.0,21/87,16.95%,CBL;MAP3K7;LRRC32;SRC;SMAD1;TGFBRAP1;SMAD7;F11R;SIRT1;ARHGEF18;ACVRL1;CLDN5;NLK;USP15;ZFYVE9;CDH5;USP9X;PARD3;HPGD;FKBP1A;ADAM9
prerank,monocyte chemotaxis (GO:0002548),-0.2717787775242525,-0.8668549790505925,0.7,0.9000882892576806,1.0,6/32,21.82%,IL6R;ANXA1;CCL14;PTPRO;CX3CL1;CCL13
prerank,positive regulation of viral genome replication (GO:0045070),0.29725425509189557,0.8664155958295104,0.6377551020408163,0.988951167135378,1.0,7/29,12.24%,IFIT1;ADAR;CNOT7;RAD23A;SRPK2;DDX3X;TMEM39A
prerank,protein localization to condensed chromosome (GO:1903083),0.3684873836726379,0.8663893586209676,0.6236363636363637,0.9882901753771784,1.0,3/12,14.70%,CHAMP1;MIS12;MTBP
prerank,positive regulation of DNA binding (GO:0043388),-0.2622823622150412,-0.8663857497703631,0.6919315403422983,0.900435941323102,1.0,7/31,16.33%,IGF1;SIRT2;SKI;FOXC1;NIBAN2;NGF;TGFB1
prerank,mRNA 3'-end processing (GO:0031124),-0.22442870853623043,-0.8663682175427175,0.7357357357357357,0.899800790181728,1.0,27/78,24.32%,SRSF5;SRSF11;PABPN1;CASC3;RPRD1B;SRSF2;SRSF6;SRSF1;POLDIP3;DDX39B;CSTF3;CDC73;SYMPK;CSTF2;THOC5;SLU7;PAF1;CDC40;RNPS1;GRSF1;CPSF3;PABPC1;EIF4A3;TUT1;NCBP2;THOC1;RBM8A
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3586503394908184,-0.8662198726489057,0.6352459016393442,0.8994263947862831,1.0,5/12,28.92%,PPARA;ABCA5;ABCA1;NR1H2;ITGB3
prerank,regulation of viral life cycle (GO:1903900),-0.3040999086062385,-0.8655432546635232,0.65807962529274,0.9002052684420686,1.0,8/21,25.91%,HS3ST5;AXL;TSG101;TRIM5;VPS4A;NECTIN2;TRIM62;PPIA
prerank,positive regulation of double-strand break repair (GO:2000781),-0.25473661001981474,-0.8652511183228657,0.7120418848167539,0.900145502978774,1.0,13/39,21.21%,SPIRE1;SPIDR;FMN2;ERCC6;SHLD1;MGMT;PARP3;MMS19;ACTR2;SMCHD1;PARP1;RIF1;DTX3L
prerank,regulation of chromosome segregation (GO:0051983),0.34714541400710464,0.8652365576040842,0.666077738515901,0.9903396275912718,1.0,1/16,0.79%,RAD18
prerank,protein-containing complex subunit organization (GO:0043933),0.2393416455479465,0.864972927236853,0.7321688500727802,0.9902458284333647,1.0,27/109,17.73%,SH3BGR;CAPZA2;KIFAP3;SKAP2;NDUFAF1;KPNA3;NUP54;MAGI1;GEMIN5;SLC2A1;MDM2;TFAP4;CREBBP;ELOB;PICALM;NUP35;HES1;APC;PARD3;NDC1;DNM1L;PTK2B;TUBGCP2;LIN7A;CD2AP;CAPZA1;ST13
prerank,sterol homeostasis (GO:0055092),0.2588806747481879,0.8646932119787514,0.7039764359351989,0.9901627734995649,1.0,10/65,13.68%,INSIG1;HDAC9;APOE;SOAT1;LAMTOR1;SIRT1;SCARB1;LDLRAP1;NPC2;NPC1
prerank,histone H3-K9 demethylation (GO:0033169),0.38147952332593993,0.8646604169942884,0.6111111111111112,0.9895114386352357,1.0,6/11,19.34%,KDM3A;KDM4D;JMJD1C;PHF8;KDM4C;KDM3B
prerank,regulation of microtubule depolymerization (GO:0031114),0.31218861562234806,0.8646399015734377,0.6571936056838366,0.988837883613781,1.0,6/25,8.01%,CLASP2;MAP1S;CIB1;FGF13;CAMSAP2;TRPV4
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.33192230298031755,0.8645642684200168,0.6481149012567325,0.9882916575983564,1.0,3/18,9.24%,POLE;POLD3;POLA1
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.3251376916230756,-0.8645606163526064,0.6492027334851936,0.9009235100247186,1.0,3/16,20.22%,CLDN11;CLDN14;CLDN12
prerank,amyloid-beta metabolic process (GO:0050435),0.3463398349194894,0.8644729704159383,0.6238532110091743,0.9877944815469232,1.0,2/16,4.46%,PSEN2;MME
prerank,peptide catabolic process (GO:0043171),0.32217410958219717,0.863926492219839,0.6649659863945578,0.9884057625273932,1.0,1/23,0.21%,LVRN
prerank,response to muscle stretch (GO:0035994),-0.32980479476584496,-0.8638347411542081,0.654945054945055,0.9017963938332902,1.0,2/15,3.91%,GSN;CTNNB1
prerank,cholesterol homeostasis (GO:0042632),0.2602278569184412,0.8636502481890952,0.6992481203007519,0.9883448690206547,1.0,10/64,13.68%,INSIG1;HDAC9;APOE;SOAT1;LAMTOR1;SIRT1;SCARB1;LDLRAP1;NPC2;NPC1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.3663322422576168,0.8633869954662429,0.632295719844358,0.9882385525550909,1.0,4/12,18.03%,SIRT1;ING2;CD44;RPL26
prerank,tRNA transport (GO:0051031),0.29071917104421435,0.8631519179137516,0.659432387312187,0.9880763663093414,1.0,11/35,19.50%,TOMM20;NUP54;NUP50;NUP35;YBX1;SSB;NDC1;NUP160;POM121;NUP42;NUP133
prerank,negative regulation of macrophage activation (GO:0043031),0.3468040668002475,0.8630114225409379,0.6361974405850092,0.9876904814503825,1.0,2/16,2.28%,PTPRC;FCGR2B
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.27503835081857214,0.8625173341471173,0.7023026315789473,0.9881291617264586,1.0,9/44,13.86%,EBP;INSIG1;HMGCR;SC5D;OSBPL1A;PARK7;HSD17B4;ACOT8;OSBPL2
prerank,pentose-phosphate shunt (GO:0006098),0.3775257883268216,0.8621879386301144,0.6489151873767258,0.9881824667687942,1.0,3/11,11.74%,TALDO1;RPIA;PGLS
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.36141563085376277,0.862093726025026,0.6420664206642066,0.9876810185444248,1.0,1/14,0.62%,IMPDH1
prerank,C21-steroid hormone metabolic process (GO:0008207),0.32718593832941667,0.8617246415403307,0.6471663619744058,0.9878422732739509,1.0,3/20,15.98%,TSPO;STARD3NL;STARD3
prerank,regulation of RNA splicing (GO:0043484),0.2592260105193573,0.8614307663764778,0.6894977168949772,0.9878037951313912,1.0,11/69,8.03%,KHDRBS3;RBM22;HNRNPH2;SF1;QKI;HNRNPK;FAM50A;SRSF10;RBM20;RPS26;YTHDC1
prerank,Golgi inheritance (GO:0048313),-0.36062390225423085,-0.8613693159175987,0.6568421052631579,0.9064275381528489,1.0,2/11,11.74%,GOLGA2;STK25
prerank,mesenchymal to epithelial transition (GO:0060231),-0.37774687629914433,-0.8612979434640774,0.6255144032921811,0.9058956916099773,1.0,5/10,24.71%,BMP4;SALL1;FZD7;PAX2;BASP1
prerank,regulation of cell size (GO:0008361),0.3097092499002468,0.861290114794282,0.648506151142355,0.987420434553751,1.0,5/23,13.32%,VAV3;RPTOR;AKT1S1;LARS1;PLEK
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.29102540243348385,0.861212867191673,0.6587837837837838,0.9868567636701165,1.0,7/33,13.44%,EZH2;RPTOR;PHB2;RGCC;PLCB1;DDX3X;ANKRD17
prerank,regulation of proteolysis (GO:0030162),-0.24773799421982173,-0.8611471964236039,0.7081218274111675,0.9055101153695202,1.0,20/48,30.72%,OGT;CYFIP2;FBXW11;BTRC;IST1;CAMK2N1;NEDD8;GSAP;TBC1D10A;RNF139;STUB1;BAG6;CLN3;AKT1;PERP;HDAC6;FGFR4;CDK5;CAV1;DNAJC1
prerank,glycolytic process (GO:0006096),0.3085839108067552,0.8610475596461317,0.6354515050167224,0.9865302992299263,1.0,3/28,10.79%,ENO4;TPI1;GPI
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.38338402963439067,0.8606667132025024,0.6517509727626459,0.9867199395252502,1.0,2/10,9.47%,UPP1;UPP2
prerank,gene silencing by miRNA (GO:0035195),-0.2717926547222158,-0.8604549196435192,0.6862745098039216,0.9062452260160748,1.0,8/32,14.53%,ZC3H7A;PUM1;ZC3H7B;PUM2;AGO3;RBM4;LIMD1;DICER1
prerank,glycosphingolipid metabolic process (GO:0006687),0.2821208172515429,0.860453695018303,0.675,0.9864999733850769,1.0,6/42,6.56%,GLB1;SMPD4;ST6GALNAC3;ESYT2;UGCG;ST8SIA1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.2748460615256072,-0.8603982511351214,0.6816037735849056,0.9056916515153586,1.0,10/29,25.86%,DDO;GSTZ1;ALDH4A1;ACADSB;PRODH;KYAT1;HOGA1;FAH;SARDH;MTRR
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.29987385984021075,-0.8602270135447906,0.6753554502369669,0.9053668634472962,1.0,7/20,20.43%,OSR1;HECW1;CAB39;ACTN2;CAMK2D;HECW2;NEDD4
prerank,mitochondrion localization (GO:0051646),-0.30647125060342373,-0.8596226763318204,0.672566371681416,0.9058922624030866,1.0,13/19,48.61%,TRAK1;NECTIN2;MFN1;ATCAY;MARK2;MSTO1;MUL1;BRAT1;TRAK2;MEF2A;MTM1;TLE6;HAP1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3174014776673188,0.8593922104240377,0.6484517304189436,0.9881504025060165,1.0,6/22,12.56%,GSK3A;EFNA1;RELA;LYN;PICALM;SP1
prerank,protein mannosylation (GO:0035268),0.32434584046160525,0.8591025085014695,0.6334519572953736,0.9881641322436296,1.0,5/22,12.38%,TMTC2;POMGNT2;DPY19L4;DPY19L1;CRPPA
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.20162762487356095,-0.858918988031767,0.8237547892720306,0.9067680876746707,1.0,12/140,8.09%,LPAR1;HTR2C;CACNA1C;ADCY5;DLG4;PLCE1;P2RX4;EDNRA;PDGFRA;ADRA1B;FIS1;CCR9
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.37249478848313733,0.8587980709100446,0.615686274509804,0.9881667501296045,1.0,3/10,8.12%,NEXMIF;RGCC;NOTCH1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.30232122904826486,0.8584832495433188,0.6855670103092784,0.988174580333299,1.0,9/29,15.89%,LEF1;EP300;RUVBL1;TERT;CREBBP;TLE4;TRRAP;SMARCA4;TCF7L1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.36448061440271673,0.8582461282196763,0.6389413988657845,0.9880299385174062,1.0,3/12,15.98%,TSPO;STARD3NL;STARD3
prerank,response to iron ion (GO:0010039),-0.35321487706972277,-0.8580755543543033,0.6674107142857143,0.9078879222224746,1.0,1/12,0.21%,BMP6
prerank,positive chemotaxis (GO:0050918),-0.3148125319642872,-0.8579052173193085,0.6566523605150214,0.9075573530112743,1.0,10/17,33.48%,NRP1;SCG2;TSC2;SEMA5A;MET;CX3CL1;VEGFA;SCRIB;FGF10;FGF7
prerank,RNA export from nucleus (GO:0006405),-0.21516666980573473,-0.8577949440204594,0.780952380952381,0.9070979967883291,1.0,37/100,25.47%,SRSF5;SRSF11;CASC3;SRSF2;ALKBH5;SRSF6;NUP205;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;HNRNPA1;NUP93;NUP88;DDX19B;SEH1L;THOC5;SLU7;CDC40;UPF1;RNPS1;NUP85;AAAS;CPSF3;RAE1;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13;ZC3H11A
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.29126342535804334,-0.8577868424331585,0.6502347417840375,0.9064328015538629,1.0,9/23,19.50%,PRKAG2;BMP7;CEMIP;CAB39;TNKS1BP1;WNK3;UBE2K;TGFB1;IRGM
prerank,positive regulation of myelination (GO:0031643),0.36902781392215217,0.8575940006882603,0.6437847866419295,0.9888380264516117,1.0,3/11,14.68%,TNFRSF1B;TENM4;PARD3
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.32125537161013296,-0.8572217227467134,0.66,0.9069609832545962,1.0,7/16,24.31%,ABHD5;LDLR;SLC27A1;GPLD1;SREBF1;CTDNEP1;NR1H2
prerank,cellular response to reactive oxygen species (GO:0034614),0.2595166278885191,0.8571130254998706,0.7054263565891473,0.9892728086750118,1.0,10/59,12.92%,MAPK3;ROMO1;TNFAIP3;MAPK8;SIRT1;RELA;CYP1B1;PARK7;RPS3;CHUK
prerank,positive regulation of isotype switching (GO:0045830),-0.3225399701016023,-0.8569978098102152,0.6659877800407332,0.9067517566787738,1.0,9/15,41.94%,PAXIP1;SHLD1;TGFB1;RIF1;SHLD2;CD40;MAD2L2;CLCF1;TNFSF13
prerank,positive regulation of transport (GO:0051050),0.24934248478478352,0.8568596045125266,0.7448680351906158,0.9891296417660549,1.0,10/85,9.14%,GSK3A;FCGR2B;CAMK1D;ACTB;NEDD4L;LMAN2;APOE;ZNF205;MERTK;CD47
prerank,response to muramyl dipeptide (GO:0032495),-0.3522434435047917,-0.8568354069292614,0.6536082474226804,0.9064232750511062,1.0,4/12,18.73%,VIM;TRIM41;PTPN22;CHMP5
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.36617588339736074,0.8565636252156766,0.6278195488721805,0.9891237616489027,1.0,4/12,16.27%,CCT2;CCT5;TCP1;DKC1
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.2739761689116993,0.8563458474616189,0.7048929663608563,0.9889276704645352,1.0,5/43,6.50%,CBL;PTPRJ;RAB7A;EPS15L1;ARHGEF7
prerank,protein-containing complex disassembly (GO:0032984),0.26448159008508515,0.8562481192434566,0.7027027027027027,0.9884580871231089,1.0,8/54,10.91%,MAP1LC3B;HSPA8;RPL23;AXIN1;PYM1;EPG5;TECPR1;UBQLN1
prerank,regulation of dendritic spine development (GO:0060998),0.328936315262172,0.8562177052568344,0.6345454545454545,0.9878264542411975,1.0,5/19,15.68%,SHANK3;APOE;TANC2;PPFIA2;ARF6
prerank,response to sterol (GO:0036314),-0.3477751668499748,-0.8560663276832665,0.6482300884955752,0.9074137888179108,1.0,4/11,16.96%,TGFBR1;TGFBR2;TGFB1;RORA
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.3027237114736686,-0.85602878558664,0.6666666666666666,0.9068033408749137,1.0,3/18,14.79%,WNK1;PPARA;PTPN22
prerank,mitotic spindle assembly (GO:0090307),0.2743460655625619,0.8559501416099324,0.6967213114754098,0.9877308250561232,1.0,11/42,17.26%,ABRAXAS1;CLASP2;MZT1;KIF2A;BCCIP;KIF3B;CHEK2;ARHGEF10;STAG2;KPNB1;CLASP1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.34870990589780015,0.8559366990150565,0.6574074074074074,0.9870682428250381,1.0,2/14,9.27%,MAPK3;CSF1R
prerank,positive regulation of reproductive process (GO:2000243),-0.2639442857177746,-0.8556501286713917,0.731651376146789,0.9069290673248964,1.0,5/31,12.45%,SMURF2;SIRT2;LHFPL2;GLRA1;ACVR1B
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.3353839161098834,0.8555242752241161,0.6660412757973734,0.9872598671351346,1.0,5/19,12.58%,PRKCH;F11R;TJP1;CLDN5;IKBKB
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.23506369016273468,-0.8554536971710481,0.7577464788732394,0.9067011994408622,1.0,15/55,21.97%,CYLD;TGFBR1;NUPR1;PML;GSDME;FIS1;BCL2L11;TP53;TRIM39;RACK1;TRAF2;TRAF7;LTBR;BCL2;TNFSF12
prerank,nuclear transport (GO:0051169),0.337674592095028,0.855404653252408,0.6559714795008913,0.9868416250158571,1.0,4/16,12.99%,BANF1;NXT1;RSRC1;XPO1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.2786486739191263,0.8553487716118079,0.657331136738056,0.9862715263181676,1.0,8/40,10.41%,SMG1;FXR1;FBXO5;UBE2V2;BCLAF1;RFWD3;UBE2V1;ING2
prerank,error-prone translesion synthesis (GO:0042276),-0.29401026762778426,-0.8551048213802909,0.6688034188034188,0.9067321924613232,1.0,14/21,42.25%,RFC1;RPA1;UBC;PRIMPOL;RFC2;PCNA;POLE2;POLI;REV3L;RPA3;RFC3;MAD2L2;UBA52;RPA2
prerank,cardiac atrium morphogenesis (GO:0003209),-0.32159328371741636,-0.8543471701456888,0.6720554272517321,0.9076926150715215,1.0,1/16,0.29%,NOTCH2
prerank,mRNA transport (GO:0051028),-0.21268293395715623,-0.8542774529205067,0.8019169329073482,0.9071525623519514,1.0,37/101,25.47%,SRSF5;SRSF11;CASC3;SRSF2;KIF5C;ALKBH5;SRSF6;NUP205;SRSF1;POLDIP3;DDX39B;NXF1;NUP155;NUP188;HNRNPA2B1;SYMPK;NUP93;NUP88;DDX19B;SEH1L;THOC5;SLU7;CDC40;UPF1;RNPS1;NUP85;AAAS;CPSF3;RAE1;NUP37;NUP214;EIF4A3;NCBP2;THOC1;RBM8A;SEC13;ZC3H11A
prerank,cellular response to decreased oxygen levels (GO:0036294),0.25632896449470327,0.8542246494535186,0.7125925925925926,0.9881300458107815,1.0,16/65,13.58%,HIPK2;ZFP36L1;SCN2A;CARD16;RGCC;SIRT1;TSC1;MDM2;TERT;BAD;UBQLN1;HP1BP3;HYOU1;EGLN2;BNIP3L;EPAS1
prerank,folic acid metabolic process (GO:0046655),0.3271404198981897,0.854168932654256,0.6729678638941399,0.9875475856358237,1.0,2/18,6.26%,ALDH1L1;MTHFS
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.34363961511776364,-0.8540079398110981,0.678714859437751,0.9070735663034095,1.0,3/13,13.30%,CYFIP2;LGMN;TBC1D10A
prerank,cell differentiation in hindbrain (GO:0021533),-0.35426358396036706,-0.8540072253505986,0.6774847870182555,0.9064016891474522,1.0,2/11,5.68%,GRID2;ATP7A
prerank,regulation of interleukin-4 production (GO:0032673),0.321333871241104,0.85393531905099,0.6827458256029685,0.9873784998177052,1.0,4/21,17.43%,LEF1;SYK;DDIT3;SLC7A5
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.37707224066549005,-0.8537382526887894,0.6596153846153846,0.9062955921764387,1.0,4/10,31.48%,PLA2G4A;PLA2G6;PLA2G7;PLA2G15
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.31876093427696356,-0.853607406598588,0.6645021645021645,0.905908733069123,1.0,8/16,22.17%,BMP7;RREB1;NAPEPLD;VSTM2A;SIX1;PTGS2;TFE3;FLCN
prerank,substantia nigra development (GO:0021762),-0.25629819132786086,-0.8536041424600117,0.7320574162679426,0.9052434175728618,1.0,8/37,10.00%,PLP1;MBP;RHOA;SIRT2;GLUD1;NDUFS3;NDRG2;CKB
prerank,N-glycan processing (GO:0006491),-0.3133920927032126,-0.8532257872958465,0.6622807017543859,0.9053584505922481,1.0,4/18,10.85%,MAN1C1;FUT8;GANC;MAN2A2
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.32489119881332473,-0.8531913426143818,0.6644295302013423,0.9047574689493119,1.0,3/15,8.19%,BMP4;MED1;FOXC1
prerank,positive regulation of establishment of protein localization (GO:1904951),0.3279050364822194,0.8531877798888312,0.6617647058823529,0.9884071257797192,1.0,5/18,16.27%,CCT2;CCT5;CORO2B;TCP1;DKC1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.3227036237186611,-0.8530618036430642,0.6741071428571429,0.9043385116988423,1.0,7/16,29.11%,OGFOD1;IRAK3;UPF1;CLN3;SHFL;HDAC6;MTRF1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.27440804580523487,0.8528727863253556,0.7164948453608248,0.9884159731196803,1.0,7/42,9.24%,POLK;POLE;SIRT1;POLD3;TRIM25;SPRTN;POLA1
prerank,regulation of neuron death (GO:1901214),0.24738637096281388,0.8528672595759288,0.7140762463343109,0.9877288265281571,1.0,14/82,12.00%,SNCG;FCGR2B;EIF2S1;SIGMAR1;FYN;TNFRSF1B;AKT1S1;WNT5A;TSC1;PARK7;NAE1;EGLN2;PICALM;PRNP
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.34917744639625176,-0.8528413731761347,0.656,0.9041221240994656,1.0,3/11,8.94%,NUPR1;YBX3;BIRC3
prerank,response to steroid hormone (GO:0048545),0.29571300317410476,0.8526136007891864,0.6768707482993197,0.9875838739911951,1.0,3/31,5.01%,SOX30;PAQR8;UBE3A
prerank,response to hexose (GO:0009746),0.3064321726045681,0.8525793761181664,0.6788685524126455,0.9869689436759793,1.0,4/25,11.28%,SELENOT;IRS2;EIF2B3;ZBED3
prerank,positive regulation of exocytosis (GO:0045921),0.28103270814817943,0.8524489995757615,0.6903225806451613,0.9865403836128638,1.0,6/35,10.78%,CLASP2;RAB7A;CADPS;RAB2B;CHMP2A;ATP6AP1
prerank,spliceosomal complex assembly (GO:0000245),0.27487939845762843,0.8524189930317309,0.693200663349917,0.9859078162017271,1.0,8/46,10.63%,SNRPD2;NCBP1;SNRPD1;SF1;SRSF10;YTHDC1;SF3A1;SRPK2
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.36766092120995963,-0.8523530113119824,0.6673596673596673,0.9045005727453594,1.0,4/10,19.62%,JARID2;KDM1A;DNMT1;RIF1
prerank,cortical cytoskeleton organization (GO:0030865),-0.25336293360400175,-0.8522373160621958,0.7015706806282722,0.9040434072480777,1.0,12/41,12.89%,EPB41L3;RHOA;ROCK2;ROCK1;NLGN1;EZR;RND3;RHOBTB2;FHOD1;RHOB;RHOBTB1;DLG1
prerank,carboxylic acid transport (GO:0046942),0.26249435565696827,0.8519716763791126,0.6976377952755906,0.986224771790296,1.0,5/55,5.75%,SLC7A8;SLC1A1;SLC36A4;SLC3A2;SLC6A6
prerank,regulation of response to stress (GO:0080134),0.37978740589377014,0.851821186219565,0.6232464929859719,0.9858943608777686,1.0,3/10,18.87%,STOX1;CORO2B;EIF4G1
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3093158419530445,0.8516012686806188,0.6773109243697479,0.9856546645334867,1.0,3/25,5.56%,TMTC2;WFS1;TRPM7
prerank,response to interferon-beta (GO:0035456),0.3226951875084742,0.8515543092999198,0.6578947368421053,0.9850718340494711,1.0,5/22,13.25%,IFITM2;XAF1;IFITM3;IFITM1;NDUFA13
prerank,positive regulation of protein depolymerization (GO:1901881),-0.3492075714587593,-0.851219253626041,0.660455486542443,0.9055877303486026,1.0,4/11,18.57%,STMN2;WDR1;NES;SEMA5A
prerank,megakaryocyte differentiation (GO:0030219),0.3762187866694113,0.8511528360481546,0.6571969696969697,0.9852881372950224,1.0,1/11,1.51%,TAL1
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.25173810223004756,-0.8511417392789085,0.7474489795918368,0.9050819787182847,1.0,8/39,14.26%,MCU;NLGN2;GLUD1;RBP4;AIMP1;TM7SF3;NNAT;PSMD9
prerank,vesicle transport along microtubule (GO:0047496),0.31736878409244895,0.8511400290733088,0.6844919786096256,0.9846233516632783,1.0,6/23,13.19%,DYNC1I1;KIFAP3;FYCO1;RAB1A;KIF13A;KIF3B
prerank,cyclooxygenase pathway (GO:0019371),-0.3670038956898719,-0.8511398889572924,0.6639004149377593,0.9044225199090762,1.0,6/10,27.52%,PTGDS;PTGIS;PTGES;PTGS2;TBXAS1;HPGDS
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.3465935965766436,0.8510605636266048,0.6809338521400778,0.984105024506864,1.0,5/16,18.79%,MLYCD;SIRT1;ADIPOR1;FOXK2;PDK3
prerank,establishment of epithelial cell polarity (GO:0090162),0.33221766217750115,0.8508653302617729,0.6616541353383458,0.9838400002822674,1.0,7/19,18.62%,RAP2A;MYO9A;OPHN1;PARD3;CLASP1;MYO18A;CYTH1
prerank,peptidyl-amino acid modification (GO:0018193),0.372055219156073,0.8507373280548606,0.6627218934911243,0.9834376765494963,1.0,2/10,10.53%,METAP2;METAP1
prerank,ceramide catabolic process (GO:0046514),0.3442241293048115,0.8507233481084954,0.6461538461538462,0.9827824225420277,1.0,3/14,12.52%,ACER2;ACER3;GM2A
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.35758992698003667,-0.850690281534889,0.6666666666666666,0.9046917338898061,1.0,8/11,44.95%,SERTAD2;ARID1B;PADI2;SERTAD1;ZMIZ2;ELOF1;CDCA4;CHEK1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.31336654756001614,0.8502340923821393,0.6743362831858407,0.983125442642752,1.0,6/22,17.41%,UTP20;RPS21;EXOSC9;WDR12;ERI2;URB1
prerank,positive regulation of protein processing (GO:0010954),-0.3068726830095801,-0.8502251088492052,0.6898148148148148,0.9049822265794336,1.0,4/19,9.62%,GSN;RHBDD1;CLEC3B;CCBE1
prerank,receptor internalization (GO:0031623),0.27456259821886975,0.850190137076741,0.7047619047619048,0.9825431962768748,1.0,9/44,14.61%,SAG;DNM3;RAMP2;SYK;SNX1;CD81;PICALM;LDLRAP1;AP2M1
prerank,B cell proliferation (GO:0042100),0.32525787237120946,0.8493232181977028,0.6556776556776557,0.9838144916786697,1.0,1/17,2.02%,PTPRC
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2643788796101921,0.8492135101275654,0.714968152866242,0.9833754841484174,1.0,9/54,12.92%,TNFAIP3;RFFL;BIRC2;SPATA2;CARD16;SYK;RBCK1;IKBKB;CHUK
prerank,nucleus organization (GO:0006997),0.2684985361647569,0.8491582826967893,0.7056910569105691,0.9828101510809,1.0,12/47,19.50%,SYNE1;LEMD3;NUP54;CHMP1A;REEP3;CHMP2A;NUP35;NDC1;VPS4B;USP36;PITPNB;NUP133
prerank,regulation of lymphocyte activation (GO:0051249),0.37011927181418713,0.849154381825474,0.6711798839458414,0.9821327106752025,1.0,12/12,63.02%,PAG1;SIT1;CD4;CD19;LCK;CRTAM;CCL5;THEMIS2;IKZF3;LAT;DCAF15;KAT2A
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.33059168598943545,0.8490053646303,0.6754850088183422,0.9817445991667683,1.0,5/17,20.24%,BACH2;CD55;STAT3;CD46;BTN3A3
prerank,regulation of tube diameter (GO:0035296),0.36184400467794037,0.8488961139930149,0.667953667953668,0.9806161930930795,1.0,3/13,11.33%,GCLC;GCLM;NOS3
prerank,vascular process in circulatory system (GO:0003018),0.36184400467794037,0.8488961139930149,0.667953667953668,0.9806161930930795,1.0,3/13,11.33%,GCLC;GCLM;NOS3
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.3379385240474079,-0.8487713216419851,0.6795698924731183,0.9073573840412298,1.0,5/13,16.82%,BMP7;BMP4;MED1;NR3C2;NR3C1
prerank,regulation of translational initiation (GO:0006446),0.25509632531806714,0.8487703503701984,0.7234678624813154,0.9801945292807588,1.0,8/63,11.45%,ATF3;NCBP1;EIF3B;PAIP2B;EIF4H;EIF4G2;DDX3X;EIF4B
prerank,peptidyl-lysine trimethylation (GO:0018023),0.30661444650670994,0.8481035063062553,0.6924398625429553,0.9809895077580091,1.0,9/26,17.39%,BEND3;TET3;SETD5;SETD3;SETD1B;KMT5B;ETFBKMT;SETD2;TET2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.3436670879608408,-0.8472151834493897,0.6753812636165577,0.9099321629066951,1.0,4/13,10.73%,ADCY1;RELN;LGMN;EPHB2
prerank,apoptotic nuclear changes (GO:0030262),-0.2829445976717909,-0.8469585282460942,0.698876404494382,0.9097964385056629,1.0,17/24,46.27%,DICER1;DFFA;CASP3;ACIN1;EXOG;H1-0;CDK5RAP3;DNASE2;DEDD2;HMGB1;GPER1;HMGB2;ACVR1C;DFFB;TOP2A;FOXL2;BLCAP
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.3184811880813152,0.8469304718427038,0.6678082191780822,0.9828470049104125,1.0,6/20,16.87%,RSC1A1;RHOQ;PICALM;TMEM59;AP2M1;PPP2R5A
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),-0.326866085785099,-0.8468799421404406,0.6637168141592921,0.9092985084882512,1.0,6/14,30.61%,NRP1;FOXC1;VEGFA;VEGFB;PGF;FLT4
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.3205397059330989,0.8466746846582487,0.7058823529411765,0.9827194249063753,1.0,2/20,2.75%,GSK3A;BCL2L2
prerank,arachidonic acid metabolic process (GO:0019369),-0.25571069961297266,-0.8465616451114144,0.7245657568238213,0.9093104628292475,1.0,4/35,7.13%,PTGDS;PLA2G4A;EPHX1;PTGIS
prerank,regulation of multicellular organism growth (GO:0040014),0.34386725960193526,0.8463562860394074,0.6636197440585009,0.9827364589637498,1.0,3/15,11.24%,SOD1;PPIB;APP
prerank,neuron projection regeneration (GO:0031102),0.38410875398674527,0.8463012051405038,0.6552380952380953,0.9821742319734504,1.0,1/10,2.90%,MTR
prerank,regulation of myotube differentiation (GO:0010830),0.31099939340306604,0.8461765239839943,0.6971235194585449,0.9817664691175632,1.0,5/24,8.12%,HDAC9;HDAC3;ATP11A;BDNF;NOTCH1
prerank,myelination in peripheral nervous system (GO:0022011),0.34900767776358943,0.8461521857920687,0.6437007874015748,0.9811446400914126,1.0,5/13,14.68%,SOD1;NF1;ADGRG6;ARHGEF10;PARD3
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.28593474861677715,0.846037330239747,0.6870860927152318,0.9807048189979827,1.0,6/32,13.04%,AEN;HIPK2;EP300;SIRT1;CDIP1;RRP8
prerank,regulation of p38MAPK cascade (GO:1900744),-0.2542203471246446,-0.8460346887149026,0.7193396226415094,0.9097589721456791,1.0,8/35,14.79%,SASH1;CYLD;XDH;EZR;ULK4;PER1;DLG1;PTPN22
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.30010038025853325,-0.845896051233147,0.7088607594936709,0.909386569824791,1.0,4/21,10.73%,CGNL1;ARHGAP12;LZTR1;EPHB2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.30984639600295055,0.845426015869564,0.6854130052724078,0.9813643054539337,1.0,4/21,9.23%,BIRC2;SOX2;FYN;PCID2
prerank,atrioventricular valve development (GO:0003171),-0.3208184187592446,-0.8452840071714832,0.6795918367346939,0.9098907237273939,1.0,5/14,20.00%,TGFBR2;ACVR1;MDM4;BMPR1A;BMPR2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.3667563295746042,0.8452709978367346,0.6457925636007827,0.9810009422729873,1.0,3/11,14.71%,SIRT1;ING2;CD44
prerank,protein sumoylation (GO:0016925),0.2704034275649874,0.845085159548658,0.7221324717285945,0.9807366266840157,1.0,15/49,18.34%,TRIM28;SAE1;UBE2I;NUP54;UBA2;NUP50;PIAS2;TRPM4;PIAS1;NUP35;NDC1;NUP160;RANGAP1;POM121;NUP42
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.24731167984987895,-0.8449629689346678,0.7467700258397932,0.9098458949488525,1.0,10/42,20.94%,SPIDR;ERCC6;SHLD1;MMS19;KDM1A;ACTR2;SMCHD1;PARP1;RIF1;RTEL1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.2971016987859121,-0.8449601319075662,0.6799163179916318,0.9091862541074593,1.0,3/19,5.58%,AXL;ZBTB1;MMP14
prerank,regulation of chromatin organization (GO:1902275),0.3494719446921843,0.8447878920057789,0.6566371681415929,0.98069472054353,1.0,3/14,13.42%,HPF1;SETD5;TLK2
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.3659573777313161,-0.8446813827687971,0.6569767441860465,0.9084119470869391,1.0,4/10,48.81%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.3659573777313161,-0.8446813827687971,0.6569767441860465,0.9084119470869391,1.0,4/10,48.81%,CEP250;CACNA2D4;TULP1;CNGB1
prerank,serine family amino acid metabolic process (GO:0009069),0.3448972919587072,0.844656272402142,0.6554770318021201,0.9802987239689006,1.0,1/16,0.80%,GCLC
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.23932718605004297,0.8445280822063729,0.7424023154848046,0.9798976361870297,1.0,10/90,7.43%,ALMS1;UCP2;HDAC3;TSHR;KDM3A;ELOVL6;GATM;SYK;OMA1;ADIPOR2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.3284767188231571,0.8442955577409059,0.6767857142857143,0.9797224422173983,1.0,3/17,12.48%,PTPRC;TERT;N4BP2L2
prerank,negative regulation of synaptic transmission (GO:0050805),0.30621074152420574,0.8441592362173392,0.6736111111111112,0.9793404437515424,1.0,3/23,9.21%,PLK2;PNKD;ARF1
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3186069998537631,0.8433377120915432,0.7086330935251799,0.9804129200659906,1.0,7/21,18.22%,PSEN2;SPPL3;DAG1;MYH9;APH1A;ADAM9;SPPL2A
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.27116888316739135,-0.8432745231002703,0.7182044887780549,0.9106184985863142,1.0,16/29,34.23%,RFC1;RAD50;TNKS1BP1;MRE11;RPA1;PPP6C;PPP6R3;RTEL1;TELO2;PPIA;HSP90AA1;CDK2;TERF1;TERF2;GAR1;TINF2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.3306351374414164,0.8425186794501479,0.6852207293666027,0.9814876691061185,1.0,3/17,9.17%,PRKG1;CDKN1A;SOD2
prerank,mRNA metabolic process (GO:0016071),0.24151390835014708,0.8421621437717696,0.7532097004279601,0.9816327162913309,1.0,24/90,17.04%,ZC3H12D;NCBP1;PRPF3;NUDT12;SFPQ;SRSF4;SF3A1;PRMT9;DXO;AKAP8L;U2AF1;CPSF6;AGO4;PTBP1;PCBP3;SRSF7;USP39;SSB;TCERG1;SLBP;RNASE4;U2AF2;CNOT10;NONO
prerank,muscle tissue morphogenesis (GO:0060415),-0.3182495979386705,-0.8418836604443755,0.6828193832599119,0.9127401460624956,1.0,2/16,4.63%,TGFBR3;BMP4
prerank,negative regulation of JNK cascade (GO:0046329),-0.2691980176410487,-0.8418814974345136,0.7156626506024096,0.9120791501207139,1.0,10/31,21.43%,CYLD;TAOK3;HIPK3;PER1;SIRPA;FKTN;DACT1;PTPN22;PINK1;SH3RF2
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.3622469191193925,0.8417678130447038,0.6596558317399618,0.9817912877829357,1.0,2/11,6.20%,ATL1;LPCAT3
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.2831622320717027,0.8415052871163315,0.6844741235392321,0.9817027873022832,1.0,5/34,10.60%,TNFAIP3;RAB7B;LYN;NFKBIL1;MFHAS1
prerank,regulation of developmental growth (GO:0048638),-0.27059623433892466,-0.8412660938023911,0.7297297297297297,0.912618786047789,1.0,6/29,10.74%,IGF1;NRCAM;GHR;CTTN;NIPBL;GSK3B
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.24498279240950074,0.8409464836542058,0.755223880597015,0.9822074489130308,1.0,13/74,11.33%,TNFAIP3;SRC;MAP2K5;RFFL;TNFRSF10B;ICAM1;EYA3;ITGA6;RELA;PARK7;TERT;DDX3X;NOS3
prerank,regulation of cellular catabolic process (GO:0031329),-0.22651732162603772,-0.8405484952063924,0.8156424581005587,0.9133815890009134,1.0,20/62,21.15%,ITPR1;PSAP;DEPDC5;MAPT;NUPR1;USP13;ROCK1;PIP4K2B;ATM;MTMR4;KEAP1;USP10;DAPK2;ABL2;RAB8A;FBXL2;DAPK1;OSBPL7;HSPB1;KAT8
prerank,lipid homeostasis (GO:0055088),0.2613524014914665,0.8403760838709398,0.7320061255742726,0.9827823854355974,1.0,9/57,11.67%,FITM2;APOE;ACOX3;USF2;SIRT1;IRS2;PRKAA2;DDX3X;PNPLA8
prerank,organelle disassembly (GO:1903008),-0.2615794133804066,-0.840292467794724,0.7089552238805971,0.9132300285001548,1.0,8/33,14.37%,ULK2;UFL1;VCP;GOLGA2;DDRGK1;MRRF;TEX264;EIF2D
prerank,postreplication repair (GO:0006301),0.26493225700002876,0.8402648998776433,0.7107438016528925,0.9823537276186636,1.0,7/45,10.19%,RAD18;POLK;UBE2V2;POLD3;TRIM25;SPRTN;UBE2V1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.23473158626891144,0.8400598477409839,0.7909215955983494,0.9821463468826039,1.0,19/112,12.86%,CBL;MAP3K7;LRRC32;SRC;ZFP36L1;SMAD1;TGFBRAP1;SMAD7;F11R;SIRT1;ARHGEF18;WNT5A;ACVRL1;CLDN5;NLK;USP15;ZFYVE9;CRKL;CDH5
prerank,endocrine system development (GO:0035270),-0.2922921287147938,-0.8396166187890525,0.7009803921568627,0.9139008436413385,1.0,5/21,10.03%,GLI2;TGFBR1;WNT4;DKK3;SALL1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.32809688616561783,0.8387500906370609,0.7025089605734767,0.9842514959928856,1.0,6/17,13.96%,F11R;PPP1R12A;CLDN5;IKBKB;CDH5;PROC
prerank,cilium-dependent cell motility (GO:0060285),0.30752368447927203,0.8387444534232162,0.6814946619217082,0.9835936330312134,1.0,2/22,5.92%,DNAH3;RFX3
prerank,regulation of cell morphogenesis (GO:0022604),0.29710738401333703,0.8385166885967946,0.7221238938053097,0.9833827283814404,1.0,10/30,16.92%,SH3D19;FITM2;ZMYM4;CFL1;MYO9A;CD44;MOV10;WTIP;LARP4;STRIP1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),-0.30672687833127743,-0.8380839755881201,0.6674008810572687,0.9162688493128476,1.0,4/18,10.74%,RIMS1;NLGN1;SYN1;GSK3B
prerank,positive regulation of embryonic development (GO:0040019),-0.2947803245906866,-0.8380404757168362,0.6917960088691796,0.9156878037567319,1.0,5/19,14.16%,OSR1;WNT4;NIBAN2;NR2C2;RACK1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.28942651731273467,-0.8378375139415204,0.6856492027334852,0.9154308253356406,1.0,7/20,26.46%,EGFR;PKD1;CCND3;CCNYL1;AKT1;SPDYA;TTBK1
prerank,nucleosome organization (GO:0034728),0.2565146750709846,0.8374743809830453,0.7203791469194313,0.9848497379979027,1.0,14/55,19.00%,DMAP1;NAP1L4;VPS72;RSF1;SMARCD1;ZNHIT1;BRD2;INO80;SMARCA4;SETD2;NPM1;ACTR6;ATRX;SMARCB1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.32525191880931176,-0.8374584560055596,0.7019027484143763,0.9155127863204515,1.0,9/15,34.85%,NLGN2;NLGN1;STXBP1;ADRA1A;USP46;CLN3;DRD2;ZDHHC3;BAIAP3
prerank,response to amino acid starvation (GO:1990928),0.24574580439020322,0.8374429636262251,0.7496159754224271,0.9842454743110644,1.0,20/72,19.41%,MAPK3;EIF2S1;RPTOR;ATP6V1D;ATP6V0D1;CDKN1A;MAPK8;LAMTOR1;ATP6V0E1;LARS1;RRAGC;ATP6V1B2;TFEB;KPTN;SESN3;DAPL1;ATP6V1A;SH3GLB1;SESN1;LARP1
prerank,negative regulation of lipid storage (GO:0010888),-0.3045177334878614,-0.8374255070152314,0.6787330316742082,0.9149081531676181,1.0,7/19,24.31%,ABHD5;PPARA;TTC39B;ABCA1;PTPN2;OSBPL8;NR1H2
prerank,protein localization to cilium (GO:0061512),0.28722933872593553,0.8371324546817993,0.7036423841059603,0.9842332941985663,1.0,4/32,11.50%,ROPN1;ATP6V1D;RABEP1;IFT140
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.26839106831609155,-0.8367442083337122,0.7168949771689498,0.915611684246372,1.0,5/27,15.06%,NFAT5;RHOA;IRAK1;SIRPA;HSPD1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3579209203029881,-0.8367425538336234,0.6761487964989059,0.9149546827794561,1.0,3/10,13.54%,KMT2A;SMAD4;CAMK1
prerank,protein autophosphorylation (GO:0046777),0.22470406430083711,0.8365715606365228,0.8158602150537635,0.9847494991389776,1.0,18/157,9.67%,PRKX;MAP3K11;MAPK3;OXSR1;SRC;MEX3B;PRKD2;MAP3K9;TEK;SMG1;SLK;PIM1;PIKFYVE;PEAK1;MINK1;CSF1R;LYN;PAK1
prerank,mRNA catabolic process (GO:0006402),0.26928061912440376,0.8354827888922476,0.7186495176848875,0.986357497199458,1.0,14/44,20.89%,ZC3H12D;NUDT12;EXOSC9;XRN2;DXO;AGO4;TUT7;TUT4;NBDY;CNOT10;RC3H1;DIS3L2;AGO1;ERN1
prerank,lipid oxidation (GO:0034440),0.3541245670914807,0.83537411680052,0.704331450094162,0.9859151126700298,1.0,2/12,11.20%,ADIPOR2;ADIPOR1
prerank,cellular response to amino acid starvation (GO:0034198),0.2455614448534494,0.8350760160748045,0.7596302003081664,0.9858672541901645,1.0,19/71,19.07%,MAPK3;EIF2S1;RPTOR;ATP6V1D;ATP6V0D1;CDKN1A;MAPK8;LAMTOR1;ATP6V0E1;LARS1;RRAGC;ATP6V1B2;TFEB;KPTN;SESN3;DAPL1;ATP6V1A;SH3GLB1;SESN1
prerank,cellular response to lipopolysaccharide (GO:0071222),-0.20705074790604006,-0.8348037647862414,0.8413793103448276,0.9181837799662572,1.0,22/101,19.50%,PABPN1;MAPK14;AXL;VIM;RHOA;IRAK1;LBP;CDC73;TRIM41;NFKB1;SIRPA;IL18;PTPN22;PDE4B;PAF1;UPF1;DEFA6;SELENOS;TGFB1;MTDH;CHMP5;IRGM
prerank,regulation of mononuclear cell migration (GO:0071675),0.3005615958671533,0.8345834484966973,0.6714542190305206,0.9862772874857264,1.0,3/23,9.34%,MAPK3;CSF1R;LYN
prerank,purine ribonucleotide metabolic process (GO:0009150),0.2472740935942226,0.8345599745619526,0.7683284457478006,0.9856477959152258,1.0,11/68,13.49%,MLYCD;ACAT1;DBI;GPAT4;SULT1A1;RHOQ;BAD;ACOT8;NT5C2;EFL1;GMPR2
prerank,positive regulation of macrophage activation (GO:0043032),-0.3009238394411362,-0.8344380875750005,0.6796338672768879,0.9182479410669205,1.0,6/17,27.56%,LBP;THBS1;IL33;HSPD1;TTBK1;KARS1
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.23744793070219447,-0.8343419361294804,0.7583333333333333,0.9177692151980288,1.0,14/49,18.76%,LDLRAD4;PRKCZ;JAM3;SORL1;SMAD6;GSK3B;HSF1;PPM1A;DACT1;RAF1;PEX5;CDC42;CRYAB;RIOK3
prerank,regulation of cell population proliferation (GO:0042127),0.19833043786631405,0.8335462245396364,0.9291754756871036,0.9871382014320353,1.0,80/691,11.69%,MAZ;ROMO1;JAG2;BNIPL;UTP20;PTPRJ;EZH2;FRZB;LEF1;TIAM1;ACER2;SHCBP1;RPL23;DERL2;IFNLR1;RERG;GREM1;DNAJA3;CRLF1;ING4;GNRH1;FABP7;STOX1;MCTS1;TBC1D8;BCL6B;ZFP36L1;IFI35;BIRC2;NME1;CD164;TSHR;MEIS1;SMARCA2;SLC35F6;SINHCAF;CDKN1A;CIB1;TSPO;P3H2;TBX1;CHTOP;TMEM115;PLPP1;RGCC;FBXO5;SIRT1;IRS2;RNF187;NOTCH1;CNOT7;CDK4;ACVRL1;IFITM1;TSC1;TJP1;RELA;CD47;SOD2;MDM2;CSF1R;LYN;CYP1B1;JUND;PAK1;TFAP4;CLDN5;TRPM4;ESM1;RPS9;SRPK2;CD81;HP1BP3;RHOG;CTBP1;APP;PIAS1;NOS3;FLT1;ACER3
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3142306107248814,0.8332148551336844,0.6776429809358753,0.9871752344756163,1.0,4/21,11.27%,PDE4D;CNKSR3;SMAD7;DMD
prerank,inositol phosphate metabolic process (GO:0043647),0.26785130402880797,0.8331831415948996,0.7306501547987616,0.9865716431414255,1.0,12/46,19.01%,PPIP5K2;NUDT11;PLCG1;INPP5D;PLCB1;IP6K2;INPP4B;ITPK1;IMPA1;ITPKB;MINPP1;CALM1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.3235133995512242,0.8328009255217153,0.6913793103448276,0.9867258460280303,1.0,5/18,13.89%,TNFRSF1B;NOTCH1;NF1;TENM4;HES1
prerank,striated muscle contraction (GO:0006941),-0.23209043846767657,-0.8319840733098482,0.7506849315068493,0.9216858723809648,1.0,3/53,4.20%,ATP1A2;ATP1B1;TPM1
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.35579635359943157,0.8318890283922209,0.6653919694072657,0.987993336679005,1.0,1/12,1.52%,ATF6
prerank,protein destabilization (GO:0031648),0.28270710076948974,0.8308748865440245,0.7152209492635024,0.989423691312134,1.0,8/32,12.85%,EP300;CCDC88C;SIRT1;RAD23A;MDM2;CREBBP;PRNP;CUL3
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.3456555229652532,0.8304636674341185,0.6493506493506493,0.9896075660274414,1.0,2/14,4.99%,PTPRC;TNFRSF1B
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.3044267951224914,0.8304316506368681,0.7041322314049587,0.9890025303159621,1.0,4/26,8.34%,EEF1A1;ZFP36L1;PTPN12;PLCG1
prerank,positive regulation of monooxygenase activity (GO:0032770),0.2982624655329891,0.8300646636724273,0.6907216494845361,0.989095125858999,1.0,5/26,14.38%,APOE;PARK7;TERT;SCARB1;GCH1
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.31664859237767584,-0.829950086570493,0.7139689578713969,0.9249228411832467,1.0,2/16,4.10%,ANK2;TAPT1
prerank,negative regulation of chemokine production (GO:0032682),0.3425520856871745,0.8298449117347897,0.6749049429657795,0.9889058738858356,1.0,1/14,3.46%,MAP2K5
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.25106802192583244,0.8292716707478963,0.7573415765069552,0.9894335615539975,1.0,20/57,21.19%,RPL35A;RPL5;EMG1;RPS28;RPS24;LTV1;RBIS;WDR12;PAK1IP1;XPO1;LTO1;NPM1;RPL38;RPL26;NVL;RPL14;RPL7;TGS1;GTF3A;SDAD1
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.2213366607558438,-0.8291717757553098,0.8052325581395349,0.9257915581609006,1.0,16/66,27.55%,FOXP1;IGF1;MALT1;AIM2;USP50;SIRPA;GBP5;GSDMD;HSPB1;CX3CL1;PANX1;GIT1;TRIM16;CX3CR1;ZC3H12A;EGR1
prerank,O-glycan processing (GO:0016266),-0.23112713841763394,-0.8290897575139011,0.7994269340974212,0.9252916970517762,1.0,9/54,22.34%,GALNT13;GXYLT2;POFUT1;XXYLT1;ST3GAL4;GALNT14;ST6GAL1;GALNT12;C1GALT1C1
prerank,homocysteine metabolic process (GO:0050667),-0.34492341947653055,-0.8288102943528225,0.6965376782077393,0.925154473272708,1.0,2/11,11.45%,MTHFR;NOX4
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2256865521209623,0.828624588843007,0.8064066852367688,0.9901256747670488,1.0,16/128,10.64%,FBXL6;ALMS1;HAUS5;CEP41;HAUS4;TUBB;CCNH;DCTN2;CDKN1A;ODF2;WEE1;DCTN3;CEP164;PLCB1;PPP1R12A;DYNLL1
prerank,mitotic cytokinetic process (GO:1902410),-0.2938415772863541,-0.8285751234418425,0.7031963470319634,0.924928047263412,1.0,7/20,25.18%,RHOA;KLHDC8B;MITD1;CHMP2B;CHMP5;VPS4A;CNTROB
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3679327320555028,0.8284549724018931,0.7049504950495049,0.9884883586116896,1.0,4/11,16.85%,PANK2;ACAT1;PANK1;PANK4
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3679327320555028,0.8284549724018931,0.7049504950495049,0.9884883586116896,1.0,4/11,16.85%,PANK2;ACAT1;PANK1;PANK4
prerank,coenzyme A biosynthetic process (GO:0015937),0.3679327320555028,0.8284549724018931,0.7049504950495049,0.9884883586116896,1.0,4/11,16.85%,PANK2;ACAT1;PANK1;PANK4
prerank,recombinational repair (GO:0000725),0.24528593906899648,0.8282991252513159,0.7819767441860465,0.988138633983094,1.0,15/77,14.62%,ZSWIM7;ERCC4;YY1;XRCC1;SFPQ;KDM4D;SEM1;RAD51B;EXD2;RFWD3;HUS1;NBN;PSMD14;RMI1;INO80
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.3416056816045048,-0.8282306045358814,0.6652892561983471,0.9249090407042848,1.0,4/11,19.92%,THBS1;CD34;BMPR1A;PTGS2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.2639681320077665,0.8279633105414255,0.7275641025641025,0.9881612123872912,1.0,15/49,17.44%,BCL2L2;SRC;SGMS1;BCLAF1;BAD;DDX3X;UBQLN1;BMF;PTPMT1;NDUFA13;DDIT3;DNM1L;BECN1;BCAP31;BAX
prerank,vasoconstriction (GO:0042310),0.35502322617038407,0.8278799789200725,0.6869918699186992,0.987684863005473,1.0,3/11,14.65%,EDNRB;ACTA2;PIK3C2A
prerank,extracellular transport (GO:0006858),0.35245619166804104,0.8270952200087643,0.6611721611721612,0.9886031809044957,1.0,1/12,2.16%,CABYR
prerank,tRNA export from nucleus (GO:0006409),-0.2662444224793503,-0.8269770800588369,0.7506297229219143,0.9260186372611141,1.0,16/32,33.08%,NUP205;NUP155;NUP188;NUP93;NUP88;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;SEC13;NUP153;RAN;NUP43;NUP210
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.2662444224793503,-0.8269770800588369,0.7506297229219143,0.9260186372611141,1.0,16/32,33.08%,NUP205;NUP155;NUP188;NUP93;NUP88;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;SEC13;NUP153;RAN;NUP43;NUP210
prerank,platelet aggregation (GO:0070527),0.2836495612346,0.8269360907236446,0.7147887323943662,0.9882494496328098,1.0,8/33,15.44%,PIK3CG;ACTB;MYL9;METAP1;PLEK;CSRP1;FIBP;MYH9
prerank,visual system development (GO:0150063),0.274836012969286,0.8266224047216661,0.7203252032520325,0.9882390651245799,1.0,4/37,4.77%,ATF6;HIPK2;MEIS1;SOX2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.32839150477605145,0.8265203659997864,0.6960431654676259,0.9877852015421567,1.0,2/16,10.75%,TRIB3;ERLIN2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.3140381465272243,0.8262116238630616,0.7330895795246801,0.9877399283695084,1.0,2/19,6.26%,ALDH1L1;MTHFS
prerank,positive regulation of translation (GO:0045727),0.23490904129439077,0.8255246817292201,0.7742857142857142,0.9884846559501645,1.0,11/94,10.75%,JMJD4;EIF5AL1;EIF5A;FASTKD2;LARP4B;FXR1;RPL5;PYM1;NGRN;RPS9;DDX3X
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3108526748007039,0.825472856708512,0.696551724137931,0.9879327091667592,1.0,4/20,7.94%,ATP2A2;WFS1;RAP1GDS1;SELENOK
prerank,regulation of lymphocyte differentiation (GO:0045619),0.319356999601466,0.8248961012888841,0.7264808362369338,0.9884151701150878,1.0,1/18,3.77%,ZFP36L1
prerank,toll-like receptor signaling pathway (GO:0002224),0.2378983193336695,0.8248880581908682,0.7764350453172205,0.9877707586570554,1.0,11/84,12.92%,PIK3AP1;MAP3K7;TAB2;TIRAP;BIRC2;TAB3;EPG5;TRAF3;TNIP2;IKBKB;CHUK
prerank,regulation of protein kinase B signaling (GO:0051896),0.21376695696988274,0.8248476262544121,0.8580562659846548,0.9871973969932071,1.0,23/193,11.67%,RAC2;MAZ;PIK3CG;TRIB3;PIK3AP1;PTPRJ;SRC;TEK;FYN;CIB1;RET;SIRT1;TXN;IRS2;DAG1;PHLPP1;PARK7;OTUD3;MFHAS1;ESR1;RHOG;PIK3CD;PIK3R5
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.33389676313114985,-0.824799869520204,0.6895833333333333,0.9295313978968659,1.0,3/12,7.62%,DSCAM;NKD1;SDK2
prerank,regulation of actin nucleation (GO:0051125),-0.33086612634427026,-0.8247753986714423,0.7058823529411765,0.9289155611798673,1.0,5/12,28.64%,GSN;WASHC5;ARFIP2;PICK1;ARPIN
prerank,genitalia development (GO:0048806),-0.3381739288177019,-0.8244383565529102,0.7164502164502164,0.9288589771255934,1.0,3/12,11.84%,PKD1;DNAJC19;TBX3
prerank,phospholipid biosynthetic process (GO:0008654),0.2771134042965195,0.8243252487789331,0.7415540540540541,0.9875638874449255,1.0,7/36,14.26%,GPAM;FITM2;SGMS1;MBOAT1;IDI1;AGPAT3;GNPAT
prerank,protein localization to microtubule organizing center (GO:1905508),0.334675448274193,0.8242322261910722,0.6950092421441775,0.9870899258007262,1.0,6/15,21.30%,DCTN2;CEP83;HOOK3;CCDC14;CEP192;BBS4
prerank,amide transport (GO:0042886),-0.27028951100564114,-0.8240357722502701,0.7582938388625592,0.9289084081072864,1.0,9/26,24.54%,PDPN;PLEKHA8;SLC25A32;SLC27A1;SLC19A1;SLC5A6;GLTP;ABCB9;AQP11
prerank,purine-containing compound catabolic process (GO:0072523),-0.32609698702753614,-0.8237691571303227,0.6995515695067265,0.9287549400726627,1.0,2/13,7.08%,DPYD;XDH
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.23608334875725615,0.8233838484759003,0.7863247863247863,0.9881927451284402,1.0,10/82,10.64%,ALMS1;HAUS5;CEP41;HAUS4;TUBB;DCTN2;ODF2;DCTN3;CEP164;DYNLL1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.3528580879799891,0.8233021860340606,0.7012987012987013,0.9876906315565109,1.0,1/12,0.92%,SEMA6A
prerank,protein localization to lysosome (GO:0061462),-0.26216410623952624,-0.8231870169019003,0.7380352644836272,0.9292315452644636,1.0,14/28,27.04%,SORL1;ZFYVE16;NCOA4;M6PR;AP4M1;SZT2;GGA3;NEDD4;MFSD1;VPS4A;HGS;LAMTOR5;LMBRD1;SH3BP4
prerank,PERK-mediated unfolded protein response (GO:0036499),0.370083708579772,0.822966450753384,0.6834677419354839,0.9877066336032847,1.0,3/10,16.57%,EIF2S1;DDIT3;QRICH1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2704677870647129,0.8228585717132114,0.7475728155339806,0.9872766260402553,1.0,5/40,9.74%,ZRANB3;POLE;EXD2;RFWD3;MSH3
prerank,positive regulation of vasculature development (GO:1904018),0.23530115715529396,0.8227990144584573,0.7988826815642458,0.986726129025598,1.0,16/94,12.86%,PDCL3;HIPK2;PRKD2;RAMP2;TEK;RAPGEF3;SIRT1;WNT5A;PLCG1;CYP1B1;TIE1;NOS3;FLT1;PIK3CD;SP1;CDH5
prerank,base-excision repair (GO:0006284),0.26055182104391583,0.8223941861673232,0.7389937106918238,0.9869329350971773,1.0,8/48,12.39%,PNKP;XRCC1;TDG;POLE;POLD3;USP47;SMUG1;MPG
prerank,regulation of organelle assembly (GO:1902115),0.24299651508799008,0.8223575416464042,0.7874251497005988,0.9863533203475867,1.0,13/72,13.12%,ALMS1;PLK2;TBC1D8;VPS11;TBC1D10B;USP6NL;PIKFYVE;TBC1D12;IFT140;ADPRH;TBC1D24;TBC1D14;RABGAP1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.3196010959987125,0.8221313853021741,0.686456400742115,0.986133324432063,1.0,4/18,7.18%,GRIK5;GRIK2;SLC17A6;NAPA
prerank,gonad development (GO:0008406),-0.24101669334248732,-0.8220847392880483,0.7389033942558747,0.9306854713765591,1.0,6/41,12.77%,NR2F2;KIT;WNT4;SALL1;NCOA4;MSH2
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.3400299023070444,0.8220592553820633,0.6811881188118812,0.9856288905709509,1.0,4/12,20.79%,TERT;ESR1;NCOR1;PPARG
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.33119565843974735,0.8219411822936568,0.6958955223880597,0.9852373790401634,1.0,2/15,5.00%,EZH2;PHB2
prerank,nucleosome disassembly (GO:0006337),-0.31992914497185027,-0.821885593812643,0.7073170731707317,0.9297290313847,1.0,4/14,22.68%,SET;SMARCD3;SMARCD2;SMARCC1
prerank,chromatin disassembly (GO:0031498),-0.31992914497185027,-0.821885593812643,0.7073170731707317,0.9297290313847,1.0,4/14,22.68%,SET;SMARCD3;SMARCD2;SMARCC1
prerank,lipid translocation (GO:0034204),0.30895099048987085,0.8218037518407678,0.7314487632508834,0.9848511839013291,1.0,7/21,18.56%,ATP8A1;ATP11A;TMEM30B;ATP11C;ATP10A;TMEM30A;ATP9B
prerank,cellular response to superoxide (GO:0071451),0.35572439225511077,0.8215376208603462,0.7088353413654619,0.9847184894836353,1.0,3/10,11.33%,SOD1;SOD2;NOS3
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.22961496592866262,0.8214326703392187,0.7966804979253111,0.9842582574833432,1.0,27/100,18.19%,GSK3A;TRIB3;ARIH1;COP1;FOXF2;SMAD7;DESI1;GNA12;RAD23A;MDM2;PARK7;CCAR2;RYBP;PIAS1;ELOB;XPO1;TLK2;GIPC1;RNF180;UCHL5;FBXO22;UBQLN4;TAF1;N4BP1;BBS7;RAD23B;GABARAP
prerank,thymus development (GO:0048538),0.34783858090972797,0.8208673137114137,0.6918819188191881,0.9847260403947695,1.0,2/13,6.09%,SOD1;TBX1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.330779732737317,-0.820796162285054,0.688659793814433,0.9311094505890917,1.0,1/12,3.91%,CTNNB1
prerank,autonomic nervous system development (GO:0048483),-0.29817879578253986,-0.8203326732211804,0.7268722466960352,0.9313091140826697,1.0,3/17,10.78%,NRP1;SEMA3A;FN1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.31030113189397435,-0.8202004389557866,0.7494780793319415,0.9308885584471,1.0,9/16,30.65%,PARP14;PIBF1;NF2;PTPN2;HGS;INPP5F;VHL;BCL3;CAV1
prerank,response to axon injury (GO:0048678),0.32381196579025395,0.8201547841257023,0.7086466165413534,0.9855198895439675,1.0,2/18,2.90%,SOD1;MTR
prerank,heart morphogenesis (GO:0003007),-0.22951237439249125,-0.8199529861160552,0.8083333333333333,0.9306534036125218,1.0,11/50,19.97%,TGFBR3;FLRT2;TGFBR1;EPHB4;NIPBL;ACVR1;TBX3;PTK2;MDM4;BMPR1A;OLFM1
prerank,translesion synthesis (GO:0019985),-0.24037342529962835,-0.8194062484670168,0.8094059405940595,0.9309934780886474,1.0,30/42,46.52%,RFC1;RCHY1;ZBTB1;VCP;RPA1;UBC;NPLOC4;POLDIP2;USP10;PRIMPOL;RFC2;POLN;PCNA;POLE2;POLI;UBE2L6;REV3L;ISG15;FAAP20;RPA3;RFC3;MAD2L2;UBA52;USP43;POLD2;RPA2;PCLAF;RFC4;POLD4;POLD1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.31054729662863195,0.8191897682930382,0.7116788321167883,0.986746189674183,1.0,6/20,16.65%,APOE;LPCAT3;MBTPS1;LDLRAP1;ACADL;KPNB1
prerank,positive regulation of chemokine production (GO:0032722),0.2647353755224242,0.8190686095645776,0.7593167701863354,0.9863414053134912,1.0,6/44,11.24%,TIRAP;SYK;WNT5A;CSF1R;DDX3X;APP
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.2688945173798317,-0.8190627909443877,0.7396593673965937,0.9310297792764649,1.0,6/28,10.74%,ADCY1;RELN;YTHDF1;LGMN;EPHB2;GSK3B
prerank,telomere maintenance (GO:0000723),0.25914996873832485,0.8182953780688507,0.7784615384615384,0.9872860915148282,1.0,12/50,16.71%,CTC1;ERCC4;DCLRE1B;POLD3;ACD;TERT;HUS1;NBN;LTO1;TERF2IP;ATR;PRKDC
prerank,synaptic vesicle membrane organization (GO:0048499),-0.29518670634940153,-0.8180939726353265,0.7407407407407407,0.9321773112423909,1.0,9/17,31.55%,SNAP25;STX3;STX1A;SNAP29;SYP;STX1B;AP3D1;SYNGR1;TOR1A
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.30370677404919066,0.8179925137518179,0.7135036496350365,0.9872460968951215,1.0,5/22,11.76%,MAP3K4;MINK1;PJA2;MFHAS1;RELL1
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.3383802414897968,0.8179629869127679,0.7235621521335807,0.9866646640809924,1.0,4/14,13.02%,MAP2K5;MMRN2;NOTCH1;HDAC5
prerank,organonitrogen compound catabolic process (GO:1901565),0.2506026234456577,0.8179173138588893,0.8009554140127388,0.9860988934046513,1.0,3/57,3.18%,LVRN;AMDHD2;PPT1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.3055596491429812,0.8174844595332437,0.699825479930192,0.986301558716426,1.0,4/23,10.86%,PLK2;PRCC;WEE1;CHFR
prerank,negative regulation of complement activation (GO:0045916),0.37447858803708867,0.8174289076565571,0.6976744186046512,0.9857730736584845,1.0,3/10,18.35%,A2M;CD55;CD46
prerank,cellular glucan metabolic process (GO:0006073),-0.3407800761933838,-0.8174198094024294,0.7122736418511066,0.9327847976856383,1.0,4/11,19.45%,PRKAG2;GSK3B;PYGM;PHKG2
prerank,positive regulation of cellular metabolic process (GO:0031325),0.23107206074967176,0.817024525356157,0.8064516129032258,0.9859471368242148,1.0,12/98,9.90%,ROMO1;CHCHD2;IFNLR1;GREM1;PAX8;APOE;CDKN1A;PPARD;ACACB;RAB1A;IL10RB;IFNAR1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.3425840709108096,0.8164333146467404,0.7120315581854043,0.9864764257437009,1.0,1/13,5.41%,CYRIB
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.2684257666324683,0.8164236663227601,0.7423510466988728,0.9858490686822811,1.0,4/37,9.26%,NCBP1;NUDT5;RNASE6;XRN2
prerank,regulation of lipase activity (GO:0060191),-0.32545934239359475,-0.8161995322902937,0.7233115468409586,0.9343930481568862,1.0,3/13,13.31%,PCSK5;RHOA;PCSK6
prerank,histone deubiquitination (GO:0016578),0.3158000398719133,0.8158242694970016,0.702048417132216,0.9863634827698959,1.0,7/18,19.45%,ATXN7L3;USP22;USP15;TRRAP;BRCC3;USP36;UIMC1
prerank,response to nitric oxide (GO:0071731),0.35300965284195085,0.8157111646000038,0.7030075187969925,0.9859428730384989,1.0,2/13,7.38%,MTR;TXN
prerank,positive regulation of cell death (GO:0010942),0.2523928564453152,0.8152777964534829,0.7603833865814696,0.9861619068833821,1.0,10/59,13.97%,ACER2;FCGR2B;EIF2S1;FYN;SLC6A6;WNT5A;PICALM;PRNP;FAF1;APC
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.2720558976290902,-0.8151024869757436,0.7517564402810304,0.9357229952890573,1.0,4/24,9.19%,CTNNB1;EPHA7;NUPR1;BACE1
prerank,mesenchymal cell development (GO:0014031),0.3181253551019153,0.8146625175026979,0.7195767195767195,0.9866875519916877,1.0,3/18,8.12%,CDH2;HEY2;NOTCH1
prerank,DNA replication initiation (GO:0006270),0.27299350057689786,0.8145439083369274,0.7417763157894737,0.9862894605027069,1.0,6/37,11.53%,ORC3;POLE;CDC45;ORC4;POLA1;ORC2
prerank,organelle transport along microtubule (GO:0072384),0.2860103824554441,0.8145339943580177,0.7354409317803661,0.9856634940660565,1.0,8/31,14.63%,DYNC1I1;MAP1S;COPG2;UXT;RAB6A;RAB1A;COPG1;BICD2
prerank,primary miRNA processing (GO:0031053),-0.3577227365643257,-0.813521538991561,0.7190265486725663,0.9379193521908119,1.0,3/10,9.35%,SMAD3;SRRT;HNRNPA2B1
prerank,vesicle transport along actin filament (GO:0030050),0.30879872039682726,0.8131897157110304,0.7163636363636363,0.9876359593242734,1.0,4/19,13.07%,MYO5A;ACTN4;MYO1D;MYO1E
prerank,negative regulation of phagocytosis (GO:0050765),-0.29991130453030784,-0.8129258072223036,0.762114537444934,0.9383900455515831,1.0,7/17,22.27%,PIP4P2;PLSCR1;SYT11;SIRPA;RACK1;SNX3;APPL1
prerank,second-messenger-mediated signaling (GO:0019932),-0.20946922207215612,-0.8128516844238713,0.8961424332344213,0.9378604778906894,1.0,10/82,10.84%,MCU;PPP1R9A;NUDT4;PLCE1;P2RX4;CHRM3;CCR9;KSR2;ACKR3;DDAH1
prerank,cellular response to oxygen levels (GO:0071453),0.3651561892420085,0.8127175407885778,0.7164461247637051,0.9879110895747156,1.0,3/10,10.78%,ATP6V0D1;NDUFS2;ATP6AP1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.2912896029159273,0.8124223886890886,0.7424242424242424,0.987856931712349,1.0,2/27,4.74%,ZC3H12D;RNASE6
prerank,macrophage chemotaxis (GO:0048246),0.3663826342621816,0.8121461535691622,0.6673387096774194,0.9877568121025875,1.0,1/10,8.29%,EDNRB
prerank,vitamin transport (GO:0051180),0.2832526729599909,0.8120554346424711,0.725328947368421,0.9873011898400186,1.0,3/29,5.06%,ABCG2;SLC52A2;SLC52A3
prerank,regulation of mRNA polyadenylation (GO:1900363),0.31948971190421926,0.811910388173749,0.7238938053097345,0.9869233689415611,1.0,5/17,15.61%,NCBP1;CPSF6;ZC3H14;RNF20;ZC3H3
prerank,glial cell development (GO:0021782),-0.27086129750448634,-0.8118641674307259,0.7435294117647059,0.9389783945364026,1.0,17/25,41.64%,CDK6;MXRA8;NRROS;TPPP;PICK1;EIF2B5;CSPG5;MDK;EIF2B2;EIF2B4;MYRF;NSUN5;SOX11;SOX10;MT3;SOX4;EIF2B1
prerank,integrated stress response signaling (GO:0140467),0.3381888306256528,0.8116236854869403,0.7276422764227642,0.9868476098333412,1.0,4/14,16.57%,EIF2S1;OMA1;DDIT3;QRICH1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.23811117812504717,0.8114743029902601,0.8209606986899564,0.9864941176410281,1.0,9/72,9.60%,ERCC3;ERCC4;RNASE6;POLK;POLD3;GTF2H1;XRN2;DXO;EXD2
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.35126688702799236,-0.8114528270589808,0.7,0.9384050696648693,1.0,5/10,18.99%,AP2B1;AP2A2;AP2A1;VLDLR;MYLIP
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.35126688702799236,-0.8114528270589808,0.7,0.9384050696648693,1.0,5/10,18.99%,AP2B1;AP2A2;AP2A1;VLDLR;MYLIP
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.29658717562134773,0.8113445955951497,0.7508896797153025,0.98609696501303,1.0,2/25,1.65%,TAL1;ABCB10
prerank,positive regulation of actin filament polymerization (GO:0030838),0.2642229020094263,0.8112338118965415,0.7597402597402597,0.9856768119536266,1.0,10/44,17.07%,VASP;EVL;ARPC4;PFN1;CDC42EP3;LMOD1;WHAMM;ARF6;PTK2B;BAIAP2
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.31220940499785266,0.8112067492253017,0.7233644859813084,0.9850885947018662,1.0,5/18,12.56%,GSK3A;EFNA1;RELA;PICALM;SP1
prerank,organic substance transport (GO:0071702),-0.19750054020651844,-0.8111011430848439,0.896774193548387,0.938404035557405,1.0,24/121,15.61%,CALCRL;ABCA9;SLC47A1;SNX4;LRP1B;ARRDC3;ABCA4;ABCA5;SLC35F3;TCN2;PLEKHA8;SLC22A4;SCAMP2;FLVCR1;CHKA;RAMP1;KIF3A;ABCA1;SLC22A6;VAMP2;ABCD2;RCN3;SCAMP5;SLC19A1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.3316447293598913,-0.8107182603547816,0.7348178137651822,0.9384165280559421,1.0,1/12,0.28%,FOXP1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.36993761633265015,0.810155734677275,0.7178502879078695,0.9865125549014506,1.0,4/10,20.68%,TXN;PARK7;PDE8A;LRRK2
prerank,histone mRNA catabolic process (GO:0071044),-0.31693024327168734,-0.8100908962170935,0.751131221719457,0.9389338527587852,1.0,6/15,23.73%,EXOSC10;DCP2;ATM;UPF1;TUT1;ERI1
prerank,polyol biosynthetic process (GO:0046173),0.32981343554156634,0.8100155137328805,0.7325800376647834,0.9861392988469244,1.0,4/16,16.65%,PPIP5K2;ACER3;IP6K2;ITPKB
prerank,positive regulation of chromatin organization (GO:1905269),0.34456019801767235,0.8096559859022618,0.7246376811594203,0.9862004204489437,1.0,5/12,18.64%,TAL1;ACD;TERF2IP;SIN3A;ATRX
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.27426371453056786,0.8095945516215595,0.7655172413793103,0.9856913170143909,1.0,4/33,9.17%,TNFAIP3;PRKG1;CDKN1A;SOD2
prerank,purine nucleotide biosynthetic process (GO:0006164),0.34389040929015774,0.8094589722645787,0.7129277566539924,0.9853052582667531,1.0,2/12,6.40%,PRPS1L1;PRPS1
prerank,polyol metabolic process (GO:0019751),0.26161157575621946,0.8093049151647908,0.758998435054773,0.9849507132627369,1.0,12/46,19.01%,PPIP5K2;NUDT11;PLCG1;INPP5D;PLCB1;IP6K2;INPP4B;ITPK1;IMPA1;ITPKB;MINPP1;CALM1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.28046935727025246,0.8090454087522341,0.7342192691029901,0.9848019020593347,1.0,11/32,20.83%,PNKD;PREPL;DTNBP1;MCTP2;MCTP1;SNAPIN;VPS18;SLC30A1;RIMS2;LRRK2;RAB5A
prerank,modulation by host of symbiont process (GO:0051851),0.27521494059515333,0.8089071906822057,0.7482876712328768,0.9844241744460156,1.0,6/31,12.56%,LEF1;EP300;TFAP4;TARDBP;CHD1;SP1
prerank,tRNA 5'-end processing (GO:0099116),0.331502519226473,0.8088240572709867,0.7151277013752456,0.9839622405995992,1.0,3/15,15.03%,RPP25L;POP5;SSB
prerank,hippo signaling (GO:0035329),0.2852662614170848,0.808748286666727,0.7540453074433657,0.9834921448818954,1.0,5/26,9.11%,AMOTL1;YWHAB;LATS2;TJP1;MOB1B
prerank,positive regulation of interleukin-12 production (GO:0032735),0.2780113162516007,0.8087253372526121,0.7420494699646644,0.9828984031087781,1.0,3/31,9.71%,TIRAP;SYK;PLCB1
prerank,t-circle formation (GO:0090656),-0.3491942330646461,-0.8086859689052781,0.7229166666666667,0.9394262992205946,1.0,6/10,36.71%,SMARCAL1;BLM;SLX4;TERF1;ERCC1;DNA2
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3491942330646461,-0.8086859689052781,0.7229166666666667,0.9394262992205946,1.0,6/10,36.71%,SMARCAL1;BLM;SLX4;TERF1;ERCC1;DNA2
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3491942330646461,-0.8086859689052781,0.7229166666666667,0.9394262992205946,1.0,6/10,36.71%,SMARCAL1;BLM;SLX4;TERF1;ERCC1;DNA2
prerank,glutamine family amino acid catabolic process (GO:0009065),0.34808159522246407,0.8086809233917648,0.7395437262357415,0.9823409839868202,1.0,2/13,2.95%,GLS2;GLS
prerank,mitochondrion transport along microtubule (GO:0047497),0.33819048430449716,0.8085571942693399,0.6958174904942965,0.9819468210492053,1.0,2/13,7.10%,MAP1S;UXT
prerank,RNA biosynthetic process (GO:0032774),-0.253188758568437,-0.8084450789873994,0.779126213592233,0.9392017742109392,1.0,14/31,32.66%,NCOA6;POLR2A;SETX;TAF6;TAF12;PRIM2;GTF2B;TAF13;PRMT5;SMN1;POLA2;PRIM1;TAF7;TAF5
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.29783775486123,0.808047888072695,0.7294520547945206,0.9823077090163725,1.0,5/22,13.97%,CDK5RAP1;CDKN1A;LATS2;TFAP4;APC
prerank,positive regulation of supramolecular fiber organization (GO:1902905),-0.20364485385501385,-0.8073245074536806,0.8773584905660378,0.9406032788963302,1.0,27/86,27.97%,NAV3;MAPT;OCLN;FER;CTTN;STMN2;AKAP9;SLAIN2;BIN1;SYNPO2;BAIAP2L1;FCHSD2;WDR1;DCTN1;CDC42EP5;CDC42EP1;SEMA5A;MET;CX3CL1;EFEMP2;PFN2;GPX1;CDC42EP2;NCKAP1L;ARL2;TOGARAM1;MAPRE1
prerank,negative regulation of interleukin-1 production (GO:0032692),0.29175459881075194,0.8071955442287329,0.7466442953020134,0.9833099020417239,1.0,2/23,6.13%,TNFAIP3;CARD16
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.2814868271248353,0.806952537330925,0.756140350877193,0.9831310181115981,1.0,7/27,15.65%,SPRED1;PTTG1IP;SIRT1;YJU2;MDM2;CD44;ATR
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.29099692128369004,0.8063406505199268,0.7317073170731707,0.983635148057876,1.0,4/24,11.87%,PTPRJ;TEK;TSC1;MAP4K4
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.3523882092258417,0.8062688791190429,0.6902985074626866,0.9831473407883677,1.0,1/10,0.90%,NCBP1
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.3235229654921481,0.8062074408988038,0.7237076648841355,0.9826381035772306,1.0,1/16,0.62%,IMPDH1
prerank,histone lysine methylation (GO:0034968),-0.2454000544476499,-0.8060122019459837,0.7994987468671679,0.9422450866759137,1.0,11/33,19.46%,PRDM5;KMT2A;PAXIP1;EHMT2;RBBP5;SETDB2;KMT2B;SMYD2;DPY30;KMT2D;N6AMT1
prerank,positive regulation of insulin secretion (GO:0032024),-0.24905038437932958,-0.8055677581381698,0.8050632911392405,0.9424360010295533,1.0,15/36,27.69%,MCU;NLGN2;GLUD1;RBP4;ANO1;TM7SF3;NNAT;PSMD9;GPLD1;TCF7L2;PLA2G6;ADCY8;CAPN10;AACS;LRRC8A
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.22980180503461128,0.8054681872796806,0.8360902255639098,0.9833834343411804,1.0,15/88,14.60%,ILF3;PATL2;APOE;FXR1;PAIP2B;EDNRB;CNOT7;TSC1;DDX3X;NANOS3;RPS3;PLAT;YBX1;CAPRIN1;CNOT1
prerank,Golgi localization (GO:0051645),-0.3384255834862343,-0.8053687036108693,0.7243460764587525,0.9421032713994472,1.0,5/11,25.15%,UVRAG;STK25;TBCCD1;CDC42;RIPOR1
prerank,ncRNA export from nucleus (GO:0097064),-0.2510925228760213,-0.8053548375305289,0.7979539641943734,0.9414739473384823,1.0,18/36,33.08%,NUP205;NUP155;NUP188;PHAX;NUP93;NUP88;SEH1L;NUP85;AAAS;RAE1;NUP37;NUP214;NCBP2;SEC13;NUP153;RAN;NUP43;NUP210
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.24552106370229904,-0.805298842721326,0.7755102040816326,0.9409055022790194,1.0,14/37,33.72%,DLG4;SIRT2;AATF;OPTN;NFKB1;RIN3;SIRT5;PINK1;PAX2;ITGB3;ANKRD13D;ABCA2;EDN1;ANKRD13B
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.2628269573513257,0.8049890506231486,0.7796327212020033,0.9836554314507007,1.0,12/39,17.90%,ACER2;NEXMIF;ACTN4;NOTCH1;HOXA7;MAP4K4;AP1AR;SEMA3E;CORO2B;MELTF;CORO1C;CASK
prerank,steroid biosynthetic process (GO:0006694),0.2449746018884938,0.8049266181320753,0.7774390243902439,0.9831590085610903,1.0,9/56,13.86%,EBP;INSIG1;HMGCR;SC5D;OSBPL1A;HSD17B4;ACOT8;LSS;OSBPL2
prerank,regulation of superoxide anion generation (GO:0032928),0.3294633116706756,0.8048941825789341,0.722007722007722,0.982601279215951,1.0,2/14,6.82%,SOD1;SYK
prerank,positive regulation of protein deacetylation (GO:0090312),0.3369532012516846,0.8048937667156498,0.738898756660746,0.9819765755340231,1.0,3/14,11.17%,AKAP8L;ING2;CTBP1
prerank,cellular response to unfolded protein (GO:0034620),0.2899365043800045,0.8048498548267435,0.7504132231404959,0.9814364966484391,1.0,2/26,1.88%,ABCB10;HSPA8
prerank,positive regulation of organelle assembly (GO:1902117),0.2550742211003942,0.8047060849341299,0.7881219903691814,0.9810883456726697,1.0,10/44,16.86%,LCP1;RALB;CNOT2;G3BP2;CNOT6;ASAP1;CNOT1;CNOT6L;RAB3GAP1;PIP4K2A
prerank,autophagy of peroxisome (GO:0030242),0.35394846505514643,0.8046815554197423,0.7375478927203065,0.9805206481748229,1.0,4/12,16.42%,MAP1LC3B;TRAPPC8;NBR1;PIK3R4
prerank,DNA replication checkpoint signaling (GO:0000076),0.32581812972300817,0.8045547247441763,0.7091561938958707,0.9801325521231452,1.0,3/16,11.41%,CDC45;NAE1;HUS1
prerank,mitotic sister chromatid segregation (GO:0000070),0.22647281671723485,0.8043271692928063,0.8171589310829818,0.9799438987372979,1.0,21/98,19.18%,KIF18A;NUDC;BOD1;DCTN2;TENT4A;CHMP1A;CDCA8;AKAP8L;CHMP2A;MIS12;CUL3;POGZ;CSNK2A2;PHF8;INO80;KPNB1;BECN1;VPS4B;NAA50;DIS3L2;KMT5A
prerank,aminoglycan catabolic process (GO:0006026),0.2778444668357546,0.8041909446744248,0.7342419080068143,0.9795664582563983,1.0,6/28,12.23%,SGSH;GLB1;FUCA1;HGSNAT;IDS;AGRN
prerank,insulin receptor signaling pathway (GO:0008286),0.24284280655914597,0.8041861152064054,0.8101644245142003,0.978954515029039,1.0,21/69,18.85%,GSK3A;BCAR3;ATP6V1D;ATP6V0D1;AP3S1;IRS2;ATP6V0E1;RHOQ;ATP6AP1;GRB14;APC;PIK3C2A;ATP6V1B2;NAMPT;SHC1;BAIAP2;INSR;C2CD5;IRS1;ATP6V1A;ZNF106
prerank,regulation of autophagosome maturation (GO:1901096),0.34233683708486445,0.8038988934592873,0.7232824427480916,0.9788607847307988,1.0,4/13,15.33%,FYCO1;TBC1D25;TMEM39A;UBQLN4
prerank,telomere maintenance via telomerase (GO:0007004),-0.25933466190215493,-0.8033920599268376,0.8,0.9436277655286167,1.0,15/28,34.23%,RFC1;RAD50;TNKS1BP1;MRE11;RPA1;PPP6C;PPP6R3;RTEL1;TELO2;HSP90AA1;CDK2;TERF1;TERF2;GAR1;TINF2
prerank,protein targeting to membrane (GO:0006612),0.23270465700409343,0.8029400472726805,0.8304843304843305,0.9800107671844016,1.0,14/83,14.68%,RTP3;CHM;SGTB;ZDHHC14;PIKFYVE;PXMP2;ZDHHC15;ICMT;VPS37B;SEC62;PRKCI;ZDHHC9;ZDHHC7;PARD3
prerank,carbohydrate transport (GO:0008643),-0.33579896169771967,-0.8026193553897096,0.7542735042735043,0.9442806324858561,1.0,9/11,61.37%,AQP11;SLC50A1;SLC26A6;SLC2A2;SLC23A1;SLC23A2;AQP1;SLC2A5;AQP9
prerank,carbohydrate derivative catabolic process (GO:1901136),0.31175379159563477,0.8025601662126999,0.7527075812274369,0.9800877897331121,1.0,3/18,10.96%,BPGM;FUCA1;STT3B
prerank,peptidyl-arginine modification (GO:0018195),0.329877158205169,0.8024119356084827,0.7157057654075547,0.9797418992357756,1.0,2/15,9.70%,NDUFAF5;PARK7
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.31368501266201987,0.802080060837137,0.7424812030075187,0.9797368959777526,1.0,3/17,7.27%,SPRED1;CALM3;SMAD7
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.2974417157951653,-0.8016457799524296,0.7399103139013453,0.9452753068419129,1.0,6/17,16.73%,VCP;RHBDD1;HERPUD1;NPLOC4;SELENOS;HM13
prerank,positive regulation of intracellular transport (GO:0032388),0.2670598156880151,0.8008106525369,0.7716150081566069,0.9814606135855802,1.0,5/38,9.82%,PRR5L;ZFAND1;ICE1;RUFY3;EIPR1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.25772281611405723,-0.8007283711133961,0.785234899328859,0.9462205731993307,1.0,11/27,27.71%,NAPEPLD;LPIN1;CHKA;SLC27A1;ETNK2;PCYT2;PLA2G6;LPIN2;CHKB;NAAA;LPIN3
prerank,regulation of microglial cell activation (GO:1903978),0.3308005362822755,0.8005766315362478,0.7393715341959335,0.9812819412963336,1.0,1/15,2.02%,PTPRC
prerank,cellular glucose homeostasis (GO:0001678),-0.23907309523120748,-0.8002222133575322,0.8477157360406091,0.9464745405337361,1.0,13/41,22.80%,ZBTB20;LRRC8D;PPARGC1A;SLC39A14;PRKACA;NUCKS1;UNC13B;RACK1;FOXK1;PIK3R1;PCK2;ADCY8;HK2
prerank,protein O-linked mannosylation (GO:0035269),-0.28983755232020125,-0.7999868121403704,0.7472283813747228,0.9462257663463816,1.0,6/18,12.95%,TMTC4;TMTC1;DPM1;RXYLT1;LARGE1;FKTN
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.22531464770240966,-0.7997702858101416,0.832,0.9452966503570733,1.0,19/51,25.00%,SIRT2;PPP2R2A;LMNA;NUP205;IST1;NUP155;NUP188;AHCTF1;NUP93;SEH1L;CHMP2B;NUP85;NUP37;CC2D1B;VPS4A;EMD;LBR;LEMD2;SEC13
prerank,mitotic nuclear membrane organization (GO:0101024),-0.22531464770240966,-0.7997702858101416,0.832,0.9452966503570733,1.0,19/51,25.00%,SIRT2;PPP2R2A;LMNA;NUP205;IST1;NUP155;NUP188;AHCTF1;NUP93;SEH1L;CHMP2B;NUP85;NUP37;CC2D1B;VPS4A;EMD;LBR;LEMD2;SEC13
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.36088060986377546,0.7997221085144434,0.7238095238095238,0.9821916745305609,1.0,3/10,14.82%,ATP5MG;ATP5MC2;ATP5F1C
prerank,keratan sulfate catabolic process (GO:0042340),-0.33330687459370933,-0.7996946656545472,0.7402862985685071,0.9447753910336343,1.0,6/11,21.48%,OGN;HEXA;HEXB;PRELP;GNS;LUM
prerank,protein processing (GO:0016485),0.22514289235551838,0.7993133352766733,0.8573551263001485,0.9823403319260865,1.0,10/102,10.21%,PCSK1;PSEN2;MME;SEC11A;METAP2;SPCS3;SPPL3;OMA1;SPRTN;VSIR
prerank,regulation of monocyte chemotaxis (GO:0090025),0.2905505387631303,0.7992564850774598,0.7692307692307693,0.9818163426702263,1.0,3/24,9.34%,CXCL12;GREM1;LYN
prerank,polyamine metabolic process (GO:0006595),0.331574672012684,0.7992371273633282,0.7371428571428571,0.9812341029743062,1.0,4/13,15.28%,SMOX;DHPS;AMD1;ODC1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.30240702517318097,-0.7988954985397333,0.7415254237288136,0.9455171494579705,1.0,5/14,17.85%,DDX1;CSTF2;RTCB;RTRAF;ZBTB8OS
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.2755242032365577,-0.7988852728504909,0.7540983606557377,0.9448805016860764,1.0,7/23,19.85%,JAK1;PARP14;IFNGR1;PTPN2;IFNGR2;IRGM;STAT1
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.3495593314505506,0.798823643012542,0.7410207939508506,0.9813510735472275,1.0,3/12,17.83%,ZNF205;CYBA;RAB27A
prerank,cellular response to estrogen stimulus (GO:0071391),0.32720766723825395,0.7988194133518777,0.7097378277153558,0.9807401550998636,1.0,2/14,10.29%,ARID5A;WBP2
prerank,brain morphogenesis (GO:0048854),-0.3204921389839971,-0.7985270141179985,0.7372881355932204,0.9448413427510194,1.0,2/12,5.16%,CTNNA2;FBXW11
prerank,icosanoid metabolic process (GO:0006690),-0.23645389824045085,-0.7979999620768915,0.8219895287958116,0.9450666926774716,1.0,20/40,46.19%,PLA2G4A;EPHX1;PTGIS;GGT5;PTGS2;GPX1;TBXAS1;MAPKAPK2;ABCC10;FADS1;ALOX12;PTGS1;PLA2G4C;DAGLA;FAAH;CYP2S1;LTA4H;PTGR1;MGLL;GGT1
prerank,endoplasmic reticulum organization (GO:0007029),0.23561552501417551,0.7977856077041114,0.8210059171597633,0.9820498301245754,1.0,10/72,12.00%,REEP1;SMPD4;ATL1;LMAN2;LPCAT3;REEP3;DOP1B;APP;ZBED3;PRNP
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.31814921247593064,0.7977824985790153,0.7424812030075187,0.9814415222786531,1.0,2/17,5.66%,ALG6;ALG8
prerank,regulation of astrocyte differentiation (GO:0048710),0.3382683842837859,0.7976519159924814,0.7271028037383177,0.9810500650907861,1.0,3/12,16.08%,NOTCH1;HES1;ID2
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.26855747293496934,-0.7974709719685407,0.7740384615384616,0.9452706210554628,1.0,4/24,7.76%,ANK3;CEMIP;AKT2;FIS1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.2695323270334164,0.7960570732296277,0.7659574468085106,0.9832892613894169,1.0,5/35,10.37%,TAL1;ABCB10;ZFP36L1;LYN;ACVR2A
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.26649922265724274,0.7960438380847674,0.7852233676975945,0.9826978342468247,1.0,7/38,10.56%,TRIB3;PTPRJ;CIB1;SIRT1;DAG1;PHLPP1;OTUD3
prerank,cell junction maintenance (GO:0034331),-0.3133754661856115,-0.795681048017222,0.7376344086021506,0.9476651213668089,1.0,3/14,15.65%,NLGN2;MYADM;DCTN1
prerank,cellular component disassembly (GO:0022411),0.24733055656889708,0.7956768584407949,0.8062992125984252,0.9827524832659945,1.0,4/53,4.45%,LCP1;BSG;EXOC8;MMP12
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.2855547586835113,0.795300169772804,0.7529021558872305,0.9828337937872307,1.0,9/26,19.33%,TRIB3;ADIPOR2;PRKAA2;ERLIN2;ADIPOR1;ACADL;EIF6;ELOVL5;NR1H3
prerank,extracellular matrix disassembly (GO:0022617),0.24713130690198032,0.7950050157856954,0.7984,0.9827547232558558,1.0,4/53,4.45%,LCP1;BSG;EXOC8;MMP12
prerank,melanosome organization (GO:0032438),0.2845294755774161,0.7950016009162203,0.7614840989399293,0.9821452295225186,1.0,6/26,16.55%,DTNBP1;AP1G1;PIKFYVE;KIF13A;SNAPIN;BLOC1S5
prerank,regulation of mast cell activation (GO:0033003),0.36199852753189365,0.7949624286993596,0.7364185110663984,0.9816074546324758,1.0,2/10,9.52%,LYN;CD84
prerank,catecholamine biosynthetic process (GO:0042423),-0.32996750339100656,-0.7949452808418063,0.718562874251497,0.9482495663996702,1.0,1/11,2.80%,MOXD1
prerank,visual perception (GO:0007601),0.22760479059096184,0.7946813839620084,0.851528384279476,0.9814697316181736,1.0,8/84,10.61%,RS1;ATF6;WFS1;DRAM2;EYA3;MYO9A;PITPNA;ABLIM1
prerank,glycoprotein biosynthetic process (GO:0009101),-0.20355119072839184,-0.7942251010311032,0.8727272727272727,0.9488667573843349,1.0,34/79,35.59%,IGF1;ATP7A;CSGALNACT2;PMM2;GOLGA2;FUT10;CHST11;LARGE1;B3GALT5;ST3GAL4;B3GALNT1;TNIP1;BMPR1B;B3GALT1;ST8SIA2;CHST8;BMPR2;ALG5;ALG10B;CANT1;SERP1;FOXL1;CHST12;ALG1;B4GALT7;B3GALT2;DDOST;CHST10;GCNT1;TMEM106A;ST3GAL5;ST8SIA5;ST8SIA3;B4GALT5
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.29907218178321016,0.7941726637022133,0.7513321492007105,0.9817789348773058,1.0,6/20,18.22%,PSEN2;RELA;MBTPS1;APH1A;ADAM9;SPPL2A
prerank,negative regulation of hemostasis (GO:1900047),-0.3265218464382633,-0.7936434481883612,0.7281947261663286,0.9491579563482575,1.0,3/12,11.40%,TFPI;VTN;CD34
prerank,protein autoprocessing (GO:0016540),0.31781082927613874,0.7933839115734258,0.7295719844357976,0.9825574583226927,1.0,2/17,9.15%,OMA1;SPRTN
prerank,heterochromatin assembly (GO:0031507),-0.2810857166038405,-0.7933431977725016,0.7600896860986547,0.9490412426185499,1.0,10/20,29.81%,HDAC1;SIRT2;ZNFX1;CENPV;HELLS;SMCHD1;NRDE2;BAHD1;HMGA2;SUV39H1
prerank,protein hydroxylation (GO:0018126),0.3249135529821651,0.7928548210155353,0.7424242424242424,0.9829199569677615,1.0,3/15,10.95%,JMJD4;P3H2;PLOD3
prerank,microglial cell activation (GO:0001774),-0.27608402432690937,-0.7918316593574026,0.7720090293453724,0.9509203600460959,1.0,13/21,51.20%,MAPT;IFNGR1;CX3CL1;CX3CR1;SNCA;C1QA;CLU;TYROBP;ITGB2;ITGAM;AGER;AIF1;TREM2
prerank,positive regulation of behavior (GO:0048520),-0.335755144553367,-0.7916146335990177,0.7075098814229249,0.9506212961887055,1.0,4/10,23.57%,CFAP20;NLGN1;NPAS2;STRA6
prerank,histone H3-K4 trimethylation (GO:0080182),-0.3377975600301873,-0.7915637107487602,0.7489795918367347,0.9500497131257166,1.0,2/11,2.15%,OGT;KMT2A
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3293350021037836,-0.7914880698393111,0.720682302771855,0.9495263138264146,1.0,6/11,24.31%,LDLR;SLC27A1;GPLD1;SREBF1;CTDNEP1;NR1H2
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.3325272169123008,0.7914091700874404,0.7321772639691715,0.9849377904653039,1.0,4/13,16.52%,SYK;CD81;CD9;CDH13
prerank,negative regulation of Notch signaling pathway (GO:0045746),-0.2544962325247865,-0.7913864279299185,0.7788697788697788,0.949064976425106,1.0,5/28,8.96%,EGFR;MMP14;WWP2;NOTCH3;NIBAN2
prerank,cellular response to hormone stimulus (GO:0032870),0.2343757935522862,0.7912137303305979,0.8363363363363363,0.9846711771570984,1.0,9/69,10.73%,ARID5A;GAS2L1;SRC;PAX8;ZFP36L1;RAMP2;WBP2;LMO2;THRB
prerank,positive regulation of MAP kinase activity (GO:0043406),0.23696849308413412,0.7908242071328891,0.8140556368960469,0.9846891827796435,1.0,9/66,11.67%,MAP3K11;PIK3CG;EZH2;MAP3K7;MAP3K4;PAK1;RPS3;FLT1;PIK3R5
prerank,C4-dicarboxylate transport (GO:0015740),0.3356245341070275,0.7907584092502304,0.7547169811320755,0.9841942988682394,1.0,3/14,12.68%,SLC1A1;SLC1A2;SLC25A12
prerank,proton transmembrane transport (GO:1902600),0.2618437881526696,0.7903071885511975,0.7747603833865815,0.9844090177421868,1.0,5/36,11.65%,UCP2;SLC25A27;ATP6V0D1;ATP6V0E1;COX15
prerank,regulation of histone deacetylation (GO:0031063),0.33776879554660455,0.7901439732685512,0.7304832713754646,0.9840988289878296,1.0,3/13,11.17%,AKAP8L;ING2;CTBP1
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.2553648775070079,-0.7899809334415965,0.8032036613272311,0.9507894301204322,1.0,8/24,17.53%,SEC31A;SEC24D;TAPBP;PDIA3;SEC23A;SEC24C;ACE;SEC24A
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.23610911254760983,0.789513652105127,0.8194029850746268,0.984601995826322,1.0,6/65,6.50%,CBL;PTPRJ;BCAR3;PTPN12;EPS15L1;ARHGEF7
prerank,positive regulation of mitochondrion organization (GO:0010822),0.24164773991815694,0.7894935185138383,0.825,0.9840227526282215,1.0,14/57,17.44%,GSK3A;RALA;ZNF205;DDHD1;PARK7;FBXO7;BAD;BMF;MIEF1;CAMKK2;VPS35;DNM1L;BNIP3;BAX
prerank,lamellipodium assembly (GO:0030032),-0.2623954526387854,-0.7893120623206951,0.8163265306122449,0.951273907082638,1.0,9/26,21.40%,KIT;VCL;SPATA13;ABLIM2;ABLIM3;PTPRO;ARFIP2;ARHGEF4;P2RY12
prerank,DNA alkylation (GO:0006305),0.29568475641490105,0.7892966690875225,0.7606382978723404,0.9831320290115501,1.0,2/19,5.90%,DMAP1;BEND3
prerank,DNA methylation or demethylation (GO:0044728),0.29568475641490105,0.7892966690875225,0.7606382978723404,0.9831320290115501,1.0,2/19,5.90%,DMAP1;BEND3
prerank,regulation of endocytic recycling (GO:2001135),-0.3249398828085487,-0.7891333223758157,0.7828947368421053,0.9508882629845306,1.0,4/11,16.65%,ATP9A;SORL1;ACTN2;EHD1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.24006610048352936,0.7889456155573676,0.8157894736842105,0.9831284031365024,1.0,6/66,4.79%,RBM22;TRIM28;DMAP1;CCT2;HDAC3;CCT5
prerank,protein tetramerization (GO:0051262),0.23821495009305044,0.7888548771588564,0.8338278931750742,0.9826785255980703,1.0,11/67,14.86%,THG1L;GLS;B2M;SSBP1;ACACB;SOD2;CPSF6;TRPM4;CUTC;OSBPL2;HOMER1
prerank,regulation of synapse maturation (GO:0090128),-0.3382524201379548,-0.7886502446495833,0.76171875,0.951000303560329,1.0,2/10,5.19%,NRXN1;RELN
prerank,regulation of protein sumoylation (GO:0033233),0.3118730533221195,0.7884789188961299,0.7566607460035524,0.9827111326914871,1.0,4/17,11.30%,SAE1;UBA2;PARK7;PIAS1
prerank,mitotic DNA replication (GO:1902969),0.3585155223127666,0.7884394198799121,0.7495183044315993,0.9821660798725691,1.0,2/10,9.24%,CDC45;POLA1
prerank,mRNA modification (GO:0016556),-0.2647353874748852,-0.7877803659321574,0.7769953051643192,0.9518202726462286,1.0,7/22,23.82%,PUS7;VIRMA;CBLL1;TRUB1;PCIF1;TRMT6;CMTR1
prerank,negative regulation of kinase activity (GO:0033673),0.23823376975930965,0.787728950973907,0.8297213622291022,0.9828373743832827,1.0,8/62,9.70%,TRIB3;PTPRC;GNAQ;SPRED1;DTNBP1;AKT1S1;IRS2;PARK7
prerank,glycerolipid metabolic process (GO:0046486),0.3457575174380776,0.7876410579571674,0.7355679702048417,0.9823899085963912,1.0,2/11,11.10%,DGKB;PGP
prerank,ruffle organization (GO:0031529),-0.2930221360473203,-0.7869413945856774,0.7687366167023555,0.9525153892950311,1.0,3/16,6.12%,LIMA1;TPM1;PIP5K1A
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.3276184097436306,0.786693135489565,0.7431906614785992,0.98342611388534,1.0,3/14,12.87%,SYK;CD81;CD55
prerank,cellular defense response (GO:0006968),-0.2318038255863495,-0.7865909115291583,0.859375,0.9524290256900624,1.0,6/40,14.52%,DCDC2;LBP;CCR9;LSP1;TCIRG1;RAB23
prerank,regulation of DNA metabolic process (GO:0051052),0.2495119585556618,0.7865689462205008,0.8205546492659054,0.9830314727752352,1.0,13/44,18.24%,STOX1;SMG1;UBE2V2;UBE2V1;KPNA1;NBN;HELB;TERF2IP;WDR70;SMARCAD1;SMG6;POLH;SMG5
prerank,protein localization to Golgi apparatus (GO:0034067),0.27971760117316496,0.7865317053504444,0.7738287560581584,0.9824895805674657,1.0,6/27,10.14%,ARL5C;RAB6A;TMED10;ARL5B;ZDHHC15;GCC2
prerank,P-body assembly (GO:0033962),0.33288435041273345,0.7861910733264728,0.7102272727272727,0.9825132151896179,1.0,2/12,9.62%,PATL2;PATL1
prerank,positive regulation of lymphocyte activation (GO:0051251),0.27327116450578126,0.786166999263269,0.7890909090909091,0.9819516287160681,1.0,5/28,17.31%,CYRIB;CD47;TNIP2;PRKDC;SH3KBP1
prerank,response to amyloid-beta (GO:1904645),0.25562543696184414,0.7861312916137576,0.8186274509803921,0.981404697473335,1.0,8/44,14.21%,CACNA1A;FCGR2B;MMP12;FYN;ICAM1;APP;PRNP;GRIN2A
prerank,carboxylic acid catabolic process (GO:0046395),0.3361387897887376,0.7860391384721394,0.7277992277992278,0.9809449650647278,1.0,2/12,11.93%,AMDHD2;ACOT8
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.22599830143321922,0.7859816464427967,0.8683068017366136,0.9804428397010503,1.0,15/88,13.78%,TAL1;SLF1;TIRAP;RAB7A;PFN1;ICE1;RGCC;SYK;PARK7;CHMP2A;RPS3;BMF;CDH5;PLEK;FAF1
prerank,positive regulation of neuron death (GO:1901216),0.2512825820604604,0.785853271251683,0.8092948717948718,0.9800762579714921,1.0,9/46,13.25%,FCGR2B;EIF2S1;FYN;WNT5A;SRPK2;NF1;PICALM;PRNP;DDIT3
prerank,regulation of stem cell proliferation (GO:0072091),0.30579121931277,0.7857633511022004,0.7486238532110092,0.979627102020209,1.0,3/17,10.31%,PTPRC;ZFP36L1;TERT
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.32595207017451344,-0.7856051046217444,0.7385892116182573,0.9533645024373066,1.0,7/11,38.64%,EXOSC10;LARP7;EXOSC2;EXOSC3;EXOSC5;TENT4B;FBL
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.3213201911556529,0.7855250482450574,0.7481060606060606,0.979417392579787,1.0,2/15,7.95%,SMAD7;CUEDC2
prerank,embryonic heart tube development (GO:0035050),0.31887138767139594,0.7854462786819449,0.759469696969697,0.9789647385788341,1.0,5/14,19.37%,CITED2;HES1;SOX17;RYR2;IFT122
prerank,protein secretion (GO:0009306),-0.21583331956912744,-0.785261005546818,0.8784530386740331,0.953251438543922,1.0,14/56,18.89%,WLS;TANGO2;RAB3C;PCSK5;RAB8B;MON1A;ANXA1;STEAP3;ABCA1;RCN3;OLFM2;RAB8A;SCG2;MTTP
prerank,nuclear pore organization (GO:0006999),-0.3037037384007236,-0.784960385468178,0.7333333333333333,0.9530930262689747,1.0,4/14,13.25%,NUP205;AHCTF1;NUP93;SEH1L
prerank,arachidonic acid secretion (GO:0050482),-0.3451070846309543,-0.784941688530624,0.7473903966597077,0.9518210580795685,1.0,4/10,30.26%,ANXA1;ACE;BDKRB2;DRD2
prerank,arachidonate transport (GO:1903963),-0.3451070846309543,-0.784941688530624,0.7473903966597077,0.9518210580795685,1.0,4/10,30.26%,ANXA1;ACE;BDKRB2;DRD2
prerank,regulation of centrosome cycle (GO:0046605),0.29417245578248163,0.7844503929951921,0.7735507246376812,0.9800621689883476,1.0,5/21,18.05%,CHMP1A;SIRT1;CHMP2A;NPM1;VPS4B
prerank,positive regulation of bone resorption (GO:0045780),0.3412623124578915,0.7842346020126159,0.7495219885277247,0.9798347913006376,1.0,2/11,10.78%,SYK;ATP6AP1
prerank,glycolipid biosynthetic process (GO:0009247),-0.23316242811876509,-0.7842137983144982,0.8217821782178217,0.9523566288749508,1.0,19/38,35.48%,A4GALT;B4GALT6;DPM1;ST6GALNAC5;LARGE1;ST3GAL4;PIGV;PIGG;PIGA;PIGM;PGAP4;PIGF;MPPE1;DPM2;PIGC;DPM3;ST3GAL5;ST8SIA5;ST8SIA3
prerank,regulation of actin filament polymerization (GO:0030833),0.23304274941874087,0.7839245888764688,0.8469539375928677,0.9797282361525403,1.0,14/69,17.07%,VASP;EVL;PFN1;CYRIB;KANK3;SSH2;PAK3;ESAM;CDC42EP3;TWF1;LMOD1;ARF6;PTK2B;BAIAP2
prerank,protein monoubiquitination (GO:0006513),0.2649888595914191,0.7834571809818145,0.8213716108452951,0.9799066107100302,1.0,8/36,14.35%,RAD18;TRIM25;ATXN7L3;UBE3D;CUL3;UBE2R2;RNF20;FANCL
prerank,regulation of plasminogen activation (GO:0010755),0.3396968709279342,0.7834090657121737,0.7431906614785992,0.9793912355013893,1.0,1/12,1.93%,PLGRKT
prerank,regulation of defense response to virus by host (GO:0050691),0.27221834898891506,0.7829700727961271,0.7777777777777778,0.979516367274551,1.0,2/30,2.87%,TNFAIP3;IFNLR1
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.277530415407666,-0.7829027462721726,0.8120805369127517,0.9538813445647024,1.0,5/19,18.44%,NFAT5;PLCE1;NFATC2;PPP3CC;NFATC4
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.2847237727403101,-0.7826264720402345,0.8008565310492506,0.9536876862597203,1.0,4/19,9.23%,CBFB;IRAK1;IFIH1;ELF1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.2827631208815663,-0.7826255399043028,0.7676056338028169,0.9530426545138,1.0,6/18,27.56%,LBP;THBS1;IL33;HSPD1;NECTIN2;KARS1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.2948704524610659,0.7819210448669563,0.7673611111111112,0.9806526672593011,1.0,5/20,10.65%,HEY1;HEY2;NOTCH1;ACVRL1;RBPJ
prerank,phospholipid translocation (GO:0045332),0.27462441100514967,0.7818158730577279,0.7976588628762542,0.9802324815009191,1.0,6/28,14.35%,ATP8A1;ATP11A;TMEM30B;P2RX7;ATP11C;ATP10A
prerank,regulation of cellular metabolic process (GO:0031323),0.24922575220421989,0.7816414384390621,0.7884615384615384,0.9799373392908396,1.0,13/45,19.14%,PANK2;LAMTOR1;ACACB;ARF1;CYP1B1;NPC2;VPS35;MBOAT7;ACACA;EIF6;KIF16B;PDK3;ABCG1
prerank,cellular response to ionizing radiation (GO:0071479),0.24859229692376897,0.7809218693194999,0.846875,0.9805607623141209,1.0,11/47,15.65%,EEF1D;RAD1;CDKN1A;SIRT1;CLOCK;KDM4D;MDM2;HUS1;TLK2;INO80;ATR
prerank,negative regulation of T cell activation (GO:0050868),0.26581458917996464,0.7805290543659259,0.7983471074380165,0.9806217823372863,1.0,4/35,14.50%,FCGR2B;RIPOR2;CD274;PAG1
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.24832187862625504,-0.7804184269310095,0.8045112781954887,0.9559039803011323,1.0,4/30,15.06%,PIBF1;PRKCZ;CD34;HSPD1
prerank,response to lipopolysaccharide (GO:0032496),0.2107804604729845,0.7803485787481472,0.8941655359565808,0.9803313616114825,1.0,19/138,13.15%,TNFAIP3;TAB2;TIRAP;SBNO2;TNFRSF1B;MAPK8;CARD16;SELP;WNT5A;ERBIN;RELA;IFNAR1;NFKBIL1;NOS3;SCARB1;TNIP2;PLAA;OTUD5;CD274
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.2890084973850725,-0.7802305173111962,0.7673913043478261,0.9555605385293534,1.0,5/15,17.85%,DDX1;CSTF2;RTCB;RTRAF;ZBTB8OS
prerank,negative regulation of histone modification (GO:0031057),0.3209656087835664,0.7800597471178987,0.7433962264150943,0.980233434257055,1.0,1/14,0.88%,AASS
prerank,positive regulation of interferon-beta production (GO:0032728),-0.24190393922678718,-0.779855536495384,0.841025641025641,0.9555111422719524,1.0,15/33,37.66%,IFIH1;RNF135;POLR3C;MAVS;RIOK3;FLOT1;TLR3;OAS2;HSP90AA1;POLR3G;TOMM70;TLR7;POLR3D;ISG15;DHX58
prerank,modulation by host of viral genome replication (GO:0044827),0.3288599151562382,0.7790783487591824,0.751412429378531,0.9812794902817698,1.0,7/13,23.52%,PPIB;IFI27;YTHDC2;EIF2AK4;TBC1D20;VAPA;FMR1
prerank,negative regulation of potassium ion transport (GO:0043267),-0.3033701195976731,-0.7786414920314331,0.755939524838013,0.9567770539823389,1.0,3/13,9.72%,CAB39;BIN1;ACTN2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.34288818882755473,-0.7785001956276387,0.7775330396475771,0.9563204254103046,1.0,4/10,26.35%,GHR;STAT6;PRLR;STAT5A
prerank,histone H3-K4 methylation (GO:0051568),-0.2610924517435226,-0.7783906337995299,0.8288508557457213,0.9558475839995431,1.0,8/26,20.59%,OGT;KMT2A;PAXIP1;RBBP5;KMT2B;DPY30;KMT2D;SETD4
prerank,negative regulation of transport (GO:0051051),0.24270181478257485,0.7782707608946359,0.8297546012269938,0.9820331068775167,1.0,3/51,4.59%,RSC1A1;FCGR2B;RAB7A
prerank,sulfur compound catabolic process (GO:0044273),0.2599289790138389,0.7780147938670343,0.7911184210526315,0.9818885820384772,1.0,4/38,5.45%,GLB1;MLYCD;FITM2;ACAT1
prerank,negative regulation of telomere maintenance (GO:0032205),0.3112260088397596,0.7772869374507949,0.7729636048526863,0.9825186403150535,1.0,6/15,18.06%,ERCC4;TNKS;NBN;TERF2IP;SMG6;TNKS2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.3013472912837403,-0.7771476812643664,0.7649484536082474,0.9570648384847781,1.0,9/15,32.61%,RAB3GAP2;SEC61A1;EDEM1;SRPRB;SRP14;ZFAND2A;SEC61G;SPCS1;SRPRA
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.3200942844644249,0.7770851360053477,0.7598499061913696,0.9822727128372656,1.0,3/15,13.36%,NEK11;HUS1;CHEK2
prerank,regulation of interleukin-10 production (GO:0032653),0.2518695853790402,0.7770343248981508,0.8206785137318255,0.9817624752106789,1.0,5/44,13.15%,FCGR2B;SYK;CD47;VSIR;CD274
prerank,regulation of cell death (GO:0010941),0.22333122203403769,0.7770324562112655,0.861671469740634,0.9811714867243324,1.0,18/94,17.23%,RAD18;SNCG;SLC25A24;TXNDC12;ACER2;TNFRSF1B;TSC1;PARK7;CHMP2A;ACER3;BNIP3L;FAF1;APC;SPEF1;VPS35;BNIP3;BECN1;PDE8A
prerank,negative regulation of cholesterol transport (GO:0032375),-0.3356374677190803,-0.77702163385639,0.744136460554371,0.9566028280227269,1.0,2/10,31.45%,NFKB1;ABCA2
prerank,cellular response to interferon-gamma (GO:0071346),0.22532849132440347,0.7769486454089606,0.8746355685131195,0.9807273683464507,1.0,15/88,15.72%,TRIM8;GBP3;IRF9;B2M;GBP4;ICAM1;WNT5A;TRIM25;CCL25;CD47;MID1;IRF2;CD44;MT2A;CAMK2G
prerank,negative regulation of myoblast differentiation (GO:0045662),-0.3060119568925766,-0.776852962132959,0.7717391304347826,0.9562132026612161,1.0,3/13,16.33%,BMP4;TBX3;TGFB1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.22670965834051587,-0.7767981563713005,0.8734177215189873,0.9556440538313651,1.0,21/41,44.85%,PLA2G4A;ACSL1;EPHX1;FADS2;DEGS1;GPX1;FADS3;DECR2;SCD;ELOVL1;GSTM2;FADS1;ALOX12;PTGS1;PLA2G4C;DAGLA;FAAH;ACOX1;SCD5;PTGR1;MGLL
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.3193497846864635,0.7764417277535288,0.751953125,0.9809883116865332,1.0,3/14,9.97%,TIRAP;HNRNPC;TARDBP
prerank,positive regulation of neuron migration (GO:2001224),0.3329318077025817,0.7762974702523663,0.7253384912959381,0.9806507573724697,1.0,1/11,0.92%,SEMA6A
prerank,cell-cell junction maintenance (GO:0045217),0.33092978867948314,0.7761092588237538,0.7664783427495292,0.9803722959226165,1.0,2/11,9.27%,TJP1;CSF1R
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.25307959265086605,-0.776053157971186,0.8217821782178217,0.9561163507947287,1.0,1/26,0.15%,ATP1A2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.23682569272442286,-0.7757801968303273,0.8835443037974684,0.9558665026402031,1.0,9/33,15.50%,PKD1;APPL2;CDKN1B;CDC73;DDRGK1;STXBP4;TRIM39;PAF1;MN1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.286619464216883,0.7756891905736483,0.7803571428571429,0.9804784088109025,1.0,6/21,14.13%,CLASP2;CIB1;FGF13;CAMSAP2;APC;SPEF1
prerank,cellular response to amyloid-beta (GO:1904646),0.2572134025335058,0.7754994629328161,0.8013355592654424,0.9802195601455889,1.0,7/35,14.21%,CACNA1A;FCGR2B;FYN;ICAM1;APP;PRNP;GRIN2A
prerank,protein localization to kinetochore (GO:0034501),0.31577357361495195,0.7753638774627567,0.7549549549549549,0.9798471502048614,1.0,3/14,14.70%,CHAMP1;MIS12;MTBP
prerank,acylglycerol catabolic process (GO:0046464),0.27593963556660245,0.7752030957693633,0.802405498281787,0.9795397512500523,1.0,29/30,65.22%,FABP7;ABHD12;ABHD16A;FABP6;ABHD12B;APOC3;PNLIPRP2;LIPI;PNPLA1;PNPLA5;FABP2;CPS1;APOA2;LIPG;ABHD6;FABP12;FABP4;ABHD2;LIPC;LIPH;FABP3;MGLL;FAAH;DAGLA;PNPLA3;FABP5;LPL;PNPLA2;LYPLA2
prerank,signal transduction by p53 class mediator (GO:0072331),-0.2381113949216942,-0.7751559171560684,0.875609756097561,0.9561667052431536,1.0,5/30,11.69%,DDX5;FHIT;PAXIP1;TP53;STK11
prerank,protein complex oligomerization (GO:0051259),0.22220363561133397,0.7751539474788072,0.8944281524926686,0.979024388307724,1.0,15/85,14.86%,RS1;EHD4;ATL1;BEND3;LRRC8C;TRMT61B;CPSF6;CHMP2A;MAT2A;HGSNAT;G3BP2;CUTC;LETM1;FUS;HOMER1
prerank,response to interleukin-1 (GO:0070555),-0.20387916657835267,-0.7750537233221124,0.908284023668639,0.9556790075863482,1.0,13/73,16.53%,ADAMTS12;HDAC4;RBMX;IRAK1;PTGIS;IRAK3;NFKB1;ANXA1;CCL14;SIRPA;UPF1;USP10;TANK
prerank,maturation of 5.8S rRNA (GO:0000460),-0.28299205079222617,-0.7747679750100086,0.7618025751072961,0.9554618909548044,1.0,8/17,24.88%,NSA2;EXOSC10;LAS1L;MTREX;C1D;RPF1;NOL9;MAK16
prerank,B cell homeostasis (GO:0001782),0.34788340964064024,0.7745944009896675,0.744466800804829,0.9793173425633839,1.0,2/10,9.34%,TNFAIP3;LYN
prerank,cellular senescence (GO:0090398),-0.2507462782774411,-0.7745016754913279,0.8079625292740047,0.9552139118700116,1.0,5/27,11.84%,MAPK14;PRKCD;PML;SMC6;TBX3
prerank,response to leucine (GO:0043201),0.34282161619518975,0.7741171703373115,0.7276264591439688,0.9789098887292634,1.0,4/10,19.07%,RPTOR;LARS1;SESN3;SESN1
prerank,cellular response to leucine (GO:0071233),0.34282161619518975,0.7741171703373115,0.7276264591439688,0.9789098887292634,1.0,4/10,19.07%,RPTOR;LARS1;SESN3;SESN1
prerank,nucleoside catabolic process (GO:0009164),0.339541906500585,0.7737782557187574,0.7603960396039604,0.9788783598353248,1.0,2/11,9.47%,UPP1;UPP2
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.2745228301507466,-0.7734341585205323,0.7923250564334086,0.956162980002106,1.0,4/18,13.61%,MCU;SPIRE1;FIS1;RALBP1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.30613242890611375,-0.773320371249613,0.7768052516411379,0.9557016327959481,1.0,5/13,22.58%,NIBAN2;NEDD4;CADM4;HGS;EMILIN1
prerank,negative regulation of leukocyte activation (GO:0002695),-0.3005455307658076,-0.7732482980476969,0.7880085653104925,0.9551825125274511,1.0,2/15,6.98%,LRFN5;IL31RA
prerank,negative regulation of autophagy (GO:0010507),-0.2179893370009264,-0.7731132992302303,0.8977272727272727,0.9547671493093797,1.0,15/54,19.69%,SNRNP70;LEPR;SIRT2;NUPR1;KDM4A;KLHL22;GOLGA2;NRBP2;CTSA;PTPN22;MTMR9;QSOX1;MET;FOXK1;PINK1
prerank,linoleic acid metabolic process (GO:0043651),-0.29066256961079706,-0.7730952664562505,0.7760180995475113,0.9541577136210155,1.0,6/17,37.57%,ACSL1;FADS2;ELOVL1;GSTM2;FADS1;ALOX12
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2172069026243609,-0.7716377389791113,0.8373983739837398,0.9557059738812973,1.0,20/56,31.68%,SFTPA2;SFTPA1;IRAK1;LBP;LGMN;UBC;TAB1;LACC1;IRAK4;IRAK2;CNPY3;CTSK;TLR3;BCL10;MAPKAPK2;CTSB;TIFA;CTSS;S100A1;TLR7
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.31793748963631824,-0.7715626196543032,0.7560483870967742,0.9551678169079417,1.0,2/11,5.33%,NECAB1;BACE2
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.27374749779646285,0.7714183116280185,0.8466898954703833,0.9821560363885617,1.0,5/28,12.94%,CXCL12;PFN1;PAK3;ESAM;NAA80
prerank,double-strand break repair via homologous recombination (GO:0000724),0.21932333077924776,0.7713270830342674,0.8930555555555556,0.9817221401753192,1.0,16/95,14.62%,ZSWIM7;ERCC4;YY1;XRCC1;SFPQ;CDC45;KDM4D;SEM1;RAD51B;EXD2;RFWD3;HUS1;NBN;PSMD14;RMI1;INO80
prerank,mitochondrion disassembly (GO:0061726),-0.23269681449320345,-0.771318517040471,0.8502415458937198,0.9549085089959268,1.0,4/34,7.76%,AMBRA1;ULK2;WIPI1;FIS1
prerank,excitatory postsynaptic potential (GO:0060079),-0.2719336493184689,-0.7713176914010211,0.8120805369127517,0.9542749244712991,1.0,7/19,24.73%,GRID2;GRIN2B;GSK3B;GRIN2D;GRIN1;MPP2;AKT1
prerank,endocardial cushion development (GO:0003197),0.2859283831841871,0.7713074191843945,0.7608318890814558,0.9811651595511598,1.0,4/21,11.33%,HEY1;NOTCH1;ACVRL1;NOS3
prerank,sister chromatid segregation (GO:0000819),0.26851628928439863,0.7712191265616236,0.7750809061488673,0.9807291118540931,1.0,4/31,10.59%,KIF18A;CHAMP1;CDCA8;MIS12
prerank,inner ear receptor cell stereocilium organization (GO:0060122),0.344364589675798,0.7708900470618107,0.7366336633663366,0.9806982195884345,1.0,1/10,2.27%,SOD1
prerank,membrane raft organization (GO:0031579),-0.294481770123326,-0.7708095662356976,0.7775377969762419,0.9544067801727347,1.0,7/15,28.62%,ANXA2;FLOT2;MYADM;FLOT1;CLN3;EMP2;ABCA7
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.2495271569028838,0.7700557147025235,0.8083333333333333,0.981437011814367,1.0,6/42,11.87%,PTPRJ;TEK;CIB1;CCL25;TSC1;MAP4K4
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.263062309395212,0.7688361732918485,0.8003472222222222,0.9828055886374194,1.0,3/29,8.70%,ERCC3;CCNH;GTF2H1
prerank,regulation of receptor recycling (GO:0001919),-0.2925210104550565,-0.7687652190868898,0.7775377969762419,0.9567688701067257,1.0,7/16,30.14%,ANXA2;OPTN;TBC1D16;RAB29;INPP5F;SNCA;SCRIB
prerank,endothelial cell differentiation (GO:0045446),-0.30937468131160945,-0.7685028436316947,0.7627118644067796,0.9565016492694369,1.0,4/12,21.94%,FSTL1;SCUBE1;BMPR2;KDM6B
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.33547993483867017,-0.7682832631109072,0.772635814889336,0.9561865739699171,1.0,3/10,12.56%,MTHFD2L;MTHFR;MTHFD1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.26944739205247925,0.7677828968544814,0.7960199004975125,0.9839336592780471,1.0,6/28,12.29%,GAS2L1;CLASP2;MAP1S;CAMSAP2;PRUNE1;FKBP4
prerank,endocardial cushion morphogenesis (GO:0003203),0.2915469488147881,0.7675927697570801,0.7535714285714286,0.9836421243052168,1.0,4/18,11.33%,HEY1;NOTCH1;ACVRL1;NOS3
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2741354693497498,0.7673981548184026,0.8219895287958116,0.9833661201086193,1.0,10/25,19.33%,LONP1;OMA1;AUP1;CUL3;UFD1;YME1L1;ATXN3;UGGT1;POMT2;DERL1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.32710676162324687,0.7671121547787374,0.7527472527472527,0.9832226724968874,1.0,2/12,7.95%,INSIG1;KDELR2
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.32392011244697205,0.7670905000801671,0.7816091954022989,0.9826694110386069,1.0,2/12,10.43%,PPP3CB;TRPM4
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.27454882634717437,0.7662507922162093,0.7996515679442509,0.9834494131594742,1.0,2/27,3.96%,RRM2B;NME1
prerank,response to estradiol (GO:0032355),-0.23795685337485786,-0.7660236221838621,0.8582474226804123,0.9588205478214613,1.0,6/31,16.33%,EGFR;CTNNB1;SOCS2;ANXA1;GGT5;TGFB1
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.2798446748560774,0.7659462748020144,0.8126094570928196,0.9833732496229621,1.0,4/23,13.32%,GSK3A;EP300;PGP;PLEK
prerank,covalent chromatin modification (GO:0016569),0.3126595875434791,0.7658892253656467,0.7728155339805826,0.9828749489603316,1.0,4/14,10.47%,SIRT1;SETD5;PARK7;CHD1
prerank,urogenital system development (GO:0001655),-0.31913837256173194,-0.7658811278660009,0.8025210084033614,0.958393014046533,1.0,3/11,12.16%,OSR1;EPHB2;ANXA1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.326754380981719,0.7657357896422957,0.7610789980732178,0.9825279856888206,1.0,3/12,13.36%,NAE1;HUS1;CHEK2
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.2640777488141681,-0.7656950348624195,0.8056768558951966,0.9580374666460846,1.0,5/22,16.14%,MAN1C1;UGGT2;UBC;EDEM1;RNF139
prerank,regulation of macrophage activation (GO:0043030),-0.2446210234236596,-0.7654140923492255,0.8259803921568627,0.9577928289805828,1.0,6/30,15.06%,LRFN5;IL31RA;LBP;THBS1;IL33;HSPD1
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.2712276207908783,-0.7652054104243458,0.7967667436489607,0.9574659294985375,1.0,5/21,19.98%,ZWINT;KLHL22;BUB3;ATM;ZW10
prerank,response to acidic pH (GO:0010447),0.32013609799309556,0.7648495326896145,0.7712665406427222,0.9833332160389316,1.0,2/13,7.99%,RAB11B;RAB11FIP5
prerank,negative regulation of GTPase activity (GO:0034260),-0.2596147670931698,-0.7646465956441637,0.8314350797266514,0.9576481562993938,1.0,4/22,11.42%,CPEB2;WNK1;GPSM1;GMIP
prerank,copper ion homeostasis (GO:0055070),-0.28220477829254537,-0.7645843335481142,0.8034557235421166,0.9571020972085873,1.0,6/17,18.64%,ATP7A;XIAP;SLC31A1;COMMD1;SLC31A2;COX19
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.28898319028396563,-0.7644871824133745,0.7775229357798165,0.9565949743442191,1.0,3/15,6.61%,LPGAT1;PPARGC1A;PPARA
prerank,microtubule bundle formation (GO:0001578),0.24396114876434724,0.7643288172719979,0.8377483443708609,0.9835837974069936,1.0,7/42,17.26%,GAS2L1;MAP1S;NAV1;SPEF1;CLIP1;NCKAP5;CLASP1
prerank,diacylglycerol metabolic process (GO:0046339),0.27461997686883965,0.7640197235780123,0.7712854757929883,0.9835007687829563,1.0,2/23,2.63%,DGKB;GPAM
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.2888614594656037,0.7629320935849292,0.7966942148760331,0.9846473441339036,1.0,3/20,5.60%,ZFP36L1;MEIS1;CIB1
prerank,negative regulation of endocytosis (GO:0045806),-0.26047303255564935,-0.7624285098501757,0.8223234624145785,0.9589878654880263,1.0,10/24,32.29%,EPHA3;SYT11;SCAMP5;LRSAM1;PRKD1;NR1H2;ABCA7;PACSIN3;CAV1;CD300A
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.28873338533587234,-0.7621958381032116,0.811816192560175,0.9586762223277605,1.0,2/16,1.67%,DPYD;DPYSL3
prerank,regulation of lipid storage (GO:0010883),0.2752855569518683,0.7618403621061206,0.8094405594405595,0.9857667017405837,1.0,5/22,15.40%,SIRT1;ALKBH7;MEST;NFKBIA;FTO
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.3377625977684392,0.7617223998740597,0.7602996254681648,0.985377802980737,1.0,2/10,8.12%,TNFRSF1B;NOTCH1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.3196894708489689,0.761673324761472,0.7532228360957642,0.9848634584049081,1.0,2/13,6.67%,PDE4D;CALM3
prerank,protein targeting to lysosome (GO:0006622),-0.2657169281084075,-0.7613018653532204,0.7995226730310262,0.959302742963118,1.0,10/20,22.20%,SORL1;ZFYVE16;NCOA4;M6PR;AP4M1;GGA3;NEDD4;VPS4A;GNPTAB;HGS
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.28592256652157955,-0.7611347680573736,0.7666666666666667,0.958902372677343,1.0,7/16,30.03%,KCNC2;DDAH1;GUCY1A1;GUCY1B1;DDAH2;NDNF;NOS1
prerank,transferrin transport (GO:0033572),0.2610343895246995,0.7609936486116545,0.8151815181518152,0.9853160485071418,1.0,5/33,10.78%,ATP6V1D;RAB11B;ATP6V0D1;ATP6V0E1;ATP6AP1
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.2661202175610995,-0.7609148732672373,0.8341346153846154,0.9585943894672064,1.0,4/23,10.49%,WNT5B;BMP4;SMO;GJA1
prerank,myelin assembly (GO:0032288),-0.32142134367904873,-0.7609141366382356,0.80083857442348,0.957964397024229,1.0,6/10,32.25%,EPB41L3;DICER1;TPPP;CNTNAP1;ABCA2;GPC1
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.33298760341409744,0.7608473280101248,0.752851711026616,0.9849641142752477,1.0,3/11,14.59%,TRIM28;PPHLN1;TASOR
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.22771633942848368,0.7597297654582991,0.8870481927710844,0.9861342226924321,1.0,5/69,8.24%,PTPRJ;PTPRC;TIRAP;SYK;WNT5A
prerank,synaptic vesicle localization (GO:0097479),-0.3045814090166953,-0.7596411135131728,0.7866379310344828,0.9591289785576057,1.0,4/13,15.98%,KIF5C;SYNDIG1;NLGN1;KIF5A
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.2755092189954631,0.759489181944128,0.8212996389891697,0.9859287646731021,1.0,2/22,8.70%,ERCC3;GTF2H1
prerank,male gonad development (GO:0008584),0.2597996331153042,0.7591517867374196,0.8205980066445183,0.9858673242125121,1.0,4/34,10.41%,NR5A1;MAMLD1;WNT5A;ING2
prerank,signal transduction in response to DNA damage (GO:0042770),0.236226590610223,0.7591108135992215,0.8346839546191248,0.985337891571805,1.0,11/49,16.89%,TIPRL;ACER2;RAD1;CLOCK;HUS1;NBN;DOT1L;CHEK2;BRIP1;ATR;USP28
prerank,regulation of mitotic spindle organization (GO:0060236),-0.2353919150420932,-0.7585979481986869,0.8455882352941176,0.9599566206869136,1.0,8/35,20.52%,DYNC1H1;PARP3;EML3;DCTN1;CHMP2B;CHMP5;RAE1;MAP9
prerank,lymphocyte chemotaxis (GO:0048247),0.2601743339450597,0.7582709997521861,0.8126036484245439,0.9860790251217095,1.0,4/34,15.42%,PIK3CG;CCL25;PIK3CD;GAS6
prerank,xenobiotic transport (GO:0042908),-0.280430171718411,-0.7579725258107458,0.834070796460177,0.9602178265610755,1.0,3/17,10.49%,SLC47A1;SLC22A4;GJA1
prerank,regulation of activated T cell proliferation (GO:0046006),0.2647585999765847,0.7570404469837424,0.827027027027027,0.9873906891728285,1.0,4/30,13.15%,PRKAR1A;RPS3;PRNP;CD274
prerank,nucleotide metabolic process (GO:0009117),0.2783750674285152,0.757007026257142,0.8120689655172414,0.9868543370814049,1.0,4/23,10.66%,REXO2;NUDT5;PARK7;PNP
prerank,microtubule anchoring at centrosome (GO:0034454),-0.326552924593834,-0.7568477071719718,0.7704918032786885,0.9611992389565328,1.0,3/10,15.65%,NINL;KIF3A;DCTN1
prerank,regulation of nuclear division (GO:0051783),0.2900405935415463,0.7563329061208961,0.776595744680851,0.9872675179419874,1.0,2/20,7.08%,PIN1;FBXO5
prerank,regulation of mitochondrion organization (GO:0010821),0.24236889270753678,0.7560429246555366,0.8395904436860068,0.9871028673724883,1.0,5/47,7.30%,GSK3A;STOX1;CYRIB;EP300;OMA1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),-0.1997244011070551,-0.7551900581727712,0.9171779141104295,0.9629485353482256,1.0,16/67,18.81%,PLD1;CYLD;FER;P2RX4;DCDC2;GAP43;TBC1D22B;RABEP2;TBC1D10A;TBC1D13;TBC1D9B;ATP8B1;TWF2;IFT20;CDC42;CAPZB
prerank,mitochondrial protein processing (GO:0034982),0.3278835603007859,0.7551116139469692,0.7585551330798479,0.9879203882761108,1.0,2/11,7.30%,IMMP2L;OMA1
prerank,positive regulation of lamellipodium organization (GO:1902745),0.25606257373380303,0.7551060713319436,0.8266897746967071,0.9873470755787832,1.0,3/32,6.50%,RAC2;SRC;ARHGEF7
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.2527991937444374,0.7547272968104429,0.835820895522388,0.9873006021468526,1.0,6/37,7.72%,RPTOR;STOX1;SPRED1;CALM3;SMAD7;AXIN1
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.3245547207610834,-0.7544050312151999,0.8008298755186722,0.9634235911221067,1.0,3/10,13.66%,ITGA5;VTN;GRB10
prerank,phospholipid metabolic process (GO:0006644),-0.2007495117230479,-0.754399893050522,0.9192546583850931,0.9627970382843841,1.0,10/71,10.96%,PLA2G4A;PLPPR1;AGPAT4;PLPP3;AGPAT5;PIP5K1A;PLPPR5;PIP4K2B;SMPD3;PLPPR4
prerank,positive regulation of signaling receptor activity (GO:2000273),0.2549530110620505,0.7543722262330376,0.8399339933993399,0.9872637831096157,1.0,4/36,9.95%,SHANK3;GREM1;PARK7;BUD31
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.27394742415030626,-0.754353804095931,0.8181818181818182,0.9622180789774818,1.0,6/18,26.87%,ROCK1;SLC39A8;ITGA4;ADD2;PODXL2;CX3CR1
prerank,positive regulation of T cell activation (GO:0050870),0.22797476776576814,0.7539693572428486,0.8659476117103235,0.9872867044239346,1.0,11/62,19.58%,PTPRC;CYRIB;CD47;PNP;CD81;CD274;DOCK8;IL7;CD46;TFRC;XBP1
prerank,response to ketone (GO:1901654),-0.25643242597231064,-0.753788267662126,0.8516746411483254,0.9623580683646034,1.0,9/24,34.58%,TGFBR3;THBS1;TGFB1;CATSPER2;TGFB3;YAP1;CAV1;ABCB4;CATSPER3
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.31030160615487923,0.753740282015536,0.777988614800759,0.9870389885041183,1.0,2/15,10.90%,STOX2;USP22
prerank,negative regulation of insulin secretion (GO:0046676),-0.27367491791690945,-0.7534129912230372,0.8093126385809313,0.9622198320178421,1.0,8/17,41.72%,PSMD9;CCN3;ADRA2A;SFRP1;SIRT4;PIM3;CHGA;INHBB
prerank,DNA modification (GO:0006304),0.2812420172118451,0.753053668417048,0.8133561643835616,0.9874549150536472,1.0,5/22,15.09%,TDG;ACD;SMUG1;MPG;TERF2IP
prerank,protein localization to vacuole (GO:0072665),0.3169376937129323,0.7525633512570871,0.7666034155597723,0.9876261325936602,1.0,5/13,18.74%,GLMP;CD81;KPTN;RNF128;SH3GLB1
prerank,positive regulation of fibroblast proliferation (GO:0048146),0.2659342722903578,0.7523576501224082,0.8188034188034188,0.9873350485693043,1.0,4/27,8.63%,CDKN1A;BMI1;WNT5A;CDK4
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.24433171142936372,-0.7520315747832736,0.8310185185185185,0.9634821941952069,1.0,8/27,24.70%,PPARA;ABCA5;NFKB1;IL18;ABCA1;AGTR1;NR1H2;MAPK9
prerank,reverse cholesterol transport (GO:0043691),0.3275920637516445,0.7518599307588556,0.7945205479452054,0.9874880665513264,1.0,2/13,12.07%,APOE;SCARB1
prerank,negative regulation of blood coagulation (GO:0030195),0.24592563057189304,0.7511612272777679,0.8327814569536424,0.9879574649681542,1.0,6/38,13.96%,APOE;F8;NOS3;A2M;PLAT;PROC
prerank,protein autoubiquitination (GO:0051865),0.22769673901361287,0.7511558720134273,0.8922610015174507,0.9873885430065777,1.0,11/61,13.45%,RAD18;UBE3A;NFX1;RNF187;MDM2;UBE3D;KLHL24;RNF13;RNF11;CUL3;RNF146
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.2809693485913948,-0.7510614445972947,0.8087912087912088,0.964186807653575,1.0,6/16,18.50%,A4GALT;B4GALT6;ST6GALNAC5;LARGE1;ST6GALNAC6;ST8SIA2
prerank,negative regulation of histone methylation (GO:0031061),0.34191539202428856,0.7507506852622922,0.7702702702702703,0.987410753818732,1.0,1/10,0.88%,AASS
prerank,negative regulation of macroautophagy (GO:0016242),0.26520642443254205,0.7507336608397108,0.8180212014134276,0.9868576611247077,1.0,11/26,21.41%,SMG1;TSC1;SCFD1;FEZ2;TMEM39A;UBQLN4;USP36;LZTS1;LRRK2;RUBCN;PIK3CA
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.24287533636300965,0.7506603404957451,0.8485342019543974,0.9863873483758555,1.0,10/45,15.72%,TRIM8;IRF9;B2M;ICAM1;TRIM25;MID1;IRF2;CD44;MT2A;CAMK2G
prerank,cellular response to pH (GO:0071467),0.2930147162239655,0.7506095396633551,0.7848101265822784,0.9858773351483566,1.0,2/17,7.99%,RAB11B;RAB11FIP5
prerank,negative regulation of cell cycle process (GO:0010948),0.2310547089952195,0.7503494141870614,0.8719512195121951,0.985678605348764,1.0,8/61,10.45%,EZH2;EED;FBXO5;UXT;BMI1;RYBP;CHMP2A;MGA
prerank,zinc ion transmembrane transport (GO:0071577),-0.25628322633541917,-0.7503372186310004,0.8520286396181385,0.9644894240085564,1.0,8/22,24.91%,SLC39A14;SLC30A10;SLC39A13;SLC30A4;SLC39A8;SLC39A7;SLC39A6;SLC30A5
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.21647790681803816,0.7499697472543525,0.9216867469879518,0.9856298068304314,1.0,15/84,14.60%,ILF3;PIN1;PATL2;APOE;FXR1;PAIP2B;CNOT7;TSC1;DDX3X;NANOS3;RPS3;PRNP;YBX1;CAPRIN1;CNOT1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.23653292660898662,0.7496407595862558,0.872168284789644,0.985527141122928,1.0,7/47,13.32%,TRIB3;PRMT3;FYN;EP300;ERLIN2;PGP;PLEK
prerank,superoxide metabolic process (GO:0006801),-0.2327977771572881,-0.7494387109568378,0.8581235697940504,0.9650371628816863,1.0,10/29,23.25%,ATP7A;SH3PXD2A;CCS;NOX4;SOD3;PREX1;PRDX2;PRDX1;SH3PXD2B;NRROS
prerank,positive regulation of protein transport (GO:0051222),-0.19844914491371304,-0.7492833191522099,0.9123867069486404,0.9646308405413235,1.0,21/67,26.00%,BMP6;IGF1;EZR;PPID;UNC13B;VAMP2;RACK1;ARHGEF5;OAZ1;EXOC1;TGFB1;CNST;OAZ2;RAB29;CLN3;IER3IP1;TGFB3;RIPOR1;APBB1;PPIA;SYTL4
prerank,synaptic vesicle transport (GO:0048489),0.32658209185430725,0.7491561805472586,0.7996219281663516,0.9856454489677735,1.0,5/11,19.48%,TMEM230;SPG11;SNAPIN;RAB27A;KIF5B
prerank,macrophage activation (GO:0042116),0.25571894192443856,0.7484893316200317,0.8330494037478705,0.9859996584515272,1.0,6/34,14.52%,SBNO2;IFI35;SYK;APP;CD93;CRTC3
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.31382983349921384,0.7484444493129907,0.7730627306273062,0.9854942873017514,1.0,1/13,1.15%,CBL
prerank,cochlea morphogenesis (GO:0090103),0.3369816305381745,0.7482939144694888,0.766859344894027,0.9851303292204501,1.0,1/10,6.09%,TBX1
prerank,miRNA metabolic process (GO:0010586),0.284380204054226,0.748005494294981,0.7964601769911505,0.9849945148485844,1.0,6/20,19.04%,BCDIN3D;XPO5;TUT7;TUT4;PARN;DIS3L2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.3317588245306685,0.7478324236247627,0.782608695652174,0.984687112517762,1.0,4/11,20.37%,PARK7;FBXO7;NONO;REST
prerank,organic hydroxy compound transport (GO:0015850),-0.2218979056557251,-0.7475453629270941,0.8871391076115486,0.9663609247785345,1.0,7/36,16.40%,RBP4;OSBP;RXRA;RALBP1;NCOA1;STARD5;ATP8B1
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.3308478944292777,-0.7470411268174503,0.7923728813559322,0.9664199887814048,1.0,3/10,20.94%,ATP7A;KYAT1;QDPR
prerank,hemidesmosome assembly (GO:0031581),0.32657712653096393,0.7469155301660104,0.7713178294573644,0.9854004649331845,1.0,2/11,8.76%,DST;ITGA6
prerank,carboxylic acid transmembrane transport (GO:1905039),0.2435991794577747,0.746774239512673,0.8597359735973598,0.9850389833307807,1.0,2/40,1.29%,SLC7A8;SLC36A4
prerank,regulation of T cell activation (GO:0050863),0.24055223873050824,0.7464676625088322,0.84,0.9848888108947187,1.0,3/42,9.14%,TNFRSF1B;CYRIB;CD47
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.28846243333888294,0.7457470743269121,0.7893772893772893,0.9852938535048332,1.0,3/18,9.70%,SIRT1;SOD2;PARK7
prerank,ERAD pathway (GO:0036503),0.21827764705121114,0.7456192141159576,0.9097525473071325,0.9849041690944722,1.0,24/83,19.64%,DERL2;YOD1;WFS1;FAM8A1;SGTB;TRIM25;AUP1;RHBDD2;ERLIN2;UBQLN1;STT3B;PSMC6;DNAJC10;UFD1;UBQLN2;DNAJB14;ATXN3;UGGT1;UBXN4;POMT2;DNAJB9;CCDC47;DERL1;SEL1L
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.23722139886259488,-0.7450147017706282,0.8654822335025381,0.9684512780872357,1.0,7/30,17.43%,UFL1;KIT;BMP4;TP53;LMBR1L;TGFB1;ACE
prerank,negative regulation of hormone secretion (GO:0046888),0.3334355349082589,0.7447610917542229,0.7764705882352941,0.9855544343787918,1.0,2/10,17.65%,RAB11FIP5;RAB11FIP1
prerank,positive regulation of vacuole organization (GO:0044090),-0.32276246643971235,-0.7446210634237939,0.8217213114754098,0.9683607470904005,1.0,4/10,16.23%,ANXA2;RAB3GAP2;PIP4K2B;LRSAM1
prerank,establishment of protein localization to organelle (GO:0072594),0.22213081032767099,0.7443056203449249,0.8942731277533039,0.9856147144012878,1.0,18/72,18.70%,MMP12;PHB2;RALA;PTTG1IP;SYK;NXT1;NUP50;RANBP17;ZDHHC15;E2F3;TSPAN17;IPO8;HIKESHI;KPNB1;STAT3;POM121;RYR2;LAMP2
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.30614588212709193,0.7442568581139815,0.7952468007312614,0.985121165431309,1.0,5/14,13.44%,PPP2R2D;PPP2CA;PPP2CB;PPP3CA;PPP5C
prerank,regulation of B cell differentiation (GO:0045577),0.29243943604652967,0.7430101321488457,0.7960992907801419,0.9863372460326432,1.0,2/17,6.82%,ZFP36L1;SYK
prerank,positive regulation of glial cell differentiation (GO:0045687),0.29271979116510527,0.7428480927282862,0.8046594982078853,0.9859999386174799,1.0,5/17,16.08%,TNFRSF1B;NOTCH1;TENM4;HES1;ID2
prerank,tryptophan catabolic process (GO:0006569),-0.308392442407884,-0.7421760716056486,0.814968814968815,0.9708448410656129,1.0,11/11,69.19%,KYAT1;AFMID;KYNU;KMO;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.31655321262937103,-0.7415207801065559,0.7987804878048781,0.9710811940896215,1.0,2/10,7.23%,DGKH;GAP43
prerank,regulation of glucose metabolic process (GO:0010906),0.25132267735706343,0.741218249227001,0.8389830508474576,0.9876637859101852,1.0,5/34,11.20%,SDHAF3;MLYCD;SIRT1;IRS2;ADIPOR1
prerank,cellular response to acid chemical (GO:0071229),-0.2376201667847696,-0.7410227292706308,0.8596059113300493,0.9711068387805548,1.0,3/27,2.43%,CPEB4;CPEB1;CAPN2
prerank,negative regulation of bone mineralization (GO:0030502),0.31043320320829365,0.7408483927476887,0.8025830258302583,0.9876159474950612,1.0,3/13,16.32%,GREM1;TRPM4;PTK2B
prerank,regulation of cell cycle process (GO:0010564),-0.1821398101870765,-0.7403615184364966,0.9708029197080292,0.9713383038831849,1.0,28/104,26.38%,DYNC1H1;CTNNB1;RPRD1B;CUL9;PIK3C3;AHCTF1;UVRAG;E4F1;OBSL1;RAB11A;SND1;USP19;ENTR1;CAV2;CCP110;TTL;CEP250;CDC42;ATF5;TXLNG;MAP9;MYO19;FLCN;RAB11FIP4;BCL2L1;PRMT5;GIT1;SFRP1
prerank,establishment of melanosome localization (GO:0032401),0.2849291482897808,0.7402094149115395,0.8186714542190305,0.9879540524628514,1.0,5/19,17.83%,RAB11B;MYO5A;BLOC1S5;BBS7;RAB27A
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2269525811709178,0.7399841208751488,0.882636655948553,0.9876516041535323,1.0,18/62,20.86%,POLR2J;POLR2B;FXR1;NUP54;NUP50;NUP35;IPO8;NDC1;WTIP;NUP160;STAT3;POM121;NUP42;EIF4G1;NUP133;AGO1;PPARG;TNRC6A
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2963081583020396,0.7395248048633146,0.8031914893617021,0.9877229356844306,1.0,2/16,14.18%,ERCC4;RMI1
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.2545315940468391,-0.7391897588520252,0.8581730769230769,0.9721807516428227,1.0,5/22,11.17%,BMP7;BMP4;ROCK1;CDKN1B;TP53
prerank,melanosome localization (GO:0032400),0.2770510864546096,0.7385331525460073,0.8251748251748252,0.9884837239135381,1.0,6/21,18.14%,RAB11B;MYO5A;BLOC1S5;BBS7;RAB27A;VPS33A
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.31509461226660557,-0.7382904688972509,0.8174097664543525,0.9726939026849646,1.0,5/10,39.09%,HIPK3;PTPN22;DNAJA1;MAPK8IP1;DUSP19
prerank,protein-DNA complex disassembly (GO:0032986),0.29529310483351573,0.7377546210187867,0.8152753108348135,0.9889770584000186,1.0,4/16,19.00%,RPL23;SMARCD1;SMARCA4;SMARCB1
prerank,phosphate ion homeostasis (GO:0055062),0.325031855632287,0.7371330574336596,0.7762906309751434,0.9892544952816923,1.0,1/10,5.35%,XPR1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3132843815120187,0.7369307260437205,0.7988826815642458,0.9889678010042497,1.0,2/12,7.51%,MLYCD;IRS2
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.32212836403635614,-0.7368179803075294,0.8285123966942148,0.9738777824303806,1.0,9/10,53.31%,NAF1;RPUSD4;GAR1;NOP10;TSR3;RPUSD1;NHP2;RPUSD2;RPUSD3
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.22990982323158732,-0.7363851172199379,0.8658227848101265,0.9737372774469831,1.0,17/32,32.19%,TAOK3;MRE11;BRSK1;TRIM39;ATM;TAOK1;RINT1;FOXN3;BABAM1;BLM;NOP53;TOPBP1;CDC14B;TAOK2;HMGA2;CDK5RAP3;CLSPN
prerank,female gonad development (GO:0008585),0.28714790170159415,0.7362871143864979,0.8052631578947368,0.989266798008629,1.0,2/19,4.27%,SOD1;NR5A1
prerank,myelination (GO:0042552),0.237069169409644,0.7357350790709511,0.8555194805194806,0.9894249209135779,1.0,12/46,14.68%,MAL;MPZ;SCN2A;NFASC;PMP22;MARVELD1;ACER3;NF1;SBF2;ADGRG6;ARHGEF10;PARD3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.30318957923563206,0.7352174278418075,0.8226415094339623,0.9895370860958926,1.0,2/14,9.70%,TXNDC12;PARK7
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.22983855673244843,-0.7343472099011031,0.8753180661577609,0.9756671539065828,1.0,19/33,39.56%,IGF1;MAPT;MPV17L;HUWE1;GHITM;PINK1;FLCN;AKT1;BCL2L1;GPX1;TMEM14A;FXN;SLC25A5;ADCK1;PRELID1;CLU;HGF;MUL1;OPA1
prerank,regulation of response to interferon-gamma (GO:0060330),-0.28603645454454485,-0.734136116734548,0.8219780219780219,0.9752949866909348,1.0,5/14,19.85%,JAK1;IFNGR1;PTPN2;IFNGR2;STAT1
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.20859009465068473,0.7340634336913712,0.930780559646539,0.9905069427524197,1.0,11/94,10.64%,ALMS1;HAUS5;CEP41;HAUS4;TUBB;DCTN2;SCLT1;ODF2;DCTN3;CEP164;DYNLL1
prerank,C-terminal protein amino acid modification (GO:0018410),0.33210039879470404,0.7339688457838528,0.7972972972972973,0.9900675915707171,1.0,5/11,19.51%,AGTPBP1;ICMT;ATG7;LCMT1;FOLH1
prerank,pancreas development (GO:0031016),0.3127570725219129,0.7339468088391151,0.8047445255474452,0.9895311150802721,1.0,1/12,4.01%,SELENOT
prerank,protein import into peroxisome matrix (GO:0016558),0.30824931728045146,0.7336818666136374,0.8154121863799283,0.9893227404514089,1.0,2/12,6.55%,PEX1;PEX7
prerank,negative regulation of cell division (GO:0051782),-0.30364118487575276,-0.7335648165000128,0.7971014492753623,0.9753712030726716,1.0,3/11,21.15%,ORC6;BLM;VPS4A
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.3204439696185213,0.7335524497705519,0.8035019455252919,0.9889206088340476,1.0,1/11,1.75%,AMDHD2
prerank,positive regulation of leukocyte migration (GO:0002687),-0.2338243367386995,-0.7333188592571206,0.8608695652173913,0.9750377399706273,1.0,2/27,5.11%,IL6R;JAM3
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),-0.3181393403010128,-0.7329668580941804,0.8242424242424242,0.9748304258844168,1.0,7/10,46.36%,SIRT2;CDC42;RCC2;RACGAP1;ECT2;KNSTRN;SPAG5
prerank,lipid transport (GO:0006869),0.20712905303899198,0.7321798508239756,0.9344490934449093,0.9901068173149069,1.0,16/97,15.78%,ATP8A1;ABCC4;GOT2;APOE;PRELID3B;UGCG;PPARD;PRELID2;PITPNA;SCARB1;GM2A;NPC2;OSBPL2;SPNS2;SLCO1C1;CERT1
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.3282962800944233,0.7317616054770092,0.7891566265060241,0.9900632303057139,1.0,3/10,18.60%,PRKG1;CD9;RDX
prerank,regulation of cell-substrate adhesion (GO:0010810),0.23578939084717299,0.7317286243097306,0.8650519031141869,0.9895427844446653,1.0,10/42,17.35%,RAC2;NOTCH1;MINK1;TSC1;NPNT;NF1;CORO2B;FBLN2;CORO1C;ATXN3
prerank,negative regulation of TOR signaling (GO:0032007),0.24203836404407167,0.731118662124595,0.8711256117455138,0.9897800648568233,1.0,9/36,16.28%,GSK3A;EPM2A;AKT1S1;SIRT1;TSC1;PRKAA2;TMEM127;KPTN;SESN3
prerank,atrioventricular valve morphogenesis (GO:0003181),0.2805356740231375,0.7308808510119279,0.8247232472324724,0.9895096760670095,1.0,4/19,8.64%,HEY1;HEY2;NOTCH1;EFNA1
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.2578821871830273,-0.7308526053276623,0.8807785888077859,0.9768045077632402,1.0,2/20,3.39%,DCUN1D5;TGFBR1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.2754888722580676,-0.7307218509226451,0.8272138228941684,0.9763057900146386,1.0,6/16,27.37%,THBS1;JCAD;AGTR1;VEGFA;GATA2;FGFBP1
prerank,response to organic cyclic compound (GO:0014070),-0.20162723378456573,-0.7297286095135296,0.9528023598820059,0.9768494561738998,1.0,10/52,17.11%,IGFBP5;CTNNB1;HLCS;SOCS2;ANXA1;IL18;GGT5;SPP1;TGFB1;ALPL
prerank,melanosome transport (GO:0032402),0.2854691115270727,0.7294749953776776,0.8235294117647058,0.990260899237965,1.0,5/18,17.83%,RAB11B;MYO5A;BLOC1S5;BBS7;RAB27A
prerank,pigment granule transport (GO:0051904),0.2854691115270727,0.7294749953776776,0.8235294117647058,0.990260899237965,1.0,5/18,17.83%,RAB11B;MYO5A;BLOC1S5;BBS7;RAB27A
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.3270736040899194,0.7292934511053631,0.7898989898989899,0.9899318350146222,1.0,1/10,1.75%,AMDHD2
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.21571888725679741,0.7289108178658841,0.917037037037037,0.9898327873051826,1.0,5/73,8.24%,PTPRJ;PTPRC;TIRAP;SYK;WNT5A
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.29450642610193556,-0.7285064701328975,0.8421052631578947,0.9777715242216753,1.0,6/12,24.56%,TET1;MPHOSPH8;SETDB2;RESF1;DNMT1;ATF7IP
prerank,pre-miRNA processing (GO:0031054),0.3042643983217108,0.7280565630365974,0.8273244781783681,0.9903517298002569,1.0,4/14,15.16%,ADAR;AGO4;TUT7;TUT4
prerank,glycoprotein metabolic process (GO:0009100),-0.2007902255648999,-0.727961465441654,0.9459459459459459,0.9778224905528409,1.0,12/53,18.50%,MAN1C1;NGLY1;FUT8;ADAMTS9;GANC;MAN2A2;LARGE1;PCSK6;ST3GAL4;TNIP1;ST6GALNAC6;ST8SIA2
prerank,regulation of cytokinesis (GO:0032465),0.21151375693574165,0.7264973861212405,0.9218045112781955,0.991788641851341,1.0,20/78,20.05%,PIN1;PLK2;CSPP1;PRPF40A;CALM3;KIF13A;CUL3;GIPC1;KLHL13;PIK3R4;SETD2;BECN1;KLHL9;SH3GLB1;ZFYVE19;PRKCE;CALM1;PKN2;CDC14A;ZFYVE26
prerank,cellular response to virus (GO:0098586),0.25086073615194754,0.7264719943652604,0.8540268456375839,0.9912621465641933,1.0,5/30,14.26%,EIF5A;ARF1;DDX3X;CHUK;LGALS8
prerank,mitotic chromosome condensation (GO:0007076),0.26219196709714243,0.7256251554670069,0.8325041459369817,0.9917840301346109,1.0,5/26,14.40%,TENT4A;CHMP1A;AKAP8L;CSNK2A2;PHF8
prerank,regulation of lymphocyte proliferation (GO:0050670),0.28500546242468333,0.7251032911790444,0.8143133462282398,0.9918771844245138,1.0,1/16,4.99%,TNFRSF1B
prerank,glucose catabolic process to pyruvate (GO:0061718),-0.2391785780836817,-0.7244816297256127,0.8920863309352518,0.9805859222651044,1.0,11/24,31.60%,PKM;FOXK1;ALDOA;ENO2;PGK1;HK2;PGAM1;PFKM;GAPDH;ALDOC;PFKL
prerank,canonical glycolysis (GO:0061621),-0.2391785780836817,-0.7244816297256127,0.8920863309352518,0.9805859222651044,1.0,11/24,31.60%,PKM;FOXK1;ALDOA;ENO2;PGK1;HK2;PGAM1;PFKM;GAPDH;ALDOC;PFKL
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.3168217936269595,0.7239350518831411,0.8101010101010101,0.9928265384690318,1.0,4/10,19.04%,CHFR;TUT7;TUT4;DIS3L2
prerank,regulation of spindle assembly (GO:0090169),-0.24275698112476246,-0.7238930640052914,0.8815489749430524,0.9806037157406078,1.0,5/25,18.73%,DYNC1H1;RNF4;EML3;CHMP2B;CHMP5
prerank,mitochondrial membrane organization (GO:0007006),0.24373849918493062,0.7237762357539073,0.8850574712643678,0.992455363567937,1.0,9/32,17.64%,IMMT;MAIP1;CHCHD6;BAD;CHCHD3;DNAJC11;MICOS10;BNIP3;RCC1L
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.22068213438062884,-0.7234961400082047,0.916010498687664,0.980421642969678,1.0,2/34,1.90%,IGF1;PDGFRB
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.31863932575748205,0.7233981950524865,0.8282442748091603,0.9923789676235799,1.0,5/12,16.55%,APOE;TMED10;PICALM;PRNP;FKBP1A
prerank,positive regulation of secretion by cell (GO:1903532),-0.18812536542314637,-0.72298732861047,0.9772727272727273,0.9803930397397165,1.0,13/70,16.55%,BMP6;IGF1;P2RX4;SLC12A2;RAB27B;EZR;STXBP5;PPID;RAB9A;UNC13B;EXOC1;TGFB1;STX1A
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.3135440468598106,0.7228128402273046,0.815442561205273,0.9925270248920864,1.0,1/11,3.13%,GREM1
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.2573087475102366,0.7221298971452669,0.8599290780141844,0.9927924228238066,1.0,6/26,13.89%,TAL1;MDM2;USP22;APP;CUL3;HES1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.27545216361598573,-0.7220948285904198,0.8318965517241379,0.9808006622913888,1.0,6/15,22.20%,SMPD3;SNF8;TSG101;STAM;VPS4A;HGS
prerank,B cell activation involved in immune response (GO:0002312),0.2962461703743774,0.7216896436147013,0.8240574506283662,0.9927595578329245,1.0,1/13,2.28%,FCGR2B
prerank,negative regulation of protein processing (GO:0010955),-0.29404256157745196,-0.7210824189625675,0.8394495412844036,0.9813252627547764,1.0,4/12,25.88%,GAS1;THBS1;CTSZ;SERPINE1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.21837589457127426,0.7210560772906623,0.9152542372881356,0.9929768572809048,1.0,13/58,17.17%,ABRAXAS1;ERCC4;KDM2A;DCLRE1B;UBE2V2;POLA1;NBN;PSMD14;BRCC3;NSD2;PRKDC;XRCC4;DCLRE1C
prerank,ceramide transport (GO:0035627),-0.2925465180761714,-0.7208351365021819,0.8580508474576272,0.980972131214084,1.0,2/12,8.52%,PSAP;PLEKHA8
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.27899219554846466,-0.7205554140528262,0.8509316770186336,0.9806650871960502,1.0,2/15,9.82%,MOXD1;SAT1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.2583140471365237,0.71961167201064,0.8724137931034482,0.9941902708173095,1.0,2/25,3.41%,GSK3A;INSYN2A
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.23131516364035634,-0.7193357598207862,0.8891625615763546,0.9814674768105169,1.0,13/26,35.42%,FBN1;CDK6;RARA;TCTA;PTPN2;TLR3;INHBA;GPR137B;CEACAM1;TMEM178A;MAFB;ZFPM1;GPR137
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.2584754018694927,-0.7192037681477569,0.8366445916114791,0.9809919436052366,1.0,9/18,31.29%,NELL1;VGLL4;EZR;DACT1;MSN;AMER1;HSP90AA1;RGP1;CDK5RAP3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.2812619269187475,0.7190300745838327,0.8183520599250936,0.9943609527348025,1.0,4/17,10.65%,HEY1;HEY2;NOTCH1;RBPJ
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),-0.2852208438677001,-0.7189343211327621,0.8329764453961456,0.9806746298756258,1.0,4/13,18.84%,UFL1;DDRGK1;RACK1;PPP1R15B
prerank,response to unfolded protein (GO:0006986),0.22770081609927703,0.7188503393352749,0.8996815286624203,0.9940207759707863,1.0,15/48,20.90%,HSPA8;HSPA4L;DNAJB5;STT3B;HSPE1;DDIT3;ERP44;HSPA13;SERPINH1;HSPA14;BAX;DERL1;HSPB8;ERN1;HSP90AB1
prerank,amino sugar biosynthetic process (GO:0046349),0.31155398621454017,0.7185378377201657,0.8392156862745098,0.9938615070640127,1.0,1/12,1.75%,AMDHD2
prerank,regulation of protein targeting to membrane (GO:0090313),-0.2342035576856375,-0.7184378642476389,0.9028132992327366,0.9806134972871323,1.0,4/28,7.76%,ANK3;CEMIP;AKT2;FIS1
prerank,cellular macromolecule catabolic process (GO:0044265),0.2284549373741455,0.7184091368587057,0.890302066772655,0.9934565716559399,1.0,8/49,15.59%,NCBP1;RNASE6;MAGEC2;XRN2;STT3B;CHEK2;UBE2G1;PPP1R8
prerank,glycerophospholipid metabolic process (GO:0006650),0.21242775355567237,0.7182770376967561,0.9473684210526315,0.9930561783542629,1.0,12/75,14.31%,SERINC1;SMPD4;PLCG1;PIGH;CSF1R;PLCB1;SERINC5;PGP;PIGB;ABHD12;PLEK;PNPLA6
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.2554456310906024,0.7182111427233232,0.8658940397350994,0.9925755699868652,1.0,8/27,18.88%,RUVBL2;EP300;RUVBL1;CREBBP;TRRAP;TAF6L;NAA50;MSL3
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.2342693402616102,-0.7181045933109546,0.8737623762376238,0.9803365431827765,1.0,3/25,8.96%,IGF1;PER2;NIBAN2
prerank,filopodium assembly (GO:0046847),0.2826861618356008,0.7179920560727356,0.8297101449275363,0.9922802130022312,1.0,3/16,14.13%,DNM3;FGD5;SPEF1
prerank,negative regulation of protein ubiquitination (GO:0031397),0.2277098141567537,0.7179411240442121,0.9161392405063291,0.9917806913611693,1.0,8/50,11.45%,TNFAIP3;PRMT3;FBXO5;SMAD7;IVNS1ABP;PARK7;SPOPL;RPS3
prerank,fatty acid metabolic process (GO:0006631),0.20029478231443412,0.7178424049800528,0.9498567335243553,0.991339324160934,1.0,12/115,11.93%,ACSL5;CRAT;MLYCD;GPAM;PPARD;ADIPOR2;NUDT19;ACSL4;ALKBH7;ADIPOR1;PNPLA8;ACOT8
prerank,carbohydrate catabolic process (GO:0016052),0.23916662469212957,0.7177658615291485,0.8768233387358185,0.9908862265912843,1.0,2/38,5.74%,ENO4;TPI1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),-0.22834235850020945,-0.7173311254567377,0.9006928406466512,0.9805960994477264,1.0,8/28,20.32%,NUPR1;DDRGK1;PTK2;RNF139;ATP5IF1;OSBPL7;PSMC5;PSMC3
prerank,cholesterol transport (GO:0030301),0.2298353697319729,0.7169248256352162,0.8973941368078175,0.9913403589479373,1.0,9/45,15.98%,APOE;SOAT1;SCARB1;LDLRAP1;NPC2;NPC1;OSBPL2;SERAC1;STARD3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.30894021496282525,-0.7160480545691499,0.8742138364779874,0.9807495502871244,1.0,4/10,18.44%,NFAT5;NFATC2;PPP3CC;NFATC4
prerank,calcineurin-mediated signaling (GO:0097720),-0.30894021496282525,-0.7160480545691499,0.8742138364779874,0.9807495502871244,1.0,4/10,18.44%,NFAT5;NFATC2;PPP3CC;NFATC4
prerank,cellular response to misfolded protein (GO:0071218),0.27247543441794864,0.7151334930736505,0.8507194244604317,0.9928406316597357,1.0,9/20,20.98%,AUP1;CUL3;UFD1;DNAJB14;ATXN3;UGGT1;POMT2;DERL1;KLHL15
prerank,regulation of glycogen metabolic process (GO:0070873),-0.28691075499997937,-0.7150358253073538,0.8583333333333333,0.981190568563543,1.0,9/12,56.42%,PPP1R3B;AKT1;INPP5K;PPP1R3C;RUBCNL;PPP1R3E;KHK;PPP1R3D;GCGR
prerank,early endosome to late endosome transport (GO:0045022),-0.25192524270805977,-0.7148574076711638,0.8853932584269663,0.9807449797886348,1.0,8/20,24.14%,PIK3C3;EEA1;STX8;SNF8;PTPN23;HOOK2;LMTK2;EMP2
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.29979021709857406,0.7143385642492504,0.8396946564885496,0.9932356963567848,1.0,5/13,18.46%,TMEM30B;CD81;BCAP31;TMEM30A;EDEM2
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.24480571678771196,0.7139724438317162,0.8825448613376835,0.9931113919105714,1.0,5/33,10.31%,CTC1;ANKRD28;DCLRE1B;ACD;TERT
prerank,release of cytochrome c from mitochondria (GO:0001836),0.27918170322685365,0.7138575216525573,0.8414179104477612,0.9926895564365923,1.0,5/17,17.44%,SOD2;FZD9;BAD;DNM1L;BAX
prerank,indolalkylamine catabolic process (GO:0046218),-0.3083730856138589,-0.7136841766993577,0.8577405857740585,0.9814141850093512,1.0,10/10,69.19%,KYAT1;KYNU;KMO;IL4I1;HAAO;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.2727792035232634,-0.7134895367891612,0.8501118568232662,0.9810121516861687,1.0,5/15,24.70%,BMP4;SMO;SIX1;VEGFA;PAX2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.32438959083596813,0.7134662276879351,0.8197674418604651,0.992582957538072,1.0,1/10,2.84%,PRKCH
prerank,negative regulation of anoikis (GO:2000811),0.29342857788335797,0.713132813877715,0.8412408759124088,0.9924160969254512,1.0,2/14,8.12%,SRC;NOTCH1
prerank,carnitine metabolic process (GO:0009437),0.308856465139351,0.712895284556045,0.8425047438330171,0.9921490131754364,1.0,1/12,1.49%,CRAT
prerank,positive regulation of protein export from nucleus (GO:0046827),0.2932066456807874,0.7126405075415845,0.8238532110091743,0.991888816372033,1.0,2/15,7.09%,RBM22;RAPGEF3
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.25764055667171165,-0.7118794517538846,0.8657718120805369,0.9821710119217528,1.0,4/18,11.66%,PUM1;PUM2;BIRC3;NPLOC4
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.31766326405883444,0.7115776392903702,0.8051470588235294,0.9925513425796553,1.0,1/10,1.79%,PDE4D
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.20800602699334925,0.7113204310717193,0.9399707174231332,0.9922917178573537,1.0,10/76,11.78%,GSK3A;TRIB3;ARIH1;COP1;SMAD7;AXIN1;RAD23A;MDM2;PIAS1;ELOB
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.19081250079170142,0.7097994235447893,0.981651376146789,0.9934380183659042,1.0,30/148,16.18%,PIN1;RPL23;HIPK2;RFFL;RAD1;EP300;RPL5;MDM2;TTC5;TAF15;ING2;PRKAA2;HUS1;TOP3A;PAK1IP1;TAF4B;NBN;CHD3;TBP;ING5;CHEK2;MAP2K6;CSNK2A2;RMI1;BRIP1;DYRK2;ATR;TAF1;RBBP4;TAF3
prerank,DNA double-strand break processing (GO:0000729),-0.25748558636410257,-0.7097495465032858,0.8539325842696629,0.98377640632718,1.0,10/18,36.71%,UBE2N;RAD50;MRE11;ATM;BLM;SLX4;KAT5;BARD1;SETMAR;DNA2
prerank,negative regulation of cell death (GO:0060548),0.20565361685975397,0.7095146547485536,0.9295977011494253,0.9932262312029734,1.0,6/88,5.25%,RAD18;MECOM;TXNDC12;FYN;TNFRSF1B;WFS1
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),-0.27828333885377543,-0.7093424875347535,0.8376068376068376,0.9835666479798105,1.0,7/14,42.35%,ACE;ENPEP;AGTR1;EDN1;ACE2;EDN3;CORIN
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.2718581757216878,-0.7091632630943867,0.8725701943844493,0.9831162281540403,1.0,5/16,22.49%,RPA1;PURA;BLM;RECQL;MCM6
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.3021558065943488,-0.7088080605093384,0.8426294820717132,0.9828763393087476,1.0,8/10,53.37%,AKT1;TICAM1;MYD88;TLR4;CD68;TREM2;TLR6;CD36
prerank,cellular response to fatty acid (GO:0071398),-0.28410975172362785,-0.7082481350085562,0.8466386554621849,0.9828272464775553,1.0,6/12,43.64%,PID1;ZC3H12A;LPL;DGAT2;PDK4;NR1H4
prerank,dorsal/ventral pattern formation (GO:0009953),-0.24837320683727068,-0.7081130943162959,0.8747099767981439,0.982343078746424,1.0,8/20,29.15%,GLI2;NBL1;ACVR1;BMPR1B;BMPR1A;PTCH1;SFRP1;MDFI
prerank,positive regulation of sodium ion transport (GO:0010765),0.30670571088453413,0.7071803895860265,0.8099808061420346,0.9952870719766566,1.0,2/12,6.95%,AHCYL1;CNKSR3
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.25423006840831763,-0.706968677161919,0.8552036199095022,0.9829102009521193,1.0,7/18,41.72%,PSMD9;CCN3;ADRA2A;SFRP1;SIRT4;CHGA;INHBB
prerank,negative regulation of cyclase activity (GO:0031280),-0.2802940956355376,-0.7066740888559463,0.8812095032397408,0.9825745518312732,1.0,2/14,7.81%,ADGRV1;GABBR2
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.2861184761598074,-0.7065768746489665,0.8733905579399142,0.9820500280018134,1.0,8/13,36.33%,TOB1;PABPC1;BTG2;POLR2G;TNRC6C;EIF4ENIF1;TNRC6B;ZFP36
prerank,steroid metabolic process (GO:0008202),-0.18313797505440893,-0.7063883365470481,0.9780564263322884,0.9816325335952804,1.0,18/72,30.15%,CYP27A1;CYP7B1;LGMN;MSMO1;CYP26B1;FDX1;FDFT1;CYP51A1;PIAS4;ARV1;PRLR;DHRS4;LIPA;CUBN;AMACR;GBA2;DHCR24;DHRS11
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.22721675775357092,-0.7061722575386432,0.9020979020979021,0.9812127112710891,1.0,9/27,27.52%,IRAK3;SYT11;SIRPA;PTPN22;SELENOS;CX3CL1;C1QTNF3;NCKAP1L;ZC3H12A
prerank,cell projection assembly (GO:0030031),0.26034395533334,0.7059701534921425,0.888268156424581,0.9960812444157944,1.0,3/22,11.14%,RAC2;RHOQ;RHOG
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.28380247496042044,-0.7054267894005859,0.8556263269639066,0.9813659429727413,1.0,2/13,7.81%,ADGRV1;GABBR2
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.2856804213490978,0.7049359190396127,0.8467432950191571,0.9966927831190379,1.0,6/15,20.79%,PPARD;IRS2;LDLRAP1;IRS1;PRKCE;PPARG
prerank,coenzyme A metabolic process (GO:0015936),0.29290950322854525,0.704469437756775,0.8547169811320755,0.9966900694781499,1.0,2/14,5.45%,PANK2;ACAT1
prerank,microtubule depolymerization (GO:0007019),0.2778221609494124,0.7044364323061946,0.8342245989304813,0.9961714571138177,1.0,4/17,18.29%,KIF18A;KIF2A;NCKAP5;KIF24
prerank,negative regulation of protein secretion (GO:0050709),0.23741554696431244,0.7040778741200567,0.8573743922204214,0.99601077259326,1.0,4/38,10.11%,HMGCR;APOE;RAB11FIP5;RHBDF2
prerank,positive regulation of extracellular matrix organization (GO:1903055),0.27189903384590663,0.7034446895120947,0.8516483516483516,0.9961479786451096,1.0,3/18,9.30%,CLASP2;RGCC;COLGALT1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.28871503891049977,-0.7031763588545594,0.8357289527720739,0.9829825286439035,1.0,4/12,35.35%,BMP7;FLOT1;SKAP1;THY1
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.29332690723583726,-0.7027612029810913,0.8378947368421052,0.9827727151025121,1.0,3/11,11.90%,PUM1;PUM2;LIMD1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.27880395521563917,0.702224879709714,0.8397085610200364,0.9969193973903528,1.0,4/16,16.71%,PNKP;KDM4D;KMT5B;PRKDC
prerank,vesicle organization (GO:0016050),0.22144902464261848,0.7021841322416676,0.92,0.9964093550320936,1.0,12/46,19.03%,SORT1;EXOC8;VPS11;LAMTOR1;AKTIP;RAB22A;LAPTM4B;HOOK3;VPS18;ALS2;PI4K2B;FNBP1L
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.268816568564669,0.7014627464138538,0.8513986013986014,0.996647699598274,1.0,7/20,20.71%,IMPDH1;NT5C2;GMPR2;HPRT1;GART;PPAT;ATIC
prerank,histone H2A monoubiquitination (GO:0035518),-0.2578871580050357,-0.7014351599660755,0.8648648648648649,0.9834875852070017,1.0,6/17,19.16%,DDB1;DDB2;RNF168;PCGF2;BCOR;PCGF6
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.20356788250545482,0.7013532550585841,0.941944847605225,0.9962223110389515,1.0,17/78,18.19%,GSK3A;TRIB3;ARIH1;COP1;SMAD7;RAD23A;MDM2;UBQLN1;PIAS1;ELOB;RNF180;FBXO22;TAF1;UBQLN2;BCAP31;BBS7;GABARAP
prerank,regulation of exocytosis (GO:0017157),0.2218867620557053,0.7011432417974218,0.919431279620853,0.9958772667356762,1.0,6/46,10.78%,CLASP2;STXBP5L;RALA;CADPS;RAB2B;ATP6AP1
prerank,regulation of protein export from nucleus (GO:0046825),0.2636962200933898,0.700989682338509,0.8653846153846154,0.9954984629722492,1.0,8/23,19.56%,RBM22;RAPGEF3;PARK7;IFI27;GAS6;RANGAP1;YWHAE;SP100
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.2523115673203651,0.7002038268954541,0.8809106830122592,0.9958251000188801,1.0,8/26,18.87%,RPTOR;RGCC;PLCB1;DDX3X;ANKRD17;MTBP;RDX;EIF4G1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.28749312631674734,0.7001119367679726,0.8476702508960573,0.995362989873384,1.0,1/15,2.84%,PRKCH
prerank,negative regulation of gluconeogenesis (GO:0045721),0.3088691577424939,0.7000369232963725,0.8297029702970297,0.9948913649565869,1.0,2/11,11.10%,EP300;PGP
prerank,cellular lipid catabolic process (GO:0044242),0.2472562645273255,0.6995538526557804,0.8877551020408163,0.9948475833370788,1.0,5/27,12.55%,PPARD;NUDT19;CYP1B1;ACOT8;ABHD12
prerank,bile acid and bile salt transport (GO:0015721),0.2525577681265399,0.6992564314461995,0.8957264957264958,0.9945980669343442,1.0,1/24,1.48%,ABCC4
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.2786681964418264,-0.6992251875885177,0.8571428571428571,0.9851445997690046,1.0,2/12,8.03%,BTRC;GOLGA2
prerank,mesoderm development (GO:0007498),0.26501243802190894,0.699183168725806,0.864376130198915,0.994130645485016,1.0,3/18,10.17%,TBX1;TIE1;MEST
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.2581487828838004,0.6987655946435986,0.875,0.9940373413626921,1.0,6/24,16.32%,APOE;UBE3A;EFNA1;PSMD14;UCHL5;PTK2B
prerank,regulation of transposition (GO:0010528),-0.27774775281156955,-0.6985511561278204,0.8592436974789915,0.9851889828548901,1.0,9/13,58.40%,SIRT7;UBR2;TEX15;SMYD5;PIWIL2;TDRD9;DDX4;PIWIL4;SPOCD1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.24168228195821212,0.6983763465767064,0.8741610738255033,0.9938706602243875,1.0,3/31,13.15%,FCGR2B;LYN;CD274
prerank,regulation of steroid biosynthetic process (GO:0050810),0.30266236542896463,0.6981168373126021,0.833969465648855,0.993602746278331,1.0,2/11,7.36%,NR5A1;SIRT1
prerank,protein localization to centrosome (GO:0071539),-0.2521238644363455,-0.6979303979233791,0.8744186046511628,0.9851651213668091,1.0,3/17,10.46%,PIBF1;NUDCD3;GOLGB1
prerank,positive regulation of type I interferon production (GO:0032481),0.20571136750252123,0.6965211804012446,0.956140350877193,0.9947117312507149,1.0,16/73,19.11%,LRRFIP1;POLR1C;EP300;RELA;DDX3X;CREBBP;POLR3F;CHUK;POLR3B;SETD2;PRKDC;PTPN11;POLR3K;POLR3GL;TRIM56;DHX36
prerank,regulation of microtubule nucleation (GO:0010968),-0.30132568652827874,-0.6960441300998543,0.8640167364016736,0.9864360675101652,1.0,3/10,15.65%,EML2;CKAP5;DCTN1
prerank,RNA methylation (GO:0001510),0.2104837715703423,0.6960273123682102,0.9490445859872612,0.994676201331071,1.0,3/60,2.31%,TRMO;BCDIN3D;THUMPD2
prerank,cell proliferation in forebrain (GO:0021846),-0.2987896213015615,-0.6957678025402886,0.8647058823529412,0.9860808691523192,1.0,2/10,11.49%,CEP120;NUMBL
prerank,lysosome localization (GO:0032418),0.22974555631139384,0.6956880299976197,0.9105180533751962,0.9944970663938779,1.0,10/37,19.60%,PIK3CG;LAMTOR1;PIK3CD;SNAPIN;S100A13;MYH9;TFEB;VPS33A;KIF5B;PLEKHM2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.28103610821160363,0.6951088858226836,0.8477064220183487,0.9945698656847656,1.0,2/15,7.15%,SORT1;BDNF
prerank,phosphate ion transport (GO:0006817),0.27721852793730417,0.6950685911042158,0.8635547576301615,0.9940696357451653,1.0,2/16,9.77%,XPR1;SLC37A3
prerank,high-density lipoprotein particle assembly (GO:0034380),0.31202166777506296,0.6946540528004664,0.8256513026052105,0.9939309634800951,1.0,1/10,4.37%,APOE
prerank,DNA replication (GO:0006260),0.1936460125829829,0.6945092793235667,0.9736111111111111,0.9935127521690297,1.0,19/105,15.71%,PNKP;ING4;ORC3;RAD1;POLE;CDC45;ORC4;CDK2AP1;POLA1;HUS1;ORC2;TOP3A;NBN;HELB;ING5;RMI1;BRIP1;ATR;TOP1
prerank,regulation of cell aging (GO:0090342),0.3055930307790462,0.6937708901269297,0.8287292817679558,0.9937356479301723,1.0,4/11,18.45%,ING2;NEK6;RSL1D1;NUAK1
prerank,endodermal cell fate commitment (GO:0001711),0.311473263733936,0.6934633305080303,0.8494208494208494,0.9934919954539312,1.0,1/10,4.77%,SOX2
prerank,positive regulation of keratinocyte migration (GO:0051549),-0.2948810544447881,-0.6930361691359037,0.8303964757709251,0.9880132454087246,1.0,6/10,33.48%,EPB41L4B;IQSEC1;MAPRE2;FGF10;MTOR;FGF7
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.22160312620960393,-0.6927393242366053,0.9178082191780822,0.987691514144981,1.0,9/28,21.21%,ERCC6;SHLD1;HSF1;PARP3;SIRT7;ACTR2;SMCHD1;RIF1;DTX3L
prerank,striated muscle cell differentiation (GO:0051146),-0.25262259472755494,-0.69262842696654,0.8675213675213675,0.9871832515105741,1.0,3/16,8.65%,AKAP13;SKI;SIK1
prerank,phasic smooth muscle contraction (GO:0014821),0.30266131056992207,0.6925782373941433,0.8475247524752475,0.9938617275150435,1.0,10/10,69.75%,EDNRB;EDN2;HTR1D;TIFAB;GDNF;HTR2B;EDN3;PTGER3;EDN1;DRD2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.2683038185683694,-0.6921211881705153,0.8847826086956522,0.9870513802740357,1.0,10/15,39.96%,PRKCD;SMPD3;RACK1;PLA2G6;ORMDL3;SMPD2;SPHK1;ORMDL1;ORMDL2;SPHK2
prerank,neuron apoptotic process (GO:0051402),-0.24261403948057453,-0.6919419877423989,0.8816964285714286,0.9866085067381785,1.0,5/19,14.61%,TRPC5;CIT;FAM162A;TNFRSF21;ATN1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.2350221444277238,0.6916995847241815,0.9155629139072847,0.9942017569121352,1.0,7/36,14.38%,SPR;APOE;TERT;NOSTRIN;NOS3;SCARB1;GCH1
prerank,mRNA methylation (GO:0080009),-0.2639622521553605,-0.6916075240088105,0.896551724137931,0.9863096573079554,1.0,5/15,23.82%,VIRMA;CBLL1;PCIF1;TRMT6;CMTR1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.2265732400999556,-0.6913510280387339,0.8956310679611651,0.985944080508698,1.0,6/25,15.76%,AMPD3;DGUOK;ADK;GMPS;MTHFD1;PRPSAP2
prerank,respiratory chain complex IV assembly (GO:0008535),-0.23446830248516956,-0.6911556475201348,0.897025171624714,0.9854886071660502,1.0,14/21,43.58%,COX16;COX19;COX17;COX18;PET100;COX20;COX14;BCS1L;COA5;SCO1;COA3;SURF1;COA6;FASTKD3
prerank,rRNA 3'-end processing (GO:0031125),0.3053653165774778,0.6907896339655943,0.8400770712909441,0.9945796306463183,1.0,2/10,8.82%,RPS21;EXOSC9
prerank,regulation of gene silencing by RNA (GO:0060966),0.21961845572758207,0.6907362915226269,0.9124797406807131,0.9935434219498941,1.0,13/50,20.04%,POLR2J;POLR2B;NUP54;NUP50;NUP35;IPO8;NDC1;NUP160;POM121;NUP42;EIF4G1;NUP133;AGO1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.21961845572758207,0.6907362915226269,0.9124797406807131,0.9935434219498941,1.0,13/50,20.04%,POLR2J;POLR2B;NUP54;NUP50;NUP35;IPO8;NDC1;NUP160;POM121;NUP42;EIF4G1;NUP133;AGO1
prerank,cellular copper ion homeostasis (GO:0006878),0.2876190553303194,0.6907315756631305,0.855787476280835,0.9930038681171185,1.0,4/14,14.84%,ARF1;APP;PRNP;MT2A
prerank,cobalamin metabolic process (GO:0009235),0.2678968677254459,0.6902215390711609,0.8738898756660746,0.9929923211579722,1.0,1/17,2.90%,MTR
prerank,Golgi ribbon formation (GO:0090161),0.2973812389709405,0.6897883786365241,0.8364661654135338,0.9928837748703299,1.0,3/13,10.14%,TRIP11;TMED5;GCC2
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.2717870265531405,0.6891630035295823,0.8825688073394495,0.9929450252060893,1.0,1/17,2.31%,CXCL12
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.28011634055349566,0.6883468541088571,0.8460111317254174,0.992647297693559,1.0,3/16,8.79%,SRC;CLASP2;ACVRL1
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.28011634055349566,0.6883468541088571,0.8460111317254174,0.992647297693559,1.0,3/16,8.79%,SRC;CLASP2;ACVRL1
prerank,hydrogen peroxide metabolic process (GO:0042743),0.26467916532664454,0.6867829222650408,0.8679927667269439,0.9936257158737617,1.0,3/19,14.60%,SOD1;PARK7;CYBA
prerank,histone mRNA metabolic process (GO:0008334),0.24351822837002451,0.6860207967746668,0.8958677685950414,0.9938503095918066,1.0,7/27,18.82%,NCBP1;TUT7;SSB;TUT4;SLBP;LSM1;SNRPD3
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.2850128101780378,0.6848403020368591,0.8571428571428571,0.9944732825833255,1.0,1/13,1.75%,AMDHD2
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.22003195577521562,-0.6843246107773788,0.9232558139534883,0.9912288416173488,1.0,5/26,12.82%,GRIN2B;MBP;ROCK2;AIM2;USP50
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.22258775544663748,0.6828091053183074,0.9333333333333333,0.9959239498575065,1.0,7/43,13.42%,ABRAXAS1;CDKN1A;NAE1;CHFR;HUS1;NBN;BRCC3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.29720806074679423,0.681736123544675,0.8568773234200744,0.9958603807924276,1.0,3/11,19.01%,CALM3;FKBP1A;CALM1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.29720806074679423,0.681736123544675,0.8568773234200744,0.9958603807924276,1.0,3/11,19.01%,CALM3;FKBP1A;CALM1
prerank,adipose tissue development (GO:0060612),-0.2904854384088694,-0.6812880462629954,0.8819742489270386,0.9932747966318053,1.0,6/11,41.21%,LRP5;PGRMC2;SH3PXD2B;DYRK1B;DGAT2;SOX8
prerank,phosphate ion transmembrane transport (GO:0035435),0.29117124693343555,0.6812663854717096,0.8389513108614233,0.9957651443328505,1.0,2/12,9.77%,XPR1;SLC37A3
prerank,positive regulation of vasoconstriction (GO:0045907),-0.27102827674921537,-0.6812233915960241,0.8946280991735537,0.9927106348920053,1.0,4/13,32.18%,ADRA1B;ADRA1A;CAV1;TBXA2R
prerank,long-chain fatty acid metabolic process (GO:0001676),0.20404455856900655,0.6807269037260627,0.9534883720930233,0.9957403683944127,1.0,11/64,16.92%,ACSL5;ELOVL6;CYP1B1;ACSL4;PNPLA8;HSD17B4;ACOT8;DAGLB;HPGD;ACADL;AIG1
prerank,positive regulation of TOR signaling (GO:0032008),0.2224176412692581,0.6806717849257831,0.934453781512605,0.9952602652795982,1.0,6/40,12.90%,RPTOR;HDAC3;LAMTOR1;SIK3;LARS1;RRAGC
prerank,regulation of myelination (GO:0031641),-0.22281516775873558,-0.6804258047048637,0.926208651399491,0.992804823321986,1.0,12/25,35.72%,SIRT2;TNFRSF21;DICER1;RNF10;TPPP;EIF2AK3;LGI4;MYRF;NSUN5;ZPR1;TMEM98;PTN
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.2581188641335782,-0.6794530535520577,0.8950749464668094,0.9930839635210448,1.0,8/14,40.48%,PPARA;AKT2;ABCD2;AKT1;MFSD2A;TWIST1;TYSND1;MTLN
prerank,quinone biosynthetic process (GO:1901663),0.28315330602476274,0.6791976649501945,0.8773946360153256,0.9960821125640734,1.0,6/14,19.39%,COQ2;PDSS2;COQ5;PDSS1;COQ3;COQ10A
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.2902167719107276,-0.6785915055785859,0.8864097363083164,0.9931862422431884,1.0,3/10,15.34%,DNAJC19;MTMR9;MTMR4
prerank,inhibitory synapse assembly (GO:1904862),-0.283344766832132,-0.67817325552772,0.8661087866108786,0.9929341775805327,1.0,5/11,24.41%,GABRA2;GABRG2;LGI2;PLXNB1;GABRA1
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.23351064306902886,-0.6781193114324289,0.8986784140969163,0.992369166309236,1.0,8/21,31.48%,ACBD5;LPIN1;CYP26B1;LPIN2;HOGA1;FAH;LPIN3;PLA2G15
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.2442989921707045,-0.6777828668244448,0.8906882591093117,0.9920238603308663,1.0,10/18,33.67%,MMP14;STX8;VPS4A;APPL1;CLN3;VAMP8;SPTBN1;CDK5;ABCA2;VTI1B
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.27235400818032096,-0.6773287024406163,0.875268817204301,0.9917919242748777,1.0,7/13,34.32%,RAB23;ENTPD7;AK3;GTPBP1;MFN1;RAN;AK4
prerank,sterol transport (GO:0015918),0.2617991470865396,0.6770499984996308,0.8832116788321168,0.9974861384412597,1.0,5/19,15.98%,LDLRAP1;NPC2;NPC1;OSBPL2;STARD3
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.28833741486728076,-0.6762832348635398,0.8786692759295499,0.9914164924415247,1.0,4/10,21.20%,PRKCD;SMPD3;RACK1;PLA2G6
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.28833741486728076,-0.6762832348635398,0.8786692759295499,0.9914164924415247,1.0,4/10,21.20%,PRKCD;SMPD3;RACK1;PLA2G6
prerank,tetrapyrrole metabolic process (GO:0033013),0.2598315487802577,0.6761132052387301,0.8898756660746003,0.9977918740614098,1.0,1/18,2.90%,MTR
prerank,cellular biogenic amine metabolic process (GO:0006576),-0.2731165860755786,-0.6748519181223108,0.8669438669438669,0.992004600808876,1.0,4/12,22.64%,ATP7A;HNMT;SMS;OAZ2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),-0.21944359693392157,-0.6744382927163429,0.9451073985680191,0.9917480579000502,1.0,11/25,31.60%,PKM;FOXK1;ALDOA;ENO2;PGK1;HK2;PGAM1;PFKM;GAPDH;ALDOC;PFKL
prerank,protein localization to chromatin (GO:0071168),0.2614475220580514,0.6742469396795892,0.8934280639431617,0.9989417401864104,1.0,4/18,14.59%,RUVBL2;ESR1;PPHLN1;TASOR
prerank,regulation of macrophage migration (GO:1905521),0.3047805455243423,0.6737413274321455,0.8745019920318725,0.9988471615524276,1.0,3/10,16.32%,CD81;MTUS1;PTK2B
prerank,mesoderm formation (GO:0001707),0.2636628284539739,0.6732654796970724,0.8876611418047882,0.9987615077131389,1.0,2/17,12.06%,ITGA2;ITGA3
prerank,Golgi to endosome transport (GO:0006895),0.27283153461285836,0.6728620446596052,0.8870370370370371,0.9985789487753501,1.0,6/16,17.69%,SORT1;RAB14;DOP1B;AP1AR;CORO7;KIF16B
prerank,intracellular cholesterol transport (GO:0032367),0.2672358439903175,0.6727584603529743,0.8780487804878049,0.998132680267845,1.0,5/15,14.18%,LDLRAP1;NPC2;NPC1;OSBPL2;SERAC1
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.20914837802724767,0.6726844841788984,0.9511811023622048,0.9976668289564299,1.0,13/49,20.86%,RAB7B;MYL9;CIB1;EP300;MTURN;AGO4;PITHD1;MOV10;EIF6;SIN3A;AGO1;CNOT4;TNRC6A
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2541804727809193,0.6722809920620517,0.8711340206185567,0.9974685252041873,1.0,4/20,13.97%,CDK5RAP1;LATS2;TFAP4;APC
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.23167551687702387,-0.67149519113353,0.9290780141843972,0.9934912442654135,1.0,11/23,36.46%,DNASE1L1;DICER1;DFFA;CASP3;EXOG;H1-0;DNASE2;HMGB1;HMGB2;MUS81;SETMAR
prerank,regulation of T cell proliferation (GO:0042129),0.20444914552124335,0.6710146812128217,0.956390977443609,0.9980354565183019,1.0,4/61,13.15%,PTPRC;TNFRSF1B;PNP;CD274
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.21073931660577838,0.6709333097965324,0.9401294498381877,0.9975660121644092,1.0,2/51,2.31%,MAPK3;CXCL12
prerank,mitochondrial transcription (GO:0006390),-0.28755466776852606,-0.6699208674869501,0.893970893970894,0.9941671434775073,1.0,7/10,41.41%,SLC25A33;MTERF2;FOXO3;MRPL12;TEFM;POLRMT;TWNK
prerank,positive regulation of cell development (GO:0010720),0.22982755868190574,0.6697962090880142,0.9206611570247933,0.9980136230870531,1.0,5/31,13.67%,MME;RFX3;BAD;ATP6AP1;FAIM
prerank,GPI anchor metabolic process (GO:0006505),-0.21924614651278204,-0.6693410891184612,0.9347319347319347,0.9939956545386137,1.0,12/26,33.50%,DPM1;GPLD1;PIGV;PIGG;PIGA;PIGM;PGAP4;PIGF;MPPE1;DPM2;PIGC;DPM3
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.23423752564757266,0.6689831735048454,0.9254966887417219,0.9981996495957438,1.0,5/29,11.24%,GRIK2;NETO1;APOE;MCTP1;APP
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.2926917777047693,0.6684885464033673,0.8813229571984436,0.9980981729425451,1.0,3/12,13.32%,SGTB;SEC62;SEC61A2
prerank,regulation of interferon-beta production (GO:0032648),0.21438172478546677,0.667329431052803,0.9376,0.9985467275064298,1.0,8/46,13.62%,TIRAP;YY1;NLRC3;TRAF3;DDX3X;POLR3F;RNF216;POLR3B
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.2090314886215322,0.6670512077279085,0.9625585023400937,0.9982478339600713,1.0,8/54,11.45%,TNFAIP3;PRMT3;RPL5;SMAD7;IVNS1ABP;PARK7;SPOPL;RPS3
prerank,positive regulation of macrophage migration (GO:1905523),0.25360460294759757,0.666838129533315,0.8935779816513761,0.9978893603192771,1.0,2/19,9.27%,MAPK3;CSF1R
prerank,mRNA polyadenylation (GO:0006378),0.23548053782233652,0.6667702181751427,0.9113712374581939,0.9968729233632838,1.0,9/26,21.55%,AHCYL1;PAPOLA;APP;SCAF8;WDR33;CLP1;PAPOLG;MTPAP;TENT2
prerank,RNA polyadenylation (GO:0043631),0.23548053782233652,0.6667702181751427,0.9113712374581939,0.9968729233632838,1.0,9/26,21.55%,AHCYL1;PAPOLA;APP;SCAF8;WDR33;CLP1;PAPOLG;MTPAP;TENT2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.20192459156893955,-0.6665844296403904,0.9534883720930233,0.9954955017842085,1.0,4/35,8.23%,CDH10;CDH11;NLGN1;CDH7
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.27109901651855306,0.6663838020906155,0.8532289628180039,0.9966791296445714,1.0,2/13,8.25%,RIC3;TMEM35A
prerank,negative regulation of neurogenesis (GO:0050768),0.2257152992996021,0.6651664957466664,0.9336569579288025,0.9971624781701511,1.0,8/34,17.74%,B2M;RUFY3;NOTCH1;NF1;YWHAH;HOOK3;LRP4;LINGO1
prerank,regulation of cholesterol storage (GO:0010885),-0.2517351108066878,-0.6651158223606352,0.9140461215932913,0.9959903282335958,1.0,4/15,16.65%,PPARA;TTC39B;ABCA1;EHD1
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.27715450536516506,0.6650870752167573,0.8957952468007313,0.996701604729884,1.0,3/15,14.60%,TENT4A;CNOT7;CNOT1
prerank,establishment of protein localization to extracellular region (GO:0035592),0.21875306393611677,0.6646075400477524,0.946843853820598,0.9965596694424914,1.0,10/39,19.64%,MIA2;ARL4D;COPG2;PPY;COPG1;TANGO6;TVP23B;MIA3;PDIA4;SEL1L
prerank,protein catabolic process (GO:0030163),0.20382932253476274,0.6642885733475038,0.9765625,0.9962941659395511,1.0,8/59,15.11%,HSPA8;PPT1;APOE;MAGEC2;TPP1;STT3B;CHEK2;UBE2G1
prerank,positive regulation of vasculogenesis (GO:2001214),-0.2902974959815191,-0.662933931992431,0.8983402489626556,0.9970973739251685,1.0,6/10,36.14%,CD34;RAPGEF2;HIF1AN;CEACAM1;RRAS;RIN2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.27757765444855287,-0.6622624942712286,0.8924731182795699,0.9969753681675789,1.0,4/11,22.38%,NBL1;RIN3;CCN3;DUSP1
prerank,negative regulation of hydrolase activity (GO:0051346),0.2115602221338399,0.6613254702444613,0.942215088282504,0.998142698571922,1.0,3/49,7.31%,PPP1R36;LRCH1;F11R
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.23633793242903367,-0.6605477747394688,0.9044444444444445,0.9976487223719076,1.0,9/18,32.06%,USP13;BCL2L11;TMEM259;RNFT1;PIK3R1;BAG6;RNF185;BOK;NCK1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.24751189064864884,-0.660455113270772,0.9194915254237288,0.9971062022610361,1.0,8/16,32.17%,PIGV;PIGG;PIGX;PIGA;PIGM;PIGF;DPM2;PIGC
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.26638206899128664,-0.6596988440261523,0.9116997792494481,0.9970518769508103,1.0,7/13,29.15%,PKD1;FLNA;KEAP1;DBN1;SUFU;GET4;MDFI
prerank,glycerophospholipid catabolic process (GO:0046475),0.22966298357927098,0.6590597529562567,0.9237588652482269,0.9994202697651634,1.0,4/27,14.31%,SMPD4;PNPLA8;ABHD12;PNPLA6
prerank,cellular response to leucine starvation (GO:1990253),-0.2739300472086672,-0.6585540719117994,0.9079229122055674,0.9972666024132115,1.0,5/10,33.29%,GCN1;IMPACT;SESN2;MTOR;RRAGD
prerank,positive regulation of T cell proliferation (GO:0042102),-0.18216912135764418,-0.6582020923427753,0.9751381215469613,0.9968954971742726,1.0,6/55,14.02%,IGF1;IGFBP2;ANXA1;IL18;IGF2;IL6ST
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.2930183252771341,0.6578598399452834,0.8977695167286245,0.9998691236585234,1.0,1/10,6.67%,CALM3
prerank,regulation of membrane depolarization (GO:0003254),0.25183796900927846,0.6576700464712926,0.8932384341637011,0.9994867123615672,1.0,2/18,7.27%,NEDD4L;SMAD7
prerank,steroid hormone biosynthetic process (GO:0120178),0.22687483519104745,0.6570578830054316,0.9347826086956522,0.9994589112436832,1.0,4/29,15.98%,TSPO;HSD17B11;STARD3NL;STARD3
prerank,rRNA modification (GO:0000154),0.24905319961719902,0.6568667533290721,0.928698752228164,0.9990780928826148,1.0,1/21,1.10%,THUMPD1
prerank,piRNA metabolic process (GO:0034587),0.2552910883627456,0.6563066771768887,0.8971631205673759,0.9990142861897615,1.0,19/19,74.50%,MYBL1;PLD6;PIWIL1;TDRD1;BTBD18;GPAT2;ASZ1;HENMT1;MOV10L1;MAEL;FKBP6;PIWIL4;TDRD12;DDX4;TDRD9;PIWIL2;EXD1;TEX15;TDRKH
prerank,regulation of T cell differentiation (GO:0045580),-0.20598170417145406,-0.655514986957861,0.961439588688946,0.9982110527368047,1.0,3/33,6.96%,CBFB;ZBTB1;CAMK4
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.26280774625270964,-0.6550968128493994,0.8997867803837953,0.9978939379082852,1.0,3/13,17.29%,AXL;IFIH1;MAVS
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.2774918092567461,-0.6547334372133746,0.8875739644970414,0.9975397704371235,1.0,4/10,23.37%,EMC7;EMC1;EMC8;EMC9
prerank,glial cell differentiation (GO:0010001),-0.20813611154429215,-0.6546848805792072,0.9489795918367347,0.9969656864103772,1.0,18/28,42.49%,NFIB;RELN;TPPP;PAX2;PICK1;EIF2B5;CDK5;FGF10;GPC1;MYRF;SOX11;ERBB3;GPR157;SOX10;METRN;SOX4;SOX8;PTPRZ1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.26864818397597634,0.6543493064900807,0.8905109489051095,1.0,1.0,3/15,12.07%,FITM2;CNEP1R1;SCARB1
prerank,positive regulation of cholesterol transport (GO:0032376),0.23368350622241363,0.653410723358861,0.9328493647912885,1.0,1.0,3/27,7.36%,APOE;LPCAT3;SIRT1
prerank,regulation of hemopoiesis (GO:1903706),-0.28144811803994585,-0.6528103630664653,0.901840490797546,0.9976671972757961,1.0,5/10,35.72%,CBFB;MYSM1;IL17D;MAFB;PTN
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.2328574808880544,-0.6525848308378083,0.9265402843601895,0.9972245393994984,1.0,7/20,24.04%,MCU;MICU2;AFG3L2;MCUR1;SPG7;MCUB;STOML2
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.2743174918959994,-0.6513563271397845,0.8957446808510638,0.9974865265650765,1.0,1/12,1.65%,ACSL1
prerank,chromosome organization (GO:0051276),0.1807020928529678,0.6513162180480025,0.9855491329479769,1.0,1.0,16/99,15.89%,EZH2;HDAC3;SOX2;FAM50A;SIRT1;CDCA8;RFWD3;MSH3;COPS7B;PWWP3A;DOT1L;HDAC5;COPS8;EZH1;SMARCA4;TCF7L1
prerank,regulation of stem cell population maintenance (GO:2000036),0.2520855762298577,0.6511906431608664,0.9071428571428571,1.0,1.0,5/18,20.37%,CNOT2;CNOT1;TAF6L;ZC3H13;REST
prerank,ncRNA 3'-end processing (GO:0043628),0.26693843206932183,0.6508719551552721,0.9101123595505618,1.0,1.0,6/14,20.42%,PTCD1;INTS14;SSB;INTS6;TRNT1;INTS2
prerank,NAD biosynthetic process (GO:0009435),0.25006410384521427,0.6508000097782305,0.9259927797833934,1.0,1.0,5/20,16.97%,NUDT12;NADSYN1;NAMPT;NAXD;NMNAT1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.2211977490583686,0.6501660550533622,0.9431438127090301,1.0,1.0,6/32,16.56%,LPCAT3;GPAT4;SLC44A1;CEPT1;CSNK2A2;SLC44A2
prerank,lymphocyte migration (GO:0072676),0.22470816436656577,0.6495387637037946,0.9219015280135824,1.0,1.0,2/32,8.53%,RET;CCL25
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.24533655420013029,-0.6493846917916938,0.9223946784922394,0.998228600815839,1.0,6/15,26.66%,ALDH4A1;GGT5;PRODH;HOGA1;SARDH;CHAC2
prerank,regulation of cilium assembly (GO:1902017),0.1969411679329091,0.648713648987343,0.9714714714714715,1.0,1.0,9/62,13.12%,EVI5L;TBC1D30;TBC1D8;TBC1D10B;USP6NL;IFT140;TBC1D24;TBC1D14;RABGAP1
prerank,negative regulation of organelle assembly (GO:1902116),-0.19530228276202194,-0.6483492569350001,0.9539951573849879,0.99829346584629,1.0,20/35,37.79%,SMAD4;NUPR1;FEZ1;CCP110;LIMK2;PINK1;PHF23;RBM14;YAP1;MDM1;CDK10;TBC1D7;CEP97;KAT2B;TRIM37;TCHP;SMCR8;KAT2A;TESK1;STYXL1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.2789691570510977,0.6481708639327549,0.8952205882352942,0.999483656891304,1.0,3/11,16.75%,SYK;PTK2B;SHC1
prerank,cellular response to interleukin-2 (GO:0071352),0.2789691570510977,0.6481708639327549,0.8952205882352942,0.999483656891304,1.0,3/11,16.75%,SYK;PTK2B;SHC1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.2307863615169729,-0.648120415407884,0.9348739495798319,0.9978149146401409,1.0,12/19,37.55%,PMM2;RENBP;UGDH;NAGK;GFPT1;GNPDA2;GNPDA1;GFPT2;GNPNAT1;PMM1;UAP1;NANS
prerank,cellular response to interleukin-15 (GO:0071350),-0.2581887932386255,-0.6478791203820637,0.9076212471131639,0.9967602646400641,1.0,2/13,12.58%,JAK1;GRB2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.2581887932386255,-0.6478791203820637,0.9076212471131639,0.9967602646400641,1.0,2/13,12.58%,JAK1;GRB2
prerank,regulation of telomere maintenance (GO:0032204),0.2274023272923563,0.6474320042348791,0.9377104377104377,0.9994973691052242,1.0,8/26,19.11%,ERCC4;SMG1;NBN;TERF2IP;SMG6;SMG5;ATRX;DHX36
prerank,cell projection organization (GO:0030030),0.22054307929369657,0.6449928988132372,0.9411764705882353,1.0,1.0,6/30,16.77%,RAC2;RHOQ;RHOG;PLEK;PACSIN2;CYFIP1
prerank,negative regulation of secretion (GO:0051048),-0.2736773406275083,-0.6448337767817988,0.9114688128772636,0.9981875868304408,1.0,6/10,49.93%,VAMP8;PTGER3;EGF;ERBB3;SPX;NRG1
prerank,macrophage migration (GO:1905517),-0.2610628263293643,-0.6447105460907481,0.9114688128772636,0.9976772054839806,1.0,3/13,23.92%,P2RX4;P2RY12;CKLF
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.267018199582564,0.6439043405321325,0.911275415896488,1.0,1.0,2/15,7.09%,RIPOR2;RAPGEF3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.25661646931104165,-0.6431951078781237,0.9036402569593148,0.9980174863167324,1.0,2/13,16.12%,IL33;SELENOS
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.26622358982391814,0.6429840228077932,0.8903591682419659,1.0,1.0,3/13,17.36%,CRLF1;TYK2;STAT3
prerank,DNA methylation (GO:0006306),0.23000902357100472,0.6429272576823889,0.9258620689655173,1.0,1.0,2/23,5.90%,DMAP1;BEND3
prerank,potassium ion export across plasma membrane (GO:0097623),-0.2549355560954013,-0.6421959860334346,0.925764192139738,0.9980718857136569,1.0,5/13,45.65%,KCNK5;KCNQ1;KCNE4;KCNIP2;KCNH2
prerank,actin filament-based transport (GO:0099515),0.2391878855937725,0.6418437564385037,0.9345132743362832,1.0,1.0,4/21,13.07%,MYO5A;ACTN4;MYO1D;MYO1E
prerank,regulation of mitochondrial fusion (GO:0010635),0.2762161242443101,0.6413964139773003,0.8909090909090909,1.0,1.0,4/11,19.26%,OMA1;VAT1;BNIP3;TFRC
prerank,negative regulation of interferon-gamma production (GO:0032689),0.2399970029970688,0.6412557722896389,0.9390681003584229,1.0,1.0,5/23,15.42%,VSIR;PRNP;CD274;DDIT3;GAS6
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.2659363480496859,0.6411379646172675,0.903954802259887,0.9997189421745589,1.0,1/13,3.55%,EXTL2
prerank,cardiac cell development (GO:0055006),-0.26692265755301176,-0.6407775192336534,0.9260780287474333,0.9983688917079752,1.0,3/11,24.61%,CXADR;VEGFA;MYH11
prerank,protein alkylation (GO:0008213),-0.21895754043395746,-0.6405435577862963,0.9351230425055929,0.9979194110135412,1.0,8/22,28.31%,CAMKMT;FAM98A;EEF1AKMT1;PRMT2;METTL21A;PRMT8;PRMT1;EEF2KMT
prerank,intracellular sterol transport (GO:0032366),0.26427711530582765,0.6388685786926905,0.9125475285171103,1.0,1.0,4/13,14.18%,NPC2;NPC1;OSBPL2;SERAC1
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.2685315596454537,-0.6388081675144881,0.9139344262295082,0.998422136775611,1.0,4/11,20.50%,EFNB2;TGFB1;SOX6;FZD7
prerank,myelin maintenance (GO:0043217),0.2832656761703946,0.6369122600371754,0.8849056603773585,1.0,1.0,1/10,2.27%,SOD1
prerank,negative regulation by host of viral transcription (GO:0043922),-0.2613735603469157,-0.6366503866689966,0.9269311064718163,0.9991424678991585,1.0,5/12,29.06%,HDAC1;JUN;PSMC3;INPP5K;HMGA2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.28232488074315865,0.6357538416678201,0.9023904382470119,1.0,1.0,10/10,71.79%,ETFBKMT;OXA1L;GZMA;DRD5;PRKN;HP;AOC3;MT3;SNCA;HDAC6
prerank,glycerolipid catabolic process (GO:0046503),0.24504666682978563,0.6348922980507654,0.911660777385159,1.0,1.0,3/19,14.31%,SMPD4;ABHD12;PNPLA6
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.25664923957380636,-0.6347276843661221,0.905982905982906,0.9996781343496486,1.0,1/12,7.69%,RBP4
prerank,histone H3-K36 demethylation (GO:0070544),-0.27388293002203545,-0.6346210456606027,0.899009900990099,0.9991336816883338,1.0,2/10,5.39%,KDM4A;KDM7A
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.26407405667343714,0.6343270529880096,0.9154411764705882,1.0,1.0,2/13,12.56%,PLCG1;SP1
prerank,neuromuscular process (GO:0050905),0.25538400231466124,0.634213447503063,0.9040590405904059,1.0,1.0,5/16,17.75%,AGTPBP1;TPP1;MYCBP2;GCH1;PAFAH1B1
prerank,GPI anchor biosynthetic process (GO:0006506),-0.2007106809479871,-0.6337686957615346,0.9623529411764706,0.9990563478813604,1.0,14/30,33.50%,DPM1;PIGV;PIGG;PIGX;PIGA;PIGM;PGAP4;PIGS;PIGF;GPAA1;MPPE1;DPM2;PIGC;DPM3
prerank,positive regulation of pseudopodium assembly (GO:0031274),-0.2756266812164156,-0.6336229306651902,0.9120654396728016,0.9979277496825605,1.0,5/10,33.82%,CDC42EP5;CDC42EP1;CDC42;CDC42EP2;WASHC1
prerank,regulation of pseudopodium assembly (GO:0031272),-0.2756266812164156,-0.6336229306651902,0.9120654396728016,0.9979277496825605,1.0,5/10,33.82%,CDC42EP5;CDC42EP1;CDC42;CDC42EP2;WASHC1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.23732586875312162,-0.6332663777726257,0.9241379310344827,0.997538821843429,1.0,6/17,30.02%,ANXA4;ANXA1;PTPN22;OTUD7B;SSC5D;BCL3
prerank,ganglioside biosynthetic process (GO:0001574),0.25670671855783617,0.633059306051076,0.8905109489051095,1.0,1.0,4/15,18.73%,ST6GALNAC3;ST3GAL1;ST8SIA6;ST3GAL2
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.2344205518667985,-0.6312827630713018,0.9355509355509356,0.9980707837856552,1.0,6/17,35.94%,PRKCZ;RARA;CEBPB;CD86;HAVCR2;FCER1G
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.25647714758252954,0.6311492854286135,0.9214953271028037,1.0,1.0,5/15,19.64%,DERL2;AUP1;UFD1;DERL1;SEL1L
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.2649169912039537,0.6307895212762494,0.9097605893186004,1.0,1.0,1/12,3.39%,PAX8
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.2672672274206239,0.6295511266551622,0.9172932330827067,1.0,1.0,3/13,16.03%,NUDT12;NAMPT;NAXD
prerank,ubiquinone metabolic process (GO:0006743),0.2559263571375712,0.6286649736644931,0.9171374764595104,1.0,1.0,6/15,19.39%,COQ2;PDSS2;COQ5;PDSS1;COQ3;COQ10A
prerank,regulation of acrosome reaction (GO:0060046),-0.26786345460820965,-0.6283994555465192,0.9294354838709677,0.9990862802729414,1.0,1/10,7.68%,GLRA1
prerank,regulation of store-operated calcium entry (GO:2001256),-0.2698070730854767,-0.6282793026466761,0.9218436873747495,0.9985369726640703,1.0,1/10,3.04%,STIM1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.2452136129497765,0.6279506424615359,0.9191729323308271,1.0,1.0,1/18,2.44%,DERL2
prerank,regulation of DNA recombination (GO:0000018),0.21482885532568427,0.6276783002564481,0.9751655629139073,1.0,1.0,6/32,17.06%,ZRANB3;MSH3;KPNA1;TERF2IP;SETD2;SMARCAD1
prerank,regulation of keratinocyte migration (GO:0051547),-0.2541582503698793,-0.6276720294628302,0.9272727272727272,0.9982788914332901,1.0,6/12,33.48%,EPB41L4B;IQSEC1;MAPRE2;FGF10;MTOR;FGF7
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.2495542258279847,-0.6276621013326372,0.944558521560575,0.99768505895056,1.0,9/14,38.62%,ZNHIT6;NOL9;RPF2;FTSJ3;BOP1;NIFK;RPL7L1;PES1;DDX18
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.1934180696215183,0.627170218745123,0.9709480122324159,1.0,1.0,8/57,13.42%,ABRAXAS1;NEK11;CDKN1A;RFWD3;HUS1;NBN;CHEK2;BRCC3
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.26577458446754865,-0.6268708765182908,0.9383983572895277,0.9975483828773755,1.0,1/11,3.86%,SCARA3
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.2744971352670162,0.6267339553366578,0.9122448979591836,1.0,1.0,2/11,13.15%,VSIR;CD274
prerank,macromolecule catabolic process (GO:0009057),-0.2028186554674928,-0.6259405975576208,0.9532710280373832,0.9974642963484779,1.0,14/26,38.20%,LGMN;UVRAG;SNX25;UCHL3;LRSAM1;TGFB1;NEDD4;CLPX;CLN5;MTOR;SMURF1;MVB12A;CLN8;IDE
prerank,hexose transmembrane transport (GO:0008645),0.23445597146614436,0.6253654147348418,0.9469026548672567,1.0,1.0,2/21,8.55%,PPARD;SLC2A1
prerank,modulation by symbiont of host process (GO:0044003),0.2711550527069376,0.6253332210416119,0.874251497005988,1.0,1.0,1/10,5.39%,B2M
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.24947732243462847,-0.6242633441512121,0.9290322580645162,0.9978266786423886,1.0,4/13,22.26%,NUPR1;FEZ1;PINK1;PHF23
prerank,positive regulation of ruffle assembly (GO:1900029),-0.2504450296499848,-0.6233791228171467,0.9355555555555556,0.9977207650431774,1.0,5/13,23.84%,NLGN1;FAM98A;PLEKHM1;P2RY12;EPS8L2
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.2685814469178891,-0.622719549068109,0.9273084479371316,0.9975062389334821,1.0,1/10,3.58%,TGFBR2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.2581719982131713,0.6219428066490658,0.9179389312977099,1.0,1.0,1/14,2.47%,PSEN2
prerank,regulation of RNA export from nucleus (GO:0046831),0.272047620272633,0.6199787347806889,0.9011857707509882,1.0,1.0,5/11,21.43%,AKAP8L;CPSF6;SETD2;NSUN2;DHX9
prerank,development of primary male sexual characteristics (GO:0046546),0.21234570320029933,0.6198771246914575,0.9586092715231788,1.0,1.0,3/34,8.24%,NR5A1;MAMLD1;WNT5A
prerank,peptidyl-lysine methylation (GO:0018022),-0.20097704019082974,-0.6197873670725061,0.9582366589327146,0.9984805961877025,1.0,17/26,43.57%,SETD7;EHMT2;ATPSCKMT;EEF1AKMT1;SMYD2;N6AMT1;SETD4;METTL21A;EEF2KMT;SUV39H1;EEF1AKMT2;SMYD1;ANTKMT;SUV39H2;VCPKMT;SETD6;TRMT112
prerank,fibrinolysis (GO:0042730),0.2588988637077028,0.6193404558378998,0.9143389199255121,1.0,1.0,13/13,74.13%,PLAT;FGG;SERPINF2;KRT1;F2;GP1BA;CPB2;SERPINB2;PLG;HRG;PLAU;PLAUR;SERPINE1
prerank,negative regulation of translational initiation (GO:0045947),0.2575496042900186,0.6188003948786871,0.9270216962524654,1.0,1.0,7/13,23.57%,PAIP2B;EIF3E;LARP1;EIF2AK4;PAIP2;FMR1;AGO2
prerank,protein localization to mitochondrion (GO:0070585),0.26649531184894804,0.6184058930648543,0.9377289377289377,1.0,1.0,2/11,10.39%,RALA;MAIP1
prerank,positive regulation of innate immune response (GO:0045089),0.2137209083321681,0.6181561663402538,0.9603960396039604,1.0,1.0,5/30,13.62%,IFI35;WNT5A;POLR3F;NLRC5;POLR3B
prerank,snRNA 3'-end processing (GO:0034472),0.23280304314347094,0.6174950470869687,0.9494584837545126,1.0,1.0,6/19,20.42%,USB1;EXOSC9;INTS14;INTS6;EXOSC7;INTS2
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.2244533231353391,0.6172330541965246,0.9602888086642599,1.0,1.0,4/22,14.14%,ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.2244533231353391,0.6172330541965246,0.9602888086642599,1.0,1.0,4/22,14.14%,ZDHHC14;ZDHHC15;ZDHHC9;ZDHHC7
prerank,organophosphate catabolic process (GO:0046434),0.27003954554014187,0.6169274887578199,0.9202334630350194,0.9999490088736835,1.0,11/11,73.01%,ABHD12;ENPP2;PNLIPRP2;APOA2;LIPG;PON1;PDXP;NUDT15;PLBD1;ANGPTL3;PLBD2
prerank,RNA interference (GO:0016246),-0.22821442050469812,-0.6155168761922162,0.9377682403433476,1.0,1.0,6/17,28.69%,TSN;AGO3;DICER1;NRDE2;DROSHA;CELF1
prerank,cellular response to interferon-beta (GO:0035458),0.25606393622839124,0.6154986613423727,0.9357798165137615,1.0,1.0,2/14,13.25%,IFITM2;NDUFA13
prerank,purine nucleotide metabolic process (GO:0006163),0.22414867380580578,0.6149156522800023,0.9464594127806563,1.0,1.0,4/24,12.10%,PRPS1L1;PRPS1;PNP;NT5C2
prerank,defense response to fungus (GO:0050832),0.2445753005645145,0.6144964442308114,0.9177570093457944,0.9997274104152446,1.0,1/17,6.00%,FAM3A
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.22366495310204426,0.6142555798475806,0.9533333333333334,0.9993315063017503,1.0,3/24,11.27%,PDE4D;CALM3;DMD
prerank,negative regulation of receptor internalization (GO:0002091),-0.2522086705145651,-0.6141040852426061,0.946611909650924,1.0,1.0,2/12,15.36%,DLG4;RIN3
prerank,negative regulation of transposition (GO:0010529),0.24040561663929436,0.6135146158502267,0.9289827255278311,0.9992067944252232,1.0,4/16,18.67%,TUT7;TUT4;MOV10;MYBL1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.2131979725577011,0.6131245504814713,0.9593639575971732,0.9989027231039366,1.0,4/29,12.92%,BIRC2;TRAF3;IKBKB;CHUK
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.2568643477841853,-0.6119346810531721,0.9388185654008439,1.0,1.0,6/10,56.18%,ADRA2A;HBEGF;EGF;BTC;NCF1;TGFA
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2102523019545238,0.6116833671683947,0.9512195121951219,0.9991357443815017,1.0,4/30,12.92%,BIRC2;TRAF3;IKBKB;CHUK
prerank,modulation by symbiont of entry into host (GO:0052372),-0.23362899250973262,-0.6116511139589828,0.9386892177589852,1.0,1.0,9/16,35.03%,HS3ST5;EXOC7;TRIM5;NECTIN2;TRIM62;FUCA2;CAV1;TRIM21;TRIM68
prerank,eye photoreceptor cell development (GO:0042462),-0.23142254996073963,-0.611381553929994,0.9308176100628931,0.9997289002696098,1.0,8/15,48.88%,TOPORS;VEGFA;RP1;THY1;RPGRIP1;TULP1;MYO7A;RORB
prerank,ureteric bud morphogenesis (GO:0060675),0.24353071029870277,0.611240722965212,0.9373881932021467,0.9988498604844396,1.0,2/16,11.13%,PAX8;NPNT
prerank,homologous chromosome segregation (GO:0045143),-0.21223669838215162,-0.6106138303247595,0.9598214285714286,0.9994822629373354,1.0,11/20,53.01%,FMN2;SIRT7;PTTG1;PRDM9;TERB1;MEI4;FANCD2;ZCWPW1;SGO1;MAJIN;MEIOB
prerank,regulation of interleukin-6 production (GO:0032675),0.17473380651635576,0.6099250824443775,0.9941605839416059,0.9990549892577136,1.0,8/96,11.24%,TNFAIP3;TIRAP;RAB7B;SYK;NLRC3;WNT5A;CD47;APP
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.22068934896025333,-0.6094384581693215,0.9639830508474576,0.99943139288452,1.0,13/18,45.00%,ATP7A;ABL2;AGTR1;RFK;PDP1;POR;FXN;EDN1;EDN3;AGT;NOD2;GDNF;PDP2
prerank,ovarian follicle development (GO:0001541),0.25452641694181327,0.6092152963934718,0.9330855018587361,0.9989044839459457,1.0,1/13,2.27%,SOD1
prerank,regulation of ruffle assembly (GO:1900027),0.22635243309764685,0.6091492113352418,0.9652014652014652,0.998422796363517,1.0,2/23,4.80%,EVL;PFN1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.2276900412845643,0.6089860929043518,0.9457943925233645,0.9979935992642482,1.0,7/21,20.79%,APOE;SIRT1;NFKBIA;PLTP;EEPD1;NR1H3;PPARG
prerank,plasma membrane tubulation (GO:0097320),-0.24249833496330472,-0.6088331399813393,0.9322381930184805,0.9991230378761112,1.0,5/13,32.07%,BIN3;PACSIN1;PACSIN3;CAVIN2;MICALL1
prerank,ubiquinone biosynthetic process (GO:0006744),0.24633636749925647,0.6086605758464656,0.9317343173431735,0.9976603512630529,1.0,6/15,19.39%,COQ2;PDSS2;COQ5;PDSS1;COQ3;COQ10A
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.21651297936431013,0.6077680019682543,0.9705882352941176,0.997617562333754,1.0,9/25,21.60%,APP;PICALM;ARF6;MTMR2;UBQLN2;RAC1;ANKRD13A;PSEN1;ATXN2
prerank,ESCRT III complex disassembly (GO:1904903),0.26755858949599826,0.6075587527519022,0.9222011385199241,0.9966953866864485,1.0,2/10,10.29%,CHMP1A;CHMP2A
prerank,ESCRT complex disassembly (GO:1904896),0.26755858949599826,0.6075587527519022,0.9222011385199241,0.9966953866864485,1.0,2/10,10.29%,CHMP1A;CHMP2A
prerank,electron transport chain (GO:0022900),0.24632885322533635,0.607528690572247,0.9226305609284333,0.9962009043488951,1.0,3/15,13.83%,ETFA;SDHA;PDIA5
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),-0.20287720043704688,-0.6074044059772896,0.9788732394366197,0.9991906674088926,1.0,4/25,13.03%,FAM162A;BCL2L11;TP53;PDCD5
prerank,negative regulation of intracellular protein transport (GO:0090317),0.2253547294950652,0.6070957407410237,0.9406919275123559,0.9959175322408864,1.0,3/22,11.73%,INSIG1;PARK7;MDFIC
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.20450377356718186,0.6060984117246976,0.9686028257456829,0.9959116867644858,1.0,5/35,12.85%,RIPOR2;SCAI;RASIP1;ITGA3;CUL3
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.23838599818239337,0.6054110176078202,0.9449225473321858,0.9957645018708996,1.0,6/19,18.55%,POLD3;TERT;PNP;GMPR2;GMPR;HPRT1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.22667742191291484,-0.6042472063948797,0.9535353535353536,1.0,1.0,10/16,44.00%,SHLD1;SMCHD1;RIF1;SHLD2;POLQ;FANCB;CGAS;MAD2L2;RMI2;PARPBP
prerank,negative regulation of centrosome duplication (GO:0010826),-0.25653886057744857,-0.6031670534829584,0.940552016985138,0.9999916778977561,1.0,7/11,43.67%,RBM14;MDM1;KAT2B;TRIM37;KAT2A;CCNF;BRCA1
prerank,negative regulation of leukocyte migration (GO:0002686),-0.2540235186981087,-0.6031507585178861,0.9294117647058824,0.9994031883901596,1.0,1/10,3.68%,BMP5
prerank,chromatin assembly (GO:0031497),0.19934599630873717,0.6029963060606329,0.9656946826758147,0.9964259405123922,1.0,8/38,18.64%,NAP1L4;SIRT1;RSF1;BRD2;EZH1;RBBP4;NPM1;ATRX
prerank,neural crest cell differentiation (GO:0014033),-0.221559435003982,-0.6025185279798309,0.9519650655021834,0.9991004850730845,1.0,13/18,50.55%,TAPT1;LRP6;PEF1;TCOF1;NOLC1;FBXL17;SOX11;SOX8;KBTBD8;HTR2B;MEF2C;NRG1;SNAI2
prerank,muscle tissue development (GO:0060537),0.254318273313232,0.6024611070435816,0.945054945054945,0.9961882372775638,1.0,3/13,13.51%,PGM5;NF1;CSRP1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.21355060227889366,0.6019343506002836,0.964824120603015,0.9959326128550364,1.0,1/26,1.15%,CBL
prerank,leukocyte tethering or rolling (GO:0050901),-0.22330132268636782,-0.6012063690289414,0.9617117117117117,0.9991100006825424,1.0,5/17,26.87%,ROCK1;ITGA4;ADD2;PODXL2;CX3CR1
prerank,secretory granule organization (GO:0033363),0.2670136933077537,0.6008096448407303,0.9117647058823529,0.9959728621130882,1.0,1/10,5.93%,DTNBP1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.2635798392999822,0.6004823753832224,0.9437751004016064,0.9956036134830164,1.0,2/11,11.20%,PTPRT;ADIPOR1
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.2577396261373296,-0.6001866544551773,0.9241516966067864,0.9989801605893662,1.0,3/10,20.59%,SETD7;SMYD2;SETD4
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.21929616478657377,-0.5999767174621606,0.9503239740820735,0.9984844923968971,1.0,8/18,43.61%,GPLD1;SPG21;BAG6;CMKLR1;FCER1G;SH2B2;BCAR1;C3AR1
prerank,mitochondrial genome maintenance (GO:0000002),-0.25430575590398086,-0.5998531074342061,0.9359504132231405,0.9979483984329476,1.0,4/11,19.88%,SLC25A36;MPV17;PARP1;SLC25A33
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.20379724641294045,-0.5997903682133354,0.971764705882353,0.9973779983012762,1.0,18/22,65.86%,IL18;TGFB1;SPHK1;ZBTB7B;NOD2;NR1H4;MYD88;LY9;SLAMF6;PRKCQ;CARD9;IL23A;IL6;CCL1;IL12B;IL23R;IL2;OSM
prerank,iron-sulfur cluster assembly (GO:0016226),0.2175064356605901,0.599189982838259,0.9768211920529801,0.9957207237930074,1.0,4/24,13.29%,CIAPIN1;ISCU;GLRX3;HSCB
prerank,apoptotic mitochondrial changes (GO:0008637),-0.18604301144512242,-0.5990930465450255,0.9748743718592965,0.9970876455281815,1.0,9/32,26.08%,ERBB4;FIS1;HSPD1;THEM4;BCL2;HK2;BCL2L1;CAMK2A;AIFM2
prerank,negative regulation of histone acetylation (GO:0035067),0.2588896802799446,0.5975133068703113,0.923679060665362,0.9960138792728909,1.0,2/11,11.17%,SIRT1;CTBP1
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.2658636565397379,0.596486082535597,0.9365079365079365,0.9959722389456381,1.0,2/10,11.17%,SIRT1;CTBP1
prerank,fatty acid oxidation (GO:0019395),0.18249845560450614,0.5959757253239224,0.992412746585736,0.9957031145316689,1.0,11/57,17.54%,ACAT1;PPARD;ADIPOR2;ADIPOR1;HSD17B4;BDH2;ECHDC1;ECHS1;ACAA2;ACADL;PEX13
prerank,fatty acid biosynthetic process (GO:0006633),-0.16245125060225893,-0.5951461845945966,0.9942363112391931,0.9981601065276843,1.0,24/63,38.99%,HACD3;HACD1;HACD4;TECR;ACLY;ABHD3;ACOT7;PTGS2;DEGS1;ABCD3;EPHX2;ELOVL4;FADS3;DECR2;CBR4;SCD;ELOVL1;LIAS;FADS1;ACSBG1;LPL;ALOX12;HSD17B8;OXSM
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.2211914692984059,0.5947622071913117,0.9464594127806563,0.995724793544957,1.0,3/21,13.25%,TXNDC12;PARK7;DDIT3
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.24792272279139016,-0.5942699415203317,0.9489795918367347,0.9979467730597308,1.0,5/10,29.76%,AKT2;GPLD1;AKT1;SNCA;SLC45A3
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.19358500851381974,0.5935167305384931,0.9899159663865547,0.995744131085059,1.0,12/44,20.96%,PRR5L;ZFP36L1;CNOT7;NANOS3;CNOT1;MOV10;FTO;RC3H1;DHX36;METTL14;TNRC6A;CNOT8
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.23188815344191394,0.5930000149711612,0.9521178637200737,0.9954653354085196,1.0,3/18,12.56%,PLCG1;FLT1;SP1
prerank,RNA stabilization (GO:0043489),0.20183730488308668,0.5920363328069475,0.9785831960461285,0.995389326738623,1.0,12/33,21.97%,TAF15;YBX1;FUS;NOCT;ZCCHC17;DKC1;PARN;NSUN2;DHX36;LARP1;TENT2;TRDMT1
prerank,regulation of cholesterol efflux (GO:0010874),0.20442137718184547,0.5915792820420345,0.9713261648745519,0.9950910806164124,1.0,3/30,7.36%,APOE;LAMTOR1;SIRT1
prerank,apoptotic DNA fragmentation (GO:0006309),-0.22117113916138256,-0.5912053446781963,0.9639065817409767,0.9985783621444788,1.0,8/16,35.72%,DICER1;DFFA;CASP3;EXOG;H1-0;DNASE2;HMGB1;HMGB2
prerank,cGMP biosynthetic process (GO:0006182),0.2640208733588194,0.5908518528133561,0.925343811394892,0.9948959067855414,1.0,2/10,14.11%,NPPC;NPR2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.2231615756649014,-0.5898417871290004,0.9714912280701754,0.9985177883266841,1.0,4/16,20.29%,TMEM50A;SNF8;CHMP5;STAM
prerank,ncRNA metabolic process (GO:0034660),0.19770237336141352,0.58977536969872,0.973109243697479,0.9948698115792908,1.0,6/37,16.47%,BCDIN3D;XPO5;TUT7;TUT4;PARN;DTD1
prerank,actin-myosin filament sliding (GO:0033275),-0.17964520222162128,-0.5893507368966932,0.9925558312655087,0.9975503361094109,1.0,3/38,9.72%,VIM;TPM1;ACTN2
prerank,muscle filament sliding (GO:0030049),-0.17964520222162128,-0.5893507368966932,0.9925558312655087,0.9975503361094109,1.0,3/38,9.72%,VIM;TPM1;ACTN2
prerank,negative regulation of cell activation (GO:0050866),0.23941201251355054,0.5870163779991961,0.9333333333333333,0.9954994952375608,1.0,2/14,11.33%,APOE;NOS3
prerank,pyrimidine-containing compound metabolic process (GO:0072527),-0.23900691796560833,-0.5869259013349217,0.9578059071729957,0.9979231836551254,1.0,5/11,32.46%,ENPP3;NT5C3A;SLC19A2;DCK;SLC25A19
prerank,respiratory electron transport chain (GO:0022904),0.23942804220218253,0.5846775482923117,0.9566854990583804,0.9959468881375463,1.0,3/14,12.68%,ETFA;SDHA;SLC25A12
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.2524412902349199,-0.583595338017608,0.9479166666666666,0.9985736438253616,1.0,2/10,14.53%,TSN;DICER1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.25144058478345266,-0.58347007466549,0.956,0.9980336263039389,1.0,7/10,46.71%,NPLOC4;RIOK3;GPATCH3;DHX58;C1QBP;TKFC;TSPAN6
prerank,maturation of LSU-rRNA (GO:0000470),0.20500118560073205,0.5828879251235688,0.9689119170984456,0.9961244925713801,1.0,7/26,17.55%,RRP15;SNU13;WDR12;RPL35;RSL1D1;URB1;EIF6
prerank,sulfur amino acid catabolic process (GO:0000098),0.25859904594526745,0.5817258769275676,0.9265536723163842,0.9960511897475909,1.0,10/10,74.16%,TXN2;BLMH;MAT1A;GADL1;TST;MPST;ADO;CTH;CBS;MTRR
prerank,calcium ion import across plasma membrane (GO:0098703),-0.22271064471377397,-0.5801733171437449,0.9602649006622517,0.9986905984792783,1.0,6/14,37.02%,SLC24A2;CACNA2D1;TRPV2;SLC8A2;ATP2B4;TRPM2
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.2431019296322798,-0.5791262112784819,0.9508547008547008,0.9984667406830143,1.0,3/10,27.55%,SORL1;HSP90AA1;EGR1
prerank,negative regulation of DNA replication (GO:0008156),-0.22750040979807923,-0.5776818842976816,0.9611231101511879,0.9983871799476856,1.0,9/13,54.52%,S100A11;TSPYL2;CDAN1;TERF1;GMNC;PDS5A;RAD17;GMNN;CDC6
prerank,regulation of anoikis (GO:2000209),0.22280499150362826,0.5775069253375075,0.9602076124567474,0.9972221891105082,1.0,2/19,8.12%,SRC;NOTCH1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.23876396566471647,-0.5774904457194646,0.9585062240663901,0.9978745334992003,1.0,7/12,31.45%,CLCN2;MBTPS2;SREBF1;DGKQ;H6PD;RAN;ABCA2
prerank,ganglioside metabolic process (GO:0001573),-0.20231280511789182,-0.5754857274976459,0.9693396226415094,0.9979486031852598,1.0,10/20,35.48%,HEXA;HEXB;ST6GALNAC5;ST6GALNAC6;ST8SIA2;ST6GALNAC4;ABCA2;NEU1;ST3GAL5;ST8SIA3
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2334202134692756,0.5732440310566495,0.9611307420494699,0.9983329559145563,1.0,6/16,19.11%,ERCC4;TNKS;SMG6;TNKS2;SMG5;DHX36
prerank,inositol phosphate dephosphorylation (GO:0046855),0.24932521498964288,0.5732427422233913,0.9253731343283582,0.9973199341429534,1.0,11/11,75.08%,SYNJ2;IMPA1;INPP5B;SYNJ1;INPP5J;PTEN;INPP1;IMPA2;INPP5K;OCRL;INPP5A
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.24932521498964288,0.5732427422233913,0.9253731343283582,0.9973199341429534,1.0,11/11,75.08%,SYNJ2;IMPA1;INPP5B;SYNJ1;INPP5J;PTEN;INPP1;IMPA2;INPP5K;OCRL;INPP5A
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.22442742237683955,-0.5730197699108582,0.9642058165548099,0.998159043385958,1.0,1/14,1.93%,PKD1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.2304620618998596,0.5718907654884241,0.9607072691552063,0.9973134545795772,1.0,1/14,3.80%,NUDT5
prerank,oligodendrocyte differentiation (GO:0048709),-0.20468984276821167,-0.5714732022006614,0.9588377723970944,0.9980712018776178,1.0,12/19,42.49%,SOX6;TPPP;EIF2B5;EIF2B2;EIF2B4;CDK5;MYRF;NSUN5;SOX10;SOX8;EIF2B1;PTPRZ1
prerank,cGMP metabolic process (GO:0046068),-0.22714392840977812,-0.5706690792499886,0.9597457627118644,0.9977680471043786,1.0,4/12,25.95%,GUCY1A1;NPR1;GUCY1B1;PDE2A
prerank,regulation of transferase activity (GO:0051338),0.2226509474087511,0.5705457077914247,0.9648148148148148,0.9972904093722716,1.0,1/17,1.46%,JMJD8
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.2323400849599477,0.5701043475563213,0.9613259668508287,0.9969301297969798,1.0,1/15,3.77%,ZFP36L1
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.23968099969000234,0.569978038536633,0.9524680073126143,0.9964662837500975,1.0,2/13,9.70%,TXN;PARK7
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.23968442027381132,-0.5699627278150138,0.9688149688149689,0.9973914911713371,1.0,6/11,33.14%,NOL11;SIRT7;NOP53;PIH1D1;MTOR;DDX11
prerank,negative regulation of biosynthetic process (GO:0009890),-0.2129084518446029,-0.5692094288584015,0.9752808988764045,0.9970465887236446,1.0,3/16,13.98%,SLC30A10;PPARA;ABCD2
prerank,regulation of interferon-alpha production (GO:0032647),-0.1948649123695383,-0.5679550889301268,0.985981308411215,0.9968660235001778,1.0,5/23,19.85%,PTPRS;IFIH1;HSPD1;MAVS;STAT1
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.17155010811570595,-0.5678544140731421,0.9898734177215189,0.9963115638509379,1.0,20/36,52.10%,AXL;PARP14;UBE2K;MAVS;IRGM;AGPAT1;PARP9;EDN1;LAPTM5;AGPAT2;HSPA1A;TRIM6;TXK;HSPA1B;CASP1;ZBP1;CXCR4;CD300LF;FADD;C1QTNF4
prerank,regulation of mitotic spindle assembly (GO:1901673),0.22094946567492843,0.5676756253466438,0.9684014869888475,0.9967741836587577,1.0,2/19,10.29%,CHMP1A;CHMP2A
prerank,tyrosine metabolic process (GO:0006570),0.24466551954372204,0.5662950959047919,0.9499036608863198,0.9967340003525961,1.0,1/11,9.26%,THAP4
prerank,replication fork processing (GO:0031297),0.18625388495448508,0.5659244436317625,0.9869706840390879,0.9963361599009588,1.0,3/38,9.63%,ZRANB3;EXD2;RFWD3
prerank,regulation of chromosome organization (GO:0033044),-0.1905488071800788,-0.5650937428954896,0.9862385321100917,0.9965572347568145,1.0,4/22,17.74%,MAPT;CENPV;UPF1;YLPM1
prerank,negative regulation of cation channel activity (GO:2001258),0.2031652212938711,0.5639704248571268,0.9865546218487395,0.9965018452528446,1.0,3/26,10.91%,CALM3;KCNAB1;UBQLN1
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.2355511764403831,-0.5636333620600076,0.9678714859437751,0.9958075170259615,1.0,5/11,36.33%,AGO3;RBM4;NOTCH4;TNRC6C;ZFP36
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.2355511764403831,-0.5636333620600076,0.9678714859437751,0.9958075170259615,1.0,5/11,36.33%,AGO3;RBM4;NOTCH4;TNRC6C;ZFP36
prerank,mRNA stabilization (GO:0048255),0.1858202626367781,0.5635789376491506,0.9833887043189369,0.9961325053279564,1.0,7/40,15.62%,TIRAP;HNRNPC;TARDBP;TAF15;YBX1;FUS;NOCT
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.195198923551976,0.5628213840698093,0.9829642248722317,0.9958726565751657,1.0,1/29,2.31%,CXCL12
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.25285925644651996,0.55891693110185,0.9614643545279383,0.9965969303918262,1.0,1/10,7.27%,SMAD7
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.23375383657465143,-0.558584127092064,0.9596602972399151,0.9966962810938249,1.0,2/11,24.58%,AGTR1;PLA2G7
prerank,ribosomal subunit export from nucleus (GO:0000054),0.23821908397013186,0.555286607050252,0.9675572519083969,0.9972380305218348,1.0,6/13,21.55%,LTV1;XPO1;NPM1;EIF6;SDAD1;NMD3
prerank,response to fatty acid (GO:0070542),-0.20108356517622733,-0.5552744686418798,0.9808102345415778,0.997013904688335,1.0,1/17,3.64%,PID1
prerank,midbody abscission (GO:0061952),0.2183231818876873,0.5534648969190872,0.9669117647058824,0.9972705433215676,1.0,2/17,10.29%,CHMP1A;CHMP2A
prerank,calcium ion import into cytosol (GO:1902656),-0.20664204670519107,-0.5511340697501694,0.9634408602150538,0.997507641001597,1.0,6/15,37.02%,SLC24A2;CACNA2D1;TRPV2;SLC8A2;ATP2B4;TRPM2
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.23394842944126332,-0.5491725194500531,0.9659318637274549,0.9974181515506505,1.0,6/10,43.12%,FN1;GATA6;CD24;TSKU;TYROBP;CDH3
prerank,phospholipid catabolic process (GO:0009395),0.20306580931643575,0.5489389906761888,0.9875666074600356,0.9981000864715788,1.0,3/24,14.31%,SMPD4;ABHD12;PNPLA6
prerank,female gamete generation (GO:0007292),-0.17463239384169088,-0.5479743934650009,0.9928400954653938,0.9971287209769083,1.0,2/29,5.60%,DIAPH2;FMN2
prerank,protein deneddylation (GO:0000338),-0.23615712713756387,-0.5463143798147297,0.9731958762886598,0.9969511390449513,1.0,6/10,38.68%,COPS2;COPS5;COPS7A;TOR1A;COPS6;GPS1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.20577376809151232,0.545715040743456,0.98,0.9985025664651391,1.0,3/20,11.24%,TXN;P2RX7;APP
prerank,positive regulation of immune system process (GO:0002684),-0.2041796839955705,-0.5455068320373866,0.9760869565217392,0.9965449356203552,1.0,6/16,41.61%,ANXA1;VEGFA;NCKAP1L;RSAD2;PIK3CB;TGFB2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.22386841609642788,0.5453953791744971,0.979047619047619,0.9980786692895867,1.0,13/13,77.63%,PCID2;LCMT1;CDK5RAP2;USP44;TPR;CCNB1;XRCC3;NDC80;GEN1;MAD2L1;DYNC1LI1;ANAPC15;DUSP1
prerank,endoderm development (GO:0007492),0.22386841609642785,0.5437991289941888,0.9762845849802372,0.9980165794511808,1.0,13/13,77.63%,SOX17;KIF16B;EOMES;APELA;DUSP2;DUSP5;GATA4;TBX20;DUSP4;LHX1;LAMC1;SOX7;DUSP1
prerank,prostanoid metabolic process (GO:0006692),0.22857887346019576,0.5437466528726578,0.9584120982986768,0.9975275972494678,1.0,3/13,15.95%,PLAA;PTGR2;HPGD
prerank,regulation of sensory perception of pain (GO:0051930),0.23548462468677422,0.5421879586801657,0.9618320610687023,0.99744165717946,1.0,1/11,7.41%,TMEM100
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.2315799684035982,-0.5382514538102943,0.9791231732776617,0.9976609829012512,1.0,1/10,4.62%,KIT
prerank,lymphocyte mediated immunity (GO:0002449),0.22515141594336788,0.5366677637652671,0.9702602230483272,0.9983511826245662,1.0,3/12,20.24%,CD55;CD46;BTN3A3
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.22185358777575787,-0.5351572341017355,0.9642105263157895,0.9977791488091057,1.0,5/11,31.55%,VCP;UGGT2;BAG6;RNF185;TOR1A
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.21496793157179,0.5322307361866639,0.9753954305799648,0.9989369833953008,1.0,2/15,10.75%,NLRC3;DDX3X
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.23215357759795022,0.53133155919722,0.9613152804642167,0.9986458473899512,1.0,1/11,7.27%,SMAD7
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.21272145789194527,-0.5307496404318904,0.9830148619957537,0.998130214815738,1.0,7/13,34.56%,RAB23;APOD;CABP1;SUFU;NUP153;CHP1;BARD1
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.20070334086912842,0.5298341360967393,0.9802158273381295,0.9984880068038517,1.0,18/18,79.95%,ALKBH7;BAD;BNIP3;SLC25A4;TMEM102;SLC25A31;HEBP2;NAIF1;PMAIP1;PPIF;BAK1;MUL1;SLC25A5;CAMK2A;BCL2L1;BCL2;THEM4;SPG7
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.22720477690176488,-0.5289889147130103,0.9723404255319149,0.9978854595408276,1.0,5/10,37.52%,SRI;PDE4B;CACNA2D1;NIPSNAP2;CACNB3
prerank,oxoacid metabolic process (GO:0043436),-0.17080005852086122,-0.5273142806205444,0.9773869346733668,0.997638358234864,1.0,2/27,5.81%,DDO;ENPP1
prerank,neutrophil activation (GO:0042119),0.22812937186998627,0.5261983297542614,0.9689320388349515,0.9987723846368335,1.0,1/12,6.82%,SYK
prerank,double-strand break repair via break-induced replication (GO:0000727),0.22492153170119267,0.5223017697246318,0.9672447013487476,0.9990965205771517,1.0,12/12,77.52%,CDC45;MCM2;GINS2;MCM5;MCM7;MCM3;GINS4;MCMDC2;MUS81;CDC7;MCM4;MCM6
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.18934218517312656,0.5214457587083174,0.9859154929577465,0.9987822378735192,1.0,5/22,18.05%,UBAP1;VPS37B;PLAA;VPS37C;VPS4B
prerank,regulation of multicellular organismal development (GO:2000026),0.18875600379460739,0.5208193763064888,0.9797979797979798,0.9984150839976937,1.0,5/25,19.11%,TDG;RAB14;SOX17;INSR;DHX36
prerank,androgen metabolic process (GO:0008209),0.2025751104077908,0.5200327194785979,0.9786856127886323,0.9980673802359844,1.0,2/18,11.92%,HSD17B11;HSD17B4
prerank,response to glucocorticoid (GO:0051384),0.1816510594181719,0.5199999860524132,0.9848993288590604,0.9975760666648691,1.0,1/26,3.77%,ZFP36L1
prerank,L-serine metabolic process (GO:0006563),0.2373347773419355,0.5199140117273443,0.9807692307692307,0.9970947760134565,1.0,2/10,11.42%,SERINC5;SERINC3
prerank,zymogen activation (GO:0031638),0.16895798437149576,0.5182280610090759,0.9964912280701754,0.9969392482618498,1.0,5/39,14.21%,OMA1;VSIR;BAD;PLAT;GRIN2A
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.202959456726426,-0.5175628787988674,0.9855371900826446,0.9988300499085245,1.0,4/14,33.80%,IL18;IL17D;CD80;PAEP
prerank,regulation of interleukin-17 production (GO:0032660),0.17770762358413222,0.5152223415237178,0.9918300653594772,0.9970545821599083,1.0,4/31,17.43%,VSIR;PRNP;DDIT3;SLC7A5
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.20288139118216336,-0.5147019483881631,0.9827213822894169,0.9987600157625114,1.0,3/13,24.44%,ENPP1;BPNT1;ABHD14B
prerank,positive regulation of interferon-alpha production (GO:0032727),-0.18502637431752894,-0.5141642600611308,0.9977220956719818,0.9982686598775437,1.0,5/19,25.52%,IFIH1;HSPD1;MAVS;STAT1;TLR3
prerank,oogenesis (GO:0048477),0.2044125262812994,0.5077454970939974,0.9754253308128544,0.9979089998560825,1.0,2/15,11.32%,MARF1;NANOS3
prerank,mitotic sister chromatid cohesion (GO:0007064),0.20551295316098767,0.5073095758145185,0.9819819819819819,0.9974846743627369,1.0,1/16,3.95%,BOD1
prerank,outer dynein arm assembly (GO:0036158),0.20723664872470726,0.5064622311641799,0.9850746268656716,0.9971495141299572,1.0,1/14,6.56%,DNAL1
prerank,inositol phosphate catabolic process (GO:0071545),-0.20382401395830574,-0.5020752050486723,0.9831223628691983,0.9995687822866609,1.0,8/12,47.21%,NUDT3;INPP5A;OCRL;INPP5K;IMPA2;INPP1;PTEN;INPP5J
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.14472496232115944,-0.5016973241913056,1.0,0.9990519574521651,1.0,21/45,47.79%,MALT1;AIM2;USP50;GBP5;GSDMD;HSPB1;PANX1;TRIM16;EGR1;TMEM106A;LPL;TYROBP;CASP8;CCL19;NOD2;PYCARD;MYD88;TLR4;FZD5;AGER;CASP1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.16645568401082625,-0.5003338589275703,0.9853300733496333,0.9986792306119704,1.0,7/26,28.99%,SLC30A10;PPARA;ABCD2;SLC25A33;GRIN1;SLC5A3;SNCA
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.2054709980179453,-0.49956075879099315,0.9933481152993349,0.9981975708572727,1.0,9/12,46.19%,SRR;MTHFD1;PSPH;PSAT1;CBS;PHGDH;SEPHS2;CTH;GGT1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.21479193511920933,-0.4938091570395123,0.987012987012987,0.9983899427709739,1.0,7/10,41.44%,ACAD11;ETFB;ACADS;ACADVL;IVD;ACADM;GCDH
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.16746671205869357,-0.49032328132400227,0.9953379953379954,0.9982393352776595,1.0,9/22,33.14%,NOL11;WDR43;ATF4;UTP15;ERBB2;EIF2AK3;PIH1D1;MTOR;DDX11
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.2045779595123292,-0.4882098619263875,0.9772256728778468,0.9979326578606506,1.0,1/11,4.63%,BMP4
prerank,positive regulation of interleukin-6 production (GO:0032755),0.14817480577870623,0.48817429596513723,1.0,0.9994272056646046,1.0,5/68,11.24%,TIRAP;RAB7B;SYK;WNT5A;APP
prerank,lipoxygenase pathway (GO:0019372),0.19920894023103963,0.4870801897162518,0.9760147601476015,0.9990859840760634,1.0,14/14,80.10%,HPGD;ALOX12B;ALOX15;PON3;GPX4;PON1;LTC4S;PON2;ALOX5AP;ALOX5;ALOXE3;ALOX12;GPX1;PTGS2
prerank,meiosis I (GO:0007127),0.17640769068468096,0.48335558112270727,0.9947826086956522,0.9990678946126601,1.0,4/23,18.67%,ING2;FOXJ3;ZSCAN21;MYBL1
prerank,defense response to protozoan (GO:0042832),0.2080188426743001,0.4761690020112583,0.9852670349907919,0.9994370717284883,1.0,1/12,6.30%,GBP4
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.1924079249849217,-0.47567722792677836,0.9895397489539749,0.9986429661610512,1.0,4/13,22.88%,NFU1;MMS19;ISCA1;CIAO1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.19594424912104466,0.47468899379531554,0.9823874755381604,0.999107645282196,1.0,14/14,80.42%,EARS2;TFAM;TFB1M;TFB2M;PNPT1;FASTKD5;TWNK;POLRMT;TEFM;MRPL12;FOXO3;MTERF2;SLC25A33;FASTKD1
prerank,metallo-sulfur cluster assembly (GO:0031163),0.17537635409286978,0.4727391672753337,0.9950083194675541,0.9988336190679182,1.0,2/22,7.19%,CIAPIN1;ISCU
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.1699227338400655,0.47093768926662116,0.9912891986062717,0.9985228673743981,1.0,23/23,83.03%,ELOVL6;HPGD;ALOX12B;ALOX15;GPX4;ACSBG2;CYP1A1;GSTP1;LTC4S;GSTM4;CYP2E1;ALOX5;ALOXE3;ASAH2;LTA4H;ALOX12;ACSBG1;FADS1;GSTM2;EPHX2;GSTM1;PTGS2;ACOT7
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.19917972207206,-0.46939636937989376,0.9814814814814815,0.9986309062573462,1.0,1/10,13.49%,IL33
prerank,sensory perception of pain (GO:0019233),0.17531376458071282,0.46606952854543454,0.9962825278810409,0.9985231411363155,1.0,2/21,10.82%,MME;P2RX7
prerank,DNA catabolic process (GO:0006308),0.20169640999366256,0.4616080009780898,0.9908592321755028,0.9984449851589002,1.0,2/11,18.25%,XRN2;FBH1
prerank,superoxide anion generation (GO:0042554),-0.18193714278445963,-0.46001356876654054,0.9894736842105263,0.9988035488047671,1.0,9/13,60.70%,NOX4;NCF2;ALOX12;CYBB;TAFA4;NCF1;NOX3;NCF4;DUOX1
prerank,purine nucleotide catabolic process (GO:0006195),-0.18044544476180657,-0.45411615673607675,0.9956331877729258,0.998688357361635,1.0,7/13,41.57%,XDH;ITPA;GPX1;NT5C;GDA;NT5C1A;NT5E
prerank,pseudouridine synthesis (GO:0001522),-0.1731712390984499,-0.4417293610240709,1.0,0.9988731535014375,1.0,10/13,50.56%,PUS7;TRUB1;PUS3;GAR1;NOP10;PUS1;PUS7L;NHP2;PUSL1;RPUSD2
prerank,regulation of phosphate metabolic process (GO:0019220),0.1740408354943126,0.4409951521208555,0.9964349376114082,0.9995990802391381,1.0,6/16,21.39%,IKBKB;SMG6;SMG5;IGBP1;SMG7;PSEN1
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.1678316591370937,-0.4409838186108509,0.9895833333333334,0.9983411048124682,1.0,4/15,25.67%,RIOK2;PTTG1;HECW2;CDC27
prerank,toxin transport (GO:1901998),0.19258785943979936,0.43560599205590944,0.9899396378269618,0.9994322100877732,1.0,2/10,15.64%,RAB40B;ANTXR1
prerank,negative regulation of immune effector process (GO:0002698),0.1800360263972755,0.4243945240436204,0.9963302752293578,0.999525648079364,1.0,4/13,20.60%,CD47;CD55;RC3H1;GRN
prerank,inorganic ion transmembrane transport (GO:0098660),0.17338338580860385,0.40603201708621156,0.9941520467836257,0.9997872378095058,1.0,1/12,10.43%,TRPM4
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.13096210645384265,0.3750155373991572,1.0,1.0,1.0,29/29,86.93%,TAF15;YBX1;FUS;NOCT;LARP1;FMR1;PKP1;MEIOC;NBAS;PKP3;AXIN2;ELAVL1;VIP;DND1;TENT5B;HNRNPU;RBM24;SLC11A1;GDNF;E2F1;DHX34;TENT5D;EIF4ENIF1;TENT5C;PAIP1;PABPC1;THRAP3;CIRBP;TENT5A
prerank,positive regulation of interleukin-1 production (GO:0032732),0.11586010602799438,0.3697282738374905,1.0,0.999659350338852,1.0,4/51,11.24%,TMED10;WNT5A;P2RX7;APP
prerank,regulation of regulatory T cell differentiation (GO:0045589),-0.11432224143093137,-0.3405478860511791,1.0,0.9999479112407542,1.0,1/22,5.12%,CBFB
